Citrus Sinensis ID: 005718
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 681 | 2.2.26 [Sep-21-2011] | |||||||
| O81905 | 850 | Receptor-like serine/thre | yes | no | 0.947 | 0.758 | 0.450 | 1e-154 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.944 | 0.759 | 0.447 | 1e-152 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.878 | 0.763 | 0.442 | 1e-150 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.941 | 0.760 | 0.438 | 1e-149 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.930 | 0.761 | 0.416 | 1e-141 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.969 | 0.770 | 0.412 | 1e-140 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.960 | 0.770 | 0.403 | 1e-139 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.933 | 0.752 | 0.405 | 1e-136 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.926 | 0.739 | 0.413 | 1e-135 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.913 | 0.763 | 0.409 | 1e-134 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 546 bits (1406), Expect = e-154, Method: Compositional matrix adjust.
Identities = 307/681 (45%), Positives = 409/681 (60%), Gaps = 36/681 (5%)
Query: 21 LSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPD-TVVWVANR 79
+S T + + + I +VS +FELGFF PG YLGIWYK + T VWVANR
Sbjct: 27 ISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVANR 86
Query: 80 NSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSR-EVKNP-VAQLLDTGNLVLREKFS 137
++P+ S L I ++ NLV+L+Q+D +WS+NL+ +V++P VA+LLD GN VLR+ S
Sbjct: 87 DTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD--S 143
Query: 138 SNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRV 197
N++ LWQSFD P+DTLL M +GWD KTG R++ SW++ DDPS G+F+F+LE
Sbjct: 144 KNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEG 203
Query: 198 LPHLCIYNGSVKLSCTGPWNGLAFGADPTNT--SYLFRPIVEQKEDEIIYRYESYSSRIL 255
P + ++N ++ +GPWNG+ F P Y+ KE E+ Y + S +
Sbjct: 204 FPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKE-EVTYSFRITKSDVY 262
Query: 256 MMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGF 315
L I+ SG +QR W E + W F+ AP + C Y CG C + + C C+KGF
Sbjct: 263 SRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGF 322
Query: 316 KLKLQNNQTWPRE-----CVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEA 370
K + N Q W CVR C + F++ +KLP S++ + +KECE
Sbjct: 323 KPR--NPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQ 380
Query: 371 ECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGDKKLL 430
+CL++C C A+AN+ + G GSGC+ W G+L DIR GQ +YVR+ ++ DK+
Sbjct: 381 KCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYA--KGGQDLYVRLAATDLEDKRNR 438
Query: 431 WIFVI---LVLPAALLPGFFIFCRWRRKHKEK---ETTMESSQ----DLLKFDIYMSVAT 480
+I + + LL F IF W+RK K ET + Q DLL ++ +S +
Sbjct: 439 SAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVIS--S 496
Query: 481 RTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE 540
R + E + D D LP V+ AT NFS KLG+GGFG VYKGKLL+GQE
Sbjct: 497 RRHISRENNTD------DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQE 550
Query: 541 VAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFF 600
+AVKRLS S QG EFKNE+ LIA+LQH NLVRL+ CCV+ GEK+LIYEY+ N SL+
Sbjct: 551 MAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSH 610
Query: 601 LFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 660
LFD SR L WQ R II GIA+GLLYLHQ SR RIIHRDLKASNILLD M PKISDF
Sbjct: 611 LFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDF 670
Query: 661 GMARMFCGDELQGNTKRVVGT 681
GMAR+F DE + NT++VVGT
Sbjct: 671 GMARIFGRDETEANTRKVVGT 691
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 540 bits (1390), Expect = e-152, Method: Compositional matrix adjust.
Identities = 300/670 (44%), Positives = 407/670 (60%), Gaps = 27/670 (4%)
Query: 27 TITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVP-DTVVWVANRNSPIVD 85
+ T + I + ++S SQIFELGFF+P S YLGIWYK +P T VWVANR++P+
Sbjct: 31 SATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSS 90
Query: 86 SNAVLTIGNNGNLVLLNQTDGIIWSSNLSR-EVKNPVA-QLLDTGNLVLREKFSSNTSEG 143
SN L I +N NLV+ +Q+D +WS+N++ +V++PVA +LLD GN VLR+ S N
Sbjct: 91 SNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD--SKNNKPS 147
Query: 144 SYLWQSFDCPSDTLLIGMNMGWDLKTGR-ERYLTSWRTADDPSPGNFTFRLEIRVLPHLC 202
+LWQSFD P+DTLL M MGWD K+G R L SW+T DDPS G+F+ +L P
Sbjct: 148 GFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFY 207
Query: 203 IYNGSVKLSCTGPWNGLAFGADP--TNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKI 260
IYN +GPW G F + P Y+ E + +++Y Y + I +L +
Sbjct: 208 IYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQ-QVVYSYRVNKTNIYSILSL 266
Query: 261 NPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLKLQ 320
+ +G +QRL W E + W+ + +P + C Y CG C + + C C+KGF+
Sbjct: 267 SSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGFEP--M 324
Query: 321 NNQTWPRE----CVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNC 376
N Q R+ CVR C R+ F++ ++LP + S+++ + LKECE CLK C
Sbjct: 325 NEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGC 384
Query: 377 TCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGDKKLLWIFVI- 435
C A+AN+ + GGSGC++W G L DIR GQ +YVRV + DK++ +I
Sbjct: 385 NCTAFANTDIRNGGSGCVIWSGGLFDIRNYA--KGGQDLYVRVAAGDLEDKRIKSKKIIG 442
Query: 436 --LVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKF-DIYMSVATRTNEPSEGDGDA 492
+ + LL F IF W+RK K T DL++ D M+ + + +
Sbjct: 443 SSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYT----S 498
Query: 493 KGTRRDSV-LPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG 551
K + D + LP +++ AT NFS KLG+GGFG VYKG LL+G+E+AVKRLS S
Sbjct: 499 KENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSS 558
Query: 552 QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLG 611
QG EF NE+ LIAKLQH NLVRL+GCCV++GEK+LIYEY+ N SL+ LFD +R+ L
Sbjct: 559 QGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLN 618
Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
WQ R II GIA+GLLYLHQ SR RIIHRDLKASN+LLD +M PKISDFGMAR+F +E
Sbjct: 619 WQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREET 678
Query: 672 QGNTKRVVGT 681
+ NT+RVVGT
Sbjct: 679 EANTRRVVGT 688
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 531 bits (1369), Expect = e-150, Method: Compositional matrix adjust.
Identities = 299/676 (44%), Positives = 395/676 (58%), Gaps = 78/676 (11%)
Query: 20 LLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVP-DTVVWVAN 78
LL+ ATD + + DG+ +VS FE+GFFSPG S+ +YLGIWYK++ TVVWVAN
Sbjct: 19 LLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWVAN 78
Query: 79 RNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNL-----SREVKNPVAQLLDTGNLVLR 133
R+SP+ D + L + NG+L L N + IIWSS+ ++NP+ Q+LDTGNLV+R
Sbjct: 79 RDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQILDTGNLVVR 138
Query: 134 EKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRL 193
++ + Y+WQS D P D L GM G + TG R+LTSWR DDPS GN+T ++
Sbjct: 139 ----NSGDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKM 194
Query: 194 EIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPT---NTSYLFRPIVEQKEDEIIYRYESY 250
+ +P + SV + TGPWNGL F P N Y + + E+E+ Y Y+
Sbjct: 195 DPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVF--TEEEVYYTYKLE 252
Query: 251 SSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCE 310
+ +L +++NP+G +QR W + W + +A + C Y CG+ C+++++ C
Sbjct: 253 NPSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINESPACR 312
Query: 311 CLKGFKLKLQNNQT---WPRECVRSHSSDCITRER-FIKFDDIKLPYLVDVSLNESMNLK 366
CLKGF K W CVR DC E F+K +KLP +++M+L
Sbjct: 313 CLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLN 372
Query: 367 ECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYN-NGQPIYVRVPDSEPG 425
EC+ CL+NCTC AY+ + GG GC++WFGDLIDIR+ YN NGQ +YVR+ SE
Sbjct: 373 ECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIRE---YNENGQDLYVRLASSEI- 428
Query: 426 DKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDIYMSVATRTNEP 485
ET S V++R E
Sbjct: 429 ----------------------------------ETLQRESS---------RVSSRKQE- 444
Query: 486 SEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKR 545
D LP L +VS AT FS KLG+GGFGPVYKG L GQEVAVKR
Sbjct: 445 ----------EEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKR 494
Query: 546 LSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPS 605
LS S QG++EFKNE+ LIAKLQHRNLV+++G CV++ E++LIYEY PNKSL+ F+FD
Sbjct: 495 LSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKE 554
Query: 606 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665
R L W RV+II+GIA+G+LYLH+ SRLRIIHRDLKASN+LLDSDMN KISDFG+AR
Sbjct: 555 RRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLART 614
Query: 666 FCGDELQGNTKRVVGT 681
GDE + NT RVVGT
Sbjct: 615 LGGDETEANTTRVVGT 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 528 bits (1361), Expect = e-149, Method: Compositional matrix adjust.
Identities = 298/680 (43%), Positives = 403/680 (59%), Gaps = 39/680 (5%)
Query: 21 LSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVP-DTVVWVANR 79
+S T + T + I + ++S SQIFELGFF+P S YLGIWYK +P T VWVANR
Sbjct: 25 VSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANR 84
Query: 80 NSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSR-EVKNPVA-QLLDTGNLVLREKFS 137
++P+ SN L I N NLV+ +Q+D +WS+N++ +V++PVA +LLD GN +LR+
Sbjct: 85 DNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRD--- 140
Query: 138 SNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRV 197
S LWQSFD P+DTLL M +GWD KTG R L SW+T DDPS G F+ +LE
Sbjct: 141 ---SNNRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSE 197
Query: 198 LPHLCIYNGSVKLSCTGPWNGLAFGADP--TNTSYLFRPIVEQKEDEIIYRYESYSSRIL 255
P I + L +GPWNG+ F + P Y+ KE E+ Y Y + +
Sbjct: 198 FPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKE-EVTYSYRINKTNLY 256
Query: 256 MMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGF 315
L +N +G +QRL W E + W+ + +P + C Y CG C + NC C+KGF
Sbjct: 257 SRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGF 316
Query: 316 KLKLQNNQTWPRE-----CVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEA 370
K N Q W C+R C R+ F + +KLP ++ + LK C+
Sbjct: 317 KP--VNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKE 374
Query: 371 ECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGDKKLL 430
CL++C C A+AN+ + GGSGC++W +++D+R GQ +YVR+ +E DK++
Sbjct: 375 RCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYA--KGGQDLYVRLAAAELEDKRIK 432
Query: 431 WIFVI---LVLPAALLPGFFIFCRWRRKHKEKETTME------SSQDLLKFDIYMSVATR 481
+I + + LL F IF W+RK K T SQD L D+ +S
Sbjct: 433 NEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGY 492
Query: 482 TNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEV 541
T++ + + L +++ AT NFS KLG+GGFG VYKG+LL+G+E+
Sbjct: 493 TSKEKKSEYLELPLL--------ELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEI 544
Query: 542 AVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL 601
AVKRLS S QG EF NE+ LIAKLQH NLVRL+GCCV++GEK+LIYEY+ N SL+ L
Sbjct: 545 AVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHL 604
Query: 602 FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661
FD +R+ L WQ R II GIA+GLLYLHQ SR RIIHRDLKASN+LLD +M PKISDFG
Sbjct: 605 FDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFG 664
Query: 662 MARMFCGDELQGNTKRVVGT 681
MAR+F +E + NT+RVVGT
Sbjct: 665 MARIFGREETEANTRRVVGT 684
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 504 bits (1297), Expect = e-141, Method: Compositional matrix adjust.
Identities = 287/689 (41%), Positives = 396/689 (57%), Gaps = 55/689 (7%)
Query: 23 LATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPD-TVVWVANRNS 81
++ DTI + DGE ++S+ + F GFFS G S+ +Y+GIWY Q+ T+VWVANR+
Sbjct: 17 ISVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDH 76
Query: 82 PIVDSNAVLTIGNNGNLVLL---NQTDGIIWSSNLSREVKNP--VAQLLDTGNLVLREKF 136
PI D++ ++ N GNL + N+T+ +IWS+N+S + P VA L D GNLVL +
Sbjct: 77 PINDTSGMVKFSNRGNLSVYASDNETE-LIWSTNVSDSMLEPTLVATLSDLGNLVLFDPV 135
Query: 137 SSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIR 196
+ G W+SFD P+DT L M +G+ K G +R LTSW++ DP G+ R+E R
Sbjct: 136 T-----GRSFWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERR 190
Query: 197 VLPHLCIYNGSVKLSCTGPWNGLAFGADPT-NTSYLFRPIVEQKEDEIIYRYESYSSRIL 255
P L +Y G G W G + P Y+F EDE+ + Y + ++
Sbjct: 191 GFPQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVI 250
Query: 256 MMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSV--DDTANCECLK 313
+N +G + R W W F++ P C Y +CG N C T C CL
Sbjct: 251 TRTMVNETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLP 310
Query: 314 GFKLKLQNNQTWPRE-CVRSHSSDCITRER---------FIKFDDIKLPYLVDVSLNESM 363
GF+ K PR +R S C ++R F+K +K+P D S++ ++
Sbjct: 311 GFEPKF------PRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNI 364
Query: 364 NLKECEAECLKNCTCRAYANS--KVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPD 421
LKEC+ CLKNC+C AYA++ + G GCL W G ++D R T N+GQ Y+RV
Sbjct: 365 TLKECKQRCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDAR--TYLNSGQDFYIRVDK 422
Query: 422 SE---------PGDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKF 472
E G +++L I + L+ A +L +FC R + K S+
Sbjct: 423 EELARWNRNGLSGKRRVLLILISLI-AAVMLLTVILFCVVRERRKSNRHRSSSAN----- 476
Query: 473 DIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYK 532
+ V +E + D R+ LP F L ++ AAT NFS Q KLG GGFGPVYK
Sbjct: 477 --FAPVPFDFDESFRFEQDKA---RNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYK 531
Query: 533 GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592
G L N E+AVKRLS SGQG++EFKNE+ LI+KLQHRNLVR++GCCVE EK+L+YEY+
Sbjct: 532 GVLQNRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYL 591
Query: 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD 652
PNKSL++F+F + L W R++I+ GIA+G+LYLHQ SRLRIIHRDLKASNILLDS+
Sbjct: 592 PNKSLDYFIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSE 651
Query: 653 MNPKISDFGMARMFCGDELQGNTKRVVGT 681
M PKISDFGMAR+F G++++G T RVVGT
Sbjct: 652 MIPKISDFGMARIFGGNQMEGCTSRVVGT 680
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 501 bits (1289), Expect = e-140, Method: Compositional matrix adjust.
Identities = 287/695 (41%), Positives = 415/695 (59%), Gaps = 35/695 (5%)
Query: 6 FFFTFSCFVFLLGSLLSLATDTI--TPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLG 63
F F + L+ LS+ +T+ T + I + LVS IFE+GFF S++ YLG
Sbjct: 15 FLLVFVVMI-LIHPALSIYINTLSSTESLTISSNKTLVSPGSIFEVGFFRTN-SRW-YLG 71
Query: 64 IWYKQVPD-TVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSR--EVKNP 120
+WYK+V D T VWVANR++P+ ++ L I N NLVLL+ ++ +W +NL+R E
Sbjct: 72 MWYKKVSDRTYVWVANRDNPLSNAIGTLKISGN-NLVLLDHSNKPVWWTNLTRGNERSPV 130
Query: 121 VAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRT 180
VA+LL GN V+R+ SSN YLWQSFD P+DTLL M +G++LKTG R+LTSWR+
Sbjct: 131 VAELLANGNFVMRD--SSNNDASEYLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRS 188
Query: 181 ADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNT--SYLFRPIVEQ 238
+DDPS GNF+++LE + LP + + + +GPWNG+ F P + SY+ +E
Sbjct: 189 SDDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIEN 248
Query: 239 KEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAP-NNFCQLYGYCGA 297
E E+ Y + ++ L + G QRL W+ W F+++P + C Y CG
Sbjct: 249 NE-EVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGP 307
Query: 298 NSVCSVDDTANCECLKGFK---LKLQNNQTWPRECVRSHSSDCITRERFIKFDDIKLPYL 354
+ C V+ + C C++GF ++ + + W C+R C + + F + +KLP
Sbjct: 308 YAYCDVNTSPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSC-SGDGFTRMKKMKLPET 366
Query: 355 VDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRK-ITGYNNGQ 413
+++ S+ +KEC+ C+ +C C A+AN+ + GGSGC++W L DIR T +GQ
Sbjct: 367 TMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDAIDGQ 426
Query: 414 PIYVRVPDSEPGDKKLLWIFVI-LVLPAALLPGFFIFCRWRRKHKEKETT------MESS 466
+YVR+ ++ K+ +I L + ++L +FC W+RK K + + + +
Sbjct: 427 DLYVRLAAADIAKKRNASGKIISLTVGVSVLLLLIMFCLWKRKQKRAKASAISIANTQRN 486
Query: 467 QDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGG 526
Q+L ++ +S E G+ K + LP + +V ATENFS KLG+GG
Sbjct: 487 QNLPMNEMVLS------SKREFSGEYKFEELE--LPLIEMETVVKATENFSSCNKLGQGG 538
Query: 527 FGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 586
FG VYKG+LL+G+E+AVKRLS S QG EF NE+ LIA+LQH NLV+++GCC+E EK+
Sbjct: 539 FGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEKM 598
Query: 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 646
LIYEY+ N SL+ +LF +R L W R I G+A+GLLYLHQ SR RIIHRDLK SN
Sbjct: 599 LIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVSN 658
Query: 647 ILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
ILLD +M PKISDFGMAR+F DE + NT +VVGT
Sbjct: 659 ILLDKNMIPKISDFGMARIFERDETEANTMKVVGT 693
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 496 bits (1278), Expect = e-139, Method: Compositional matrix adjust.
Identities = 283/702 (40%), Positives = 409/702 (58%), Gaps = 48/702 (6%)
Query: 10 FSCFVFLLGSLLSLATDTITPATLIGDG---EKLVSSSQIFELGFFSPGKSKYKYLGIWY 66
S F++ S+A +TI + DG + LVS + FELGFFSPG S +++LGIWY
Sbjct: 11 LSLFLYFFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWY 70
Query: 67 KQVPD-TVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREV---KNPVA 122
+ D VVWVANR +PI D + VL I N+GNLVLL+ + +WSSN+ N V
Sbjct: 71 GNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVV 130
Query: 123 QLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTAD 182
+ DTGN VL E T +W+SF+ P+DT L M + + +TG SWR+
Sbjct: 131 SIHDTGNFVLSE-----TDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSET 185
Query: 183 DPSPGNFTFRLEIRVLPHLCIYNGS-VKLSCTGPWNGLAFGADPTN---TSYLFRPIVEQ 238
DPSPGN++ ++ P + ++ G+ + +G WN F P T+YL+ +
Sbjct: 186 DPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSS 245
Query: 239 KEDE---IIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYC 295
DE + + Y +L+ K+ +G + L W+E W F + P++ C Y C
Sbjct: 246 PPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRC 305
Query: 296 GANSVCSVDDTAN-CECLKGFKLKLQNNQTWPRECVRSHSSDC-----ITRERFIKFDDI 349
G +C + + C C+ G++ N W R C R C + + F+ +
Sbjct: 306 GKFGICDMKGSNGICSCIHGYEQVSVGN--WSRGCRRRTPLKCERNISVGEDEFLTLKSV 363
Query: 350 KLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGY 409
KLP ++ + ++ ++C CL+NC+C AY+ GG GC++W DL+D+++
Sbjct: 364 KLPDF-EIPEHNLVDPEDCRERCLRNCSCNAYS----LVGGIGCMIWNQDLVDLQQFEA- 417
Query: 410 NNGQPIYVRVPDSEPGDKKLLWIFVIL-VLPAALLPGFFIFCRWRRKHKEKETTMESSQD 468
G +++R+ DSE G+ + I VI+ VL +L G F WR K K+ + ++
Sbjct: 418 -GGSSLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKN 476
Query: 469 LLKFDIYMSVATRTNEPSEG---------DGDAKGTRRDSVLPCFSLASVSAATENFSMQ 519
+ ++ T++ E + +G A T S LP FSL +++ AT +F +
Sbjct: 477 T-DTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNT---SELPVFSLNAIAIATNDFCKE 532
Query: 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
+LG GGFGPVYKG L +G+E+AVKRLS +SGQG+ EFKNE++LIAKLQHRNLVRL+GCC
Sbjct: 533 NELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCC 592
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
E EK+L+YEYMPNKSL+FFLFD ++ L+ W+ R IIEGIA+GLLYLH+ SRLRIIH
Sbjct: 593 FEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIH 652
Query: 640 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
RDLK SN+LLD++MNPKISDFGMAR+F G++ + NT RVVGT
Sbjct: 653 RDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGT 694
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 484 bits (1247), Expect = e-136, Method: Compositional matrix adjust.
Identities = 280/690 (40%), Positives = 402/690 (58%), Gaps = 54/690 (7%)
Query: 24 ATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPD-TVVWVANRNSP 82
+ +TI + + DG+ + S + F GFFS G SK +Y+GIWY QV + T+VWVANR+ P
Sbjct: 21 SDNTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHP 80
Query: 83 IVDSNAVLTIGNNGNLVLLNQTDGI--IWSSNLSREVKNP--VAQLLDTGNLVLREKFSS 138
I D++ ++ GNL + +G IWS+++ ++ P VA+L D GNLVL + +
Sbjct: 81 INDTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLDPVT- 139
Query: 139 NTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVL 198
G W+SF+ P++TLL M G+ ++G +R +TSWR+ DP GN T+R+E R
Sbjct: 140 ----GKSFWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGF 195
Query: 199 PHLCIYNGSVKLSCTGPWNGLAFGADPTNTS-YLFRPIVEQKEDEIIYRYESYSSRILMM 257
P + +Y G TG W G + P T+ ++F DE+ Y + +
Sbjct: 196 PQMMMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTR 255
Query: 258 LKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTAN--CECLKGF 315
+ +N +G +QR W+ W F++AP + C +Y +CG N C T C CL G+
Sbjct: 256 MVLNETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGY 315
Query: 316 KLKLQNNQTWPRECVRSHSSDCITR----------ERFIKFDDIKLPYLVDVSLNESMNL 365
+ K PR+ +SD TR E F K +K+P V+++ ++ L
Sbjct: 316 EPKT------PRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITL 369
Query: 366 KECEAECLKNCTCRAYANS--KVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSE 423
KECE CLKNC+C AYA++ + G GCL W G+++D R T ++GQ Y+RV SE
Sbjct: 370 KECEQRCLKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTR--TYLSSGQDFYLRVDKSE 427
Query: 424 ---------PGDKKLLWIFVILV-LPAALLPGFFIFCRWRRKHKEKETTMESSQDLL--K 471
G K+L+ I + L+ + LL F + R RR+ + ++
Sbjct: 428 LARWNGNGASGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSS 487
Query: 472 FDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVY 531
FD+ S E R LP F L++++ AT NF+ Q KLG GGFGPVY
Sbjct: 488 FDLEDSFILEELEDKS---------RSRELPLFELSTIATATNNFAFQNKLGAGGFGPVY 538
Query: 532 KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591
KG L NG E+AVKRLS SGQG++EFKNE+ LI+KLQHRNLVR++GCCVE EK+L+YEY
Sbjct: 539 KGVLQNGMEIAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEY 598
Query: 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 651
+PNKSL++F+F + L W R+ II GI +G+LYLHQ SRLRIIHRDLKASN+LLD+
Sbjct: 599 LPNKSLDYFIFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDN 658
Query: 652 DMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+M PKI+DFG+AR+F G++++G+T RVVGT
Sbjct: 659 EMIPKIADFGLARIFGGNQIEGSTNRVVGT 688
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 482 bits (1240), Expect = e-135, Method: Compositional matrix adjust.
Identities = 286/691 (41%), Positives = 407/691 (58%), Gaps = 60/691 (8%)
Query: 21 LSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPD-TVVWVANR 79
+S+ T + T + I + +VS +FELGFF + YLGIWYK++ T VWVANR
Sbjct: 30 ISVNTLSATESLTISSNKTIVSPGGVFELGFFRILGDSW-YLGIWYKKISQRTYVWVANR 88
Query: 80 NSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPV-AQLLDTGNLVLREKFSS 138
++P+ + +L I +N NLV+L+ +D +WS+NL+ V++ V A+LLD GN VLR +
Sbjct: 89 DTPLSNPIGILKI-SNANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVLRGSKIN 147
Query: 139 NTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVL 198
+ E +LWQSFD P+DTLL M +G D K G R++TSW+++ DPS G+F F+LE L
Sbjct: 148 ESDE--FLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETLGL 205
Query: 199 PHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVE-QKEDEIIYRYE------SYS 251
P + +++ +GPW+GL F I+E Q+ D+IIY + +Y+
Sbjct: 206 PEFFGFTSFLEVYRSGPWDGLRFSG-----------ILEMQQWDDIIYNFTENREEVAYT 254
Query: 252 SRI-----LMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDT 306
R+ L IN G ++ +W W +F+ P + C LYG CG + C + +
Sbjct: 255 FRVTDHNSYSRLTINTVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTS 314
Query: 307 ANCECLKGFKLKLQNNQTWPR-----ECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNE 361
C C+KGF+ + Q W C R C +RF + ++K+P +++
Sbjct: 315 PTCNCIKGFQP--LSPQDWASGDVTGRCRRKTQLTC-GEDRFFRLMNMKIPATTAAIVDK 371
Query: 362 SMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPD 421
+ LKECE +C +C C AYANS + GGSGC++W G+ DIR +GQ ++VR+
Sbjct: 372 RIGLKECEEKCKTHCNCTAYANSDIRNGGSGCIIWIGEFRDIRNYAA--DGQDLFVRLAA 429
Query: 422 SEPGDKKLLWIFVILVLPAA---LLPGFFIFCRWRRKHKEKETTM------ESSQDLLKF 472
+E G+++ + +I ++ L+ F I+C W++K K T + Q+L+
Sbjct: 430 AEFGERRTIRGKIIGLIIGISLMLVLSFIIYCFWKKKQKRARATAAPIGYRDRIQELIIT 489
Query: 473 D-IYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVY 531
+ + MS R E D LP +V ATENFS LG GGFG VY
Sbjct: 490 NGVVMSSGRRLLGEEE----------DLELPLTEFETVVMATENFSDSNILGRGGFGIVY 539
Query: 532 KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591
KG+LL+GQE+AVKRLS S QG EFKNE+ LIA+LQH NLVRL+ CC+ EKILIYEY
Sbjct: 540 KGRLLDGQEIAVKRLSEMSSQGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEY 599
Query: 592 MPNKSLNFFLFDPSR-THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 650
+ N SL+ LF+ ++ ++ L WQTR II GIA+GLLYLHQ SR +IIHRDLKASN+LLD
Sbjct: 600 LENGSLDSHLFETTQSSNKLNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLD 659
Query: 651 SDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+M PKISDFGMAR+F DE + NT++VVGT
Sbjct: 660 KNMTPKISDFGMARIFERDETEANTRKVVGT 690
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 479 bits (1234), Expect = e-134, Method: Compositional matrix adjust.
Identities = 280/684 (40%), Positives = 402/684 (58%), Gaps = 62/684 (9%)
Query: 21 LSLATDTITPATLIGDGEKLVSSSQIFELGFFS---PGKSKYKYLGIWYKQVPDTVVWVA 77
++L + ITP + DG+ L S Q+F+LGFFS + ++++LG+WY + P VVWVA
Sbjct: 21 VALDYNVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWYME-PFAVVWVA 79
Query: 78 NRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIW-----SSNLSREVKNPVAQLLDTGNLVL 132
NRN+P+ ++ L + + G+L L + +W S+ S+ NP+ ++ +GNL+
Sbjct: 80 NRNNPLYGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGNLI- 138
Query: 133 REKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFR 192
S+ E + LWQSFD P +T+L GM +G + KT E L+SW+T DPSPG+FT
Sbjct: 139 -----SSDGEEAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLS 193
Query: 193 LEIRVLPHLCIY-NGSVKLSCT-GPWNGLAFGADPT--NTSYLFRPIVEQKEDEIIYRYE 248
L+ R LP L + NG S G WNGL+F P + LF E+ Y +
Sbjct: 194 LDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQEVNYSW- 252
Query: 249 SYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVD--DT 306
+ RI+ L +N +G + R I + + W + TAP + C Y CGA +VC ++ +T
Sbjct: 253 TPRHRIVSRLVLNNTGKLHRFIQSKQNQ-WILANTAPEDECDYYSICGAYAVCGINSKNT 311
Query: 307 ANCECLKGFKLKLQNNQTWPR---ECVRSHSSDCITRERFIKFDDIKLPYLVDVS----- 358
+C CL+GFK K R CV ++C ++ F+KF +KLP D S
Sbjct: 312 PSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLP---DTSWSWYD 368
Query: 359 LNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVR 418
M L++C+ +C NC+C AYAN+ + GG GCL+WFGDL+D+R+ + + GQ +Y+R
Sbjct: 369 AKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSF--GQDVYIR 426
Query: 419 VPDSEPGDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDIYMSV 478
+ GF R+ + ++ ++
Sbjct: 427 M-------------------------GFAKIEFKGREVVGMVVGSVVAIAVVLVVVFACF 461
Query: 479 ATRTNEPSEGDGDAKGTRRDSV-LPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLN 537
+ + G+ KG + + LP F ++S AT++FS LG GGFGPVYKGKL +
Sbjct: 462 RKKIMKRYRGENFRKGIEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLED 521
Query: 538 GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL 597
GQE+AVKRLS+ SGQG++EFKNE+ LIAKLQHRNLVRL+GCC++ E +LIYEYMPNKSL
Sbjct: 522 GQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSL 581
Query: 598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 657
+FF+FD R+ L W+ R+ II G+A+G+LYLHQ SRLRIIHRDLKA N+LLD+DMNPKI
Sbjct: 582 DFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKI 641
Query: 658 SDFGMARMFCGDELQGNTKRVVGT 681
SDFG+A+ F GD+ + +T RVVGT
Sbjct: 642 SDFGLAKSFGGDQSESSTNRVVGT 665
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 681 | ||||||
| 224115098 | 802 | predicted protein [Populus trichocarpa] | 0.942 | 0.800 | 0.507 | 0.0 | |
| 359493711 | 1081 | PREDICTED: G-type lectin S-receptor-like | 0.911 | 0.574 | 0.491 | 1e-176 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.964 | 0.790 | 0.484 | 1e-175 | |
| 224115136 | 843 | predicted protein [Populus trichocarpa] | 0.954 | 0.771 | 0.471 | 1e-171 | |
| 359493730 | 770 | PREDICTED: G-type lectin S-receptor-like | 0.897 | 0.793 | 0.476 | 1e-169 | |
| 147799241 | 818 | hypothetical protein VITISV_027305 [Viti | 0.941 | 0.783 | 0.478 | 1e-168 | |
| 359493727 | 1767 | PREDICTED: uncharacterized protein LOC10 | 0.930 | 0.358 | 0.480 | 1e-167 | |
| 359493740 | 2422 | PREDICTED: uncharacterized protein LOC10 | 0.976 | 0.274 | 0.465 | 1e-167 | |
| 359493736 | 822 | PREDICTED: G-type lectin S-receptor-like | 0.957 | 0.793 | 0.475 | 1e-166 | |
| 147816068 | 819 | hypothetical protein VITISV_030742 [Viti | 0.938 | 0.780 | 0.474 | 1e-166 |
| >gi|224115098|ref|XP_002316939.1| predicted protein [Populus trichocarpa] gi|222860004|gb|EEE97551.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 659 bits (1699), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/689 (50%), Positives = 455/689 (66%), Gaps = 47/689 (6%)
Query: 1 MGNPPFFFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYK 60
M + PFF FS LS + D ITP + DG+ L+S SQ FELGFFSPG SKY+
Sbjct: 1 MESLPFFIFFSTLFIQSLHFLSFSADIITPDLPVKDGQTLISVSQSFELGFFSPGTSKYR 60
Query: 61 YLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNP 120
Y+GIWYK+ P+TVVWVANRN+P+ D VLTI N GNLVLL+Q IIWSSN S + P
Sbjct: 61 YVGIWYKKSPETVVWVANRNNPLTDHFGVLTIDNRGNLVLLDQIKNIIWSSNSSSIIAGP 120
Query: 121 VAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRT 180
VAQLLD+GNLV+R+ SS +E SY WQSFD PSDTLL GM +GW+LKTG+ERYL +WR+
Sbjct: 121 VAQLLDSGNLVVRDNGSSRNTE-SYRWQSFDQPSDTLLPGMKLGWNLKTGQERYLITWRS 179
Query: 181 ADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKE 240
DPSPG+FT+RL+I LP L I GSVK +GPWNG+ FG P + +F PI+ + E
Sbjct: 180 ISDPSPGDFTYRLDIHGLPQLFIVVGSVKKVRSGPWNGIFFGGTPKVHNSVFEPILVRNE 239
Query: 241 DEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSV 300
DEI Y Y ++ + L +N SG V+RL+ + ++GW ++ P + C+ YG CGAN +
Sbjct: 240 DEIYYTYRLLNNSVCSRLTLNQSGAVERLVMYGQNSGWTTIYSVPVDTCENYGQCGANGI 299
Query: 301 CSVDDTANCECLKGFK------LKLQNNQTWPRECVRSHSSDCITRERFIKFDDIKLPYL 354
C + CECLKGFK L +QN R+C + DC + E F+K +KLP L
Sbjct: 300 CRTRTSPICECLKGFKSIPEEELDIQNFYG-SRKCETRLTLDCQSGEGFLKLPGVKLPDL 358
Query: 355 VDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGG--SGCLMWFGDLIDIRKITGYNNG 412
++ LNESMNLKECEAEC KNC+C A+A + ++GGG SGCLMWFG+LIDIR+ +G G
Sbjct: 359 LEFRLNESMNLKECEAECFKNCSCSAFATTNLSGGGDGSGCLMWFGNLIDIREQSGSTIG 418
Query: 413 QPIYVRVPDSEPGDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKF 472
Q I++RVP SE R ++ K +T + +S L
Sbjct: 419 QDIHIRVPASE-----------------------LEMARSSKRKKMLKTALVASMSAL-L 454
Query: 473 DIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYK 532
I++S R E E P F L +++ AT NF+ +G GGFG VYK
Sbjct: 455 GIFVSGMDRRKEGMEA-------------PLFDLDTIATATNNFAPDSIIGAGGFGSVYK 501
Query: 533 GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592
GKLL GQE+AVK+LS SGQG++EF+NE++LIAKLQHRNLV L+G C+ + E++LIYEYM
Sbjct: 502 GKLLTGQEIAVKKLSMNSGQGVEEFRNEVVLIAKLQHRNLVGLLGSCIHREERMLIYEYM 561
Query: 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD 652
PNKSL++F+FD R+ LLGW+ R II GIA+GLLYLHQ S+L+I+HRDLK SN+LLDS+
Sbjct: 562 PNKSLDYFIFDHERSALLGWKERFVIILGIARGLLYLHQDSKLQIVHRDLKPSNVLLDSN 621
Query: 653 MNPKISDFGMARMFCGDELQGNTKRVVGT 681
+ PKISDFG+AR+ D + T+RV+GT
Sbjct: 622 LIPKISDFGLARISGDDGKETKTRRVIGT 650
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493711|ref|XP_002281022.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 625 bits (1613), Expect = e-176, Method: Compositional matrix adjust.
Identities = 329/669 (49%), Positives = 430/669 (64%), Gaps = 48/669 (7%)
Query: 25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIV 84
D+I I D E LVSS Q FELGFFSPG SK +YLGIWYK P T VWVANRN+PI
Sbjct: 296 ADSIRMDQSISDSETLVSSGQSFELGFFSPGSSKNRYLGIWYKNTPQTAVWVANRNNPIA 355
Query: 85 DSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGS 144
DS VLTI NNG LVLLNQ+ +IWS NLSR +NPVAQLL+TGNLVLR+ SN + S
Sbjct: 356 DSYGVLTIINNGALVLLNQSKSVIWSPNLSRVPENPVAQLLETGNLVLRD--GSNETSKS 413
Query: 145 YLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIY 204
Y+WQSFD PSDT+L GM +GW+LKTG +R LTSW+++DDPS G+F++ +I VLP+L +
Sbjct: 414 YIWQSFDDPSDTMLPGMKVGWNLKTGLQRKLTSWKSSDDPSLGDFSYGFDINVLPYLVLG 473
Query: 205 NGSVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSG 264
GS K+ +GPWNGL F + +++ + DE+ YES +++I+ L +N SG
Sbjct: 474 VGSSKIVRSGPWNGLEFNGVYVLDNSVYKAVFVANNDEVYALYESNNNKIISRLTLNHSG 533
Query: 265 DVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLKLQNNQT 324
+QRL+ + S+ W ++ P+ C+ YG+CGAN +C + CECL GF K Q +
Sbjct: 534 FLQRLLLKKGSSVWDELYSIPSELCENYGHCGANGICRIGKLQICECLTGFTPKSQ--EE 591
Query: 325 W-----PRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCR 379
W C R DC E F+K +KLP L+D + ++L+EC+ CL NC+C
Sbjct: 592 WDMFNTSSGCTRRMPLDCQIEEGFVKVTGVKLPDLIDFHVIMGVSLRECKVSCLNNCSCT 651
Query: 380 AYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPG------DKKLLWIF 433
AYA + G G GCLMW GDLIDIR++T + + IY+R+ SE G KKL+ I
Sbjct: 652 AYAYTNPNGSG-GCLMWSGDLIDIRELTSEKHAEDIYIRMHTSELGLNTNQKKKKLVIIL 710
Query: 434 VILVLPAALLPGF-FIFCRWRRKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDA 492
VI L G F F W+++ TM + Q+
Sbjct: 711 VISTFSGILTLGLSFWFRFWKKR------TMGTDQE------------------------ 740
Query: 493 KGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ 552
+ + LP F L +++ AT NFS K+G GGFG VYKG L G VAVKRLS S Q
Sbjct: 741 -SKKENLELPLFDLPTIATATNNFSNTNKIGAGGFGSVYKGNLPEGVAVAVKRLSKNSAQ 799
Query: 553 GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW 612
G++EFKNE +LIAKLQH+NLVRL+GCC++ E+IL+YEYMPNKSL++F+FD +R LL W
Sbjct: 800 GVQEFKNEAVLIAKLQHKNLVRLLGCCIQGEERILLYEYMPNKSLDYFIFDQNRRALLAW 859
Query: 613 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 672
R +I+ GIA+GLLYLHQ SR +IIHRDLK SNILLD ++NPKISDFG+AR+F +E++
Sbjct: 860 DKRCEIVMGIARGLLYLHQDSRFQIIHRDLKTSNILLDDNLNPKISDFGLARIFGENEME 919
Query: 673 GNTKRVVGT 681
TKR+VGT
Sbjct: 920 TRTKRIVGT 928
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 621 bits (1602), Expect = e-175, Method: Compositional matrix adjust.
Identities = 337/696 (48%), Positives = 441/696 (63%), Gaps = 39/696 (5%)
Query: 1 MGNPPFFFTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYK 60
MG F S FL S+ S A ++I + DG+ LVSS FELGFFSPG S+ +
Sbjct: 8 MGGQTILFLLSIVFFL--SIPSTAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNR 65
Query: 61 YLGIWYKQVPD-TVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKN 119
Y+GIWYK++ TVVWVANRN+P+ DS+ +L ++GNL +N T+G IWSSN+SR N
Sbjct: 66 YMGIWYKKISSFTVVWVANRNTPLNDSSGMLKFVDHGNLAFINSTNGTIWSSNISRAAIN 125
Query: 120 PVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWR 179
PVAQLLDTGNLV+R + ++ ++LWQSFD P D+ L GM G TG RYLTSW+
Sbjct: 126 PVAQLLDTGNLVVRAE--NDNDPENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWK 183
Query: 180 TADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGAD---PTNTSYLFRPIV 236
+ DPS G +T +L+ LP + GSV +GPWNGL F N Y F +
Sbjct: 184 SPSDPSTGKYTNKLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGMINLKPNPIYTFEFVF 243
Query: 237 EQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCG 296
Q +EI Y+Y+ +S +L + ++P G +QR W + + W ++ TA + C + CG
Sbjct: 244 NQ--EEIYYKYQIANSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLTANMDNCDRFALCG 301
Query: 297 ANSVCSVDDTANCECLKGFKLKLQNNQT---WPRECVRSHSSDCITRERFIKFDDIKLPY 353
A+ VC+++++ C+CLK F+ K T W + CVR DC E FIK+ IK+P
Sbjct: 302 AHGVCNINNSPACDCLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPD 361
Query: 354 LVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYN-NG 412
N+++NL+ECE CLKNC+C AYAN V GGSGC++WFGDLIDIR+ YN NG
Sbjct: 362 TRKSWYNKTINLEECEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQ---YNENG 418
Query: 413 QPIYVRV-------PDSEPGDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMES 465
Q IY+R+ P G K++ I + + L A L +F R+ RK+K+++ T E
Sbjct: 419 QDIYIRIAASVIDKPVKSRGKKRVRIIVIPVSLVAFSLLALCLFLRFLRKNKQQQLTREG 478
Query: 466 SQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEG 525
+ V T E D + D LP F LA+++ AT FS+ KLG+G
Sbjct: 479 N-----------VVTN----PEQDRTKESRNEDLELPLFDLATLTDATNCFSINNKLGQG 523
Query: 526 GFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 585
GFGPVYKG L +GQE+AVKRLS +S QG+ EF+NE++ IAKLQHRNLV+L+GCC+E E+
Sbjct: 524 GFGPVYKGILQDGQEIAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEER 583
Query: 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKAS 645
+LIYEYMPNKSL+ F+FD R LL W R II GIA+GLLYLHQ SRLRIIHRDLKAS
Sbjct: 584 MLIYEYMPNKSLDSFIFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKAS 643
Query: 646 NILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
NILLD +MNPKISDFGMAR F GDE NT R+VGT
Sbjct: 644 NILLDYEMNPKISDFGMARSFGGDETSANTSRIVGT 679
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115136|ref|XP_002316951.1| predicted protein [Populus trichocarpa] gi|222860016|gb|EEE97563.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 609 bits (1571), Expect = e-171, Method: Compositional matrix adjust.
Identities = 323/685 (47%), Positives = 431/685 (62%), Gaps = 35/685 (5%)
Query: 12 CFVFLLGSLL------SLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIW 65
FVF++ LL S A D+I+P+ + DG+ LVS FELGFFSPG SK YLGIW
Sbjct: 4 AFVFIITKLLLFLFKFSTALDSISPSEFMIDGKTLVSEKGTFELGFFSPGISKKSYLGIW 63
Query: 66 YKQVP-DTVVWVANRNSPIVDSNAVLTIGNNGNLVLL-NQTDGIIWSSNLSREVKNPVAQ 123
YK +P T+VWVANR +PI DS+ +L + N ++VLL N T+ ++WSSN +++ +P+ Q
Sbjct: 64 YKNIPVRTIVWVANRRNPINDSSGLLKVDNCSDIVLLSNNTNTVVWSSNSTKKASSPILQ 123
Query: 124 LLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADD 183
LLD+GNLVLR+K N LWQSFD P DT+L GM +GWDL+ G + L+SW+++DD
Sbjct: 124 LLDSGNLVLRDK---NDGRSGLLWQSFDYPCDTMLPGMKIGWDLRAGFDWRLSSWKSSDD 180
Query: 184 PSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPT---NTSYLFRPIVEQKE 240
PSPG+FT +E P + + GS K +GPWNG+ F N + F + E
Sbjct: 181 PSPGDFTMGIERESNPEVVAWKGSKKHYRSGPWNGVGFSGSTEVKPNPVFYFTFVSNNIE 240
Query: 241 DEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSV 300
I+ +S S+ I ++ + + D Q W+E + W + + P + C YG CGAN+
Sbjct: 241 VYYIFNLKSESTVITRLVLNHTTSDRQCYTWNEETQTWVLQVSVPRDHCDNYGLCGANAN 300
Query: 301 CSVDDTANCECLKGFKLKLQ---NNQTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDV 357
C + C+CL+ FK K N W + CVR+ DC + FIKFD +KLP
Sbjct: 301 CIFNAIPVCQCLEKFKPKSPEEWNKMDWSQGCVRNKELDCQKGDGFIKFDGLKLPDATHS 360
Query: 358 SLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYV 417
+N+ MNLKEC+A+CL NC+C AY+N + GGGSGC WFGDL+DIR + G GQ +Y+
Sbjct: 361 WVNKDMNLKECKAKCLGNCSCMAYSNLDIRGGGSGCANWFGDLMDIRLVPG--GGQELYI 418
Query: 418 RVPDSEPGDKKL---LWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDI 474
R+ SE GD++ + I I L+ G K K K SS+
Sbjct: 419 RMHASEIGDREAKANMKIAAIATAVVGLILGTLTISYHVSKEKAKSAENTSSE------- 471
Query: 475 YMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGK 534
RT + D + G + D LP F+ ++++ AT NFS+ KLGEGGFGPVY+GK
Sbjct: 472 ------RTENDWKNDTNNGGQKEDMELPLFAFSAIADATNNFSVNNKLGEGGFGPVYRGK 525
Query: 535 LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN 594
L +G E+AVKRLS SGQG EFKNE++LI KLQHRNLV+L+GCC ++ EK+LIYEYMPN
Sbjct: 526 LEDGLEIAVKRLSRCSGQGFSEFKNEVILINKLQHRNLVKLLGCCSQREEKMLIYEYMPN 585
Query: 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 654
+SL+FF+FD ++ LL W R II GIA+GLLYLHQ SRLRIIHRDLKASN+LLD MN
Sbjct: 586 RSLDFFIFDETKGRLLDWSRRFNIISGIARGLLYLHQDSRLRIIHRDLKASNVLLDDHMN 645
Query: 655 PKISDFGMARMFCGDELQGNTKRVV 679
PKISDFG+ARMF D+ +G+T RV
Sbjct: 646 PKISDFGLARMFVADQTEGDTSRVT 670
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493730|ref|XP_003634656.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 600 bits (1548), Expect = e-169, Method: Compositional matrix adjust.
Identities = 324/680 (47%), Positives = 414/680 (60%), Gaps = 69/680 (10%)
Query: 8 FTFSCFVFLLGSLLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYK 67
F FS LL +S A DTI I DGE + S+ F+LGFFSPG SK +YLGIWYK
Sbjct: 9 FIFSYVFSLL--RISTAVDTINVNQHIRDGETITSAGGTFQLGFFSPGDSKNRYLGIWYK 66
Query: 68 QV-PDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLD 126
+V P TVVWVANR SP+ DS+ VL + G LV+++ T+GI+W+SN SR ++P AQLL+
Sbjct: 67 KVAPQTVVWVANRESPLTDSSGVLKVTQQGTLVVVSGTNGILWNSNSSRSAQDPNAQLLE 126
Query: 127 TGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSP 186
+GNLV+R +++ ++LWQSFD P DTLL GM GW+ TG +RYL+SW++ADDPS
Sbjct: 127 SGNLVMRN--GNDSDPENFLWQSFDYPCDTLLPGMKFGWNRVTGLDRYLSSWKSADDPSK 184
Query: 187 GNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADP--TNTSYLFRPIVEQKEDEII 244
GNFT+ +++ P + NG GPWNG+ FG P TN S LF E EI
Sbjct: 185 GNFTYGIDLSGFPQPFLRNGLTVKFRAGPWNGVRFGGIPQLTNNS-LFTFDYVSNEKEIY 243
Query: 245 YRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVD 304
+ Y +S + + + P G +R W + W ++ TA + C Y CG +C +D
Sbjct: 244 FIYYLVNSSVFVRRVLTPDGYSRRFTWTDKKNEWTLYSTAQRDDCDNYAICGVYGICKID 303
Query: 305 DTANCECLKGFKLKLQNN---QTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNE 361
++ CEC+KGF+ K Q+N W + CVRS DC + F+K+ +KLP + +E
Sbjct: 304 ESPKCECMKGFRPKFQSNWDMADWSKGCVRSTPLDCQKGDGFVKYSGVKLPDTRNSWFDE 363
Query: 362 SMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPD 421
SMNLKEC + CL+NC+C AYANS + GGGSGCL+WF DLIDIR T NGQ Y R+
Sbjct: 364 SMNLKECASLCLRNCSCTAYANSDIRGGGSGCLLWFDDLIDIRDFT--QNGQEFYARMAA 421
Query: 422 SEPGDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDIYMSVATR 481
SE G HK KE Q+ L
Sbjct: 422 SESG---------------------------YMDHKSKEGENNEGQEHLD---------- 444
Query: 482 TNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEV 541
LP F+LA++ AT NFS + KLGEGGFGPVYKG L GQE+
Sbjct: 445 -------------------LPLFNLATLLNATNNFSEENKLGEGGFGPVYKGILQEGQEI 485
Query: 542 AVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL 601
AVK +S S QGLKEFKNE+ I KLQHRNLV+L+GCC+ E++LIYEYMPNKSL+ ++
Sbjct: 486 AVKMMSKTSRQGLKEFKNEVESITKLQHRNLVKLLGCCIHGRERLLIYEYMPNKSLDLYI 545
Query: 602 FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661
FD R+ +L W R II GIA+GLLYLHQ SRLRIIHRDLKA NILLD++M PKISDFG
Sbjct: 546 FDHMRSRVLDWPKRFLIINGIARGLLYLHQDSRLRIIHRDLKAENILLDNEMTPKISDFG 605
Query: 662 MARMFCGDELQGNTKRVVGT 681
+AR F G+E + NT RVVGT
Sbjct: 606 IARSFGGNETEANTTRVVGT 625
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147799241|emb|CAN77004.1| hypothetical protein VITISV_027305 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 597 bits (1538), Expect = e-168, Method: Compositional matrix adjust.
Identities = 332/694 (47%), Positives = 437/694 (62%), Gaps = 53/694 (7%)
Query: 10 FSCFVFLLGSLLSL-----ATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGI 64
F+ VFL ++S+ A D+IT I DGE ++S+ FELGF G SK +YLGI
Sbjct: 4 FTELVFLFSYVISILRISTAVDSITANQHIKDGETIISAGGNFELGFVHLGTSKNQYLGI 63
Query: 65 WYKQV-PDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQ 123
WYK+V P TVVWVANR P+ DS+ L + + G+LV+LN ++G+IWSSN SR +NP AQ
Sbjct: 64 WYKKVTPRTVVWVANRELPVTDSSGXLKVTDQGSLVILNGSNGLIWSSNSSRSARNPTAQ 123
Query: 124 LLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADD 183
LLD+GNLV+ K +++ ++LWQSFD P DTLL GM G + TG +RYL+SW++ DD
Sbjct: 124 LLDSGNLVI--KSGNDSDPDNFLWQSFDYPGDTLLPGMKHGRNTVTGLDRYLSSWKSNDD 181
Query: 184 PSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPT-------NTSYLFRPIV 236
PS G+FT+ L+ P L + +GS + +GPWNG+ F P N S++F
Sbjct: 182 PSKGDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIRFNGFPELRPNPVFNYSFVF---- 237
Query: 237 EQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCG 296
E E+ + Y+ +S +L L +NP+G+VQRLIW + W V+ TA + C Y CG
Sbjct: 238 --NEKEMYFTYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWNVYSTAYKDDCDSYALCG 295
Query: 297 ANSVCSVDDTANCECLKGFKLKLQ---NNQTWPRECVRSHSSDCITRERFIKFDDIKLPY 353
A S C++ + C C+KGF K + W CVR S DC + F K+ +KLP
Sbjct: 296 AYSTCNIHRSPRCGCMKGFVPKFPYQWDTMDWSNGCVRKTSLDCQKGDGFAKYSGVKLPD 355
Query: 354 LVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQ 413
+ NESMNLKEC + C +NC+C AY NS + GGGSGCL+WFGDLIDI++ T NGQ
Sbjct: 356 TRNSWFNESMNLKECASLCFRNCSCSAYTNSDIKGGGSGCLLWFGDLIDIKEFT--ENGQ 413
Query: 414 PIYVRVPDSE----PGDKKLLWIFVILVLPAALLPGFFIFCRW--RRKHKEKETTMESSQ 467
Y+R+ SE K W+ V V A ++ + + +++ K K TT +++
Sbjct: 414 DFYIRMAASELDAISKVTKRRWVIVSTVSIAGMILLSLVVTLYLLKKRLKRKGTTELNNE 473
Query: 468 DLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGF 527
TNE E D LP F L ++ AT NFS KLGEGGF
Sbjct: 474 -----------GAETNERQE----------DLELPLFXLDTILNATHNFSRNNKLGEGGF 512
Query: 528 GPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587
GPVYKG L +G+E+AVKRLS +S QGL EFKNE++ I+KLQHRNLV+L+GCC+ EK+L
Sbjct: 513 GPVYKGMLQDGKEIAVKRLSKESNQGLDEFKNEVIYISKLQHRNLVKLLGCCIHGEEKML 572
Query: 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNI 647
IYEYMPNKSLNFF+FD ++ +L W R II GIA+GLLYLHQ SRLRIIHRDLKA N+
Sbjct: 573 IYEYMPNKSLNFFIFDGIQSMVLDWPKRFVIINGIARGLLYLHQDSRLRIIHRDLKADNV 632
Query: 648 LLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
LLD++MNP+ISDFGMAR F G+E TKRVVGT
Sbjct: 633 LLDNEMNPRISDFGMARSFGGNETIARTKRVVGT 666
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493727|ref|XP_002280656.2| PREDICTED: uncharacterized protein LOC100243545 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 596 bits (1536), Expect = e-167, Method: Compositional matrix adjust.
Identities = 326/679 (48%), Positives = 418/679 (61%), Gaps = 45/679 (6%)
Query: 13 FVFLLGSL-LSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPD 71
F ++L L +S+A DTI I DGE + S+ FELGFFSPG SK +YLGIWYK+
Sbjct: 11 FSYVLSLLRISVAVDTIIVNQNITDGETITSAGGSFELGFFSPGNSKNRYLGIWYKKASK 70
Query: 72 T-VVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNL 130
VVWVANR SPI DS+ VL + G LVL+N T+GI+W+S SR ++P AQLL++GNL
Sbjct: 71 KPVVWVANRESPITDSSGVLKVTQPGILVLVNGTNGILWNSTSSRSAQDPNAQLLESGNL 130
Query: 131 VLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFT 190
V+R ++ ++LWQSFD P DTLL GM +G + G +RYL+SW++ADDPS GNFT
Sbjct: 131 VMRN--GNDRDPENFLWQSFDYPCDTLLPGMKLGRNRVAGLDRYLSSWKSADDPSKGNFT 188
Query: 191 FRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADP---TNTSYLFRPIVEQKEDEIIYRY 247
+ ++ P L + NG GPWNG+ F P N Y + + +KE I Y Y
Sbjct: 189 YWIDPSGFPQLLLRNGLAVAFRPGPWNGIRFSGIPQLTINPVYSYEYVSNEKE--IYYIY 246
Query: 248 ESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTA 307
+S ++M L + P G QR IW + W ++ TA + C Y CG N +C +D +
Sbjct: 247 SLVNSSVIMRLVLTPDGAAQRSIWTDKKNEWTLYSTAQRDQCDNYAICGVNGICKIDQSP 306
Query: 308 NCECLKGFKLKLQNN---QTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMN 364
NCEC+KGF+ K Q+N + W CVRS DC + F+K+ +KLP NESMN
Sbjct: 307 NCECMKGFRPKFQSNWDMEDWSNGCVRSTPLDCQKGDGFVKYSGVKLPDTRSSWFNESMN 366
Query: 365 LKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRV--PDS 422
LKEC + CL NC+C AYANS + GGGSGCL+WFGDLIDIR T NGQ YVR+ D
Sbjct: 367 LKECASLCLSNCSCTAYANSDIRGGGSGCLLWFGDLIDIRDFT--ENGQEFYVRMAAADL 424
Query: 423 EPGDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDIYMSVATRT 482
E +K L + + +L+ +L F YM ++
Sbjct: 425 ETTKEKRLGNRLNSIFVNSLI----------------------LHSILHFAAYMEHNSKG 462
Query: 483 NEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVA 542
E +EG + LP F L ++ AT NFS KLGEGGFGPVYKG L GQE+A
Sbjct: 463 GENNEGQEHLE-------LPLFDLDTLLNATNNFSSDNKLGEGGFGPVYKGILQEGQEIA 515
Query: 543 VKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLF 602
VK +S S QGLKEFKNE+ IAKLQHRNLV+L+GCC+ E++LIYE+MPNKSL+ F+F
Sbjct: 516 VKMMSKTSRQGLKEFKNEVESIAKLQHRNLVKLLGCCIHGRERLLIYEHMPNKSLDLFIF 575
Query: 603 DPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662
D R +L W R II GIAQGLLYLH+ SRLRIIHRDLKA NILLD++M PKISDFG+
Sbjct: 576 DQMRRRVLDWPKRFLIINGIAQGLLYLHRDSRLRIIHRDLKAENILLDNEMIPKISDFGI 635
Query: 663 ARMFCGDELQGNTKRVVGT 681
F G+E++ NT RV T
Sbjct: 636 TGSFGGNEIETNTTRVART 654
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493740|ref|XP_002280379.2| PREDICTED: uncharacterized protein LOC100262430 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 595 bits (1535), Expect = e-167, Method: Compositional matrix adjust.
Identities = 327/702 (46%), Positives = 435/702 (61%), Gaps = 37/702 (5%)
Query: 10 FSCFVFLLGSL-LSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQ 68
F+ V + L +S+A DT+T +I DGE + S+ FELGFFSP S+ +Y+GIWYK+
Sbjct: 4 FATLVLVFSILRVSIAVDTLTVNQIITDGETITSAGGSFELGFFSPDSSRNRYVGIWYKK 63
Query: 69 VPD-TVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDT 127
V TVVWVANR P+ S+ +L + + G LV+LN T+ IWSSN SR +NP AQLLD+
Sbjct: 64 VATRTVVWVANRQIPLTASSGILKVTDRGTLVILNGTNTTIWSSNSSRPAQNPNAQLLDS 123
Query: 128 GNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPG 187
GNLV++ S++ ++LWQSFD P +TLL GM G + TG +RYL+SW+T DDPS G
Sbjct: 124 GNLVMKNGNDSDSE--NFLWQSFDYPCNTLLPGMKFGRNRVTGLDRYLSSWKTTDDPSIG 181
Query: 188 NFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPT---NTSYLFRPIVEQKEDEII 244
NFT+RL+ P L + NGS +GPWNGL F P N+ Y + I KE
Sbjct: 182 NFTYRLDPGGSPQLLVRNGSTVTFRSGPWNGLRFSGFPQLRPNSVYSYAFIFNDKE--TY 239
Query: 245 YRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVD 304
Y +E +S ++ L ++P G QR W + ++ W ++ +A + C Y CG +C ++
Sbjct: 240 YTFELVNSSVITRLVLSPEGYAQRFTWIDRTSDWILYSSAQTDDCDSYALCGVYGICEIN 299
Query: 305 DTANCECLKGFKLKLQNN---QTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNE 361
+ CEC+KGF+ K Q+N W CVRS C F+K+ +KLP + NE
Sbjct: 300 RSPKCECMKGFEPKFQSNWDMADWSDGCVRSTPMVCQKSNGFLKYSGVKLPDTRNSWFNE 359
Query: 362 SMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPD 421
SMNLKEC + CL NC+C AY NS + GGGSGCL+WFGDLIDIR+ T NGQ Y+R+
Sbjct: 360 SMNLKECASLCLGNCSCTAYTNSDIRGGGSGCLLWFGDLIDIREYT--ENGQDFYIRMAK 417
Query: 422 SEPGDKKLLWIFVILVLPAALLPGFFIFCRW------------RRKHKEKETTMESSQDL 469
SE G L ++ ++ + + C + +RK T L
Sbjct: 418 SELG-MSLSVPYLRIINSVQVFNDKYCTCVYAFAMTNSGSKGAKRKWVIVSTVSIVGIIL 476
Query: 470 LKFDIYMSVATRTNEPSEGDG-----DAKGT-----RRDSVLPCFSLASVSAATENFSMQ 519
L + + V + +G+ + KG D LP F L ++ AT+NFS
Sbjct: 477 LSLVLTLYVLRKKRLRRKGNNLYSKHNCKGAEINEREEDLELPLFDLDTILNATDNFSND 536
Query: 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
KLGEGGFGPVYKG L +G+E+AVKRLS +S QGL EFKNE+ I+KLQHRNLV+L+GCC
Sbjct: 537 NKLGEGGFGPVYKGMLQDGKEIAVKRLSKESRQGLDEFKNEVTHISKLQHRNLVKLLGCC 596
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
+ EK+LIYEYMPNKSL+FF+FD ++ +L W R II GIA+GLLYLHQ SRLRIIH
Sbjct: 597 IHGEEKMLIYEYMPNKSLDFFIFDGMQSLVLDWPKRFVIINGIARGLLYLHQDSRLRIIH 656
Query: 640 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
RDLKA N+LLD++MNP+ISDFGMAR F G+E + TKRVVGT
Sbjct: 657 RDLKADNVLLDNEMNPRISDFGMARSFRGNESEARTKRVVGT 698
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493736|ref|XP_002280506.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 592 bits (1525), Expect = e-166, Method: Compositional matrix adjust.
Identities = 325/684 (47%), Positives = 425/684 (62%), Gaps = 32/684 (4%)
Query: 13 FVFLLGSL-LSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPD 71
F ++L L +S+A DTI I DGE + S+ FELGFFSPG SK +YLGIWYK+V
Sbjct: 11 FSYVLSLLRISVAVDTIIVNQNITDGETITSAGGSFELGFFSPGNSKNRYLGIWYKKVAT 70
Query: 72 -TVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNL 130
TVVWVANR SP+ DS+ VL + G LVL+N T+GI+W+S+ SR ++P AQLL++GNL
Sbjct: 71 GTVVWVANRESPLTDSSGVLKVTEQGILVLVNDTNGILWNSSSSRSAQDPNAQLLESGNL 130
Query: 131 VLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFT 190
V+R +++ ++LWQSFD P DTLL GM GW+ TG +RYL+SW++ DDPS GNFT
Sbjct: 131 VMRN--GNDSDPENFLWQSFDYPCDTLLPGMKFGWNRVTGLDRYLSSWKSTDDPSKGNFT 188
Query: 191 FRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADP--TNTSYLFRPIVEQKEDEIIYRYE 248
+ +++ P + NG GPWNG+ FG P TN S LF E EI Y
Sbjct: 189 YGIDLSGFPQPFLRNGLAVKFRAGPWNGVRFGGIPQLTNNS-LFTSDYVSNEKEIYSIYY 247
Query: 249 SYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTAN 308
+S + + + P G +R W + W ++ TA ++ C Y CG +C +D++
Sbjct: 248 LVNSSVFVRRVLTPDGYSRRFTWTDKKNEWTLYATAQSDDCDNYAICGVYGICKIDESPK 307
Query: 309 CECLKGFKLKLQNN---QTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNL 365
CEC+KGF+ K Q+N W C+RS DC + F+K+ +KLP + NESMNL
Sbjct: 308 CECMKGFRPKFQSNWDMADWSNGCIRSTPLDCQKGDGFVKYSGVKLPDTRNSWFNESMNL 367
Query: 366 KECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPG 425
KEC + CL+NC+C AYANS + GGGSGCL+WFGDLIDIR T +NGQ YVR+ SE G
Sbjct: 368 KECASLCLRNCSCTAYANSDIRGGGSGCLLWFGDLIDIRDFT--HNGQEFYVRMAASELG 425
Query: 426 DKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDIYMSVATRTNEP 485
F + F+ ++KH + + LL + + V + +
Sbjct: 426 MN-----FSFFLPEKHQSDTNFM----KKKHVIIISISTTGIVLLSLVLTLYVLKKRKKQ 476
Query: 486 SEGDGDAKGTRRDS--------VLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLN 537
+ G RD LP F L ++ AT NFS KLGEGGFGP G L
Sbjct: 477 LKRKGYMDHNSRDENNEGQAHLELPLFDLDTLLNATNNFSSYNKLGEGGFGP---GILQE 533
Query: 538 GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL 597
GQE+AVK +S+ S QGLKEFKNE+ IAKLQHRNLV+L+GCC+ E++LIYEYMPNKSL
Sbjct: 534 GQEIAVKMMSNTSRQGLKEFKNEVESIAKLQHRNLVKLLGCCIHGRERMLIYEYMPNKSL 593
Query: 598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 657
+FF+FD ++ L W R II GIA+GLLYLHQ SRLRIIHRDLKA NILLD++M+PKI
Sbjct: 594 DFFIFDQMQSVALDWSKRFLIINGIARGLLYLHQDSRLRIIHRDLKAENILLDNEMSPKI 653
Query: 658 SDFGMARMFCGDELQGNTKRVVGT 681
SDFG+AR F G+E + NT RV GT
Sbjct: 654 SDFGIARCFGGNETEANTTRVAGT 677
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147816068|emb|CAN61538.1| hypothetical protein VITISV_030742 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 591 bits (1524), Expect = e-166, Method: Compositional matrix adjust.
Identities = 321/677 (47%), Positives = 420/677 (62%), Gaps = 38/677 (5%)
Query: 21 LSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYK-QVPDTVVWVANR 79
+S+ DTIT LI D E + S+ FELGFFSP SK++YLGI YK ++ VVWVANR
Sbjct: 20 ISIGVDTITVNQLITDAETITSAGGSFELGFFSPANSKHRYLGIRYKKELNRAVVWVANR 79
Query: 80 NSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSN 139
+P+ DS+ VL + + G LV+L+ + +WSS SR +NP AQLLD+GNLV++ N
Sbjct: 80 ENPLNDSSGVLKVTSQGILVVLDGANKTLWSSTSSRPAQNPNAQLLDSGNLVMKNGNDGN 139
Query: 140 TSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLP 199
++LWQSFD P +TLL GM +GW+ TG +RYL+SW++ADDPS G FT+ ++ P
Sbjct: 140 PE--NFLWQSFDYPCNTLLPGMKLGWNRVTGLDRYLSSWKSADDPSIGTFTYGIDPSGSP 197
Query: 200 HLCIYNGSVKLSCTGPWNGLAFGADPT---NTSYLFRPIVEQKEDEIIYRYESYSSRILM 256
+ + N SV +GPWNG+ F P N Y + ++ +KE I + Y +S +L
Sbjct: 198 QIFVRNVSVVTFRSGPWNGIRFSGYPHFTPNPVYTYDFVLNEKE--IYFIYYLVNSSLLT 255
Query: 257 MLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFK 316
L + P G QR W + W + + N+ C Y CGAN +C +D + CEC+KGF+
Sbjct: 256 RLVLTPDGYAQRFTWIDEKGQWVKYSSVQNDDCDNYALCGANGICKIDQSPKCECMKGFR 315
Query: 317 LKLQNN---QTWPRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECL 373
+ Q+N W CVRS DC +RF+KF +KLP NESMNLKEC + CL
Sbjct: 316 PRFQSNWDMADWSDGCVRSTPLDCQKGDRFVKFSGVKLPDTRTSWFNESMNLKECASLCL 375
Query: 374 KNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEP--------- 424
+NC+C AY NS ++G GSGCL+WFG+L DIR+ NGQ YVR+ SE
Sbjct: 376 RNCSCTAYVNSNISGEGSGCLLWFGNLTDIREFA--ENGQEFYVRMSASESDAFSSTNIS 433
Query: 425 GDKKLLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDIYMSVATRTNE 484
KK + VI + ++ + + K +++ LK YM + E
Sbjct: 434 SKKKQKQVIVISISITGIVLLILVLTWYMLKKMKQQ---------LKRKGYMEHNSDGGE 484
Query: 485 PSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK 544
SEG + LP F LA++ AT NFS KLGEGGFGPVYKG L +G+E+AVK
Sbjct: 485 TSEGQEHLE-------LPLFELATLLNATNNFSSDNKLGEGGFGPVYKGILEDGEEIAVK 537
Query: 545 RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDP 604
RLS S QGLKEFKNE+ IAKLQHRNLV+L+GCC+ EK+LIYEY+PNKSL+ F+FD
Sbjct: 538 RLSKTSRQGLKEFKNEVESIAKLQHRNLVKLLGCCICGREKMLIYEYLPNKSLDLFIFDQ 597
Query: 605 SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
R +L W R II GIA+GLLYLHQ SRLRIIHRDLKA N+LLD+DMNPKISDFG+AR
Sbjct: 598 MRGIVLDWPKRFLIINGIARGLLYLHQDSRLRIIHRDLKAENVLLDNDMNPKISDFGIAR 657
Query: 665 MFCGDELQGNTKRVVGT 681
F G+EL +T RV GT
Sbjct: 658 SFGGNELXASTTRVAGT 674
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 681 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.582 | 0.507 | 0.408 | 7.5e-148 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.947 | 0.758 | 0.450 | 8.4e-145 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.942 | 0.757 | 0.448 | 1.7e-144 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.944 | 0.762 | 0.442 | 6.1e-142 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.574 | 0.479 | 0.374 | 2.8e-135 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.947 | 0.759 | 0.411 | 2.8e-130 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.951 | 0.769 | 0.411 | 4e-122 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.264 | 0.223 | 0.664 | 4.5e-122 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.286 | 0.242 | 0.609 | 2.5e-119 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.264 | 0.223 | 0.637 | 2.5e-119 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 837 (299.7 bits), Expect = 7.5e-148, Sum P(2) = 7.5e-148
Identities = 170/416 (40%), Positives = 243/416 (58%)
Query: 20 LLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVP-DTVVWVAN 78
LL+ ATD + + DG+ +VS FE+GFFSPG S+ +YLGIWYK++ TVVWVAN
Sbjct: 19 LLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWVAN 78
Query: 79 RNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLS-----REVKNPVAQLLDTGNLVLR 133
R+SP+ D + L + NG+L L N + IIWSS+ S ++NP+ Q+LDTGNLV+R
Sbjct: 79 RDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQILDTGNLVVR 138
Query: 134 EKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRL 193
++ + Y+WQS D P D L GM G + TG R+LTSWR DDPS GN+T ++
Sbjct: 139 ----NSGDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKM 194
Query: 194 EIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPT-NTSYLFRPIVEQKEDEIIYRYESYSS 252
+ +P + SV + TGPWNGL F P + ++R E+E+ Y Y+ +
Sbjct: 195 DPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVYYTYKLENP 254
Query: 253 RILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECL 312
+L +++NP+G +QR W + W + +A + C Y CG+ C+++++ C CL
Sbjct: 255 SVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINESPACRCL 314
Query: 313 KGFKLKLQNNQT---WPRECVRSHSSDCITRER-FIKFDDIKLPYLVDVSLNESMNLKEC 368
KGF K W CVR DC E F+K +KLP +++M+L EC
Sbjct: 315 KGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNEC 374
Query: 369 EAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYN-NGQPIYVRVPDSE 423
+ CL+NCTC AY+ + GG GC++WFGDLIDIR+ YN NGQ +YVR+ SE
Sbjct: 375 KKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIRE---YNENGQDLYVRLASSE 427
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1415 (503.2 bits), Expect = 8.4e-145, P = 8.4e-145
Identities = 307/681 (45%), Positives = 413/681 (60%)
Query: 22 SLATDTITPAT--LIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPD-TVVWVAN 78
S++ +T++ + I +VS +FELGFF PG YLGIWYK + T VWVAN
Sbjct: 26 SISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVAN 85
Query: 79 RNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSR-EVKNP-VAQLLDTGNLVLREKF 136
R++P+ S L I ++ NLV+L+Q+D +WS+NL+ +V++P VA+LLD GN VLR+
Sbjct: 86 RDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD-- 142
Query: 137 SSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIR 196
S N++ LWQSFD P+DTLL M +GWD KTG R++ SW++ DDPS G+F+F+LE
Sbjct: 143 SKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETE 202
Query: 197 VLPHLCIYNGSVKLSCTGPWNGLAFGADPTNT--SYLFRPIVEQKEDEIIYRYESYSSRI 254
P + ++N ++ +GPWNG+ F P Y+ KE E+ Y + S +
Sbjct: 203 GFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKE-EVTYSFRITKSDV 261
Query: 255 LMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKG 314
L I+ SG +QR W E + W F+ AP + C Y CG C + + C C+KG
Sbjct: 262 YSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKG 321
Query: 315 FKLKLQNNQTWP-RE----CVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECE 369
FK + N Q W R+ CVR C + F++ +KLP S++ + +KECE
Sbjct: 322 FKPR--NPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECE 379
Query: 370 AECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGDKKL 429
+CL++C C A+AN+ + G GSGC+ W G+L DIR GQ +YVR+ ++ DK+
Sbjct: 380 QKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYA--KGGQDLYVRLAATDLEDKRN 437
Query: 430 LWIFVI---LVLPAALLPGFFIFCRWRRKHKEK---ETTMESSQDLLKFDIYMS---VAT 480
+I + + LL F IF W+RK K ET + Q L D+ M+ +++
Sbjct: 438 RSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQ-LRSRDLLMNEVVISS 496
Query: 481 RTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQE 540
R + E + D D LP V+ AT NFS KLG+GGFG VYKGKLL+GQE
Sbjct: 497 RRHISRENNTD------DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQE 550
Query: 541 VAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFF 600
+AVKRLS S QG EFKNE+ LIA+LQH NLVRL+ CCV+ GEK+LIYEY+ N SL+
Sbjct: 551 MAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSH 610
Query: 601 LFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 660
LFD SR L WQ R II GIA+GLLYLHQ SR RIIHRDLKASNILLD M PKISDF
Sbjct: 611 LFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDF 670
Query: 661 GMARMFCGDELQGNTKRVVGT 681
GMAR+F DE + NT++VVGT
Sbjct: 671 GMARIFGRDETEANTRKVVGT 691
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1412 (502.1 bits), Expect = 1.7e-144, P = 1.7e-144
Identities = 302/673 (44%), Positives = 410/673 (60%)
Query: 24 ATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVP-DTVVWVANRNSP 82
AT+++T I + ++S SQIFELGFF+P S YLGIWYK +P T VWVANR++P
Sbjct: 32 ATESLT----ISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNP 87
Query: 83 IVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSR-EVKNPVA-QLLDTGNLVLREKFSSNT 140
+ SN L I +N NLV+ +Q+D +WS+N++ +V++PVA +LLD GN VLR+ S N
Sbjct: 88 LSSSNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD--SKNN 144
Query: 141 SEGSYLWQSFDCPSDTLLIGMNMGWDLKTGR-ERYLTSWRTADDPSPGNFTFRLEIRVLP 199
+LWQSFD P+DTLL M MGWD K+G R L SW+T DDPS G+F+ +L P
Sbjct: 145 KPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFP 204
Query: 200 HLCIYNGSVKLSCTGPWNGLAFGADP--TNTSYLFRPIVEQKEDEIIYRYESYSSRILMM 257
IYN +GPW G F + P Y+ E + +++Y Y + I +
Sbjct: 205 EFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQ-QVVYSYRVNKTNIYSI 263
Query: 258 LKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKL 317
L ++ +G +QRL W E + W+ + +P + C Y CG C + + C C+KGF+
Sbjct: 264 LSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGFEP 323
Query: 318 KLQNNQTWPRE----CVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECL 373
N Q R+ CVR C R+ F++ ++LP + S+++ + LKECE CL
Sbjct: 324 --MNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCL 381
Query: 374 KNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGDKKLLWIF 433
K C C A+AN+ + GGSGC++W G L DIR GQ +YVRV + DK++
Sbjct: 382 KGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYA--KGGQDLYVRVAAGDLEDKRIKSKK 439
Query: 434 VI---LVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKF-DIYMSVATRTNEPSEGD 489
+I + + LL F IF W+RK K T DL++ D M+ + +
Sbjct: 440 IIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYT-- 497
Query: 490 GDAKGTRRDSV-LPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSS 548
+K + D + LP +++ AT NFS KLG+GGFG VYKG LL+G+E+AVKRLS
Sbjct: 498 --SKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSK 555
Query: 549 QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH 608
S QG EF NE+ LIAKLQH NLVRL+GCCV++GEK+LIYEY+ N SL+ LFD +R+
Sbjct: 556 MSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSS 615
Query: 609 LLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668
L WQ R II GIA+GLLYLHQ SR RIIHRDLKASN+LLD +M PKISDFGMAR+F
Sbjct: 616 NLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGR 675
Query: 669 DELQGNTKRVVGT 681
+E + NT+RVVGT
Sbjct: 676 EETEANTRRVVGT 688
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1388 (493.7 bits), Expect = 6.1e-142, P = 6.1e-142
Identities = 300/678 (44%), Positives = 411/678 (60%)
Query: 22 SLATDTI--TPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVP-DTVVWVAN 78
S++ +T+ T + I + ++S SQIFELGFF+P S YLGIWYK +P T VWVAN
Sbjct: 24 SVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVAN 83
Query: 79 RNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSR-EVKNPVA-QLLDTGNLVLREKF 136
R++P+ SN L I N NLV+ +Q+D +WS+N++ +V++PVA +LLD GN +LR+
Sbjct: 84 RDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRD-- 140
Query: 137 SSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIR 196
S LWQSFD P+DTLL M +GWD KTG R L SW+T DDPS G F+ +LE
Sbjct: 141 ----SNNRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETS 196
Query: 197 VLPHLCIYNGSVKLSCTGPWNGLAFGADP--TNTSYLFRPIVEQKEDEIIYRYESYSSRI 254
P I + L +GPWNG+ F + P Y+ KE E+ Y Y + +
Sbjct: 197 EFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKE-EVTYSYRINKTNL 255
Query: 255 LMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKG 314
L +N +G +QRL W E + W+ + +P + C Y CG C + NC C+KG
Sbjct: 256 YSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKG 315
Query: 315 FKLKLQNNQTWP-RE----CVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECE 369
FK N Q W R+ C+R C R+ F + +KLP ++ + LK C+
Sbjct: 316 FKPV--NEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCK 373
Query: 370 AECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGDKKL 429
CL++C C A+AN+ + GGSGC++W +++D+R GQ +YVR+ +E DK++
Sbjct: 374 ERCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYA--KGGQDLYVRLAAAELEDKRI 431
Query: 430 LWIFVI---LVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKF-DIYMS--VATRTN 483
+I + + LL F IF W+RK K T + D ++ D ++ V +R
Sbjct: 432 KNEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRG 491
Query: 484 EPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAV 543
S+ + K + LP L +++ AT NFS KLG+GGFG VYKG+LL+G+E+AV
Sbjct: 492 YTSK---EKKSEYLE--LPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAV 546
Query: 544 KRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD 603
KRLS S QG EF NE+ LIAKLQH NLVRL+GCCV++GEK+LIYEY+ N SL+ LFD
Sbjct: 547 KRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFD 606
Query: 604 PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
+R+ L WQ R II GIA+GLLYLHQ SR RIIHRDLKASN+LLD +M PKISDFGMA
Sbjct: 607 QTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMA 666
Query: 664 RMFCGDELQGNTKRVVGT 681
R+F +E + NT+RVVGT
Sbjct: 667 RIFGREETEANTRRVVGT 684
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 697 (250.4 bits), Expect = 2.8e-135, Sum P(2) = 2.8e-135
Identities = 160/427 (37%), Positives = 240/427 (56%)
Query: 16 LLGSLLSLATD--TITPATLIGDGEKLVSSSQIFELGFFSPGKSK---YKYLGIWYKQVP 70
L+ S LS+A D ITP + DG+ L S Q+F+LGFFS + + +++LG+WY + P
Sbjct: 14 LISSSLSVALDYNVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWYME-P 72
Query: 71 DTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSN-----LSREVKNPVAQLL 125
VVWVANRN+P+ ++ L + + G+L L + +WSS+ S+ NP+ ++
Sbjct: 73 FAVVWVANRNNPLYGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPLLKIS 132
Query: 126 DTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPS 185
+GNL+ S+ E + LWQSFD P +T+L GM +G + KT E L+SW+T DPS
Sbjct: 133 CSGNLI------SSDGEEAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPS 186
Query: 186 PGNFTFRLEIRVLPHLCIY-NGSVKLSCT-GPWNGLAFGADPT--NTSYLFRPIVEQKED 241
PG+FT L+ R LP L + NG S G WNGL+F P + LF
Sbjct: 187 PGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQ 246
Query: 242 EIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVC 301
E+ Y + RI+ L +N +G + R I + + W + TAP + C Y CGA +VC
Sbjct: 247 EVNYSWTP-RHRIVSRLVLNNTGKLHRFIQSKQNQ-WILANTAPEDECDYYSICGAYAVC 304
Query: 302 SVD--DTANCECLKGFKLKLQNNQTWPRE---CVRSHSSDCITRERFIKFDDIKLPYL-- 354
++ +T +C CL+GFK K R CV ++C ++ F+KF +KLP
Sbjct: 305 GINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSW 364
Query: 355 --VDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNG 412
D NE M L++C+ +C NC+C AYAN+ + GG GCL+WFGDL+D+R+ + + G
Sbjct: 365 SWYDAK-NE-MTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSF--G 420
Query: 413 QPIYVRV 419
Q +Y+R+
Sbjct: 421 QDVYIRM 427
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1278 (454.9 bits), Expect = 2.8e-130, P = 2.8e-130
Identities = 283/687 (41%), Positives = 406/687 (59%)
Query: 22 SLATDTITPATLIGDG---EKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPD-TVVWVA 77
S+A +TI + DG + LVS + FELGFFSPG S +++LGIWY + D VVWVA
Sbjct: 23 SMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWYGNIEDKAVVWVA 82
Query: 78 NRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREV---KNPVAQLLDTGNLVLRE 134
NR +PI D + VL I N+GNLVLL+ + +WSSN+ N V + DTGN VL E
Sbjct: 83 NRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIHDTGNFVLSE 142
Query: 135 KFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLE 194
T +W+SF+ P+DT L M + + +TG SWR+ DPSPGN++ ++
Sbjct: 143 -----TDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVD 197
Query: 195 IRVLPHLCIYNGS-VKLSCTGPWNGLAFGADPTN---TSYLFRPIVEQKEDE---IIYRY 247
P + ++ G+ + +G WN F P T+YL+ + DE + + Y
Sbjct: 198 PSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPDETGSVYFTY 257
Query: 248 ESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTA 307
+L+ K+ +G + L W+E W F + P++ C Y CG +C + +
Sbjct: 258 VPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFGICDMKGSN 317
Query: 308 N-CECLKGFKLKLQNNQTWPRECVRSHSSDC-----ITRERFIKFDDIKLPYLVDVSLNE 361
C C+ G++ N W R C R C + + F+ +KLP ++ +
Sbjct: 318 GICSCIHGYEQVSVGN--WSRGCRRRTPLKCERNISVGEDEFLTLKSVKLPDF-EIPEHN 374
Query: 362 SMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVPD 421
++ ++C CL+NC+C AY S V GG GC++W DL+D+++ G +++R+ D
Sbjct: 375 LVDPEDCRERCLRNCSCNAY--SLV--GGIGCMIWNQDLVDLQQFEA--GGSSLHIRLAD 428
Query: 422 SEPGDKKLLWIFVIL-VLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFDIYMSVAT 480
SE G+ + I VI+ VL +L G F WR K K+ + ++ + ++ T
Sbjct: 429 SEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNT-DTSVVVADLT 487
Query: 481 RTNEPSE---GDGDA--KGTR-RDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGK 534
++ E + G D +G S LP FSL +++ AT +F + +LG GGFGPVYKG
Sbjct: 488 KSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGV 547
Query: 535 LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN 594
L +G+E+AVKRLS +SGQG+ EFKNE++LIAKLQHRNLVRL+GCC E EK+L+YEYMPN
Sbjct: 548 LEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPN 607
Query: 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 654
KSL+FFLFD ++ L+ W+ R IIEGIA+GLLYLH+ SRLRIIHRDLK SN+LLD++MN
Sbjct: 608 KSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMN 667
Query: 655 PKISDFGMARMFCGDELQGNTKRVVGT 681
PKISDFGMAR+F G++ + NT RVVGT
Sbjct: 668 PKISDFGMARIFGGNQNEANTVRVVGT 694
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1201 (427.8 bits), Expect = 4.0e-122, P = 4.0e-122
Identities = 283/688 (41%), Positives = 393/688 (57%)
Query: 17 LGSLLSLAT-DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQV-PDTVV 74
L S +S +T ++ T I +G+ L+S + FELGFF+P S +Y+GIWYK + P TVV
Sbjct: 20 LCSNVSCSTSNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIWYKNIEPQTVV 79
Query: 75 WVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLRE 134
WVANR P++D L I ++GNLV++N + IWS+N+ E N VA L TG+LVL
Sbjct: 80 WVANREKPLLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNNTVAVLFKTGDLVL-- 137
Query: 135 KFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLE 194
S++ + W+SF+ P+DT L GM + + G R W++ DPSPG ++ ++
Sbjct: 138 --CSDSDRRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYSMGID 195
Query: 195 IRVLPHLCIYNGSVKLSCTGPWNGLAFGADP-----TNTSYLFRPIVEQKEDEIIY-RYE 248
+ I+ G + +GPWN F P TN Y F+ D +Y Y
Sbjct: 196 PVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYV 255
Query: 249 SYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVD---D 305
+ S + I P G ++ W++ W + P+ C+ Y CG SVC D
Sbjct: 256 ASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCDDSKEFD 315
Query: 306 TANCECLKGFKLKLQ---NNQTWPRECVRSHSSDCIT------RERFIKFDDIKLPYLVD 356
+ C C+ GF+ Q NN+ + C R +C + F IK+P
Sbjct: 316 SGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPDFGS 375
Query: 357 VSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNNGQPIY 416
V L+ N + C+ C ++C+C+AYA V G GC++W DLID+ G I
Sbjct: 376 VVLHN--NSETCKDVCARDCSCKAYA--LVVG--IGCMIWTRDLIDMEHFE--RGGNSIN 427
Query: 417 VRVPDSEPGDKK---LLWIFVILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFD 473
+R+ S+ G K LWI V V+ A LL G I+ W+ K K + + +D+ D
Sbjct: 428 IRLAGSKLGGGKENSTLWIIVFSVIGAFLL-GLCIWILWKFK-KSLKAFLWKKKDITVSD 485
Query: 474 IYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKG 533
I + ++ GD T D LP FS SV++AT +F+ + KLG+GGFG VYKG
Sbjct: 486 IIENRDYSSSPIKVLVGDQVDTP-D--LPIFSFDSVASATGDFAEENKLGQGGFGTVYKG 542
Query: 534 KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 593
G+E+AVKRLS +S QGL+EFKNE++LIAKLQHRNLVRL+GCC+E EK+L+YEYMP
Sbjct: 543 NFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMP 602
Query: 594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 653
NKSL+ FLFD S+ L W+ R ++I GIA+GLLYLH+ SRL+IIHRDLKASNILLD++M
Sbjct: 603 NKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEM 662
Query: 654 NPKISDFGMARMFCGDELQGNTKRVVGT 681
NPKISDFGMAR+F + NT RVVGT
Sbjct: 663 NPKISDFGMARIFNYRQDHANTIRVVGT 690
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 616 (221.9 bits), Expect = 4.5e-122, Sum P(2) = 4.5e-122
Identities = 121/182 (66%), Positives = 147/182 (80%)
Query: 501 LPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNE 560
L F + ++ AT NFS+ KLG+GGFG VYKGKL +G+E+AVKRLSS SGQG +EF NE
Sbjct: 476 LDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 535
Query: 561 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-LGWQTRVKII 619
++LI+KLQHRNLVR++GCC+E+ EK+LIYE+M NKSL+ FLFD SR L + W R II
Sbjct: 536 IVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFD-SRKRLEIDWPKRFDII 594
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
+GIA+GLLYLH SRLR+IHRDLK SNILLD MNPKISDFG+ARM+ G E Q NT+RVV
Sbjct: 595 QGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVV 654
Query: 680 GT 681
GT
Sbjct: 655 GT 656
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 610 (219.8 bits), Expect = 2.5e-119, Sum P(2) = 2.5e-119
Identities = 120/197 (60%), Positives = 148/197 (75%)
Query: 487 EGDGDAKGTRRDSV--LPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK 544
+ D G R V + F + ++ AT NFS KLG+GGFGPVYKGKL++G+E+ VK
Sbjct: 457 QNDAWKNGFERQDVSGVNFFEMHTIRTATNNFSPSNKLGQGGFGPVYKGKLVDGKEIGVK 516
Query: 545 RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDP 604
RL+S SGQG +EF NE+ LI+KLQHRNLVRL+G C++ EK+LIYE+M NKSL+ F+FDP
Sbjct: 517 RLASSSGQGTEEFMNEITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDP 576
Query: 605 SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
L W R II+GIA+GLLYLH+ SRLR+IHRDLK SNILLD MNPKISDFG+AR
Sbjct: 577 CLKFELDWPKRFNIIQGIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLAR 636
Query: 665 MFCGDELQGNTKRVVGT 681
MF G + Q NT+RVVGT
Sbjct: 637 MFQGTQYQDNTRRVVGT 653
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 599 (215.9 bits), Expect = 2.5e-119, Sum P(2) = 2.5e-119
Identities = 116/182 (63%), Positives = 146/182 (80%)
Query: 501 LPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNE 560
L F + ++ AT NFS+ KLG+GGFGPVYKGKL +G+E+AVKRLSS SGQG +EF NE
Sbjct: 479 LDFFDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 538
Query: 561 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-LGWQTRVKII 619
++LI+KLQH+NLVR++GCC+E EK+LIYE+M N SL+ FLFD SR L + W R+ II
Sbjct: 539 IVLISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDTFLFD-SRKRLEIDWPKRLDII 597
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
+GIA+G+ YLH+ S L++IHRDLK SNILLD MNPKISDFG+ARM+ G E Q NT+RVV
Sbjct: 598 QGIARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVV 657
Query: 680 GT 681
GT
Sbjct: 658 GT 659
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_LG_XI001046 | hypothetical protein (802 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 681 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-42 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-41 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 8e-40 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 1e-39 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-38 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 7e-36 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-28 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-24 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-21 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 1e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-20 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 2e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-17 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 1e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-15 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-07 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 1e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-04 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.001 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.001 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.003 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.003 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.003 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 0.003 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.003 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.003 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.004 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 9e-42
Identities = 59/154 (38%), Positives = 80/154 (51%), Gaps = 11/154 (7%)
Query: 517 SMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHR 570
++ KLGEG FG VYKGKL EVAVK L S Q ++EF E ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
N+V+L+G C E+ ++ EYM L +L L + IA+G+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE 119
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
IHRDL A N L+ ++ KISDFG++R
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR 150
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 1e-41
Identities = 60/154 (38%), Positives = 83/154 (53%), Gaps = 10/154 (6%)
Query: 517 SMQCKLGEGGFGPVYKGKLLNG-----QEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHR 570
++ KLGEG FG VYKG L EVAVK L S Q ++EF E ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
N+V+L+G C E+ +++ EYMP L +L +R L + IA+G+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE 120
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
IHRDL A N L+ ++ KISDFG++R
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR 151
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 8e-40
Identities = 55/121 (45%), Positives = 74/121 (61%), Gaps = 7/121 (5%)
Query: 33 LIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTI 92
+ G+ LVSS +FELGFF Y I YK TVVWVANR++P S+ LT+
Sbjct: 3 PLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTL 61
Query: 93 GNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDC 152
++GNLV+ + + ++WSSN +R N V LLD GNLVL + S+G++LWQSFD
Sbjct: 62 QSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYD------SDGNFLWQSFDY 115
Query: 153 P 153
P
Sbjct: 116 P 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 1e-39
Identities = 54/116 (46%), Positives = 70/116 (60%), Gaps = 7/116 (6%)
Query: 70 PDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGN 129
TVVWVANR +P+ DS+ L + ++GNLVL + ++WSSN S + VA L D GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 130 LVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPS 185
LVL + G LWQSFD P+DTLL G G ++ G R LTSW++ DPS
Sbjct: 61 LVLY------DNSGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 6e-39
Identities = 60/163 (36%), Positives = 86/163 (52%), Gaps = 10/163 (6%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLMGCC 579
LGEGGFG VY + G++VA+K + + L E E+ ++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
++ L+ EY SL L + L ++I+ I +GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 640 RDLKASNILLDSD-MNPKISDFGMARMFCGDELQGNTKRVVGT 681
RDLK NILLDSD K++DFG++++ D+ T VGT
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI--VGT 156
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 61/155 (39%), Positives = 80/155 (51%), Gaps = 14/155 (9%)
Query: 521 KLGEGGFGPVYKGKLLNGQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRL 575
KLGEG FG VYKGKL EVAVK L S + K+F E ++ KL H N+VRL
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
+G C E+ L+ EYM L +L F L + + IA+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ +HRDL A N L+ D+ KISDFG++R
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 56/155 (36%), Positives = 80/155 (51%), Gaps = 11/155 (7%)
Query: 516 FSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQH 569
+ KLGEG FG VYKG L +VAVK L + + +EF E ++ KL H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
N+VRL+G C + ++ EYMP L FL L + +++ IA+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+HRDL A N L+ ++ KISDFG++R
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSR 150
|
Length = 258 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 7e-36
Identities = 52/119 (43%), Positives = 73/119 (61%), Gaps = 8/119 (6%)
Query: 33 LIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTI 92
+ G+ LVS + +FELGFF+ + Y I YK TVVWVANR++P V + LT+
Sbjct: 3 TLSSGQTLVSGNSLFELGFFTLI-MQNDYNLILYKSSSRTVVWVANRDNP-VSDSCTLTL 60
Query: 93 GNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFD 151
++GNLVL + ++WSSN + N V LLD GNLV+ + S+G++LWQSFD
Sbjct: 61 QSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYD------SDGNFLWQSFD 113
|
Length = 114 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 59/165 (35%), Positives = 81/165 (49%), Gaps = 13/165 (7%)
Query: 521 KLGEGGFGPVYKGKLLN-GQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
KLG G FG VYK K G+ VAVK L S+ + + + E+ ++ +L H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTH-LLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
++ L+ EY L +L L KI I +GL YLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLH---SNG 118
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
IIHRDLK NILLD + KI+DFG+A+ + + VGT
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGT 161
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 55/173 (31%), Positives = 78/173 (45%), Gaps = 21/173 (12%)
Query: 516 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLV 573
+ + KLGEG FG VY + G+ VA+K + + + +E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLY 628
RL ++ + L+ EY L L Q I L Y
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQ--------ILSALEY 112
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
LH I+HRDLK NILLD D + K++DFG+AR E VGT
Sbjct: 113 LHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGT 159
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 57/172 (33%), Positives = 81/172 (47%), Gaps = 21/172 (12%)
Query: 520 CKLGEGGFGPVYKGKLL-NGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
LG G FG VY G+ +AVK LS S + L+ + E+ +++ LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 577 GCCVEQGEK-ILIY-EYMPNKSL-----NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
G ++ + + I+ EY+ SL F Q I +GL YL
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ--------ILEGLAYL 117
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
H I+HRD+K +NIL+DSD K++DFG A+ E T V GT
Sbjct: 118 H---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 5e-28
Identities = 54/152 (35%), Positives = 81/152 (53%), Gaps = 13/152 (8%)
Query: 521 KLGEGGFGPVYKGKLLN-----GQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRNLVR 574
+LGEG FG V + G++VAVK L+ S Q +F+ E+ ++ L H N+V+
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 575 LMGCCVEQGEKI--LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
G C + G + LI EY+P+ SL +L + + + I +G+ YL
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS- 127
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
R IHRDL A NIL++S+ KISDFG+A+
Sbjct: 128 --QRYIHRDLAARNILVESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 55/170 (32%), Positives = 82/170 (48%), Gaps = 11/170 (6%)
Query: 515 NFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRN 571
N+ + +G G FG VYKG L G VA+K++S + + LK E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
+V+ +G +I EY N SL + + + + QGL YLH+
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLHE 117
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+IHRD+KA+NIL D K++DFG+A + VVGT
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGT 162
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 56/180 (31%), Positives = 88/180 (48%), Gaps = 33/180 (18%)
Query: 516 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-----FKNEMMLIAKLQH 569
+ ++GEG +G VYK + G+ VA+K++ ++ KE E+ L+ KL+H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE---KEGFPITAIREIKLLQKLRH 57
Query: 570 RNLVRLMGCCVE--QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG------ 621
N+VRL +G +++EYM + L L P VK E
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE----------VKFTESQIKCYM 106
Query: 622 --IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
+ +GL YLH I+HRD+K SNIL+++D K++DFG+AR + T RV+
Sbjct: 107 KQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 58/158 (36%), Positives = 79/158 (50%), Gaps = 7/158 (4%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
E+ ++ KLG G FG V+ G +VAVK L + + F E ++ KL+H LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLV 64
Query: 574 RLMGCCVEQGEKILIY-EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
+L C + E I I EYM SL FL L V + IA+G+ YL
Sbjct: 65 QLYAVC-SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLE-- 120
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
IHRDL A NIL+ ++ KI+DFG+AR+ DE
Sbjct: 121 -SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 53/161 (32%), Positives = 77/161 (47%), Gaps = 21/161 (13%)
Query: 522 LGEGGFGPVYKGKLLNGQE------VAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVR 574
LGEG FG V+ G+ + + VAVK L + ++ F+ E L+ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRTHLLGWQTRVKIIEGIA 623
G C E I+++EYM + LN FL S L ++I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
G++YL + +HRDL N L+ D+ KI DFGM+R
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 60/174 (34%), Positives = 87/174 (50%), Gaps = 33/174 (18%)
Query: 521 KLGEGGFGPVYKGKLLN-GQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
K+GEG G VYK G+EVA+K RL Q+ + + NE++++ +H N+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNIVDYYD 82
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG-IA-------QGLLYL 629
+ E ++ EYM SL T ++ Q V++ E IA QGL YL
Sbjct: 83 SYLVGDELWVVMEYMDGGSL---------TDII-TQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 681
H +IHRD+K+ NILL D + K++DFG F + +KR VVGT
Sbjct: 133 HS---QNVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKEKSKRNSVVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 53/159 (33%), Positives = 81/159 (50%), Gaps = 18/159 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
E F+++ KLG G FG V++G N VA+K L S ++F+ E+ + +L+H++L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDP-----SRTHLL--GWQTRVKIIEGIAQGL 626
L C +I E M SL FL P L+ Q +A+G+
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQ--------VAEGM 117
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665
YL + IHRDL A NIL+ D+ K++DFG+AR+
Sbjct: 118 AYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARL 153
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 9/162 (5%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
K+G+GGFG VYK + G+EVA+K + +S + ++ NE+ ++ K +H N+V+ G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
+++ E ++ E+ SL L S L + + + +GL YLH IIH
Sbjct: 67 LKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIH 121
Query: 640 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
RD+KA+NILL SD K+ DFG++ +VGT
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGT 160
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 5e-23
Identities = 63/155 (40%), Positives = 81/155 (52%), Gaps = 15/155 (9%)
Query: 518 MQCKLGEGGFGPV--YKGKLLN---GQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRN 571
LGEG FG V Y N G+ VAVK L + GQ +K E+ ++ L H N
Sbjct: 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 572 LVRLMGCCVEQGEKI--LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
+V+ GCC EQG K LI EY+P SL +L P H L + + I +G+ YL
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PK--HKLNLAQLLLFAQQICEGMAYL 123
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
H IHRDL A N+LLD+D KI DFG+A+
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 56/163 (34%), Positives = 83/163 (50%), Gaps = 23/163 (14%)
Query: 522 LGEGGFGPVYKGKL--LNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
LGEG FG VYKG+L N + VA+K L + + +EF+ E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLF-------------DPSRTHLLGWQTRVKIIEG 621
L+G C ++ +++EY+ + L+ FL D + L + I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
IA G+ YL S +HRDL A N L+ + KISDFG++R
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 52/160 (32%), Positives = 85/160 (53%), Gaps = 22/160 (13%)
Query: 522 LGEGGFGPVYKG-----KLLNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 575
LG G FG VYKG VA+K L ++ + KE +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 576 MGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRT----HLLGWQTRVKIIEGIAQGLLYLH 630
+G C+ ++ LI + MP L ++ + +LL W + IA+G+ YL
Sbjct: 75 LGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
+ R++HRDL A N+L+ + + KI+DFG+A++ DE
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 56/151 (37%), Positives = 73/151 (48%), Gaps = 18/151 (11%)
Query: 522 LGEGGFGPVYKGKLL--NGQE--VAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
LG G FG V KG L +G+E VAVK L G KEF E ++A+L H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRT---HLLGWQTRVKIIEGIAQGLLYLHQYS 633
G C + +L+ E P L +L L +V A G+ YL
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES-- 113
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+HRDL A N+LL + KISDFGM+R
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 98.7 bits (244), Expect = 4e-22
Identities = 56/176 (31%), Positives = 85/176 (48%), Gaps = 14/176 (7%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQH-R 570
++ + KLGEG FG VY + + + VA+K L+ + + ++ F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
N+V+L ++G L+ EY+ SL L R L + I+ I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 631 QYSRLRIIHRDLKASNILLDSDMN-PKISDFGMARMFCGD----ELQGNTKRVVGT 681
IIHRD+K NILLD D K+ DFG+A++ + VGT
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 47/143 (32%), Positives = 76/143 (53%), Gaps = 6/143 (4%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 581
+G+G FG V G GQ+VAVK L S + F E ++ L+H NLV+L+G ++
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 582 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRD 641
++ EYM SL +L R ++ ++ + +G+ YL + +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 642 LKASNILLDSDMNPKISDFGMAR 664
L A N+L+ D+ K+SDFG+A+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (239), Expect = 1e-21
Identities = 55/170 (32%), Positives = 86/170 (50%), Gaps = 26/170 (15%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRL-SSQSGQGLKEFKN---EMMLIAKLQHRNLVRL 575
KLGEG +G VYK + G+ VA+K++ +G+ E+ L+ +L+H N+V+L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP--STALREISLLKELKHPNIVKL 63
Query: 576 MGCCVEQGEKI-LIYEYMPN--KSL---NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
+ K+ L++EY K P+ + +Q + +GL Y
Sbjct: 64 LDVIH-TERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQ--------LLRGLAYC 114
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
H + RI+HRDLK NIL++ D K++DFG+AR F G L+ T VV
Sbjct: 115 HSH---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 1e-21
Identities = 29/67 (43%), Positives = 44/67 (65%), Gaps = 1/67 (1%)
Query: 337 CITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMW 396
C + F++ ++KLP ++ S+ LKECE CL NC+C AYA + + GGSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIW 59
Query: 397 FGDLIDI 403
G+L+D+
Sbjct: 60 TGELVDM 66
|
Length = 66 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 54/150 (36%), Positives = 85/150 (56%), Gaps = 14/150 (9%)
Query: 522 LGEGGFGPVYKGKL-LNGQE---VAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRNLVRLM 576
+G G FG V +G+L L G++ VA+K L + S + +F E ++ + H N++RL
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH--LLGWQTRVKIIEGIAQGLLYLHQYSR 634
G + ++I EYM N SL+ FL R + V ++ GIA G+ YL S
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL----RENDGKFTVGQLVGMLRGIASGMKYL---SE 124
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ +HRDL A NIL++S++ K+SDFG++R
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 7e-21
Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 17/169 (10%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
++G+G FG VY + +G+ +K LS+ S + ++ NE+ ++ KL H N+++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 578 CCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQ---GLLYLHQY 632
E+G+ ++ EY L+ + +I++ Q L YLH
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPF----PEEQILDWFVQLCLALKYLH-- 120
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
SR +I+HRD+K NI L S+ K+ DFG++++ T VVGT
Sbjct: 121 SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 8e-21
Identities = 49/166 (29%), Positives = 81/166 (48%), Gaps = 28/166 (16%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN-----EMMLIAKLQ 568
+ KLGEG + VYK + G+ VA+K++ + K+ N E+ L+ +L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMP--------NKSLNFFLFDPSRTHLLGWQTRVKIIE 620
H N++ L+ + L++E+M +KS+ + P+ T
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIKSYMLMT------ 111
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
+GL YLH I+HRDLK +N+L+ SD K++DFG+AR F
Sbjct: 112 --LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 8e-21
Identities = 47/155 (30%), Positives = 82/155 (52%), Gaps = 6/155 (3%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
++G G FG V+ G L ++VA+K + + ++F E ++ KL H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
E+ L++E+M + L+ +L ++ +T + + + +G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
DL A N L+ + K+SDFGM R D+ +T
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 9e-21
Identities = 51/149 (34%), Positives = 74/149 (49%), Gaps = 6/149 (4%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 581
LG G FG V+ GK +VA+K + + +F E ++ KL H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 582 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRD 641
Q ++ EYM N L +L R LG + + + + + + YL IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 642 LKASNILLDSDMNPKISDFGMARMFCGDE 670
L A N L+ D K+SDFG+AR D+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQ 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 54/145 (37%), Positives = 76/145 (52%), Gaps = 6/145 (4%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLMGCC 579
K+G+G FG VYKG L EVAVK S LK F E ++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
V++ ++ E +P SL FL L + +++ A G+ YL + IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 640 RDLKASNILLDSDMNPKISDFGMAR 664
RDL A N L+ + KISDFGM+R
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-20
Identities = 37/108 (34%), Positives = 54/108 (50%), Gaps = 3/108 (2%)
Query: 213 TGPWNGLAFGADP--TNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQRLI 270
+GPWNG+ F P SY E E E+ Y Y ++ I L ++ G ++R
Sbjct: 3 SGPWNGIRFSGIPEMQKLSYYVYNFTENNE-EVYYTYRMTNNSIYSRLTLSSEGSLERFT 61
Query: 271 WHEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECLKGFKLK 318
W S W +F++AP + C +YG CG C V+ + C C+KGF K
Sbjct: 62 WIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPK 109
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 53/180 (29%), Positives = 85/180 (47%), Gaps = 30/180 (16%)
Query: 522 LGEGGFGPVYKGK---LLNGQE---VAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVR 574
+G+G FG V++ + LL + VAVK L + S +F+ E L+A+ H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-------------------LGWQTR 615
L+G C L++EYM LN FL S L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGDELQGN 674
+ I + +A G+ YL S + +HRDL N L+ +M KI+DFG++R ++ D + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 58/157 (36%), Positives = 80/157 (50%), Gaps = 6/157 (3%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
E + KLG G FG V+ G +VA+K L S + F E L+ +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLV 64
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
RL V Q +I EYM N SL FL P L + + IA+G+ ++
Sbjct: 65 RLYAV-VTQEPIYIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIE--- 119
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
R IHRDL+A+NIL+ + KI+DFG+AR+ +E
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 51/169 (30%), Positives = 85/169 (50%), Gaps = 10/169 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
E F + KLGEG +G VYK GQ VA+K + + L+E E+ ++ + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYI 60
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
V+ G + + ++ EY S++ + ++T L + I+ +GL YLH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGLEYLHS- 117
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+ IHRD+KA NILL+ + K++DFG++ + NT V+GT
Sbjct: 118 --NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGT 162
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 23/161 (14%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRN 571
+ LG+G G VYK + G+ A+K++ + K+ E+ + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG--------IA 623
+V+ G ++GE ++ EYM SL L + KI E I
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLL-----------KKVGKIPEPVLAYIARQIL 109
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+GL YLH + IIHRD+K SN+L++S KI+DFG+++
Sbjct: 110 KGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISK 148
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 58/169 (34%), Positives = 89/169 (52%), Gaps = 21/169 (12%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLS----SQSGQG-LKEFKNEMMLIAKLQHRNLVRL 575
LG G FG VY+G L +G AVK +S Q+GQ +K+ + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 576 MGCCVEQGEKILIY-EYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
+G + + + I+ E +P SL L + ++ TR I GL YLH
Sbjct: 68 LGT-EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLH-- 119
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
R +HRD+K +NIL+D++ K++DFGMA+ K G+
Sbjct: 120 DR-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGS 164
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 58/188 (30%), Positives = 100/188 (53%), Gaps = 27/188 (14%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRL---SSQSG---QGLKEFKNEMM 562
+ ++ + KLGEG FG VYK ++ G+ VA+K++ + + G L+E K
Sbjct: 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK---- 59
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKI--------LIYEYMPNKSLNFFLFDPSRTHLLGWQT 614
++ KL+H N+V L+ VE+ +K ++ YM + L+ L +P L ++
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENP-SVKLT--ES 115
Query: 615 RVK-IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 673
++K + + +G+ YLH+ I+HRD+KA+NIL+D+ KI+DFG+AR + G
Sbjct: 116 QIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172
Query: 674 NTKRVVGT 681
GT
Sbjct: 173 KGGGGGGT 180
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 24/157 (15%)
Query: 522 LGEGGFGPVYKGKL-----LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
LG+G FG V + G+ VAVK+L + + L++F+ E+ ++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 577 GCCVEQGEK--ILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLLY 628
G C G + L+ EY+P SL +L D + L Q I +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665
L R +HRDL NIL++S+ KI DFG+ ++
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKV 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 55/169 (32%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGKL--LNG----QEVAVKRL-SSQSGQGLKEFKNEMM 562
++ ++ LG G FG VY+G +G +VAVK L S S Q +F E +
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKI 618
+++K H+N+VRL+G E+ + ++ E M L FL + P R L + +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMAR 664
+A+G YL + IHRD+ A N LL KI+DFGMAR
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 517 SMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
+M+ KLG G +G VY+G VAVK L + ++EF E ++ +++H NLV+L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
+G C + +I E+M +L +L + +R + + + I+ + YL + +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669
IHRDL A N L+ + K++DFG++R+ GD
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 57/159 (35%), Positives = 92/159 (57%), Gaps = 12/159 (7%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 575
LG G FG VYKG + E VA+K L+ +G + EF +E +++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
+G C+ + L+ + MP+ L ++ + +G Q + IA+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEER--- 128
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN 674
R++HRDL A N+L+ S + KI+DFG+AR+ GDE + N
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 57/169 (33%), Positives = 84/169 (49%), Gaps = 29/169 (17%)
Query: 518 MQCKLGEGGFGPVYKGK---LLNGQE---VAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
++ +LGEG FG V+ + LL Q+ VAVK L S ++F+ E L+ LQH++
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH----------------LLGWQTR 615
+VR G C E ++++EYM + LN FL R+H L
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFL----RSHGPDAKILAGGEDVAPGQLTLGQM 124
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ I IA G++YL + L +HRDL N L+ + KI DFGM+R
Sbjct: 125 LAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 7e-19
Identities = 56/152 (36%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 521 KLGEGGFGPVYKGKLLNGQ----EVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRL 575
KLG+G FG V +G+ VAVK L S + +F E ++ L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLG---WQTRVKIIEGIAQGLLYLHQY 632
G V +++ E P SL L + H L V+I A G+ YL
Sbjct: 62 YGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLESK 116
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
R IHRDL A NILL SD KI DFG+ R
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 9e-19
Identities = 55/165 (33%), Positives = 85/165 (51%), Gaps = 21/165 (12%)
Query: 522 LGEGGFGPVYKGKL----LNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
LGEG FG V +G+L + +VAVK +L + ++EF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 576 MGCCVEQGEK------ILIYEYMPNKSLNFFLFDPSRTHL----LGWQTRVKIIEGIAQG 625
+G C E ++I +M + L+ FL SR L QT +K + IA G
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLY-SRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD 669
+ YL S IHRDL A N +L DM ++DFG+++ ++ GD
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 45/153 (29%), Positives = 84/153 (54%), Gaps = 11/153 (7%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--EMMLIAKLQHRNLVRLMG 577
K+GEG +G VYK + L G+ VA+K++ + E+ L+ +L H N+++L+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK-IIEGIAQGLLYLHQYSRLR 636
+G+ L++E+M + + L + L ++ +K + + QGL + H +
Sbjct: 66 VFRHKGDLYLVFEFM--DTDLYKLIKDRQRGLP--ESLIKSYLYQLLQGLAFCHSH---G 118
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669
I+HRDLK N+L++++ K++DFG+AR F
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 51/154 (33%), Positives = 75/154 (48%), Gaps = 7/154 (4%)
Query: 518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
+ KLG G FG V++G N VAVK L + K+F E ++ KL+H L++L
Sbjct: 10 LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYA 68
Query: 578 CCVEQGEKILIY-EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
C E I I E M SL +L + L + + +A G+ YL +
Sbjct: 69 VCT-LEEPIYIVTELMKYGSLLEYLQGGAGRAL-KLPQLIDMAAQVASGMAYLEAQN--- 123
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
IHRDL A N+L+ + K++DFG+AR+ D
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 56/184 (30%), Positives = 82/184 (44%), Gaps = 32/184 (17%)
Query: 521 KLGEGGFGPVYKGKLLNGQE-----------------VAVKRL-SSQSGQGLKEFKNEMM 562
KLGEG FG V+ + Q+ VAVK L S ++F E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--------FDPSRTHLLGWQT 614
++++L N+ RL+G C +I EYM N LN FL + L + T
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 615 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--EL 671
+ + IA G+ YL L +HRDL N L+ + KI+DFGM+R ++ D +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 672 QGNT 675
QG
Sbjct: 189 QGRA 192
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 53/152 (34%), Positives = 82/152 (53%), Gaps = 18/152 (11%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKR-----LSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
LG+G FG VY ++ G+E+AVK+ S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 576 MGCCVEQGEKILIY-EYMPNKSLNFFLFDPSRTH--LLGWQTRVKIIEGIAQGLLYLHQY 632
GC + E + I+ EYMP S+ D + + L TR K I +G+ YLH
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGSVK----DQLKAYGALTETVTR-KYTRQILEGVEYLH-- 121
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
I+HRD+K +NIL DS N K+ DFG ++
Sbjct: 122 -SNMIVHRDIKGANILRDSAGNVKLGDFGASK 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 54/154 (35%), Positives = 78/154 (50%), Gaps = 14/154 (9%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
+LG G FG V GK +VA+K + S EF E ++ KL H LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VKIIEGIAQGLLYL--HQYSRLR 636
+Q ++ EYM N L +L R H +Q +++ + + +G+ YL Q+
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYL----REHGKRFQPSQLLEMCKDVCEGMAYLESKQF---- 121
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
IHRDL A N L+D K+SDFG++R DE
Sbjct: 122 -IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 58/170 (34%), Positives = 83/170 (48%), Gaps = 27/170 (15%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN---GQE---VAVKRLSSQSGQGLKEFKNEMMLIAKLQ 568
N ++ +LGEG FG V+ + N Q+ VAVK L S K+F E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH--------------LLGWQT 614
H ++V+ G CVE I+++EYM + LN FL R H L
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFL----RAHGPDAVLMAEGNRPAELTQSQ 121
Query: 615 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ I + IA G++YL + +HRDL N L+ ++ KI DFGM+R
Sbjct: 122 MLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 6e-18
Identities = 53/154 (34%), Positives = 87/154 (56%), Gaps = 18/154 (11%)
Query: 522 LGEGGFGPVYKG--KLLNGQEVAVKRLSSQSGQGLKE---FKNEMMLIAKLQHRNLVRLM 576
+G G FG V++G K+ +EVAV + + G K+ F +E ++ + H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDP----SRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
G + ++I EYM N +L+ +L D S L+G ++ GIA G+ YL
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG------MLRGIAAGMKYL--- 123
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
S + +HRDL A NIL++S++ K+SDFG++R+
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 52/166 (31%), Positives = 89/166 (53%), Gaps = 17/166 (10%)
Query: 521 KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQG------LKEFKNEMMLIAKLQHRNLV 573
++GEG G V+K K G+ VA+K+++ + +G L+E K + QH +V
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVV 62
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
+L+ +L+ EYMP+ L+ L D R L Q + + + +G+ Y+H
Sbjct: 63 KLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERP-LPEAQVK-SYMRMLLKGVAYMHA-- 117
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
I+HRDLK +N+L+ +D KI+DFG+AR+F +E + + +V
Sbjct: 118 -NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 56/160 (35%), Positives = 77/160 (48%), Gaps = 20/160 (12%)
Query: 522 LGEGGFGPVYKGKLLN-------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLV 573
LG G FG VY+G + VAVK L + Q KEF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH----LLGWQTRVKIIEGIAQGLLYL 629
+L+G C+ + +I E M L +L D LL + + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 630 HQYSRLRIIHRDLKASNILL-----DSDMNPKISDFGMAR 664
Q + IHRDL A N L+ D+D KI DFG+AR
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 56/164 (34%), Positives = 92/164 (56%), Gaps = 13/164 (7%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFK-NEMMLIAKLQHRNLVRLM 576
K+GEG +G VYK + L G+ VA+K RL ++ +G+ E+ L+ +L H N+VRL+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLL 64
Query: 577 GCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
V K+ L++E++ + L ++ D S L + + QG+ Y H +
Sbjct: 65 DV-VHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHSH--- 118
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
R++HRDLK N+L+D + K++DFG+AR F G ++ T VV
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-17
Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 12/95 (12%)
Query: 326 PRECVRSHSSDCITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSK 385
P C S+D F+K D+KLP ++ +++L+EC CL NC+C AYA +
Sbjct: 2 PLNCGGDGSTD-----GFLKLPDVKLPDN-ASAIT-AISLEECREACLSNCSCTAYAYNN 54
Query: 386 VTGGGSGCLMWFGDLIDIRKITGYNNGQPIYVRVP 420
G GCL+W G L ++R + G +Y+R+
Sbjct: 55 ---GSGGCLLWNGLLNNLRS--LSSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 52/150 (34%), Positives = 81/150 (54%), Gaps = 9/150 (6%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
K+GEG +G VYKG+ GQ VA+K RL S+ E+ L+ +LQH N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK-IIEGIAQGLLYLHQYSRLR 636
+++ LI+E++ + P ++ VK + I QG+L+ H R
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMD--AELVKSYLYQILQGILFCH---SRR 121
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMF 666
++HRDLK N+L+D+ K++DFG+AR F
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAF 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 53/144 (36%), Positives = 79/144 (54%), Gaps = 8/144 (5%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
+GEG FG V +G+ GQ+VAVK + + F E ++ KL H+NLVRL+G +
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
G I++ E M +L FL R L+ ++ +A+G+ YL +++HR
Sbjct: 70 HNGLYIVM-ELMSKGNLVNFLRTRGRA-LVSVIQLLQFSLDVAEGMEYLESK---KLVHR 124
Query: 641 DLKASNILLDSDMNPKISDFGMAR 664
DL A NIL+ D K+SDFG+AR
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 50/172 (29%), Positives = 72/172 (41%), Gaps = 35/172 (20%)
Query: 522 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFK-----NEMMLIAKL-QHRNLVR 574
+GEG F V K +E A+K L + Q +KE K E ++ +L H +++
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 575 LMGCCVEQGEKILIYEYMPN----------KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
L ++ + EY PN SL+ + I
Sbjct: 67 LYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDE-------------KCTRFYAAEILL 113
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
L YLH IIHRDLK NILLD DM+ KI+DFG A++ + + K
Sbjct: 114 ALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 52/154 (33%), Positives = 86/154 (55%), Gaps = 22/154 (14%)
Query: 522 LGEGGFGPVYKGKL-LNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
+G G FG V +G+L L G+ VA+K L S + + ++F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
G + ++I E+M N +L+ FL F L+G ++ GIA G+ YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV--IQLVG------MLRGIAAGMKYL- 122
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
S + +HRDL A NIL++S++ K+SDFG++R
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 55/157 (35%), Positives = 80/157 (50%), Gaps = 5/157 (3%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
E+ + KLG G FG V+ G N +VAVK L + ++ F E L+ LQH LV
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 64
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
RL ++ +I EYM SL FL +L + IA+G+ Y+
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE--- 120
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
R IHRDL+A+N+L+ + KI+DFG+AR+ +E
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 50/172 (29%), Positives = 83/172 (48%), Gaps = 24/172 (13%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRL-SSQSGQGLKEFKNEMMLIAK 566
+ ++ LGEG FG V K + + VAVK L + + L + +EM ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 567 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRTHL--LGW 612
+ +H+N++ L+G C ++G ++ EY + +L FL D R L
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 613 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ V +A+G+ +L + IHRDL A N+L+ D KI+DFG+AR
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 49/156 (31%), Positives = 72/156 (46%), Gaps = 16/156 (10%)
Query: 522 LGEGGFGPVYKGKLLNGQE------VAVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVR 574
LG G FG V+ K +E V VK L + EF+ E+ + KL H+N+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLLY 628
L+G C E +I EY L FL + + L + +V + IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
L S R +HRDL A N L+ S K+S +++
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 54/167 (32%), Positives = 79/167 (47%), Gaps = 30/167 (17%)
Query: 521 KLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
+LGEG FG V+ + N VAVK L + K+F+ E L+ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH-----------------LLGWQTRVK 617
G C + I+++EYM + LN FL R H LG +
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFL----RAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
I IA G++YL + +HRDL N L+ +++ KI DFGM+R
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 1e-16
Identities = 53/170 (31%), Positives = 79/170 (46%), Gaps = 24/170 (14%)
Query: 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEF---KNEMMLIAKLQHRNLVRLMG 577
LG+G FG V + + G+ A+K L + KE E +++++ H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 578 CCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
+ EK+ L+ EY P L L F R + I L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAE--------IVLALEYLH- 110
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
L II+RDLK NILLD+D + K++DFG+A+ + + NT GT
Sbjct: 111 --SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 49/172 (28%), Positives = 81/172 (47%), Gaps = 32/172 (18%)
Query: 516 FSMQCKLGEGGFGPVYKGKLLN---GQEVAVKRL--SSQSGQGLKEFK-NEMMLIAKLQH 569
+ ++ +G G +G VYK K N G+E A+K+ + G+ + E+ L+ +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 570 RNLVRLMGCCVEQGEKI--LIYEYMPNKSLNFFLF--DPSRTHL-------LGWQTRVKI 618
N+V L+ +E +K L+++Y + F R + L WQ
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ----- 116
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMF 666
I G+ YLH ++HRDLK +NIL+ + KI D G+AR+F
Sbjct: 117 ---ILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 59/178 (33%), Positives = 91/178 (51%), Gaps = 26/178 (14%)
Query: 521 KLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLV 573
+LGE FG VYKG L Q VA+K L ++ L+E FK+E M+ ++LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLF-----------DPSRT--HLLGWQTRVKIIE 620
L+G ++ +I+ Y + L+ FL D +T L V I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--ELQGNT 675
IA G+ +L S ++H+DL N+L+ +N KISD G+ R ++ D +L GN+
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 50/175 (28%), Positives = 92/175 (52%), Gaps = 26/175 (14%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLS------SQSGQGLKEFKNEMMLIAKLQHRNLVR 574
LG G F Y+ + + G +AVK+++ S+ + ++ + E+ L+A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
++G E L E+M S++ L + + ++ + E + +GL YLH+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHEN 122
Query: 633 SRLRIIHRDLKASNILLDSD-MNPKISDFGMA-RMFC----GDELQGNTKRVVGT 681
+IIHRD+K +N+L+DS +I+DFG A R+ E QG +++GT
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGT 171
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 24/160 (15%)
Query: 516 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLIAK 566
+ + +LG+G FG VY + G+ VA+K++ K+F + E+ + K
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRK 53
Query: 567 LQ-HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK-IIEGIAQ 624
L H N+V+L E E ++EYM N + R ++ ++ II I Q
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYMEG---NLYQLMKDRKGKPFSESVIRSIIYQILQ 110
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
GL ++H + HRDLK N+L+ KI+DFG+AR
Sbjct: 111 GLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 50/173 (28%), Positives = 92/173 (53%), Gaps = 15/173 (8%)
Query: 515 NFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAKLQHRN 571
+F + K+G+G FG V+K + + + A+K+ LS + + +E +E ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL---LGWQTRVKIIEGIAQGLLY 628
++R +++G+ ++ EY N L+ L L W+ ++I+ G+A +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
LH +I+HRD+K+ N+ LD+ N KI D G+A++ + NT +VGT
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 51/150 (34%), Positives = 77/150 (51%), Gaps = 6/150 (4%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
+LG G FG V+ GK +VA+K ++ + ++F E ++ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
+Q ++ E+M N L +L R L + + + + +G+ YL + S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGDE 670
DL A N L+ S K+SDFGM R DE
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 53/168 (31%), Positives = 93/168 (55%), Gaps = 9/168 (5%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRN 571
NF K+GEG +G VYK + L G+ VA+K RL +++ E+ L+ +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
+V+L+ + + L++E++ ++ L F+ D S + + + QGL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
+ R++HRDLK N+L++++ K++DFG+AR F G ++ T VV
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV 162
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 55/163 (33%), Positives = 89/163 (54%), Gaps = 14/163 (8%)
Query: 522 LGEGGFGPVYKGKL-LNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
+G G FG V G+L L G+ VA+K L + + + ++F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQT--RVKIIEGIAQGLLYLHQYSR 634
G + +++ EYM N SL+ FL R H + V ++ GIA G+ YL S
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFL----RKHDGQFTVIQLVGMLRGIASGMKYL---SD 124
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
+ +HRDL A NIL++S++ K+SDFG++R+ D T R
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 60/193 (31%), Positives = 95/193 (49%), Gaps = 46/193 (23%)
Query: 521 KLGEGGFGPVYKGKLLNGQE-----------------VAVKRLSSQSGQGLK-EFKNEMM 562
KLGEG FG V+ +++N Q+ VAVK L + + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLL------------ 610
++++L+ N++RL+G CV++ +I EYM N LN FL S HL
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAVPP 128
Query: 611 -------GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
+ + + + IA G+ YL S L +HRDL N L+ ++ KI+DFGM+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 664 R-MFCGD--ELQG 673
R ++ GD +QG
Sbjct: 186 RNLYAGDYYRIQG 198
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 57/181 (31%), Positives = 89/181 (49%), Gaps = 31/181 (17%)
Query: 521 KLGEGGFGPVYKGKLLNGQE---------------VAVKRLSSQSGQGLK-EFKNEMMLI 564
KLGEG FG V+ + E VAVK L + + + +F E+ ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL----FDPSRTHL-----LGWQTR 615
++L++ N++RL+G CV +I EYM N LN FL + + TH +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--ELQ 672
+ + IA G+ YL + L +HRDL N L+ + KI+DFGM+R ++ GD +Q
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 673 G 673
G
Sbjct: 189 G 189
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 48/152 (31%), Positives = 83/152 (54%), Gaps = 11/152 (7%)
Query: 522 LGEGGFGPVYKGKLLNGQ-EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
LG+G +G VY + L+ Q +A+K + + + ++ E+ L + L+HRN+V+ +G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 581 EQGEKILIYEYMPNKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
E G + E +P SL+ L + P + + QT + + I +GL YLH +I
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDN---EQTIIFYTKQILEGLKYLHD---NQI 129
Query: 638 IHRDLKASNILLDSDMNP-KISDFGMARMFCG 668
+HRD+K N+L+++ KISDFG ++ G
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 45/171 (26%), Positives = 72/171 (42%), Gaps = 29/171 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQGLK-EFKNEMMLIAK 566
E ++ +LG+G FG VY+G VA+K ++ + + EF NE ++ +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYM-------------PNKSLNFFLFDPSRTHLLGWQ 613
++VRL+G +++ E M P N L P+ +
Sbjct: 66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125
Query: 614 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
IA G+ YL + +HRDL A N ++ D+ KI DFGM R
Sbjct: 126 AE------IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-16
Identities = 56/159 (35%), Positives = 86/159 (54%), Gaps = 17/159 (10%)
Query: 522 LGEGGFGPV----YKGKLLN-GQEVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRL 575
LGEG FG V Y + N G++VAVK L +SG + + K E+ ++ L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 576 MGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL--HQ 631
G C E G LI E++P+ SL +L P + + + ++K I +G+ YL Q
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
Y +HRDL A N+L++S+ KI DFG+ + D+
Sbjct: 130 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 51/161 (31%), Positives = 79/161 (49%), Gaps = 31/161 (19%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVK----------RLSSQSGQGLKEFKNEMMLIAKLQHR 570
+G+G +G VY + G+ +AVK R S+ +K ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 571 NLVRLMGCCVEQGEKIL-IY-EYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIA 623
N+V+ +G E E+ L I+ EY+P S+ L F+ Q
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV--------L 118
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+GL YLH I+HRDLKA N+L+D+D KISDFG+++
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 50/157 (31%), Positives = 90/157 (57%), Gaps = 16/157 (10%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFK-NEMMLIAKLQ---HRNLVRL 575
+GEG +G VYK + L G+ VA+K++ S +G+ E+ L+ +L+ H N+VRL
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 576 MGCC-VEQGEKI----LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
+ C + ++ L++E++ ++ L +L + L + ++ + +G+ +LH
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDFLH 124
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667
+ RI+HRDLK NIL+ SD KI+DFG+AR++
Sbjct: 125 SH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 49/172 (28%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 571
+++ + +G G VY L N ++VA+KR+ + + E + E+ +++ H N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
+V+ V E L+ Y+ SL + L +++ + +GL YLH
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNTKRVVGT 681
+ IHRD+KA NILL D + KI+DFG++ GD + K VGT
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 51/163 (31%), Positives = 86/163 (52%), Gaps = 24/163 (14%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRN 571
NF KLGEG + VYKG+ G+ VA+K L ++ G + E+ L+ +L+H N
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHEN 59
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL--------FDPSRTHLLGWQTRVKIIEGIA 623
+VRL + + +L++EYM +K L ++ DP+ +Q +
Sbjct: 60 IVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQ--------LL 110
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
+G+ + H+ R++HRDLK N+L++ K++DFG+AR F
Sbjct: 111 KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAF 150
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 8e-16
Identities = 51/144 (35%), Positives = 75/144 (52%), Gaps = 6/144 (4%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRNLVRLMGCCV 580
LG+G FG V+KG L + VAVK Q LK +F +E ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
++ ++ E +P +F F + L + VK A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 641 DLKASNILLDSDMNPKISDFGMAR 664
DL A N L+ + KISDFGM+R
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 45/151 (29%), Positives = 68/151 (45%), Gaps = 16/151 (10%)
Query: 521 KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMM---LIAKLQHRNLVRLM 576
+LG G G V K G+ +AVK + + K + ++ K +V
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFL---FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
G G+ + EYM SL+ L +LG KI + +GL YLH
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLH--E 118
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ +IIHRD+K SNIL++S K+ DFG++
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 9e-16
Identities = 53/157 (33%), Positives = 83/157 (52%), Gaps = 6/157 (3%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ KL+H LV
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 64
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
+L E+ I + EYM SL FL +L Q V + IA G+ Y+
Sbjct: 65 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 119
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
R+ +HRDL+A+NIL+ ++ K++DFG+AR+ +E
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 54/159 (33%), Positives = 84/159 (52%), Gaps = 28/159 (17%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKR--LSSQSGQG-------LKEFKNEMMLIAKLQHRN 571
+G G FG VY G +G+ +AVK+ L S S L E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSL-----NFFLFDPSRTHLLGWQTRVK-IIEGIAQG 625
+V+ +G ++ + EY+P S+ N+ F+ +T V+ + I +G
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE---------ETLVRNFVRQILKG 118
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
L YLH +R IIHRD+K +NIL+D+ KISDFG+++
Sbjct: 119 LNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 56/164 (34%), Positives = 86/164 (52%), Gaps = 26/164 (15%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRL 575
LG G FG V+KG + + VA+K + +SG Q +E + M+ + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 576 MGCCVEQGEKI-LIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLLY 628
+G C G + L+ + P SL + DP R LL W + IA+G+ Y
Sbjct: 75 LGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQR--LLNWCVQ------IAKGMYY 124
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 672
L ++ R++HR+L A NILL SD +I+DFG+A + D+ +
Sbjct: 125 LEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 47/169 (27%), Positives = 83/169 (49%), Gaps = 16/169 (9%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG-----QEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL 567
+ ++ L EG FG ++ G L++ +EV VK + + + + E L+ L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 568 QHRNLVRLMGCCVEQGEK-ILIYEYMPNKSLNFFLFDPS-----RTHLLGWQTRVKIIEG 621
H+N++ ++ C+E GE ++Y YM +L FL L Q V +
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD 669
IA G+ YLH + +IH+D+ A N ++D ++ KI+D ++R +F D
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 54/164 (32%), Positives = 90/164 (54%), Gaps = 20/164 (12%)
Query: 522 LGEGGFGPVYKGKLLNGQ---EVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
LGEG FG V +G+L +VAVK +++ + +++F +E + + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 577 GCCVEQGEK------ILIYEYMPNKSLNFFLFDPSR----THLLGWQTRVKIIEGIAQGL 626
G C++ E ++I +M + L+ FL SR L Q VK + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGD 669
YL S IHRDL A N +L+ +MN ++DFG++ +++ GD
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 45/158 (28%), Positives = 82/158 (51%), Gaps = 20/158 (12%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
E++ + ++G G +G VYK + + G+ VA+K + + G + + E+ ++ + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA-------QG 625
V G + + + ++ EY SL ++ +R L Q IA +G
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQ-DIYQVTRGPLSELQ--------IAYVCRETLKG 113
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
L YLH+ IHRD+K +NILL D + K++DFG++
Sbjct: 114 LAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 8/152 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
+ + +G+G FG V G G +VAVK + + + + F E ++ +L+H NLV
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 62
Query: 574 RLMGCCVEQ-GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
+L+G VE+ G ++ EYM SL +L R+ +LG +K + + + YL
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ +HRDL A N+L+ D K+SDFG+ +
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 48/144 (33%), Positives = 83/144 (57%), Gaps = 6/144 (4%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
+LG+G FG VYK K G A K + ++S + L+++ E+ ++A H +V+L+G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
G+ ++ E+ P +++ + + R L Q +V I + + L YLH ++IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQV-ICRQMLEALQYLHS---MKIIH 133
Query: 640 RDLKASNILLDSDMNPKISDFGMA 663
RDLKA N+LL D + K++DFG++
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 54/159 (33%), Positives = 80/159 (50%), Gaps = 6/159 (3%)
Query: 512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
E+ + KLG G FG V+ G +VAVK L + + F E ++ KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDK 62
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
LV+L E+ I + EYM SL FL D L V + +A G+ Y+
Sbjct: 63 LVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE- 119
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
R+ IHRDL+++NIL+ + KI+DFG+AR+ +E
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 56/158 (35%), Positives = 85/158 (53%), Gaps = 8/158 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNL 572
E+ + KLG+G FG V+ G +VA+K L + G + E F E ++ KL+H L
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKL 63
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
V L E+ I + E+M SL FL + +L Q V + IA G+ Y+
Sbjct: 64 VPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAAQIADGMAYIE-- 119
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
R+ IHRDL+A+NIL+ ++ KI+DFG+AR+ +E
Sbjct: 120 -RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 19/159 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKR-LSSQSGQGLKEFK-NEMMLIAKLQHR 570
+ + +GEG +G V K + G+ VA+K+ S+ + +K+ E+ ++ +L+H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQG 625
N+V L +G L++EY+ L P WQ + Q
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LLQA 112
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ Y H IIHRD+K NIL+ K+ DFG AR
Sbjct: 113 IAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 9e-15
Identities = 55/167 (32%), Positives = 81/167 (48%), Gaps = 25/167 (14%)
Query: 521 KLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQG--LKEFKNEMMLIAKLQHRNLVRLMG 577
K+G G FG VY L+ E+ AVK + Q +KE +EM ++ L+H NLV+ G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 578 CCVEQGEKILIY-EYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
V + EK+ I+ EY +L L RV ++ + +GL YLH +
Sbjct: 67 VEVHR-EKVYIFMEYCSGGTLEELLEHGRILDEHV------IRVYTLQ-LLEGLAYLHSH 118
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMF------CGDELQG 673
I+HRD+K +NI LD + K+ DFG A G+E+Q
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS 162
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 40/150 (26%), Positives = 75/150 (50%), Gaps = 9/150 (6%)
Query: 516 FSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRNLV 573
F++ +G+G FG VYK Q VA+K + ++ +++ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
+ G ++ + +I EY S D + L I+ + GL YLH+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMA 663
IHRD+KA+NILL + + K++DFG++
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 32/182 (17%)
Query: 521 KLGEGGFGPVYKGKLLNGQE-----------------VAVKRLSSQSGQGLK-EFKNEMM 562
KLGEG FG V+ + ++ VAVK L + + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--------FDPSRTHLLGWQT 614
++++L+ N++RL+ C+ +I EYM N LN FL + + + + T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 615 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD--EL 671
+ + IA G+ YL S L +HRDL N L+ + KI+DFGM+R ++ GD +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 672 QG 673
QG
Sbjct: 189 QG 190
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 46/153 (30%), Positives = 70/153 (45%), Gaps = 8/153 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGL-KEFKNEMMLIAKLQHRN 571
E +LGEG G V K +L N + A+K +++ L K+ E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 572 LVRLMGCCVE--QGEKILIYEYMPNKSLNFFLFD-PSRTHLLGWQTRVKIIEGIAQGLLY 628
+V+ G ++ + EY SL+ R +G + KI E + +GL Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661
LH +IIHRD+K SNILL K+ DFG
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 52/159 (32%), Positives = 85/159 (53%), Gaps = 20/159 (12%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
LG G FG VYKG + E VA+K L + S + KE +E ++A + + ++ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT----HLLGWQTRVKIIEGIAQGLLYLHQ 631
+G C+ + LI + MP L ++ + +LL W + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLEE 127
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
R++HRDL A N+L+ + + KI+DFG+A++ DE
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 53/168 (31%), Positives = 83/168 (49%), Gaps = 21/168 (12%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLNG---QEVAVKRLSSQSGQG-LKEFKNEMMLIAKL-QH 569
+ Q +GEG FG V K ++ + A+KR+ + + ++F E+ ++ KL H
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------FDP------SRTHLLGWQTRV 616
N++ L+G C +G L EY P+ +L FL DP S L Q +
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 617 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+A+G+ YL Q + IHRDL A NIL+ + KI+DFG++R
Sbjct: 128 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 52/151 (34%), Positives = 77/151 (50%), Gaps = 14/151 (9%)
Query: 522 LGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
LG+G FG VY G+ L ++V S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 576 MGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
GC ++ EK L EYMP S+ L + L TR K I +G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTR-KYTRQILEGMSYLHSN- 125
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
I+HRD+K +NIL DS N K+ DFG ++
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 48/153 (31%), Positives = 73/153 (47%), Gaps = 14/153 (9%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
++G G FG VY + + + VA+K++S QS + ++ E+ + +L+H N +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VKIIEGIAQGLLYLHQYSR 634
GC + + L+ EY + D H Q I G QGL YLH + R
Sbjct: 82 GCYLREHTAWLVMEYCLGSAS-----DILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667
IHRD+KA NILL K++DFG A +
Sbjct: 137 ---IHRDIKAGNILLTEPGTVKLADFGSASLVS 166
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 47/153 (30%), Positives = 84/153 (54%), Gaps = 19/153 (12%)
Query: 522 LGEGGFGPVYKGKLL--NGQEV--AVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLM 576
+G+G FG VY G L+ +GQ++ AVK L+ + + +++F E +++ H N++ L+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 577 GCCV-EQGEKILIYEYMPNKSLNFFLFDPSRT----HLLGWQTRVKIIEGIAQGLLYLHQ 631
G C+ +G +++ YM + L F+ + L+G+ +V A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV------AKGMEYLAS 116
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ +HRDL A N +LD K++DFG+AR
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 55/179 (30%), Positives = 86/179 (48%), Gaps = 32/179 (17%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKR-LSSQSGQG-----LKEFKNEMMLIAKLQHRNLV 573
K+G+G FG V+K + Q VA+K+ L +G L+E K ++ L+H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQLLKHENVV 74
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW--QTRVK--------IIEGIA 623
L+ C + Y K + +F+ L G VK +++ +
Sbjct: 75 NLIEICRTKATP-----YNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL 129
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC---GDELQGNTKRVV 679
GL Y+H R +I+HRD+KA+NIL+ D K++DFG+AR F + T RVV
Sbjct: 130 NGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 50/160 (31%), Positives = 85/160 (53%), Gaps = 16/160 (10%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGL---KEFKN---EMMLIAKLQHRNLVRL 575
LG+G +G VY G GQ +AVK++ + L KE++ E+ L+ L+H N+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
+G C++ + E++P S++ L F P + T+ +I++G+A YLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHNNC 122
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 673
++HRD+K +N++L + K+ DFG AR L G
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 19/154 (12%)
Query: 521 KLGEGGFGPVYKGKLLNGQE-VAVKRLSSQS-GQGLKEFK-NEMMLIAKLQHRNLVRLMG 577
K+GEG +G V+K K E VA+KR+ +G+ E+ L+ +L+H+N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 578 CCVEQGEKILIYEYMPNKSLNFF-----LFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
+ L++EY +F DP +Q + +GL + H +
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQ--------LLKGLAFCHSH 118
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
++HRDLK N+L++ + K++DFG+AR F
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 55/174 (31%), Positives = 86/174 (49%), Gaps = 26/174 (14%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE--------VAVKRLSSQ-SGQGLKEFKNEMMLI 564
+ + LGEG FG V + + + VAVK L + + L + +EM L+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 565 AKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRTH--LL 610
+ +H+N++ L+G C ++G +I EY +L FL FD ++ L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 611 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
++ V +A+G+ YL SR R IHRDL A N+L+ D KI+DFG+AR
Sbjct: 132 SFKDLVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 51/181 (28%), Positives = 94/181 (51%), Gaps = 27/181 (14%)
Query: 516 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAKLQHRN 571
F + ++GEG +G VYK + G+ VA+K++ + + G + + E+ ++ +L HRN
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRN 67
Query: 572 LVRLMGCCV----------EQGEKILIYEYMPNKSLNFF---LFDPSRTHLLGWQTRVKI 618
+V L ++G L++EYM + + L S H+
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI------KSF 121
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
++ + +GL Y H+ + L HRD+K SNILL++ K++DFG+AR++ +E + T +V
Sbjct: 122 MKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 679 V 679
+
Sbjct: 179 I 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 50/156 (32%), Positives = 83/156 (53%), Gaps = 21/156 (13%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFK-NEMMLIAKLQHRNLVRLMG 577
K+GEG +G VYK + + + +A+K++ Q +G+ E+ L+ ++QH N+VRL
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 578 CCVEQGEKILIYEYMP---NKSLNF---FLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
+ L++EY+ K ++ F +P +Q I+ GIA Y H
Sbjct: 69 VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ----ILRGIA----YCHS 120
Query: 632 YSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMF 666
+ R++HRDLK N+L+D N K++DFG+AR F
Sbjct: 121 H---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153
|
Length = 294 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 44/152 (28%), Positives = 83/152 (54%), Gaps = 6/152 (3%)
Query: 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
+ + + +LG+G FG VYK + G A K + +S + L++F E+ ++++ +H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
+V L + + ++ E+ +L+ + + R L Q R + + + L +LH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRY-VCRQMLEALNFLHS 121
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
+ ++IHRDLKA NILL D + K++DFG++
Sbjct: 122 H---KVIHRDLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 52/164 (31%), Positives = 81/164 (49%), Gaps = 23/164 (14%)
Query: 521 KLGEGGFGPVYKGKLL-----NGQEVAVKRLSS-QSGQGLKEFKNEMMLIAKLQHRNLVR 574
+LGE FG +YKG L + Q VA+K L + Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--------------VKIIE 620
L+G ++ +++EY+ L+ FL S +G + + I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
IA G+ YL + +H+DL A NIL+ ++ KISD G++R
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 54/186 (29%), Positives = 81/186 (43%), Gaps = 47/186 (25%)
Query: 515 NFSMQCKLGEGGFGPVYKG-----KLLNG-QEVAVKRLSSQSGQG-LKEFKNEMMLIAKL 567
N + LGEG FG V K K G VAVK L + L++ +E L+ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL----------------------FDPS 605
H ++++L G C + G +LI EY SL FL +P
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 606 RTHL-------LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 658
L WQ I++G+ YL + ++++HRDL A N+L+ KIS
Sbjct: 121 ERALTMGDLISFAWQ--------ISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKIS 169
Query: 659 DFGMAR 664
DFG++R
Sbjct: 170 DFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 50/171 (29%), Positives = 90/171 (52%), Gaps = 11/171 (6%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAKLQHRN 571
+F + KLG+G +G VYK K L + Q A+K L S S + ++ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH-LLGWQTRVKIIEGIAQGLLYLH 630
++ ++ + ++ EY P L+ + + L+ Q +I + +GL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+ +I+HRDLK++NILL ++ KI D G++++ + K +GT
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 20/179 (11%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL-------SSQSGQGLKEFKNEMMLI 564
NF ++ K+G+G F VYK LL+G+ VA+K++ + LKE L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56
Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGI 622
+L H N+++ + +E E ++ E L+ + F + L+ +T K +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKR-LIPERTIWKYFVQL 115
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
L ++H RI+HRD+K +N+ + + K+ D G+ R F ++ VGT
Sbjct: 116 CSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 11/150 (7%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVA---VKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
++G G FG V G+ G A VK L +S + F E+ +L H N+++ +
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW-QTRV--KIIEGIAQGLLYLHQYS 633
G C+E +L+ E+ P L +L +R + Q V ++ +A GLL+LHQ
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMA 663
IH DL N L +D++ KI D+G+A
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 59/176 (33%), Positives = 88/176 (50%), Gaps = 15/176 (8%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRL-----SSQSGQGLKEFKNEMMLIAKLQ 568
N+ + LG+G FG VY + G+E+AVK++ S ++ + + + E+ L+ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 569 HRNLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
H +V+ GC + E+ L E+MP S+ L S L TR K I +G+
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTR-KYTRQILEGV 119
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN-TKRVVGT 681
YLH I+HRD+K +NIL DS N K+ DFG ++ L G K V GT
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT 172
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 54/171 (31%), Positives = 89/171 (52%), Gaps = 21/171 (12%)
Query: 516 FSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQH 569
F++ LG+G FG V + +L + Q+VAVK L + S ++EF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 570 RNLVRLMGCCVEQGEK------ILIYEYMPNKSLNFFLFDPSRT----HLLGWQTRVKII 619
N+++L+G + K ++I +M + L+ FL SR L QT V+ +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRFM 119
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-MFCGD 669
IA G+ YL S IHRDL A N +L+ +M ++DFG+++ ++ GD
Sbjct: 120 IDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 54/159 (33%), Positives = 84/159 (52%), Gaps = 16/159 (10%)
Query: 522 LGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
LG G FG VYKG + E VA+K L + S + KE +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH--LLGWQTRVKIIEGIAQGLLYLHQYS 633
+G C+ + L+ + MP L D R + +G Q + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCL----LDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE-- 127
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 672
+R++HRDL A N+L+ S + KI+DFG+AR+ DE +
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 53/160 (33%), Positives = 85/160 (53%), Gaps = 12/160 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
E+ ++ KLG G FG V+ +VAVK + S ++ F E ++ LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 64
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE---GIAQGLLYLH 630
+L V + +I E+M SL FL ++ Q K+I+ IA+G+ ++
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
Q + IHRDL+A+NIL+ + + KI+DFG+AR+ +E
Sbjct: 120 QRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 47/149 (31%), Positives = 78/149 (52%), Gaps = 10/149 (6%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
++G G FG VY + + N + VA+K++S QS + ++ E+ + KL+H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
GC + + L+ EY + + L + + L + + G QGL YLH ++
Sbjct: 82 GCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAVTHGALQGLAYLHSHN--- 135
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARM 665
+IHRD+KA NILL K+ DFG A +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASI 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 57/178 (32%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRL-----SSQSGQGLKEFKNEMMLIAKL 567
N+ + LG G FG VY + G+E+AVK++ S ++ + + + E+ L+ L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 568 QHRNLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTH-LLGWQTRVKIIEGIAQ 624
+H +V+ GC + EK L EYMP S+ D + + L + I Q
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQ 117
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN-TKRVVGT 681
G+ YLH I+HRD+K +NIL DS N K+ DFG ++ + G K V GT
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 5e-13
Identities = 46/178 (25%), Positives = 76/178 (42%), Gaps = 57/178 (32%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMMLIAKLQHRN 571
+G G +G V G++VA+K++S F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 572 LVRLM-----GCCVEQGEKILIYEYMP--------------NKSLNFFLFDPSRTHLLGW 612
++ L+ + + ++ E M + + +FL+ +L
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLY-----QIL-- 113
Query: 613 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
+GL YLH +IHRDLK SNIL++S+ + KI DFG+AR DE
Sbjct: 114 -----------RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 52/157 (33%), Positives = 84/157 (53%), Gaps = 11/157 (7%)
Query: 511 AATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFK--NEMMLIAKL 567
AAT +++ KLGEG + VYKG +NGQ VA+K +S ++ +G+ F E L+ L
Sbjct: 3 AATSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGL 60
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
+H N+V L + ++EYM + + P H + R+ + + + +GL
Sbjct: 61 KHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLH--PYNVRLFMFQ-LLRGLA 117
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
Y+H I+HRDLK N+L+ K++DFG+AR
Sbjct: 118 YIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 46/174 (26%), Positives = 71/174 (40%), Gaps = 25/174 (14%)
Query: 522 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGC- 578
+GEG +G VYK + GQ VA+K + +E K E ++ K H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 579 -----CVEQGEKILIYEYMPNKS----LNFFLFDPSR--THLLGWQTRVKIIEGIAQGLL 627
+ L+ E S + R + + I+ +GL
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY-----ILRETLRGLA 127
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
YLH+ ++IHRD+K NILL + K+ DFG++ D G +GT
Sbjct: 128 YLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNTFIGT 176
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 47/154 (30%), Positives = 79/154 (51%), Gaps = 10/154 (6%)
Query: 516 FSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLS---SQSGQGLKEFKNEMMLIAKLQHRN 571
F+ ++G G FG VY + + EV A+K++S QS + ++ E+ + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
+ GC + + L+ EY + + L + + L + I G QGL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAITHGALQGLAYLHS 143
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665
++ +IHRD+KA NILL K++DFG A +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 47/146 (32%), Positives = 74/146 (50%), Gaps = 7/146 (4%)
Query: 521 KLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRNLVRLMGC 578
++G G FG V+ G+L + VAVK LK +F E ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 579 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRII 638
C ++ ++ E + + +F F + L + ++++E A G+ YL I
Sbjct: 62 CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 639 HRDLKASNILLDSDMNPKISDFGMAR 664
HRDL A N L+ KISDFGM+R
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 47/154 (30%), Positives = 79/154 (51%), Gaps = 9/154 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKR-LSSQSGQGLKEFK-NEMMLIAKLQHR 570
E + +GEG +G V K K GQ VA+K+ L S+ + +K+ E+ ++ +L+H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
NLV L+ + L++E++ + L+ P + L K + I +G+ + H
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCH 117
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
++ IIHRD+K NIL+ K+ DFG AR
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 51/173 (29%), Positives = 91/173 (52%), Gaps = 20/173 (11%)
Query: 521 KLGEGGFGPVYKGKLLN--GQEVAVKRL---SSQSGQGLKEFKNEMML--IAKLQHRNLV 573
++GEG +G V+K + L G+ VA+KR+ + + G L + +L + +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 574 RLMGCCV-----EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
RL C + + L++E++ ++ L +L D + +T ++ + +GL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
LH + R++HRDLK NIL+ S K++DFG+AR++ Q VV T
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 172
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 51/169 (30%), Positives = 83/169 (49%), Gaps = 21/169 (12%)
Query: 514 ENFSMQCKLGEGGFGPVYKG---KLLNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAKL-Q 568
E+ + +GEG FG V + K A+K L + + ++F E+ ++ KL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------FDPS--RTH----LLGWQTR 615
H N++ L+G C +G + EY P +L FL DP+ + H L Q
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
++ +A G+ YL S + IHRDL A N+L+ ++ KI+DFG++R
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 57/183 (31%), Positives = 95/183 (51%), Gaps = 36/183 (19%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL---SSQSG---QGLKEFKNEMMLIAK 566
+ + ++ EG +G VY+ + G+ VA+K+L + G L+E N ++ K
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI-NILL---K 60
Query: 567 LQHRNLVRL----MGCCVEQGEKILIY---EYMPN--KSLNFFLFDPSRTHLLGWQTRVK 617
LQH N+V + +G +++ IY EY+ + KSL + + L Q+ VK
Sbjct: 61 LQHPNIVTVKEVVVGSNLDK-----IYMVMEYVEHDLKSL----METMKQPFL--QSEVK 109
Query: 618 -IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
++ + G+ +LH I+HRDLK SN+LL++ KI DFG+AR + G L+ T+
Sbjct: 110 CLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQ 165
Query: 677 RVV 679
VV
Sbjct: 166 LVV 168
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 9e-13
Identities = 50/168 (29%), Positives = 73/168 (43%), Gaps = 32/168 (19%)
Query: 522 LGEGGFGPVYKGKL-LNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC 578
+G G +G V G++VA+K+LS QS K E+ L+ + H N++ L+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 579 CVEQGEKILIYEYMPNKSLNFF-------------LFDPSRTHLLGWQTRVKIIEGIAQG 625
+ P SL F L + + L ++ I +G
Sbjct: 83 ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRG 130
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 673
L Y+H IIHRDLK SNI ++ D KI DFG+AR DE+ G
Sbjct: 131 LKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTG 174
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 42/149 (28%), Positives = 71/149 (47%), Gaps = 11/149 (7%)
Query: 521 KLGEGGFGPVYKG--KLLNGQE--VAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRL 575
+GEG FG VY+G ++ VAVK + + ++E F E ++ + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
+G E I + E P L +L + L + + ++ L YL
Sbjct: 73 IGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMAR 664
R +HRD+ A N+L+ S K+ DFG++R
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 50/154 (32%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 520 CKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
KLGEG + VYKG+ L GQ VA+K RL + G + E L+ L+H N+V L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLH 69
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
+ L++EY+ + L ++ L +Q + +GL Y H
Sbjct: 70 DIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQ--------LLRGLAYCH 120
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
Q R++HRDLK N+L+ K++DFG+AR
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 26/166 (15%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
LGEG FG V K K +VAVK L S + + L + +EM ++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
++ L+G C + G +I EY +L +L ++P++ L ++ V
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+A+G+ YL + + IHRDL A N+L+ D KI+DFG+AR
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 51/163 (31%), Positives = 88/163 (53%), Gaps = 20/163 (12%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRL-----SSQSGQGLKEFKNEMMLIAKL 567
+ + KLG+G +G V+K + VA+K++ ++ Q + F+ E+M + +L
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ--RTFR-EIMFLQEL 63
Query: 568 -QHRNLVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
H N+V+L+ + +K L++EYM L+ + R ++L + I+ + +
Sbjct: 64 GDHPNIVKLLNVIKAENDKDIYLVFEYM-ETDLHAVI----RANILEDVHKRYIMYQLLK 118
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667
L Y+H S +IHRDLK SNILL+SD K++DFG+AR
Sbjct: 119 ALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 51/148 (34%), Positives = 76/148 (51%), Gaps = 12/148 (8%)
Query: 521 KLGEGGFGPVYKGKL-LNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
KLGEG + VYKGK +NG+ VA+K RL + G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-IEGIAQGLLYLHQYSRLR 636
+ L++EY+ + P H VK+ + + +GL Y+HQ
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHPGGLH----PENVKLFLFQLLRGLSYIHQRY--- 123
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMAR 664
I+HRDLK N+L+ K++DFG+AR
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 46/152 (30%), Positives = 77/152 (50%), Gaps = 9/152 (5%)
Query: 520 CKLGEGGFGPVYKGK-LLNGQEVAVKR-LSSQSGQGLKEFK-NEMMLIAKLQHRNLVRLM 576
K+GEG +G V+K + GQ VA+K+ + S+ +K+ E+ ++ +L+H NLV L+
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
+ + L++EY + LN + KII Q + + H+++
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--- 120
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCG 668
IHRD+K NIL+ K+ DFG AR+ G
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTG 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 50/157 (31%), Positives = 83/157 (52%), Gaps = 16/157 (10%)
Query: 521 KLGEGGFGPVYKG--KLLNGQ-EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHR----NLV 573
+LG G FG V KG K+ Q +VA+K L +++ K ++EMM A++ H+ +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE---KSVRDEMMREAEIMHQLDNPYIV 58
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
R++G C E +L+ E LN FL + + V+++ ++ G+ YL +
Sbjct: 59 RMIGVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
+HRDL A N+LL + KISDFG+++ D+
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 515 NFSMQCKLGEGGFGPVY--KGKLLNGQEVAVK-RLSSQSGQGLKEFKNEMMLIAKLQHRN 571
+ + K+GEG FG +Y K K + V + L+ + + K E++L+AK++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSL-------NFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
+V E G ++ EY L LF S +L W + I+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF--SEDQILSWFVQ------ISL 112
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMAR 664
GL ++H +I+HRD+K+ NI L + M K+ DFG+AR
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 9/149 (6%)
Query: 521 KLGEGGFGPVYKGKL---LNGQEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
++G G FG V G++ +V VK L S S Q +F E LQH NL++ +
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV--KIIEGIAQGLLYLHQYSR 634
G C E +L+ E+ P L +L + L+ ++ IA GLL+LH+ +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMA 663
IH DL N LL +D+ KI D+G++
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 51/157 (32%), Positives = 87/157 (55%), Gaps = 16/157 (10%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQ-GLK-EFKNEMMLIAKLQ---HRNLVR 574
++G G +G VYK + +G VA+K + Q+ + GL E+ L+ +L+ H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 575 LMGCC----VEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
LM C ++ K+ L++E++ ++ L +L D L +T ++ +GL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
H I+HRDLK NIL+ S K++DFG+AR++
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 54/166 (32%), Positives = 91/166 (54%), Gaps = 16/166 (9%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
++GEG +G VY+ + +G+ VA+K++ + + G + + E+ L+ L+H N+V L
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELK 72
Query: 577 GCCV-EQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK-IIEGIAQGLLYLHQYS 633
V + + I L+ EY + L L + +++VK ++ + +GL YLH+
Sbjct: 73 EVVVGKHLDSIFLVMEYC-EQDLASLLDNMPTPFS---ESQVKCLMLQLLRGLQYLHENF 128
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
IIHRDLK SN+LL KI+DFG+AR + G + T +VV
Sbjct: 129 ---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 41/153 (26%), Positives = 81/153 (52%), Gaps = 11/153 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
E+F + ++G G +G VYK + +N G+ A+K + + G+ + E++++ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLN--FFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
V G + + + + E+ SL + + P + + +R + QGL YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
+ +HRD+K +NILL + + K++DFG++
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 48/147 (32%), Positives = 77/147 (52%), Gaps = 10/147 (6%)
Query: 521 KLGEGGFGPVYKGKL-LNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
KLGEG + VYKG+ L VA+K RL + G + E+ L+ L+H N+V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
+ L++EY+ +K L +L D + + + + +GL Y H R ++
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCH---RRKV 125
Query: 638 IHRDLKASNILLDSDMNPKISDFGMAR 664
+HRDLK N+L++ K++DFG+AR
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 45/144 (31%), Positives = 80/144 (55%), Gaps = 6/144 (4%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
+LG+G FG VYK + G A K + ++S + L+++ E+ ++A H N+V+L+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
+ ++ E+ +++ + + R L Q RV + + + L YLH+ +IIH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERP-LTEPQIRV-VCKQTLEALNYLHEN---KIIH 126
Query: 640 RDLKASNILLDSDMNPKISDFGMA 663
RDLKA NIL D + K++DFG++
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 51/163 (31%), Positives = 81/163 (49%), Gaps = 25/163 (15%)
Query: 522 LGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVR 574
+GEG FG V K G ++ +K +S+ ++F E+ ++ KL H N++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNIIN 60
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFL-------FDPS--RTH----LLGWQTRVKIIEG 621
L+G C +G L EY P+ +L FL DP+ + L Q +
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+A+G+ YL S+ + IHRDL A NIL+ + KI+DFG++R
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 48/177 (27%), Positives = 82/177 (46%), Gaps = 26/177 (14%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
K+GEG G V G++VAVK++ + Q + NE++++ QH N+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK------IIEGIAQGL 626
V + + E ++ E++ +L T ++ TR+ + + + L
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGAL---------TDIVT-HTRMNEEQIATVCLAVLKAL 128
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 681
+LH +IHRD+K+ +ILL SD K+SDFG FC + +R +VGT
Sbjct: 129 SFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 47/147 (31%), Positives = 76/147 (51%), Gaps = 10/147 (6%)
Query: 521 KLGEGGFGPVYKGKLLNGQE-VAVKRLS---SQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
++G G FG VY + E VAVK++S Q+ + ++ E+ + +L+H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
GC +++ L+ EY + + L + + L + I G QGL YLH ++
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEI-AAITHGALQGLAYLHSHN--- 141
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMA 663
+IHRD+KA NILL K++DFG A
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSA 168
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 47/177 (26%), Positives = 79/177 (44%), Gaps = 26/177 (14%)
Query: 521 KLGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
+G+G FG V K GK+L +E+ ++ + Q L +E+ ++ +L+H N+VR
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKHPNIVR 63
Query: 575 LMGCCV-EQGEKILIY-EYMPNKSLNFFLFDPSRTHLLGWQTRV---KIIEGIAQGLLYL 629
+ + + I EY L + + + I + Q LL L
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER-----KYIEEEFIWRILTQLLLAL 118
Query: 630 H-----QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+ ++HRDLK +NI LD++ N K+ DFG+A++ D K VGT
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGT 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 50/169 (29%), Positives = 78/169 (46%), Gaps = 29/169 (17%)
Query: 516 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN---------------- 559
+ +Q +LG+G FG VY VK + + + LK K
Sbjct: 2 YILQQRLGKGSFGTVY----------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ 51
Query: 560 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 619
E L++KL H +V+ +E+ +I EY + L+ L + T + +V
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQV--C 109
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668
E Q LL +H + RI+HRDLKA NI L +++ KI DFG++R+ G
Sbjct: 110 EWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-11
Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 522 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
+ G G YKGK + NG + VK ++ + E + + KLQH N+V+L+G C
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCR 753
Query: 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
+ LI+EY+ K+L+ L + L W+ R KI GIA+ L +LH ++
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807
Query: 641 DLKASNILLDSDMNPKISDFGMARMFCGD 669
+L I++D P + + + C D
Sbjct: 808 NLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835
|
Length = 968 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 51/166 (30%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRN 571
LGEG FG V K K VAVK L + + L + +EM ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSR--THLLGWQTRVKI 618
++ L+G C + G ++ EY +L +L FD + L ++ V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+A+G+ YL + + IHRDL A N+L+ D KI+DFG+AR
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 55/181 (30%), Positives = 93/181 (51%), Gaps = 16/181 (8%)
Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFK-NEMM 562
++ SV + ++ K+G+G G VY + GQEVA+K+++ Q Q KE NE++
Sbjct: 10 TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEIL 68
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
++ + +H N+V + + E ++ EY+ SL + + T + Q +
Sbjct: 69 VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQI-AAVCREC 124
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVG 680
Q L +LH ++IHRD+K+ NILL D + K++DFG FC +KR +VG
Sbjct: 125 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVG 177
Query: 681 T 681
T
Sbjct: 178 T 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 55/179 (30%), Positives = 80/179 (44%), Gaps = 25/179 (13%)
Query: 514 ENFSMQCKLGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAK 566
N S LG G FG V + K +VAVK L + +E +E+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 567 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT-----HLLGWQTRVKIIE 620
L H N+V L+G C G ++I EY L FL + LL + +V
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV---- 150
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE---LQGNTK 676
A+G+ +L + IHRDL A N+LL KI DFG+AR D ++GN +
Sbjct: 151 --AKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNAR 204
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 49/166 (29%), Positives = 74/166 (44%), Gaps = 15/166 (9%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKE---FKNEMMLIAKLQHRNLVRLMGC 578
+G G FG V+ + Q++ + + E +NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 579 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRII 638
+E +++ EY P +L ++ LL T I+ Q LL LH I+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDEDT---ILHFFVQILLALHHVHTKLIL 123
Query: 639 HRDLKASNILLDS-DMNPKISDFGMARMFCGDELQGNTK--RVVGT 681
HRDLK NILLD M KI DFG+++ L +K VVGT
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISK-----ILSSKSKAYTVVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 48/170 (28%), Positives = 76/170 (44%), Gaps = 24/170 (14%)
Query: 506 LASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN----- 559
+V T + +G G FG V + L GQ VA+K++ +K F
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAK 54
Query: 560 ----EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR 615
E+ L+ L+H N++ L + E I + L+ L + L Q
Sbjct: 55 RTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL----TSRPLEKQFI 110
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665
+ I +GL Y+H ++HRDLK SNIL++ + + KI DFG+AR+
Sbjct: 111 QYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 50/148 (33%), Positives = 78/148 (52%), Gaps = 12/148 (8%)
Query: 521 KLGEGGFGPVYKGKL-LNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
KLGEG + V+KG+ L VA+K RL + G + E+ L+ L+H N+V L
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-IEGIAQGLLYLHQYSRLR 636
L++EY+ +K L ++ D + VKI + I +GL Y H R +
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSM---HNVKIFLYQILRGLAYCH---RRK 124
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMAR 664
++HRDLK N+L++ K++DFG+AR
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 11/153 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
++ + ++G G +G VYK L G+ AVK + + G + E+ ++ + +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLN--FFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
V G + + + + EY SL + + P + + R + QGL YLH
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH 123
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
++ HRD+K +NILL + + K++DFG+A
Sbjct: 124 SKGKM---HRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 51/173 (29%), Positives = 75/173 (43%), Gaps = 29/173 (16%)
Query: 522 LGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
LG+GGFG V GK+ +++ KRL + G+ + NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVSL 58
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFL-------FDPSRTHLLGWQTRVKIIEGIAQGLLY 628
+ + L+ M L + + F +R Q I GL +
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ--------IICGLEH 110
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
LHQ RI++RDLK N+LLD N +ISD G+A G K GT
Sbjct: 111 LHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 26/166 (15%)
Query: 522 LGEGGFGPVY--------KGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKL-QHRN 571
LGEG FG V K K VAVK L + + L + +EM ++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRT--HLLGWQTRVKI 618
++ L+G C + G +I EY +L +L +D +R + ++ V
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+A+G+ YL + + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 7e-11
Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 14/180 (7%)
Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMML 563
S+ SV + ++ K+G+G G VY + GQEVA+K+++ Q + NE+++
Sbjct: 10 SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILV 69
Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 623
+ + ++ N+V + + E ++ EY+ SL D + +
Sbjct: 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECL 125
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 681
Q L +LH ++IHRD+K+ NILL D + K++DFG FC +KR +VGT
Sbjct: 126 QALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 9e-11
Identities = 50/171 (29%), Positives = 88/171 (51%), Gaps = 13/171 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRN 571
E F+ ++G+G FG VYKG +EV A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKS-LNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
+ R G ++ + +I EY+ S L+ P + I+ I +GL YLH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLH 118
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
R IHRD+KA+N+LL + K++DFG+A +++ NT VGT
Sbjct: 119 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 54/168 (32%), Positives = 82/168 (48%), Gaps = 19/168 (11%)
Query: 512 ATENFSMQCKLGEGGFGPVYKG------KLLNGQEVAVKRLS-SQSGQGLKEFKNEMMLI 564
A E +M +LG+G FG VY+G K VA+K ++ + S + EF NE ++
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 565 AKLQHRNLVRLMGCCVEQGEKIL-IYEYMPNKSLNFFLF----DPSRTHLLGWQTRVKII 619
+ ++VRL+G V QG+ L I E M L +L + + + K+I
Sbjct: 64 KEFNCHHVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 620 E---GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ IA G+ YL+ + +HRDL A N ++ D KI DFGM R
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 48/148 (32%), Positives = 78/148 (52%), Gaps = 16/148 (10%)
Query: 522 LGEGGFGPVYKG--KLLNGQE--VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
LG G FG + +G KL + +E VA+ L + S + + F E + + + H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH---LLGWQTRVKIIEGIAQGLLYLHQYS 633
G +++ EYM N +L+ FL R H L+ Q + ++ G+A G+ YL S
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFL----RKHEGQLVAGQL-MGMLPGLASGMKYL---S 124
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFG 661
+ +H+ L A +L++SD+ KIS F
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 14/151 (9%)
Query: 520 CKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--EMMLIAKLQ-HRNLVRL 575
K+GEG F V K + G+ A+K + + + L++ N E+ + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 576 MGCCVEQ--GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
+ ++ G L++E M +N + R L + + + + L ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM---DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH--- 117
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
R I HRD+K NIL+ D K++DFG R
Sbjct: 118 RNGIFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 50/180 (27%), Positives = 88/180 (48%), Gaps = 14/180 (7%)
Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMML 563
S+ SV + ++ K+G+G G VY + GQEVA+++++ Q + NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 623
+ + ++ N+V + + E ++ EY+ SL D + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECL 126
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 681
Q L +LH ++IHRD+K+ NILL D + K++DFG FC +KR +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 48/180 (26%), Positives = 89/180 (49%), Gaps = 14/180 (7%)
Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMML 563
++ S+ + ++ K+G+G G V+ + GQEVA+K+++ Q + NE+++
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69
Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 623
+ +L++ N+V + + E ++ EY+ SL D + +
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECL 125
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 681
Q L +LH ++IHRD+K+ N+LL D + K++DFG FC +KR +VGT
Sbjct: 126 QALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 52/164 (31%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
K+GEG G V + +G++VAVK + + Q + NE++++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
+ E ++ E++ +L + S+T L Q + E + Q L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALTDIV---SQTRLNEEQI-ATVCESVLQALCYLHSQG---VIH 140
Query: 640 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 681
RD+K+ +ILL D K+SDFG FC + KR +VGT
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGT 180
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 49/171 (28%), Positives = 86/171 (50%), Gaps = 26/171 (15%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAKLQH---RNLVRLM 576
+G G +G VY+GK + G+ VA+K ++ + + + + E+ L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK----IIEGIAQGLLYLHQY 632
G ++ +I EY S+ RT + K II + L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV--------RTLMKAGPIAEKYISVIIREVLVALKYIHKV 120
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV--VGT 681
+IHRD+KA+NIL+ + N K+ DFG+A + Q ++KR VGT
Sbjct: 121 G---VIHRDIKAANILVTNTGNVKLCDFGVAALL----NQNSSKRSTFVGT 164
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 45/167 (26%), Positives = 82/167 (49%), Gaps = 13/167 (7%)
Query: 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCV 580
+G G +G VYKG+ + ++A ++ +G +E K E+ ++ K HRN+ G +
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 581 EQG------EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
++ + L+ E+ S+ L ++ + L + I I +GL +LHQ+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
++IHRD+K N+LL + K+ DFG++ D G +GT
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGT 174
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 46/180 (25%), Positives = 75/180 (41%), Gaps = 14/180 (7%)
Query: 488 GDGDAKGTRRD---SVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK 544
D A + D ++P A A+ +++ L G G V+ GQ V
Sbjct: 37 DDDSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATK-PGQPDPVV 95
Query: 545 RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDP 604
Q G L E ML+ + H +++R+ V ++ +P+ S + + +
Sbjct: 96 LKIGQKGTTLIE----AMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLT 148
Query: 605 SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
R+ L + I + I +GL YLH RIIHRD+K NI ++ I D G A+
Sbjct: 149 KRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 17/153 (11%)
Query: 520 CKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQH-RNLVRLM 576
+LG G +G V K + + G +AVKR+ + + Q K ++ + + V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 577 GCCVEQGEKILIYEYMPNKSLNFF---LFDPSRT---HLLGWQTRVKIIEGIAQGLLYLH 630
G +G+ + E M + SL+ F ++D T +LG KI I + L YLH
Sbjct: 67 GALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEYLH 120
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
S+L +IHRD+K SN+L++ + K+ DFG++
Sbjct: 121 --SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 23/162 (14%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQ-----GLKEFKNEMMLIAKL 567
+ +GEG +G V G +VA+K++S Q L+E K ++ +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRF 60
Query: 568 QHRNLVRLMGC----CVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
+H N++ ++ E + ++ E M L+ +T L + I
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQI 115
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+GL Y+H + ++HRDLK SN+LL+++ + KI DFG+AR
Sbjct: 116 LRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 48/157 (30%), Positives = 80/157 (50%), Gaps = 16/157 (10%)
Query: 521 KLGEGGFGPVYKG--KLLNGQE-VAVKRLSSQSGQGLKEFKNEMMLIAK----LQHRNLV 573
+LG G FG V KG K+ ++ VAVK L + + K+E++ A L + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
R++G C E +L+ E LN FL + + + +++ ++ G+ YL + +
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN 115
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
+HRDL A N+LL + KISDFG+++ DE
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 47/154 (30%), Positives = 76/154 (49%), Gaps = 26/154 (16%)
Query: 521 KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRNLVRLMGC 578
++G G G VYK G+ A+K + ++ + E+ ++ + H N+V+
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 579 CVEQGEKILIYEYMPNKSLN-------FFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
GE ++ E+M SL FL D +R +I+ GIA YLH
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----------QILSGIA----YLH- 185
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665
R I+HRD+K SN+L++S N KI+DFG++R+
Sbjct: 186 --RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI 217
|
Length = 353 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 30/174 (17%)
Query: 525 GGFGPVYKG-KLLNGQEVAVKRLSSQSGQG---LKEFKNEMMLIAKLQHRNLVRLMGCCV 580
G +G V+ K G A+K + + + E ++++ Q +V+L
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF- 62
Query: 581 EQGEK--ILIYEYMPN---KSL--NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
QG+K L+ EY+P SL N D I I L YLH
Sbjct: 63 -QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR--------IYIAEIVLALEYLHSNG 113
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARM-FCGDELQGN-----TKRVVGT 681
IIHRDLK NIL+DS+ + K++DFG++++ ++ N KR+VGT
Sbjct: 114 ---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 512 ATENFSMQCKLGEGGFGPVYKG---KLLNGQ---EVAVKRLS-SQSGQGLKEFKNEMMLI 564
+ E ++ +LG+G FG VY+G ++ G+ VAVK ++ S S + EF NE ++
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63
Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLF-------DPSRTHLLGWQTRVK 617
++VRL+G + +++ E M + L +L + Q ++
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ IA G+ YL+ + +HRDL A N ++ D KI DFGM R
Sbjct: 124 MAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 55/175 (31%), Positives = 78/175 (44%), Gaps = 30/175 (17%)
Query: 522 LGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
LG+GGFG V GKL +++ KRL + +G + E ++AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFL---------FDPSRTHLLGWQTRVKIIEGIAQGL 626
+ + L+ M L + + F R Q I GL
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ--------IISGL 110
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+LHQ RII+RDLK N+LLD+D N +ISD G+A + Q TK GT
Sbjct: 111 EHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGT 160
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 45/178 (25%), Positives = 77/178 (43%), Gaps = 36/178 (20%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG------------------LKEFKNEMM 562
LGEG +G V K L G+ VA+K++ L+E K
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK---- 72
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN---KSLNFFLFDPSRTHLLGWQTRVKII 619
++ +++H N++ L+ VE L+ + M + K ++ + L Q + I+
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD------RKIRLTESQVKC-IL 125
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
I GL LH++ +HRDL +NI ++S KI+DFG+AR + +
Sbjct: 126 LQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
|
Length = 335 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 12/153 (7%)
Query: 516 FSMQCKLGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQGLKEFK---NEMMLIAKLQHRN 571
F + ++G+GG+G V+ K + E VA+KR+ L E + E ++ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW-QTRVKIIEGIAQGLLYLH 630
LV+L+ + L EY+P L + +L R + E + LH
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFE-AVDALH 118
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
L IHRDLK N L+D+ + K++DFG++
Sbjct: 119 ---ELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 48/177 (27%), Positives = 76/177 (42%), Gaps = 25/177 (14%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQ---SGQGLKEFKNEMMLIAKLQHR 570
+F + +G+G FG V + + +++ A+K ++ Q ++ NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 571 NLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQ 624
LV L + E + L+ + + L + L F Q + I E I
Sbjct: 61 FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE-------QVKFWICE-IVL 111
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
L YLH IIHRD+K NILLD + I+DF +A D T GT
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGT 162
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 49/148 (33%), Positives = 78/148 (52%), Gaps = 12/148 (8%)
Query: 521 KLGEGGFGPVYKGKL-LNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
KLGEG + V+KG+ L VA+K RL + G + E+ L+ L+H N+V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-IEGIAQGLLYLHQYSRLR 636
+ L++EY+ + L +L + L VKI + + +GL Y H + +
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYLDNCGN---LMSMHNVKIFMFQLLRGLSYCH---KRK 123
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMAR 664
I+HRDLK N+L++ K++DFG+AR
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 43/146 (29%), Positives = 71/146 (48%), Gaps = 11/146 (7%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRLMGCC 579
LG G G V K K + G +A K + + + K+ E+ ++ + + +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 580 VEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
+ + + E+M SL+ P +LG KI + +GL YL Y+ RI
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL--YNVHRI 125
Query: 638 IHRDLKASNILLDSDMNPKISDFGMA 663
+HRD+K SNIL++S K+ DFG++
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 20/160 (12%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKR-LSSQSGQGLKEFK-NEMMLIAKLQHRN-LVRLM 576
K+GEG +G VYK + G+ VA+K+ +G+ E+ L+ L +VRL+
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 577 GCCVEQGE----KILIY---EYMPNKSLNFFLFDPSR--THLLGWQTRVKIIEGIAQGLL 627
VE E K +Y EY+ + L F+ R L +T + + +G+
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMF 666
+ H++ ++HRDLK N+L+D KI+D G+ R F
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 44/179 (24%), Positives = 85/179 (47%), Gaps = 24/179 (13%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQHR 570
NF ++ K+G G F VY+ LL+ + VA+K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--------FDPSRTHLLGWQTRVKIIEGI 622
N+++ + +E E ++ E L+ + P RT W+ V++ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV---WKYFVQLCSAV 119
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
H +SR R++HRD+K +N+ + + K+ D G+ R F ++ +VGT
Sbjct: 120 E------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 46/172 (26%), Positives = 80/172 (46%), Gaps = 15/172 (8%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE---FKNEMMLIAKLQH 569
++ +G G FG V+ + ++ A+K ++ LK+ NE ++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
++RL +Q ++ EY+P L +L + R T + I L YL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYL 117
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
H I++RDLK NILLD + + K++DFG A+ +L+ T + GT
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGT 161
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 3e-09
Identities = 53/164 (32%), Positives = 74/164 (45%), Gaps = 15/164 (9%)
Query: 522 LGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAKLQHRNLVRLMG 577
LG G FG V + + A+K LS LK+ NE ++ ++H LV L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
+ L+ EY+P L F S R + + L YLH L I
Sbjct: 69 SFQDDSNLYLVMEYVPGGEL-FSHLRKSG-RFPEPVARFYAAQ-VVLALEYLHS---LDI 122
Query: 638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
++RDLK N+LLDSD KI+DFG A+ ++G T + GT
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGT 161
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 55/168 (32%), Positives = 76/168 (45%), Gaps = 32/168 (19%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC 578
+G G +G V G VAVK+LS QS K E+ L+ ++H N++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 579 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR--VK-----------IIEGIAQG 625
+ P +SL F THL+G VK +I I +G
Sbjct: 85 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 673
L Y+H IIHRDLK SN+ ++ D KI DFG+AR DE+ G
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG 176
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 4e-09
Identities = 46/160 (28%), Positives = 69/160 (43%), Gaps = 19/160 (11%)
Query: 522 LGEGGFGPVYKGKLLNGQEV-AVKRLSSQS--GQGLKE-FKNEMMLIAKLQHRNLVRLMG 577
LG GGFG V K+ + A+K + + G +E +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
++ ++ EY L L D R + R I + YLH I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARF-YIACVVLAFEYLH---NRGI 114
Query: 638 IHRDLKASNILLDSDMNPKISDFGMAR---------MFCG 668
I+RDLK N+LLDS+ K+ DFG A+ FCG
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCG 154
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 48/171 (28%), Positives = 89/171 (52%), Gaps = 13/171 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRN 571
E F+ K+G+G FG V+KG Q+V A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV-KIIEGIAQGLLYLH 630
+ + G ++ + +I EY+ S L +P +T++ I+ I +GL YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLD----ETQIATILREILKGLDYLH 118
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+ IHRD+KA+N+LL K++DFG+A +++ N VGT
Sbjct: 119 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 45/162 (27%), Positives = 72/162 (44%), Gaps = 22/162 (13%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHR 570
E ++ ++G G +G V G++VA+K+LS QS K E+ L+ +QH
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPS--------RTHLLGWQTRVKIIEGI 622
N++ L+ + + + F+L P H L ++ +
Sbjct: 75 NVIGLLDVFTSA----VSGDEFQD----FYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM 126
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
GL Y+H IIHRDLK N+ ++ D KI DFG+AR
Sbjct: 127 LCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 43/172 (25%), Positives = 69/172 (40%), Gaps = 20/172 (11%)
Query: 517 SMQCKLGE----GGFGPVYKGKLLNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAKLQHR 570
+ +G+ + K K VAVK+ L S S + LK + E++ +LQH
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLL-GWQTRV--KIIEGIAQGLL 627
N++ + + E ++ M S L +TH G I++ + L
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLL----KTHFPEGLPELAIAFILKDVLNALD 115
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
Y+H IHR +KAS+ILL D +S + G +RVV
Sbjct: 116 YIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIK---HGKRQRVV 161
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 20/153 (13%)
Query: 522 LGEGGFGPVYKGKLLN---GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQH-RNLVRLM 576
+G G FG V K +L+ G +AVKR+ S + K ++ ++ + +V+
Sbjct: 12 IGRGAFGTVNK--MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69
Query: 577 GCCVEQGEKILIYEYMPNKSLNF--FLFDPSRTHL----LGWQTRVKIIEGIAQGLLYLH 630
G +G+ + E M F ++++ ++ + LG KI + L YL
Sbjct: 70 GALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILG-----KIAVATVKALNYLK 124
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
+ L+IIHRD+K SNILLD + N K+ DFG++
Sbjct: 125 E--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 44/179 (24%), Positives = 83/179 (46%), Gaps = 24/179 (13%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSS---QSGQGLKEFKNEMMLIAKLQHR 570
NF ++ K+G G F VY+ LL+G VA+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--------FDPSRTHLLGWQTRVKIIEGI 622
N+++ +E E ++ E L+ + P +T W+ V++ +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV---WKYFVQLCSAL 119
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
H +SR R++HRD+K +N+ + + K+ D G+ R F ++ +VGT
Sbjct: 120 E------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 46/170 (27%), Positives = 87/170 (51%), Gaps = 11/170 (6%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQG-LKEFKNEMMLIAKLQHRN 571
E F+ ++G+G FG V+KG Q+V A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
+ + G ++ + +I EY+ S D R +++ I +GL YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+ IHRD+KA+N+LL + K++DFG+A +++ NT VGT
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 48/165 (29%), Positives = 81/165 (49%), Gaps = 16/165 (9%)
Query: 521 KLGEGGFGPV-YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
K+GEG G V + G++VAVK++ + Q + NE++++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHL-LGWQTRVKIIEGIAQGLLYLHQYSRLRII 638
+ E ++ E++ +L + TH + + + + + L YLH +I
Sbjct: 89 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQG---VI 140
Query: 639 HRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 681
HRD+K+ +ILL SD K+SDFG FC + KR +VGT
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFG----FCAQVSKEVPKRKSLVGT 181
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 43/166 (25%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 522 LGEGGFGP--VYK----GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
LG+G FG +Y+ L+ +EV + RLS + ++ NE+++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
++ ++ EY +L + + L + + + I + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
I+HRD+K NI L K+ DFG++++ G E + VVGT
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSM-AETVVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 45/149 (30%), Positives = 63/149 (42%), Gaps = 45/149 (30%)
Query: 538 GQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK 595
GQ VA+K+LS Q+ K E++L+ + H+N++ L+ + P K
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FTPQK 88
Query: 596 SLNFF--------------------LFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
SL F D R L +Q G+ +LH
Sbjct: 89 SLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC--------GIKHLHSAG-- 138
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMAR 664
IIHRDLK SNI++ SD KI DFG+AR
Sbjct: 139 -IIHRDLKPSNIVVKSDCTLKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 40/176 (22%), Positives = 71/176 (40%), Gaps = 58/176 (32%)
Query: 521 KLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSG------QGLKEFKNEMMLIAKLQHRNLV 573
+G G +G V +G++VA+K++ + L+E K ++ +H N++
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRHFKHDNII 67
Query: 574 --------------------RLMGCCVEQGEKILIYEYMP--NKSLNFFLFDPSRTHLLG 611
LM + +I+ P + + +FL+
Sbjct: 68 AIRDILRPPGADFKDVYVVMDLMESDLHH----IIHSDQPLTEEHIRYFLYQ-------- 115
Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667
+ +GL Y+H + +IHRDLK SN+L++ D +I DFGMAR
Sbjct: 116 ----------LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 16/157 (10%)
Query: 522 LGEGGFGPVYK-------GKLLNGQEVAVKRLS-----SQSGQGLKEFKNEMMLIAK-LQ 568
LG G FG VYK LL +E+ V + + + + + +E+ +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV-KIIEGIAQGLL 627
H N+VR +E ++ + + L + R+ I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
YLH+ R I+HRDL +NI+L D I+DFG+A+
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 38/146 (26%), Positives = 66/146 (45%), Gaps = 29/146 (19%)
Query: 538 GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL--------------MGCCVEQG 583
+ VAVK++ Q +K E+ +I +L H N+V++ +G E
Sbjct: 30 DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89
Query: 584 EKILIYEYMPN---KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640
++ EYM L L +Q + +GL Y+H + ++HR
Sbjct: 90 SVYIVQEYMETDLANVLEQGPLSEEHARLFMYQ--------LLRGLKYIHSAN---VLHR 138
Query: 641 DLKASNILLDS-DMNPKISDFGMARM 665
DLK +N+ +++ D+ KI DFG+AR+
Sbjct: 139 DLKPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 44/160 (27%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAKLQHRNLVRLMGC 578
CK+G G +G VYK K +G++ L G G+ E+ L+ +L+H N++ L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 579 CVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY-----LHQ 631
+ ++ L+++Y + + F + + V++ G+ + LLY +H
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASK---ANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 632 YSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARMF 666
++HRDLK +NIL+ + P KI+D G AR+F
Sbjct: 124 LHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 45/144 (31%), Positives = 67/144 (46%), Gaps = 29/144 (20%)
Query: 538 GQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK 595
G VAVK+LS Q+ K E++L+ + H+N++ L+ + P K
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTPQK 93
Query: 596 SLNFF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLK 643
SL F L D + + L + ++ + G+ +LH IIHRDLK
Sbjct: 94 SLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 150
Query: 644 ASNILLDSDMNPKISDFGMARMFC 667
SNI++ SD KI DFG+AR C
Sbjct: 151 PSNIVVKSDCTLKILDFGLARTAC 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 16/150 (10%)
Query: 522 LGEGGFGPV------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
LG+GGFG V GK+ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG--IAQGLLYLHQYS 633
+ L+ M L F ++ G++ + I GL LHQ
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEA---GFEEGRAVFYAAEICCGLEDLHQE- 121
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMA 663
RI++RDLK NILLD + +ISD G+A
Sbjct: 122 --RIVYRDLKPENILLDDHGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 7e-08
Identities = 42/152 (27%), Positives = 75/152 (49%), Gaps = 13/152 (8%)
Query: 521 KLGEGGFGPVYKGKLL----NGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
K+GEG FG K L+ +G++ +K + S S + +E + E+ +++ ++H N+V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
E G ++ +Y L + + R L +I++ Q L L
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDL-YKKINAQRGVLF---PEDQILDWFVQICLALKHVHD 119
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
+I+HRD+K+ NI L D K+ DFG+AR+
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 45/183 (24%), Positives = 85/183 (46%), Gaps = 13/183 (7%)
Query: 506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIA 565
L+++ F + +G G +G VYKG+ + ++A ++ + +E K E+ ++
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLK 67
Query: 566 KL-QHRNLVRLMGCCVEQG------EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI 618
K HRN+ G +++ + L+ E+ S+ L ++ + L I
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYI 126
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
I +GL +LH + ++IHRD+K N+LL + K+ DFG++ D G
Sbjct: 127 CREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTF 181
Query: 679 VGT 681
+GT
Sbjct: 182 IGT 184
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 24/155 (15%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVA---VKRLSSQSGQGLKEFKNEMMLIAK----LQHRNLV 573
++G G FG V ++ VA VK L + + KE +NE + LQH N++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKE-QNEFLQQGDPYRILQHPNIL 58
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKIIEGIAQGLL 627
+ +G CVE +L++EY L +L S+ LL ++ IA G+
Sbjct: 59 QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMACEIAAGVT 113
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662
++H + +H DL N L SD+ K+ D+G+
Sbjct: 114 HMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 53/163 (32%), Positives = 77/163 (47%), Gaps = 23/163 (14%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRNLVRLM 576
+G+G FG V K +G+ AVK L ++ KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 577 GCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
+ +K+ + +Y+ L FF R + R E IA L YLH L
Sbjct: 63 -YSFQTADKLYFVLDYVNGGEL-FFHLQRER-SFPEPRARFYAAE-IASALGYLHS---L 115
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMAR----------MFCG 668
II+RDLK NILLDS + ++DFG+ + FCG
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG 158
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 42/172 (24%), Positives = 76/172 (44%), Gaps = 57/172 (33%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMMLIAKLQHRN 571
+G G +G V K ++VA+K+++ F N E+ L+ L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIA-------NAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 572 LVRL----MGCCVEQGEKI-LIYEYM---------PNKSLN-----FFLFDPSRTHLLGW 612
++ + E + ++YE M +++L+ +FL+
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQ--------- 116
Query: 613 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ +GL Y+H + ++HRDLK SN+LL+++ + KI DFG+AR
Sbjct: 117 ---------LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 20/162 (12%)
Query: 522 LGEGGFGPV---YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
+G G +G V Y +L Q+VAVK+LS QS + E+ L+ ++H N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 577 -----GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
+E ++ + + LN + + L + +I + +GL Y+H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIV----KCQKLSDEHVQFLIYQLLRGLKYIHS 136
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG 673
IIHRDLK SN+ ++ D +I DFG+AR DE+ G
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG 174
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-07
Identities = 23/83 (27%), Positives = 44/83 (53%), Gaps = 8/83 (9%)
Query: 339 TRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLK-NCTCRAYANSKVTGGGSGCLMW- 396
+ + F++ + KLP + ++ +L+EC ++CL NC+CR++ + G GCL+W
Sbjct: 2 SDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWS 57
Query: 397 FGDLIDIRKITGYNNGQPIYVRV 419
L D R + G +Y ++
Sbjct: 58 ESSLGDARL--FPSGGVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 26/58 (44%), Positives = 37/58 (63%), Gaps = 3/58 (5%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
I +GL YLH I+HRD+K N+L++S+ KI DFG+AR+ DE + T+ VV
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 521 KLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
K+GEG G V + +G+ VAVK++ + Q + NE++++ QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII-EGIAQGLLYLHQYSRLRII 638
+ E ++ E++ +L + TH + ++ + + + L LH +I
Sbjct: 87 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALSVLHAQG---VI 138
Query: 639 HRDLKASNILLDSDMNPKISDFGMARMFCGD---ELQGNTKRVVGT 681
HRD+K+ +ILL D K+SDFG FC E+ K +VGT
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVP-RRKSLVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 25/57 (43%), Positives = 32/57 (56%), Gaps = 13/57 (22%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM----------ARMFCG 668
I GL +LH+ II+RDLK N+LLDS+ + KI+DFGM FCG
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG 158
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 25/57 (43%), Positives = 33/57 (57%), Gaps = 13/57 (22%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM----------ARMFCG 668
IA GL +LH II+RDLK N++LD++ + KI+DFGM R FCG
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCG 163
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 17/166 (10%)
Query: 522 LGEGGFGPV------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
LG+GGFG V GK+ + + KR+ + G+ + NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG--IAQGLLYLHQYS 633
+ L+ M L F +++ G++ + I GL LH+ +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP---GFEEERALFYAAEILCGLEDLHREN 122
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMA-RMFCGDELQGNTKRV 678
++RDLK NILLD + +ISD G+A ++ G+ ++G V
Sbjct: 123 ---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTV 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 23/160 (14%)
Query: 522 LGEGGFGPVYKGKLLN---------GQEVAVKR-LSSQSGQGLKEFKNEMMLIAKLQHRN 571
LG+G F +YKG L GQEV+V + + F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
LV+L G CV E I++ EY+ L+ FL L W+ V + +A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDV--AKQLASALHYLED 119
Query: 632 YSRLRIIHRDLKASNILL---DSDMNP----KISDFGMAR 664
+++H ++ NIL+ + K+SD G+
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 47/155 (30%), Positives = 69/155 (44%), Gaps = 26/155 (16%)
Query: 522 LGEGGFGPV------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
LG+GGFG V GK+ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFL-------FDPSRTHLLGWQTRVKIIEGIAQGLLY 628
+ L+ M L F + FD R + I GL
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE--------ITCGLED 117
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
LH R RI++RDLK NILLD + +ISD G+A
Sbjct: 118 LH---RERIVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 31/159 (19%)
Query: 522 LGEGGFGPV-YKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGC 578
+G G +G V G +VA+K+L QS K E+ L+ ++H N++ L+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 579 CVEQGEKILIYEYMPNKSLN----FFLFDPSRTHLLG--------WQTRVK-IIEGIAQG 625
+ P+ SL+ F+L P LG + R++ ++ + +G
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
L Y+H IIHRDLK N+ ++ D KI DFG+AR
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 39/147 (26%), Positives = 73/147 (49%), Gaps = 6/147 (4%)
Query: 522 LGEGGFG-PVYKGKLLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
+GEG FG + + + Q+ A+K + +S +++ + E +L+AK++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
G ++ EY L + R L T ++ + G+ ++H+ R++H
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLH 123
Query: 640 RDLKASNILLDSDMNPKISDFGMARMF 666
RD+K+ NI L + K+ DFG AR+
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLL 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 41/146 (28%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 522 LGEGGFGPVYKGKLLNGQE-VAVKRLS-SQSGQGLKEFK-NEMMLIAKLQHRNLVRLMGC 578
+GEG +G V K + +E VA+K+ S+ + +KE E+ ++ L+ N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 579 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRII 638
+G+ L++EY+ L P+ K+ I Q + +H + I+
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGV------PPEKVRSYIYQLIKAIHWCHKNDIV 122
Query: 639 HRDLKASNILLDSDMNPKISDFGMAR 664
HRD+K N+L+ + K+ DFG AR
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 45/160 (28%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAKLQHRNLVRLMGC 578
CK+G G +G VYK K +G++ L G G+ E+ L+ +L+H N++ L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 579 CVEQGEK--ILIYEYMPNKSLNFFLFD-PSRTHLLGWQTRVKIIEG----IAQGLLYLHQ 631
+ ++ L+++Y + + F S+ + Q +++ I G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 632 YSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARMF 666
++HRDLK +NIL+ + P KI+D G AR+F
Sbjct: 127 N---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 41/158 (25%), Positives = 74/158 (46%), Gaps = 21/158 (13%)
Query: 522 LGEGGFGPVYKGKL--------LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
LG+G F ++KG L+ EV +K L + F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
G CV E I++ EY+ SL+ +L +L+ ++++ + +A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 634 RLRIIHRDLKASNILL-----DSDMNP---KISDFGMA 663
+ H ++ A N+LL NP K+SD G++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-07
Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 20/157 (12%)
Query: 538 GQEVAVKRLSSQSGQGLKE---FKNEMMLIAKLQHRNLVRLM--GCCVEQGEKILIYEYM 592
G EVA+K L + + + + F+ E L A+L H N+V L+ G G ++EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL--- 649
P ++L L + L +++ + L H I+HRDLK NI++
Sbjct: 62 PGRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQT 115
Query: 650 DSDMNPKISDFGMARMFCG----DELQGN-TKRVVGT 681
+ K+ DFG+ + G D T V+GT
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGT 152
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 43/145 (29%), Positives = 72/145 (49%), Gaps = 12/145 (8%)
Query: 522 LGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQHRNLVRLMGCC 579
LG G G VYK LL + +AVK + L K+ +E+ ++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
+ + E+M SL+ + P H+LG +I + +GL YL L+I+H
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPE--HVLG-----RIAVAVVKGLTYLWS---LKILH 118
Query: 640 RDLKASNILLDSDMNPKISDFGMAR 664
RD+K SN+L+++ K+ DFG++
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST 143
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 54/167 (32%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 522 LGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRNLVRLM 576
+G+G FG V K +G AVK L ++ KE + M +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 577 GCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG-IAQGLLYLHQYSR 634
+ EK+ + +Y+ L FF R L + R + +A + YLH
Sbjct: 63 -YSFQTAEKLYFVLDYVNGGEL-FFHLQRERCFL---EPRARFYAAEVASAIGYLHS--- 114
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
L II+RDLK NILLDS + ++DFG+ + G E + T GT
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 33/86 (38%), Positives = 49/86 (56%), Gaps = 6/86 (6%)
Query: 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 646
LI +Y+ L L+ R H + RV I E I L +LHQ L II+RD+K N
Sbjct: 82 LILDYVNGGELFTHLY--QREHFTESEVRVYIAE-IVLALDHLHQ---LGIIYRDIKLEN 135
Query: 647 ILLDSDMNPKISDFGMARMFCGDELQ 672
ILLDS+ + ++DFG+++ F +E +
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 18/151 (11%)
Query: 522 LGEGGFGPV------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
LG+GGFG V GK+ +++ KRL +SG+ + + E++ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ---GLLYLHQY 632
+ L+ M L + +++ L ++I AQ G+L+LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL----EMERVIHYSAQITCGILHLHS- 113
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
+ I++RD+K N+LLD N ++SD G+A
Sbjct: 114 --MDIVYRDMKPENVLLDDQGNCRLSDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 47/168 (27%), Positives = 75/168 (44%), Gaps = 33/168 (19%)
Query: 522 LGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEM----MLIAKLQHRNLVRLM 576
LG+G FG V +L EV A+K L + M +L +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 577 GCCVEQGEKIL-IYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
CC + +++ + EY+ L F + FD R+ + + L++LH
Sbjct: 63 -CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAE--------VTLALMFLH 113
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR----------MFCG 668
++ +I+RDLK NILLD++ + K++DFGM + FCG
Sbjct: 114 RHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG 158
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 18/163 (11%)
Query: 522 LGEGGFGPVYKGKLLNGQE----VAVKRLSS----QSGQGLKEFKNEMMLIAKLQHRNLV 573
LG+GG+G V++ + + G + A+K L ++ + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
L+ G+ LI EY+ L L R + T + I+ L +LHQ
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLALEHLHQ-- 118
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
II+RDLK NILLD+ + K++DFG+ C + + T
Sbjct: 119 -QGIIYRDLKPENILLDAQGHVKLTDFGL----CKESIHEGTV 156
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 43/148 (29%), Positives = 69/148 (46%), Gaps = 12/148 (8%)
Query: 522 LGEGGFGPV------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
LG+GGFG V GK+ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
+ L+ M L F +++ G+ + I A+ L R
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP---GFDEQRAIFYA-AELCCGLEDLQRE 121
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMA 663
RI++RDLK NILLD + +ISD G+A
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 30/146 (20%), Positives = 56/146 (38%), Gaps = 13/146 (8%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV-RLMGCC 579
L G VY ++ +K S+ +E + ++ + + V +++
Sbjct: 5 LLKGGLTNRVYLLGT-KDEDYVLKINPSREKGADREREVAILQLLA-RKGLPVPKVLASG 62
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
G L+ E++ ++L+ + + I E +A+ L LHQ L + H
Sbjct: 63 ESDGWSYLLMEWIEGETLDEVSE----------EEKEDIAEQLAELLAKLHQLPLLVLCH 112
Query: 640 RDLKASNILLDSDMNPKISDFGMARM 665
DL NIL+D I D+ A
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 39/120 (32%), Positives = 56/120 (46%), Gaps = 24/120 (20%)
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT--HLLGWQTRVKIIEGIAQGLLYL 629
+V G GE + E+M SL+ L R ++LG KI + +GL YL
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYL 115
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFG--------MARMFCG-------DELQGN 674
+ + +I+HRD+K SNIL++S K+ DFG MA F G + LQG
Sbjct: 116 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 173
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 30/167 (17%)
Query: 522 LGEGGFGPVYKGKLLN----GQEVAVKRLSSQSGQGLK-----EFKNEMMLIAKLQHRNL 572
LG+G FG V+ + + GQ A+K L + LK K E ++A++ H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHPFI 60
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-IEGIAQGLLYLHQ 631
V+L +G+ LI +++ L F ++ + VK + +A L +LH
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH- 115
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR----------MFCG 668
L II+RDLK NILLD + + K++DFG+++ FCG
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 46/138 (33%), Positives = 67/138 (48%), Gaps = 25/138 (18%)
Query: 539 QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 598
+ VA+K+LS + F+N+ AK +R LV LM C + L+ + P KSL
Sbjct: 50 RNVAIKKLS-------RPFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 599 FF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 646
F L D + + L + ++ + G+ +LH IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 647 ILLDSDMNPKISDFGMAR 664
I++ SD KI DFG+AR
Sbjct: 157 IVVKSDCTLKILDFGLAR 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 33/168 (19%)
Query: 522 LGEGGFGPVYKGKLL-NGQEVAVKRLSS----QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
LG+G FG V +L +G+ AVK L Q + +L H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 577 GCCVEQGEKIL-IYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
CC + +++ + E++ L F + FD +R + I L++LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE--------ITSALMFLH 113
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR----------MFCG 668
II+RDLK N+LLD + + K++DFGM + FCG
Sbjct: 114 DKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG 158
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 28/165 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
E F + + G FG VY G K N + AVK + + N+ M+ R+
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKK------ADMINKNMVHQVQAERDA 57
Query: 573 VRLMGC--CV------EQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGW---QTRVKIIE 620
+ L V + + L+ EY+ + L H+ G+ + VK I
Sbjct: 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLL------HIYGYFDEEMAVKYIS 111
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665
+A L YLH++ IIHRDLK N+L+ ++ + K++DFG++++
Sbjct: 112 EVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 19/180 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGL--KEFKNEMMLIAKLQHRN 571
++F +LG G G V K + + ++L + + E+ ++ +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT--HLLGWQTRVKIIEGIAQGLLYL 629
+V G GE + E+M SL+ L + R +LG K+ + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYL 119
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFG--------MARMFCGDELQGNTKRVVGT 681
+ + +I+HRD+K SNIL++S K+ DFG MA F G + +R+ GT
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 177
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 56/189 (29%), Positives = 86/189 (45%), Gaps = 24/189 (12%)
Query: 506 LASVSAATENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLI 564
L S+ T+ + + +G+G +G VYK +G AVK L S +E + E ++
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 565 AKL-QHRNLVRLMGCCVEQ-----GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK- 617
L H N+V+ G + G+ L+ E S+ + LL R+
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDE 127
Query: 618 -----IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 672
I+ G GL +LH RIIHRD+K +NILL ++ K+ DFG++ L+
Sbjct: 128 AMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184
Query: 673 GNTKRVVGT 681
NT VGT
Sbjct: 185 RNTS--VGT 191
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 46/138 (33%), Positives = 67/138 (48%), Gaps = 25/138 (18%)
Query: 539 QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 598
+ VA+K+LS + F+N+ AK +R LV LM C + L+ + P KSL
Sbjct: 43 RNVAIKKLS-------RPFQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKSLE 92
Query: 599 FF--------LFDPSRTHL----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 646
F L D + + L + ++ + G+ +LH IIHRDLK SN
Sbjct: 93 EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 149
Query: 647 ILLDSDMNPKISDFGMAR 664
I++ SD KI DFG+AR
Sbjct: 150 IVVKSDCTLKILDFGLAR 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 44/162 (27%), Positives = 73/162 (45%), Gaps = 26/162 (16%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHR 570
+F M LG G FG V K G+ A+K L + +K+ ++ E ++ +L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ------ 624
+V +M ++ + E++ L F THL + + +A+
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGEL----F----THL---RKAGRFPNDVAKFYHAEL 127
Query: 625 --GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
YLH II+RDLK N+LLD+ + K++DFG A+
Sbjct: 128 VLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 28/89 (31%), Positives = 43/89 (48%), Gaps = 21/89 (23%)
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
LM C+++ I +P +LG K+ I + L YL + +
Sbjct: 95 LMSTCLDK-LLKRIQGPIPE-------------DILG-----KMTVAIVKALHYLKE--K 133
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMA 663
+IHRD+K SNILLD+ N K+ DFG++
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 51/163 (31%), Positives = 74/163 (45%), Gaps = 23/163 (14%)
Query: 522 LGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRNLVRLM 576
+G+G FG V K L+G+ AVK L + KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-IEGIAQGLLYLHQYSRL 635
+ EK+ N FF R+ + R + IA L YLH +
Sbjct: 63 -YSFQTTEKLYFVLDFVNGGELFFHLQRERSFP---EPRARFYAAEIASALGYLHS---I 115
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMAR----------MFCG 668
I++RDLK NILLDS + ++DFG+ + FCG
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG 158
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 17/168 (10%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEV----AVKRLSS----QSGQGLKEFKNEMMLIAK 566
NF + LG G +G V+ + ++G + A+K L Q + + + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 567 LQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG-IAQ 624
++ + + + K+ LI +Y+ L L R + V+I G I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEIVL 116
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 672
L +LH +L II+RD+K NILLDS+ + ++DFG+++ F DE++
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 38/149 (25%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 521 KLGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
+LG+G +G VYK G + +E+ ++ S+ Q + E + ++ K +V
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIME----LDILHKAVSPYIVD 63
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
G +G + EYM SL+ T + +I + +GL +L +
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--E 121
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMA 663
IIHRD+K +N+L++ + K+ DFG++
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 51/169 (30%), Positives = 72/169 (42%), Gaps = 35/169 (20%)
Query: 522 LGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAKLQHRNLVRLM 576
LG+G FG V +L E A+K L + + M+ L +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 577 GCCVEQGEKILIY--EYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
C Q ++ L + EY+ L F + FD +R + I GL +L
Sbjct: 63 --CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAE--------IICGLQFL 112
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM----------FCG 668
H+ II+RDLK N+LLD D + KI+DFGM + FCG
Sbjct: 113 HKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG 158
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 50/166 (30%), Positives = 73/166 (43%), Gaps = 27/166 (16%)
Query: 522 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMM----LIAKLQHRNLVRLM 576
LG+G FG V+ +L Q A+K L + + M+ L +H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 577 GCCVEQGEKIL-IYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
C + E + + EY+ L F + FD R + I GL +LH
Sbjct: 63 -CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAE--------IICGLQFLH 113
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
I++RDLK NILLD+D + KI+DFGM C + + G+ K
Sbjct: 114 SKG---IVYRDLKLDNILLDTDGHIKIADFGM----CKENMLGDAK 152
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 46/173 (26%), Positives = 80/173 (46%), Gaps = 45/173 (26%)
Query: 522 LGEGGFGPVYKGKLLNGQE-VAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGC- 578
+G G FG VY+ ++ E VA+K++ ++KN E++++ L H N++ L
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYY 128
Query: 579 ---CVEQGEKIL----IYEYMP-------------NKSLNFFLFDPSRTHLLGWQTRVKI 618
C ++ EK + + E++P N +L FL L +Q
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFL-----VKLYSYQ----- 178
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARMFCGDE 670
+ + L Y+H S+ I HRDLK N+L+D + + K+ DFG A+ +
Sbjct: 179 ---LCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ 225
|
Length = 440 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 26/57 (45%), Positives = 34/57 (59%), Gaps = 13/57 (22%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM----------ARMFCG 668
I+ GL +LH R II+RDLK N++LDS+ + KI+DFGM R FCG
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCG 163
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 29/135 (21%)
Query: 542 AVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE---YMPNKSLN 598
A R + Q +NE++ + +L H N++++ E+IL E YM + +
Sbjct: 202 AGSRAAIQ-------LENEILALGRLNHENILKI--------EEILRSEANTYMITQKYD 246
Query: 599 F----FLFDPS---RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 651
F F++D + + L QTR I++ + + Y+H ++IHRD+K NI L+
Sbjct: 247 FDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302
Query: 652 DMNPKISDFGMARMF 666
D + DFG A F
Sbjct: 303 DGKIVLGDFGTAMPF 317
|
Length = 501 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 21/45 (46%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
I GL Y+H + ++HRDLK N+L+++D KI DFG+AR F
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 46/171 (26%), Positives = 65/171 (38%), Gaps = 38/171 (22%)
Query: 522 LGEGGFGPV----YKGKLLNGQEVAVKRL------SSQSGQGLKEFKNEMMLIAKLQHRN 571
LG G FG V YK G+ A+K L + + L K +H
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLL 627
LV L C + + EY L + F R + GL
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAAC--------VVLGLQ 115
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR----------MFCG 668
YLH+ +I++RDLK N+LLD++ KI+DFG+ + FCG
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCG 163
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 46/169 (27%), Positives = 73/169 (43%), Gaps = 34/169 (20%)
Query: 514 ENFSMQCKLGEGGFGPV-YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH--- 569
E+F +G+G FG V K G+ A+K L K+EM +L H
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL----------LKSEMFKKDQLAHVKA 50
Query: 570 -RNL---------VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 619
R++ V L + LI E++P L T L+ + T + +
Sbjct: 51 ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDL--------MTMLIKYDTFSEDV 102
Query: 620 EG--IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
+A+ +L + +L IHRD+K NIL+D + K+SDFG++ F
Sbjct: 103 TRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 42/155 (27%), Positives = 68/155 (43%), Gaps = 28/155 (18%)
Query: 522 LGEGGFGPVYKGKLLNGQEV-AVKRLSS----QSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
+G G FG V+ + + +V A+K L + Q + E ++A +V+L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIA-HVRAERDILADADSPWIVKLY 67
Query: 577 GCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG------IAQGLLY 628
Q E+ L + EYMP L + R + IA+ +L
Sbjct: 68 --YSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETARFYIAELVLA 113
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
L +L IHRD+K NIL+D+D + K++DFG+
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 25/57 (43%), Positives = 33/57 (57%), Gaps = 13/57 (22%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM----------ARMFCG 668
IA GL +LH II+RDLK N++LDS+ + KI+DFGM + FCG
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCG 163
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 50/166 (30%), Positives = 76/166 (45%), Gaps = 15/166 (9%)
Query: 522 LGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEM----MLIAKLQHRNLVRLM 576
+G+G FG V + ++ AVK L ++ KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG-IAQGLLYLHQYSRL 635
+ + +Y+ L F+ R L + R + IA L YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGEL-FYHLQRERCFL---EPRARFYAAEIASALGYLHS---L 115
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
I++RDLK NILLDS + ++DFG+ + E G T GT
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 18/41 (43%), Positives = 28/41 (68%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662
IA+ +L + +L IHRD+K N+LLD+ + K+SDFG+
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 15/165 (9%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEV----AVKRLSS----QSGQGLKEFKNEMMLIAK 566
NF + LG G +G V+ + + G + A+K L Q + ++ + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 567 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
+ Q LV L + + LI +Y+ + L+ R + + R E I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY--QRDNFSEDEVRFYSGE-IILA 117
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
L +LH +L I++RD+K NILLDS+ + ++DFG+++ F +E
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 44/157 (28%), Positives = 66/157 (42%), Gaps = 11/157 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQ--EVAVKRLSSQSGQGLKEFK---NEMMLIAKLQ 568
E+F+ LG G FG V N VA+KR K+ +E ++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
H V L G ++ L+ E++ FL R + V AQ +L
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR-----FPNDVGCFYA-AQIVLI 143
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665
L I++RDLK N+LLD D K++DFG A++
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180
|
Length = 340 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 19/180 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAKLQHRN 571
++F +LG G G V+K +G +A K + + ++ + E+ ++ +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT--HLLGWQTRVKIIEGIAQGLLYL 629
+V G GE + E+M SL+ L R +LG K+ + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYL 119
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFG--------MARMFCGDELQGNTKRVVGT 681
+ + +I+HRD+K SNIL++S K+ DFG MA F G + +R+ GT
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 177
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 19/43 (44%), Positives = 29/43 (67%)
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
Q LL +H +IHRD+K++NILL S+ K+ DFG ++M+
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY 193
|
Length = 496 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 9e-05
Identities = 19/41 (46%), Positives = 26/41 (63%), Gaps = 3/41 (7%)
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ L Y+H + + HRDLK NIL ++D KI DFG+AR
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 9e-05
Identities = 56/209 (26%), Positives = 79/209 (37%), Gaps = 68/209 (32%)
Query: 522 LGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAKLQHRN 571
LG G FG V + K + + VAVK L + G E+K M +LI H N
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKML--KEGATASEYKALMTELKILIHIGHHLN 72
Query: 572 LVRLMGCCVEQGEKIL-IYEYMPNKSLNFFL------FDPSRTHLL-------------- 610
+V L+G C + G ++ I EY +L+ +L F P R
Sbjct: 73 VVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQR 132
Query: 611 -------------GWQT--RVKIIEGIAQG-------------LLYLHQYSR-------L 635
G+ + +E +G + Y Q +R
Sbjct: 133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR 192
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ IHRDL A NILL + KI DFG+AR
Sbjct: 193 KCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 43/151 (28%), Positives = 72/151 (47%), Gaps = 12/151 (7%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGC 578
+G+G +G V + +G++ +K+L+ + S + K + E L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 579 CVEQGEKILIYEYM---PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
+GE L+Y M L + + LL V+ IA L YLH+
Sbjct: 68 W--EGEDGLLYIVMGFCEGGDL-YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK--- 121
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMF 666
I+HRDLK N+ L K+ D G+AR+
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 43/165 (26%), Positives = 67/165 (40%), Gaps = 23/165 (13%)
Query: 525 GGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKN----EMMLIAKLQHRNLVRLMGCC 579
G FG VY K G A+K L + N +++ + + + +L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW---QTRVKIIEGIAQGLLYLHQYSRLR 636
+ L+ EY+ S LG + I + G+ LHQ
Sbjct: 67 QSKDYLYLVMEYLNGGDCA------SLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--- 117
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
IIHRD+K N+L+D + K++DFG++R G E K+ VGT
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGT 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 32/115 (27%), Positives = 51/115 (44%), Gaps = 7/115 (6%)
Query: 549 QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH 608
++ G K E+ ++ + HR ++ L+ K + MP + F + R+
Sbjct: 125 KAVTGGKTPGREIDILKTISHRAIINLIHA---YRWKSTVCMVMPKYKCDLFTY-VDRSG 180
Query: 609 LLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
L + + I + + L YLH IIHRD+K NI LD N + DFG A
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 40/149 (26%), Positives = 68/149 (45%), Gaps = 13/149 (8%)
Query: 522 LGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
+G GGFG VY GK+ + + KR+ + G+ L + M+ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 576 MGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
M +K+ I + M L++ L S+ + I GL ++H +R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEAEMRFYAAEIILGLEHMH--NR 116
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMA 663
+++RDLK +NILLD + +ISD G+A
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 50/171 (29%), Positives = 79/171 (46%), Gaps = 20/171 (11%)
Query: 522 LGEGGFGPVYK-GKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCC 579
+G+G +G V+K NG + AVK L +E + E ++ L H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 580 ----VEQGEKI-LIYEYMPNKSLN----FFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
V+ G+++ L+ E S+ FL R + I+ GL +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFL---KRGERMEEPIIAYILHEALMGLQHLH 141
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+ IHRD+K +NILL ++ K+ DFG++ L+ NT VGT
Sbjct: 142 VN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGT 187
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 21/57 (36%), Positives = 30/57 (52%), Gaps = 13/57 (22%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR----------MFCG 668
I L YLH +++RDLK N++LD D + KI+DFG+ + FCG
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 48/162 (29%), Positives = 72/162 (44%), Gaps = 21/162 (12%)
Query: 522 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMM---LIAKLQHRNLVRLMG 577
LG+G FG V +L G+ AVK L + + M+ ++A + +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 578 CCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
C + E + + E++ L F + D R L ++ E I GL +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAE-IVCGLQFLHSKG--- 116
Query: 637 IIHRDLKASNILLDSDMNPKISDFGM----------ARMFCG 668
II+RDLK N++LD D + KI+DFGM A FCG
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG 158
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 46/166 (27%), Positives = 69/166 (41%), Gaps = 30/166 (18%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQHRNLVRLMG 577
LG+G FG V + +G+ A+K L + E + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 578 CCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
+ + EY+ L F L F RT G + I L YLH
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAE--------IVSALDYLHSG 114
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMA----------RMFCG 668
+I++RDLK N++LD D + KI+DFG+ + FCG
Sbjct: 115 ---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 48/171 (28%), Positives = 70/171 (40%), Gaps = 33/171 (19%)
Query: 521 KLGEGGFGPVYKG-KLLNGQEVAVKRLSSQ-SGQGL--KEFKNEMMLIAKLQHRNLVRLM 576
+G+GG G VY + + VA+K++ S L K F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLG--WQ-----------TRVK----II 619
C G+ +Y MP ++ + LL WQ T V I
Sbjct: 69 SIC-SDGD--PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
I + Y+H S+ ++HRDLK NILL I D+G A +E
Sbjct: 120 HKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEE 167
|
Length = 932 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 35/110 (31%), Positives = 50/110 (45%), Gaps = 16/110 (14%)
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
H LV L C + + EY+ L F + + L R E I+ L Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNY 111
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR----------MFCG 668
LH+ II+RDLK N+LLDS+ + K++D+GM + FCG
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 158
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 21/57 (36%), Positives = 33/57 (57%), Gaps = 13/57 (22%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR----------MFCG 668
I+ L +LH+ II+RDLK N+LLD++ + K++D+GM + FCG
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG 158
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 18/40 (45%), Positives = 28/40 (70%), Gaps = 3/40 (7%)
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665
L YLH Y I+HRDLK N+L+ S + K++DFG++++
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 47/164 (28%), Positives = 69/164 (42%), Gaps = 35/164 (21%)
Query: 514 ENFSMQCKLGEGGFGPV-----------YKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMM 562
E+F + +G G FG V Y KLL+ E+ +KR S F E
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM-IKRSDSAF------FWEERD 95
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFD---PSRTHLLGWQTRVK 617
++A +V+L Q +K L + EYMP L + + P + W R
Sbjct: 96 IMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK-----W-ARFY 147
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661
E + L +H IHRD+K N+LLD + K++DFG
Sbjct: 148 TAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 40/149 (26%), Positives = 69/149 (46%), Gaps = 13/149 (8%)
Query: 522 LGEGGFGPVY------KGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
+G GGFG VY GK+ + + KR+ + G+ L + M+ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 576 MGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
M +K+ I + M L++ L S+ + + I GL ++H +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLEHMH--NR 116
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMA 663
+++RDLK +NILLD + +ISD G+A
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 20/57 (35%), Positives = 30/57 (52%), Gaps = 13/57 (22%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA----------RMFCG 668
I L YLH +++RD+K N++LD D + KI+DFG+ + FCG
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 522 LGEGGFGPVYK------GKLLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKL-QHRNLV 573
LG G FG V + GK N VAVK L + + +E +E+ +++ L QH+N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFL 601
L+G C G ++I EY L FL
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 34/107 (31%), Positives = 48/107 (44%), Gaps = 16/107 (14%)
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
LV L C L+ EY+ L F + + L R E I L +LH+
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAE-ICIALNFLHE 114
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR----------MFCG 668
II+RDLK N+LLD+D + K++D+GM + FCG
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG 158
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 41/162 (25%), Positives = 68/162 (41%), Gaps = 27/162 (16%)
Query: 522 LGEGGFGPVYKGKL---------LNGQEVAVKRL-----SSQSGQGLKEFKNEMMLIAKL 567
LG G +Y G L E +K + S L F+ M+ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMM-RQV 61
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
H+++V L G CV E I++ E++ L+ F+ S W + K+ + +A L
Sbjct: 62 SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALS 119
Query: 628 YLHQYSRLRIIHRDLKASNILL-----DSDMNP--KISDFGM 662
YL ++H ++ NILL D + P K+SD G+
Sbjct: 120 YLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 19/41 (46%), Positives = 28/41 (68%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662
IA+ +L + +L IHRD+K N+LLDS + K+SDFG+
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 22/57 (38%), Positives = 31/57 (54%), Gaps = 12/57 (21%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA----------RMFCG 668
I L YLH S +++RDLK N++LD D + KI+DFG+ + FCG
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG 158
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 19/43 (44%), Positives = 26/43 (60%), Gaps = 3/43 (6%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+AQG+ +L + IHRD+ A N+LL KI DFG+AR
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 16/40 (40%), Positives = 28/40 (70%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661
IA+ +L +H +L +HRD+K N+LLD + + +++DFG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 19/54 (35%), Positives = 30/54 (55%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
A+ L L + +I+RDLK NILLD + + DFG+ ++ D+ + NT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 17/45 (37%), Positives = 27/45 (60%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
IA+ + ++ IHRD+K NIL+D D + K++DFG+ F
Sbjct: 107 IAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 20/57 (35%), Positives = 31/57 (54%), Gaps = 10/57 (17%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR----------MFCG 668
IA+ +L L + I++RDLK NILLD+ + + DFG+++ FCG
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCG 158
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+A+G+ +L SR + IHRDL A NILL + KI DFG+AR
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 18/41 (43%), Positives = 28/41 (68%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662
IA+ +L + +L IHRD+K N+LLD+ + K+SDFG+
Sbjct: 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 22/43 (51%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+A+G+ +L SR + IHRDL A NILL + KI DFG+AR
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.004
Identities = 21/53 (39%), Positives = 31/53 (58%), Gaps = 1/53 (1%)
Query: 616 VKIIEGIA-QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667
+ +I+G+ Q L L + R+ I+HRD+K N+L+ D KI DFG A C
Sbjct: 308 INVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMC 360
|
Length = 507 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 681 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.97 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.96 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.96 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.96 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.96 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.95 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.95 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.95 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.94 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.94 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.94 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.94 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.94 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.94 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.93 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.93 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.93 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.93 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.93 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.93 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.93 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.93 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.93 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.93 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.92 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.92 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.91 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.91 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.91 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.91 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.91 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.91 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.9 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.9 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.9 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.9 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.9 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.9 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.9 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.9 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.9 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.9 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.9 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.9 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.9 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.9 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.9 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.9 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.9 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.9 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.9 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.9 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.89 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.89 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.89 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.89 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.89 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.89 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.89 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.89 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.89 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.89 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.89 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.89 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.89 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.89 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.89 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.89 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.89 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.89 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.88 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.88 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.88 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.88 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.88 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.88 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.88 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.88 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.88 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.88 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.88 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.88 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.88 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.88 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.88 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.88 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.88 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.88 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.88 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.88 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.88 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.88 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.88 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.88 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.88 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.87 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.87 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.87 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.87 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.87 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.87 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.87 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.87 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.87 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.87 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.87 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.87 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.87 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.87 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.87 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.87 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.87 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.87 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.87 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.87 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.87 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.87 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.87 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.87 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.87 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.87 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.86 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.86 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.86 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.86 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.86 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.86 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.86 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.86 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.86 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.86 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.86 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.86 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.86 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.86 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.86 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.86 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.86 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.86 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.86 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.86 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.86 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.86 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.86 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.86 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.86 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.86 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.86 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.86 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.86 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.86 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.86 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.85 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.85 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.85 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.85 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.85 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.85 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.85 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.85 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.85 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.85 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.85 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.85 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.85 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.85 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.85 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.85 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.85 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.85 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.85 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.85 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.85 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.85 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.84 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.84 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.84 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.84 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.84 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.84 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.84 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.84 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.84 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.84 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.84 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.84 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.84 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.84 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.84 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.84 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.84 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.84 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.84 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.84 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.84 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.84 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.84 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.84 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.84 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.84 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.84 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.84 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.84 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.84 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.84 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.84 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.83 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.83 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.83 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.83 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.83 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.83 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.83 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.83 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.83 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.83 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.83 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.83 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.83 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.83 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.83 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.83 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.83 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.83 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.83 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.83 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.82 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.82 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.82 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.82 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.82 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.82 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.82 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.82 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.82 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.82 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.82 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.82 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.82 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.82 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.82 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.82 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.82 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.81 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.81 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.81 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.81 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.81 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.81 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.81 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.81 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.81 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.81 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.81 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.81 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.81 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.81 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.81 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.81 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.81 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.8 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.8 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.8 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.8 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.8 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.8 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.8 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.79 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.79 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.79 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.79 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.79 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.79 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.79 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.79 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.79 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.79 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.79 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.79 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.79 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.79 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.78 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.78 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.78 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.78 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.78 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.78 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.78 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.78 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.78 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.77 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.77 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.75 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.75 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.75 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.75 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.74 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.74 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.74 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.73 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.73 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.72 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.72 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.71 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.67 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.66 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.66 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.66 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.6 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.59 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.58 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.57 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.29 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.24 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.15 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.15 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.11 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 98.97 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 98.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 98.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 98.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.84 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.83 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.77 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.66 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.6 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.59 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.56 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.56 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.53 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.5 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.48 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.41 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.37 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.35 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.22 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.2 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.19 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.18 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.15 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.14 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.08 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.07 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.07 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.0 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 97.99 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.8 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.8 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.7 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.63 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.6 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.46 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.45 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.36 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.36 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.26 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.94 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.83 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.79 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.69 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.68 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.61 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.59 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.52 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.41 | |
| PLN02236 | 344 | choline kinase | 96.33 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 96.12 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.05 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.9 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.54 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.47 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.46 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 95.41 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.27 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.87 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.75 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=310.80 Aligned_cols=168 Identities=53% Similarity=0.845 Sum_probs=154.3
Q ss_pred CCCcccHHHHHHhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEE
Q 005718 500 VLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579 (681)
Q Consensus 500 ~~~~~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~ 579 (681)
....|++.++..+|++|...+.||+|+||.||+|.+.++..||||++.....+..++|.+|+.++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988865433156799999999999999999999999
Q ss_pred EeCC-eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEe
Q 005718 580 VEQG-EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 658 (681)
Q Consensus 580 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~ 658 (681)
.+.+ +++||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999775444 78999999999999999999999998899999999999999999999999
Q ss_pred ecCCceeecC
Q 005718 659 DFGMARMFCG 668 (681)
Q Consensus 659 DFGla~~~~~ 668 (681)
|||||+....
T Consensus 220 DFGLa~~~~~ 229 (361)
T KOG1187|consen 220 DFGLAKLGPE 229 (361)
T ss_pred CccCcccCCc
Confidence 9999987644
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=264.12 Aligned_cols=152 Identities=32% Similarity=0.539 Sum_probs=135.9
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
..+|.+.+.||+|+|+.||+|+++ ++..||||.+.+. .....+.+..|+.+|+.++|||||++++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356888889999999999999985 4789999999865 4556778899999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC------CCeEEeecCCc
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD------MNPKISDFGMA 663 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~------~~~kl~DFGla 663 (681)
|||++|+|.++|.. ...+++.+...++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999943 346899999999999999999999998 9999999999999765 45899999999
Q ss_pred eeecCCC
Q 005718 664 RMFCGDE 670 (681)
Q Consensus 664 ~~~~~~~ 670 (681)
|.+....
T Consensus 163 R~L~~~~ 169 (429)
T KOG0595|consen 163 RFLQPGS 169 (429)
T ss_pred hhCCchh
Confidence 9986543
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-30 Score=224.77 Aligned_cols=110 Identities=51% Similarity=0.808 Sum_probs=82.1
Q ss_pred CCceEEEccCCCCCcCC--cceEEEeeCCcEEEEeCCCcEEEee-cCcccc-CCceEEEecCCCEEEeecCCCCCCCCce
Q 005718 70 PDTVVWVANRNSPIVDS--NAVLTIGNNGNLVLLNQTDGIIWSS-NLSREV-KNPVAQLLDTGNLVLREKFSSNTSEGSY 145 (681)
Q Consensus 70 ~~~~vW~an~~~p~~~~--~~~l~~~~~g~l~l~~~~~~~~w~~-~~~~~~-~~~~~~l~~~gnlvl~~~~~~~~~~~~~ 145 (681)
++|+||+|||+.|+... ..+|.|+.||+|+|++..++++|++ ++.+.. ....|.|+|+|||||++. .+.+
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~------~~~~ 74 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS------SGNV 74 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET------TSEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee------cceE
Confidence 36999999999999643 4889999999999999999999999 655433 588999999999999986 3889
Q ss_pred eeeeccCCCccccCCccccceeccCceeEEEEeccCCCCC
Q 005718 146 LWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPS 185 (681)
Q Consensus 146 ~wqSFd~PtDtlLpgq~l~~~~~~g~~~~l~S~~s~~dps 185 (681)
|||||||||||+||||+|+.+..++.+..++||++.+|||
T Consensus 75 lW~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 75 LWQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EEESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred EEeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 9999999999999999999988887777899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=255.72 Aligned_cols=161 Identities=31% Similarity=0.476 Sum_probs=138.8
Q ss_pred hCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC--CeEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKIL 587 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l 587 (681)
.+.|+.+++||+|.||.||+|+. ..|+.||+|++.... ........+||.+|++|.||||++|.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 45677889999999999999986 568999999997643 34456678999999999999999999999887 68999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
|+|||++ +|.-++. ...-.++..++..++.|++.||+|||..+ |+|||||.+|||||.+|.+||+|||||+++.
T Consensus 196 VFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999987 5555552 23345889999999999999999999998 9999999999999999999999999999998
Q ss_pred CCCccCCCccee
Q 005718 668 GDELQGNTKRVV 679 (681)
Q Consensus 668 ~~~~~~~~~~~~ 679 (681)
.+.....|.+++
T Consensus 270 ~~~~~~~T~rVv 281 (560)
T KOG0600|consen 270 PSGSAPYTSRVV 281 (560)
T ss_pred CCCCcccccceE
Confidence 888776676654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=249.25 Aligned_cols=160 Identities=28% Similarity=0.438 Sum_probs=134.2
Q ss_pred hCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCc-------ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSG-------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE 584 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~-------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 584 (681)
.+.|.+.+.||+|+||.|-+|.. ++++.||||.+.+... .......+|+++|++++|||||++.+++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 45677889999999999999987 4599999999986421 122345799999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC---CCeEEeecC
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFG 661 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~---~~~kl~DFG 661 (681)
.|||||||++|+|.+.+.. .+.+.+.....++.|++.|+.|||+++ |+||||||+||||..+ -.+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999999843 344666777889999999999999998 9999999999999765 679999999
Q ss_pred CceeecCCCccCCCcceecC
Q 005718 662 MARMFCGDELQGNTKRVVGT 681 (681)
Q Consensus 662 la~~~~~~~~~~~~~~~~GT 681 (681)
|||...... .+.++.||
T Consensus 325 lAK~~g~~s---fm~TlCGT 341 (475)
T KOG0615|consen 325 LAKVSGEGS---FMKTLCGT 341 (475)
T ss_pred hhhccccce---ehhhhcCC
Confidence 999885222 24556666
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=259.47 Aligned_cols=160 Identities=31% Similarity=0.455 Sum_probs=144.0
Q ss_pred CCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
..|...+.||+|+|+.||+++. ..|+.||+|++.+. .....+...+|+++.+.|+|||||+++++|.+.++.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999998 77999999999763 2345678899999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
|+|++++|..++ .+.+.+++.++..++.||+.||.|||+++ |||||||..|++|++++++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~---Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELL---KRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHH---HhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999998 35667999999999999999999999987 999999999999999999999999999999766
Q ss_pred CccCCCcceecC
Q 005718 670 ELQGNTKRVVGT 681 (681)
Q Consensus 670 ~~~~~~~~~~GT 681 (681)
+.+.. ++-||
T Consensus 172 ~Erk~--TlCGT 181 (592)
T KOG0575|consen 172 GERKK--TLCGT 181 (592)
T ss_pred ccccc--eecCC
Confidence 54432 35676
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=258.51 Aligned_cols=150 Identities=39% Similarity=0.623 Sum_probs=132.7
Q ss_pred CCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcc--cHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC-eEEEEEEec
Q 005718 516 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ--GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-EKILIYEYM 592 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~Ey~ 592 (681)
+.+.+.||+|+||+||+|.+.....||||++...... ..++|.+|+.+|.+++|||||+++|+|.+.. ...||||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 4445679999999999999966555999999864322 2569999999999999999999999999988 799999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC-CeEEeecCCceeecC
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMFCG 668 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~~~~ 668 (681)
++|+|..+|... +...+++..++.++.+||+||.|||++.. ||||||||+||||+.++ ++||+|||+++....
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 999999999664 45679999999999999999999999863 99999999999999998 999999999998754
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=259.77 Aligned_cols=154 Identities=38% Similarity=0.606 Sum_probs=138.6
Q ss_pred hCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
...+.+.+.||+|-||.||.|.++....||+|.++.. ....+.|.+|+.+|++|+|+|||+++|+|..++.++||||||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 3445667899999999999999988889999999874 456688999999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCCc
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 671 (681)
+.|+|.++|.+ ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+||||||.+.+++-
T Consensus 284 ~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 284 PKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred ccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 99999999965 34556888999999999999999999988 99999999999999999999999999996655543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=246.12 Aligned_cols=158 Identities=30% Similarity=0.412 Sum_probs=136.6
Q ss_pred CCCceeeecccCcEeEEEEEecC-CcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC-eEEEEEEe
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-EKILIYEY 591 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~Ey 591 (681)
+++..+.||+|..|+|||+.++. ++.+|+|.+... .....+++.+|++++.+.+||+||+++|.|.... ...|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 34456799999999999999964 778999999543 3455678999999999999999999999999998 59999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCCc
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 671 (681)
|++|||+.++.. .+.+++...-.|+.+|++||.|||+.. +||||||||+||||++.|++||+|||.++.+...
T Consensus 160 MDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999943 355899999999999999999999732 4999999999999999999999999999988554
Q ss_pred cCCCcceecC
Q 005718 672 QGNTKRVVGT 681 (681)
Q Consensus 672 ~~~~~~~~GT 681 (681)
...+++||
T Consensus 233 --~a~tfvGT 240 (364)
T KOG0581|consen 233 --IANTFVGT 240 (364)
T ss_pred --hccccccc
Confidence 23456776
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=245.37 Aligned_cols=161 Identities=28% Similarity=0.437 Sum_probs=142.4
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.++|++.++||+|+||+||.++.++ ++.+|+|++++.. ..+.+..++|..+|.+++||.||.++..|.+.+++|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4689999999999999999998765 7889999998752 34567789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+||+.||.|..+| ++...+++..+.-++.+|+.||.|||+.+ ||||||||+|||||++|+++|+||||++.-..
T Consensus 104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999 34455888888889999999999999998 99999999999999999999999999997755
Q ss_pred CCccCCCcceecC
Q 005718 669 DELQGNTKRVVGT 681 (681)
Q Consensus 669 ~~~~~~~~~~~GT 681 (681)
++.. +.++.||
T Consensus 178 ~~~~--t~tfcGT 188 (357)
T KOG0598|consen 178 DGDA--TRTFCGT 188 (357)
T ss_pred CCCc--cccccCC
Confidence 5444 4447887
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=266.77 Aligned_cols=153 Identities=35% Similarity=0.571 Sum_probs=135.1
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCCCcc-cHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG 583 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 583 (681)
....+....+.||+|+||+||+|+.. +...||||.+++.... ...+|++|++++..++|||||+|+|+|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 34556667789999999999999863 2457999999987554 6789999999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhHhcCCC-------C----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC
Q 005718 584 EKILIYEYMPNKSLNFFLFDPS-------R----THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD 652 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~ 652 (681)
..++|+|||.+|+|.++|.... . +..++..+.+.||.|||.||+||-+++ +|||||..+|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccc
Confidence 9999999999999999995321 1 334889999999999999999999887 9999999999999999
Q ss_pred CCeEEeecCCceee
Q 005718 653 MNPKISDFGMARMF 666 (681)
Q Consensus 653 ~~~kl~DFGla~~~ 666 (681)
..|||+||||+|.+
T Consensus 640 l~VKIsDfGLsRdi 653 (774)
T KOG1026|consen 640 LVVKISDFGLSRDI 653 (774)
T ss_pred eEEEecccccchhh
Confidence 99999999999864
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=254.23 Aligned_cols=154 Identities=34% Similarity=0.548 Sum_probs=136.2
Q ss_pred HhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCccc-HHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
.+.....+.++||+|.||.|.++....+..||||.++...... ..+|+.|+++|.+++||||++|+|+|..++.+++|+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 3455667779999999999999999888999999999865444 489999999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||++|+|..+|..+.... +.......|+.||+.||+||.+.+ +|||||.++|||+|.++++||+|||++|-+-.
T Consensus 615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccccc
Confidence 9999999999996654433 445666789999999999999887 99999999999999999999999999995433
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.5e-28 Score=247.43 Aligned_cols=159 Identities=33% Similarity=0.543 Sum_probs=135.4
Q ss_pred CCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhh--CCCCCeeEEEEEEEeCC----eEEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK--LQHRNLVRLMGCCVEQG----EKILI 588 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~~~----~~~lV 588 (681)
...+.++||+|.||.||||.+. ++.||||++.. ++.+.|.+|-++.+. ++|+||++++++-..++ +++||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 3445689999999999999995 48999999965 445667777766654 58999999999877666 89999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh------CCCCCeeecccCCCcEEEcCCCCeEEeecCC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ------YSRLRIIHRDLKASNILLDSDMNPKISDFGM 662 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~------~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl 662 (681)
+||.+.|+|.++| ....++|.+..+|+..+++||+|||+ +.+++|+|||||.+||||..+++++|+||||
T Consensus 287 t~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 287 TEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999999 55679999999999999999999997 3456899999999999999999999999999
Q ss_pred ceeecCCCccCCCcceecC
Q 005718 663 ARMFCGDELQGNTKRVVGT 681 (681)
Q Consensus 663 a~~~~~~~~~~~~~~~~GT 681 (681)
|..+........+--.|||
T Consensus 363 Al~~~p~~~~~d~~~qVGT 381 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGT 381 (534)
T ss_pred eEEecCCCCCcchhhhhhh
Confidence 9999876665555446776
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=256.47 Aligned_cols=156 Identities=32% Similarity=0.534 Sum_probs=138.9
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC----CcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 586 (681)
......+.++||.|.||.|++|.++. ...||||.++.. .+....+|+.|..+|.++.||||++|.|+....+..+
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 34566778999999999999999853 357999999975 4456778999999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
||.|||+||+|+.+|.... ..+++.+...|+++||.||+||-+.+ .|||||.++|||++.+..+||+||||+|.+
T Consensus 707 IiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred EEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeec
Confidence 9999999999999996543 34889999999999999999999887 999999999999999999999999999988
Q ss_pred cCCCcc
Q 005718 667 CGDELQ 672 (681)
Q Consensus 667 ~~~~~~ 672 (681)
.++...
T Consensus 782 edd~~~ 787 (996)
T KOG0196|consen 782 EDDPEA 787 (996)
T ss_pred ccCCCc
Confidence 666533
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=246.03 Aligned_cols=165 Identities=30% Similarity=0.424 Sum_probs=141.8
Q ss_pred HhhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCC---CcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 585 (681)
...++|.+.+.||+|+|++|++|+... ++++|||++.+. .....+-...|-.+|.+| .||.|++|+..|.+...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345789999999999999999998754 889999999764 223345567788888888 899999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
|+|+||+++|+|.++|. +...+++.....++.+|+.||+|||+++ ||||||||+|||||++|++||+|||-|++
T Consensus 150 YFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999994 3456888899999999999999999998 99999999999999999999999999999
Q ss_pred ecCCCcc---------CCC--cceecC
Q 005718 666 FCGDELQ---------GNT--KRVVGT 681 (681)
Q Consensus 666 ~~~~~~~---------~~~--~~~~GT 681 (681)
+.+.+.. +.. ..+|||
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGT 250 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGT 250 (604)
T ss_pred CChhhccccCccCcccccCcccceeee
Confidence 9764433 222 458887
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=223.66 Aligned_cols=150 Identities=32% Similarity=0.539 Sum_probs=132.1
Q ss_pred CCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCcc--cHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQ--GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
.+|...+.||+|.||.||+|+. ..|+.||||+++..... -.....+|++.|+.++|+||+.++++|.+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3567778999999999999987 45899999999864221 23467899999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+ .+|...+.+ +...++..+...++.++++||+|||.+. |+||||||.|+||++++.+||+||||||.+...
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 996 588888854 4456888999999999999999999988 999999999999999999999999999998643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=232.58 Aligned_cols=149 Identities=28% Similarity=0.418 Sum_probs=130.9
Q ss_pred CCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCc--ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
+.|+...++|+|+||.|||++.++ |+.||||++..... .-.+-.++|+++|++++|+|+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 356777899999999999999876 89999999975422 234567999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|++..-|+++= ....-++.....++++|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+||.+..
T Consensus 82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99987776554 23444788899999999999999999998 99999999999999999999999999999974
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=202.81 Aligned_cols=109 Identities=35% Similarity=0.866 Sum_probs=102.3
Q ss_pred EeeCCCCCccccccCC-CCccceecEEEeeCceEEEEEEecCCceEEEEEEcccCcEEEEEEEecCCceEEEEeecCCCC
Q 005718 211 SCTGPWNGLAFGADPT-NTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPNNFC 289 (681)
Q Consensus 211 w~sg~w~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~Ld~dG~l~~y~~~~~~~~W~~~~~~p~~~C 289 (681)
||+|+|+|..|.++|+ .....+.+.|+.+.++.+++|...+.++++|++||.+|++++|.|++.+++|...|++|.|+|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 8999999999999998 555678888999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCccccCCCCCCCCccCCccccc
Q 005718 290 QLYGYCGANSVCSVDDTANCECLKGFKLKL 319 (681)
Q Consensus 290 ~~~g~CG~~g~C~~~~~~~C~C~~Gf~~~~ 319 (681)
|+|+.||+||+|+.+..+.|.|+|||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 999999999999888888999999999863
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-26 Score=222.31 Aligned_cols=149 Identities=31% Similarity=0.450 Sum_probs=134.8
Q ss_pred CCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCc---ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|+..+.||.|+||.|.+++.+. +..+|+|++.+..- ...+...+|..+|+.+.||.++++++.+.+....+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 568888999999999999999864 78899999987532 33456788999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||.++|.|.++| ++...+++..+.-+|.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+||...+
T Consensus 124 eyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 999999999999 34456899999999999999999999988 99999999999999999999999999998854
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.4e-28 Score=232.65 Aligned_cols=166 Identities=26% Similarity=0.436 Sum_probs=139.4
Q ss_pred CCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEE-EEEeCCe-EEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMG-CCVEQGE-KILI 588 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g-~~~~~~~-~~lV 588 (681)
.+|++.++||+|.||.|||+.. .++..||.|.+.-. +.........|+.+|++|+|||||++++ -+.++.+ .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4578889999999999999975 67999999988732 3445667899999999999999999998 4555555 8999
Q ss_pred EEecCCCChhhHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 589 YEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSR-LRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|||++.|+|...+... ...+.++++++++++.|+++||.++|..-+ ..|+||||||.||+|+.+|.+||+||||+|++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999988542 345678999999999999999999998321 23899999999999999999999999999999
Q ss_pred cCCCccCCCcceecC
Q 005718 667 CGDELQGNTKRVVGT 681 (681)
Q Consensus 667 ~~~~~~~~~~~~~GT 681 (681)
..+.+- ...+|||
T Consensus 179 ~s~~tf--A~S~VGT 191 (375)
T KOG0591|consen 179 SSKTTF--AHSLVGT 191 (375)
T ss_pred cchhHH--HHhhcCC
Confidence 665543 3457887
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=225.54 Aligned_cols=150 Identities=29% Similarity=0.423 Sum_probs=128.4
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc-cc-HHHHHHHHHHHhhCCCCCeeEEEEEEEeC--CeEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QG-LKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKILI 588 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~-~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV 588 (681)
+.|+..+.|++|.||.||+|+.+ +++.||+|+++.... .. --.-++|+.+|.+.+|||||.+-.+.... +..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45778899999999999999985 478999999985421 11 12457899999999999999999887654 579999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||||++ +|..++.. ..+.+...+...++.|+++|++|||.+. |+||||||+|+|+...|.+||+||||||.+..
T Consensus 156 Me~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999986 78888743 4467888999999999999999999988 99999999999999999999999999999955
Q ss_pred C
Q 005718 669 D 669 (681)
Q Consensus 669 ~ 669 (681)
.
T Consensus 230 p 230 (419)
T KOG0663|consen 230 P 230 (419)
T ss_pred C
Confidence 4
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=198.25 Aligned_cols=115 Identities=47% Similarity=0.767 Sum_probs=100.4
Q ss_pred CccCCCCEEEeCCCeEEEEeeCCCCCCcEEEEEEEeCCCCceEEEccCCCCCcCCcceEEEeeCCcEEEEeCCCcEEEee
Q 005718 32 TLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSS 111 (681)
Q Consensus 32 ~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~l~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~ 111 (681)
+.|.+|+.|+|+++.|++|||........+.+|||.....++||.||++.| ....+.|.|+.||+|+|+|.+|.++|++
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 568889999999999999999987543488999998733789999999998 4466899999999999999999999999
Q ss_pred cCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCC
Q 005718 112 NLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCP 153 (681)
Q Consensus 112 ~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~P 153 (681)
++.+......|+|+||||||||+.+ +.+||||||||
T Consensus 81 ~~~~~~~~~~~~L~ddGnlvl~~~~------~~~~W~Sf~~P 116 (116)
T cd00028 81 NTTRVNGNYVLVLLDDGNLVLYDSD------GNFLWQSFDYP 116 (116)
T ss_pred cccCCCCceEEEEeCCCCEEEECCC------CCEEEcCCCCC
Confidence 9875345678999999999999874 78999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-26 Score=232.36 Aligned_cols=152 Identities=29% Similarity=0.446 Sum_probs=130.8
Q ss_pred HHhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHh--hCCCCCeeEEEEEEEeCC----
Q 005718 510 SAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIA--KLQHRNLVRLMGCCVEQG---- 583 (681)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~--~l~H~nIv~l~g~~~~~~---- 583 (681)
.....+..+.+.||+|.||.||+|.+ .|+.||||++...+ ++.+.+|.++.. .|+|+||+.+++.-..++
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 34557788999999999999999999 57899999997543 345556666665 459999999998766543
Q ss_pred eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeeecccCCCcEEEcCCCCeEEe
Q 005718 584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-----YSRLRIIHRDLKASNILLDSDMNPKIS 658 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-----~~~~~ivHrDlkp~NiLl~~~~~~kl~ 658 (681)
++|||.+|+++|||.++| ....++....++++..+|.||++||. ++++.|.|||||..|||+.+++.+.|+
T Consensus 283 QLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 789999999999999999 33578999999999999999999994 688899999999999999999999999
Q ss_pred ecCCceeecCC
Q 005718 659 DFGMARMFCGD 669 (681)
Q Consensus 659 DFGla~~~~~~ 669 (681)
|+|||-.+..+
T Consensus 359 DLGLAv~h~~~ 369 (513)
T KOG2052|consen 359 DLGLAVRHDSD 369 (513)
T ss_pred eceeeEEeccc
Confidence 99999988665
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.6e-27 Score=240.22 Aligned_cols=152 Identities=30% Similarity=0.465 Sum_probs=133.1
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHH--HHHHHHHHhhCC-CCCeeEEEEEEEeCC-eEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKE--FKNEMMLIAKLQ-HRNLVRLMGCCVEQG-EKI 586 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~--f~~Ei~~l~~l~-H~nIv~l~g~~~~~~-~~~ 586 (681)
..++|.+.++||.|.||.||+|+.. .++.||||++++... ..++ =++|+..|++++ ||||++|..++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 3467889999999999999999874 588999999986532 2333 378999999998 999999999999998 999
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+|||||+. +|.+++.++ ...+++.++..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+||||||.+
T Consensus 87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 99999975 777777554 678999999999999999999999998 999999999999999999999999999988
Q ss_pred cCCC
Q 005718 667 CGDE 670 (681)
Q Consensus 667 ~~~~ 670 (681)
...+
T Consensus 161 ~Skp 164 (538)
T KOG0661|consen 161 RSKP 164 (538)
T ss_pred ccCC
Confidence 6544
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=231.19 Aligned_cols=151 Identities=26% Similarity=0.498 Sum_probs=137.4
Q ss_pred hCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
..+|.+.+.||+|.||+|-++.. ..|+.||||.|++. +.++.-.+++|+++|..|+||||++++.+|...+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45788889999999999999986 56999999999865 445566789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||..+|.|.+++ .....+++.+..++++||..|+.|+|.+. ++|||||.+|||||.++++||+||||+-++..
T Consensus 132 MEYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999999 44556899999999999999999999987 99999999999999999999999999988855
Q ss_pred C
Q 005718 669 D 669 (681)
Q Consensus 669 ~ 669 (681)
+
T Consensus 206 ~ 206 (668)
T KOG0611|consen 206 K 206 (668)
T ss_pred c
Confidence 4
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=240.82 Aligned_cols=151 Identities=36% Similarity=0.513 Sum_probs=132.6
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC--C---cEEEEEEecC---CCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN--G---QEVAVKRLSS---QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG 583 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~--~---~~VAVK~l~~---~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 583 (681)
.-++..+.++||+|+||.||+|.+.. + ..||||..+. .......+|.+|.++|+.++|||||+++|++...+
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34555666899999999999998753 2 2389999885 23556789999999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCc
Q 005718 584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla 663 (681)
.++||||+|.+|+|+++|... ...++..+++.++.+.|+||+|||+.+ +|||||.++|+|++.+..+||+||||+
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999999543 235899999999999999999999988 999999999999999999999999999
Q ss_pred eeec
Q 005718 664 RMFC 667 (681)
Q Consensus 664 ~~~~ 667 (681)
+.-.
T Consensus 310 ~~~~ 313 (474)
T KOG0194|consen 310 RAGS 313 (474)
T ss_pred cCCc
Confidence 8653
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=230.84 Aligned_cols=149 Identities=30% Similarity=0.488 Sum_probs=129.0
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc--------------ccHHHHHHHHHHHhhCCCCCeeEE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--------------QGLKEFKNEMMLIAKLQHRNLVRL 575 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--------------~~~~~f~~Ei~~l~~l~H~nIv~l 575 (681)
...++|.+.+.||+|.||.|-+|... +++.||||++.+... ...+...+|+.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999874 588999999975311 123578999999999999999999
Q ss_pred EEEEEeC--CeEEEEEEecCCCChhhHhcCCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC
Q 005718 576 MGCCVEQ--GEKILIYEYMPNKSLNFFLFDPSRTHL-LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD 652 (681)
Q Consensus 576 ~g~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~ 652 (681)
+.+.-+. +..|||+|||..|.+...- ..+. ++..++.++++++..||+|||.++ ||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 9987654 6899999999999885432 2333 899999999999999999999998 9999999999999999
Q ss_pred CCeEEeecCCceee
Q 005718 653 MNPKISDFGMARMF 666 (681)
Q Consensus 653 ~~~kl~DFGla~~~ 666 (681)
+++||+|||.+-.+
T Consensus 247 g~VKIsDFGVs~~~ 260 (576)
T KOG0585|consen 247 GTVKISDFGVSNEF 260 (576)
T ss_pred CcEEeeccceeeec
Confidence 99999999999877
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-26 Score=238.74 Aligned_cols=159 Identities=30% Similarity=0.470 Sum_probs=140.3
Q ss_pred CCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
++|.+.+.||+|.||.||||+-+. .+.||+|.+.+. ...+.+.+.+|++++++++||||+.+++.|....+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 578888999999999999998764 788999999764 33456779999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 670 (681)
|+.+ +|..+|. ....+++..+..|+.++..||.|||++. |+|||+||+||||+..+++|++|||+||-+..+.
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9977 9999993 3445899999999999999999999987 9999999999999999999999999999885433
Q ss_pred ccCCCcceecC
Q 005718 671 LQGNTKRVVGT 681 (681)
Q Consensus 671 ~~~~~~~~~GT 681 (681)
...++|.||
T Consensus 155 --~vltsikGt 163 (808)
T KOG0597|consen 155 --SVLTSIKGT 163 (808)
T ss_pred --eeeeeccCc
Confidence 335667776
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-25 Score=226.48 Aligned_cols=151 Identities=30% Similarity=0.479 Sum_probs=132.5
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC--eEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG--EKILIY 589 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~ 589 (681)
..+|...+.||+|+||.||++...+ |+..|||.+........+.+.+|+.+|.+++|||||+.+|.....+ ..+++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3457778999999999999999865 8999999887654333677899999999999999999999855554 689999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC-CCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~~~~~ 668 (681)
||+++|+|.+++..... .+++..+..+..||++||+|||+++ ||||||||+||||+. ++.+||+|||+|+....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999954322 5899999999999999999999887 999999999999999 79999999999998864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-25 Score=230.21 Aligned_cols=149 Identities=26% Similarity=0.391 Sum_probs=135.5
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
..++|++++.||+|+||.||+++-++ |..+|+|++++.. ....+..++|-.+|....++.||+|+..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45789999999999999999998755 8999999998753 3445678899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
||||++||++..+| .+...|++.....++.+++.|+..||..+ +|||||||+|+|||..|++||+||||+.-+
T Consensus 219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 99999999999999 45567899999999999999999999988 999999999999999999999999999754
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=230.84 Aligned_cols=150 Identities=28% Similarity=0.461 Sum_probs=132.9
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC----Cc-ccHHHHHHHHHHHhhCC-CCCeeEEEEEEEeCCe
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ----SG-QGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGE 584 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~----~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~ 584 (681)
....|.+.+.||+|+||+|++|... .++.||||.+.+. .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3567899999999999999999874 5799999977653 11 23456778999999998 9999999999999999
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC-CCeEEeecCCc
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMA 663 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFGla 663 (681)
.++||||+.+|+|.+++.+ ...+.+.+...++.|++.|++|||..+ |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999954 345778999999999999999999988 9999999999999999 99999999999
Q ss_pred eeec
Q 005718 664 RMFC 667 (681)
Q Consensus 664 ~~~~ 667 (681)
....
T Consensus 169 ~~~~ 172 (370)
T KOG0583|consen 169 AISP 172 (370)
T ss_pred cccC
Confidence 9884
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=219.08 Aligned_cols=150 Identities=30% Similarity=0.487 Sum_probs=128.0
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc--ccHHHHHHHHHHHhhCCCCC-eeEEEEEEEeCC------
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRN-LVRLMGCCVEQG------ 583 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~------ 583 (681)
..|...++||+|+||+||+|+.. .|+.||+|+++.... ..-....+|+.++++++|+| |++|.+++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 44666678999999999999974 588999999986533 23345688999999999999 999999999877
Q ss_pred eEEEEEEecCCCChhhHhcCCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCC
Q 005718 584 EKILIYEYMPNKSLNFFLFDPSRT-HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl 662 (681)
..++|+||++ -+|..++...... +.++......++.||++||+|||+++ |+||||||+||||++.+.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 7889999996 4888888554322 34677889999999999999999988 99999999999999999999999999
Q ss_pred ceeec
Q 005718 663 ARMFC 667 (681)
Q Consensus 663 a~~~~ 667 (681)
||.+.
T Consensus 167 Ara~~ 171 (323)
T KOG0594|consen 167 ARAFS 171 (323)
T ss_pred HHHhc
Confidence 99764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-25 Score=249.52 Aligned_cols=151 Identities=36% Similarity=0.631 Sum_probs=134.5
Q ss_pred hCCCCceeeecccCcEeEEEEEecC--Cc----EEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN--GQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~--~~----~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 585 (681)
..+.+..+.||+|.||.||+|...+ +. .||||.+++. +.+...+|.+|..+|+.++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4456677899999999999998754 33 4999999875 456678999999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecC
Q 005718 586 ILIYEYMPNKSLNFFLFDPS----RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG 661 (681)
+|++|||++|+|..+|.+.+ ....++.++.+.++.+||+|+.|||+++ +|||||.++|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999997642 2456889999999999999999999987 9999999999999999999999999
Q ss_pred Cceee
Q 005718 662 MARMF 666 (681)
Q Consensus 662 la~~~ 666 (681)
|||.+
T Consensus 848 lArDi 852 (1025)
T KOG1095|consen 848 LARDI 852 (1025)
T ss_pred hhHhh
Confidence 99944
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-25 Score=232.69 Aligned_cols=154 Identities=36% Similarity=0.602 Sum_probs=136.5
Q ss_pred ccHHHHHHhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe
Q 005718 504 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 581 (681)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 581 (681)
.+..+..+..+.+.+.+.||+|.||+||+|.+.+ .||||++.-. .....++|++|+..+++.+|.||+-+.|+|..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 3445666677778888999999999999999864 6999999754 34567899999999999999999999999998
Q ss_pred CCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecC
Q 005718 582 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661 (681)
Q Consensus 582 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG 661 (681)
... .||..+|++-+|..+|+.. ...+...+.+.||.|||+||.|||.++ |||||||..||+|.+++.|||+|||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred Cce-eeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccc
Confidence 877 9999999999999999653 345788899999999999999999988 9999999999999999999999999
Q ss_pred Ccee
Q 005718 662 MARM 665 (681)
Q Consensus 662 la~~ 665 (681)
||..
T Consensus 534 Latv 537 (678)
T KOG0193|consen 534 LATV 537 (678)
T ss_pred ceee
Confidence 9864
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=230.65 Aligned_cols=162 Identities=27% Similarity=0.429 Sum_probs=140.8
Q ss_pred HhhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC---cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 585 (681)
...++|.+.++||+|.||+|+++.++. ++.+|||.+++.. ..+.+..+.|-+++... +||.+++++++|...++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 345789999999999999999999864 7899999999863 45667788898888877 699999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
+.||||..+|++..+. ....+++..+.-++..|+.||+|||+++ ||+||||.+|||||.+|++||+||||+|.
T Consensus 445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999954433 4456889999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCccCCCcceecC
Q 005718 666 FCGDELQGNTKRVVGT 681 (681)
Q Consensus 666 ~~~~~~~~~~~~~~GT 681 (681)
-...+.+ |.++-||
T Consensus 518 ~m~~g~~--TsTfCGT 531 (694)
T KOG0694|consen 518 GMGQGDR--TSTFCGT 531 (694)
T ss_pred cCCCCCc--cccccCC
Confidence 6655543 5668887
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=218.77 Aligned_cols=167 Identities=26% Similarity=0.371 Sum_probs=141.9
Q ss_pred HhhCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
...++|++.+.||.|..+.||+|.. +.++.||||++.... ..+.+++.+|+..|+.++||||++++..|+.+..+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 3457899999999999999999986 457999999998643 33468999999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|.||.+||+.+++...-+. -+.+..+..|.+++++||.|||.++ .||||||+.||||+++|.+||+|||.+-.+..
T Consensus 103 mpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred ehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999999654333 3788999999999999999999998 99999999999999999999999997765544
Q ss_pred CCccC--CCcceecC
Q 005718 669 DELQG--NTKRVVGT 681 (681)
Q Consensus 669 ~~~~~--~~~~~~GT 681 (681)
...+. ...+++||
T Consensus 179 ~G~R~~~rf~tfvgt 193 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGT 193 (516)
T ss_pred cCceeeEeeccccCc
Confidence 33222 22456665
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=222.79 Aligned_cols=153 Identities=33% Similarity=0.561 Sum_probs=131.3
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-----------------CcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-----------------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVR 574 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-----------------~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~ 574 (681)
.++|.+.++||+|+||.||++...+ +..||+|.+.... .....+|.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4578888999999999999997532 2369999987642 334567999999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCChhhHhcCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 005718 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPS----------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRII 638 (681)
Q Consensus 575 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv 638 (681)
+++++.+.+..++||||+++++|.+++.... ....+++.+...++.||++||+|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999884321 1134678899999999999999999987 99
Q ss_pred ecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 639 HRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 639 HrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||||||+|||+++++.+||+|||+++.+..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~ 190 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYA 190 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceeccc
Confidence 999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=227.99 Aligned_cols=154 Identities=30% Similarity=0.467 Sum_probs=129.9
Q ss_pred hhCCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCCC-cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeC-
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ- 582 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~- 582 (681)
+.++|++.+.||+|+||.||+|... .++.||||++.... ....+.+.+|+.++.++ +||||++++++|.+.
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4567899999999999999999741 24679999997543 23356789999999999 899999999998764
Q ss_pred CeEEEEEEecCCCChhhHhcCCCC--------------------------------------------------------
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPSR-------------------------------------------------------- 606 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 606 (681)
...++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 468899999999999998853211
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 607 ---THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 607 ---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~ 226 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 226 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccccccccc
Confidence 134778889999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-24 Score=188.11 Aligned_cols=113 Identities=45% Similarity=0.770 Sum_probs=98.5
Q ss_pred CccCCCCEEEeCCCeEEEEeeCCCCCCcEEEEEEEeCCCCceEEEccCCCCCcCCcceEEEeeCCcEEEEeCCCcEEEee
Q 005718 32 TLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSS 111 (681)
Q Consensus 32 ~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~l~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~ 111 (681)
+.|..|+.|+|+++.|++|||.... ...+.+|||...+.++||+|||+.|+.+ ++.|.|+.||+|+|++.++.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~-q~dgnlV~~~~~~~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIM-QNDYNLILYKSSSRTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCC-CCCEEEEEEECCCCcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 5678899999999999999999865 3678899999722789999999999764 4899999999999999999999999
Q ss_pred cCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccC
Q 005718 112 NLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDC 152 (681)
Q Consensus 112 ~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~ 152 (681)
++........|+|+|||||||++.. +.++||||||
T Consensus 80 ~t~~~~~~~~~~L~ddGnlvl~~~~------~~~~W~Sf~~ 114 (114)
T smart00108 80 NTTGANGNYVLVLLDDGNLVIYDSD------GNFLWQSFDY 114 (114)
T ss_pred cccCCCCceEEEEeCCCCEEEECCC------CCEEeCCCCC
Confidence 9873356788999999999999864 7799999997
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=229.36 Aligned_cols=161 Identities=30% Similarity=0.469 Sum_probs=142.9
Q ss_pred hhCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
+...|...++||+|+.|.||.+.. ..++.||||++........+-+.+|+.+|+..+|+|||.++..+..++++|+|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 445677778999999999999986 4588999999987554556678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 670 (681)
||++|+|.+++ ....+++.+...|++++++||+|||.++ |||||||.+|||++.++.+||+|||++..+..++
T Consensus 351 ym~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 351 YMEGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred ecCCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 99999999888 3345889999999999999999999998 9999999999999999999999999999997777
Q ss_pred ccCCCcceecC
Q 005718 671 LQGNTKRVVGT 681 (681)
Q Consensus 671 ~~~~~~~~~GT 681 (681)
.+ ..++|||
T Consensus 424 ~K--R~TmVGT 432 (550)
T KOG0578|consen 424 SK--RSTMVGT 432 (550)
T ss_pred Cc--cccccCC
Confidence 65 3457887
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-25 Score=209.27 Aligned_cols=150 Identities=33% Similarity=0.449 Sum_probs=133.4
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.++|.+.+.||+|.||.||.|+.+. +-.||+|++.+.. .+...++++|+++-..|+||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 3678899999999999999999854 6789999998642 33457899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+||...|+|...|.+. +...+++.....++.|+|.||.|+|..+ +|||||||+|+|++.++.+||+|||-+..-
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 9999999999999543 3345778888899999999999999887 999999999999999999999999998754
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=226.96 Aligned_cols=152 Identities=23% Similarity=0.272 Sum_probs=133.6
Q ss_pred HHhhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeE
Q 005718 510 SAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 585 (681)
....++|++.+.||+|+||.||++.... ++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 3445789999999999999999999854 788999998642 223345688999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999998832 24788899999999999999999987 99999999999999999999999999998
Q ss_pred ecC
Q 005718 666 FCG 668 (681)
Q Consensus 666 ~~~ 668 (681)
+..
T Consensus 192 ~~~ 194 (370)
T cd05621 192 MDE 194 (370)
T ss_pred ccc
Confidence 743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=225.89 Aligned_cols=148 Identities=25% Similarity=0.359 Sum_probs=131.9
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|++.+.||+|+||.||++... .++.+|||++.+.. ......+..|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999875 47899999997532 223457888999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999999843 345889999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=226.75 Aligned_cols=147 Identities=27% Similarity=0.355 Sum_probs=130.7
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|++.+.||+|+||.||++... +++.||||++.+.. ....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999874 58899999986531 233567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999999843 345788889999999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=226.30 Aligned_cols=148 Identities=24% Similarity=0.366 Sum_probs=132.4
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|++.+.||+|+||.||++... .++.||||++.... ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46889999999999999999985 48899999997531 233456889999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999843 335889999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=222.24 Aligned_cols=149 Identities=25% Similarity=0.419 Sum_probs=132.6
Q ss_pred CCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|++.+.||+|+||.||+|.... ++.||||+++... ....+.+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 368899999999999999999864 7899999997532 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+|+....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999983 2345788999999999999999999987 99999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=226.42 Aligned_cols=146 Identities=24% Similarity=0.360 Sum_probs=130.1
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
.|.+.+.||+|+||+||+|... .++.+|||++.... ....+.+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999874 47899999997532 2335678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|+++|+|.+++.. ...+++..+..++.||+.||+|||..+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 9999999999843 345788888999999999999999987 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=228.64 Aligned_cols=161 Identities=30% Similarity=0.490 Sum_probs=143.3
Q ss_pred HHHHHhhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeE
Q 005718 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 507 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 585 (681)
.+.+....++.+..+||-|.||.||.|.++. .-.||||.++.+ ....++|+.|..+|+.++|||+|+|+|+|......
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4455556677778999999999999999965 668999999864 56789999999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
|||.|||.+|+|.++|.+..+ ..++....+.|+.||+.||+||...+ +|||||.++|+|+.++..+||+||||+|+
T Consensus 339 YIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999976443 35677788999999999999999887 99999999999999999999999999999
Q ss_pred ecCCCcc
Q 005718 666 FCGDELQ 672 (681)
Q Consensus 666 ~~~~~~~ 672 (681)
+.+|.-.
T Consensus 415 MtgDTYT 421 (1157)
T KOG4278|consen 415 MTGDTYT 421 (1157)
T ss_pred hcCCcee
Confidence 9887543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=220.26 Aligned_cols=141 Identities=26% Similarity=0.323 Sum_probs=125.6
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 005718 520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK 595 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 595 (681)
+.||+|+||.||++... +++.+|+|++++.. ......+.+|+.++++++||||+++.+++..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999874 58899999997532 233457888999999999999999999999999999999999999
Q ss_pred ChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 596 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 596 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 99988843 345789999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-24 Score=227.45 Aligned_cols=149 Identities=31% Similarity=0.466 Sum_probs=133.6
Q ss_pred CCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
.-|++.+.||+|+.|.|-+|++ ..|+.+|||++.+.. ......+.+|+.+|+.+.||||+++++++.++.++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3478889999999999999998 459999999997652 223456889999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||+++|.|.+++. +...++++++.+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||||-+-.+
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999994 4556889999999999999999999988 99999999999999999999999999987543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=221.20 Aligned_cols=149 Identities=26% Similarity=0.374 Sum_probs=132.7
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|.+.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999985 47899999987532 234567899999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999843 345788888999999999999999987 99999999999999999999999999997744
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=217.71 Aligned_cols=155 Identities=31% Similarity=0.479 Sum_probs=131.2
Q ss_pred eeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 005718 519 QCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK 595 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 595 (681)
.+.||+|-||+||-|+++ .|+.||||+|.+. .......+++|+.+|..++||.||.+...|...+..++|||-+.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 378999999999999985 5999999999764 3445678999999999999999999999999999999999999665
Q ss_pred ChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC---CeEEeecCCceeecCCCcc
Q 005718 596 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARMFCGDELQ 672 (681)
Q Consensus 596 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~---~~kl~DFGla~~~~~~~~~ 672 (681)
-|.-+| ... ...++++.-..++.||+.||.|||.++ |+|+||||+||||.+.. .+||+|||+||++.....+
T Consensus 649 MLEMIL-SsE-kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 649 MLEMIL-SSE-KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred HHHHHH-Hhh-cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 555444 333 334788888889999999999999998 99999999999997543 6999999999999776655
Q ss_pred CCCcceecC
Q 005718 673 GNTKRVVGT 681 (681)
Q Consensus 673 ~~~~~~~GT 681 (681)
+.+|||
T Consensus 724 ---rsVVGT 729 (888)
T KOG4236|consen 724 ---RSVVGT 729 (888)
T ss_pred ---hhhcCC
Confidence 346776
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=223.97 Aligned_cols=147 Identities=23% Similarity=0.359 Sum_probs=130.2
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
.+|++.+.||+|+||.||++... .++.||||.+.+.. ....+.+.+|++++.+++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999875 47899999987532 223466889999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
||+++|+|.+++.. ...++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 99999999999843 345788888899999999999999987 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=223.34 Aligned_cols=156 Identities=22% Similarity=0.266 Sum_probs=135.4
Q ss_pred HHHHHhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC
Q 005718 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ 582 (681)
Q Consensus 507 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~ 582 (681)
..+....++|++.+.||+|+||.||++... .++.+|+|++.+. .....+.+.+|+.+++.++||||+++++.+.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 334455689999999999999999999986 4788999998642 123345678899999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCC
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl 662 (681)
+..++||||+++|+|.+++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 999999999999999998832 24678888899999999999999987 99999999999999999999999999
Q ss_pred ceeecCC
Q 005718 663 ARMFCGD 669 (681)
Q Consensus 663 a~~~~~~ 669 (681)
|+.+...
T Consensus 189 a~~~~~~ 195 (371)
T cd05622 189 CMKMNKE 195 (371)
T ss_pred eeEcCcC
Confidence 9987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=221.00 Aligned_cols=150 Identities=27% Similarity=0.358 Sum_probs=132.2
Q ss_pred hCCCCceeeecccCcEeEEEEEecC--CcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN--GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~--~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
.++|++.+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3578899999999999999998643 368999998643 22345678899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999843 345789999999999999999999987 9999999999999999999999999998764
Q ss_pred C
Q 005718 668 G 668 (681)
Q Consensus 668 ~ 668 (681)
.
T Consensus 183 ~ 183 (340)
T PTZ00426 183 T 183 (340)
T ss_pred C
Confidence 3
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=219.35 Aligned_cols=142 Identities=27% Similarity=0.325 Sum_probs=126.1
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 005718 520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK 595 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 595 (681)
+.||+|+||.||++... +++.||||++.+. .......+.+|+.+++.++||||+++.+++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999875 5889999999753 2234567889999999999999999999999999999999999999
Q ss_pred ChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 596 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 596 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+|..++.. ...+++.++..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 99888833 345889999999999999999999987 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-23 Score=229.40 Aligned_cols=152 Identities=18% Similarity=0.220 Sum_probs=133.0
Q ss_pred CCCceeeecccCcEeEEEEEec-C-CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-N-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
.|.+.+.||+|+||.||++... + ++.||+|.+..........+++|+.+++.++||||+++++++.+.+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888899999999999999764 3 5778888876555455567889999999999999999999999999999999999
Q ss_pred CCCChhhHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 593 PNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 593 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
++|+|.++|.+. .....+++.+...++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 999999888543 22345788999999999999999999987 999999999999999999999999999987543
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=224.94 Aligned_cols=146 Identities=25% Similarity=0.381 Sum_probs=129.7
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
.|.+.++||+|+||.||++... .++.+|+|++.+.. ....+.+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888899999999999999875 47889999987532 2335678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 9999999998843 245788888899999999999999987 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=218.09 Aligned_cols=149 Identities=26% Similarity=0.350 Sum_probs=132.0
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999985 58899999986432 223457889999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||+++++|.+++.. ...+++.....++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999843 345788999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=223.66 Aligned_cols=150 Identities=25% Similarity=0.286 Sum_probs=132.1
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
..++|++.+.||+|+||.||++... .++.+|+|++.+. .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4567999999999999999999885 4789999998642 12334567889999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||||+++|+|.+++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998833 24678888899999999999999987 9999999999999999999999999998775
Q ss_pred C
Q 005718 668 G 668 (681)
Q Consensus 668 ~ 668 (681)
.
T Consensus 194 ~ 194 (370)
T cd05596 194 A 194 (370)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-24 Score=228.76 Aligned_cols=160 Identities=32% Similarity=0.481 Sum_probs=137.5
Q ss_pred CCceeeecccCcEeEEEEEec-CCcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC------CeEEE
Q 005718 516 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------GEKIL 587 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~l 587 (681)
|...+.||+|+||.||+|+.+ .|+.||||.++.. .....+....|+++|++++|+|||++++.-.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 445578999999999999974 5999999999864 334567788999999999999999999875543 35789
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc--CCC--CeEEeecCCc
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--SDM--NPKISDFGMA 663 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~--~~~--~~kl~DFGla 663 (681)
|||||.+|||...|.++.+..-+++.+.+.+...+..||.|||+++ |+||||||.||++- +++ --||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999999888888999999999999999999999988 99999999999983 334 3699999999
Q ss_pred eeecCCCccCCCcceecC
Q 005718 664 RMFCGDELQGNTKRVVGT 681 (681)
Q Consensus 664 ~~~~~~~~~~~~~~~~GT 681 (681)
|.+..+. ....++||
T Consensus 172 rel~d~s---~~~S~vGT 186 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGT 186 (732)
T ss_pred ccCCCCC---eeeeecCc
Confidence 9996555 35678887
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=211.59 Aligned_cols=150 Identities=29% Similarity=0.472 Sum_probs=130.4
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecC--CCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe-----CCe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE-----QGE 584 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~--~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-----~~~ 584 (681)
...|...+.||+|+||.|..+... +++.||||++.. ......++..+|+++|+.++|+||+.+.+.+.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 345666789999999999999875 589999999973 345567888999999999999999999999876 357
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
.|+|+|+| ..+|..++. ..+.++......+++||++||+|+|+.+ |+||||||+|+|++.+..+||+||||||
T Consensus 101 vYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 89999999 568888883 3444888899999999999999999998 9999999999999999999999999999
Q ss_pred eecCC
Q 005718 665 MFCGD 669 (681)
Q Consensus 665 ~~~~~ 669 (681)
.+...
T Consensus 174 ~~~~~ 178 (359)
T KOG0660|consen 174 YLDKF 178 (359)
T ss_pred ecccc
Confidence 99654
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-23 Score=217.06 Aligned_cols=140 Identities=22% Similarity=0.302 Sum_probs=124.9
Q ss_pred ecccCcEeEEEEEecC-CcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCCh
Q 005718 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL 597 (681)
Q Consensus 522 LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 597 (681)
||+|+||.||++...+ ++.||+|++... .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 6999999999999854 788999998753 233456788999999999999999999999999999999999999999
Q ss_pred hhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 598 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 144 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNM 144 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence 999843 345788999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.1e-23 Score=217.96 Aligned_cols=151 Identities=22% Similarity=0.281 Sum_probs=132.4
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|.+.+.||+|+||.||+++.. .++.+|+|.+.+. .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999975 4788999998652 1223456888999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..+
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998532 235788899999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=7e-23 Score=218.01 Aligned_cols=150 Identities=23% Similarity=0.313 Sum_probs=132.2
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|++.+.||+|+||.||++... +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.++++.++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46889999999999999999975 4889999998642 2233456889999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999843 2345788999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.6e-23 Score=212.17 Aligned_cols=149 Identities=28% Similarity=0.372 Sum_probs=130.4
Q ss_pred CCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 516 FSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
|+..+.||+|+||.||++.. .+++.||||.+.... ......+.+|+.++.+++|+||+++.+++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67789999999999999987 468899999987532 22345678999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+++|+|..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99999988875422 235789999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-24 Score=213.54 Aligned_cols=150 Identities=31% Similarity=0.462 Sum_probs=121.8
Q ss_pred CCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC-----eEEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-----EKILI 588 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~lV 588 (681)
.|...+++|.|+||.||+|.+.+ ++.||||+.-...+ .--+|+.+|+++.|||||+|.-++.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 45667899999999999999854 68999998865432 1135889999999999999999887543 34689
Q ss_pred EEecCCCChhhHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC-CCeEEeecCCceee
Q 005718 589 YEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARMF 666 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFGla~~~ 666 (681)
||||+. +|...+.+. .....++.....-+..||.+||+|||+.+ |+||||||+|+|+|.+ +.+||+|||-||.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999986 676676432 22445677777889999999999999977 9999999999999976 89999999999998
Q ss_pred cCCCcc
Q 005718 667 CGDELQ 672 (681)
Q Consensus 667 ~~~~~~ 672 (681)
..++.+
T Consensus 177 ~~~epn 182 (364)
T KOG0658|consen 177 VKGEPN 182 (364)
T ss_pred ccCCCc
Confidence 766544
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-23 Score=218.60 Aligned_cols=151 Identities=21% Similarity=0.319 Sum_probs=133.5
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|.+.+.||+|+||.||++... +++.+|+|+++... ....+.+..|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999875 58899999997532 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+++|+|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+..+
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998442 245889999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-23 Score=218.38 Aligned_cols=141 Identities=26% Similarity=0.325 Sum_probs=125.3
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 005718 520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK 595 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 595 (681)
+.||+|+||.||++... +++.||+|.+... .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999875 5889999999753 2234456788999999999999999999999999999999999999
Q ss_pred ChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 596 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 596 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 99888833 345789999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=216.21 Aligned_cols=142 Identities=27% Similarity=0.319 Sum_probs=125.0
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 005718 520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK 595 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 595 (681)
+.||+|+||.||++... .++.||+|.+... .......+..|++++..++||||+++.+++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999874 5889999999753 2234467788999999999999999999999999999999999999
Q ss_pred ChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 596 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 596 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+|..++.. ...+++.++..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 99988833 3458899999999999999999997 55 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-23 Score=222.99 Aligned_cols=154 Identities=31% Similarity=0.432 Sum_probs=131.8
Q ss_pred hhCCCCceeeecccCcEeEEEEEe------cCCcEEEEEEecCCC-cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCC
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG 583 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~------~~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 583 (681)
..++|++.+.||+|+||.||++.. ..+..||||+++... ....+.+.+|+.++..+ +||||++++++|.+++
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345788899999999999999964 235689999997532 33456789999999999 8999999999999999
Q ss_pred eEEEEEEecCCCChhhHhcCCCC---------------------------------------------------------
Q 005718 584 EKILIYEYMPNKSLNFFLFDPSR--------------------------------------------------------- 606 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 606 (681)
..++||||+++|+|.+++.....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999988853210
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 607 ---------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 607 ---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 124788899999999999999999987 99999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=216.27 Aligned_cols=148 Identities=26% Similarity=0.377 Sum_probs=129.2
Q ss_pred CCCceeeecccCcEeEEEEEec----CCcEEEEEEecCC----CcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQ----SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~----~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 585 (681)
+|++.+.||+|+||.||++... .++.+|+|++.+. .....+.+..|+.++..+ +|+||+++++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788899999999999998752 4788999998642 122345688899999999 599999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++||||+++|+|.+++.. ...+++.+...++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999998843 345788999999999999999999987 99999999999999999999999999987
Q ss_pred ecC
Q 005718 666 FCG 668 (681)
Q Consensus 666 ~~~ 668 (681)
+..
T Consensus 155 ~~~ 157 (332)
T cd05614 155 FLS 157 (332)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=215.58 Aligned_cols=150 Identities=23% Similarity=0.296 Sum_probs=131.2
Q ss_pred CCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|++.++||+|+||.||++.... ++.+|+|.+.+. .......+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468889999999999999999864 678999998642 1223445888999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||+++|+|.+++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999532 335788899999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-23 Score=219.14 Aligned_cols=150 Identities=27% Similarity=0.414 Sum_probs=134.1
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|.+.+.||+|+||.||++... +++.||||++.... ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999985 58899999997532 234567899999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998543 46889999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=211.10 Aligned_cols=148 Identities=29% Similarity=0.460 Sum_probs=129.2
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
++|.+.++||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999875 57899999987532 23345778999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 975 88888743 2335788999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.2e-23 Score=229.28 Aligned_cols=153 Identities=31% Similarity=0.477 Sum_probs=134.9
Q ss_pred HHhhCCCCceeeecccCcEeEEEEEecCC-cEEEEEEecCCCcccHHHHHHHHHHHhhCC-CCCeeEEEEEEE-e-----
Q 005718 510 SAATENFSMQCKLGEGGFGPVYKGKLLNG-QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCV-E----- 581 (681)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~-~----- 581 (681)
.....+.++.+.|.+|||+.||+|....+ ..+|+|++...++...+..++|+++|++|. |+|||.+++... .
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34456778889999999999999998765 999999998778888999999999999995 999999999432 1
Q ss_pred -CCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeec
Q 005718 582 -QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 660 (681)
Q Consensus 582 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF 660 (681)
.-+.+|.||||.+|+|-+++..+.... |++.++++|+.++++|+++||.. +++|||||||.+||||..+++.||+||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 136799999999999999997654444 89999999999999999999987 578999999999999999999999999
Q ss_pred CCce
Q 005718 661 GMAR 664 (681)
Q Consensus 661 Gla~ 664 (681)
|-|.
T Consensus 191 GSat 194 (738)
T KOG1989|consen 191 GSAT 194 (738)
T ss_pred cccc
Confidence 9885
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=219.86 Aligned_cols=162 Identities=27% Similarity=0.446 Sum_probs=141.3
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCe-EEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE-KILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-~~lV~ 589 (681)
++|...+++|+|+||.++..+.+ +++.+++|.+... .....+..++|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888899999999999988875 4678999988753 33445578999999999999999999999999988 99999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
+|++||+|.+.|.+.. +..++++....++.|++.|+.|||++. |+|||||+.||+++.+..+||.|||+||.+..+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999996543 567899999999999999999999877 999999999999999999999999999999877
Q ss_pred CccCCCcceecC
Q 005718 670 ELQGNTKRVVGT 681 (681)
Q Consensus 670 ~~~~~~~~~~GT 681 (681)
... ..+++||
T Consensus 160 ~~~--a~tvvGT 169 (426)
T KOG0589|consen 160 DSL--ASTVVGT 169 (426)
T ss_pred hhh--hheecCC
Confidence 632 3456776
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=217.95 Aligned_cols=148 Identities=24% Similarity=0.366 Sum_probs=131.5
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|++.+.||+|+||.||++... .++.+|||++... .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999885 4789999998753 2234567888999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999999843 345788999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=219.98 Aligned_cols=154 Identities=29% Similarity=0.447 Sum_probs=131.3
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC------CcEEEEEEecCCC-cccHHHHHHHHHHHhhCC-CCCeeEEEEEEEeCC
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQG 583 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~------~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~ 583 (681)
..++|.+.++||+|+||.||+|.... +..||||++.... ....+.+.+|+.++.++. ||||+++++++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 45688889999999999999998632 3469999997543 233567999999999995 999999999999999
Q ss_pred eEEEEEEecCCCChhhHhcCCC----------------------------------------------------------
Q 005718 584 EKILIYEYMPNKSLNFFLFDPS---------------------------------------------------------- 605 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 605 (681)
..+|||||+++|+|.++|....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999998874321
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc
Q 005718 606 -----------------------------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 650 (681)
Q Consensus 606 -----------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~ 650 (681)
....+++.++..++.||++||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 0124778888999999999999999987 99999999999999
Q ss_pred CCCCeEEeecCCceeecC
Q 005718 651 SDMNPKISDFGMARMFCG 668 (681)
Q Consensus 651 ~~~~~kl~DFGla~~~~~ 668 (681)
+++.+||+|||+++.+..
T Consensus 272 ~~~~~kL~DfGla~~~~~ 289 (400)
T cd05105 272 QGKIVKICDFGLARDIMH 289 (400)
T ss_pred CCCEEEEEeCCcceeccc
Confidence 999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=213.48 Aligned_cols=146 Identities=27% Similarity=0.388 Sum_probs=127.2
Q ss_pred CCCceeeecccCcEeEEEEEecC-CcEEEEEEecCC---CcccHHHHHHHHHHHhhCCC-CCeeEEEEEEEeCCeEEEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQH-RNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~ 589 (681)
+|++.+.||+|+||.||+|...+ ++.||||++.+. .....+.+..|.+++..+.| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47888999999999999998764 678999998753 22345678889999999965 56889999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 99999999988843 334788999999999999999999987 999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=214.48 Aligned_cols=141 Identities=30% Similarity=0.429 Sum_probs=124.0
Q ss_pred eeecccCcEeEEEEEec----CCcEEEEEEecCC----CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 520 CKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQ----SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+.||+|+||.||++... .++.||||.++.. .......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999852 4788999998753 122345678899999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+++++|.+++.. ...+.+..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 999999988833 345778888899999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=210.24 Aligned_cols=149 Identities=23% Similarity=0.402 Sum_probs=130.4
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
++|++.+.||+|+||.||++... +++.+|||+++... ....+.+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999986 47889999987532 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|++++++..+.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+|+.+..
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 999987765542 2345788999999999999999999887 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=218.73 Aligned_cols=145 Identities=28% Similarity=0.438 Sum_probs=126.5
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
.+|+..++||+|+||.||++... +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45666789999999999999875 58899999986542 23356789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+++++|.... ...+.....++.||++||+|||+.+ |+||||||+||||++++.+||+|||+++.+..
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 9999986432 3456778899999999999999987 99999999999999999999999999987643
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=213.22 Aligned_cols=147 Identities=28% Similarity=0.379 Sum_probs=127.4
Q ss_pred CCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC---cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
+|.+.+.||+|+||.||++.... ++.||||.+.+.. ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47888999999999999998764 6799999987532 22345567788888777 6899999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||+++|+|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 99999999988843 335788999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=220.22 Aligned_cols=154 Identities=32% Similarity=0.510 Sum_probs=131.2
Q ss_pred hhCCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCCC-cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCC
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG 583 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 583 (681)
..++|++.+.||+|+||.||++... +++.||||+++... ....+.+.+|+.+++.+ +|+||++++++|.+.+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3457889999999999999998742 23579999997542 23356788999999999 8999999999999999
Q ss_pred eEEEEEEecCCCChhhHhcCCC----------------------------------------------------------
Q 005718 584 EKILIYEYMPNKSLNFFLFDPS---------------------------------------------------------- 605 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 605 (681)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999998874321
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 606 ---------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 606 ---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
....+++.+...++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 1124678889999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.4e-22 Score=212.74 Aligned_cols=151 Identities=26% Similarity=0.344 Sum_probs=133.0
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
.++|++.+.||+|+||.||++... .+..+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467999999999999999999985 47889999887542 2345679999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|+++++|.+++.. ...+++..+..++.|+++||.|||+.+ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999999999843 335788999999999999999999853 499999999999999999999999999986643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=208.06 Aligned_cols=149 Identities=28% Similarity=0.456 Sum_probs=131.1
Q ss_pred hCCCCceeeecccCcEeEEEEEec----CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
.++|++.+.||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+..+.+++||||+++++++..+++.++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888999999999999999863 35689999988642 2334678999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
||||+++|+|.+++... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999998542 335889999999999999999999887 999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=210.43 Aligned_cols=149 Identities=32% Similarity=0.444 Sum_probs=129.2
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc-ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
.++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999985 588999999875432 234567889999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
|++ ++|.+++.. ....++...+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+...
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 996 577666643 2345788899999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-23 Score=189.41 Aligned_cols=147 Identities=27% Similarity=0.456 Sum_probs=126.0
Q ss_pred CCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+|.-.++||+|.||+||+|+..+ ++.||+|+++..+ +.--...++|+.+++.++|+|||+++++...++..-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45556899999999999999755 7889999987542 22345678999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
|+. +|..+... -...++......++.|+++||.++|+++ +.||||||+|+||+.+|++|++|||+||-+.
T Consensus 83 cdq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafg 152 (292)
T KOG0662|consen 83 CDQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFG 152 (292)
T ss_pred hhH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcC
Confidence 965 67766632 2345788889999999999999999988 9999999999999999999999999999763
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=213.76 Aligned_cols=144 Identities=28% Similarity=0.437 Sum_probs=124.7
Q ss_pred CCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHH---hhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 516 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLI---AKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l---~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
|++.+.||+|+||.||++... .++.||||++++.. ....+.+..|++++ .+++||||+++++++.+++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567899999999999999875 48899999997532 22345666676654 566899999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|||+++++|...+. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 99999999988873 235899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=213.08 Aligned_cols=143 Identities=29% Similarity=0.352 Sum_probs=125.8
Q ss_pred eeecccCcEeEEEEEe----cCCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecC
Q 005718 520 CKLGEGGFGPVYKGKL----LNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 593 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~----~~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 593 (681)
+.||+|+||.||++.. ..++.+|+|++.... ......+..|+.++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999875 247899999997532 2234567889999999999999999999999999999999999
Q ss_pred CCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID 150 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence 9999998833 345889999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=213.32 Aligned_cols=141 Identities=26% Similarity=0.378 Sum_probs=123.9
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
+.||+|+||.||++... +++.+|+|.+++. .....+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999975 4789999999753 223345678898888877 899999999999999999999999999
Q ss_pred CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 999888733 345889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=212.86 Aligned_cols=150 Identities=27% Similarity=0.356 Sum_probs=132.1
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
.++|++.++||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.++++.++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467999999999999999999986 47889999887542 2335678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
|+++++|.+++.. ...+++.....++.|+++||.|||+.+ +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 9999999999843 335788899999999999999999743 49999999999999999999999999998664
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=217.85 Aligned_cols=143 Identities=22% Similarity=0.295 Sum_probs=125.9
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
...+|++.++||+|+||.||++... .++.||+|.... ..+.+|+.++++++||||+++++++......++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 3467999999999999999999875 478999996542 356789999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
++. ++|..++.. ...+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 164 ~~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 164 RYK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred cCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 995 678777733 335789999999999999999999987 9999999999999999999999999998643
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=204.69 Aligned_cols=148 Identities=32% Similarity=0.499 Sum_probs=132.5
Q ss_pred CCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecC
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 593 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 593 (681)
++|++.+.||+|+||.||++...++..+|+|.+... ....+.|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457888999999999999999988889999988753 3345788999999999999999999999999999999999999
Q ss_pred CCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 99999988532 235789999999999999999999887 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=214.41 Aligned_cols=161 Identities=29% Similarity=0.472 Sum_probs=139.5
Q ss_pred HhhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCc---ccHHHHHHHHHHHhhCC-CCCeeEEEEEEEeCCeE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~ 585 (681)
.....|.+.+.||+|.||.||++..+. |+.+|+|.+.+... ...+.+.+|+.+|+++. |||||++.+.+.+....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345678888999999999999999866 89999999987533 24468999999999997 99999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC----CCeEEeecC
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD----MNPKISDFG 661 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~----~~~kl~DFG 661 (681)
++|||++.+|.|.+.+... . +++.++..++.||+.+++|||+.+ |+||||||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999998654 3 899999999999999999999987 9999999999999643 479999999
Q ss_pred CceeecCCCccCCCcceecC
Q 005718 662 MARMFCGDELQGNTKRVVGT 681 (681)
Q Consensus 662 la~~~~~~~~~~~~~~~~GT 681 (681)
+|+.+.... ....++||
T Consensus 185 la~~~~~~~---~~~~~~Gt 201 (382)
T KOG0032|consen 185 LAKFIKPGE---RLHTIVGT 201 (382)
T ss_pred CceEccCCc---eEeeecCC
Confidence 999987622 23445665
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=212.34 Aligned_cols=141 Identities=27% Similarity=0.392 Sum_probs=123.7
Q ss_pred eeecccCcEeEEEEEecC-CcEEEEEEecCC---CcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 520 CKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
+.||+|+||.||+|.... ++.||||++.+. .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 369999999999998854 789999998753 223445678888888876 899999999999999999999999999
Q ss_pred CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
++|...+.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceec
Confidence 999988843 345788999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.2e-24 Score=229.45 Aligned_cols=151 Identities=35% Similarity=0.527 Sum_probs=131.9
Q ss_pred CceeeecccCcEeEEEEEe-cCC----cEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 517 SMQCKLGEGGFGPVYKGKL-LNG----QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~-~~~----~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
+..++||+|+||+||+|.+ +++ -+||+|++... ..+..++++.|+..|.+++||||++|+|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3457999999999999986 333 36899988765 3445789999999999999999999999998876 889999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 670 (681)
||+.|.|.+++..+ +..+..+..+.+..|||+||.|||++. +|||||.++|+|+.+...+||+|||+|+++..++
T Consensus 778 ~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999999653 345788999999999999999999876 9999999999999999999999999999998776
Q ss_pred ccC
Q 005718 671 LQG 673 (681)
Q Consensus 671 ~~~ 673 (681)
.+.
T Consensus 853 ~ey 855 (1177)
T KOG1025|consen 853 KEY 855 (1177)
T ss_pred ccc
Confidence 553
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=204.18 Aligned_cols=151 Identities=31% Similarity=0.477 Sum_probs=135.7
Q ss_pred hhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
..++|++.+.||+|++|.||+|...+++.||+|.++.. ....+++.+|+.++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 34668889999999999999999877888999998754 34467899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+++++|.+++.... ...+++.++..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 99999999985432 345789999999999999999999987 9999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=211.65 Aligned_cols=142 Identities=29% Similarity=0.376 Sum_probs=121.9
Q ss_pred eeecccCcEeEEEEEecC-CcEEEEEEecCCC---cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 520 CKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
+.||+|+||.||+|...+ ++.||||.++... ....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999854 7889999997531 23345566677777654 899999999999999999999999999
Q ss_pred CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
|+|..++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 999988843 335788999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=207.26 Aligned_cols=152 Identities=34% Similarity=0.526 Sum_probs=131.2
Q ss_pred CCCCceeeecccCcEeEEEEEe-----cCCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKL-----LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
.+|++.+.||+|+||.||+|.. ..++.+++|.+.... .....+|.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577889999999999999985 235789999997533 3344678999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC
Q 005718 588 IYEYMPNKSLNFFLFDPS--------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 653 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~ 653 (681)
||||+++++|.+++.... ....+++.+.+.++.|++.||+|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999884221 1235788999999999999999999987 99999999999999999
Q ss_pred CeEEeecCCceeecC
Q 005718 654 NPKISDFGMARMFCG 668 (681)
Q Consensus 654 ~~kl~DFGla~~~~~ 668 (681)
.+||+|||+++.+..
T Consensus 162 ~~kl~dfg~~~~~~~ 176 (283)
T cd05090 162 HVKISDLGLSREIYS 176 (283)
T ss_pred cEEeccccccccccC
Confidence 999999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=212.42 Aligned_cols=147 Identities=27% Similarity=0.396 Sum_probs=127.3
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCC-CCCeeEEEEEEEeCCeEEEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~ 589 (681)
+|...+.||+|+||.||++... +++.||+|++.+. .....+.+..|..++..+. |++|+++.+++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999875 5889999998753 1233456788999988884 678889999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 99999999988843 345889999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=212.21 Aligned_cols=149 Identities=32% Similarity=0.553 Sum_probs=128.8
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCc----EEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQ----EVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~----~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
.+|++.+.||+|+||.||+|.+. +++ .||+|.++... ....+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56889999999999999999863 333 48999987543 34457899999999999999999999999865 5679
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
|+||+++|+|.+++... ...+++...+.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999998542 335788999999999999999999987 9999999999999999999999999999775
Q ss_pred C
Q 005718 668 G 668 (681)
Q Consensus 668 ~ 668 (681)
.
T Consensus 161 ~ 161 (316)
T cd05108 161 A 161 (316)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=212.50 Aligned_cols=141 Identities=24% Similarity=0.355 Sum_probs=124.6
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
+.||+|+||.||++... .++.||||.+++.. ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999875 47899999997532 23345688899999988 799999999999999999999999999
Q ss_pred CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 999888733 345899999999999999999999987 999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=206.72 Aligned_cols=150 Identities=26% Similarity=0.327 Sum_probs=134.1
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
..+|++.+.||+|.-|+||++++.+ +..+|+|++.+.. .....+...|-++|+.+.||.++.|++.+...+..+++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3567788999999999999999976 5889999998753 33456778899999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
||||+||+|..+++. +..+.+++..+.-++.+|+-||+|||-.+ ||.|||||+||||.++|++-|+||.|+...
T Consensus 156 meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 999999999877743 56667899999999999999999999988 999999999999999999999999998755
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-22 Score=211.57 Aligned_cols=141 Identities=30% Similarity=0.371 Sum_probs=121.4
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHH-HHhhCCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMM-LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
+.||+|+||.||++... +++.+|+|++.+.. .....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999874 58899999987531 223345556655 46778999999999999999999999999999
Q ss_pred CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|+|..++. ....+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 99988883 3345889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=212.25 Aligned_cols=146 Identities=25% Similarity=0.432 Sum_probs=125.7
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC-----CeEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----GEKI 586 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~ 586 (681)
+|++.++||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999975 5889999998743 223445788999999999999999999988643 2579
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+||||++ ++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 688888732 335889999999999999999999987 999999999999999999999999999865
Q ss_pred c
Q 005718 667 C 667 (681)
Q Consensus 667 ~ 667 (681)
.
T Consensus 154 ~ 154 (338)
T cd07859 154 F 154 (338)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=223.22 Aligned_cols=156 Identities=21% Similarity=0.296 Sum_probs=133.2
Q ss_pred HHhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC---
Q 005718 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG--- 583 (681)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--- 583 (681)
....++|.+.+.||+|+||.||++... +++.||||++... .......+.+|+.++..++|+|++++...+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 344578999999999999999999864 5899999998653 2344567889999999999999999988776432
Q ss_pred -----eEEEEEEecCCCChhhHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEE
Q 005718 584 -----EKILIYEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 657 (681)
Q Consensus 584 -----~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl 657 (681)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 3689999999999999985432 2346889999999999999999999987 999999999999999999999
Q ss_pred eecCCceeecC
Q 005718 658 SDFGMARMFCG 668 (681)
Q Consensus 658 ~DFGla~~~~~ 668 (681)
+|||+++.+..
T Consensus 185 ~DFGls~~~~~ 195 (496)
T PTZ00283 185 GDFGFSKMYAA 195 (496)
T ss_pred EecccCeeccc
Confidence 99999998754
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=211.36 Aligned_cols=141 Identities=28% Similarity=0.414 Sum_probs=123.9
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
+.||+|+||.||++... +++.||||++.+. .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999985 4789999998753 223456678888888877 799999999999999999999999999
Q ss_pred CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 999988843 345788999999999999999999887 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-22 Score=210.58 Aligned_cols=141 Identities=30% Similarity=0.377 Sum_probs=121.2
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHH-HHhhCCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMM-LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
+.||+|+||.||++... +++.||+|++.+.. ....+++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999985 58899999987532 222344555554 56788999999999999999999999999999
Q ss_pred CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|+|..++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 999988843 345788999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=211.00 Aligned_cols=141 Identities=29% Similarity=0.361 Sum_probs=120.5
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHH-HHhhCCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMM-LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
+.||+|+||.||++... +++.+|+|++.+.. .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999985 47899999987532 122344555654 57888999999999999999999999999999
Q ss_pred CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
++|...+.. ...+++.....++.||++||+|||+.+ |+||||||+||+|+.++.+||+|||+++..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 999888732 345778888899999999999999887 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-22 Score=205.55 Aligned_cols=144 Identities=31% Similarity=0.419 Sum_probs=125.5
Q ss_pred ecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCCh
Q 005718 522 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL 597 (681)
Q Consensus 522 LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 597 (681)
||+|+||+||++... +++.+|+|.+.... ....+.+..|+.++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999875 57899999987532 22345678899999999999999999999999999999999999999
Q ss_pred hhHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 598 NFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 598 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
..++... .....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 8887432 23346889999999999999999999987 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.88 E-value=6e-22 Score=202.73 Aligned_cols=149 Identities=32% Similarity=0.507 Sum_probs=133.0
Q ss_pred CCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecC
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 593 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 593 (681)
++|.+.+.||+|+||.||++...++..+|+|.++.. ....++|.+|+.++.+++||||+++++++.+....++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 457888999999999999998877778999998753 3345789999999999999999999999999999999999999
Q ss_pred CCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+++|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 99999998542 225789999999999999999999887 99999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.3e-22 Score=205.54 Aligned_cols=149 Identities=30% Similarity=0.377 Sum_probs=130.5
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
+|++.++||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999874 58899999987532 1223557889999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
|+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++.+.
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999887542 2235889999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-22 Score=218.28 Aligned_cols=145 Identities=26% Similarity=0.343 Sum_probs=127.0
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
...|.+.+.||+|+||.||++.... ++.||||.... ..+.+|++++++++|+||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4578999999999999999999854 78899996432 3457899999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
+. ++|..++.. ....+++.+++.|+.||++||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 95 678777743 2335899999999999999999999987 999999999999999999999999999987543
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.8e-22 Score=204.92 Aligned_cols=150 Identities=31% Similarity=0.552 Sum_probs=131.5
Q ss_pred CCCCceeeecccCcEeEEEEEec-----CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe--CCeEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEKI 586 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~ 586 (681)
++|++.+.||+|+||.||++... .++.||+|++........+.+.+|+.++.+++||||+++.+++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57888899999999999999752 477899999987655567789999999999999999999998754 34689
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+|+||+++++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998432 235789999999999999999999987 999999999999999999999999999976
Q ss_pred cC
Q 005718 667 CG 668 (681)
Q Consensus 667 ~~ 668 (681)
..
T Consensus 159 ~~ 160 (284)
T cd05081 159 PQ 160 (284)
T ss_pred cC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-22 Score=203.84 Aligned_cols=145 Identities=42% Similarity=0.654 Sum_probs=126.1
Q ss_pred ceeeecccCcEeEEEEEec-----CCcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 518 MQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-----~~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+.+.||.|.||.||+|.+. .+..|+||.++.. .....++|.+|++.+.+++||||++++|++.+.+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4689999999999999986 2567999999653 233478999999999999999999999999988889999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+++|+|.++|... ....+++.++..|+.||++||.|||+.+ ++|+||+++||++++++.+||+|||+++..
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999999654 2345899999999999999999999987 999999999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-22 Score=203.09 Aligned_cols=151 Identities=34% Similarity=0.510 Sum_probs=135.1
Q ss_pred hCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
.++|++.++||+|+||.||+|...+++.||+|.+... ....+.+.+|+.++++++|+||+++++.+.+.+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 4678899999999999999999888889999998753 334678999999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
++++|.+++... ....+++.++..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999998543 2345788899999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.9e-22 Score=210.01 Aligned_cols=141 Identities=27% Similarity=0.369 Sum_probs=124.5
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
+.||+|+||.||++... +++.+|+|++++.. ....+.+..|+.++.++ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999975 47889999997642 23345688999999888 799999999999999999999999999
Q ss_pred CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|+|..++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 999888732 345899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.4e-22 Score=202.63 Aligned_cols=150 Identities=33% Similarity=0.557 Sum_probs=132.5
Q ss_pred hCCCCceeeecccCcEeEEEEEecC----CcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
.++|++.+.||+|+||.||+|.... ...||||.++... .....+|.+|+.++.+++|+||+++++.+.+++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578889999999999999998743 3579999987543 3345678999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||||+++++|.+++... ...+++.++..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.+.
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999998442 235789999999999999999999987 9999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.6e-22 Score=215.74 Aligned_cols=155 Identities=30% Similarity=0.460 Sum_probs=131.0
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCCCc-ccHHHHHHHHHHHhhCC-CCCeeEEEEEEEeC
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQ 582 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~ 582 (681)
.+.++|.+.++||+|+||.||+|.+. .++.||||+++.... ...+.+..|+.++.++. ||||+++++++...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34456778899999999999999863 245799999976432 23457899999999996 99999999999999
Q ss_pred CeEEEEEEecCCCChhhHhcCCC---------------------------------------------------------
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPS--------------------------------------------------------- 605 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~--------------------------------------------------------- 605 (681)
+..++||||+++|+|.+++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999885321
Q ss_pred --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcE
Q 005718 606 --------------------------------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNI 647 (681)
Q Consensus 606 --------------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~Ni 647 (681)
....+++.....++.||++||+|||+.+ ++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceE
Confidence 1124677888899999999999999876 99999999999
Q ss_pred EEcCCCCeEEeecCCceeecC
Q 005718 648 LLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 648 Ll~~~~~~kl~DFGla~~~~~ 668 (681)
|+++++.+||+|||+++.+..
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~ 291 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMR 291 (401)
T ss_pred EEeCCCEEEEEecCcceeccc
Confidence 999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.3e-22 Score=204.96 Aligned_cols=143 Identities=20% Similarity=0.349 Sum_probs=125.0
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEecCCCccc---HHHHHHHHHHHhhCCCCCeeEEEEEEEe----CCeEEEEEEec
Q 005718 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQG---LKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEKILIYEYM 592 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~---~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~Ey~ 592 (681)
..|++|+++.||+|.. +++.||||+++...... .+.|.+|+.++.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 67899999997643322 4678899999999999999999999987 35789999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
++|+|.+++.. ...+++.....++.++++||.|||... +++||||||+|||+++++.+||+|||+++.+..
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 99999999943 345789999999999999999999742 288999999999999999999999999997644
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.2e-22 Score=208.38 Aligned_cols=141 Identities=30% Similarity=0.417 Sum_probs=122.7
Q ss_pred eeecccCcEeEEEEEecC-CcEEEEEEecCCC---cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 520 CKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
+.||+|+||.||+|.... ++.||||.++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999854 7899999997531 23345567788888764 999999999999999999999999999
Q ss_pred CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|+|.+++.. ...+++.++..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 999998843 345788999999999999999999987 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.4e-22 Score=209.57 Aligned_cols=141 Identities=28% Similarity=0.346 Sum_probs=119.4
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHH-HHhhCCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMM-LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
+.||+|+||.||++... +++.+|+|++.... ......+..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999985 46789999987532 122334444544 56788999999999999999999999999999
Q ss_pred CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
++|.+++.. ...+.......++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 999998843 334677888889999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.8e-22 Score=202.21 Aligned_cols=149 Identities=33% Similarity=0.509 Sum_probs=132.3
Q ss_pred CCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecC
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 593 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 593 (681)
.+|++.+.||+|+||.||++..+.+..+|+|.+... .....+|.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 457788999999999999999877778999988653 2345678899999999999999999999999999999999999
Q ss_pred CCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+++|.+++... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence 99999998532 235789999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=201.70 Aligned_cols=149 Identities=28% Similarity=0.462 Sum_probs=133.5
Q ss_pred hCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
..+|++.+.||+|+||.||+|.. .+++.+|+|++..........+.+|+.++.+++||||+++++.+..++..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35788999999999999999997 45789999999765445566788999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+++++|.+++.. ...+++.++..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 999999998843 345789999999999999999999887 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-22 Score=204.35 Aligned_cols=153 Identities=34% Similarity=0.556 Sum_probs=138.1
Q ss_pred hhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+..+|++.++||+|+||.||+|...+++.+++|.+.........++..|+.+++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34578888999999999999999988899999999876555677899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+++++|.+++.+. ....+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 9999999999653 2345789999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=225.93 Aligned_cols=150 Identities=25% Similarity=0.341 Sum_probs=131.3
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|++.++||+|+||.||+|... .++.||||++.... ....++|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999875 48899999997532 223467999999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecC
Q 005718 590 EYMPNKSLNFFLFDP--------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG 661 (681)
||+++++|.+++... .....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988431 11233567788999999999999999987 9999999999999999999999999
Q ss_pred Cceee
Q 005718 662 MARMF 666 (681)
Q Consensus 662 la~~~ 666 (681)
+|+..
T Consensus 159 LAk~i 163 (932)
T PRK13184 159 AAIFK 163 (932)
T ss_pred cceec
Confidence 99977
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.7e-22 Score=203.87 Aligned_cols=153 Identities=30% Similarity=0.491 Sum_probs=131.2
Q ss_pred hhCCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCe
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE 584 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 584 (681)
.+++|++.+.||+|+||.||+|... .+..||||++.... .....+|.+|+.+++.++|+||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4577999999999999999999753 24679999886532 2345678999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEE
Q 005718 585 KILIYEYMPNKSLNFFLFDPSR-------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 657 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl 657 (681)
.++||||+++++|.+++.+... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999854211 234678889999999999999999887 999999999999999999999
Q ss_pred eecCCceeec
Q 005718 658 SDFGMARMFC 667 (681)
Q Consensus 658 ~DFGla~~~~ 667 (681)
+|||+|+.+.
T Consensus 161 ~dfg~~~~~~ 170 (277)
T cd05062 161 GDFGMTRDIY 170 (277)
T ss_pred CCCCCccccC
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.5e-22 Score=205.28 Aligned_cols=153 Identities=29% Similarity=0.484 Sum_probs=130.5
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC------CcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCe
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE 584 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~------~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 584 (681)
..++|++.+.||+|+||.||+|..++ +..||+|.+.... .....++.+|+.++++++|+||+++++++.+++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45789999999999999999997532 4579999886542 2334568899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEE
Q 005718 585 KILIYEYMPNKSLNFFLFDPSR-------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 657 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl 657 (681)
.++||||+++|+|.+++..... .....+.....++.|++.||.|||+.+ |+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999853211 234567788999999999999999887 999999999999999999999
Q ss_pred eecCCceeec
Q 005718 658 SDFGMARMFC 667 (681)
Q Consensus 658 ~DFGla~~~~ 667 (681)
+|||+++.+.
T Consensus 161 ~Dfg~~~~~~ 170 (288)
T cd05061 161 GDFGMTRDIY 170 (288)
T ss_pred CcCCcccccc
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.6e-22 Score=208.62 Aligned_cols=141 Identities=29% Similarity=0.391 Sum_probs=122.7
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
+.||+|+||.||++... .++.||+|.++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999986 47899999997531 23445677788888765 899999999999999999999999999
Q ss_pred CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|+|..++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 999988843 335788899999999999999999987 999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.8e-24 Score=205.66 Aligned_cols=159 Identities=30% Similarity=0.504 Sum_probs=140.1
Q ss_pred CCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
+-|.+.++||+|+||.||++.++. |+.+|||.+.- ..+.+++..|+.++.+-..|+||+++|.+.....+|+|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 457788999999999999999865 89999998864 456789999999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCCcc
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 672 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~ 672 (681)
..|+..+++. .+.+++.+.+...++...++||+|||... -||||||+.||||+-+|.+||+|||.|-.+...-.
T Consensus 111 GAGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA- 184 (502)
T KOG0574|consen 111 GAGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA- 184 (502)
T ss_pred CCCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH-
Confidence 9999999994 45667999999999999999999999876 89999999999999999999999999987744332
Q ss_pred CCCcceecC
Q 005718 673 GNTKRVVGT 681 (681)
Q Consensus 673 ~~~~~~~GT 681 (681)
+..+++||
T Consensus 185 -KRNTVIGT 192 (502)
T KOG0574|consen 185 -KRNTVIGT 192 (502)
T ss_pred -hhCccccC
Confidence 33446776
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=206.20 Aligned_cols=148 Identities=28% Similarity=0.468 Sum_probs=128.7
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
++|.+.++||+|+||.||+|... .++.||+|.++... ......+.+|+.++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999875 47789999987542 23345678899999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+++ +|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecC
Confidence 975 777777432 345788899999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=204.71 Aligned_cols=153 Identities=36% Similarity=0.594 Sum_probs=133.6
Q ss_pred hCCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 586 (681)
..+|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 457888899999999999999752 24568999987655555678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeE
Q 005718 587 LIYEYMPNKSLNFFLFDPS----------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK 656 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~k 656 (681)
+||||+++++|.+++.... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999885321 2235899999999999999999999887 99999999999999999999
Q ss_pred EeecCCceeecC
Q 005718 657 ISDFGMARMFCG 668 (681)
Q Consensus 657 l~DFGla~~~~~ 668 (681)
|+|||+++.+..
T Consensus 161 l~dfg~~~~~~~ 172 (288)
T cd05093 161 IGDFGMSRDVYS 172 (288)
T ss_pred eccCCccccccC
Confidence 999999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.1e-22 Score=202.72 Aligned_cols=143 Identities=29% Similarity=0.460 Sum_probs=122.3
Q ss_pred eecccCcEeEEEEEecC---CcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCC
Q 005718 521 KLGEGGFGPVYKGKLLN---GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKS 596 (681)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~---~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 596 (681)
+||+|+||.||+|.... ...+++|.+.... ......|.+|+.+++.++|+||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 68999999999997643 3468888876432 2334578899999999999999999999999999999999999999
Q ss_pred hhhHhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 597 LNFFLFDPSR--THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 597 L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|.+++..... ....++.....++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence 9999855322 233467788899999999999999987 999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=226.48 Aligned_cols=150 Identities=27% Similarity=0.396 Sum_probs=133.1
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|.+.++||+|+||.||+|... .++.||||+++... ......+..|+.++..++|+||+++++++......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999986 58899999997532 223467889999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+.+++|.+++.. ...+++...+.|+.||+.||+|||..+ ||||||||+||||+.++.+||+|||+++.....
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~ 157 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR 157 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccCC
Confidence 99999999999843 235788889999999999999999887 999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.7e-22 Score=205.95 Aligned_cols=152 Identities=32% Similarity=0.522 Sum_probs=130.2
Q ss_pred hCCCCceeeecccCcEeEEEEEecC---------------CcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN---------------GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLM 576 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~---------------~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~ 576 (681)
.++|++.++||+|+||.||++...+ ...||+|.+... .......|.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4578899999999999999987632 235899998764 233456799999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCChhhHhcCCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcE
Q 005718 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPS---------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNI 647 (681)
Q Consensus 577 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~Ni 647 (681)
+++...+..++||||+++++|.+++.... ....+++..++.++.|+++||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999884321 1124688899999999999999999987 99999999999
Q ss_pred EEcCCCCeEEeecCCceeec
Q 005718 648 LLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 648 Ll~~~~~~kl~DFGla~~~~ 667 (681)
++++++.+||+|||+++.+.
T Consensus 161 ll~~~~~~kl~dfg~~~~~~ 180 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLY 180 (295)
T ss_pred EEcCCCcEEecccccccccc
Confidence 99999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=212.52 Aligned_cols=147 Identities=27% Similarity=0.401 Sum_probs=127.6
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC-----eEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-----EKI 586 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~ 586 (681)
+|++.+.||+|+||.||++... +++.||||++... .....+++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999974 5889999998653 2234567899999999999999999999998776 789
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+|+||+. ++|.+.+. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 57777763 3345889999999999999999999987 999999999999999999999999999876
Q ss_pred cC
Q 005718 667 CG 668 (681)
Q Consensus 667 ~~ 668 (681)
..
T Consensus 154 ~~ 155 (372)
T cd07853 154 EP 155 (372)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=207.01 Aligned_cols=141 Identities=30% Similarity=0.414 Sum_probs=124.1
Q ss_pred eeecccCcEeEEEEEecC-CcEEEEEEecCC---CcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 520 CKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
+.||+|+||.||++.... ++.+|||.+++. .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999998864 789999999753 223456678888888888 799999999999999999999999999
Q ss_pred CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 999988843 335889999999999999999999887 999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=201.24 Aligned_cols=145 Identities=32% Similarity=0.429 Sum_probs=124.2
Q ss_pred eeecccCcEeEEEEEecC---CcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 005718 520 CKLGEGGFGPVYKGKLLN---GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK 595 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~---~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 595 (681)
+.||+|+||.||+|...+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 4579999887643 233457899999999999999999999999999999999999999
Q ss_pred ChhhHhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 596 SLNFFLFDPS--RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 596 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+|.+++.... .....++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999985432 2234567788899999999999999987 9999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.5e-22 Score=209.89 Aligned_cols=153 Identities=31% Similarity=0.524 Sum_probs=132.3
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC---Cc--EEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN---GQ--EVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~---~~--~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 585 (681)
..+...+.+.||+|-||.||+|.+.+ |+ .||||..+.+ ...+.+.|+.|..+|+.++||||++|+|+|.+ ...
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 34455566889999999999998743 33 4899988874 45567889999999999999999999999987 478
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
|||||.++-|.|..+|.. +...++..+...++.||+.+|+|||+.. +|||||.++|||+.+...+||+||||+|-
T Consensus 466 WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence 999999999999999944 4456888999999999999999999886 99999999999999999999999999998
Q ss_pred ecCCC
Q 005718 666 FCGDE 670 (681)
Q Consensus 666 ~~~~~ 670 (681)
+..+.
T Consensus 541 ~ed~~ 545 (974)
T KOG4257|consen 541 LEDDA 545 (974)
T ss_pred ccccc
Confidence 86543
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=201.12 Aligned_cols=151 Identities=32% Similarity=0.547 Sum_probs=131.7
Q ss_pred CCCCceeeecccCcEeEEEEEec----CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.+|++.+.||+|+||.||+|... ....+|+|.++... ....+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56888899999999999999864 23379999887532 23456889999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||+++++|.+++... ...+++.+...++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998432 345789999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 005718 669 D 669 (681)
Q Consensus 669 ~ 669 (681)
.
T Consensus 159 ~ 159 (267)
T cd05066 159 D 159 (267)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-21 Score=201.95 Aligned_cols=150 Identities=30% Similarity=0.506 Sum_probs=123.3
Q ss_pred CCCCceeeecccCcEeEEEEEec--CCcEEEEEEecCCC--cccHHHHHHHHHHHhhC---CCCCeeEEEEEEEe-----
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL--NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKL---QHRNLVRLMGCCVE----- 581 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~--~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~----- 581 (681)
++|++.+.||+|+||.||++... +++.||+|+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999873 36789999887532 22234566777776665 69999999999863
Q ss_pred CCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecC
Q 005718 582 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661 (681)
Q Consensus 582 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG 661 (681)
....++||||++ ++|.+++.... ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 356899999996 58888874422 234789999999999999999999987 9999999999999999999999999
Q ss_pred CceeecC
Q 005718 662 MARMFCG 668 (681)
Q Consensus 662 la~~~~~ 668 (681)
+|+.+..
T Consensus 156 ~~~~~~~ 162 (290)
T cd07862 156 LARIYSF 162 (290)
T ss_pred ceEeccC
Confidence 9987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.3e-22 Score=210.45 Aligned_cols=154 Identities=29% Similarity=0.450 Sum_probs=134.9
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
.....|.+.+.||+|.|++|.++.+. .+..||||.+.+.. ......+.+|+++|+.++|||||+++.+......+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34567889999999999999999975 48899999998753 2233458899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||||+.+|.+.++|....+ +...++..++.|+.++++|||.++ |||||||++||||+.++++||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999955433 444788889999999999999988 9999999999999999999999999999986
Q ss_pred CCC
Q 005718 668 GDE 670 (681)
Q Consensus 668 ~~~ 670 (681)
...
T Consensus 207 ~~~ 209 (596)
T KOG0586|consen 207 YGL 209 (596)
T ss_pred ccc
Confidence 543
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=211.44 Aligned_cols=146 Identities=24% Similarity=0.367 Sum_probs=127.1
Q ss_pred hCCCCceeeecccCcEeEEEEEecC---CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN---GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~---~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
..+|.+.+.||+|+||.||++...+ ++.|++|.+... +.+.+|+.++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 4679999999999999999997533 567999988653 34568999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
|++. ++|.+++ .....+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9996 5777777 23346899999999999999999999987 999999999999999999999999999876544
Q ss_pred C
Q 005718 670 E 670 (681)
Q Consensus 670 ~ 670 (681)
.
T Consensus 239 ~ 239 (392)
T PHA03207 239 P 239 (392)
T ss_pred c
Confidence 3
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=202.25 Aligned_cols=151 Identities=36% Similarity=0.598 Sum_probs=130.9
Q ss_pred CCCCceeeecccCcEeEEEEEecC------CcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~------~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 586 (681)
++|++.+.||+|+||.||+|.... ...|++|.+.... .....+|.+|+.++.+++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468888999999999999998643 2579999987543 233567899999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC
Q 005718 587 LIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 653 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~ 653 (681)
++|||+++++|.+++..... ...+++.+.+.++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999854311 145788999999999999999999987 99999999999999999
Q ss_pred CeEEeecCCceeec
Q 005718 654 NPKISDFGMARMFC 667 (681)
Q Consensus 654 ~~kl~DFGla~~~~ 667 (681)
.+||+|||+++...
T Consensus 162 ~~~L~dfg~~~~~~ 175 (283)
T cd05048 162 TVKISDFGLSRDIY 175 (283)
T ss_pred cEEECCCcceeecc
Confidence 99999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=203.34 Aligned_cols=152 Identities=34% Similarity=0.576 Sum_probs=132.6
Q ss_pred CCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
.+|.+.+.||+|+||.||++... +...+++|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45778899999999999999752 345689999876555556789999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCC
Q 005718 588 IYEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 654 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~ 654 (681)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985422 1234789999999999999999999887 999999999999999999
Q ss_pred eEEeecCCceeecC
Q 005718 655 PKISDFGMARMFCG 668 (681)
Q Consensus 655 ~kl~DFGla~~~~~ 668 (681)
+||+|||+|+....
T Consensus 162 ~~l~dfg~a~~~~~ 175 (291)
T cd05094 162 VKIGDFGMSRDVYS 175 (291)
T ss_pred EEECCCCcccccCC
Confidence 99999999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=201.94 Aligned_cols=150 Identities=34% Similarity=0.518 Sum_probs=126.6
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCc----EEEEEEecCCCc-ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQ----EVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~----~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
.+|++.+.||+|+||.||+|... +++ .+++|.+..... ....++..|+..++++.||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46778899999999999999874 343 478888764322 33467888898999999999999999875 456788
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
++||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999999542 345889999999999999999999887 9999999999999999999999999998764
Q ss_pred CC
Q 005718 668 GD 669 (681)
Q Consensus 668 ~~ 669 (681)
..
T Consensus 161 ~~ 162 (279)
T cd05111 161 PD 162 (279)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=203.67 Aligned_cols=152 Identities=32% Similarity=0.528 Sum_probs=130.8
Q ss_pred hCCCCceeeecccCcEeEEEEEec-----------------CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-----------------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVR 574 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-----------------~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~ 574 (681)
.++|++.+.||+|+||.||++... +...+|+|.+.... .....+|.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457899999999999999998532 23468999987542 334568999999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCChhhHhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCc
Q 005718 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPS--------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 646 (681)
Q Consensus 575 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N 646 (681)
+++++.+.+..++||||+++++|.+++.... ....+++.+...++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9999999999999999999999999985432 1234778899999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEeecCCceeec
Q 005718 647 ILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 647 iLl~~~~~~kl~DFGla~~~~ 667 (681)
||+++++.+||+|||+++.+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred EEEcCCCCEEeccCccccccc
Confidence 999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.8e-22 Score=210.25 Aligned_cols=152 Identities=29% Similarity=0.473 Sum_probs=128.0
Q ss_pred hCCCCceeeecccCcEeEEEEEe------cCCcEEEEEEecCCC-cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeC-C
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ-G 583 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~------~~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~-~ 583 (681)
.++|++.+.||+|+||.||+|.. ..++.||||+++... ......+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45789999999999999999974 246789999997543 23356788999999999 789999999988654 5
Q ss_pred eEEEEEEecCCCChhhHhcCCCC---------------------------------------------------------
Q 005718 584 EKILIYEYMPNKSLNFFLFDPSR--------------------------------------------------------- 606 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 606 (681)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999998853210
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 607 -------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 607 -------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~ 230 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY 230 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccc
Confidence 123678888999999999999999987 9999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=202.49 Aligned_cols=152 Identities=35% Similarity=0.598 Sum_probs=132.9
Q ss_pred hCCCCceeeecccCcEeEEEEEecC------CcEEEEEEecCCCcc-cHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~------~~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 585 (681)
..+|.+.+.||+|+||.||+|...+ ++.||||.++..... ..+.+.+|+.++.+++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3467888999999999999998643 468999999765433 457899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCC
Q 005718 586 ILIYEYMPNKSLNFFLFDPS-----------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 654 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~ 654 (681)
++||||+++++|.+++.... ....+++.+...++.|++.||+|||..+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999985421 2235788999999999999999999887 999999999999999999
Q ss_pred eEEeecCCceeec
Q 005718 655 PKISDFGMARMFC 667 (681)
Q Consensus 655 ~kl~DFGla~~~~ 667 (681)
+||+|||+++.+.
T Consensus 161 ~kl~d~g~~~~~~ 173 (280)
T cd05049 161 VKIGDFGMSRDVY 173 (280)
T ss_pred EEECCcccceecc
Confidence 9999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=196.02 Aligned_cols=152 Identities=30% Similarity=0.443 Sum_probs=131.6
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC----cc----cHHHHHHHHHHHhhC-CCCCeeEEEEEEEeC
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS----GQ----GLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ 582 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~----~~----~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 582 (681)
-+.|...+.||+|..+.|-+...+ .++++|+|++.... .. -.++-+.|+.+|+++ .||+|+++.+++..+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356677789999999999988875 47899999886421 11 134567899999998 799999999999999
Q ss_pred CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCC
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl 662 (681)
...++|+|.|+.|.|.++| ...-.+++++...|+.|+..|++|||..+ ||||||||+|||+|++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 9999999999999999999 34456899999999999999999999998 99999999999999999999999999
Q ss_pred ceeecCCC
Q 005718 663 ARMFCGDE 670 (681)
Q Consensus 663 a~~~~~~~ 670 (681)
|..+...+
T Consensus 170 a~~l~~Ge 177 (411)
T KOG0599|consen 170 ACQLEPGE 177 (411)
T ss_pred eeccCCch
Confidence 99886554
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=203.05 Aligned_cols=153 Identities=33% Similarity=0.520 Sum_probs=132.6
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-----------------CcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-----------------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVR 574 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-----------------~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~ 574 (681)
..+|++.++||+|+||.||++...+ +..||+|.+.... ....+.+.+|+.++.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578899999999999999987643 2458999987643 334678899999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCChhhHhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCc
Q 005718 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPS--------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 646 (681)
Q Consensus 575 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N 646 (681)
+++++..++..++++||+++++|.+++.... ....+++..++.++.|+++||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999985432 1235889999999999999999999887 9999999999
Q ss_pred EEEcCCCCeEEeecCCceeecC
Q 005718 647 ILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 647 iLl~~~~~~kl~DFGla~~~~~ 668 (681)
|+++.++.+||+|||+++.+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~ 182 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYS 182 (296)
T ss_pred eeecCCCceEEccccceeeccc
Confidence 9999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=212.79 Aligned_cols=139 Identities=34% Similarity=0.490 Sum_probs=124.0
Q ss_pred CceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCC
Q 005718 517 SMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKS 596 (681)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 596 (681)
...+-||.|+.|.||+|+++ ++.||||+++... ..+|+-|++|+|+||+.+.|+|....-++||||||..|.
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 34578999999999999994 5789999887532 357889999999999999999999999999999999999
Q ss_pred hhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 597 LNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 597 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
|..+|. ....+.......+..+||.||.|||.+. |||||||.-||||..+..+||+|||.++.....
T Consensus 199 L~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 199 LYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred HHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 999993 4556777888899999999999999886 999999999999999999999999999988554
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=202.15 Aligned_cols=154 Identities=28% Similarity=0.485 Sum_probs=133.6
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC-----CcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEe-CCe
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN-----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE-QGE 584 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~ 584 (681)
..++|++.+.||+|+||.||+|...+ +..|++|++.... ....+.+.+|+.++++++|+||+++++++.+ +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678889999999999999999865 6789999887542 3345678999999999999999999999876 467
Q ss_pred EEEEEEecCCCChhhHhcCCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEee
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRT-----HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD 659 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D 659 (681)
.++++||+.+++|.+++...... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998543222 46889999999999999999999887 99999999999999999999999
Q ss_pred cCCceeecC
Q 005718 660 FGMARMFCG 668 (681)
Q Consensus 660 FGla~~~~~ 668 (681)
||+++.+..
T Consensus 161 ~g~~~~~~~ 169 (280)
T cd05043 161 NALSRDLFP 169 (280)
T ss_pred CCCcccccC
Confidence 999987644
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.3e-23 Score=215.71 Aligned_cols=150 Identities=33% Similarity=0.484 Sum_probs=130.1
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.+-|...+.||.|+||.||-+... +.+.||||++.-. +.....+++.|+..|.+++|||.+.+-|++......|||
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 345777789999999999999874 5788999998743 333467899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||||- ||-.++|. -..+++.+.++..|..+.++||+|||+.+ .||||||+.||||++.+.|||+|||-|.+..+
T Consensus 105 MEYCl-GSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 105 MEYCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHHHh-ccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 99994 57777762 23456888888999999999999999988 99999999999999999999999999998865
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=200.04 Aligned_cols=149 Identities=33% Similarity=0.592 Sum_probs=125.5
Q ss_pred CceeeecccCcEeEEEEEecCC-c--EEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC------CeE
Q 005718 517 SMQCKLGEGGFGPVYKGKLLNG-Q--EVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------GEK 585 (681)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~~-~--~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~ 585 (681)
.+.+.||+|+||.||+|..... + .+|+|.++.. .....+.+..|+.++++++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4568999999999999997543 2 5899988753 234467889999999999999999999988543 246
Q ss_pred EEEEEecCCCChhhHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCC
Q 005718 586 ILIYEYMPNKSLNFFLFDP---SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl 662 (681)
++++||+++|+|.+++... .....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999887422 23345889999999999999999999987 99999999999999999999999999
Q ss_pred ceeecC
Q 005718 663 ARMFCG 668 (681)
Q Consensus 663 a~~~~~ 668 (681)
++.+..
T Consensus 159 ~~~~~~ 164 (272)
T cd05075 159 SKKIYN 164 (272)
T ss_pred ccccCc
Confidence 997643
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.5e-21 Score=202.78 Aligned_cols=149 Identities=27% Similarity=0.329 Sum_probs=130.4
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
++|++.+.||+|+||.||++... .+..+|+|.+.... ....+++.+|++++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999875 47788999886542 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+++++|.+++.. ...+++..+..++.|+++||.|||+.. +++||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 999999999843 245788999999999999999999742 39999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=201.98 Aligned_cols=141 Identities=25% Similarity=0.361 Sum_probs=120.4
Q ss_pred eecccCcEeEEEEEecC-------------------------CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEE
Q 005718 521 KLGEGGFGPVYKGKLLN-------------------------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575 (681)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~-------------------------~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l 575 (681)
+||+|+||.||+|.+.. ...|++|.+.........+|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13589998876544445678899999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC--
Q 005718 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-- 653 (681)
Q Consensus 576 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~-- 653 (681)
++++.+....++||||+++|+|..++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999888432 335788999999999999999999887 99999999999997643
Q ss_pred -----CeEEeecCCceee
Q 005718 654 -----NPKISDFGMARMF 666 (681)
Q Consensus 654 -----~~kl~DFGla~~~ 666 (681)
.+|++|||+++..
T Consensus 157 ~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred cCccceeeecCCcccccc
Confidence 3899999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-21 Score=199.14 Aligned_cols=150 Identities=33% Similarity=0.548 Sum_probs=128.4
Q ss_pred CCceeeecccCcEeEEEEEecC----CcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCe-----
Q 005718 516 FSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE----- 584 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----- 584 (681)
|++.+.||+|+||.||+|.... +..||+|+++... ....+.+.+|+..++.++|+||+++++++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998743 3679999987532 2345689999999999999999999999876654
Q ss_pred -EEEEEEecCCCChhhHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeec
Q 005718 585 -KILIYEYMPNKSLNFFLFDPS---RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 660 (681)
Q Consensus 585 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF 660 (681)
.++++||+++++|..++.... ....+++.....++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999998885432 2346889999999999999999999987 999999999999999999999999
Q ss_pred CCceeecC
Q 005718 661 GMARMFCG 668 (681)
Q Consensus 661 Gla~~~~~ 668 (681)
|+++.+..
T Consensus 158 g~~~~~~~ 165 (273)
T cd05035 158 GLSKKIYS 165 (273)
T ss_pred cceeeccc
Confidence 99987643
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=201.62 Aligned_cols=150 Identities=33% Similarity=0.547 Sum_probs=128.9
Q ss_pred CCCceeeecccCcEeEEEEEecC------CcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~~------~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
+|++.+.||+|+||.||+|.... ...+++|.+.... ....+++.+|+.+++.++||||+++++.+.+++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46788999999999999998632 2468899887543 2345678999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCc
Q 005718 588 IYEYMPNKSLNFFLFDPS---------------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 646 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N 646 (681)
++||+.+++|.+++.... ....+++.+.+.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999874321 1235788999999999999999999887 9999999999
Q ss_pred EEEcCCCCeEEeecCCceeec
Q 005718 647 ILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 647 iLl~~~~~~kl~DFGla~~~~ 667 (681)
||+++++.+||+|||+++.+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~ 178 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVY 178 (290)
T ss_pred EEEcCCCcEEecccccccccc
Confidence 999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=199.72 Aligned_cols=150 Identities=32% Similarity=0.552 Sum_probs=131.6
Q ss_pred CCCCceeeecccCcEeEEEEEecC-C---cEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN-G---QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~-~---~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.+|++.+.||+|+||.||+|.... + ..||||.+... .....++|..|+.++++++||||+++.+++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357788999999999999998753 3 36999998754 334457899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||+++++|.+++... ...+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998432 345789999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-21 Score=197.85 Aligned_cols=151 Identities=36% Similarity=0.546 Sum_probs=135.9
Q ss_pred hhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
..++|.+.+.||+|+||.||++...+++.+|||.+... ....+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 45688999999999999999999888889999998753 34567899999999999999999999999998999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+++++|.+++.+. ....+++.++..++.|++.||.|||+++ ++|+||||+||++++++.+||+|||+++.+.
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceecc
Confidence 9999999998543 2345889999999999999999999987 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=206.78 Aligned_cols=139 Identities=26% Similarity=0.366 Sum_probs=119.0
Q ss_pred ecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhC---CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 522 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL---QHRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 522 LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
||+|+||.||++... .++.||||++.+.. ......+..|..++.+. +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999875 48899999986531 12233455666666655 799999999999999999999999999
Q ss_pred CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|+|..++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 999988843 345789999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=198.81 Aligned_cols=150 Identities=32% Similarity=0.524 Sum_probs=131.0
Q ss_pred hCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
.++|++.++||+|+||.||+|...+...||+|+++.. ....++|.+|+.++.+++|+||+++++.+. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 4568999999999999999999877778999999753 334568899999999999999999999874 45679999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
++++|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 999999998542 2345789999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=200.74 Aligned_cols=153 Identities=29% Similarity=0.471 Sum_probs=132.3
Q ss_pred hCCCCceeeecccCcEeEEEEEecC------CcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~------~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 585 (681)
.++|.+.+.||+|+||.||++.... +..||+|.+.... ......+.+|+.++..++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4678889999999999999998743 3679999987543 23456789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEe
Q 005718 586 ILIYEYMPNKSLNFFLFDPSR-------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 658 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~ 658 (681)
++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999854321 224688899999999999999999887 9999999999999999999999
Q ss_pred ecCCceeecC
Q 005718 659 DFGMARMFCG 668 (681)
Q Consensus 659 DFGla~~~~~ 668 (681)
|||+++.+..
T Consensus 162 dfg~~~~~~~ 171 (277)
T cd05032 162 DFGMTRDIYE 171 (277)
T ss_pred Ccccchhhcc
Confidence 9999986543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=202.45 Aligned_cols=154 Identities=31% Similarity=0.532 Sum_probs=133.1
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC------CcEEEEEEecCC-CcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCC
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG 583 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~------~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 583 (681)
..++|++.+.||+|+||.||++.... ...+|+|.+... ......++.+|+.++.++ +|+||+++++++.+++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 45678889999999999999998642 357999998754 233446788999999999 8999999999999999
Q ss_pred eEEEEEEecCCCChhhHhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc
Q 005718 584 EKILIYEYMPNKSLNFFLFDP-------------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 650 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~ 650 (681)
..+++|||+++|+|..++... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998532 22346889999999999999999999887 99999999999999
Q ss_pred CCCCeEEeecCCceeecC
Q 005718 651 SDMNPKISDFGMARMFCG 668 (681)
Q Consensus 651 ~~~~~kl~DFGla~~~~~ 668 (681)
+++.+||+|||+++.+..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~ 184 (293)
T cd05053 167 EDHVMKIADFGLARDIHH 184 (293)
T ss_pred CCCeEEeCcccccccccc
Confidence 999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=197.53 Aligned_cols=143 Identities=31% Similarity=0.488 Sum_probs=126.5
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCCh
Q 005718 520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL 597 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 597 (681)
+.||+|+||.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999875 58899999886532 33456799999999999999999999999999999999999999999
Q ss_pred hhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 598 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
.+++.. ....+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence 999843 2335789999999999999999999887 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=198.71 Aligned_cols=145 Identities=35% Similarity=0.557 Sum_probs=128.9
Q ss_pred CCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCcccH--HHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 516 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGL--KEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~--~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
|++.+.||+|+||+||++.... ++.+|+|.+........ .....|+.++++++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678999999999999999865 56899999987543322 23456999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
++++|.+++. ....+++.++..++.|+++||+|||+.+ |+|+||||+||++++++.++|+|||++..+
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999994 3456799999999999999999999987 999999999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=203.54 Aligned_cols=153 Identities=31% Similarity=0.528 Sum_probs=131.8
Q ss_pred hCCCCceeeecccCcEeEEEEEec--------CCcEEEEEEecCCC-cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeC
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ 582 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 582 (681)
..+|.+.+.||+|+||.||++... ++..||+|.+.... ....+++.+|+.++..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467888899999999999999741 23479999887532 34457899999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChhhHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEE
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 649 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl 649 (681)
...++||||+++++|.+++..... ...+++.++..++.||++||.|||+.+ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999854321 235788999999999999999999987 9999999999999
Q ss_pred cCCCCeEEeecCCceeecC
Q 005718 650 DSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 650 ~~~~~~kl~DFGla~~~~~ 668 (681)
++++.+||+|||+|+.+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~ 189 (304)
T cd05101 171 TENNVMKIADFGLARDVNN 189 (304)
T ss_pred cCCCcEEECCCccceeccc
Confidence 9999999999999987743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=209.15 Aligned_cols=155 Identities=30% Similarity=0.493 Sum_probs=129.5
Q ss_pred hhCCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCCC-cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeC-
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ- 582 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~- 582 (681)
+.++|++.+.||+|+||.||+|... .++.||+|+++... ....+.+..|+.++.++ +|+||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3457889999999999999999642 24689999987532 22345688899999999 899999999988754
Q ss_pred CeEEEEEEecCCCChhhHhcCCCC--------------------------------------------------------
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPSR-------------------------------------------------------- 606 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 606 (681)
...++++||+++++|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 578899999999999988843211
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 607 --THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 607 --~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~ 226 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKD 226 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccC
Confidence 125789999999999999999999887 999999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=198.68 Aligned_cols=150 Identities=31% Similarity=0.526 Sum_probs=133.3
Q ss_pred CCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
.+|.+.+.||+|+||.||+|...+ ++.||+|.+... ....+++.+|++++.+++|+||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 457788999999999999998754 788999998753 345678999999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
++++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 999999998543 2345789999999999999999999887 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=197.63 Aligned_cols=150 Identities=36% Similarity=0.531 Sum_probs=132.8
Q ss_pred hhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
..++|++.++||+|+||.||+|..++++.+|+|.+... ....+.+.+|+.++++++|+||+++++++ ..+..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCC-CCcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence 35678899999999999999999888899999998764 34457899999999999999999999986 45678999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+++++|.+++... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.+.
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 82 MENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 9999999988543 2345789999999999999999999887 9999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=199.38 Aligned_cols=149 Identities=27% Similarity=0.485 Sum_probs=133.2
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
.++|++.+.||+|+||.||++... +++.+|+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 356888899999999999999875 4789999998765555556788999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+++++|.+++.. ...+++.+...++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+.
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 999999998843 335889999999999999999999987 9999999999999999999999999998664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.7e-21 Score=197.56 Aligned_cols=145 Identities=26% Similarity=0.403 Sum_probs=127.8
Q ss_pred CCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
++|++.++||+|+||.||++.. ..++.+|+|.+... .....+++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577889999999999999987 45789999998654 233456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+++++|..+. .+++.....++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++.+..
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 9999996543 3577888899999999999999987 99999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=201.22 Aligned_cols=150 Identities=27% Similarity=0.437 Sum_probs=135.0
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
+.++|++.+.||+|+||.||++... +++.+|+|.+........+.|..|+.++++++|+||+++++.+.++...++|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 3467888999999999999999875 578999999976655666789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|+++++|.+++... ...+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++...
T Consensus 83 ~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~ 153 (280)
T cd06611 83 FCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKN 153 (280)
T ss_pred ccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhh
Confidence 99999999988432 345889999999999999999999987 999999999999999999999999998755
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=201.74 Aligned_cols=152 Identities=26% Similarity=0.425 Sum_probs=135.6
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
....+|++.+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 34478999999999999999999974 68899999997655555677899999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+++++|.+++.+ ..+++.++..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||+++....+
T Consensus 96 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 96 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred cccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 99999999998832 34788999999999999999999887 999999999999999999999999999876443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-21 Score=197.51 Aligned_cols=155 Identities=29% Similarity=0.440 Sum_probs=132.8
Q ss_pred HHhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
+.+++++.....||+|+||.||+|... ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 345566666689999999999999875 4678999998876556677899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC-CCCeEEeecCCceeec
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFC 667 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~~~~ 667 (681)
+||+++++|.+++.........++..+..++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||++..+.
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999854322212277888899999999999999887 999999999999976 6799999999998663
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=199.36 Aligned_cols=148 Identities=28% Similarity=0.455 Sum_probs=131.8
Q ss_pred CCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecC
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 593 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 593 (681)
.|++.+.||+|+||.||++.... +..+++|.+........+.+.+|+.+++.++|+||+++++++..++..++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 35677899999999999999864 67889999876555567789999999999999999999999999999999999999
Q ss_pred CCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+++|..++.. ....+++.++..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 9999888743 2345889999999999999999999987 9999999999999999999999999997653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-22 Score=208.53 Aligned_cols=160 Identities=28% Similarity=0.416 Sum_probs=140.6
Q ss_pred CCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
..|+..+.||+|.||.||||.... ++.||+|++... .....+++.+|+.++...+++||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 456667899999999999999754 788999999864 344567899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCCc
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 671 (681)
|.+|++.+.| .....+.+.....|+.+++.||.|||.++ .+|||||+.|||+..++.+||+|||.|-.+.....
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999988 44555577777888999999999999987 99999999999999999999999999999876665
Q ss_pred cCCCcceecC
Q 005718 672 QGNTKRVVGT 681 (681)
Q Consensus 672 ~~~~~~~~GT 681 (681)
+. .+++||
T Consensus 167 rr--~tfvGT 174 (467)
T KOG0201|consen 167 RR--KTFVGT 174 (467)
T ss_pred cc--cccccc
Confidence 54 557887
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=200.35 Aligned_cols=152 Identities=34% Similarity=0.568 Sum_probs=132.7
Q ss_pred CCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
.+|+..++||+|+||.||++... ++..+|+|.+........+.+.+|++++.+++|+||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999642 355799999887666667789999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCe
Q 005718 588 IYEYMPNKSLNFFLFDPSR------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP 655 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~ 655 (681)
++||+++++|.+++..... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999854321 134788999999999999999999887 9999999999999999999
Q ss_pred EEeecCCceeecC
Q 005718 656 KISDFGMARMFCG 668 (681)
Q Consensus 656 kl~DFGla~~~~~ 668 (681)
||+|||+++.+..
T Consensus 162 kL~dfg~~~~~~~ 174 (280)
T cd05092 162 KIGDFGMSRDIYS 174 (280)
T ss_pred EECCCCceeEcCC
Confidence 9999999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.6e-21 Score=198.39 Aligned_cols=149 Identities=32% Similarity=0.527 Sum_probs=130.4
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+|++.+.||+|++|.||+|... +++.||||++.... ....+.+.+|+.++.+++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999975 58899999986532 22346788999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
++ ++|.+++........+++..+..++.||++||+|||+.+ |+|+||||+||++++++.+||+|||+++...
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 97 688888754444456899999999999999999999887 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-21 Score=206.22 Aligned_cols=144 Identities=25% Similarity=0.336 Sum_probs=125.3
Q ss_pred HhhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
....+|.+.+.||+|+||.||+|.... ++.||+|..... ....|+.++++++|+||+++++++.+....++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 345679999999999999999999854 678999975432 2356899999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
||+. ++|.+++.. ....+++.++..|+.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 9995 577777743 3345899999999999999999999987 999999999999999999999999999864
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.4e-21 Score=199.02 Aligned_cols=148 Identities=28% Similarity=0.364 Sum_probs=129.4
Q ss_pred CCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 516 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
|+..+.||+|+||+||++... +++.+|+|.+.... ....+.+.+|+.++.+++|+||+++.+.+.+++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999874 58899999987532 12234578899999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 99999998885432 235899999999999999999999887 9999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-21 Score=196.54 Aligned_cols=149 Identities=31% Similarity=0.548 Sum_probs=133.8
Q ss_pred hCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
.++|++.+.||+|+||.||++... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 457888899999999999999874 78899999986533 5678999999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence 9999999985432 235899999999999999999999987 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=198.68 Aligned_cols=152 Identities=29% Similarity=0.487 Sum_probs=131.8
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeC------
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ------ 582 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~------ 582 (681)
.+.+.|++.+.||+|+||.||+|... .++.+|+|++... .....++..|+.++.++ +|+||+++.+++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677888899999999999999875 4788999998653 34456788999999998 799999999998763
Q ss_pred CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCC
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl 662 (681)
...++||||+.+++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4689999999999999998542 2345889999999999999999999987 99999999999999999999999999
Q ss_pred ceeec
Q 005718 663 ARMFC 667 (681)
Q Consensus 663 a~~~~ 667 (681)
++.+.
T Consensus 158 ~~~~~ 162 (272)
T cd06637 158 SAQLD 162 (272)
T ss_pred ceecc
Confidence 98764
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-21 Score=200.08 Aligned_cols=150 Identities=33% Similarity=0.550 Sum_probs=130.1
Q ss_pred CCCCceeeecccCcEeEEEEEe-----cCCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC--CeE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKL-----LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEK 585 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 585 (681)
..|++.++||+|+||.||++.. ..+..||+|.++... ....+.+.+|+.++++++|+||+++.+++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578889999999999999974 246789999987543 33456899999999999999999999998875 568
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++||||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 9999999999999998432 235789999999999999999999987 99999999999999999999999999987
Q ss_pred ecC
Q 005718 666 FCG 668 (681)
Q Consensus 666 ~~~ 668 (681)
+..
T Consensus 159 ~~~ 161 (284)
T cd05079 159 IET 161 (284)
T ss_pred ccc
Confidence 643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=201.63 Aligned_cols=150 Identities=34% Similarity=0.532 Sum_probs=129.0
Q ss_pred CCCceeeecccCcEeEEEEEecC------CcEEEEEEecCCCcc-cHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~~------~~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
+|++.++||+|+||.||+|...+ ++.||+|++...... ..+.+.+|+.++..++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46677899999999999998632 468999999754332 34678899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCC
Q 005718 588 IYEYMPNKSLNFFLFDP-------------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 654 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~ 654 (681)
++||+.+++|.+++... .....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999998421 11235788899999999999999999887 999999999999999999
Q ss_pred eEEeecCCceeec
Q 005718 655 PKISDFGMARMFC 667 (681)
Q Consensus 655 ~kl~DFGla~~~~ 667 (681)
+||+|||+++.+.
T Consensus 163 ~kl~Dfg~~~~~~ 175 (283)
T cd05091 163 VKISDLGLFREVY 175 (283)
T ss_pred eEecccccccccc
Confidence 9999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.1e-21 Score=200.37 Aligned_cols=150 Identities=26% Similarity=0.426 Sum_probs=134.3
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
...+|++.+.||+|+||.||++... +++.+++|.+........+.+.+|+.+++.++|+||+++++.+..+.+.++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 3467889999999999999999864 578999999986555556788999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|+++++|.+++.+ ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred ccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 9999999998832 34788999999999999999999987 99999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.8e-21 Score=197.37 Aligned_cols=143 Identities=27% Similarity=0.409 Sum_probs=123.7
Q ss_pred ecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCCh
Q 005718 522 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL 597 (681)
Q Consensus 522 LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 597 (681)
||+|+||.||++... +++.+|+|++.... ....+.+..|++++.+++||||+++.+.+.++.+.++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999875 48899999986421 12234566799999999999999999999999999999999999999
Q ss_pred hhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 598 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 98875432 234788999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=202.58 Aligned_cols=151 Identities=34% Similarity=0.582 Sum_probs=129.5
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-Cc--EEEEEEecCC-CcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQ--EVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~--~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 587 (681)
.++|++.+.||+|+||.||+|.... +. .+++|.+... .....+.+.+|++++.++ +|+||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 3578888999999999999998743 43 4688877653 233456789999999999 89999999999999999999
Q ss_pred EEEecCCCChhhHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCC
Q 005718 588 IYEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 654 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~ 654 (681)
||||+++++|.+++.... ....+++.+++.++.|+++||+|||+.+ ++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999985432 1235789999999999999999999887 999999999999999999
Q ss_pred eEEeecCCceee
Q 005718 655 PKISDFGMARMF 666 (681)
Q Consensus 655 ~kl~DFGla~~~ 666 (681)
+||+|||+++..
T Consensus 163 ~kl~dfg~~~~~ 174 (303)
T cd05088 163 AKIADFGLSRGQ 174 (303)
T ss_pred EEeCccccCccc
Confidence 999999999743
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-21 Score=198.55 Aligned_cols=150 Identities=33% Similarity=0.526 Sum_probs=128.8
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCc----EEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~----~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 586 (681)
.++|++.+.||+|+||.||+|... +++ .||+|.++.. .....+++.+|+.++..++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 356888899999999999999853 344 4899998754 33345678999999999999999999999875 4577
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+++||+++|+|.+++.+. ...+++.+++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999998542 335889999999999999999999987 999999999999999999999999999987
Q ss_pred cC
Q 005718 667 CG 668 (681)
Q Consensus 667 ~~ 668 (681)
..
T Consensus 160 ~~ 161 (279)
T cd05109 160 DI 161 (279)
T ss_pred cc
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=199.66 Aligned_cols=150 Identities=31% Similarity=0.431 Sum_probs=133.0
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|++.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999875 47899999986532 233567889999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+++++|.+++.. ...++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999843 346889999999999999999999987 999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.8e-21 Score=197.80 Aligned_cols=150 Identities=31% Similarity=0.433 Sum_probs=131.5
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888899999999999999986 48899999886432 2234568899999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
|+++++|..++. ....+++.++..++.|++++|+|||+.+ ++|+||||+||+++.++.+||+|||+++.+...
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999998887763 2335889999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-23 Score=197.18 Aligned_cols=150 Identities=29% Similarity=0.443 Sum_probs=130.2
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecC--CCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~--~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
.+.|++.+.||+|+|+.||+.... .|+.+|+|.+.. ....+.+++.+|+++-..++||||++|.....+....+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 456888899999999999998764 588899887753 24457889999999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC---CCeEEeecCCceee
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFGMARMF 666 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~---~~~kl~DFGla~~~ 666 (681)
|+|++++|..-|.. ...+++..+-++++||+++|.|+|.++ |||||+||+|+||.+. .-+||+|||+|+.+
T Consensus 90 e~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999999776633 245778888899999999999999998 9999999999999543 36899999999999
Q ss_pred cC
Q 005718 667 CG 668 (681)
Q Consensus 667 ~~ 668 (681)
.+
T Consensus 164 ~~ 165 (355)
T KOG0033|consen 164 ND 165 (355)
T ss_pred CC
Confidence 73
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.2e-21 Score=202.00 Aligned_cols=152 Identities=32% Similarity=0.534 Sum_probs=131.4
Q ss_pred hCCCCceeeecccCcEeEEEEEecC--------CcEEEEEEecCCC-cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeC
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ 582 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~--------~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 582 (681)
.++|.+.+.||+|+||.||++.... ...+|+|.+.... .....++..|+.++.++ +|+||+++++++.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4678999999999999999997522 2469999987542 33456788999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChhhHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEE
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 649 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl 649 (681)
+..++||||+++++|.+++..... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999954321 235889999999999999999999887 9999999999999
Q ss_pred cCCCCeEEeecCCceeec
Q 005718 650 DSDMNPKISDFGMARMFC 667 (681)
Q Consensus 650 ~~~~~~kl~DFGla~~~~ 667 (681)
+.++.+||+|||+|+.+.
T Consensus 174 ~~~~~~kL~dfg~a~~~~ 191 (307)
T cd05098 174 TEDNVMKIADFGLARDIH 191 (307)
T ss_pred cCCCcEEECCCccccccc
Confidence 999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.4e-21 Score=197.99 Aligned_cols=148 Identities=30% Similarity=0.376 Sum_probs=129.1
Q ss_pred CCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 516 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
|+..+.||+|+||.||++... .++.+|||.+.... ....+.+.+|+.++.+++|+|++.+++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999875 57899999987532 12235678899999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+++++|.+++... ....+++.++..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++...
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 153 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence 9999999888432 2234788999999999999999999887 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=200.48 Aligned_cols=151 Identities=25% Similarity=0.399 Sum_probs=132.4
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
+|++.+.||+|+||.||++... .++.+|+|.+... .......+.+|+.++.+++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5778899999999999999985 5889999988753 2334567899999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
++++|..++........+++..+..++.|+++||.|||+.. +|+|+||||+||+++.++.+||+|||+++.+.
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999998854333446899999999999999999999742 39999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.9e-21 Score=196.28 Aligned_cols=152 Identities=23% Similarity=0.435 Sum_probs=132.5
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
.+|++.+.||+|+||.||+|... +++.||||.+... .......+.+|++++++++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888999999999999999874 5889999987642 2233457899999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||+++++|.+++.... ....++......++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998874322 2345788999999999999999999887 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-21 Score=196.78 Aligned_cols=144 Identities=25% Similarity=0.403 Sum_probs=123.0
Q ss_pred eeecccCcEeEEEEEecC-------------CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEE
Q 005718 520 CKLGEGGFGPVYKGKLLN-------------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~-------------~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 586 (681)
+.||+|+||.||+|.... ...|++|.+..........|.+|+.++..++||||+++++++.+....+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2258899887654455568899999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCC-------eEEee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-------PKISD 659 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~-------~kl~D 659 (681)
+||||+++++|..++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999988743 2345889999999999999999999887 999999999999987664 89999
Q ss_pred cCCceeecC
Q 005718 660 FGMARMFCG 668 (681)
Q Consensus 660 FGla~~~~~ 668 (681)
||++..+..
T Consensus 156 ~g~~~~~~~ 164 (262)
T cd05077 156 PGIPITVLS 164 (262)
T ss_pred CCCCccccC
Confidence 999976543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-22 Score=197.73 Aligned_cols=152 Identities=29% Similarity=0.445 Sum_probs=125.8
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-----CcEEEEEEecCCCcc--cHHHHHHHHHHHhhCCCCCeeEEEEEEEe-CCe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-----GQEVAVKRLSSQSGQ--GLKEFKNEMMLIAKLQHRNLVRLMGCCVE-QGE 584 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~ 584 (681)
...|+....||+|.||.||+|.-.+ ...+|+|+++..... -.....+|+.+++.++||||+.|..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3468888999999999999996532 237899999864221 12345789999999999999999999887 778
Q ss_pred EEEEEEecCCCChhhHhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC----CCeEEe
Q 005718 585 KILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD----MNPKIS 658 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~----~~~kl~ 658 (681)
.+|++||.++ +|..+|.. ....+.++......|+.||+.|+.|||++- |+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999987 55555532 233467888999999999999999999998 9999999999999876 899999
Q ss_pred ecCCceeecC
Q 005718 659 DFGMARMFCG 668 (681)
Q Consensus 659 DFGla~~~~~ 668 (681)
|||+||++..
T Consensus 179 DlGlaR~~~~ 188 (438)
T KOG0666|consen 179 DLGLARLFNN 188 (438)
T ss_pred cccHHHHhhc
Confidence 9999999854
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.1e-21 Score=198.68 Aligned_cols=149 Identities=31% Similarity=0.510 Sum_probs=133.8
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
.+.|++.++||+|+||.||+|.... ++.+++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 3568888999999999999999854 789999999876666678899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+++++|..++.+. ...+++..+..++.|++++|+|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceec
Confidence 9999998887432 235789999999999999999999887 999999999999999999999999998764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.6e-21 Score=195.80 Aligned_cols=150 Identities=33% Similarity=0.531 Sum_probs=131.6
Q ss_pred hCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
.++|++.++||+|+||.||++...++..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 35688889999999999999998888889999987643 34567999999999999999999999875 45688999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
++++|.+++... ....+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999998543 2335789999999999999999999987 99999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.9e-21 Score=195.04 Aligned_cols=142 Identities=30% Similarity=0.511 Sum_probs=122.7
Q ss_pred eecccCcEeEEEEEec---CCcEEEEEEecCCCc-ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCC
Q 005718 521 KLGEGGFGPVYKGKLL---NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKS 596 (681)
Q Consensus 521 ~LG~G~fG~Vy~~~~~---~~~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 596 (681)
.||+|+||.||+|.+. .+..||+|.+..... ...++|.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 345799999876432 33567999999999999999999999875 457899999999999
Q ss_pred hhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 597 LNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 597 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|.+++.. ....+++.+++.++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGA 147 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccC
Confidence 9998843 2346889999999999999999999987 99999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.9e-21 Score=195.23 Aligned_cols=149 Identities=33% Similarity=0.519 Sum_probs=130.1
Q ss_pred CCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecC
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 593 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 593 (681)
++|.+.+.||+|++|.||++....+..+|+|.+... ....+.+.+|+.++++++|+|++++++++. .+..++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 468888999999999999999877778999988753 234567899999999999999999998875 456889999999
Q ss_pred CCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 99999998543 2345789999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.1e-21 Score=195.10 Aligned_cols=148 Identities=33% Similarity=0.503 Sum_probs=130.6
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-----cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
++|.+.+.||+|++|.||++... .++.+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56888999999999999999874 58899999886432 1224578899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
|+||+++++|.+++.. ...+++.....++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998843 335788889999999999999999987 9999999999999999999999999998664
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.5e-21 Score=194.53 Aligned_cols=152 Identities=26% Similarity=0.453 Sum_probs=134.2
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|++.+.||+|+||.||+|... +++.+|+|.++.. .....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999986 6889999988642 2233568999999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||+++++|..++.+. .....+++.++..++.++++||.|||+.+ |+|+||+|+||++++++.+||+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988542 22445789999999999999999999887 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.7e-21 Score=200.68 Aligned_cols=150 Identities=32% Similarity=0.568 Sum_probs=129.1
Q ss_pred CCCCceeeecccCcEeEEEEEecC-C--cEEEEEEecCC-CcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN-G--QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~-~--~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 588 (681)
++|++.+.||+|+||.||+|...+ + ..+++|.++.. .....+.|.+|+.++.++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 568888999999999999998754 3 24788888743 334456789999999999 799999999999999999999
Q ss_pred EEecCCCChhhHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCe
Q 005718 589 YEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP 655 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~ 655 (681)
+||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985321 1235788999999999999999999887 9999999999999999999
Q ss_pred EEeecCCceee
Q 005718 656 KISDFGMARMF 666 (681)
Q Consensus 656 kl~DFGla~~~ 666 (681)
||+|||+++..
T Consensus 159 kl~dfg~~~~~ 169 (297)
T cd05089 159 KIADFGLSRGE 169 (297)
T ss_pred EECCcCCCccc
Confidence 99999998743
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.5e-21 Score=193.95 Aligned_cols=143 Identities=34% Similarity=0.485 Sum_probs=126.9
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEecCCCc-ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCChh
Q 005718 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 598 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 598 (681)
++||+|+||.||+|...+++.+|+|.+..... .....+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988888999999876432 23457899999999999999999999999999999999999999999
Q ss_pred hHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 599 FFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 599 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+++... ...+++..+..++.|++.+|.|||..+ ++||||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecc
Confidence 988432 234789999999999999999999887 9999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.5e-21 Score=196.17 Aligned_cols=151 Identities=33% Similarity=0.573 Sum_probs=132.0
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-C---cEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-G---QEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~---~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
.++|+..+.||+|+||.||+|.... + ..+|+|.+.... ....+++..|++++.+++|+||+++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3567888999999999999998753 3 369999987542 3345679999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999998432 245789999999999999999999987 9999999999999999999999999998764
Q ss_pred C
Q 005718 668 G 668 (681)
Q Consensus 668 ~ 668 (681)
.
T Consensus 159 ~ 159 (268)
T cd05063 159 D 159 (268)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-21 Score=198.24 Aligned_cols=142 Identities=27% Similarity=0.434 Sum_probs=120.5
Q ss_pred eecccCcEeEEEEEecCC---cEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCC
Q 005718 521 KLGEGGFGPVYKGKLLNG---QEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKS 596 (681)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~~---~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 596 (681)
.||+|+||.||++...++ ..+++|.+.... ....+.|.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999976443 346677666432 2345789999999999999999999999999999999999999999
Q ss_pred hhhHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 597 LNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 597 L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
|.+++.+.. .....+......++.||++||+|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence 999985432 2234566778899999999999999887 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-21 Score=201.28 Aligned_cols=152 Identities=32% Similarity=0.480 Sum_probs=131.8
Q ss_pred hCCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCCC-cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGE 584 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 584 (681)
.++|.+.+.||+|+||.||++... .+..||||+++... ....+.+.+|+.+++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 457888999999999999999742 24579999987542 33356789999999999 79999999999999999
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
.++||||+.+++|.+++.... ...+++.+...++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999985422 234799999999999999999999987 9999999999999999999999999998
Q ss_pred eecC
Q 005718 665 MFCG 668 (681)
Q Consensus 665 ~~~~ 668 (681)
.+..
T Consensus 190 ~~~~ 193 (302)
T cd05055 190 DIMN 193 (302)
T ss_pred cccC
Confidence 7643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.9e-21 Score=201.62 Aligned_cols=152 Identities=33% Similarity=0.538 Sum_probs=131.1
Q ss_pred hCCCCceeeecccCcEeEEEEEec--------CCcEEEEEEecCCC-cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeC
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ 582 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 582 (681)
..+|.+.++||+|+||.||++... ....+|+|.++... .....++..|+.++.++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 457888999999999999999752 24578999887542 33456789999999999 699999999999999
Q ss_pred CeEEEEEEecCCCChhhHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEE
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 649 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl 649 (681)
...++||||+++|+|.+++.... ....+++.+...++.|++.||.|||+.+ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999985432 1245889999999999999999999887 9999999999999
Q ss_pred cCCCCeEEeecCCceeec
Q 005718 650 DSDMNPKISDFGMARMFC 667 (681)
Q Consensus 650 ~~~~~~kl~DFGla~~~~ 667 (681)
++++.+||+|||+++.+.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~ 185 (314)
T cd05099 168 TEDNVMKIADFGLARGVH 185 (314)
T ss_pred cCCCcEEEcccccccccc
Confidence 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-21 Score=211.83 Aligned_cols=149 Identities=23% Similarity=0.438 Sum_probs=122.2
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC--------
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-------- 582 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-------- 582 (681)
...+|++.+.||+|+||.||+|... .++.||||++.... ....+|+.+++.++|+||+++.+++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4567999999999999999999875 57899999886432 2345799999999999999999887532
Q ss_pred CeEEEEEEecCCCChhhHhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC-CeEEeec
Q 005718 583 GEKILIYEYMPNKSLNFFLFD-PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDF 660 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DF 660 (681)
...++||||+++ +|.+++.. ......+++.....++.||++||+|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999985 56555532 123456889999999999999999999987 99999999999998665 7999999
Q ss_pred CCceeecC
Q 005718 661 GMARMFCG 668 (681)
Q Consensus 661 Gla~~~~~ 668 (681)
|+|+.+..
T Consensus 216 Gla~~~~~ 223 (440)
T PTZ00036 216 GSAKNLLA 223 (440)
T ss_pred ccchhccC
Confidence 99987644
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=7e-21 Score=197.73 Aligned_cols=146 Identities=39% Similarity=0.564 Sum_probs=126.6
Q ss_pred CCceeeecccCcEeEEEEEe-----cCCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC--CeEEE
Q 005718 516 FSMQCKLGEGGFGPVYKGKL-----LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKIL 587 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~-----~~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l 587 (681)
|+..+.||+|+||+||++.. .+++.||+|.++... ....+.|.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988653 346789999987542 23457789999999999999999999998764 46899
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||||+++++|.+++.. ..+++.++..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999833 34899999999999999999999987 9999999999999999999999999998764
Q ss_pred C
Q 005718 668 G 668 (681)
Q Consensus 668 ~ 668 (681)
.
T Consensus 159 ~ 159 (283)
T cd05080 159 E 159 (283)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=196.00 Aligned_cols=142 Identities=29% Similarity=0.467 Sum_probs=122.6
Q ss_pred eeecccCcEeEEEEEecCCc-----------EEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 520 CKLGEGGFGPVYKGKLLNGQ-----------EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~-----------~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
+.||+|+||.||+|...+.. .+++|.+...... ...|.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999986432 4788877654332 6789999999999999999999999988 778999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC-------CeEEeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-------NPKISDFG 661 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~-------~~kl~DFG 661 (681)
|||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999985432 25789999999999999999999887 99999999999999887 79999999
Q ss_pred CceeecC
Q 005718 662 MARMFCG 668 (681)
Q Consensus 662 la~~~~~ 668 (681)
+++.+..
T Consensus 154 ~a~~~~~ 160 (259)
T cd05037 154 IPITVLS 160 (259)
T ss_pred ccccccc
Confidence 9987543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.8e-21 Score=193.48 Aligned_cols=150 Identities=29% Similarity=0.435 Sum_probs=133.2
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+|++.+.||+|++|.||++... +++.+++|.+... .....+++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777899999999999999875 5789999988643 334567899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+++++|.+++... ....+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~ 153 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD 153 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence 9999999998543 2346889999999999999999999887 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.4e-21 Score=197.00 Aligned_cols=150 Identities=31% Similarity=0.448 Sum_probs=131.2
Q ss_pred CCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCCCcc-cHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 586 (681)
++|++.+.||+|+||.||++..+ ..+.+++|.+...... ..+++.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888899999999999999864 2457999988754333 4578999999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhcCCCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeec
Q 005718 587 LIYEYMPNKSLNFFLFDPSRT------HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 660 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF 660 (681)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998543311 25899999999999999999999887 999999999999999999999999
Q ss_pred CCceee
Q 005718 661 GMARMF 666 (681)
Q Consensus 661 Gla~~~ 666 (681)
|+++..
T Consensus 162 ~~~~~~ 167 (275)
T cd05046 162 SLSKDV 167 (275)
T ss_pred cccccc
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.6e-21 Score=194.65 Aligned_cols=148 Identities=32% Similarity=0.476 Sum_probs=127.8
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-----cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC--CeE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEK 585 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 585 (681)
++|++.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.++.+++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57888999999999999999875 48899999885321 12346788999999999999999999988764 467
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
+++|||+++++|.+++.. ...+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999998843 234788888999999999999999887 99999999999999999999999999986
Q ss_pred ec
Q 005718 666 FC 667 (681)
Q Consensus 666 ~~ 667 (681)
+.
T Consensus 156 ~~ 157 (265)
T cd06652 156 LQ 157 (265)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=194.02 Aligned_cols=151 Identities=31% Similarity=0.479 Sum_probs=133.1
Q ss_pred hhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
..++|++.++||+|+||.||++...++..+++|.+... ....+.+.+|+.++++++|+||+++.+.+.+ ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 35678899999999999999999877788999988753 3345788999999999999999999999887 778999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+++++|.+++... ....+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999998543 2345788899999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=194.26 Aligned_cols=148 Identities=32% Similarity=0.528 Sum_probs=129.8
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcc---------cHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCe
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQ---------GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE 584 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~---------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 584 (681)
+|.+...||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999874 4789999988654221 12568899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
.++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999843 345788899999999999999999987 9999999999999999999999999998
Q ss_pred eecC
Q 005718 665 MFCG 668 (681)
Q Consensus 665 ~~~~ 668 (681)
.+..
T Consensus 155 ~~~~ 158 (267)
T cd06628 155 KLEA 158 (267)
T ss_pred cccc
Confidence 7753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.4e-21 Score=196.99 Aligned_cols=153 Identities=33% Similarity=0.533 Sum_probs=131.3
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC------CcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCe
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE 584 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~------~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 584 (681)
..++|.+.+.||+|++|.||+|...+ +..|++|.+.... ......|..|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678899999999999999998753 4678999886543 3345679999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC---CeEE
Q 005718 585 KILIYEYMPNKSLNFFLFDPS----RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKI 657 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~---~~kl 657 (681)
.++||||+++++|.+++.... ....+++..++.++.||++||+|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 999999999999999985432 1235889999999999999999999987 99999999999998765 5999
Q ss_pred eecCCceeec
Q 005718 658 SDFGMARMFC 667 (681)
Q Consensus 658 ~DFGla~~~~ 667 (681)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (277)
T cd05036 161 ADFGMARDIY 170 (277)
T ss_pred ccCccccccC
Confidence 9999998764
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=193.15 Aligned_cols=147 Identities=41% Similarity=0.618 Sum_probs=130.6
Q ss_pred eeecccCcEeEEEEEecC----CcEEEEEEecCCCcc-cHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 520 CKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
+.||+|+||.||++.... +..+++|.+...... ..+.+.+|++.+..++|+||+++++++.++...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998854 778999999865333 367899999999999999999999999999999999999999
Q ss_pred CChhhHhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 595 KSLNFFLFDPSR------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 595 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
++|.+++..... ...+++.++..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999955321 356899999999999999999999987 99999999999999999999999999998755
Q ss_pred C
Q 005718 669 D 669 (681)
Q Consensus 669 ~ 669 (681)
.
T Consensus 158 ~ 158 (262)
T cd00192 158 D 158 (262)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.8e-21 Score=193.60 Aligned_cols=148 Identities=34% Similarity=0.510 Sum_probs=130.8
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-----cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
+|+..+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+.++++++|+||+++.+++.++...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999986 68899999886532 22456789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||+++....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999843 234788999999999999999999987 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.5e-21 Score=197.25 Aligned_cols=161 Identities=25% Similarity=0.358 Sum_probs=135.6
Q ss_pred ccHHHHHHhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEE-
Q 005718 504 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCV- 580 (681)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~- 580 (681)
+.+..+..+.++|++.+.||+|+||.||++... .++.+|+|.+... .....++.+|+.++.++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 334555667889999999999999999999875 4789999988653 22346788999999999 7999999999885
Q ss_pred ----eCCeEEEEEEecCCCChhhHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCe
Q 005718 581 ----EQGEKILIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP 655 (681)
Q Consensus 581 ----~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~ 655 (681)
.++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345789999999999999887432 23345788899999999999999999887 9999999999999999999
Q ss_pred EEeecCCceeecC
Q 005718 656 KISDFGMARMFCG 668 (681)
Q Consensus 656 kl~DFGla~~~~~ 668 (681)
||+|||+++.+..
T Consensus 164 kl~dfg~~~~~~~ 176 (286)
T cd06638 164 KLVDFGVSAQLTS 176 (286)
T ss_pred EEccCCceeeccc
Confidence 9999999987643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.5e-21 Score=198.51 Aligned_cols=152 Identities=32% Similarity=0.543 Sum_probs=132.0
Q ss_pred hCCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 585 (681)
.++|++.+.||+|+||.||++... ++..+|+|.+.... ....+++.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999863 35789999987542 33456799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCc
Q 005718 586 ILIYEYMPNKSLNFFLFDPS-------------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASN 646 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~N 646 (681)
++|+||+++++|.+++.... ....+++.+++.++.|++.||+|||..+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999985321 1224788899999999999999999887 9999999999
Q ss_pred EEEcCCCCeEEeecCCceeec
Q 005718 647 ILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 647 iLl~~~~~~kl~DFGla~~~~ 667 (681)
|++++++.+||+|||+++.+.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~ 181 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIY 181 (288)
T ss_pred eEecCCCceEECccccceecc
Confidence 999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=191.88 Aligned_cols=151 Identities=22% Similarity=0.351 Sum_probs=133.0
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+|+..+.||+|+||.||.+... +++.+++|.+... .....+++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788899999999999999864 4788999987643 234456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
+++++|.+++.... ...+++.++..++.|++++|+|||+.+ ++|+||+|+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999985432 345789999999999999999999887 999999999999999999999999999877443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.4e-21 Score=196.69 Aligned_cols=149 Identities=33% Similarity=0.551 Sum_probs=129.6
Q ss_pred CCCCceeeecccCcEeEEEEEecC-Cc----EEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQ----EVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~----~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
.+|++.+.||+|+||.||+|.... ++ .+|+|.+.... .....++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567888999999999999998643 32 58999887653 2345688999999999999999999999887 78899
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
|+||+++|+|.+++... ...+++..++.++.||++||+|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998542 334889999999999999999999977 9999999999999999999999999998765
Q ss_pred C
Q 005718 668 G 668 (681)
Q Consensus 668 ~ 668 (681)
.
T Consensus 161 ~ 161 (279)
T cd05057 161 V 161 (279)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.5e-21 Score=199.13 Aligned_cols=146 Identities=23% Similarity=0.379 Sum_probs=129.9
Q ss_pred CCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|++.+.||+|+||.||++.... ++.|++|.+.... ....+.+.+|+.+++.++||||+++++.+..+++.++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 368888999999999999999854 7899999987542 233457889999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 99999999999843 245788999999999999999999887 99999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9e-21 Score=204.12 Aligned_cols=148 Identities=31% Similarity=0.428 Sum_probs=125.1
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC-----
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG----- 583 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----- 583 (681)
..++|++.+.||+|+||.||++... .++.||||++... ......++.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999874 4889999998753 2234567889999999999999999999986543
Q ss_pred -eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCC
Q 005718 584 -EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662 (681)
Q Consensus 584 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl 662 (681)
..++||||++++ |...+. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 579999999764 544442 13678888899999999999999987 99999999999999999999999999
Q ss_pred ceeecC
Q 005718 663 ARMFCG 668 (681)
Q Consensus 663 a~~~~~ 668 (681)
|+....
T Consensus 170 a~~~~~ 175 (359)
T cd07876 170 ARTACT 175 (359)
T ss_pred cccccc
Confidence 986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=193.39 Aligned_cols=150 Identities=27% Similarity=0.492 Sum_probs=134.8
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
.++|++.+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++||||+++++++.++...+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 467889999999999999999875 4778999999866555678899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+++++|.+++... ...++..++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..+.
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhh
Confidence 9999999988432 245889999999999999999999887 9999999999999999999999999998664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.9e-22 Score=188.45 Aligned_cols=155 Identities=28% Similarity=0.332 Sum_probs=136.6
Q ss_pred HhhCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC-----e
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-----E 584 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~ 584 (681)
...++|.+.++||+|+|+.||.++. .+++.+|+|++.-...++.+..++|++..++++||||++++++...+. +
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3457899999999999999999984 568899999998776678889999999999999999999998876543 4
Q ss_pred EEEEEEecCCCChhhHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCc
Q 005718 585 KILIYEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla 663 (681)
.||+++|+..|+|.+.+.... .+..+++.+.+.|+.+|++||++||+.. ++.+||||||.|||+.+.+.++|.|||-+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 899999999999999986543 3447899999999999999999999975 57999999999999999999999999987
Q ss_pred eee
Q 005718 664 RMF 666 (681)
Q Consensus 664 ~~~ 666 (681)
...
T Consensus 177 ~~a 179 (302)
T KOG2345|consen 177 TQA 179 (302)
T ss_pred ccc
Confidence 654
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.7e-21 Score=198.25 Aligned_cols=151 Identities=26% Similarity=0.442 Sum_probs=134.8
Q ss_pred hhCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
...+|++.+.||.|++|.||++.. .+++.|++|.+........+.+.+|+.+++.++|+||+++++++...+..++|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 345789999999999999999986 4588999999876555556788999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
|+++++|..++.+ ..+++.++..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..+
T Consensus 97 ~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 97 YLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred ecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 9999999998832 34789999999999999999999987 999999999999999999999999999876443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=198.41 Aligned_cols=148 Identities=30% Similarity=0.463 Sum_probs=129.1
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
++|.+.+.||+|+||.||++... .++.||+|.++... ......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999875 47899999987532 33345678899999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
++ ++|..++... ...+++.....++.||++||+|||+.+ |+|+||||+||++++++.+||+|||+++...
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 97 5888877432 335788999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.7e-21 Score=202.57 Aligned_cols=151 Identities=31% Similarity=0.527 Sum_probs=130.2
Q ss_pred CCCCceeeecccCcEeEEEEEecC--------CcEEEEEEecCCC-cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCC
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG 583 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~--------~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 583 (681)
.+|.+.+.||+|+||.||++.... ...||+|.+.... ....+++.+|+.++.++ +|+||+++++++.+.+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468888999999999999997521 2368999887532 33457899999999999 8999999999999999
Q ss_pred eEEEEEEecCCCChhhHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc
Q 005718 584 EKILIYEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 650 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~ 650 (681)
..++++||+++|+|.+++.... ....+++.+++.++.|+++||+|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999985421 2235788999999999999999999987 99999999999999
Q ss_pred CCCCeEEeecCCceeec
Q 005718 651 SDMNPKISDFGMARMFC 667 (681)
Q Consensus 651 ~~~~~kl~DFGla~~~~ 667 (681)
+++.+||+|||+++.+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~ 185 (334)
T cd05100 169 EDNVMKIADFGLARDVH 185 (334)
T ss_pred CCCcEEECCcccceecc
Confidence 99999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.6e-21 Score=198.18 Aligned_cols=148 Identities=32% Similarity=0.459 Sum_probs=130.4
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcc-----cHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
+|++.+.||+|+||.||+|... +++.|+||.+...... ....+..|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777899999999999999975 5889999999754322 245677899999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999984422 36899999999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.6e-21 Score=194.56 Aligned_cols=146 Identities=29% Similarity=0.521 Sum_probs=129.5
Q ss_pred CCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCc------ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
+|++.+.||+|+||.||+|...+++.+|||.+..... ...+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4777899999999999999987889999998864321 2235688999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+||+++++|.+++.+ ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||+++..
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 999999999999843 234788899999999999999999887 999999999999999999999999999865
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=192.29 Aligned_cols=149 Identities=30% Similarity=0.544 Sum_probs=132.3
Q ss_pred CCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecC
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 593 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 593 (681)
.+|++.+.||+|+||.||++...+++.+|+|.+... .....+|.+|++++++++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 467888999999999999998877889999988753 3345679999999999999999999999999999999999999
Q ss_pred CCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+++|.+++... ...+++..+..++.|++.+|+|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 99999988432 234788999999999999999999887 99999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.2e-21 Score=200.94 Aligned_cols=141 Identities=23% Similarity=0.310 Sum_probs=114.4
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec--CCcEEEEEEecCCC-----cccHHHHHHHHHHHhhCCCCCeeE-EEEEEEeC
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL--NGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAKLQHRNLVR-LMGCCVEQ 582 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~--~~~~VAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~-l~g~~~~~ 582 (681)
....+|.+.+.||+|+||+||+|... +++.+|||++.... ....+.|.+|+++|++++|+|++. ++. .
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~ 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----T 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----c
Confidence 34578999999999999999999874 46778999876431 123567999999999999999885 443 2
Q ss_pred CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccc-CCCcEEEcCCCCeEEeecC
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDL-KASNILLDSDMNPKISDFG 661 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl-kp~NiLl~~~~~~kl~DFG 661 (681)
+..+|||||+++++|.. + . .. . ...++.|++++|.|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~-~-~--~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-A-R--PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHH-h-C--cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 46799999999999962 2 1 11 1 1467889999999999987 999999 9999999999999999999
Q ss_pred CceeecC
Q 005718 662 MARMFCG 668 (681)
Q Consensus 662 la~~~~~ 668 (681)
+|+.+..
T Consensus 158 lA~~~~~ 164 (365)
T PRK09188 158 LASVFRR 164 (365)
T ss_pred cceeccc
Confidence 9998754
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=196.27 Aligned_cols=149 Identities=32% Similarity=0.418 Sum_probs=127.8
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc-ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++++|.+.+.||+|+||.||+|... +++.+|+|++..... .....+.+|+.+++.++|+||+++.+++.+++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999874 588999999875432 22346788999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
||+. ++|.+++... ...+.+..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||+++..
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccccc
Confidence 9996 6666665332 234678888899999999999999887 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=193.39 Aligned_cols=142 Identities=31% Similarity=0.504 Sum_probs=122.9
Q ss_pred eecccCcEeEEEEEec---CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 005718 521 KLGEGGFGPVYKGKLL---NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK 595 (681)
Q Consensus 521 ~LG~G~fG~Vy~~~~~---~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 595 (681)
+||+|+||.||+|.++ +++.+|+|+++... ....+++.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 46789999987542 234568999999999999999999999875 55778999999999
Q ss_pred ChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 596 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 596 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 99999843 335789999999999999999999887 999999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-20 Score=189.95 Aligned_cols=150 Identities=25% Similarity=0.425 Sum_probs=132.0
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
+|++.+.||+|+||.||++... +++.+|+|.++.. .....+.+..|+.++++++|+||+++++.+.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999875 5789999988643 2344577889999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
++++|.+++... ....+++.....++.|+++||.|||+.+ |+|+||||+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 999999887432 3345788999999999999999999987 99999999999999999999999999987743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=194.13 Aligned_cols=147 Identities=31% Similarity=0.447 Sum_probs=128.3
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc----------ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG----------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG 583 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~----------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 583 (681)
+|.+.+.||+|+||.||+|... +++.+|+|.++.... ...+.+..|+.++.+++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677789999999999999864 588999998863211 11346888999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCc
Q 005718 584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla 663 (681)
..++||||+.+++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998443 45788899999999999999999887 999999999999999999999999999
Q ss_pred eeec
Q 005718 664 RMFC 667 (681)
Q Consensus 664 ~~~~ 667 (681)
+...
T Consensus 156 ~~~~ 159 (272)
T cd06629 156 KKSD 159 (272)
T ss_pred cccc
Confidence 8654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-20 Score=190.99 Aligned_cols=143 Identities=36% Similarity=0.524 Sum_probs=128.0
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEecCCCcc-cHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCChh
Q 005718 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 598 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 598 (681)
++||+|+||.||++...+++.|++|.+...... ..+.+.+|+.++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877899999998765333 4568999999999999999999999999999999999999999999
Q ss_pred hHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 599 FFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 599 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+++... ...+++..+..++.+++.+|+|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 998442 235788999999999999999999887 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-21 Score=209.97 Aligned_cols=156 Identities=31% Similarity=0.447 Sum_probs=127.8
Q ss_pred ceeeecccCcEeEEEEEec-CCcEEEEEEe--cC--CCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCe--EEEEEE
Q 005718 518 MQCKLGEGGFGPVYKGKLL-NGQEVAVKRL--SS--QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE--KILIYE 590 (681)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l--~~--~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~lV~E 590 (681)
..++||+|+|-+||||.+. +|-+||=--+ .+ ..+...++|..|+.+|+.|+|+||++++..+.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3478999999999999884 3666652211 11 234556899999999999999999999999987654 789999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC-CCCeEEeecCCceeecCC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCGD 669 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~~~~~~ 669 (681)
.|..|+|..|+.+.. .++.+....+++||++||.|||++. ++|||||||.+||+|+. -|.|||+|+|||.++...
T Consensus 124 L~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999995443 3677889999999999999999985 78999999999999975 479999999999998543
Q ss_pred CccCCCcceecC
Q 005718 670 ELQGNTKRVVGT 681 (681)
Q Consensus 670 ~~~~~~~~~~GT 681 (681)
.. +.++||
T Consensus 200 ~a----ksvIGT 207 (632)
T KOG0584|consen 200 HA----KSVIGT 207 (632)
T ss_pred cc----ceeccC
Confidence 32 236777
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-21 Score=197.90 Aligned_cols=149 Identities=30% Similarity=0.415 Sum_probs=130.8
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc--ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
++|++.++||+|+||.||++... .++.+|+|++..... ...+.+.+|++++++++|+||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999986 478999998865322 234678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|+++++|..+... ...+++.++..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999999877632 234789999999999999999999887 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.6e-21 Score=203.35 Aligned_cols=149 Identities=30% Similarity=0.410 Sum_probs=127.3
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC------
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------ 582 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------ 582 (681)
..++|++.+.||+|+||.||++... .++.||||++.... ....+.+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999874 57899999987532 23345678899999999999999999987643
Q ss_pred CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCC
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl 662 (681)
...++++|++ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3578999988 778887772 235889999999999999999999987 99999999999999999999999999
Q ss_pred ceeecC
Q 005718 663 ARMFCG 668 (681)
Q Consensus 663 a~~~~~ 668 (681)
++....
T Consensus 165 ~~~~~~ 170 (343)
T cd07878 165 ARQADD 170 (343)
T ss_pred ceecCC
Confidence 987643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=193.04 Aligned_cols=144 Identities=37% Similarity=0.476 Sum_probs=127.4
Q ss_pred eeecccCcEeEEEEEecC--C--cEEEEEEecCCCc-ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 520 CKLGEGGFGPVYKGKLLN--G--QEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~--~--~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
++||+|++|.||+|.+.. + ..||||.+..... ...+.+.+|+.++++++|+||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998743 2 3699999987654 556789999999999999999999999988 889999999999
Q ss_pred CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
++|.+++.+... ..+++.....++.|+++||+|||..+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999865432 46899999999999999999999987 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.6e-21 Score=195.44 Aligned_cols=152 Identities=24% Similarity=0.444 Sum_probs=132.7
Q ss_pred CCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
.+|++.+.||+|+||.||++.. .+++.++||.+... ......++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999996 46889999988643 2233467899999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||+++++|.+++... .....+++.++..++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988532 22446889999999999999999999887 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=196.09 Aligned_cols=147 Identities=31% Similarity=0.469 Sum_probs=128.5
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc-ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
++|++.+.||+|++|.||++... +++.||+|.+..... .....+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999975 578999999875322 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+.+ +|.+++.+. ...+++.....++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence 985 888887432 235788999999999999999999887 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-20 Score=198.34 Aligned_cols=144 Identities=28% Similarity=0.477 Sum_probs=118.8
Q ss_pred eeeecccCcEeEEEEEec---CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe--CCeEEEEEEecC
Q 005718 519 QCKLGEGGFGPVYKGKLL---NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEKILIYEYMP 593 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~---~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~ 593 (681)
.++||+|+||.||+|... .++.+|+|.+.... ....+.+|+.++++++||||+++++++.. +...++|+||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999864 35789999987532 23567889999999999999999998864 456899999996
Q ss_pred CCChhhHhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEE----cCCCCeEEeecCCc
Q 005718 594 NKSLNFFLFDP------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMA 663 (681)
Q Consensus 594 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl----~~~~~~kl~DFGla 663 (681)
+ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +..+.+||+|||+|
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 776666321 12235788999999999999999999987 9999999999999 45678999999999
Q ss_pred eeecC
Q 005718 664 RMFCG 668 (681)
Q Consensus 664 ~~~~~ 668 (681)
+.+..
T Consensus 160 ~~~~~ 164 (317)
T cd07868 160 RLFNS 164 (317)
T ss_pred eccCC
Confidence 98754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=194.59 Aligned_cols=149 Identities=34% Similarity=0.534 Sum_probs=130.9
Q ss_pred CCCCceeeecccCcEeEEEEEec-----CCcEEEEEEecCCCcc-cHHHHHHHHHHHhhCCCCCeeEEEEEEEe--CCeE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEK 585 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~ 585 (681)
.+|++.+.||+|+||.||++... .++.+|||.+...... ..+.|.+|+.++++++|+||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777799999999999999863 2578999999865332 46789999999999999999999999887 5688
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999998442 225889999999999999999999887 99999999999999999999999999988
Q ss_pred ec
Q 005718 666 FC 667 (681)
Q Consensus 666 ~~ 667 (681)
+.
T Consensus 159 ~~ 160 (284)
T cd05038 159 LP 160 (284)
T ss_pred cc
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.7e-21 Score=205.13 Aligned_cols=147 Identities=29% Similarity=0.417 Sum_probs=127.0
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCC-C-----CCeeEEEEEEEeCCeEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-H-----RNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H-----~nIv~l~g~~~~~~~~~l 587 (681)
+|.+.+.||+|.||+|.++... .++.||||+++.. ..-..+...|+.+|..++ | -|+|++++++...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7889999999999999999875 4899999999874 444566678999999996 4 389999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC--CeEEeecCCcee
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM--NPKISDFGMARM 665 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~--~~kl~DFGla~~ 665 (681)
|+|.++ -+|.++|.... -..++......|+.||+.||..||+.+ |||+||||+||||.+.. .+||+|||.|..
T Consensus 266 VfELL~-~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999995 58888885533 334889999999999999999999887 99999999999997543 799999999986
Q ss_pred ec
Q 005718 666 FC 667 (681)
Q Consensus 666 ~~ 667 (681)
..
T Consensus 341 ~~ 342 (586)
T KOG0667|consen 341 ES 342 (586)
T ss_pred cC
Confidence 53
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=194.28 Aligned_cols=151 Identities=26% Similarity=0.442 Sum_probs=129.6
Q ss_pred hCCCCceeeecccCcEeEEEEEecC----CcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
.++|.+.++||+|+||.||+|...+ ...|+||...... ....+.+.+|+.++++++|+||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3568888999999999999998643 2468999887654 3456689999999999999999999998865 56789
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||||+++++|.+++... ...+++.++..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+.
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999998432 235789999999999999999999887 9999999999999999999999999998764
Q ss_pred CC
Q 005718 668 GD 669 (681)
Q Consensus 668 ~~ 669 (681)
..
T Consensus 159 ~~ 160 (270)
T cd05056 159 DE 160 (270)
T ss_pred cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-21 Score=206.04 Aligned_cols=154 Identities=31% Similarity=0.502 Sum_probs=132.2
Q ss_pred eecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCChhh
Q 005718 521 KLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNF 599 (681)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 599 (681)
+||+|.||+||-|++.+ ...+|||.+........+-++.|+.+.++++|+|||+++|.+.++++.-|.||-+++|+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999866 45799999987777777889999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc-CCCCeEEeecCCceeecCCCccCCCc
Q 005718 600 FLFDPSRTHLL--GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARMFCGDELQGNTK 676 (681)
Q Consensus 600 ~l~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~-~~~~~kl~DFGla~~~~~~~~~~~~~ 676 (681)
+|... =.++ .+.+.-.+-.||++||.|||++. |||||||-+|+||+ ..|.+||+|||.+|.+.+= .-.|.
T Consensus 662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TE 734 (1226)
T KOG4279|consen 662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTE 734 (1226)
T ss_pred HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Ccccc
Confidence 99532 2233 66777788999999999999998 99999999999996 5789999999999988542 22345
Q ss_pred ceecC
Q 005718 677 RVVGT 681 (681)
Q Consensus 677 ~~~GT 681 (681)
++-||
T Consensus 735 TFTGT 739 (1226)
T KOG4279|consen 735 TFTGT 739 (1226)
T ss_pred ccccc
Confidence 55665
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=190.53 Aligned_cols=148 Identities=32% Similarity=0.537 Sum_probs=128.8
Q ss_pred CCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe-CCeEEEEEEec
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE-QGEKILIYEYM 592 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~ 592 (681)
++|++.+.||+|+||.||++... +..+++|.++.. ...+.+.+|+.++++++|+|++++++++.+ +...++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 57888899999999999999874 678999988653 335678999999999999999999998654 46789999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
++++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccc
Confidence 999999998543 2335789999999999999999999887 99999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=194.17 Aligned_cols=151 Identities=26% Similarity=0.415 Sum_probs=126.3
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHH-HhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMML-IAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
++|++.+.||+|+||.||++... +++.||+|+++... .....++..|+.. ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999985 58899999987542 2334456667665 566699999999999999999999999
Q ss_pred ecCCCChhhHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 591 YMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 591 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
|++ ++|.+++... .....+++..+..++.||+.||+|||++. +++||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 996 6787776432 23356899999999999999999999862 39999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=191.56 Aligned_cols=148 Identities=32% Similarity=0.496 Sum_probs=132.6
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc--ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+|++.+.||+|+||.||++... +++.+++|.+..... ...+.+..|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999875 578999999876543 3567899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||++..+..
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 999999999843 334788899999999999999999987 99999999999999999999999999987644
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=218.02 Aligned_cols=157 Identities=23% Similarity=0.350 Sum_probs=130.4
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC--CeEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKI 586 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~ 586 (681)
..++|.+.++||+|+||.||++.... ++.+|+|.+... .......|..|+.++..++||||+++++++.+. ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 45689999999999999999999854 678999988743 233456789999999999999999999988654 5789
Q ss_pred EEEEecCCCChhhHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeeecccCCCcEEEcCC---------
Q 005718 587 LIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSR----LRIIHRDLKASNILLDSD--------- 652 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~ivHrDlkp~NiLl~~~--------- 652 (681)
|||||+++++|.++|... .....+++..++.|+.||+.||+|||..+. .+||||||||+||||+..
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 999999999999988542 223468999999999999999999998542 359999999999999642
Q ss_pred --------CCeEEeecCCceeecC
Q 005718 653 --------MNPKISDFGMARMFCG 668 (681)
Q Consensus 653 --------~~~kl~DFGla~~~~~ 668 (681)
..+||+|||+++.+..
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~ 194 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGI 194 (1021)
T ss_pred cccccCCCCceEEccCCccccccc
Confidence 3489999999987643
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-21 Score=208.78 Aligned_cols=153 Identities=34% Similarity=0.482 Sum_probs=133.3
Q ss_pred CCCCceeeecccCcEeEEEEEecC--Cc--EEEEEEecCCCcc-cHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN--GQ--EVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~--~~--~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
++..+.++||+|.||.|++|.+.. |+ .||||.++..... ...+|++|+.+|.+|+|+||++|+|+..+ ....||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 445566899999999999998743 43 6899999876433 67899999999999999999999999887 788999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+|.++.|+|.+-|.+ .....+.......++.|||.||.||..++ +|||||.++|+||-..-.+||+||||.|-+..
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999976 34445677888899999999999999887 99999999999999999999999999998866
Q ss_pred CCc
Q 005718 669 DEL 671 (681)
Q Consensus 669 ~~~ 671 (681)
++.
T Consensus 265 ned 267 (1039)
T KOG0199|consen 265 NED 267 (1039)
T ss_pred CCc
Confidence 553
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=193.39 Aligned_cols=149 Identities=31% Similarity=0.511 Sum_probs=130.8
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc-ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
+|++.+.||+|++|.||+|... +++.||||.+..... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999985 488999999876432 23567788999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
++ +|.+++........+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 85 78887755444456899999999999999999999887 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.3e-20 Score=189.53 Aligned_cols=152 Identities=28% Similarity=0.442 Sum_probs=134.4
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
++|++.+.||+|+||.||++... ++..+++|++.... ....+.+.+|+.+++.++|+||+++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999864 57889999987532 33567899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+++++|.+++........+++.....++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 999999999854333346889999999999999999999887 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-20 Score=194.41 Aligned_cols=148 Identities=28% Similarity=0.351 Sum_probs=129.2
Q ss_pred CCCceeeecccCcEeEEEEEe----cCCcEEEEEEecCCC----cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKL----LNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~----~~~~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 585 (681)
+|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999986 357899999987532 22346788999999999 699999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++|+||+++++|.+++.. ...+++.....++.|+++||.|||+.+ ++||||+|+|||+++++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999843 335788888999999999999999887 99999999999999999999999999987
Q ss_pred ecC
Q 005718 666 FCG 668 (681)
Q Consensus 666 ~~~ 668 (681)
+..
T Consensus 155 ~~~ 157 (290)
T cd05613 155 FHE 157 (290)
T ss_pred ccc
Confidence 644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-20 Score=194.18 Aligned_cols=159 Identities=29% Similarity=0.407 Sum_probs=135.4
Q ss_pred cHHHHHHhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeC
Q 005718 505 SLASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ 582 (681)
Q Consensus 505 ~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 582 (681)
...++..+.++|++.+.||+|+||.||++... +++.+|+|.+... ....+++.+|+.++.++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 34455567889999999999999999999874 5789999998753 23346778899999999 899999999998754
Q ss_pred -----CeEEEEEEecCCCChhhHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeE
Q 005718 583 -----GEKILIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK 656 (681)
Q Consensus 583 -----~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~k 656 (681)
...++|+||+++++|.+++... .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 3589999999999999887432 23446889999999999999999999887 99999999999999999999
Q ss_pred EeecCCceeec
Q 005718 657 ISDFGMARMFC 667 (681)
Q Consensus 657 l~DFGla~~~~ 667 (681)
|+|||+++.+.
T Consensus 169 l~dfg~~~~~~ 179 (291)
T cd06639 169 LVDFGVSAQLT 179 (291)
T ss_pred Eeecccchhcc
Confidence 99999998654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.4e-21 Score=198.35 Aligned_cols=146 Identities=27% Similarity=0.416 Sum_probs=129.1
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecC
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 593 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 593 (681)
.|.....||+|+||.||++... +++.||||.+........+.+.+|+..++.++|+||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444468999999999999874 578999999876555556778999999999999999999999999999999999999
Q ss_pred CCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+++|.+++.. ..+++.+...++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 9999988732 24788999999999999999999987 9999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=229.01 Aligned_cols=143 Identities=29% Similarity=0.499 Sum_probs=123.3
Q ss_pred hCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
...+...+.||+|+||.||+|.. .++..||||++...... ...|++.+++++||||++++|+|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34577778999999999999997 46889999998753322 13468889999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+++|+|.+++. .++|.++..|+.||++||+|||+.+.++|+||||||+||+++.++.+++. ||+++..
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 99999999983 27899999999999999999997766779999999999999999988876 7776554
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-20 Score=195.71 Aligned_cols=150 Identities=27% Similarity=0.329 Sum_probs=132.9
Q ss_pred CCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCc---ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|++.+.||+|++|.||++...+ ++.+|+|.+..... ...+.+..|+.++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368888999999999999999864 88999999976432 24567899999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||+.+++|.+++... ....+++..+..++.|+++||+|||..+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999988532 3346889999999999999999999887 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-20 Score=190.57 Aligned_cols=149 Identities=30% Similarity=0.476 Sum_probs=134.2
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
.++|++.+.||+|+||.||++.... ++.+++|.+..... .+++.+|++++++++|+||+++++.+.+....++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678888999999999999999865 78999999875422 67899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+++++|.+++.. ....+++.....++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++..+..
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 999999999843 2346899999999999999999999987 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-20 Score=192.08 Aligned_cols=143 Identities=36% Similarity=0.609 Sum_probs=123.3
Q ss_pred eeecccCcEeEEEEEecC-Cc--EEEEEEecCC-CcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 520 CKLGEGGFGPVYKGKLLN-GQ--EVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~-~~--~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
+.||+|+||.||+|...+ +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999854 33 5788888753 234456889999999999 899999999999999999999999999
Q ss_pred CChhhHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecC
Q 005718 595 KSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661 (681)
Q Consensus 595 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG 661 (681)
++|.+++.... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999985421 1234789999999999999999999887 9999999999999999999999999
Q ss_pred Ccee
Q 005718 662 MARM 665 (681)
Q Consensus 662 la~~ 665 (681)
+++.
T Consensus 158 l~~~ 161 (270)
T cd05047 158 LSRG 161 (270)
T ss_pred Cccc
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-20 Score=190.80 Aligned_cols=148 Identities=32% Similarity=0.499 Sum_probs=127.9
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-----cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC--CeE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEK 585 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 585 (681)
.+|+..+.||+|+||.||++... .++.+++|++.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888899999999999999875 48899999886432 12345688999999999999999999988753 578
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++++||+++++|.+++.. ...+++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999998843 334788999999999999999999887 99999999999999999999999999986
Q ss_pred ec
Q 005718 666 FC 667 (681)
Q Consensus 666 ~~ 667 (681)
+.
T Consensus 156 ~~ 157 (266)
T cd06651 156 LQ 157 (266)
T ss_pred cc
Confidence 53
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=193.06 Aligned_cols=149 Identities=30% Similarity=0.492 Sum_probs=132.5
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+|++.+.||+|+||.||+|... +++.|++|++.... ....+.+.+|+.++++++|+||+++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999974 58899999987543 23356899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
+ +++|.+++.... ..+++.++..++.||+++|+|||+.+ ++|+||||+||++++++.++|+|||+++.+...
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999885432 45899999999999999999999887 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=202.04 Aligned_cols=148 Identities=29% Similarity=0.376 Sum_probs=125.1
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC------
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------ 582 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------ 582 (681)
..++|++.+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999874 47899999997532 23356788899999999999999999988644
Q ss_pred CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCC
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl 662 (681)
...++||||+++ +|...+. ..+++..+..++.|+++||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999975 5555552 23778888999999999999999987 99999999999999999999999999
Q ss_pred ceeecC
Q 005718 663 ARMFCG 668 (681)
Q Consensus 663 a~~~~~ 668 (681)
|+....
T Consensus 166 ~~~~~~ 171 (355)
T cd07874 166 ARTAGT 171 (355)
T ss_pred cccCCC
Confidence 987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-20 Score=200.93 Aligned_cols=148 Identities=28% Similarity=0.378 Sum_probs=125.4
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC------
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------ 582 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------ 582 (681)
..++|++.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999874 4788999999753 223456788999999999999999999987643
Q ss_pred CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCC
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl 662 (681)
...++||||+++ +|...+. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999975 5666652 23678888999999999999999987 99999999999999999999999999
Q ss_pred ceeecC
Q 005718 663 ARMFCG 668 (681)
Q Consensus 663 a~~~~~ 668 (681)
|+....
T Consensus 173 a~~~~~ 178 (364)
T cd07875 173 ARTAGT 178 (364)
T ss_pred ccccCC
Confidence 987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.6e-20 Score=194.78 Aligned_cols=143 Identities=29% Similarity=0.486 Sum_probs=118.1
Q ss_pred eeecccCcEeEEEEEecC---CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe--CCeEEEEEEecCC
Q 005718 520 CKLGEGGFGPVYKGKLLN---GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEKILIYEYMPN 594 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~---~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~~ 594 (681)
.+||+|+||.||+|...+ +..+|+|.+.... ....+.+|+.++++++||||+++++++.. +...++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 689999999999998753 4689999987532 23567889999999999999999999864 4578999999975
Q ss_pred CChhhHhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEE----cCCCCeEEeecCCce
Q 005718 595 KSLNFFLFDP------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMAR 664 (681)
Q Consensus 595 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl----~~~~~~kl~DFGla~ 664 (681)
+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||+|+
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 665555311 12335788999999999999999999987 9999999999999 566789999999999
Q ss_pred eecC
Q 005718 665 MFCG 668 (681)
Q Consensus 665 ~~~~ 668 (681)
.+..
T Consensus 161 ~~~~ 164 (317)
T cd07867 161 LFNS 164 (317)
T ss_pred ccCC
Confidence 8754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=195.71 Aligned_cols=147 Identities=29% Similarity=0.443 Sum_probs=129.9
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
.|+..+.||+|+||.||+|... .++.||+|.+.... ....+.+.+|+.++++++|+||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4666788999999999999875 47789999887542 334567899999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
++++|.+++. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence 9999998883 245788999999999999999999887 99999999999999999999999999987644
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=196.56 Aligned_cols=149 Identities=36% Similarity=0.638 Sum_probs=126.4
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCc----EEEEEEecCCCc-ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQ----EVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~----~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
++|+..+.||+|+||.||++... +++ .+|+|.+..... ....++.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 56778889999999999999864 343 578898875432 2345789999999999999999999998754 5679
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
++||+++|+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999998532 335788999999999999999999987 9999999999999999999999999999765
Q ss_pred C
Q 005718 668 G 668 (681)
Q Consensus 668 ~ 668 (681)
.
T Consensus 161 ~ 161 (303)
T cd05110 161 G 161 (303)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4e-20 Score=192.39 Aligned_cols=149 Identities=32% Similarity=0.511 Sum_probs=122.7
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc--ccHHHHHHHHHHHhhC---CCCCeeEEEEEEEeC-----C
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKL---QHRNLVRLMGCCVEQ-----G 583 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~-----~ 583 (681)
+|++.+.||+|+||.||++... +++.||+|.++.... .....+.+|+.+++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999875 488999998875321 2234556677777665 799999999988642 4
Q ss_pred eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCc
Q 005718 584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla 663 (681)
..++||||+.+ +|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57999999974 787777432 2234789999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 005718 664 RMFCG 668 (681)
Q Consensus 664 ~~~~~ 668 (681)
+.+..
T Consensus 156 ~~~~~ 160 (288)
T cd07863 156 RIYSC 160 (288)
T ss_pred ccccC
Confidence 87753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-20 Score=191.34 Aligned_cols=148 Identities=27% Similarity=0.479 Sum_probs=131.1
Q ss_pred CCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCC-CcccHHHHHHHHHHHhhCC---CCCeeEEEEEEEeCCeEEEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQ---HRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~ 589 (681)
.|+..+.||+|+||.||+|.. .+++.+++|.+... .....+++.+|+.++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999997 45889999998754 3344567889999999996 999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+++++|.+++.. ..+++.....++.|+++||.|||+.+ |+|+||+|+||++++++.++|+|||+++.+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998832 25889999999999999999999887 999999999999999999999999999877543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-20 Score=197.26 Aligned_cols=145 Identities=19% Similarity=0.302 Sum_probs=125.1
Q ss_pred ceeeeccc--CcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 518 MQCKLGEG--GFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 518 ~~~~LG~G--~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
+.++||+| +|++||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78999999874 58899999997542 223456788999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
++|+|.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.++++||+.+...
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 9999999985432 234789999999999999999999987 999999999999999999999999875443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=192.42 Aligned_cols=148 Identities=29% Similarity=0.508 Sum_probs=129.6
Q ss_pred CCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCc------ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSG------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
+|+..+.||+|++|.||++.. .+++.+|+|.+..... ...+.+++|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999986 4588999999875321 134678999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC-CeEEeecCCceee
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMF 666 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~~ 666 (681)
|+||+++++|.+++.+ ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||+++.+
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999843 335788999999999999999999987 99999999999998776 5999999999877
Q ss_pred cC
Q 005718 667 CG 668 (681)
Q Consensus 667 ~~ 668 (681)
..
T Consensus 155 ~~ 156 (268)
T cd06630 155 AA 156 (268)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.2e-20 Score=190.65 Aligned_cols=148 Identities=28% Similarity=0.442 Sum_probs=130.5
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+-|++.+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|+.++.+++|+||+++++++.+++..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34677789999999999999874 57899999886432 33456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+++++|.+++. ...+++.....++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||+++.+..
T Consensus 84 ~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 84 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 99999998883 235789999999999999999999887 99999999999999999999999999987644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.6e-20 Score=195.33 Aligned_cols=150 Identities=29% Similarity=0.451 Sum_probs=127.3
Q ss_pred CCCceeeecccCcEeEEEEEecC---CcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC--CeEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLLN---GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKI 586 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~~---~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~ 586 (681)
.|++.++||+|+||.||+|.... ++.+|+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788999999999999999754 7899999998632 33346778899999999999999999999988 8899
Q ss_pred EEEEecCCCChhhHhcCCC-C-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC----CCCeEEeec
Q 005718 587 LIYEYMPNKSLNFFLFDPS-R-THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS----DMNPKISDF 660 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~-~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~----~~~~kl~DF 660 (681)
+||||+++ +|.+++.... . ...++......++.||+.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 5655553222 2 236788999999999999999999887 999999999999999 899999999
Q ss_pred CCceeecC
Q 005718 661 GMARMFCG 668 (681)
Q Consensus 661 Gla~~~~~ 668 (681)
|+++.+..
T Consensus 157 g~~~~~~~ 164 (316)
T cd07842 157 GLARLFNA 164 (316)
T ss_pred ccccccCC
Confidence 99987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.5e-20 Score=189.03 Aligned_cols=150 Identities=29% Similarity=0.422 Sum_probs=134.9
Q ss_pred CCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCc-ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
++|++.+.||+|++|.||++.... ++.++||++..... ...+++.+|+..+.+++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 367888999999999999999865 88999999876533 4467899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
+++++|.+++... ..++...+..++.|++++|+|||+ .+ ++|+||+|+||+++.++.++|+|||+++.+...
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999432 568899999999999999999998 77 999999999999999999999999999877543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=210.02 Aligned_cols=153 Identities=22% Similarity=0.383 Sum_probs=119.3
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC--CcEEEEE------------------EecCCCcccHHHHHHHHHHHhhCCCCC
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN--GQEVAVK------------------RLSSQSGQGLKEFKNEMMLIAKLQHRN 571 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~--~~~VAVK------------------~l~~~~~~~~~~f~~Ei~~l~~l~H~n 571 (681)
..++|++.++||+|+||+||++..+. +...++| .+.. .......+.+|+.++.+++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987532 2222222 1111 1223456889999999999999
Q ss_pred eeEEEEEEEeCCeEEEEEEecCCCChhhHhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEE
Q 005718 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSR--THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 649 (681)
Q Consensus 572 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl 649 (681)
|+++++++.+.+..++|+|++.. +|..++..... .......+...|+.||+.||+|||+.+ ||||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 99999999999999999999964 55555533211 122335667789999999999999987 9999999999999
Q ss_pred cCCCCeEEeecCCceeecCC
Q 005718 650 DSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 650 ~~~~~~kl~DFGla~~~~~~ 669 (681)
+.++.+||+|||+|+.+...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~ 320 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKE 320 (501)
T ss_pred CCCCCEEEEeCCCceecCcc
Confidence 99999999999999987543
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-21 Score=191.93 Aligned_cols=161 Identities=30% Similarity=0.355 Sum_probs=137.2
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.++|...++||+|.||+|-+++-+ .++.+|+|++++.. ......-+.|-++|..-+||.+..|--.+...++++.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467888999999999999999875 48899999998753 23344567889999999999999999889999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||..+|.|..+| .+...+++.....+-..|..||.|||+.+ ||.||||.+|+|||.+|++||+||||+|.-..
T Consensus 247 MeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999998888 45566787777788899999999999987 99999999999999999999999999986544
Q ss_pred CCccCCCcceecC
Q 005718 669 DELQGNTKRVVGT 681 (681)
Q Consensus 669 ~~~~~~~~~~~GT 681 (681)
... .+.++.||
T Consensus 321 ~g~--t~kTFCGT 331 (516)
T KOG0690|consen 321 YGD--TTKTFCGT 331 (516)
T ss_pred ccc--eeccccCC
Confidence 433 24556776
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.4e-21 Score=196.36 Aligned_cols=163 Identities=29% Similarity=0.374 Sum_probs=140.5
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
..+.|+.-+.||+|+||.||-...+ .|+.+|.|++.+. ........++|-.+|.+++.+.||.+--.+...+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 4467888899999999999988765 4888898887653 23455677899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
|+..|.+|+|..+|..... .-+++..++-++.+|+.||++||... ||.|||||+|||||+.|+++|+|+|||..+.
T Consensus 263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999976554 35899999999999999999999887 9999999999999999999999999999986
Q ss_pred CCCccCCCcceecC
Q 005718 668 GDELQGNTKRVVGT 681 (681)
Q Consensus 668 ~~~~~~~~~~~~GT 681 (681)
..+.. ++| +||
T Consensus 339 ~g~~~--~~r-vGT 349 (591)
T KOG0986|consen 339 EGKPI--RGR-VGT 349 (591)
T ss_pred CCCcc--ccc-cCc
Confidence 66554 233 555
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.3e-20 Score=190.51 Aligned_cols=150 Identities=32% Similarity=0.548 Sum_probs=125.7
Q ss_pred CCceeeecccCcEeEEEEEec----CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC------
Q 005718 516 FSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------ 583 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 583 (681)
|.+.+.||+|+||.||+|... .++.||||.+... .....+++.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556789999999999999863 3578999998754 2334567899999999999999999999887543
Q ss_pred eEEEEEEecCCCChhhHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeec
Q 005718 584 EKILIYEYMPNKSLNFFLFDP---SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 660 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF 660 (681)
..++++||+.+|+|..++... .....+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 247899999999998887432 12235788999999999999999999887 999999999999999999999999
Q ss_pred CCceeecC
Q 005718 661 GMARMFCG 668 (681)
Q Consensus 661 Gla~~~~~ 668 (681)
|+++.+..
T Consensus 158 g~~~~~~~ 165 (273)
T cd05074 158 GLSKKIYS 165 (273)
T ss_pred cccccccC
Confidence 99987643
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.8e-20 Score=188.74 Aligned_cols=150 Identities=38% Similarity=0.620 Sum_probs=131.1
Q ss_pred CCceeeecccCcEeEEEEEecC-----CcEEEEEEecCCCcc-cHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 516 FSMQCKLGEGGFGPVYKGKLLN-----GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~~-----~~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
+++.+.||+|+||.||++...+ +..||+|.+...... ..+.+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3466899999999999998854 378999999765333 5678999999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+++++|.+++..... ..+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999854222 12789999999999999999999887 999999999999999999999999999876543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.8e-20 Score=190.90 Aligned_cols=149 Identities=27% Similarity=0.429 Sum_probs=131.6
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
..|+..+.||+|+||.||+|... .++.||+|.+.... ....+.+.+|+.+++++.|+||+++++.+.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34667789999999999999875 47899999887542 34467889999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
+++++|.+++.. ..+++.+...++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||+++.+...
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999999998832 34788899999999999999999887 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.8e-20 Score=193.46 Aligned_cols=149 Identities=28% Similarity=0.438 Sum_probs=133.0
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
..+|.+.+.||+|+||.||++... +++.|++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 467888999999999999999864 5788999998754445567889999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+++++|.+++.+ ..+++.++..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||++..+..
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 999999999832 34788899999999999999999887 99999999999999999999999999876644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.2e-21 Score=197.02 Aligned_cols=152 Identities=26% Similarity=0.354 Sum_probs=132.8
Q ss_pred CCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
.-|.+.+.||+|.|..|-++++ -.|+.||||++.+. +......+.+|++.|+.++|||||+|+.+...+..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4577789999999999999986 47999999999864 33345678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc-CCCCeEEeecCCceeecCC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~-~~~~~kl~DFGla~~~~~~ 669 (681)
.=++|+|.+||..+..+ +.+....+++.||+.|+.|+|..+ +|||||||+|+.+- .-|-+||.|||++-.+.+.
T Consensus 98 LGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999999765544 788889999999999999999988 99999999998775 5678999999999877554
Q ss_pred C
Q 005718 670 E 670 (681)
Q Consensus 670 ~ 670 (681)
+
T Consensus 173 ~ 173 (864)
T KOG4717|consen 173 K 173 (864)
T ss_pred c
Confidence 3
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-20 Score=193.55 Aligned_cols=148 Identities=27% Similarity=0.383 Sum_probs=130.3
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
++|++.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++..++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56788899999999999999875 47889999876542 33457899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+++++|.+++.. ...+++.....++.+++.+|.|||+.. +++||||||+||++++++.++|+|||+++.+
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence 999999988833 345789999999999999999999742 3999999999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=192.28 Aligned_cols=148 Identities=27% Similarity=0.368 Sum_probs=132.3
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
+|++.+.||+|+||.||++... .++.+|+|.+.... ....+.+.+|+.++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999985 48899999987532 2346789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|+++++|.+++... ..+++.+...++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 99999999998432 46888999999999999999999887 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=196.15 Aligned_cols=145 Identities=29% Similarity=0.425 Sum_probs=128.4
Q ss_pred CceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 005718 517 SMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK 595 (681)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 595 (681)
.....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++|+||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 33458999999999999874 58899999987554455677899999999999999999999999999999999999999
Q ss_pred ChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 596 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 596 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+|..++. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 104 ~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 104 ALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred CHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 9998772 235789999999999999999999887 99999999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.4e-20 Score=188.17 Aligned_cols=142 Identities=37% Similarity=0.549 Sum_probs=123.2
Q ss_pred eeecccCcEeEEEEEecC----CcEEEEEEecCCCc-ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 520 CKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
++||+|+||.||+|.... +..+|+|.+..... ...+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997632 26899999886433 24568999999999999999999999875 5578999999999
Q ss_pred CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
++|.+++... ..+++..+..++.|++.+|+|||..+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeec
Confidence 9999999432 35789999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.4e-20 Score=190.05 Aligned_cols=143 Identities=31% Similarity=0.557 Sum_probs=121.2
Q ss_pred eeecccCcEeEEEEEecC----CcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe-CCeEEEEEEecC
Q 005718 520 CKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE-QGEKILIYEYMP 593 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~~ 593 (681)
+.||+|+||.||+|...+ ...+|+|++... .....+.+.+|+.+++.++||||+++++++.. +...++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998632 357999988643 23446788999999999999999999998764 456889999999
Q ss_pred CCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+++|.+++... .....+..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999998432 234577888899999999999999887 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-20 Score=189.68 Aligned_cols=145 Identities=34% Similarity=0.570 Sum_probs=127.1
Q ss_pred CCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecC
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 593 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 593 (681)
++|.+.+.||+|+||.||++.. .++.+|+|.+... ...+.+.+|+.++.+++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4588889999999999999975 5778999998653 2346789999999999999999999998764 5799999999
Q ss_pred CCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+++|.+++.... ...+++.++..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVG 150 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceec
Confidence 999999985432 335788999999999999999999887 999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-20 Score=192.43 Aligned_cols=150 Identities=28% Similarity=0.423 Sum_probs=131.1
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
++|++.+.||+|+||.||++... +++.|++|+++.. .....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999986 4789999988753 22345788999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
|++++.+..++. ....+++.+...++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999877776552 2334789999999999999999999987 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5e-20 Score=191.14 Aligned_cols=157 Identities=27% Similarity=0.464 Sum_probs=133.5
Q ss_pred cHHHHHHhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEe-
Q 005718 505 SLASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE- 581 (681)
Q Consensus 505 ~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~- 581 (681)
++.++..+...|++.+.||+|+||.||+|... .++.+|+|.+... .....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34455556788999999999999999999984 4788999988653 33456788999999998 79999999999863
Q ss_pred -----CCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeE
Q 005718 582 -----QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK 656 (681)
Q Consensus 582 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~k 656 (681)
....+++|||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.+|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 45789999999999999988542 2345778888999999999999999987 99999999999999999999
Q ss_pred EeecCCceee
Q 005718 657 ISDFGMARMF 666 (681)
Q Consensus 657 l~DFGla~~~ 666 (681)
|+|||+++..
T Consensus 162 l~dfg~~~~~ 171 (282)
T cd06636 162 LVDFGVSAQL 171 (282)
T ss_pred EeeCcchhhh
Confidence 9999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-20 Score=190.13 Aligned_cols=148 Identities=28% Similarity=0.425 Sum_probs=132.6
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
++|++.+.||.|++|.||+|... +++.+|+|.+.... ......+.+|+.+++.++|+||+++.+++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35778899999999999999975 47899999987543 34456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 999999999843 26889999999999999999999887 99999999999999999999999999988754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.83 E-value=9e-20 Score=186.26 Aligned_cols=150 Identities=26% Similarity=0.406 Sum_probs=129.7
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEe-CCeEEEEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE-QGEKILIYE 590 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E 590 (681)
.|++.+.||+|++|.||++... +++.+++|++.... ....+.+.+|+.++++++|+|++++.+.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999875 47889999986532 3345678999999999999999999988764 446799999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|+++++|.+++... ....+++.++..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999988542 3345899999999999999999999987 99999999999999999999999999987743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.5e-20 Score=186.82 Aligned_cols=150 Identities=26% Similarity=0.417 Sum_probs=131.7
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+|++.+.||+|+||.||++... +++.+++|++... .....+++.+|+.++++++|+||+++++++.+.++.++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999874 5789999998643 233456889999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+.+++|.+++... ....+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.+..
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 9999999888432 2234788999999999999999999887 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-20 Score=203.26 Aligned_cols=170 Identities=26% Similarity=0.428 Sum_probs=144.7
Q ss_pred cHHHHHHhhCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEe-
Q 005718 505 SLASVSAATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE- 581 (681)
Q Consensus 505 ~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~- 581 (681)
.+..+..++..|.+.+.||+|.+|+||+++. ++++.+|||++... ....++...|..+++.. +|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3445566778899999999999999999987 45888999988764 44567788899999988 79999999999974
Q ss_pred ----CCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEE
Q 005718 582 ----QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 657 (681)
Q Consensus 582 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl 657 (681)
++++|||||||.+||..+++..-. +..+.|.....|+..+++||.+||.+. +||||||-.||||+.++.+||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 468999999999999999986544 667889999999999999999999887 999999999999999999999
Q ss_pred eecCCceeecCCCccCCCcceecC
Q 005718 658 SDFGMARMFCGDELQGNTKRVVGT 681 (681)
Q Consensus 658 ~DFGla~~~~~~~~~~~~~~~~GT 681 (681)
.|||++..++..-.+ ..+.+||
T Consensus 165 vDFGvSaQldsT~gr--RnT~iGt 186 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGR--RNTFIGT 186 (953)
T ss_pred eeeeeeeeeeccccc--ccCcCCC
Confidence 999999988554433 4446776
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.3e-20 Score=188.56 Aligned_cols=148 Identities=32% Similarity=0.504 Sum_probs=128.1
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC-----CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC--CeE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEK 585 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 585 (681)
.+|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999874 4889999987532 123456789999999999999999999998764 467
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++++||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999988842 234788899999999999999999887 99999999999999999999999999986
Q ss_pred ec
Q 005718 666 FC 667 (681)
Q Consensus 666 ~~ 667 (681)
+.
T Consensus 156 ~~ 157 (264)
T cd06653 156 IQ 157 (264)
T ss_pred cc
Confidence 53
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-20 Score=193.23 Aligned_cols=144 Identities=26% Similarity=0.410 Sum_probs=123.3
Q ss_pred eeecccCcEeEEEEEecC--------CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 520 CKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~--------~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+.||+|+||.||+|.... ...+++|.+........+++.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 234888887655445567889999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCC--------eEEeecCCc
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--------PKISDFGMA 663 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~--------~kl~DFGla 663 (681)
+++|+|..++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998543 235788999999999999999999887 999999999999987765 699999998
Q ss_pred eeecC
Q 005718 664 RMFCG 668 (681)
Q Consensus 664 ~~~~~ 668 (681)
..+..
T Consensus 156 ~~~~~ 160 (258)
T cd05078 156 ITVLP 160 (258)
T ss_pred cccCC
Confidence 76543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.3e-20 Score=192.61 Aligned_cols=149 Identities=31% Similarity=0.470 Sum_probs=128.7
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc---ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.+.|+..+.||+|+||.||+|... +++.||+|.+..... ...+++.+|+.+++.++||||+++.+++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 456888899999999999999875 588999998864322 2345788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+||+. |++.+++.. ....+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++...
T Consensus 94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99997 566666532 2335899999999999999999999887 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.2e-20 Score=191.66 Aligned_cols=150 Identities=28% Similarity=0.425 Sum_probs=127.2
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCe-----
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGE----- 584 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~----- 584 (681)
++|++.+.||+|+||.||++... +++.||+|.+.... ......+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999975 58899999886532 22346788899999999 56999999999987665
Q ss_pred EEEEEEecCCCChhhHhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC-CCCeEEeecC
Q 005718 585 KILIYEYMPNKSLNFFLFDPSR--THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFG 661 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFG 661 (681)
.++||||+++ +|.+++..... ...+++..+..++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 78777744322 346799999999999999999999887 999999999999998 8899999999
Q ss_pred Cceeec
Q 005718 662 MARMFC 667 (681)
Q Consensus 662 la~~~~ 667 (681)
+++.+.
T Consensus 157 ~~~~~~ 162 (295)
T cd07837 157 LGRAFS 162 (295)
T ss_pred cceecC
Confidence 998653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-20 Score=182.09 Aligned_cols=140 Identities=17% Similarity=0.158 Sum_probs=107.9
Q ss_pred eeeecccCcEeEEEEEecCCcEEEEEEecCCCcc--c-------HHH-----------------HHHHHHHHhhCCCCCe
Q 005718 519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ--G-------LKE-----------------FKNEMMLIAKLQHRNL 572 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~--~-------~~~-----------------f~~Ei~~l~~l~H~nI 572 (681)
...||+|+||.||+|...+|+.||||+++..... . ... ...|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3689999999999999888999999999754211 1 112 2349999999987776
Q ss_pred eEEEEEEEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeecccCCCcEEEcC
Q 005718 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL-HQYSRLRIIHRDLKASNILLDS 651 (681)
Q Consensus 573 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivHrDlkp~NiLl~~ 651 (681)
.....+.. ...+|||||++++++...+. ....++..+...++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44332222 22389999999887764432 223578899999999999999999 5666 99999999999998
Q ss_pred CCCeEEeecCCceeec
Q 005718 652 DMNPKISDFGMARMFC 667 (681)
Q Consensus 652 ~~~~kl~DFGla~~~~ 667 (681)
++.++|+|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.1e-22 Score=208.10 Aligned_cols=150 Identities=25% Similarity=0.429 Sum_probs=134.8
Q ss_pred hhCCCCceeeecccCcEeEEEEEecCC-cEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLNG-QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~~-~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
+.+.|.++..||.|+||+||++..++. -..|.|+|...+....++|+-|+++|....||+||+|++.|...+.++|+.|
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 345677888999999999999998764 4567888888788889999999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
||.||-.+.++... ...+.+.+...+++|++.||.|||++. |||||||+.|||++-+|.++|+|||.+-..
T Consensus 110 FC~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred ecCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc
Confidence 99999999888553 446889999999999999999999988 999999999999999999999999987554
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.9e-20 Score=193.03 Aligned_cols=147 Identities=28% Similarity=0.464 Sum_probs=127.3
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+|++.+.||+|+||.||++... .++.+|+|++.... ......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999985 58899999986532 22335678899999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+++ +|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFG 150 (284)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence 974 777766332 345899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-19 Score=184.46 Aligned_cols=148 Identities=34% Similarity=0.515 Sum_probs=132.8
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc--ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+|++.+.||+|++|.||++... .++.+++|.+..... ...+.+.+|++++.+++|+|++++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999875 578999999976543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+++++|.+++.. ...+++..+..++.|++.+|.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLND 151 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence 999999999843 246899999999999999999999887 99999999999999999999999999987754
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.6e-20 Score=190.90 Aligned_cols=148 Identities=29% Similarity=0.496 Sum_probs=129.1
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+|+..+.||+|++|.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999875 58899999887532 22345789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+. ++|..++... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 96 6888887443 2345789999999999999999999887 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.5e-20 Score=191.48 Aligned_cols=150 Identities=27% Similarity=0.401 Sum_probs=129.0
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc--ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC--CeEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKILI 588 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV 588 (681)
++|++.+.||+|+||.||+|... +++.+++|.++.... .....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999986 478899999875322 2234577899999999999999999999887 899999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||++ ++|.+++... ...+++.+...++.||++||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 4888887432 235899999999999999999999987 99999999999999999999999999987654
Q ss_pred C
Q 005718 669 D 669 (681)
Q Consensus 669 ~ 669 (681)
.
T Consensus 159 ~ 159 (293)
T cd07843 159 P 159 (293)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.5e-20 Score=188.36 Aligned_cols=153 Identities=26% Similarity=0.442 Sum_probs=128.6
Q ss_pred CCCceeeecccCcEeEEEEEecC--CcEEEEEEecCC----------CcccHHHHHHHHHHHhh-CCCCCeeEEEEEEEe
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLLN--GQEVAVKRLSSQ----------SGQGLKEFKNEMMLIAK-LQHRNLVRLMGCCVE 581 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~~--~~~VAVK~l~~~----------~~~~~~~f~~Ei~~l~~-l~H~nIv~l~g~~~~ 581 (681)
+|++.+.||+|+||.||++.... ++.+|+|.+... ......++..|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778999999999999999865 678999987532 12234567888888875 799999999999999
Q ss_pred CCeEEEEEEecCCCChhhHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeec
Q 005718 582 QGEKILIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 660 (681)
Q Consensus 582 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF 660 (681)
++..++||||+++++|.+++... .....+++..++.++.|++.+|.|||+.. +++|+||+|+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999887432 23445888999999999999999999632 4999999999999999999999999
Q ss_pred CCceeecCC
Q 005718 661 GMARMFCGD 669 (681)
Q Consensus 661 Gla~~~~~~ 669 (681)
|+++.....
T Consensus 159 g~~~~~~~~ 167 (269)
T cd08528 159 GLAKQKQPE 167 (269)
T ss_pred cceeecccc
Confidence 999876544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.8e-21 Score=217.38 Aligned_cols=169 Identities=24% Similarity=0.276 Sum_probs=143.4
Q ss_pred HHHHHHhhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe
Q 005718 506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 581 (681)
Q Consensus 506 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 581 (681)
..++....++|.+.++||+|+||.|..++.+. ++.+|+|++.+. ...+..-|..|-++|..-+.+=|++++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 34556667899999999999999999999865 778899999873 23455678889899888888889999999999
Q ss_pred CCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecC
Q 005718 582 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661 (681)
Q Consensus 582 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG 661 (681)
..++|+|||||+||+|..++.... .+++.-+..++..|.-||.-||+.| .|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999994332 5888888889999999999999887 9999999999999999999999999
Q ss_pred CceeecCCCccCCCcceecC
Q 005718 662 MARMFCGDELQGNTKRVVGT 681 (681)
Q Consensus 662 la~~~~~~~~~~~~~~~~GT 681 (681)
-+-.+..+++-. ...-|||
T Consensus 221 sClkm~~dG~V~-s~~aVGT 239 (1317)
T KOG0612|consen 221 SCLKMDADGTVR-SSVAVGT 239 (1317)
T ss_pred hHHhcCCCCcEE-eccccCC
Confidence 987776665543 2223676
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-19 Score=182.17 Aligned_cols=150 Identities=34% Similarity=0.554 Sum_probs=134.7
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecC
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 593 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 593 (681)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++|+||+++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677899999999999999985 588999999987554567889999999999999999999999999999999999999
Q ss_pred CCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
+++|.+++... ...+++..+..++.|++++|+|||..+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99999988442 246899999999999999999999977 999999999999999999999999999887544
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.6e-20 Score=188.43 Aligned_cols=153 Identities=29% Similarity=0.445 Sum_probs=132.6
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCC-----
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG----- 583 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~----- 583 (681)
.++++|++.+.||+|++|.||+|... .++.+++|.+.... ...+++.+|+.+++++ +|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35688999999999999999999985 47889999887643 3457799999999999 7999999999997644
Q ss_pred -eEEEEEEecCCCChhhHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecC
Q 005718 584 -EKILIYEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661 (681)
Q Consensus 584 -~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG 661 (681)
..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999998885422 2346889999999999999999999887 9999999999999999999999999
Q ss_pred Cceeec
Q 005718 662 MARMFC 667 (681)
Q Consensus 662 la~~~~ 667 (681)
+++...
T Consensus 159 ~~~~~~ 164 (275)
T cd06608 159 VSAQLD 164 (275)
T ss_pred cceecc
Confidence 997653
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=188.82 Aligned_cols=151 Identities=30% Similarity=0.417 Sum_probs=129.6
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC--CeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~ 589 (681)
++|...+.||.|++|.||++... .++.+|+|.+.... .....++.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35778899999999999999985 47889999887542 23457799999999999999999999998654 4689999
Q ss_pred EecCCCChhhHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 590 EYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||+++++|.+++... .....++......++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999998886432 23445788999999999999999999987 9999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=202.64 Aligned_cols=150 Identities=22% Similarity=0.313 Sum_probs=120.3
Q ss_pred HHHhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCC------CCeeEEEEEEEe
Q 005718 509 VSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH------RNLVRLMGCCVE 581 (681)
Q Consensus 509 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H------~nIv~l~g~~~~ 581 (681)
+....++|++.++||+|+||+||++... .++.||||+++.. ....+++..|+.++..++| .+++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3445688999999999999999999875 4788999999753 2234456667777776654 458899998876
Q ss_pred C-CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecccCCCcEEEcCCC------
Q 005718 582 Q-GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDM------ 653 (681)
Q Consensus 582 ~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NiLl~~~~------ 653 (681)
. .+.++|||++ +++|.+++.+ ...+++..+..|+.||+.||+|||+. + ||||||||+||||+.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 4 5789999988 6677777743 24588999999999999999999974 5 99999999999998765
Q ss_pred ----------CeEEeecCCceee
Q 005718 654 ----------NPKISDFGMARMF 666 (681)
Q Consensus 654 ----------~~kl~DFGla~~~ 666 (681)
.+||+|||++...
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~ 298 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDE 298 (467)
T ss_pred cccccCCCCceEEECCCCccccC
Confidence 4999999988643
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.6e-20 Score=191.26 Aligned_cols=152 Identities=29% Similarity=0.488 Sum_probs=129.4
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC----
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG---- 583 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~---- 583 (681)
...++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999985 47899999987532 223456788999999999999999999987654
Q ss_pred ------eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEE
Q 005718 584 ------EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 657 (681)
Q Consensus 584 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl 657 (681)
..++|+||+++ ++...+.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 66666633 2335889999999999999999999987 999999999999999999999
Q ss_pred eecCCceeecC
Q 005718 658 SDFGMARMFCG 668 (681)
Q Consensus 658 ~DFGla~~~~~ 668 (681)
+|||+++.+..
T Consensus 158 ~dfg~~~~~~~ 168 (302)
T cd07864 158 ADFGLARLYNS 168 (302)
T ss_pred CcccccccccC
Confidence 99999987644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=184.44 Aligned_cols=150 Identities=27% Similarity=0.418 Sum_probs=130.5
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+|+..+.||+|+||.||++... .++.+|||.+... .....+.+.+|+.++++++|+||+++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999874 5788999998653 233456899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC-CCeEEeecCCceeecC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCG 668 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFGla~~~~~ 668 (681)
+++++|.+++... ....+++..+..++.+++++|+|||+++ ++|+||||+||+++++ ..+||+|||+++.+..
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999998543 2345789999999999999999999987 9999999999999865 4689999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-19 Score=182.99 Aligned_cols=150 Identities=33% Similarity=0.479 Sum_probs=133.9
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc--ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC--CeEEEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKILIY 589 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~ 589 (681)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++|+||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999986 588999999876432 4567899999999999999999999999988 8999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+++++|.+++... ..+++.++..++.|++++|+|||+.+ ++|+||+|+||+++.++.+||+|||.++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998432 26899999999999999999999977 999999999999999999999999999887554
Q ss_pred C
Q 005718 670 E 670 (681)
Q Consensus 670 ~ 670 (681)
.
T Consensus 155 ~ 155 (260)
T cd06606 155 E 155 (260)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=189.15 Aligned_cols=152 Identities=30% Similarity=0.451 Sum_probs=135.7
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
..++.|+..+.||+|++|.||++... +++.+++|++..... ..+.+.+|++++++++|+||+++++.+...+..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45677888899999999999999986 588999999976543 5678899999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||+++++|.+++.... ..+++..+..++.|++.||+|||..+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999995432 36899999999999999999999977 99999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.9e-21 Score=193.22 Aligned_cols=154 Identities=30% Similarity=0.420 Sum_probs=129.0
Q ss_pred CCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCC-------cccHHHHHHHHHHHhhCCCCCeeEEEEEEE-eCCe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS-------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCV-EQGE 584 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~-~~~~ 584 (681)
++|-+..+||+|+|+.||++.+ ...+.||||+-.... ....+...+|.++.+.|.||-||++++++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 4566778899999999999975 457789999654321 112345678999999999999999999987 5567
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC---CCCeEEeecC
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFG 661 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~DFG 661 (681)
.+-|+|||++.+|+.+|. ..+.++++++..|++||..||.||.+. +++|||-||||.||||.. -|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 899999999999999993 456789999999999999999999997 578999999999999954 4689999999
Q ss_pred CceeecCCCc
Q 005718 662 MARMFCGDEL 671 (681)
Q Consensus 662 la~~~~~~~~ 671 (681)
|++++.++.-
T Consensus 619 LSKIMdddSy 628 (775)
T KOG1151|consen 619 LSKIMDDDSY 628 (775)
T ss_pred hhhhccCCcc
Confidence 9999976543
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=188.33 Aligned_cols=142 Identities=30% Similarity=0.415 Sum_probs=124.3
Q ss_pred ecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCCh
Q 005718 522 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL 597 (681)
Q Consensus 522 LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 597 (681)
||+|+||+||++... +++.+|+|.+.... ....+.+..|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999864 58899999886432 22345678899999999999999999999999999999999999999
Q ss_pred hhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 598 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
.+++..... ..+++.++..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~ 146 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELK 146 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence 998854322 35789999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.6e-20 Score=189.23 Aligned_cols=145 Identities=37% Similarity=0.560 Sum_probs=124.7
Q ss_pred eeecccCcEeEEEEEecC-------CcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 520 CKLGEGGFGPVYKGKLLN-------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~-------~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+.||+|+||.||+|...+ ++.++||.+.... .....++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998643 2579999886543 23467889999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC-----CeEEeecCC
Q 005718 592 MPNKSLNFFLFDPS----RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-----NPKISDFGM 662 (681)
Q Consensus 592 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~-----~~kl~DFGl 662 (681)
+++++|.+++.+.. ....+++.+++.++.|+++||+|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999985422 2234788999999999999999999877 99999999999999877 899999999
Q ss_pred ceeec
Q 005718 663 ARMFC 667 (681)
Q Consensus 663 a~~~~ 667 (681)
++.+.
T Consensus 158 ~~~~~ 162 (269)
T cd05044 158 ARDIY 162 (269)
T ss_pred ccccc
Confidence 98653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.3e-20 Score=201.87 Aligned_cols=153 Identities=25% Similarity=0.423 Sum_probs=120.2
Q ss_pred hhCCCCceeeecccCcEeEEEEEe-----------------cCCcEEEEEEecCCCcccHHH--------------HHHH
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKL-----------------LNGQEVAVKRLSSQSGQGLKE--------------FKNE 560 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~-----------------~~~~~VAVK~l~~~~~~~~~~--------------f~~E 560 (681)
..++|++.++||+|+||.||+|.. ..++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999964 234679999987543222223 3457
Q ss_pred HHHHhhCCCCCe-----eEEEEEEEe--------CCeEEEEEEecCCCChhhHhcCCC---------------------C
Q 005718 561 MMLIAKLQHRNL-----VRLMGCCVE--------QGEKILIYEYMPNKSLNFFLFDPS---------------------R 606 (681)
Q Consensus 561 i~~l~~l~H~nI-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~ 606 (681)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++|.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778866654 677887754 356899999999999999885321 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 607 THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 607 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
...+++..+..++.|++++|.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~ 360 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMC 360 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccc
Confidence 123467788899999999999999887 9999999999999999999999999997654
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=187.50 Aligned_cols=148 Identities=32% Similarity=0.532 Sum_probs=129.4
Q ss_pred CCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC--CeEEEEEE
Q 005718 516 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKILIYE 590 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E 590 (681)
|++.++||+|++|.||+|...+ ++.+|+|++.... ......+.+|+.++++++|+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5677899999999999998864 7899999998652 33446788999999999999999999999988 89999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
|+++ +|.+++... ...+++..+..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 888887432 246889999999999999999999987 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.5e-20 Score=188.27 Aligned_cols=140 Identities=29% Similarity=0.422 Sum_probs=125.3
Q ss_pred ecccCcEeEEEEEecC-CcEEEEEEecCCCc---ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCCh
Q 005718 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL 597 (681)
Q Consensus 522 LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 597 (681)
||+|+||.||++.... ++.+++|.+..... ...+.+.+|+.++.+++|+||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999865 88999999875432 3456789999999999999999999999999999999999999999
Q ss_pred hhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 598 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
.+++... ..+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||+++...
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~ 144 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGL 144 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcc
Confidence 9998432 35889999999999999999999887 9999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.8e-20 Score=188.03 Aligned_cols=148 Identities=30% Similarity=0.396 Sum_probs=131.4
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
+|+..+.||+|++|.||++... +++.+++|.+.... ....+++.+|+.++++++||||+++++.+......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777889999999999999986 47899999987643 344567899999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
++++|.+++.... ..++......++.|++++|+|||+ .+ ++|+||||+||++++++.+||+|||+++.+.
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 9999999985422 567889999999999999999998 66 9999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-20 Score=211.34 Aligned_cols=151 Identities=34% Similarity=0.474 Sum_probs=122.6
Q ss_pred HHhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC-----
Q 005718 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ----- 582 (681)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~----- 582 (681)
..-..+|...+.||+|+||.|||++.+ ||+.+|||+|... +......+.+|+.+|++|+|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 345578888899999999999999975 7999999999864 333456788999999999999999887422110
Q ss_pred --------------------------------------------------------------------------------
Q 005718 583 -------------------------------------------------------------------------------- 582 (681)
Q Consensus 583 -------------------------------------------------------------------------------- 582 (681)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 005718 583 ----------------------------------GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628 (681)
Q Consensus 583 ----------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y 628 (681)
..+||-||||+...|.+++.+..... .....++++++|+.||+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence 12467788888888887774322211 346677899999999999
Q ss_pred HHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 629 LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
+|+.+ ||||||||.||+||++..+||+|||+|+.
T Consensus 713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred HHhCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence 99998 99999999999999999999999999987
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=176.44 Aligned_cols=142 Identities=19% Similarity=0.215 Sum_probs=111.8
Q ss_pred eeeecccCcEeEEEEEecCCcEEEEEEecCCCcc--c------------------------HHHHHHHHHHHhhCCCCCe
Q 005718 519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ--G------------------------LKEFKNEMMLIAKLQHRNL 572 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~--~------------------------~~~f~~Ei~~l~~l~H~nI 572 (681)
...||+|+||.||+|...+|+.||||+++..... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998764211 0 1224678899999999987
Q ss_pred eEEEEEEEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecccCCCcEEEcC
Q 005718 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDS 651 (681)
Q Consensus 573 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NiLl~~ 651 (681)
.....+... ..+|||||++++++..... ....++..+...++.|++.+|.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544443332 2489999999886543321 12346778889999999999999999 76 99999999999998
Q ss_pred CCCeEEeecCCceeecCC
Q 005718 652 DMNPKISDFGMARMFCGD 669 (681)
Q Consensus 652 ~~~~kl~DFGla~~~~~~ 669 (681)
++.++|+|||+|+.+..+
T Consensus 153 ~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 153 DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred CCCEEEEEcccceecCCC
Confidence 889999999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-19 Score=186.88 Aligned_cols=141 Identities=28% Similarity=0.359 Sum_probs=117.7
Q ss_pred eecccCcEeEEEEEec-CCcEEEEEEecCCCc---ccHHHHHHHHHHHh---hCCCCCeeEEEEEEEeCCeEEEEEEecC
Q 005718 521 KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG---QGLKEFKNEMMLIA---KLQHRNLVRLMGCCVEQGEKILIYEYMP 593 (681)
Q Consensus 521 ~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~---~~~~~f~~Ei~~l~---~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 593 (681)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..++. ..+|+||+.+.+.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 478999998865321 12233445544433 3479999999999999999999999999
Q ss_pred CCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+++|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 9999988843 345899999999999999999999987 9999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-19 Score=184.70 Aligned_cols=141 Identities=29% Similarity=0.367 Sum_probs=125.6
Q ss_pred ecccCcEeEEEEEecC-CcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCCh
Q 005718 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL 597 (681)
Q Consensus 522 LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 597 (681)
||+|++|.||++.... ++.+++|.+.... ....+.+.+|+.++++++|+||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999854 7899999987532 23446799999999999999999999999999999999999999999
Q ss_pred hhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 598 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
.+++.. ...+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 999843 334788999999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=184.98 Aligned_cols=156 Identities=24% Similarity=0.418 Sum_probs=130.6
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe--CCeEEEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEKILIY 589 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~ 589 (681)
+|++.+.||+|+||.||++... +++.+|+|.+... .....+++..|+.++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999874 5788999988643 23345678899999999999999999998764 45679999
Q ss_pred EecCCCChhhHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 590 EYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
||+++++|.+++... .....+++..+..++.||++||+|||..+ ..+++|+||||+||+++.++.+||+|||+++.+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998542 22456889999999999999999999332 334999999999999999999999999999987
Q ss_pred cCCC
Q 005718 667 CGDE 670 (681)
Q Consensus 667 ~~~~ 670 (681)
....
T Consensus 161 ~~~~ 164 (265)
T cd08217 161 GHDS 164 (265)
T ss_pred cCCc
Confidence 5433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=193.14 Aligned_cols=150 Identities=26% Similarity=0.397 Sum_probs=128.3
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC----
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG---- 583 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~---- 583 (681)
...++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 35678999999999999999999864 58899999986432 223456889999999999999999999987653
Q ss_pred --eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecC
Q 005718 584 --EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661 (681)
Q Consensus 584 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG 661 (681)
..++||||+ +++|.+++. ...+++..+..++.||++||+|||..+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999999 678888773 235789999999999999999999887 9999999999999999999999999
Q ss_pred CceeecC
Q 005718 662 MARMFCG 668 (681)
Q Consensus 662 la~~~~~ 668 (681)
+++....
T Consensus 164 ~~~~~~~ 170 (343)
T cd07880 164 LARQTDS 170 (343)
T ss_pred ccccccc
Confidence 9987643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.3e-20 Score=189.22 Aligned_cols=149 Identities=32% Similarity=0.462 Sum_probs=132.7
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCC-CCCeeEEEEEEEeCCeEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV 588 (681)
++|.+.+.||+|+||.||++... +++.+++|++... .....+.+..|+.++.+++ |+||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999985 5889999998752 2233467889999999998 99999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||+++++|.+++.. ...+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+..
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999843 336899999999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=193.87 Aligned_cols=149 Identities=31% Similarity=0.519 Sum_probs=127.3
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeC--CeE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ--GEK 585 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~--~~~ 585 (681)
..++|++.+.||+|+||.||+|... .++.+|||++... .......+..|+.++.++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888899999999999999975 4789999988642 223445678899999999 999999999998654 468
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++||||++ ++|..++.. ..+.+..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 588888732 26788999999999999999999987 99999999999999999999999999987
Q ss_pred ecC
Q 005718 666 FCG 668 (681)
Q Consensus 666 ~~~ 668 (681)
+..
T Consensus 157 ~~~ 159 (337)
T cd07852 157 LSE 159 (337)
T ss_pred ccc
Confidence 644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-19 Score=186.73 Aligned_cols=147 Identities=27% Similarity=0.407 Sum_probs=129.8
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecC
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 593 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 593 (681)
.|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3444579999999999999874 578999998875444455678999999999999999999999999999999999999
Q ss_pred CCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||+|+||+++.++.+||+|||+++....
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence 9999999843 34788999999999999999999987 99999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=188.80 Aligned_cols=142 Identities=27% Similarity=0.410 Sum_probs=127.1
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCChh
Q 005718 520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 598 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 598 (681)
.+||+|+||.||++... +++.||||++........+.+.+|+.++++++|+||+++++.+..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 58999999999999874 58899999986544445677999999999999999999999999999999999999999999
Q ss_pred hHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 599 FFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 599 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+++.. ..+++.....++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||+++.+..
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 88732 24788999999999999999999987 99999999999999999999999999887644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.4e-19 Score=186.10 Aligned_cols=149 Identities=28% Similarity=0.458 Sum_probs=125.9
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
++|++.+.||+|.+|.||+|... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.++...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999975 58899999886532 2234678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC-CCCeEEeecCCceeec
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFC 667 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~~~~ 667 (681)
|++ ++|.+++... ....+++.....++.||+.||+|||+.+ ++|+||+|+||++++ ++.+||+|||+++.+.
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 4777766332 2233577888899999999999999887 999999999999985 5579999999998653
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-19 Score=185.58 Aligned_cols=141 Identities=28% Similarity=0.357 Sum_probs=118.0
Q ss_pred eecccCcEeEEEEEec-CCcEEEEEEecCCCc---ccHHHHHHHHH---HHhhCCCCCeeEEEEEEEeCCeEEEEEEecC
Q 005718 521 KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG---QGLKEFKNEMM---LIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 593 (681)
Q Consensus 521 ~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~---~~~~~f~~Ei~---~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 593 (681)
.||+|+||.||++... .++.||+|.+.+... .....+..|.. .+....||||+++.+++.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999874 478999998875321 12223444444 3444579999999999999999999999999
Q ss_pred CCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+++|.+++. ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 999998884 2346899999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-19 Score=189.28 Aligned_cols=150 Identities=31% Similarity=0.455 Sum_probs=127.9
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc--ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC--CeEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKIL 587 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l 587 (681)
.++|++.+.||+|+||.||+|... .++.||+|.++.... .....+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467899999999999999999985 488999999874322 2234567899999999999999999998765 56899
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||||+++ +|.+++... ...+++.++..++.||++||+|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 787777432 245889999999999999999999987 9999999999999999999999999998775
Q ss_pred C
Q 005718 668 G 668 (681)
Q Consensus 668 ~ 668 (681)
.
T Consensus 160 ~ 160 (309)
T cd07845 160 L 160 (309)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-19 Score=188.62 Aligned_cols=150 Identities=29% Similarity=0.498 Sum_probs=126.4
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC------
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------ 583 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 583 (681)
.++|++.++||+|+||.||++... +++.||||.+.... ......+.+|+.++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457999999999999999999875 58899999886432 222345678999999999999999999987654
Q ss_pred --eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecC
Q 005718 584 --EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661 (681)
Q Consensus 584 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG 661 (681)
..++||||+.+ +|.+.+.. ....+++.+...++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 45999999975 77777633 2235789999999999999999999987 9999999999999999999999999
Q ss_pred CceeecC
Q 005718 662 MARMFCG 668 (681)
Q Consensus 662 la~~~~~ 668 (681)
+++.+..
T Consensus 165 ~~~~~~~ 171 (310)
T cd07865 165 LARAFSL 171 (310)
T ss_pred CcccccC
Confidence 9987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=192.43 Aligned_cols=148 Identities=26% Similarity=0.440 Sum_probs=126.8
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC-----eE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-----EK 585 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~ 585 (681)
+++|++.+.||+|+||.||+|... +++.||+|.+.... ......+..|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999874 58899999987532 234567888999999999999999999876543 57
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++|+||+++ +|..++. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999974 7777662 335889999999999999999999987 99999999999999999999999999987
Q ss_pred ecC
Q 005718 666 FCG 668 (681)
Q Consensus 666 ~~~ 668 (681)
...
T Consensus 156 ~~~ 158 (336)
T cd07849 156 ADP 158 (336)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.3e-20 Score=194.59 Aligned_cols=158 Identities=25% Similarity=0.351 Sum_probs=134.0
Q ss_pred CCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCc--------ccHHHHHHHHHHHhhCC---CCCeeEEEEEEEe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG--------QGLKEFKNEMMLIAKLQ---HRNLVRLMGCCVE 581 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~--------~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~ 581 (681)
.+|...+.+|+|+||.|+.+.++. ...|.||.|.+... ...-..-.|+.+|..++ |+||++++.+|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 458888999999999999999865 56899999986421 12224567999999997 9999999999999
Q ss_pred CCeEEEEEEecC-CCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeec
Q 005718 582 QGEKILIYEYMP-NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 660 (681)
Q Consensus 582 ~~~~~lV~Ey~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF 660 (681)
++..||+||-.. +.+|.++| .....+++.++..|+.||+-|+++||+++ |||||||-+|+.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 999999999874 56888888 34556899999999999999999999998 999999999999999999999999
Q ss_pred CCceeecCCCccCCCcceecC
Q 005718 661 GMARMFCGDELQGNTKRVVGT 681 (681)
Q Consensus 661 Gla~~~~~~~~~~~~~~~~GT 681 (681)
|-|-.....+.. .+|||
T Consensus 715 gsaa~~ksgpfd----~f~gt 731 (772)
T KOG1152|consen 715 GSAAYTKSGPFD----VFVGT 731 (772)
T ss_pred cchhhhcCCCcc----eeeee
Confidence 999887766654 35565
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-19 Score=185.00 Aligned_cols=146 Identities=26% Similarity=0.394 Sum_probs=123.5
Q ss_pred CCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCC-CCCeeEEEEEEEeC--CeEEEEEE
Q 005718 516 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQ--GEKILIYE 590 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~E 590 (681)
|++.++||+|+||.||++... +++.+|+|+++... .........|+.++.++. |+||+++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567789999999999999875 57899999987542 222334567888898885 99999999999988 88999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|++ ++|.+.+.. ....+++.++..++.|+++||+|||+.+ ++||||||+||+++. +.+||+|||+++.+..
T Consensus 81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 997 577777743 2346899999999999999999999987 999999999999999 9999999999987643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=193.14 Aligned_cols=149 Identities=24% Similarity=0.415 Sum_probs=128.2
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEe----CCeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEK 585 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~ 585 (681)
..+|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++.+++||||+++.+++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888999999999999999875 58899999987542 2345678889999999999999999988763 3578
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++|+||+. ++|.+++. ....+++.....++.||++||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 68888873 2345899999999999999999999987 99999999999999999999999999987
Q ss_pred ecC
Q 005718 666 FCG 668 (681)
Q Consensus 666 ~~~ 668 (681)
+..
T Consensus 157 ~~~ 159 (334)
T cd07855 157 LSS 159 (334)
T ss_pred ecc
Confidence 644
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=187.43 Aligned_cols=148 Identities=28% Similarity=0.382 Sum_probs=128.3
Q ss_pred CCCceeeecccCcEeEEEEEec----CCcEEEEEEecCCC----cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 585 (681)
+|++.+.||+|++|.||++... +++.+|||.+++.. ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3778899999999999999752 46789999987431 22345688999999999 699999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++||||+++++|.+++.. ...+++.....++.|++++|.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999998843 345788899999999999999999877 99999999999999999999999999987
Q ss_pred ecC
Q 005718 666 FCG 668 (681)
Q Consensus 666 ~~~ 668 (681)
+..
T Consensus 155 ~~~ 157 (288)
T cd05583 155 FLA 157 (288)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.8e-19 Score=185.56 Aligned_cols=147 Identities=29% Similarity=0.491 Sum_probs=128.0
Q ss_pred CCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 516 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
|++.+.||+|++|.||+|... +++.|++|++.... ....+.+.+|+.++++++|+|++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999875 68899999987542 223467889999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+ ++|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||+++.+.
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 5 68888874322 235899999999999999999999887 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.1e-20 Score=180.93 Aligned_cols=140 Identities=28% Similarity=0.385 Sum_probs=126.1
Q ss_pred eeecccCcEeEEEEEe-cCCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEEEecCCCCh
Q 005718 520 CKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSL 597 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 597 (681)
+.||+|+++.|--+.. ..+.++|||++.+.......+..+|++++..- .|+||++|+.+|.+++..|||||-|.+|+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 6899999999998874 67899999999988777788999999999888 699999999999999999999999999999
Q ss_pred hhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC---CeEEeecCCcee
Q 005718 598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARM 665 (681)
Q Consensus 598 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~---~~kl~DFGla~~ 665 (681)
..+|.+ .+-+++.++.++..+|+.||.+||..+ |.||||||+|||-.+.. -+||+||.|+.-
T Consensus 164 LshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 164 LSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred HHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccc
Confidence 999943 345889999999999999999999988 99999999999997655 489999998754
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.81 E-value=6e-19 Score=186.59 Aligned_cols=148 Identities=30% Similarity=0.486 Sum_probs=127.4
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
+.|...+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++|+|++++++++.+++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 44777889999999999999874 57899999986432 223457889999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||+. |+|.+++.. ....+++.++..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||+++...
T Consensus 105 e~~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 105 EYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred eCCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 9997 477666632 2345889999999999999999999987 9999999999999999999999999988654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-19 Score=182.91 Aligned_cols=150 Identities=28% Similarity=0.475 Sum_probs=130.4
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+|++.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|+.+++.++|+||+++++.+.++...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999985 4788999998653 123456788999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC-CeEEeecCCceeecC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMFCG 668 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~~~~ 668 (681)
+++++|.+++... ....+++..+..++.|+++||.|||+.+ ++|+||||+||++++++ .+||+|||++..+..
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999988542 2335789999999999999999999987 99999999999999886 469999999987644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.7e-19 Score=179.81 Aligned_cols=152 Identities=24% Similarity=0.425 Sum_probs=134.3
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc--ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+|++.+.||+|+||.||++... +++.+++|++..... ...+++.+|+++++.++|+|++++.+.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999985 488999999876432 4567889999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 592 MPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 592 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
+++++|.+++.... ....+++.++..++.++++||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999885432 2356899999999999999999999987 999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.5e-19 Score=191.28 Aligned_cols=148 Identities=30% Similarity=0.398 Sum_probs=126.2
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC------
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------ 582 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------ 582 (681)
..++|+..+.||+|+||.||++... +++.||+|.+... .....+++.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3578999999999999999999875 5889999998643 223446778899999999999999999988644
Q ss_pred CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCC
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl 662 (681)
...++||||+. ++|.+.+.. .++......++.|+++||+|||..+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35799999996 477777632 1788889999999999999999987 99999999999999999999999999
Q ss_pred ceeecC
Q 005718 663 ARMFCG 668 (681)
Q Consensus 663 a~~~~~ 668 (681)
++....
T Consensus 165 ~~~~~~ 170 (353)
T cd07850 165 ARTAGT 170 (353)
T ss_pred ceeCCC
Confidence 987644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-19 Score=191.15 Aligned_cols=149 Identities=26% Similarity=0.455 Sum_probs=127.7
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC-----Ce
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----GE 584 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~ 584 (681)
.++|.+.+.||+|+||.||++... +++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457899999999999999999874 5889999998753 233456778899999999999999999988654 35
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
.++|+||+. ++|.+++.. ...+++.....++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 678877733 345889999999999999999999887 9999999999999999999999999998
Q ss_pred eecC
Q 005718 665 MFCG 668 (681)
Q Consensus 665 ~~~~ 668 (681)
....
T Consensus 157 ~~~~ 160 (337)
T cd07858 157 TTSE 160 (337)
T ss_pred ccCC
Confidence 7643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.8e-19 Score=182.15 Aligned_cols=142 Identities=25% Similarity=0.335 Sum_probs=119.9
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEecCCCc---ccHHHHHHHHHHH-hhCCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG---QGLKEFKNEMMLI-AKLQHRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~---~~~~~f~~Ei~~l-~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
+.||+|+||.||+|... .++.||||.+..... .....+..|..++ ...+|+|++++++++.+++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999875 478999999875321 2223445555544 455899999999999999999999999999
Q ss_pred CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
++|.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++...
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 999999843 235788999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.7e-19 Score=189.74 Aligned_cols=154 Identities=30% Similarity=0.396 Sum_probs=130.2
Q ss_pred HHHHHHhhCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC
Q 005718 506 LASVSAATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ 582 (681)
Q Consensus 506 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~ 582 (681)
..++...+++|.+.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++.+++|+||+++.+++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 455666789999999999999999999986 458899999997532 22346788899999999999999999988643
Q ss_pred ------CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeE
Q 005718 583 ------GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK 656 (681)
Q Consensus 583 ------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~k 656 (681)
...++++|++ +++|.+++. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3467888876 778887773 234789999999999999999999987 99999999999999999999
Q ss_pred EeecCCceeec
Q 005718 657 ISDFGMARMFC 667 (681)
Q Consensus 657 l~DFGla~~~~ 667 (681)
|+|||+++...
T Consensus 161 l~dfg~~~~~~ 171 (345)
T cd07877 161 ILDFGLARHTD 171 (345)
T ss_pred Eeccccccccc
Confidence 99999998653
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-20 Score=215.02 Aligned_cols=154 Identities=32% Similarity=0.444 Sum_probs=133.2
Q ss_pred HHhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEE
Q 005718 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 586 (681)
...+-+|+....||.|.||+||-+... .|+..|||-++... ....+...+|+.++..++|||+|+.+|+-.+++..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 345567777889999999999999864 58889999887542 334567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|.||||++|+|.+.+ ..+...++.....+-.|++.|++|||+++ ||||||||.||+|+.+|.+|++|||-|+.+
T Consensus 1311 IFMEyC~~GsLa~ll---~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLL---EHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHhccCcHHHHH---HhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence 999999999999998 33444556666677889999999999998 999999999999999999999999999988
Q ss_pred cCC
Q 005718 667 CGD 669 (681)
Q Consensus 667 ~~~ 669 (681)
.++
T Consensus 1385 ~~~ 1387 (1509)
T KOG4645|consen 1385 KNN 1387 (1509)
T ss_pred cCc
Confidence 654
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.6e-19 Score=188.09 Aligned_cols=147 Identities=29% Similarity=0.413 Sum_probs=123.5
Q ss_pred CCCceeeecccCcEeEEEEEec-C--CcEEEEEEecCCC--cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeC----Ce
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-N--GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ----GE 584 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~--~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~----~~ 584 (681)
+|++.+.||+|+||.||++... . +..+|+|++.... ....+.+.+|+.++.++ +|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999974 3 6789999987532 22356788999999999 599999999976543 45
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
.++++||+. ++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+|+
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788899886 68888873 3345889999999999999999999987 9999999999999999999999999998
Q ss_pred eecC
Q 005718 665 MFCG 668 (681)
Q Consensus 665 ~~~~ 668 (681)
.+..
T Consensus 154 ~~~~ 157 (332)
T cd07857 154 GFSE 157 (332)
T ss_pred eccc
Confidence 7643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.9e-20 Score=193.13 Aligned_cols=151 Identities=24% Similarity=0.373 Sum_probs=130.8
Q ss_pred HHhhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeE
Q 005718 510 SAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 585 (681)
......|..++.||-|+||.|.++.-.+ ...+|+|.+++.+ .......++|-++|.....+=||+|+-.|.+++.+
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 3445678888999999999999997544 5678999998753 23445678899999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
|+||||+++|++..+|. +-..+.+..+..++.+++.|+++.|..+ +|||||||+|||||.+|++||+||||+.-
T Consensus 705 YFVMdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred EEEEeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccc
Confidence 99999999999999983 4456788888888899999999999887 99999999999999999999999999763
Q ss_pred e
Q 005718 666 F 666 (681)
Q Consensus 666 ~ 666 (681)
+
T Consensus 779 f 779 (1034)
T KOG0608|consen 779 F 779 (1034)
T ss_pred c
Confidence 3
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=7e-20 Score=184.91 Aligned_cols=159 Identities=27% Similarity=0.441 Sum_probs=137.8
Q ss_pred cHHHHHHhhCCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEE
Q 005718 505 SLASVSAATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMG 577 (681)
Q Consensus 505 ~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g 577 (681)
..+++.....+++...++.+|.||.||+|.+. +.+.|.||.++.. +......++.|..++..+.|||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 44566666777888889999999999999654 3456888888765 3445678999999999999999999999
Q ss_pred EEEeC-CeEEEEEEecCCCChhhHhc-----CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC
Q 005718 578 CCVEQ-GEKILIYEYMPNKSLNFFLF-----DPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 651 (681)
Q Consensus 578 ~~~~~-~~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~ 651 (681)
++.+. +..+++|.++.-|+|+.+|. +....+.++..+...++.|++.|++|||.++ +||.||.++|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 99865 57899999999999999997 5566677888999999999999999999887 999999999999999
Q ss_pred CCCeEEeecCCceee
Q 005718 652 DMNPKISDFGMARMF 666 (681)
Q Consensus 652 ~~~~kl~DFGla~~~ 666 (681)
...+||+|=.|+|-+
T Consensus 432 ~LqVkltDsaLSRDL 446 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDL 446 (563)
T ss_pred heeEEeccchhcccc
Confidence 999999999999864
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.8e-19 Score=189.52 Aligned_cols=147 Identities=29% Similarity=0.396 Sum_probs=126.0
Q ss_pred CCCC-ceeeecccCcEeEEEEEec-CCcEEEEEEecCCCccc--------------HHHHHHHHHHHhhCCCCCeeEEEE
Q 005718 514 ENFS-MQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQG--------------LKEFKNEMMLIAKLQHRNLVRLMG 577 (681)
Q Consensus 514 ~~f~-~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~--------------~~~f~~Ei~~l~~l~H~nIv~l~g 577 (681)
++|. +.+.||+|+||.||++... .++.||||.++...... ...+.+|++++.+++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 3467999999999999975 58899999886532211 125788999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEE
Q 005718 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 657 (681)
Q Consensus 578 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl 657 (681)
++...+..++||||++ ++|.+++. ....+++.....++.|+++||+|||+.+ ++|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 68888873 2345788999999999999999999887 999999999999999999999
Q ss_pred eecCCceeec
Q 005718 658 SDFGMARMFC 667 (681)
Q Consensus 658 ~DFGla~~~~ 667 (681)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (335)
T PTZ00024 161 ADFGLARRYG 170 (335)
T ss_pred CCccceeecc
Confidence 9999998765
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-18 Score=179.13 Aligned_cols=148 Identities=24% Similarity=0.305 Sum_probs=120.9
Q ss_pred HHhhCCCCceeee--cccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeE
Q 005718 510 SAATENFSMQCKL--GEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 510 ~~~~~~f~~~~~L--G~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 585 (681)
....++|.+.+.+ |+|+||.||++... +++.+|+|.+........ |+.....+ +|+||+++++.+...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3344567776666 99999999999875 477899998865321111 22222222 799999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC-CeEEeecCCce
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMAR 664 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~ 664 (681)
++||||+++++|.+++.. ...+++.++..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||+++
T Consensus 85 ~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 999999999999999843 236899999999999999999999987 99999999999999998 99999999998
Q ss_pred eecC
Q 005718 665 MFCG 668 (681)
Q Consensus 665 ~~~~ 668 (681)
....
T Consensus 159 ~~~~ 162 (267)
T PHA03390 159 IIGT 162 (267)
T ss_pred ecCC
Confidence 7644
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.80 E-value=7e-19 Score=187.00 Aligned_cols=149 Identities=30% Similarity=0.444 Sum_probs=127.8
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe-CCeEE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE-QGEKI 586 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~ 586 (681)
..+++|++.+.||+|+||.||++... +++.||||++.+. .....+.+..|+.++.+++||||+++.+++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 35678999999999999999999865 6889999988643 22335678899999999999999999999876 56789
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+|+||+ +++|..++. ...+++.....++.|+++||+|||+.+ |+||||+|+||++++++.+||+|||+++..
T Consensus 87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999998 568888773 234678888899999999999999987 999999999999999999999999999865
Q ss_pred c
Q 005718 667 C 667 (681)
Q Consensus 667 ~ 667 (681)
.
T Consensus 159 ~ 159 (328)
T cd07856 159 D 159 (328)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-19 Score=184.62 Aligned_cols=148 Identities=31% Similarity=0.439 Sum_probs=127.5
Q ss_pred CCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCc-ccHHHHHHHHHHHhhCC-CCCeeEEEEEEEeCCeEEEEEEec
Q 005718 516 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
|++.+.||+|++|.||+|...+ ++.|+||++..... .......+|+..+++++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5677899999999999999864 78899999875422 22334567999999998 999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+++|.+++.... ...+++.++..++.|++++|.|||+.+ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 788888874432 346799999999999999999999987 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.6e-19 Score=189.19 Aligned_cols=148 Identities=30% Similarity=0.451 Sum_probs=129.7
Q ss_pred CCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC-----eEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-----EKI 586 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~ 586 (681)
+|++.+.||+|++|.||++.... ++.+|||++.... ....+.+.+|+.+++.++|+||+++.+++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47788999999999999999854 8899999987643 344578999999999999999999999998775 789
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+||||++ ++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.++|+|||+++..
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 478888733 336899999999999999999999987 999999999999999999999999999987
Q ss_pred cCC
Q 005718 667 CGD 669 (681)
Q Consensus 667 ~~~ 669 (681)
...
T Consensus 154 ~~~ 156 (330)
T cd07834 154 DPD 156 (330)
T ss_pred ccc
Confidence 543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.4e-19 Score=180.78 Aligned_cols=152 Identities=30% Similarity=0.462 Sum_probs=132.3
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+|++.+.||+|+||.||++... +++.+++|.+.... .....++..|+.++++++|+||+++.+++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999864 57899999987532 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 592 MPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 592 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
+++++|.+++.+.. ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999884421 2356788999999999999999999887 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.7e-19 Score=204.01 Aligned_cols=159 Identities=33% Similarity=0.497 Sum_probs=135.2
Q ss_pred HHHhhCCCCceeeecccCcEeEEEEEecC--------CcEEEEEEecCCC-cccHHHHHHHHHHHhhC-CCCCeeEEEEE
Q 005718 509 VSAATENFSMQCKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGC 578 (681)
Q Consensus 509 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~--------~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~ 578 (681)
.+...++..+.+.||+|.||+|++|.... ...||||.++... ..+.+.+..|+.+|..+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 34445556667799999999999998531 3469999998643 34567899999999999 79999999999
Q ss_pred EEeCCeEEEEEEecCCCChhhHhcCCC-------C----C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCC
Q 005718 579 CVEQGEKILIYEYMPNKSLNFFLFDPS-------R----T--HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKAS 645 (681)
Q Consensus 579 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~-------~----~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~ 645 (681)
|.+++..++|+||++.|+|.++|...+ . . ..++..+.+.++.|||+||+||++.. +|||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 999999999999999999999996544 0 0 23888999999999999999999876 999999999
Q ss_pred cEEEcCCCCeEEeecCCceeecCCC
Q 005718 646 NILLDSDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 646 NiLl~~~~~~kl~DFGla~~~~~~~ 670 (681)
||||.++..+||+||||||....++
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~ 472 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKD 472 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCC
Confidence 9999999999999999999764433
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.6e-19 Score=184.22 Aligned_cols=149 Identities=33% Similarity=0.495 Sum_probs=127.3
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
+.|+..+.||+|+||.||+|... +++.+++|.+... .....+++.+|+.+++.++|+|++++.+++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 44666789999999999999975 4788999988642 2233457889999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||+. |++.+++.. ....+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+..
T Consensus 95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9996 577776633 2334788999999999999999999887 99999999999999999999999999987644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.79 E-value=7e-19 Score=185.56 Aligned_cols=144 Identities=24% Similarity=0.236 Sum_probs=122.4
Q ss_pred eeeecccCcEeEEEEEecCCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCC
Q 005718 519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKS 596 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 596 (681)
.+.+|.|+++.||++.. +++.||||++... .....+.+..|+.++++++|+||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455556666666555 6889999998754 34456789999999999999999999999999999999999999999
Q ss_pred hhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 597 LNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 597 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
|.+++.... ...+++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+..+.
T Consensus 86 l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 86 CEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152 (314)
T ss_pred HHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence 999985432 234788889999999999999999987 9999999999999999999999999987654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.79 E-value=8e-19 Score=183.61 Aligned_cols=150 Identities=26% Similarity=0.395 Sum_probs=125.6
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC-cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
.++|++.+.||+|+||.||++.... ++.+|||.++... .....++..|+.++.+. .|+||+++++++.+....+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3668888999999999999999865 8899999997542 23345677788777777 4999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||+. ++|.+++... ...+++..+..++.||++||+|||+.. +|+||||+|+||++++++.+||+|||+++.+.
T Consensus 94 e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 94 ELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9985 4666665332 236889999999999999999999742 39999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.6e-18 Score=181.36 Aligned_cols=145 Identities=32% Similarity=0.473 Sum_probs=124.7
Q ss_pred CCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc---ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 516 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
|...+.||+|+||.||+|... .++.+++|++..... ...+.+.+|+.++++++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999874 578999999864322 2345788999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+. +++.+++.. ....+++.++..++.||+.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++...
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 96 567666632 2345889999999999999999999887 999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-18 Score=181.27 Aligned_cols=149 Identities=19% Similarity=0.302 Sum_probs=110.6
Q ss_pred hCCCCceeeecccCcEeEEEEEecCC----cEEEEEEecCCCcccH-----------HHHHHHHHHHhhCCCCCeeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNG----QEVAVKRLSSQSGQGL-----------KEFKNEMMLIAKLQHRNLVRLMG 577 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~----~~VAVK~l~~~~~~~~-----------~~f~~Ei~~l~~l~H~nIv~l~g 577 (681)
.++|.+.++||+|+||.||+|...+. ..+++|.......... .....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46799999999999999999987543 4566665432211110 11223344556778999999999
Q ss_pred EEEeCC----eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC
Q 005718 578 CCVEQG----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 653 (681)
Q Consensus 578 ~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~ 653 (681)
++.... ..++++|++.. ++.+.+.. ....++..+..++.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 776543 45777887643 55555522 223467888899999999999999887 99999999999999999
Q ss_pred CeEEeecCCceeecC
Q 005718 654 NPKISDFGMARMFCG 668 (681)
Q Consensus 654 ~~kl~DFGla~~~~~ 668 (681)
.+||+|||+|+.+..
T Consensus 164 ~~~l~DFGla~~~~~ 178 (294)
T PHA02882 164 RGYIIDYGIASHFII 178 (294)
T ss_pred cEEEEEcCCceeecc
Confidence 999999999988743
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.1e-18 Score=179.13 Aligned_cols=149 Identities=33% Similarity=0.530 Sum_probs=124.6
Q ss_pred CCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCc--ccHHHHHHHHHHHhhC---CCCCeeEEEEEEEeCCe-----
Q 005718 516 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG--QGLKEFKNEMMLIAKL---QHRNLVRLMGCCVEQGE----- 584 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~----- 584 (681)
|++.+.||+|+||.||++..+. ++.+|+|+++.... .....+.+|+.++.++ .|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678999999999999999865 88999999974322 2234566787777666 59999999999998776
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
.+++|||+.+ +|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||+++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 9999999974 7888774322 235889999999999999999999987 9999999999999999999999999998
Q ss_pred eecCC
Q 005718 665 MFCGD 669 (681)
Q Consensus 665 ~~~~~ 669 (681)
.+...
T Consensus 156 ~~~~~ 160 (287)
T cd07838 156 IYSFE 160 (287)
T ss_pred eccCC
Confidence 87443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.3e-20 Score=185.58 Aligned_cols=162 Identities=29% Similarity=0.388 Sum_probs=133.7
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC---cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 586 (681)
...+|....+||+|+||+|.++..+. .+.+|||++++.. ..+.+--+.|-++|+.. +-|.+++++.++..-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 34678888999999999999998765 5679999998752 23344556677777776 5678999999999999999
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
.||||+.+|+|..++.+ -..+.+..+..+|..||-||-+||+.+ ||.||||.+|||||.+|++||+|||+++.-
T Consensus 427 FVMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eEEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999999843 334666788889999999999999988 999999999999999999999999999965
Q ss_pred cCCCccCCCcceecC
Q 005718 667 CGDELQGNTKRVVGT 681 (681)
Q Consensus 667 ~~~~~~~~~~~~~GT 681 (681)
.-+... |+++.||
T Consensus 501 i~~~~T--TkTFCGT 513 (683)
T KOG0696|consen 501 IFDGVT--TKTFCGT 513 (683)
T ss_pred ccCCcc--eeeecCC
Confidence 444332 4556666
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.9e-19 Score=185.05 Aligned_cols=150 Identities=33% Similarity=0.513 Sum_probs=126.1
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc--ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC------
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------ 583 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 583 (681)
.++|++.++||+|+||.||++... +++.++||++..... .....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999975 478999998864322 22346788999999999999999999876543
Q ss_pred --eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecC
Q 005718 584 --EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661 (681)
Q Consensus 584 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG 661 (681)
..++|+||+.. +|...+.. ....+++.++..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999975 56666533 2345899999999999999999999987 9999999999999999999999999
Q ss_pred CceeecC
Q 005718 662 MARMFCG 668 (681)
Q Consensus 662 la~~~~~ 668 (681)
+++.+..
T Consensus 161 ~~~~~~~ 167 (311)
T cd07866 161 LARPYDG 167 (311)
T ss_pred cchhccC
Confidence 9987643
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.3e-19 Score=186.05 Aligned_cols=141 Identities=26% Similarity=0.321 Sum_probs=122.0
Q ss_pred eeeccc--CcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 520 CKLGEG--GFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 520 ~~LG~G--~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
..||+| +||+||++... .++.||||.+.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467776 89999999874 68999999987532 23346789999999999999999999999999999999999999
Q ss_pred CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+.
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~ 149 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLY 149 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHh
Confidence 99999885432 234788999999999999999999887 9999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=8e-19 Score=181.84 Aligned_cols=148 Identities=30% Similarity=0.498 Sum_probs=128.8
Q ss_pred CCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc--ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 516 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
|++.+.||+|++|.||++... +++.+++|.+..... .....+..|+.++++++|+||+++++++.++...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456789999999999999875 588899999875432 24567889999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
++ +|.+++... ...+++.++..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||.+..+...
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 75 787777432 246889999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-18 Score=185.54 Aligned_cols=146 Identities=30% Similarity=0.454 Sum_probs=124.3
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC------
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------ 583 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 583 (681)
.++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999874 58899999987532 223456889999999999999999999987543
Q ss_pred eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCc
Q 005718 584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla 663 (681)
..++|+||+.. +|..++ ...+++..+..++.|+++||+|||..+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 56999999964 676655 224788999999999999999999987 999999999999999999999999999
Q ss_pred eeec
Q 005718 664 RMFC 667 (681)
Q Consensus 664 ~~~~ 667 (681)
+...
T Consensus 165 ~~~~ 168 (342)
T cd07879 165 RHAD 168 (342)
T ss_pred cCCC
Confidence 8653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.6e-19 Score=186.39 Aligned_cols=163 Identities=26% Similarity=0.346 Sum_probs=138.3
Q ss_pred hhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecC--CCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~--~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 588 (681)
....|++.++||+||.+.||++...+.+.+|+|++.. .+.+....|.+|+.+|.+| .|.+|++|++|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 4467888999999999999999998888888887764 3556678899999999999 699999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||= ..+|..+|.+... ....| .+..+..|++.++.++|.++ |||.||||.|+|+ -.|.+||+|||+|+-+..
T Consensus 439 mE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechhcccCc
Confidence 9976 4689999854322 12234 67788999999999999988 9999999999999 467899999999999988
Q ss_pred CCccCCCcceecC
Q 005718 669 DELQGNTKRVVGT 681 (681)
Q Consensus 669 ~~~~~~~~~~~GT 681 (681)
|.+.......+||
T Consensus 512 DTTsI~kdsQvGT 524 (677)
T KOG0596|consen 512 DTTSIVKDSQVGT 524 (677)
T ss_pred cccceeeccccCc
Confidence 8877766667777
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.7e-19 Score=181.84 Aligned_cols=147 Identities=33% Similarity=0.485 Sum_probs=129.2
Q ss_pred CCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 516 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
|+..+.||+|.+|.||+|.... ++.+++|.+.... ....+.+..|+.++++++|+|++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4566889999999999999864 8899999998643 333567889999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+ ++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||+|+||++++++.+||+|||+++....
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 8 58998884422 35889999999999999999999987 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.5e-21 Score=181.69 Aligned_cols=150 Identities=30% Similarity=0.559 Sum_probs=120.8
Q ss_pred CCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCC-Cc-ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC--------
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ-SG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-------- 582 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~-~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-------- 582 (681)
..|.-..+||+|.||.||+|+..+ ++.||+|++--. .. .--....+|+++|..++|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 345555789999999999999854 778898865421 11 1234567899999999999999998887643
Q ss_pred CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCC
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl 662 (681)
...++|+++|++ +|.-+|.+ +...++..+..+++.++..||.|+|... |+|||+||+|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 357999999976 56666632 3345888999999999999999999876 99999999999999999999999999
Q ss_pred ceeecCC
Q 005718 663 ARMFCGD 669 (681)
Q Consensus 663 a~~~~~~ 669 (681)
||.+.-.
T Consensus 171 ar~fs~~ 177 (376)
T KOG0669|consen 171 ARAFSTS 177 (376)
T ss_pred ccceecc
Confidence 9877543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4e-19 Score=165.55 Aligned_cols=157 Identities=27% Similarity=0.389 Sum_probs=129.7
Q ss_pred HHHhhCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCC-CcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeE
Q 005718 509 VSAATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 509 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 585 (681)
++.+.+.......||+|++|.|-+-++ ..|..+|||++... ..+..++.+.|+.+..+- ..|.+|+++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 444556666678999999999988877 46899999999854 345667888999877665 799999999999888999
Q ss_pred EEEEEecCCCChhhHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 586 ILIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
++.||.|+ .||+.+-.+- ..+..+++...-+|+..|.+||.|||++- .+||||+||+||||+.+|++||+|||++-
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999994 5776654221 34566888888899999999999999864 69999999999999999999999999988
Q ss_pred eecC
Q 005718 665 MFCG 668 (681)
Q Consensus 665 ~~~~ 668 (681)
.+.+
T Consensus 198 ~L~d 201 (282)
T KOG0984|consen 198 YLVD 201 (282)
T ss_pred eehh
Confidence 7643
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=186.74 Aligned_cols=147 Identities=28% Similarity=0.423 Sum_probs=125.7
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC---------
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--------- 582 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--------- 582 (681)
..+|.+.+.||+|+||.||+|... .++.||+|.+........+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367889999999999999999875 4889999998765555667889999999999999999999776543
Q ss_pred -----CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC-CCCeE
Q 005718 583 -----GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPK 656 (681)
Q Consensus 583 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~-~~~~k 656 (681)
...++|+||++ ++|.+++. ...+++.....++.||++||.|||+.+ |+||||||+||+++. +..+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 58887773 234788999999999999999999887 999999999999974 55789
Q ss_pred EeecCCceeec
Q 005718 657 ISDFGMARMFC 667 (681)
Q Consensus 657 l~DFGla~~~~ 667 (681)
|+|||+++.+.
T Consensus 156 l~dfg~~~~~~ 166 (342)
T cd07854 156 IGDFGLARIVD 166 (342)
T ss_pred ECCcccceecC
Confidence 99999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=181.56 Aligned_cols=150 Identities=29% Similarity=0.394 Sum_probs=123.7
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCC-CCCeeEEEEEEEeCCeEEEEEEe
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+|...+.||+|+||.||++... .++.+|+|.+.... ......+.+|+.++.++. |+||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556689999999999999875 47899999987542 234567899999999996 99999999999999999999999
Q ss_pred cCCCChhhHhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 592 MPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 592 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+.. ++.++... ......+++.....++.|+++||+|||+.. +++||||||+||+++.++.+||+|||+|+.+.
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 864 54443211 112345889999999999999999999752 39999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-20 Score=181.94 Aligned_cols=152 Identities=27% Similarity=0.412 Sum_probs=125.5
Q ss_pred CceeeecccCcEeEEEEEe-cCCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC-----CeEEEE
Q 005718 517 SMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----GEKILI 588 (681)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~lV 588 (681)
+..+.||-|+||.||...+ ++|+.||.|++... .-...+.+.+|+++|.-++|.||+..++..... ++.|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3447899999999999987 46899999988643 223457889999999999999999988876543 256888
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
.|.| ..+|.++|.. .+.++.....-+.+||++||+|||+.+ |.||||||.|+|++++-.+||+||||||.-..
T Consensus 136 TELm-QSDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHH-Hhhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 8988 4588888844 445677777788999999999999988 99999999999999999999999999998877
Q ss_pred CCccCCC
Q 005718 669 DELQGNT 675 (681)
Q Consensus 669 ~~~~~~~ 675 (681)
++...+|
T Consensus 209 d~~~hMT 215 (449)
T KOG0664|consen 209 RDRLNMT 215 (449)
T ss_pred hhhhhhH
Confidence 7766544
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.8e-19 Score=175.06 Aligned_cols=148 Identities=25% Similarity=0.332 Sum_probs=123.6
Q ss_pred hhCCCCce-eeecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEe----CCe
Q 005718 512 ATENFSMQ-CKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE----QGE 584 (681)
Q Consensus 512 ~~~~f~~~-~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~ 584 (681)
.+++|++. ++||-|-.|+|.....+. ++.+|+|++... ...++|+++.-+. .|||||++++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45667654 579999999999998754 788999998753 4457888876665 79999999998763 356
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC---CCCeEEeecC
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFG 661 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~DFG 661 (681)
+++|||.|++|.|..-+.++ ....++++++-+|+.||+.|+.|||+.+ |.||||||+|+|... +..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 78999999999999988654 3346899999999999999999999988 999999999999964 4579999999
Q ss_pred CceeecC
Q 005718 662 MARMFCG 668 (681)
Q Consensus 662 la~~~~~ 668 (681)
+||....
T Consensus 210 FAK~t~~ 216 (400)
T KOG0604|consen 210 FAKETQE 216 (400)
T ss_pred cccccCC
Confidence 9998753
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=175.82 Aligned_cols=141 Identities=30% Similarity=0.410 Sum_probs=125.4
Q ss_pred ecccCcEeEEEEEec-CCcEEEEEEecCCCc---ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCCh
Q 005718 522 LGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL 597 (681)
Q Consensus 522 LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 597 (681)
||+|+||.||++... +++.+++|.+..... .....+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999975 488999999876422 2456889999999999999999999999999999999999999999
Q ss_pred hhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 598 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
.+++.. ...+++.....++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||+++....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 999843 235789999999999999999999977 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-18 Score=178.76 Aligned_cols=150 Identities=31% Similarity=0.450 Sum_probs=124.4
Q ss_pred CCCceeeecccCcEeEEEEEecC-CcEEEEEEecCC-----CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
+|.+.+.||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998754 444555555431 122344677899999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 589 YEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++|+||||+||++++ +.+||+|||+++.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888532 23456899999999999999999999887 999999999999975 569999999998764
Q ss_pred C
Q 005718 668 G 668 (681)
Q Consensus 668 ~ 668 (681)
.
T Consensus 157 ~ 157 (260)
T cd08222 157 G 157 (260)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=185.53 Aligned_cols=148 Identities=30% Similarity=0.437 Sum_probs=127.8
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCe----
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE---- 584 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~---- 584 (681)
..++|.+.+.||+|++|.||+|... +++.||||++... .....+.+.+|+.++++++|+||+++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999985 4789999988753 22234567889999999999999999988776654
Q ss_pred --EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCC
Q 005718 585 --KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662 (681)
Q Consensus 585 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl 662 (681)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999999 5689888732 35899999999999999999999987 99999999999999999999999999
Q ss_pred ceeec
Q 005718 663 ARMFC 667 (681)
Q Consensus 663 a~~~~ 667 (681)
++.+.
T Consensus 165 ~~~~~ 169 (343)
T cd07851 165 ARHTD 169 (343)
T ss_pred ccccc
Confidence 98764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.4e-19 Score=168.26 Aligned_cols=144 Identities=24% Similarity=0.468 Sum_probs=124.5
Q ss_pred hCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCcccHHHHHHHHHHHhhCC-CCCeeEEEEEEEeC--CeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQ--GEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~lV 588 (681)
.++|++.+++|+|.++.||.|.. .+.+.++||.+++. ..+.+.+|+.+|..+. ||||++|++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 46788999999999999999985 56788999999864 3477899999999996 99999999998765 456899
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC-CeEEeecCCceeec
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMFC 667 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~~~ 667 (681)
+||+++.+...+. ..++-.+...++.++++||.|+|+.+ |+|||+||.|++||... .++|+|+|||.++-
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998886554 24666788899999999999999998 99999999999999754 79999999999885
Q ss_pred C
Q 005718 668 G 668 (681)
Q Consensus 668 ~ 668 (681)
.
T Consensus 185 p 185 (338)
T KOG0668|consen 185 P 185 (338)
T ss_pred C
Confidence 4
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-17 Score=164.54 Aligned_cols=137 Identities=23% Similarity=0.283 Sum_probs=105.8
Q ss_pred ceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhC-----CCCCeeEEEEEEEeCC---e-EEEE
Q 005718 518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-----QHRNLVRLMGCCVEQG---E-KILI 588 (681)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-----~H~nIv~l~g~~~~~~---~-~~lV 588 (681)
-.+.||+|+||.||. +++....+||++........+.+.+|+.+++.+ .||||++++|++.++. . ..+|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 347899999999996 433333479988765444567899999999999 5799999999998874 3 3378
Q ss_pred EEe--cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeeecccCCCcEEEcCC----CCeEEeec-
Q 005718 589 YEY--MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL-LYLHQYSRLRIIHRDLKASNILLDSD----MNPKISDF- 660 (681)
Q Consensus 589 ~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~ivHrDlkp~NiLl~~~----~~~kl~DF- 660 (681)
+|| +.+++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++.. ..++|+||
T Consensus 84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 5579999999431 24444 35677888777 9999988 9999999999999743 37999995
Q ss_pred CCcee
Q 005718 661 GMARM 665 (681)
Q Consensus 661 Gla~~ 665 (681)
|.+.+
T Consensus 155 G~~~~ 159 (210)
T PRK10345 155 GESTF 159 (210)
T ss_pred CCcce
Confidence 54444
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-17 Score=165.60 Aligned_cols=149 Identities=36% Similarity=0.536 Sum_probs=132.3
Q ss_pred CCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCcc-cHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecC
Q 005718 516 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 593 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 593 (681)
|++.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999875 789999999865444 57789999999999999999999999999999999999999
Q ss_pred CCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
+++|.+++..... .+++.....++.+++++|.|||..+ ++|+||+|+||+++.++.++|+|||+++.+...
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 9999999843221 1788999999999999999999986 999999999999999999999999999987544
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.7e-18 Score=171.23 Aligned_cols=132 Identities=21% Similarity=0.156 Sum_probs=114.1
Q ss_pred cCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCChhhHhcC
Q 005718 525 GGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD 603 (681)
Q Consensus 525 G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 603 (681)
|.+|.||++... +++.+|+|++.... .+..|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999985 57899999997642 234455555666799999999999999999999999999999998843
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 604 PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 604 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
. ..+++.....++.|+++||+|||+.+ |+||||||+||+++.++.++++|||+++.+.
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~ 136 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVE 136 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccc
Confidence 2 34889999999999999999999887 9999999999999999999999999887654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.5e-18 Score=192.20 Aligned_cols=149 Identities=25% Similarity=0.334 Sum_probs=105.6
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC-----CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEE------EE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN-----GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGC------CV 580 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~------~~ 580 (681)
..++|.+.++||+|+||.||+|.+.+ +..||||++..... .+....| .+....+.++..+... +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999999854 57899998865321 1222222 1122222222221111 34
Q ss_pred eCCeEEEEEEecCCCChhhHhcCCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccC
Q 005718 581 EQGEKILIYEYMPNKSLNFFLFDPSRT-----------------HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLK 643 (681)
Q Consensus 581 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk 643 (681)
++.+.++||||+++++|.+++...... .......+..++.||++||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 567899999999999999888543211 01112345578999999999999887 9999999
Q ss_pred CCcEEEcC-CCCeEEeecCCceeec
Q 005718 644 ASNILLDS-DMNPKISDFGMARMFC 667 (681)
Q Consensus 644 p~NiLl~~-~~~~kl~DFGla~~~~ 667 (681)
|+|||+++ ++.+||+|||+|+.+.
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~ 307 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLR 307 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccc
Confidence 99999986 5799999999998664
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-19 Score=174.23 Aligned_cols=149 Identities=30% Similarity=0.385 Sum_probs=121.0
Q ss_pred CCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC-cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+.+....||.|.||+|+|-.++. |+.+|||+++... ..+.++++.|.+...+- +.||||+++|.+-..+..|+-||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 34445689999999999998854 8999999998653 35678899999877666 789999999999988999999999
Q ss_pred cCCCChhhHhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 592 MPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 592 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|+ .||+.+-.. ......+++.-.-+|.....+||.||.+.. +||||||||+||||+..|.+||+|||++-.+
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhH
Confidence 94 566554310 112334677777788888999999998754 6999999999999999999999999997655
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=159.43 Aligned_cols=150 Identities=23% Similarity=0.360 Sum_probs=125.9
Q ss_pred hhCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCC-CCeeEEEEEEEeCCeEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH-RNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~ 589 (681)
...+|.++++||.|+||.+|.|.. ..|+.||||.-+... ....+.-|..+...++| ..|..+..+..+..+..+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 356799999999999999999986 569999999876543 23566778888888865 67888999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC---CCeEEeecCCceee
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFGMARMF 666 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~---~~~kl~DFGla~~~ 666 (681)
|.+ +.+|++++.-. ...++.++.+-++-|++.-++|+|..+ +|||||||+|+|+.-+ ..+.++||||||.+
T Consensus 91 dLL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 998 77888887332 234788999999999999999999988 9999999999999643 46889999999988
Q ss_pred cCC
Q 005718 667 CGD 669 (681)
Q Consensus 667 ~~~ 669 (681)
-+-
T Consensus 165 ~d~ 167 (341)
T KOG1163|consen 165 RDI 167 (341)
T ss_pred ccc
Confidence 543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4e-19 Score=190.28 Aligned_cols=163 Identities=27% Similarity=0.453 Sum_probs=140.5
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
.+.++|.....+|.|.+|.|||++.. .++..|||.++.....+..-...|+.+++.-+|+||+.++|-+...+..++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 34578889999999999999999985 48899999999877777788889999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+.+|+|.++-+ -..++++.+...+.+..++||+|||+.+ -+|||||-.|||+++.+.+|++|||.+-.+..-
T Consensus 92 EycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 9999999987762 3446788888899999999999999988 799999999999999999999999998766432
Q ss_pred CccCCCcceecC
Q 005718 670 ELQGNTKRVVGT 681 (681)
Q Consensus 670 ~~~~~~~~~~GT 681 (681)
- ++.+.++||
T Consensus 166 i--~KrksfiGt 175 (829)
T KOG0576|consen 166 I--AKRKSFIGT 175 (829)
T ss_pred h--hhhhcccCC
Confidence 2 223445665
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.3e-18 Score=166.63 Aligned_cols=150 Identities=25% Similarity=0.379 Sum_probs=121.9
Q ss_pred CCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCC-CcccHHHHHHHHHHHhhCC-CCCeeEEEEEEEeCCeEEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E 590 (681)
++.+.+..||.|..|+|++...+. +..+|||.+... ...+.++++..++++.+-+ .|.||+.+|+|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 445556789999999999999854 789999998764 3445667777887766654 8999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
.|.- -++.+|. ...+++++.-.-++...+.+||.||.+.+ +|||||+||+|||+|+.|++|++|||++-.+.+
T Consensus 172 lMs~-C~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 172 LMST-CAEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHH-HHHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec
Confidence 9843 3333432 23445788888899999999999999866 799999999999999999999999999976643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.6e-18 Score=167.80 Aligned_cols=162 Identities=25% Similarity=0.378 Sum_probs=134.6
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCC---CcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 586 (681)
..++|.+.++||+|+|.+|..++++. .+.+|+|++++. ...+..-...|-.+.... +||.+|.+..++.....++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 34689999999999999999999854 678899998864 233445566777777666 8999999999999999999
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
.|.||+++|+|..++ ++...++++.+..+...|.-||.|||+.+ ||.||||.+|+|||.++++||+|+|+.|.-
T Consensus 328 fvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999998666 44456888888889999999999999988 999999999999999999999999999975
Q ss_pred cCCCccCCCcceecC
Q 005718 667 CGDELQGNTKRVVGT 681 (681)
Q Consensus 667 ~~~~~~~~~~~~~GT 681 (681)
.++... |.++.||
T Consensus 402 l~~gd~--tstfcgt 414 (593)
T KOG0695|consen 402 LGPGDT--TSTFCGT 414 (593)
T ss_pred CCCCcc--cccccCC
Confidence 443322 3445665
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-17 Score=164.32 Aligned_cols=153 Identities=23% Similarity=0.329 Sum_probs=129.0
Q ss_pred hhCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
..-+|.+.++||+|.||.++.|+. -+++.||||.-... ...-+++.|.+..+.| ..++|.+++-+..++.+..||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 346799999999999999999984 57899999976543 3446778888888888 5689999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC-----CCeEEeecCCce
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-----MNPKISDFGMAR 664 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~-----~~~kl~DFGla~ 664 (681)
|.+ +-||++++.- .+..++.+++..+|.|++.-++|+|+++ +|.|||||+|+||... ..+.|+||||||
T Consensus 104 dLL-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhh-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 998 6788887733 3445899999999999999999999998 9999999999999643 458999999999
Q ss_pred eecCCCcc
Q 005718 665 MFCGDELQ 672 (681)
Q Consensus 665 ~~~~~~~~ 672 (681)
.+.+..++
T Consensus 178 ~YrDp~Tk 185 (449)
T KOG1165|consen 178 EYRDPKTK 185 (449)
T ss_pred hhcCcccc
Confidence 98665443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=7e-18 Score=185.41 Aligned_cols=149 Identities=32% Similarity=0.453 Sum_probs=119.0
Q ss_pred CCceeeecccCcEe-EEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEEEecC
Q 005718 516 FSMQCKLGEGGFGP-VYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMP 593 (681)
Q Consensus 516 f~~~~~LG~G~fG~-Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~ 593 (681)
|...+.+|.|.-|+ ||+|.. +++.||||++-.. ...-..+|+..|..- .|||||++++.-.++...||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 34446788998875 799998 6789999998642 345567899998887 79999999999889999999999995
Q ss_pred CCChhhHhcCCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC---C--CCeEEeecCCceeec
Q 005718 594 NKSLNFFLFDPSRTHL-LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---D--MNPKISDFGMARMFC 667 (681)
Q Consensus 594 ~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~---~--~~~kl~DFGla~~~~ 667 (681)
-+|.+++........ ..-...+.+..|+++||++||+.+ ||||||||.||||+. + ..++|+|||++|.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 599999855311111 111345678899999999999976 999999999999976 2 478999999999998
Q ss_pred CCCcc
Q 005718 668 GDELQ 672 (681)
Q Consensus 668 ~~~~~ 672 (681)
.+...
T Consensus 663 ~~~sS 667 (903)
T KOG1027|consen 663 GGKSS 667 (903)
T ss_pred CCcch
Confidence 77654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-16 Score=155.78 Aligned_cols=143 Identities=38% Similarity=0.631 Sum_probs=126.5
Q ss_pred ecccCcEeEEEEEecC-CcEEEEEEecCCCcc-cHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCChhh
Q 005718 522 LGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNF 599 (681)
Q Consensus 522 LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 599 (681)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..+++++|++|+++++++......++++||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 889999999864322 35789999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC-CCCeEEeecCCceeecCC
Q 005718 600 FLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCGD 669 (681)
Q Consensus 600 ~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~~~~~~ 669 (681)
++.... ..+++..+..++.+++++|.|||+.+ ++|+||+|.||+++. ++.++|+|||.+......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 984322 35788999999999999999999987 999999999999999 899999999999877543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.3e-17 Score=160.79 Aligned_cols=142 Identities=14% Similarity=0.114 Sum_probs=116.5
Q ss_pred HhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHH---------HHHHHHHHhhCCCCCeeEEEEEEEe
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKE---------FKNEMMLIAKLQHRNLVRLMGCCVE 581 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~---------f~~Ei~~l~~l~H~nIv~l~g~~~~ 581 (681)
...++|+..+++|.|+||.||+... ++..+|||.+.+......+. +.+|+..+.++.|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4568999999999999999999766 56789999997643322222 6899999999999999999988664
Q ss_pred C--------CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC
Q 005718 582 Q--------GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 653 (681)
Q Consensus 582 ~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~ 653 (681)
. ...+|||||+++.+|.++.. ++. ....+++.+|..||..+ ++||||||+||+++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 35789999999999977641 222 34568999999999988 99999999999999888
Q ss_pred CeEEeecCCceeecC
Q 005718 654 NPKISDFGMARMFCG 668 (681)
Q Consensus 654 ~~kl~DFGla~~~~~ 668 (681)
++|+|||..+.+..
T Consensus 173 -i~liDfg~~~~~~e 186 (232)
T PRK10359 173 -LRIIDLSGKRCTAQ 186 (232)
T ss_pred -EEEEECCCcccccc
Confidence 99999999987743
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.1e-17 Score=160.19 Aligned_cols=136 Identities=20% Similarity=0.290 Sum_probs=114.3
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEecCCCcc--------cHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ--------GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~--------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
+.||+|++|.||+|.. .+..+++|+....... ....+.+|+.++..++|+++.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6678999976543211 124678899999999999988877777778888999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+++++|.+++... .. ++..++.+++.+|.+||..+ ++|+|++|+|||++ ++.++|+|||+++...
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999888321 12 77899999999999999987 99999999999999 7899999999998643
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=6e-17 Score=163.03 Aligned_cols=149 Identities=16% Similarity=0.120 Sum_probs=114.0
Q ss_pred HHhhCCCCceeeecccCcEeEEEEE--ecCCcEEEEEEecCCCcc------------------------cHHHHHHHHHH
Q 005718 510 SAATENFSMQCKLGEGGFGPVYKGK--LLNGQEVAVKRLSSQSGQ------------------------GLKEFKNEMML 563 (681)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fG~Vy~~~--~~~~~~VAVK~l~~~~~~------------------------~~~~f~~Ei~~ 563 (681)
..-...|.+.+.||+|+||.||+|. ..+|+.||||.++..... ....+..|+..
T Consensus 24 ~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 103 (237)
T smart00090 24 LNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN 103 (237)
T ss_pred HhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence 3334458888999999999999998 467999999998753210 01235689999
Q ss_pred HhhCCC--CCeeEEEEEEEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecc
Q 005718 564 IAKLQH--RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRD 641 (681)
Q Consensus 564 l~~l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD 641 (681)
+.++.+ ..+.++++. ...++||||+++.+|...+.. ...+...+...++.||+.+|++||..+ +|+|||
T Consensus 104 L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~D 174 (237)
T smart00090 104 LQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGD 174 (237)
T ss_pred HHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCC
Confidence 999975 345555543 235899999999888655422 223455667789999999999999875 499999
Q ss_pred cCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 642 LKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 642 lkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||+||+++ ++.++|+|||+|+....
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhccCC
Confidence 999999999 88999999999997644
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.3e-18 Score=180.87 Aligned_cols=159 Identities=26% Similarity=0.300 Sum_probs=133.9
Q ss_pred CCCCceeeecccCcEeEEEEEecCCc-EEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLNGQ-EVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~~~-~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
.+++.+..||-|+||.|=++..+... .+|+|.+++. .....+....|-.+|...+.|.||+++..|.+.+..|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45566678999999999999885533 4888888764 2334556788999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
|-|-+|.|..+|.+ ...+...+...++.++.+|++|||..+ ||.|||||+|++||.+|-+||.|||+||.+...
T Consensus 500 EaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999944 334777788889999999999999988 999999999999999999999999999988544
Q ss_pred CccCCCcceecC
Q 005718 670 ELQGNTKRVVGT 681 (681)
Q Consensus 670 ~~~~~~~~~~GT 681 (681)
. +|-++.||
T Consensus 574 ~---KTwTFcGT 582 (732)
T KOG0614|consen 574 R---KTWTFCGT 582 (732)
T ss_pred C---ceeeecCC
Confidence 3 24456666
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.8e-16 Score=153.06 Aligned_cols=132 Identities=19% Similarity=0.197 Sum_probs=105.9
Q ss_pred ceeeecccCcEeEEEEEecCCcEEEEEEecCCCcc----cHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ----GLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~----~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
+...|++|+||+||.+.. ++.+++.+.+...... ....|.+|+++|+++ +|+++++++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997766 6778887777654321 122588999999999 45889999886 4569999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccc-CCCcEEEcCCCCeEEeecCCceeec
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDL-KASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl-kp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
++.+|...+. . ....++.|++++|+++|..+ |+|||| ||+|||++.++.++|+|||+|+...
T Consensus 81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 9988864431 0 12357789999999999988 999999 7999999999999999999998654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=157.40 Aligned_cols=146 Identities=18% Similarity=0.175 Sum_probs=113.2
Q ss_pred HHHHhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcc----------------------cHHHHHHHHHHHh
Q 005718 508 SVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ----------------------GLKEFKNEMMLIA 565 (681)
Q Consensus 508 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~----------------------~~~~f~~Ei~~l~ 565 (681)
++......|.+.+.||+|+||.||++...+++.||||++...... ....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 344444457788999999999999999888999999987642200 1123677888999
Q ss_pred hCCCC--CeeEEEEEEEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccC
Q 005718 566 KLQHR--NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLK 643 (681)
Q Consensus 566 ~l~H~--nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk 643 (681)
.+.|+ .++..++ ....++||||+++++|..... . .....++.++++++.++|+.+ |+|||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---~------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---L------EDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---c------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 98877 4555544 245589999999999876541 0 234578899999999999977 9999999
Q ss_pred CCcEEEcCCCCeEEeecCCceeecCC
Q 005718 644 ASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 644 p~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
|+||++++++.++|+|||+|.-...+
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~~ 178 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDHP 178 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCCc
Confidence 99999999999999999999766543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=160.46 Aligned_cols=138 Identities=33% Similarity=0.459 Sum_probs=123.5
Q ss_pred CcEeEEEEEecC-CcEEEEEEecCCCccc-HHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCChhhHhcC
Q 005718 526 GFGPVYKGKLLN-GQEVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD 603 (681)
Q Consensus 526 ~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 603 (681)
+||.||++...+ ++.+++|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999864 8899999998654444 68999999999999999999999999999999999999999999999843
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 604 PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 604 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
.. .+++..+..++.+++++|.|||..+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~ 140 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPG 140 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence 22 2788999999999999999999987 999999999999999999999999999887543
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-16 Score=179.25 Aligned_cols=139 Identities=21% Similarity=0.294 Sum_probs=112.8
Q ss_pred CCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCc-------ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG-------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~-------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 586 (681)
..|...++||+|+||.||++.+.....++.+++.+... ...+++.+|++++.+++|++++....++.+....+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 34456689999999999999885544333222222111 12356889999999999999998888888878889
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||+|+..
T Consensus 413 lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999998872 45678999999999999987 9999999999999 6789999999999976
Q ss_pred c
Q 005718 667 C 667 (681)
Q Consensus 667 ~ 667 (681)
.
T Consensus 478 ~ 478 (535)
T PRK09605 478 D 478 (535)
T ss_pred C
Confidence 4
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-16 Score=155.83 Aligned_cols=132 Identities=22% Similarity=0.331 Sum_probs=107.5
Q ss_pred eecccCcEeEEEEEecCCcEEEEEEecCCCc--------ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG--------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~--------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
.||+|+||.||+|.. ++..+++|....... ...+++.+|+.++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 567899998654211 11356788999999998887665555666777789999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
++++|.+.+.... ..++.+++++|.+||..+ ++|+|++|+||+++ ++.++++|||+|+...
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 9999988873211 078999999999999987 99999999999999 8899999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.8e-17 Score=156.45 Aligned_cols=146 Identities=21% Similarity=0.382 Sum_probs=119.3
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEE-EEEeCCeEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMG-CCVEQGEKILIY 589 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g-~~~~~~~~~lV~ 589 (681)
.+.|.+.+.||+|.||.+-+++++. .+.+++|.+... ....++|.+|...--.| .|.||+.-++ .|...+..+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3568888999999999999999975 567888887653 34568899998765555 6899887654 466677889999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc--CCCCeEEeecCCceee
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--SDMNPKISDFGMARMF 666 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~--~~~~~kl~DFGla~~~ 666 (681)
||++.|+|.+-+.. .-+.+.-...++.|++.||.|+|+.+ +||||||.+||||- +...+||+|||+++..
T Consensus 102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999877732 33566777789999999999999998 99999999999993 3448999999999865
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.9e-16 Score=163.88 Aligned_cols=145 Identities=25% Similarity=0.353 Sum_probs=121.3
Q ss_pred CCCceeeecccCcEeEEEEEecCC--cEEEEEEecCCCcccHHHHHHHHHHHhhCCC----CCeeEEEEEE-EeCCeEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLLNG--QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH----RNLVRLMGCC-VEQGEKIL 587 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~~~--~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H----~nIv~l~g~~-~~~~~~~l 587 (681)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997553 4788887765433333377888888888863 5899999988 47778999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC-----CCeEEeecCC
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-----MNPKISDFGM 662 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~-----~~~kl~DFGl 662 (681)
||+.+ +.+|.++..... .+.++..+.+.|+.|++.+|++||+.+ ++||||||+|+++... ..++|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 778888764333 567899999999999999999999988 9999999999999765 4699999999
Q ss_pred ce
Q 005718 663 AR 664 (681)
Q Consensus 663 a~ 664 (681)
||
T Consensus 174 ar 175 (322)
T KOG1164|consen 174 AR 175 (322)
T ss_pred Cc
Confidence 99
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.4e-16 Score=163.56 Aligned_cols=149 Identities=24% Similarity=0.454 Sum_probs=128.8
Q ss_pred HHHhhCCCCceeeecccCcEeEEEEEec----CCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCC
Q 005718 509 VSAATENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG 583 (681)
Q Consensus 509 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 583 (681)
+....+.|..+++||+|.|+.||++.+. ..+.||+|.+... ....+..+|+++|..+ .+.||+.+.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445678899999999999999999863 3578999999764 3446789999999999 6899999999999999
Q ss_pred eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC-CCeEEeecCC
Q 005718 584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGM 662 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFGl 662 (681)
...+|+||+++-...+++.. ++..+...++..+.+||+++|+++ ||||||||+|+|.+.. +.-.|.||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999999888833 567888899999999999999998 9999999999999754 5678999999
Q ss_pred ceeecC
Q 005718 663 ARMFCG 668 (681)
Q Consensus 663 a~~~~~ 668 (681)
|.-+..
T Consensus 180 A~~~d~ 185 (418)
T KOG1167|consen 180 AQRYDG 185 (418)
T ss_pred HHHHHh
Confidence 985433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.5e-16 Score=171.39 Aligned_cols=147 Identities=25% Similarity=0.325 Sum_probs=122.2
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
.++.|.+...+|.|+|+.|-++... .++..+||++.+... +-.+|+.++.+. +|+||+++.+.+.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3567888888999999999998874 478899999986522 223466555555 8999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEE-cCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL-DSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl-~~~~~~kl~DFGla~~~~~ 668 (681)
|++.++.+.+-+.. .. ....++..|+.+|+.++.|||+++ +|||||||+|||+ ++.++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~---~~-~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRS---KP-EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHh---cc-hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 99999888777632 22 222777789999999999999987 9999999999999 5899999999999998866
Q ss_pred C
Q 005718 669 D 669 (681)
Q Consensus 669 ~ 669 (681)
+
T Consensus 469 ~ 469 (612)
T KOG0603|consen 469 S 469 (612)
T ss_pred h
Confidence 5
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.9e-16 Score=158.28 Aligned_cols=154 Identities=23% Similarity=0.270 Sum_probs=128.0
Q ss_pred HhhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhCC-C-CC----eeEEEEEEEeCC
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-H-RN----LVRLMGCCVEQG 583 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H-~n----Iv~l~g~~~~~~ 583 (681)
..+++|.+..++|+|.||.|.+..... +..||||+++.. ....+..+-|+++|.++. + |+ ++++.+++.-.+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 347889999999999999999998754 688999999863 445667788999999993 2 33 788889999999
Q ss_pred eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC------------
Q 005718 584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS------------ 651 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~------------ 651 (681)
+.+||+|.+ +-|+.++|.. ....+++......|+.|+++++++||+.. ++|-||||+|||+.+
T Consensus 165 hiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred ceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 999999999 4588889844 34456888999999999999999999987 999999999999832
Q ss_pred --------CCCeEEeecCCceeecCCC
Q 005718 652 --------DMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 652 --------~~~~kl~DFGla~~~~~~~ 670 (681)
+..+||+|||-|+.-..+.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h 266 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH 266 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc
Confidence 2358999999999875544
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.5e-15 Score=138.71 Aligned_cols=136 Identities=22% Similarity=0.223 Sum_probs=116.1
Q ss_pred ceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCC--CCeeEEEEEEEeCCeEEEEEEecCCC
Q 005718 518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH--RNLVRLMGCCVEQGEKILIYEYMPNK 595 (681)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~g 595 (681)
+.+.|++|.++.||++...+ ..+++|....... ...+..|+.++..++| .++++++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999855 7899998876433 5678999999999976 58999999888888899999999987
Q ss_pred ChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 596 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 596 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
.+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.+++.|||+++..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 77532 45677788999999999999875567999999999999999899999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.3e-15 Score=146.29 Aligned_cols=139 Identities=21% Similarity=0.221 Sum_probs=100.4
Q ss_pred eeeecccCcEeEEEEEecCCcEEEEEEecCCCcc--cHHH----------------------HHHHHHHHhhCCCC--Ce
Q 005718 519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ--GLKE----------------------FKNEMMLIAKLQHR--NL 572 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~--~~~~----------------------f~~Ei~~l~~l~H~--nI 572 (681)
.+.||+|+||.||++...+++.||||++...... .... ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999988753211 1111 13566666666443 35
Q ss_pred eEEEEEEEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecccCCCcEEEcC
Q 005718 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDS 651 (681)
Q Consensus 573 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NiLl~~ 651 (681)
.+.+++ ...++||||++++.+......... .. .+...++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 555543 245899999999554322111100 11 5567899999999999998 66 99999999999999
Q ss_pred CCCeEEeecCCceeecCC
Q 005718 652 DMNPKISDFGMARMFCGD 669 (681)
Q Consensus 652 ~~~~kl~DFGla~~~~~~ 669 (681)
++.++|+|||.|+....+
T Consensus 150 ~~~~~liDfg~a~~~~~~ 167 (187)
T cd05119 150 DGKVYIIDVPQAVEIDHP 167 (187)
T ss_pred CCcEEEEECcccccccCc
Confidence 899999999999877553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.2e-15 Score=155.57 Aligned_cols=135 Identities=26% Similarity=0.327 Sum_probs=110.9
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCC-----C---CCeeEEEEEEEeC-
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-----H---RNLVRLMGCCVEQ- 582 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----H---~nIv~l~g~~~~~- 582 (681)
..+|.++++||=|.|++||++.+. ..+.||+|+.+.. ....+..+.||++|++++ | .+||+|++.|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 368999999999999999999874 4678999999863 445667789999999883 3 3599999999864
Q ss_pred ---CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC
Q 005718 583 ---GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD 652 (681)
Q Consensus 583 ---~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~ 652 (681)
.+.+||+|++.. +|..+|... ..+-++...+.+|++||+.||.|||..+ +|||-||||+||||..+
T Consensus 156 pNG~HVCMVfEvLGd-nLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGD-NLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCCcEEEEEehhhhh-HHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 589999999954 555555332 3334788999999999999999999987 79999999999999654
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.3e-15 Score=120.55 Aligned_cols=66 Identities=45% Similarity=1.095 Sum_probs=57.4
Q ss_pred CCCCCeEEEeccccCCcccceeeccccCHHHHHHHhhcCCceeeeeeccccCCCccceeecccccch
Q 005718 337 CITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDI 403 (681)
Q Consensus 337 C~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~y~~~~~~~~gC~~w~~~l~~~ 403 (681)
|+.+++|+++++|++|+.....++.+.++++|++.|++||||+||+|.++. ++++|++|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 545789999999999998777666678999999999999999999998654 567899999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.5e-15 Score=157.02 Aligned_cols=157 Identities=24% Similarity=0.307 Sum_probs=131.9
Q ss_pred HHhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCC------CCeeEEEEEEEeC
Q 005718 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH------RNLVRLMGCCVEQ 582 (681)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H------~nIv~l~g~~~~~ 582 (681)
+..-..|.+....|+|-|++|.+|... .++.||||+|... ..-.+.=+.|+++|++|+. -|+++|+..|.+.
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 344578888899999999999999874 4789999999874 2334555789999999953 4899999999999
Q ss_pred CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC-CCeEEeecC
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFG 661 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFG 661 (681)
+++|||+|-+ ..+|.++|......--|....+..++.|+.-||..|...+ |+|.||||+|||+++. ..+||+|||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 9999999988 4588888866555556788899999999999999999887 9999999999999875 468999999
Q ss_pred CceeecCCCc
Q 005718 662 MARMFCGDEL 671 (681)
Q Consensus 662 la~~~~~~~~ 671 (681)
-|-....++.
T Consensus 583 SA~~~~enei 592 (752)
T KOG0670|consen 583 SASFASENEI 592 (752)
T ss_pred cccccccccc
Confidence 9988766553
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.4e-15 Score=149.27 Aligned_cols=146 Identities=32% Similarity=0.410 Sum_probs=117.8
Q ss_pred CCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC------e
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------E 584 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~ 584 (681)
.+|.-...++.|.- .|..+.+ -.++.||+|++... .....++..+|..++..+.|+|+++++.++.-.+ .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45655677888877 5555544 34789999987643 2345677889999999999999999999998654 5
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
.|+|||||. .+|...+. -.++-.+...|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 699999995 47776663 12566788899999999999999988 9999999999999999999999999998
Q ss_pred eecCC
Q 005718 665 MFCGD 669 (681)
Q Consensus 665 ~~~~~ 669 (681)
.-+.+
T Consensus 167 ~e~~~ 171 (369)
T KOG0665|consen 167 TEDTD 171 (369)
T ss_pred ccCcc
Confidence 65443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.56 E-value=9e-14 Score=145.29 Aligned_cols=150 Identities=35% Similarity=0.529 Sum_probs=128.2
Q ss_pred CCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcc---cHHHHHHHHHHHhhCCCC-CeeEEEEEEEeCCeEEEEEEe
Q 005718 516 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ---GLKEFKNEMMLIAKLQHR-NLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~---~~~~f~~Ei~~l~~l~H~-nIv~l~g~~~~~~~~~lV~Ey 591 (681)
|.+.+.||.|+|+.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++...+......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 567789999999999999987 78899988765332 367899999999999888 799999999877788999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC-CeEEeecCCceeecCCC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMFCGDE 670 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~~~~~~ 670 (681)
+.++++.+++........+.......++.|++.++.|+|..+ ++||||||+||+++... .+|++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999976633211135788999999999999999999988 99999999999999988 79999999999765543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=5e-14 Score=142.14 Aligned_cols=136 Identities=23% Similarity=0.258 Sum_probs=105.4
Q ss_pred eeec-ccCcEeEEEEEecCCcEEEEEEecCCC-------------cccHHHHHHHHHHHhhCCCCCe--eEEEEEEEeCC
Q 005718 520 CKLG-EGGFGPVYKGKLLNGQEVAVKRLSSQS-------------GQGLKEFKNEMMLIAKLQHRNL--VRLMGCCVEQG 583 (681)
Q Consensus 520 ~~LG-~G~fG~Vy~~~~~~~~~VAVK~l~~~~-------------~~~~~~f~~Ei~~l~~l~H~nI--v~l~g~~~~~~ 583 (681)
..|| .|+.|+||+.... +..++||++.... ......+.+|+.++.+++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4677 7889999998874 6788888775311 1223568889999999988774 77777754432
Q ss_pred ----eEEEEEEecCC-CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEe
Q 005718 584 ----EKILIYEYMPN-KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 658 (681)
Q Consensus 584 ----~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~ 658 (681)
..++|+||+++ .+|.+++.+ ..++.. .+.+|+++|.+||..+ |+||||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 689888733 123332 3678999999999988 9999999999999998999999
Q ss_pred ecCCceeec
Q 005718 659 DFGMARMFC 667 (681)
Q Consensus 659 DFGla~~~~ 667 (681)
|||.++...
T Consensus 185 Dfg~~~~~~ 193 (239)
T PRK01723 185 DFDRGELRT 193 (239)
T ss_pred ECCCcccCC
Confidence 999998865
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.4e-14 Score=163.58 Aligned_cols=148 Identities=24% Similarity=0.333 Sum_probs=116.1
Q ss_pred HHhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCC---CCCeeEEEEEEEeCCeEE
Q 005718 510 SAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ---HRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~ 586 (681)
+.....|.+.+.||+|+||+||+|...+++.||+|.-++....+ |.-=..++.||+ -+.|..+..++.-.+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 34457788999999999999999999889999999988754332 111122333333 233444555555667788
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc-------CCCCeEEee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-------SDMNPKISD 659 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~-------~~~~~kl~D 659 (681)
||+||.+.|+|.+++. ..+.++|...+.++.|+++-+++||..+ |||+||||+|+||. ....++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999994 5567899999999999999999999987 99999999999994 234689999
Q ss_pred cCCceee
Q 005718 660 FGMARMF 666 (681)
Q Consensus 660 FGla~~~ 666 (681)
||-|--+
T Consensus 845 fG~siDm 851 (974)
T KOG1166|consen 845 FGRSIDM 851 (974)
T ss_pred cccceee
Confidence 9998644
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.7e-13 Score=148.58 Aligned_cols=141 Identities=22% Similarity=0.270 Sum_probs=100.0
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEecCCCcccH----------------------------------------HHHHH
Q 005718 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGL----------------------------------------KEFKN 559 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~----------------------------------------~~f~~ 559 (681)
+.||.|++|+||+|++++|+.||||+.++...... -+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999876421100 02445
Q ss_pred HHHHHhhC----CCCCeeEEEEEEE-eCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 005718 560 EMMLIAKL----QHRNLVRLMGCCV-EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ-GLLYLHQYS 633 (681)
Q Consensus 560 Ei~~l~~l----~H~nIv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~yLH~~~ 633 (681)
|...+.++ +|.+-+.+-..+. .....+|||||+++++|.+........ . .+..++..+++ .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhCC
Confidence 55555544 2333233322332 234579999999999998776321111 1 23456666666 467888877
Q ss_pred CCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 634 ~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
++|+|+||.||++++++.+++.|||+++.+..
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999998854
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.5e-12 Score=106.05 Aligned_cols=79 Identities=37% Similarity=0.869 Sum_probs=62.5
Q ss_pred CCCCCC---CeEEEeccccCCcccceeeccccCHHHHHHHhhcCCceeeeeeccccCCCccceeecccccchhhhcccCC
Q 005718 335 SDCITR---ERFIKFDDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFGDLIDIRKITGYNN 411 (681)
Q Consensus 335 ~~C~~~---~~~~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~y~~~~~~~~gC~~w~~~l~~~~~~~~~~~ 411 (681)
++|... +.|.+++++++|+..... .+.++++|++.|++||+|+||+|.+ ++.+|++|...+.+.+.... .
T Consensus 3 ~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~--~ 75 (84)
T cd01098 3 LNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSS--G 75 (84)
T ss_pred cccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecC--C
Confidence 456543 689999999999776543 5679999999999999999999974 34579999999888665433 3
Q ss_pred CCceeeeeC
Q 005718 412 GQPIYVRVP 420 (681)
Q Consensus 412 ~~~lyvrv~ 420 (681)
+..+||||+
T Consensus 76 ~~~~yiKv~ 84 (84)
T cd01098 76 GGTLYLRLA 84 (84)
T ss_pred CcEEEEEeC
Confidence 578999985
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.9e-12 Score=103.29 Aligned_cols=71 Identities=21% Similarity=0.361 Sum_probs=59.8
Q ss_pred CCCCCeEEEeccccCCcccceeeccccCHHHHHHHhhc---CCceeeeeeccccCCCccceeecccc-cchhhhcccCCC
Q 005718 337 CITRERFIKFDDIKLPYLVDVSLNESMNLKECEAECLK---NCTCRAYANSKVTGGGSGCLMWFGDL-IDIRKITGYNNG 412 (681)
Q Consensus 337 C~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~---nCsC~a~~y~~~~~~~~gC~~w~~~l-~~~~~~~~~~~~ 412 (681)
|..+..|+++.++++|+... .++++|++.|++ ||+|.||+|.+. +.||++|.++| ++++.... .+
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~--~g 73 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFS--HG 73 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccC--CC
Confidence 44567899999999986655 588999999999 999999999752 45899999999 99988765 57
Q ss_pred Cceeee
Q 005718 413 QPIYVR 418 (681)
Q Consensus 413 ~~lyvr 418 (681)
.++|+|
T Consensus 74 ~~Ly~r 79 (80)
T cd00129 74 FDLYEN 79 (80)
T ss_pred ceeEeE
Confidence 889987
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.4e-11 Score=117.53 Aligned_cols=131 Identities=23% Similarity=0.174 Sum_probs=97.8
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCe-eEEEEEEEeCCeEEEEEEecCCCChh
Q 005718 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-VRLMGCCVEQGEKILIYEYMPNKSLN 598 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gsL~ 598 (681)
+.|+.|.++.||++... ++.+++|....... ....+..|+..+..+.+.++ .+++.+. .+..++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 67899999999999874 67899998765422 23456789999888865443 4555543 33458999999998875
Q ss_pred hHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 599 FFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 599 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
... . ....++.+++++|+.||... ...++|+|++|.||+++ ++.++++|||.|..-
T Consensus 80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 320 0 11245678999999999876 23469999999999999 678999999998853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.4e-11 Score=134.81 Aligned_cols=145 Identities=18% Similarity=0.225 Sum_probs=94.7
Q ss_pred CCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCccc----------------------------------HH---
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQG----------------------------------LK--- 555 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~----------------------------------~~--- 555 (681)
..|+. +.||+|++|+||+|++++ |+.||||++++..... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 789999999999999987 9999999998642100 01
Q ss_pred ---HHHHHHHHHhhC----CCCCeeEEEEEEEe-CCeEEEEEEecCCCChhhHhcCCCCC---CCCCHHHHHHHHHHHHH
Q 005718 556 ---EFKNEMMLIAKL----QHRNLVRLMGCCVE-QGEKILIYEYMPNKSLNFFLFDPSRT---HLLGWQTRVKIIEGIAQ 624 (681)
Q Consensus 556 ---~f~~Ei~~l~~l----~H~nIv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia~ 624 (681)
+|.+|+.-+.++ .+.+.+.+-.++.+ ....+|||||++++.+.++-.-...+ +.+.......++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 244454444444 24444444344333 45678999999999997642111111 01222222222222
Q ss_pred HHHHHHhCCCCCeeecccCCCcEEEcCCC----CeEEeecCCceeecCC
Q 005718 625 GLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFGMARMFCGD 669 (681)
Q Consensus 625 ~L~yLH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~DFGla~~~~~~ 669 (681)
++..+ ++|+|+||.||+++.++ .+++.|||++..+..+
T Consensus 276 ----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 276 ----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 33444 99999999999999888 9999999999988554
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.6e-10 Score=108.62 Aligned_cols=137 Identities=14% Similarity=0.110 Sum_probs=99.5
Q ss_pred eeecccCcEeEEEEEecC-------CcEEEEEEecCCC------------c----------ccHHHH----HHHHHHHhh
Q 005718 520 CKLGEGGFGPVYKGKLLN-------GQEVAVKRLSSQS------------G----------QGLKEF----KNEMMLIAK 566 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~-------~~~VAVK~l~~~~------------~----------~~~~~f----~~Ei~~l~~ 566 (681)
..||.|.-+.||.|...+ +..+|||+.+... . ...+.+ ++|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999998653 4789999775311 0 001223 389999999
Q ss_pred CC--CCCeeEEEEEEEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeecccC
Q 005718 567 LQ--HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL-HQYSRLRIIHRDLK 643 (681)
Q Consensus 567 l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivHrDlk 643 (681)
+. ..++++++++ ...+|||||+.+..+..... +...++..+...+..+++.+|..| |..+ |||+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 84 3677888865 45689999998754422111 111234456667889999999999 7766 9999999
Q ss_pred CCcEEEcCCCCeEEeecCCceeec
Q 005718 644 ASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 644 p~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+.|||++ ++.++|+|||-|....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 4689999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.1e-11 Score=144.82 Aligned_cols=94 Identities=19% Similarity=0.287 Sum_probs=72.6
Q ss_pred hCCC-CCeeEEEEEE-------EeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 005718 566 KLQH-RNLVRLMGCC-------VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637 (681)
Q Consensus 566 ~l~H-~nIv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 637 (681)
.++| .||.++++++ .+.+..++++||+ .++|.++|... ...+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3345 5777777776 3334667888987 56999999542 345899999999999999999999887 9
Q ss_pred eecccCCCcEEEcC-------------------CCCeEEeecCCcee
Q 005718 638 IHRDLKASNILLDS-------------------DMNPKISDFGMARM 665 (681)
Q Consensus 638 vHrDlkp~NiLl~~-------------------~~~~kl~DFGla~~ 665 (681)
+||||||+||||+. ++.+||+|||+++.
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~ 148 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRR 148 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccc
Confidence 99999999999954 44566666666664
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.2e-11 Score=137.71 Aligned_cols=144 Identities=25% Similarity=0.320 Sum_probs=111.0
Q ss_pred ceeeecccCcEeEEEEEec-CCcEEEEEEec----CC-Cc-ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 518 MQCKLGEGGFGPVYKGKLL-NGQEVAVKRLS----SQ-SG-QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~----~~-~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
....+|.|++|.|+..... ..+..+.|..+ .. .. .....+..|+.+-..++|+|++..+....+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3478999999977776542 23333333222 11 11 112236678888889999999888887777777777799
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|++. +|..++.. ...+...++..++.|+++|+.|||+.+ |.|||||++|+++..++.+||+|||.+..+.-
T Consensus 402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 9999 99888833 235777889999999999999999998 99999999999999999999999999987753
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.8e-10 Score=104.78 Aligned_cols=135 Identities=21% Similarity=0.279 Sum_probs=102.7
Q ss_pred eeecccCcEeEEEEEecCCcEEEEE-EecCCC-------cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 520 CKLGEGGFGPVYKGKLLNGQEVAVK-RLSSQS-------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~VAVK-~l~~~~-------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
..+.+|+-+.+|.+.+.+. .+.+| ++.+.- ....++-.+|.+++.+++-..|....-+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3578999999999977443 34444 343321 11234678899999999766666666666788888999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
.++..|.+.+... +..++..+-+-+.-||..+ |+|+||.++||++.... +.++||||++.-...
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~~ 144 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSDEV 144 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccccH
Confidence 9999999888332 2467788888899999998 99999999999997655 999999999865443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.7e-10 Score=110.24 Aligned_cols=143 Identities=17% Similarity=0.245 Sum_probs=110.6
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEecCCCc-ccHHHHHHHHHHHhhCCC--CCeeEEEEEEEeCC---eEEEEEEecC
Q 005718 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQH--RNLVRLMGCCVEQG---EKILIYEYMP 593 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~---~~~lV~Ey~~ 593 (681)
+.|+.|..+.||++...+|+.+++|....... ....++..|..++..+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987668899998765322 235678999999999965 45677887766542 5689999999
Q ss_pred CCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 005718 594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS---------------------------------------- 633 (681)
Q Consensus 594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------- 633 (681)
+.++.+.+.. ..++..++..++.++++.|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888665421 23566777788888888888888521
Q ss_pred -------------CCCeeecccCCCcEEEcC--CCCeEEeecCCceee
Q 005718 634 -------------RLRIIHRDLKASNILLDS--DMNPKISDFGMARMF 666 (681)
Q Consensus 634 -------------~~~ivHrDlkp~NiLl~~--~~~~kl~DFGla~~~ 666 (681)
...++|+|++|.||+++. +..+.|+||+.+..-
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 245799999999999998 566899999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.4e-09 Score=99.59 Aligned_cols=147 Identities=23% Similarity=0.281 Sum_probs=107.4
Q ss_pred ceeeecccCcEeEEEEEecCCcEEEEE-EecCC-------CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 518 MQCKLGEGGFGPVYKGKLLNGQEVAVK-RLSSQ-------SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~~~~VAVK-~l~~~-------~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
....|-+|+-+.|+++... |+...|| ++.+. .....++.++|+++|.+.+--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 3478999999999999984 4554444 44332 1223467889999999987666665555677777788999
Q ss_pred EecCC-CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC---CeEEeecCCcee
Q 005718 590 EYMPN-KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARM 665 (681)
Q Consensus 590 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~---~~kl~DFGla~~ 665 (681)
||.++ .++.+++.........+ ......+..|-+.+.-||.++ |||+||..+||+|..++ .+.++||||+..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 47777775433332222 222578888999999999998 99999999999997655 458999999876
Q ss_pred ecCC
Q 005718 666 FCGD 669 (681)
Q Consensus 666 ~~~~ 669 (681)
-...
T Consensus 166 s~~~ 169 (229)
T KOG3087|consen 166 SRLP 169 (229)
T ss_pred ccCc
Confidence 4333
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=7.7e-11 Score=133.89 Aligned_cols=142 Identities=25% Similarity=0.258 Sum_probs=114.2
Q ss_pred CCCceeeecccCcEeEEEEEecCCcEEEEEEecCCC-cccHHHHHHHHHHH--hhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS-GQGLKEFKNEMMLI--AKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l--~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
++...+.||++.|=+|.++++++|. |+||++.+.. ....+.|.++++-+ ..++|||++.+.-+-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777799999999999999998886 8899887653 44556666655544 445899999988776677777888888
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
..+ +|.+-| ..+..+...+..-|+.|++.||.-+|..+ |.|+|||.+||||++-.-+.|+||.-=|
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence 865 555554 33445677888899999999999999988 9999999999999999999999997544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=98.93 E-value=5.1e-09 Score=106.84 Aligned_cols=147 Identities=21% Similarity=0.319 Sum_probs=96.3
Q ss_pred CCceeeecccCcEeEEEEEecC-CcEEEEEEecCC---CcccHHHHHHHHHHHhhCCC----------CCeeEEEEEEE-
Q 005718 516 FSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQH----------RNLVRLMGCCV- 580 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H----------~nIv~l~g~~~- 580 (681)
+...+.||.|+++.||++.+.+ ++++|||..... .....+++++|.-....+.+ -.++-.++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4456899999999999999965 889999977532 23356778887766655433 12222222211
Q ss_pred --------eC---C-----eEEEEEEecCCCChhhHhc---CCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeec
Q 005718 581 --------EQ---G-----EKILIYEYMPNKSLNFFLF---DPSR-THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHR 640 (681)
Q Consensus 581 --------~~---~-----~~~lV~Ey~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHr 640 (681)
.. . ..+++|+-+ .++|.+++. .... ...+....++.+..|+.+.+++||+.+ ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 11 1 235677777 567877652 1111 223445666778899999999999998 9999
Q ss_pred ccCCCcEEEcCCCCeEEeecCCceee
Q 005718 641 DLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 641 Dlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
||||+|++++.+|.++|+||+-....
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~ 195 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRA 195 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEET
T ss_pred ccceeeEEEcCCCCEEEcChHHHeec
Confidence 99999999999999999999887655
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.8e-10 Score=124.90 Aligned_cols=144 Identities=24% Similarity=0.307 Sum_probs=116.0
Q ss_pred eecccCcEeEEEEEe----cCCcEEEEEEecCCCcc--cHHHHHHHHHHHhhCC-CCCeeEEEEEEEeCCeEEEEEEecC
Q 005718 521 KLGEGGFGPVYKGKL----LNGQEVAVKRLSSQSGQ--GLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYEYMP 593 (681)
Q Consensus 521 ~LG~G~fG~Vy~~~~----~~~~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~ 593 (681)
.+|+|.||.|++..- ..+...|+|.+++.... .......|..++...+ ||.++++.-.+......+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999997642 33667888888764221 1124566778888886 9999999999999999999999999
Q ss_pred CCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCC
Q 005718 594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 670 (681)
+|.|...+.+ ...+.......+...++-+++++|+.+ |+|||+|++||+++.+|++|+.|||++|+.-...
T Consensus 81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 9999877732 334566666677788999999999887 9999999999999999999999999999875443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=4.1e-10 Score=109.67 Aligned_cols=140 Identities=23% Similarity=0.458 Sum_probs=112.6
Q ss_pred CCceeeecccCcEeEEEEEecCCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecC
Q 005718 516 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 593 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 593 (681)
..+..+|.+...|..|+|++.. ..+++|++.-. ...-.++|..|.-.|+.+.||||+.++|.|....+..++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 3345678888999999999954 45666766532 22334678889999999999999999999999999999999999
Q ss_pred CCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEe
Q 005718 594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 658 (681)
Q Consensus 594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~ 658 (681)
.|+|...|++. ..-..+..++.+++.+||+|++|||+.. +-|..--|....++||++.+++|+
T Consensus 271 ~gslynvlhe~-t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 271 FGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred chHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee
Confidence 99999999653 3334677889999999999999999975 234445688999999999987763
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.8e-09 Score=107.53 Aligned_cols=88 Identities=27% Similarity=0.483 Sum_probs=69.2
Q ss_pred CCCCeeEEEEEEEe---------------------------CCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHH
Q 005718 568 QHRNLVRLMGCCVE---------------------------QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620 (681)
Q Consensus 568 ~H~nIv~l~g~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 620 (681)
+|||||++.++|.+ +...|+||.-++. +|..++... ..+...+.-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence 58888888887754 2356888887754 788888432 345677888999
Q ss_pred HHHHHHHHHHhCCCCCeeecccCCCcEEEc--CCC--CeEEeecCCc
Q 005718 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLD--SDM--NPKISDFGMA 663 (681)
Q Consensus 621 ~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~--~~~--~~kl~DFGla 663 (681)
|+++|+.|||.++ |.|||+|.+||||. ++. .+.|+|||.+
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEccccee
Confidence 9999999999987 99999999999993 444 4689999965
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=8.3e-08 Score=98.10 Aligned_cols=142 Identities=18% Similarity=0.109 Sum_probs=101.5
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEecCCCc-----------ccHHHHHHHHHHHhhCCC--CCeeEEEEEEEeC----
Q 005718 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG-----------QGLKEFKNEMMLIAKLQH--RNLVRLMGCCVEQ---- 582 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~-----------~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~---- 582 (681)
+.+-+.....|++... +|+.+.||+...... .....+.+|...+.++.. -.+++++++....
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445777766 667899997754221 111247889999888843 4445566666542
Q ss_pred -CeEEEEEEecCCC-ChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC-------CC
Q 005718 583 -GEKILIYEYMPNK-SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-------DM 653 (681)
Q Consensus 583 -~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~-------~~ 653 (681)
...+||+|++++- +|.+++.+.. ....+...+..++.++++.+.-||..+ |+|+|++++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 3578999999985 8888874321 123455677789999999999999998 999999999999975 46
Q ss_pred CeEEeecCCceee
Q 005718 654 NPKISDFGMARMF 666 (681)
Q Consensus 654 ~~kl~DFGla~~~ 666 (681)
.+.|+||+.++..
T Consensus 183 ~~~LIDl~r~~~~ 195 (268)
T PRK15123 183 KLSVIDLHRAQIR 195 (268)
T ss_pred eEEEEECCccccc
Confidence 8999999999753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.9e-08 Score=95.76 Aligned_cols=126 Identities=25% Similarity=0.285 Sum_probs=83.2
Q ss_pred eEEEEEecCCcEEEEEEecCCC--------------c------------ccHHHHHHHHHHHhhCCCC--CeeEEEEEEE
Q 005718 529 PVYKGKLLNGQEVAVKRLSSQS--------------G------------QGLKEFKNEMMLIAKLQHR--NLVRLMGCCV 580 (681)
Q Consensus 529 ~Vy~~~~~~~~~VAVK~l~~~~--------------~------------~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~ 580 (681)
.||.|...++..+|||..+... . .......+|.+.|.++... ++++++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999899999999775421 0 0123578899999999765 677777552
Q ss_pred eCCeEEEEEEecC--CCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeecccCCCcEEEcCCCCeEE
Q 005718 581 EQGEKILIYEYMP--NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL-HQYSRLRIIHRDLKASNILLDSDMNPKI 657 (681)
Q Consensus 581 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivHrDlkp~NiLl~~~~~~kl 657 (681)
...|||||++ +..+..+.... ++......++.++++.+..+ |..+ |+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 3479999998 65554433111 11233456777788766664 6666 9999999999999888 9999
Q ss_pred eecCCceeec
Q 005718 658 SDFGMARMFC 667 (681)
Q Consensus 658 ~DFGla~~~~ 667 (681)
+|||.|....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=9.1e-09 Score=111.69 Aligned_cols=100 Identities=34% Similarity=0.506 Sum_probs=89.9
Q ss_pred HhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccC
Q 005718 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLK 643 (681)
Q Consensus 564 l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk 643 (681)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+.. ....+++.-...++.+|++||+|||... -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 3567899999999999999999999999999999999955 3445889999999999999999999754 23999999
Q ss_pred CCcEEEcCCCCeEEeecCCceeec
Q 005718 644 ASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 644 p~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
++|+++|....+||+|||+..+..
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred cccceeeeeEEEEechhhhccccc
Confidence 999999999999999999998874
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.2e-07 Score=84.24 Aligned_cols=88 Identities=24% Similarity=0.287 Sum_probs=64.0
Q ss_pred eEEEeeCCcEEEEeCC-CcEEEeecCccc-cCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCCccccCCccccce
Q 005718 89 VLTIGNNGNLVLLNQT-DGIIWSSNLSRE-VKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWD 166 (681)
Q Consensus 89 ~l~~~~~g~l~l~~~~-~~~~w~~~~~~~-~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~PtDtlLpgq~l~~~ 166 (681)
.+.++.||+||+++.. +.+||++++... .....+.|+++|||||++.+ +.++|+| +|-
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~------g~~vW~S-----~t~--------- 82 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGD------GRVVWSS-----NTT--------- 82 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCC------CCEEEEe-----ccc---------
Confidence 4556689999999875 579999998643 23378899999999999864 6789997 110
Q ss_pred eccCceeEEEEeccCCCCCCcceEEEeecCCccEEEEEcCCeEEEeeC
Q 005718 167 LKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTG 214 (681)
Q Consensus 167 ~~~g~~~~l~S~~s~~dps~G~y~~~~~~~g~~~~~~~~~~~~~w~sg 214 (681)
...|.|.+.|+++|++.++-. .+.+.|.+.
T Consensus 83 -----------------~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf 112 (114)
T smart00108 83 -----------------GANGNYVLVLLDDGNLVIYDS-DGNFLWQSF 112 (114)
T ss_pred -----------------CCCCceEEEEeCCCCEEEECC-CCCEEeCCC
Confidence 123678999999999876532 235778653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.60 E-value=6e-09 Score=118.14 Aligned_cols=152 Identities=24% Similarity=0.351 Sum_probs=119.6
Q ss_pred hCCCCceeeecccCcEeEEEEEecC--CcEEEEEEecCCC--cccHHHHHHHHHHHhhCC-CCCeeEEEEEEEeCCeEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN--GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~--~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~l 587 (681)
...|.+.+.||+|.|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3456677889999999998887643 4456777665432 223344555777777775 9999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeecccCCCcEEEcCCC-CeEEeecCCcee
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH-QYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARM 665 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~ 665 (681)
++||.+++++.+.+..... ...+....-.+..|+..++.|+| +.+ +.||||||+|.+++..+ ..|++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccCCc-cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999999877742221 12344566678999999999999 776 99999999999999999 999999999988
Q ss_pred ecC
Q 005718 666 FCG 668 (681)
Q Consensus 666 ~~~ 668 (681)
+..
T Consensus 175 ~~~ 177 (601)
T KOG0590|consen 175 YRN 177 (601)
T ss_pred ccc
Confidence 866
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.1e-07 Score=97.01 Aligned_cols=140 Identities=21% Similarity=0.307 Sum_probs=112.8
Q ss_pred EeEEEEEe-cCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe----CCeEEEEEEecCC-CChhhHh
Q 005718 528 GPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEKILIYEYMPN-KSLNFFL 601 (681)
Q Consensus 528 G~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~Ey~~~-gsL~~~l 601 (681)
.+.||+.. .+|..+++|++.....+.......-++.++++.|.|||++..++.. +..+++||+|+++ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 46788876 4789999999965433333334456788999999999999998873 3478999999986 6776665
Q ss_pred cCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 602 FDP------------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 602 ~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
+.. ..+...++...+.++.|++.||.++|+.+ +.-+-|.|.+||++.+.+++|+..|+..++..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 432 12334678899999999999999999998 888999999999999999999999999988776
Q ss_pred C
Q 005718 670 E 670 (681)
Q Consensus 670 ~ 670 (681)
+
T Consensus 447 ~ 447 (655)
T KOG3741|consen 447 P 447 (655)
T ss_pred C
Confidence 6
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.5e-07 Score=82.33 Aligned_cols=88 Identities=22% Similarity=0.248 Sum_probs=64.2
Q ss_pred EEEee-CCcEEEEeCC-CcEEEeecCccc-cCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCCccccCCccccce
Q 005718 90 LTIGN-NGNLVLLNQT-DGIIWSSNLSRE-VKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWD 166 (681)
Q Consensus 90 l~~~~-~g~l~l~~~~-~~~~w~~~~~~~-~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~PtDtlLpgq~l~~~ 166 (681)
+.++. ||+||+++.. +.+||++++... .....+.|+++|||||++.+ +.++|+|=-.
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~------g~~vW~S~~~-------------- 83 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGS------GTVVWSSNTT-------------- 83 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCC------CcEEEEeccc--------------
Confidence 44555 9999999875 579999998642 35678899999999999864 6789996110
Q ss_pred eccCceeEEEEeccCCCCCCcceEEEeecCCccEEEEEcCCeEEEeeCC
Q 005718 167 LKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP 215 (681)
Q Consensus 167 ~~~g~~~~l~S~~s~~dps~G~y~~~~~~~g~~~~~~~~~~~~~w~sg~ 215 (681)
...+.+.+.|+++|+..++-.+ ..+.|.+..
T Consensus 84 -----------------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~ 114 (116)
T cd00028 84 -----------------RVNGNYVLVLLDDGNLVLYDSD-GNFLWQSFD 114 (116)
T ss_pred -----------------CCCCceEEEEeCCCCEEEECCC-CCEEEcCCC
Confidence 0246789999999998775333 456787653
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.56 E-value=8.1e-07 Score=78.56 Aligned_cols=99 Identities=26% Similarity=0.407 Sum_probs=70.8
Q ss_pred CEEEeCCCeEEEEeeCCCCCCcEEEEEEEeCCCCceEEEc-cCCCCCcCCcceEEEeeCCcEEEEeCCCcEEEeecCccc
Q 005718 38 EKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVA-NRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSRE 116 (681)
Q Consensus 38 ~~l~S~~g~f~~gf~~~~~~~~~~l~i~~~~~~~~~vW~a-n~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~ 116 (681)
+++.+.+|.+.|-|..+|+ | +.|+. ..++||.+ +...+.. ..+.+.|+.||||||+|..+.++|++.. .
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----L-vl~~~-~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~--~ 81 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----L-VLYDS-NGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFD--Y 81 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----E-EEEET-TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTT--S
T ss_pred cccccccccccceECCCCe-----E-EEEcC-CCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecC--C
Confidence 4566656999999999886 3 55553 45789999 5454422 4689999999999999999999999942 2
Q ss_pred cCCceEEEec--CCCEEEeecCCCCCCCCceeeeeccCC
Q 005718 117 VKNPVAQLLD--TGNLVLREKFSSNTSEGSYLWQSFDCP 153 (681)
Q Consensus 117 ~~~~~~~l~~--~gnlvl~~~~~~~~~~~~~~wqSFd~P 153 (681)
...+.+..++ +||++ +... ..+.|.|=+.|
T Consensus 82 ptdt~L~~q~l~~~~~~-~~~~------~~~sw~s~~dp 113 (114)
T PF01453_consen 82 PTDTLLPGQKLGDGNVT-GKND------SLTSWSSNTDP 113 (114)
T ss_dssp SS-EEEEEET--TSEEE-EEST------SSEEEESS---
T ss_pred CccEEEeccCcccCCCc-cccc------eEEeECCCCCC
Confidence 4567888888 99999 7542 56889886665
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=6.5e-07 Score=88.92 Aligned_cols=135 Identities=20% Similarity=0.213 Sum_probs=94.8
Q ss_pred CCceeeecccCcEeEEEEEecCCcEEEEEEecCCC----------------------cccHHHHHHHHHHHhhCCCC--C
Q 005718 516 FSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS----------------------GQGLKEFKNEMMLIAKLQHR--N 571 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~----------------------~~~~~~f~~Ei~~l~~l~H~--n 571 (681)
..+.++||.|.-+.||.|..+.|.++|||.=+... ........+|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 44568999999999999999999999999433210 01123567899999999654 7
Q ss_pred eeEEEEEEEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC
Q 005718 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 651 (681)
Q Consensus 572 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~ 651 (681)
|.+.+++ +...+||||.++-.|...-. ..-... .++..|++-+.-+-..+ +||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~---~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPD---EILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC-----cccCHH---HHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 8887764 55679999999977643221 111222 33333444333333444 999999999999999
Q ss_pred CCCeEEeecCCcee
Q 005718 652 DMNPKISDFGMARM 665 (681)
Q Consensus 652 ~~~~kl~DFGla~~ 665 (681)
++.++++||==+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999965543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.2e-06 Score=86.43 Aligned_cols=109 Identities=24% Similarity=0.240 Sum_probs=86.6
Q ss_pred cHHHHHHHHHHHhhCC--CCCeeEEEEEEEeCC----eEEEEEEecCC-CChhhHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 005718 553 GLKEFKNEMMLIAKLQ--HRNLVRLMGCCVEQG----EKILIYEYMPN-KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625 (681)
Q Consensus 553 ~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~----~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~ 625 (681)
....+.+|...+.++. .-.+++.+++..... ..+||+|++++ .+|.+++.+... .+......++.++++.
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARL 130 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHH
Confidence 3456788888888874 445667777776532 45899999987 479888843211 4556778899999999
Q ss_pred HHHHHhCCCCCeeecccCCCcEEEcCCC---CeEEeecCCceeec
Q 005718 626 LLYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARMFC 667 (681)
Q Consensus 626 L~yLH~~~~~~ivHrDlkp~NiLl~~~~---~~kl~DFGla~~~~ 667 (681)
++-||..+ |+|+|+++.|||++.+. .+.++||+.++...
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999998 99999999999999887 89999999988764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.48 E-value=3.4e-06 Score=81.97 Aligned_cols=139 Identities=15% Similarity=0.153 Sum_probs=104.1
Q ss_pred ecccCcEeEEEEEecCCcEEEEEEecCCC------cccHHHHHHHHHHHhhCC--CCCeeEEEEEEEeC----CeEEEEE
Q 005718 522 LGEGGFGPVYKGKLLNGQEVAVKRLSSQS------GQGLKEFKNEMMLIAKLQ--HRNLVRLMGCCVEQ----GEKILIY 589 (681)
Q Consensus 522 LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~------~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~----~~~~lV~ 589 (681)
-++|+-+.|++-.+. |+.+-+|+..... +.....|.+|...|.++. ...+.++....... -..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 456888889998774 4478888776221 345678999999999994 34466666332222 2468999
Q ss_pred EecCC-CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCC--eEEeecCCcee
Q 005718 590 EYMPN-KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--PKISDFGMARM 665 (681)
Q Consensus 590 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~--~kl~DFGla~~ 665 (681)
|-+++ .+|.+++.+.. ....+...+..+..++++.+.-||..+ +.|+|+-+.||+++.++. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 68888874322 224567778899999999999999988 999999999999986666 99999987764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=9.2e-07 Score=97.36 Aligned_cols=121 Identities=17% Similarity=0.258 Sum_probs=98.6
Q ss_pred cCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHH
Q 005718 536 LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR 615 (681)
Q Consensus 536 ~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~ 615 (681)
.++.+|.|...+.......+...+-+.-|+.++||||++++......+..|||+|-+ ..|..++.+ +.....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHHH
Confidence 357788888887654433455677788999999999999999999999999999988 466666632 224555
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 616 ~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
...+.||+.||.+||+.+ .++|++|.-+-|++++.|+.||++|-++...
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 667899999999999766 5999999999999999999999999887554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.4e-06 Score=96.48 Aligned_cols=142 Identities=18% Similarity=0.214 Sum_probs=92.9
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEecCCCccc------------------------------HH----------HHHH
Q 005718 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQG------------------------------LK----------EFKN 559 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~------------------------------~~----------~f~~ 559 (681)
+.|+.++-|+||+|++++|+.||||+.++.-... .+ ++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6799999999999999999999999998742110 00 1333
Q ss_pred HHHHHhhC----CCCCeeEEEEEEE-eCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCC
Q 005718 560 EMMLIAKL----QHRNLVRLMGCCV-EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL-LYLHQYS 633 (681)
Q Consensus 560 Ei~~l~~l----~H~nIv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~ 633 (681)
|..-+.++ ++..-+++=.++. -.....|+|||++|..+.++..-.. ..++ +..++..++++. ..+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d---~k~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGID---RKELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCC---HHHHHHHHHHHHHHHHHhcC
Confidence 44434333 2222223333333 3467789999999999887742222 2233 223444333332 2222234
Q ss_pred CCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 634 ~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
++|.|..|.||+++.++.+.+.|||+...+.++
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 999999999999999999999999999877543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=3.5e-07 Score=104.74 Aligned_cols=111 Identities=27% Similarity=0.414 Sum_probs=76.6
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
..+|..+++|..|++|.||..+++. .+.+|+| +.++.- -+++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l----ilRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL----ILRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch----hhhc---cccccCCccee------------------
Confidence 4678889999999999999998865 5678884 433210 0111 22223344444
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|+-...+. ....++. +++.+++|||+.+ |+|||+||+|.+|+.-|++|+.||||+++.
T Consensus 136 ---gDc~tllk---~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 ---GDCATLLK---NIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred ---chhhhhcc---cCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 33333331 1112221 2278999999888 999999999999999999999999999864
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.2e-05 Score=80.38 Aligned_cols=140 Identities=16% Similarity=0.199 Sum_probs=85.9
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCC--CeeEEEEEEEeCCeEEEEEEecCCCC-
Q 005718 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHR--NLVRLMGCCVEQGEKILIYEYMPNKS- 596 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~~~~~~~lV~Ey~~~gs- 596 (681)
..|++|..+.||+. .+..+++|...... ......+|.+++..+..- .+.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999984 24456778776432 345568899999888543 35778888878888889999999863
Q ss_pred hhhHhc--------------------CCCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHh-CCCCCeeecccC
Q 005718 597 LNFFLF--------------------DPSRTHLLGWQTRVK-IIE----------GIAQ-GLLYLHQ-YSRLRIIHRDLK 643 (681)
Q Consensus 597 L~~~l~--------------------~~~~~~~l~~~~~~~-i~~----------~ia~-~L~yLH~-~~~~~ivHrDlk 643 (681)
+...+. ............... +.. .+.+ ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 221110 000000011111000 000 0111 1122221 123357899999
Q ss_pred CCcEEEcCCCCeEEeecCCcee
Q 005718 644 ASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 644 p~NiLl~~~~~~kl~DFGla~~ 665 (681)
|.||++++++ +.|+||+.|..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.26 E-value=5e-07 Score=98.44 Aligned_cols=148 Identities=23% Similarity=0.275 Sum_probs=116.3
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec--CCcEEEEEEecCCCcccHH--HHHHHHHHHhhC-CCCCeeEEEEEEEeCCeE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL--NGQEVAVKRLSSQSGQGLK--EFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~--~~~~VAVK~l~~~~~~~~~--~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 585 (681)
....+|.++..||.|.|+.|++...+ ++..+++|.+......... .-..|+.+...+ .|.++++....+....+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567888999999999999988643 4678888887654322222 224566655555 688888888888888888
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC-CCeEEeecCCce
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMAR 664 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFGla~ 664 (681)
++=.||++++++...+ .-...+....++.+..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+.
T Consensus 342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 8999999999887555 23344667788899999999999999876 9999999999999876 788999999986
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.22 E-value=9.1e-07 Score=96.42 Aligned_cols=151 Identities=25% Similarity=0.316 Sum_probs=117.5
Q ss_pred CCCCceeeecc--cCcEeEEEEEe---cCCcEEEEEEecCC--CcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeE
Q 005718 514 ENFSMQCKLGE--GGFGPVYKGKL---LNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 514 ~~f~~~~~LG~--G~fG~Vy~~~~---~~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 585 (681)
..|...+.+|. |.+|.||.+.. .++..+|+|+-+.. .+.....=.+|+...+++ .|+|.++....+..++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34556688999 99999999976 34778999985432 223333335677777777 599999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeeecccCCCcEEEcCC-CCeEEeec
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ----GLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDF 660 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DF 660 (681)
++-+|++. .+|..+... ....++......+..+..+ ||.++|... ++|-|+||.||++..+ ..+++.||
T Consensus 194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999996 666666532 2333566677777777777 999999987 9999999999999999 89999999
Q ss_pred CCceeecCCC
Q 005718 661 GMARMFCGDE 670 (681)
Q Consensus 661 Gla~~~~~~~ 670 (681)
|+.+.+....
T Consensus 268 ~~v~~i~~~~ 277 (524)
T KOG0601|consen 268 GLVSKISDGN 277 (524)
T ss_pred ceeEEccCCc
Confidence 9999886554
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.8e-06 Score=81.31 Aligned_cols=62 Identities=26% Similarity=0.121 Sum_probs=53.6
Q ss_pred CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
|+|.+++.+ +...+++.++..|+.||++||+|||+.+ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~ 62 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE 62 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc
Confidence 688888843 2445899999999999999999999875 999999999999999 9999987543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.19 E-value=6.9e-06 Score=79.53 Aligned_cols=105 Identities=23% Similarity=0.224 Sum_probs=83.0
Q ss_pred HHHHHHHhhCCC-CCeeEEEEEEEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 005718 558 KNEMMLIAKLQH-RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636 (681)
Q Consensus 558 ~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 636 (681)
..|..++..+++ +++++++|+|- .++|.||...+++...-..-..-...+|..|.+||.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888876 69999999993 3689999988766422100011123689999999999999999999865556
Q ss_pred eeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 637 IIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 637 ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+.-+|++|+|+-+++++++|++|...+-..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999887654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.18 E-value=4.3e-06 Score=68.33 Aligned_cols=61 Identities=34% Similarity=0.852 Sum_probs=47.0
Q ss_pred CCeEEEeccccCCcccceeeccccCHHHHHHHhhc-CCceeeeeeccccCCCccceeec-ccccchh
Q 005718 340 RERFIKFDDIKLPYLVDVSLNESMNLKECEAECLK-NCTCRAYANSKVTGGGSGCLMWF-GDLIDIR 404 (681)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~-nCsC~a~~y~~~~~~~~gC~~w~-~~l~~~~ 404 (681)
...|..++++.++...... ....++++|++.|++ +|+|.||.|.. ++.+|.+|. +.+.+..
T Consensus 3 ~~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~ 65 (78)
T smart00473 3 DDCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDAR 65 (78)
T ss_pred CceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccce
Confidence 3568899999988544432 345799999999999 99999999964 344699998 6666655
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.15 E-value=5.8e-05 Score=73.77 Aligned_cols=140 Identities=16% Similarity=0.184 Sum_probs=92.3
Q ss_pred HhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHH---------HHHHHHHHhhCCCC---CeeEEEEE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKE---------FKNEMMLIAKLQHR---NLVRLMGC 578 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~---------f~~Ei~~l~~l~H~---nIv~l~g~ 578 (681)
....+|...+.+-......|.+-.. +++...+|..+.......+. ..+++..+.+++.. ....++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3457788878888877777777776 56788888877543322222 22333334444322 22232322
Q ss_pred EEe-----CCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC
Q 005718 579 CVE-----QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 653 (681)
Q Consensus 579 ~~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~ 653 (681)
... ....+|+|||++|..|.++.. ++. .++..+.+.+.-||..+ +.|+|..|.|++++.+
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-
Confidence 222 134578999999988865431 121 34566778899999988 9999999999999855
Q ss_pred CeEEeecCCceee
Q 005718 654 NPKISDFGMARMF 666 (681)
Q Consensus 654 ~~kl~DFGla~~~ 666 (681)
.+++.||+..+..
T Consensus 172 ~i~iID~~~k~~~ 184 (229)
T PF06176_consen 172 GIRIIDTQGKRMS 184 (229)
T ss_pred cEEEEECcccccc
Confidence 4999999987754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.14 E-value=3.9e-05 Score=76.70 Aligned_cols=145 Identities=22% Similarity=0.211 Sum_probs=87.3
Q ss_pred eeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCC--CCeeEEEEEEEeC---CeEEEEEEecC
Q 005718 519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH--RNLVRLMGCCVEQ---GEKILIYEYMP 593 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~---~~~~lV~Ey~~ 593 (681)
++.|+.|..+.||+....+ ..+++|..... .....+..|..++..+.. ..+.+++.+.... ...+++||+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3688999999999999877 68999987653 455677888888888743 3467777755433 35789999999
Q ss_pred CCChhh----------------Hh---cCC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 005718 594 NKSLNF----------------FL---FDP-SRTHLLGWQT---------RVKI------------IEGIAQ-GLLYLHQ 631 (681)
Q Consensus 594 ~gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-~L~yLH~ 631 (681)
+..+.. .+ ... .......... .... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 010 0111111100 0000 111222 3333332
Q ss_pred ----CCCCCeeecccCCCcEEEc-CCCCeEEeecCCceee
Q 005718 632 ----YSRLRIIHRDLKASNILLD-SDMNPKISDFGMARMF 666 (681)
Q Consensus 632 ----~~~~~ivHrDlkp~NiLl~-~~~~~kl~DFGla~~~ 666 (681)
.....++|+|+.|.|||++ +++.+.|.||+.+..-
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 2345699999999999999 6666689999988754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.8e-05 Score=87.40 Aligned_cols=138 Identities=18% Similarity=0.227 Sum_probs=88.5
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEecCCCccc-------------------------------HH------HHHHHHH
Q 005718 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQG-------------------------------LK------EFKNEMM 562 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~-------------------------------~~------~f~~Ei~ 562 (681)
+.|+..+.|+||+|++++|+.||||+.++.-... .+ +|..|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999987642110 00 2334443
Q ss_pred H----HhhCCCCC------eeEEEEEEEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-Hh
Q 005718 563 L----IAKLQHRN------LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL-HQ 631 (681)
Q Consensus 563 ~----l~~l~H~n------Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~ 631 (681)
- .+.+.|-+ |.+++- .-...+.|+||||+|..+.+.-.- ....++.. .++..+.++...+ -.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~---~i~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI--DKRGISPH---DILNKLVEAYLEQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH--HHcCCCHH---HHHHHHHHHHHHHHHh
Confidence 2 23334555 333332 223578999999999877665311 11223333 3333333332222 22
Q ss_pred CCCCCeeecccCCCcEEEcC----CCCeEEeecCCceeec
Q 005718 632 YSRLRIIHRDLKASNILLDS----DMNPKISDFGMARMFC 667 (681)
Q Consensus 632 ~~~~~ivHrDlkp~NiLl~~----~~~~kl~DFGla~~~~ 667 (681)
. +++|+|-.|.||++.. ++.+.+-|||+.+.+.
T Consensus 320 ~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 T---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred c---CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 2 4999999999999984 6689999999988664
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.07 E-value=7.4e-07 Score=95.43 Aligned_cols=81 Identities=28% Similarity=0.352 Sum_probs=72.2
Q ss_pred eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCc
Q 005718 584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla 663 (681)
..++.|+++...+|.++|..+......++...+.++.|++.|++| ++ .+|+|+||.||+...+..+||.||||.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999776666677889999999999999999 44 899999999999999999999999998
Q ss_pred eeecCCC
Q 005718 664 RMFCGDE 670 (681)
Q Consensus 664 ~~~~~~~ 670 (681)
.-....+
T Consensus 404 ts~~~~~ 410 (516)
T KOG1033|consen 404 TSQDKDE 410 (516)
T ss_pred eecccCC
Confidence 8776555
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.07 E-value=5e-05 Score=77.02 Aligned_cols=142 Identities=15% Similarity=0.128 Sum_probs=87.4
Q ss_pred eecccCc-EeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEEEecCCCChh
Q 005718 521 KLGEGGF-GPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLN 598 (681)
Q Consensus 521 ~LG~G~f-G~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 598 (681)
.|..|.. ..||+.... +..+.||+..... ...+.+|++++..+ .+--+.+++++....+..++|||++++.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555555 778998764 4678888776432 34567788888887 3455778888877777789999999998776
Q ss_pred hHhc-------------------CCCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----C
Q 005718 599 FFLF-------------------DPSR-THLLG--WQTRVKIIE--------------------GIAQGLLYLHQ----Y 632 (681)
Q Consensus 599 ~~l~-------------------~~~~-~~~l~--~~~~~~i~~--------------------~ia~~L~yLH~----~ 632 (681)
.... .... ...+. ....+.-.. .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4321 0000 00111 000000000 01111222211 1
Q ss_pred CCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 633 ~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
..+.++|+|+.|.|||++.+..+.|+||+.|.+-
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g 194 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA 194 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence 2345899999999999999877899999988743
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.00 E-value=8.3e-05 Score=73.49 Aligned_cols=153 Identities=18% Similarity=0.203 Sum_probs=100.6
Q ss_pred ccHHHHHHhhCCCCcee---eecccCcEeEEEEEecCCcEEEEEEecCCCcc-------------------cH-----HH
Q 005718 504 FSLASVSAATENFSMQC---KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ-------------------GL-----KE 556 (681)
Q Consensus 504 ~~~~~~~~~~~~f~~~~---~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~-------------------~~-----~~ 556 (681)
.++..+........+.. .|.+|.-+.||+|...++..+|||+.+..... .. .-
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 34444444444444444 45677788999999888999999988753210 00 12
Q ss_pred HHHHHHHHhhC--CCCCeeEEEEEEEeCCeEEEEEEecCCCChh-hHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 005718 557 FKNEMMLIAKL--QHRNLVRLMGCCVEQGEKILIYEYMPNKSLN-FFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633 (681)
Q Consensus 557 f~~Ei~~l~~l--~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~-~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~ 633 (681)
..+|..-|.++ .+-.+.+.+++. +..|||||+....+- -.| ..-.+...+...+..++++.+.-|-...
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 35577777777 355666666653 447999999654211 111 1111222356667777888888776633
Q ss_pred CCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 634 ~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
++||+||..=|||+. ++.+.|+|||=|....
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 499999999999999 8899999999887664
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=3.1e-06 Score=85.46 Aligned_cols=96 Identities=29% Similarity=0.346 Sum_probs=79.0
Q ss_pred HHHhhCCCCCeeEEEEEEEeCC-----eEEEEEEecCCCChhhHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 005718 562 MLIAKLQHRNLVRLMGCCVEQG-----EKILIYEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635 (681)
Q Consensus 562 ~~l~~l~H~nIv~l~g~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 635 (681)
.-|-.+-|.|||+++.|+.+.+ +..++.|||+-|+|..+|.+.. ....+..+.-.+++-||..||.|||+. .+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 3444557999999999987654 4688999999999999996432 234466677778999999999999997 57
Q ss_pred CeeecccCCCcEEEcCCCCeEEe
Q 005718 636 RIIHRDLKASNILLDSDMNPKIS 658 (681)
Q Consensus 636 ~ivHrDlkp~NiLl~~~~~~kl~ 658 (681)
+|+|+++..+-|++..++-+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred ccccCCcchhheeecCCceEEec
Confidence 89999999999999999988874
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00054 Score=66.29 Aligned_cols=125 Identities=23% Similarity=0.397 Sum_probs=89.7
Q ss_pred CCCCceeeecccCc-EeEEEEEecCCcEEEEEEecCC---C--------c----------ccHHHHHHHHHHHhhCC---
Q 005718 514 ENFSMQCKLGEGGF-GPVYKGKLLNGQEVAVKRLSSQ---S--------G----------QGLKEFKNEMMLIAKLQ--- 568 (681)
Q Consensus 514 ~~f~~~~~LG~G~f-G~Vy~~~~~~~~~VAVK~l~~~---~--------~----------~~~~~f~~Ei~~l~~l~--- 568 (681)
.+++..+.||.|.- |.||+++. +|+.+|+|..+.- . . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 77888999999999 99999999 6679999983220 0 0 11235889999988884
Q ss_pred CCCe--eEEEEEEEeC------------------CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 005718 569 HRNL--VRLMGCCVEQ------------------GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628 (681)
Q Consensus 569 H~nI--v~l~g~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y 628 (681)
+.++ |+.+||..-. ..+-||.||.+... .+ ...-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~----~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL----QIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc----chhHHHHHHHHHHH
Confidence 4466 8888886322 12356777664432 11 12335677888889
Q ss_pred HHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCc
Q 005718 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663 (681)
Q Consensus 629 LH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla 663 (681)
+|..+ |+-+|++++|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99887 999999999985 3589999865
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00028 Score=84.27 Aligned_cols=79 Identities=18% Similarity=0.393 Sum_probs=57.4
Q ss_pred eeeecccCcEeEEEEEecCC---cEEEEEEecCCC-cccHHHHHHHHHHHhhCC-CCCe--eEEEEEEEeC---CeEEEE
Q 005718 519 QCKLGEGGFGPVYKGKLLNG---QEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQ-HRNL--VRLMGCCVEQ---GEKILI 588 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~~---~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~nI--v~l~g~~~~~---~~~~lV 588 (681)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|.++++.+. |.+| .+++++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 47789999999999877553 356667654322 123457889999999995 6654 8888888764 467899
Q ss_pred EEecCCCCh
Q 005718 589 YEYMPNKSL 597 (681)
Q Consensus 589 ~Ey~~~gsL 597 (681)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987643
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00069 Score=70.80 Aligned_cols=77 Identities=13% Similarity=0.095 Sum_probs=57.3
Q ss_pred ceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCC---CCeeEEEEEEEeC---CeEEEEEEe
Q 005718 518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH---RNLVRLMGCCVEQ---GEKILIYEY 591 (681)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H---~nIv~l~g~~~~~---~~~~lV~Ey 591 (681)
-.+.|+.|..+.||+....++ .+.+|..+. ......|..|.+.|+.+.. ..+.++++++... +..+||||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 346899999999999877555 455666432 1134688899999988843 4688999888643 568999999
Q ss_pred cCCCCh
Q 005718 592 MPNKSL 597 (681)
Q Consensus 592 ~~~gsL 597 (681)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00042 Score=69.87 Aligned_cols=73 Identities=12% Similarity=0.216 Sum_probs=45.9
Q ss_pred eeecccCcE-eEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCC---CeeEEEEEEEeC---CeEEEEEEec
Q 005718 520 CKLGEGGFG-PVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHR---NLVRLMGCCVEQ---GEKILIYEYM 592 (681)
Q Consensus 520 ~~LG~G~fG-~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~l~g~~~~~---~~~~lV~Ey~ 592 (681)
+.|+.|+.. .||+. +..+.+|.... ......+.+|.+.+..+... .+.++++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567777766 48875 23456675443 22345788999998887532 455555544332 2358899999
Q ss_pred CCCChh
Q 005718 593 PNKSLN 598 (681)
Q Consensus 593 ~~gsL~ 598 (681)
++.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00077 Score=65.69 Aligned_cols=133 Identities=17% Similarity=0.218 Sum_probs=90.4
Q ss_pred eeeecccCcEeEEEEEecCCcEEEEEEecCCC----------------cccHHHHHHHHHHHhhCC------CCCeeEEE
Q 005718 519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS----------------GQGLKEFKNEMMLIAKLQ------HRNLVRLM 576 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~----------------~~~~~~f~~Ei~~l~~l~------H~nIv~l~ 576 (681)
...||+|+.=.||. +++....+||+..... ....++.++|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 36799999888884 4455677888887654 123466777776665555 78999999
Q ss_pred EEEEeCCeEEEEEEecCC------CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc
Q 005718 577 GCCVEQGEKILIYEYMPN------KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 650 (681)
Q Consensus 577 g~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~ 650 (681)
|+...+...-+|+|.+.+ -+|.+++. ...++. . +...+-+-..||-.++ |+.+||+|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999999999998743 35666662 223443 2 3333445556666665 99999999999996
Q ss_pred CCC----CeEEeec-CCce
Q 005718 651 SDM----NPKISDF-GMAR 664 (681)
Q Consensus 651 ~~~----~~kl~DF-Gla~ 664 (681)
... .+.|+|- |-..
T Consensus 153 ~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred ecCCCceEEEEEeCCCCcc
Confidence 432 4666663 5443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0013 Score=66.06 Aligned_cols=141 Identities=19% Similarity=0.245 Sum_probs=80.8
Q ss_pred eeecccCcEeEEEEEecC--CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCC-eeEEEEEEEeCCeEEEEEEecCCCC
Q 005718 520 CKLGEGGFGPVYKGKLLN--GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN-LVRLMGCCVEQGEKILIYEYMPNKS 596 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~--~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~Ey~~~gs 596 (681)
+.|..|-...+|+....+ ++.+.+|........ ...-.+|+.++..+...+ .+++++... + .+||||+++..
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCc
Confidence 567778888999988764 567888876543221 123346888888874333 445554332 2 37999999876
Q ss_pred hhhH-------h----------cCCCCC--------CCCC-HHHHHHHHH----------------------HHHHHHHH
Q 005718 597 LNFF-------L----------FDPSRT--------HLLG-WQTRVKIIE----------------------GIAQGLLY 628 (681)
Q Consensus 597 L~~~-------l----------~~~~~~--------~~l~-~~~~~~i~~----------------------~ia~~L~y 628 (681)
+... + +..... .... +.....+.. .+.+.+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 0 010000 0111 111111111 11111112
Q ss_pred H----HhC-CCCCeeecccCCCcEEEcC-CCCeEEeecCCcee
Q 005718 629 L----HQY-SRLRIIHRDLKASNILLDS-DMNPKISDFGMARM 665 (681)
Q Consensus 629 L----H~~-~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~~ 665 (681)
| ... ....++|+|+.+.|||++. +..+.|+||-.|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 2 111 2346899999999999998 57899999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.002 Score=69.55 Aligned_cols=75 Identities=13% Similarity=0.192 Sum_probs=55.2
Q ss_pred eeecccCcEeEEEEEecCC-cEEEEEEecCC-----C--cccHHHHHHHHHHHhhCC---CCCeeEEEEEEEeCCeEEEE
Q 005718 520 CKLGEGGFGPVYKGKLLNG-QEVAVKRLSSQ-----S--GQGLKEFKNEMMLIAKLQ---HRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~-~~VAVK~l~~~-----~--~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV 588 (681)
+.||.|.+..||+....+| +.+.||.-.+. . +...+++..|.+.|..+. -.++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6899999999999999776 48999974421 1 234567788888887762 3467888876 44667899
Q ss_pred EEecCCCC
Q 005718 589 YEYMPNKS 596 (681)
Q Consensus 589 ~Ey~~~gs 596 (681)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00094 Score=62.63 Aligned_cols=129 Identities=19% Similarity=0.245 Sum_probs=86.8
Q ss_pred ceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCee-EEEEEEEeCCeEEEEEEecCCCC
Q 005718 518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV-RLMGCCVEQGEKILIYEYMPNKS 596 (681)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~~gs 596 (681)
..+.|++|.+|.||++.+. +..+|+|+-+.+ .....+..|.++|..+.-.++. +++.+-. .++.|||.++-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcc
Confidence 4478999999999999985 458899887754 3457888999999999776654 4555433 345699999988
Q ss_pred hhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccC-CCcEEEcCCCCeEEeecCCceee
Q 005718 597 LNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLK-ASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 597 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk-p~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|.+.-... +.+... .+++.---|...+ |-|+.|. |...+|..+..+.|+||.-|++-
T Consensus 99 L~~~~~~~------~rk~l~----~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 99 LGKLEIGG------DRKHLL----RVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhcc------cHHHHH----HHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 87654211 122222 3334433344334 8888875 44444545559999999999843
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0009 Score=68.38 Aligned_cols=139 Identities=14% Similarity=0.103 Sum_probs=77.9
Q ss_pred eecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCe-eEEEEEEEeCCeEEEEEEecCCCChhh
Q 005718 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-VRLMGCCVEQGEKILIYEYMPNKSLNF 599 (681)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gsL~~ 599 (681)
.+..|-...+|+... +++.+.+|........-.-...+|..+++.+....+ .++++... .++||||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 345677778898874 566777887654322211235678888888854333 44554432 368999999876542
Q ss_pred H-----------------hcCCC-CCCCCCHHHHH-HHHH---------HHHHHHHHHHhC-----CCCCeeecccCCCc
Q 005718 600 F-----------------LFDPS-RTHLLGWQTRV-KIIE---------GIAQGLLYLHQY-----SRLRIIHRDLKASN 646 (681)
Q Consensus 600 ~-----------------l~~~~-~~~~l~~~~~~-~i~~---------~ia~~L~yLH~~-----~~~~ivHrDlkp~N 646 (681)
. |+... ....++...++ .+.. .+.+.+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 11112222111 1111 111122222211 12358999999999
Q ss_pred EEEcCCCCeEEeecCCcee
Q 005718 647 ILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 647 iLl~~~~~~kl~DFGla~~ 665 (681)
|++++++ ++|+||..|..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0023 Score=66.76 Aligned_cols=143 Identities=17% Similarity=0.156 Sum_probs=86.1
Q ss_pred eeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCC--CeeEEEEE------EEeCCeEEEEEE
Q 005718 519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHR--NLVRLMGC------CVEQGEKILIYE 590 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~------~~~~~~~~lV~E 590 (681)
.+.|..|....+|+....+ ..+++|+... ...++...|++++..+++. .+++++.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778778899987644 4677887754 2345667788877777433 35555442 123456689999
Q ss_pred ecCCCChhh----Hh----------c----C--CC--CCCCCCHHHHH----------HHHHHHHHHHHHHHh----CCC
Q 005718 591 YMPNKSLNF----FL----------F----D--PS--RTHLLGWQTRV----------KIIEGIAQGLLYLHQ----YSR 634 (681)
Q Consensus 591 y~~~gsL~~----~l----------~----~--~~--~~~~l~~~~~~----------~i~~~ia~~L~yLH~----~~~ 634 (681)
|+++..+.. .+ + . .. ......|.... .....+...+.++.. .-.
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 00 0 0 00 00111222111 111223344555543 123
Q ss_pred CCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 635 LRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 635 ~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
..++|+|+.|.||+++++..+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4599999999999999887789999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.013 Score=61.87 Aligned_cols=141 Identities=18% Similarity=0.177 Sum_probs=76.3
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCC--CCCeeEEEE------EEEeCCeEEEEEEe
Q 005718 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ--HRNLVRLMG------CCVEQGEKILIYEY 591 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~--H~nIv~l~g------~~~~~~~~~lV~Ey 591 (681)
+.|..|....+|+....++ .+.+|+.... ..+....|+.++..+. .-.+.+++. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566677778999887555 5778877521 2233344555555542 222444442 12234567899999
Q ss_pred cCCCChhh-----H------h---cCC------CC--CCCC-CHHHHHH------------HH-HHHHHHHHHHHhC---
Q 005718 592 MPNKSLNF-----F------L---FDP------SR--THLL-GWQTRVK------------II-EGIAQGLLYLHQY--- 632 (681)
Q Consensus 592 ~~~gsL~~-----~------l---~~~------~~--~~~l-~~~~~~~------------i~-~~ia~~L~yLH~~--- 632 (681)
+++..+.. . | +.. .. ...+ .|..... .. ..+...+..+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99875421 1 1 000 00 0011 1111111 11 1111222333211
Q ss_pred -CCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 633 -SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 633 -~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
-..+++|+|+.|.||+++.+...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23469999999999999866656899999875
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0013 Score=52.97 Aligned_cols=48 Identities=13% Similarity=0.293 Sum_probs=33.4
Q ss_pred ccccCCcccceeeccccCHHHHHHHhhcCCceeeeeeccccCCCccceeecc
Q 005718 347 DDIKLPYLVDVSLNESMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFG 398 (681)
Q Consensus 347 ~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~y~~~~~~~~gC~~w~~ 398 (681)
+++.++..+.... ...+.++|++.|+.+|+|.||.|.. +...|+++..
T Consensus 10 ~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~ 57 (73)
T cd01100 10 SNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSS 57 (73)
T ss_pred CCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccC
Confidence 4555554333322 2458999999999999999999974 2334998754
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.024 Score=59.55 Aligned_cols=142 Identities=19% Similarity=0.210 Sum_probs=81.3
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCC--CCeeEEEEEE------EeCCeEEEEEEe
Q 005718 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH--RNLVRLMGCC------VEQGEKILIYEY 591 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~------~~~~~~~lV~Ey 591 (681)
+.++.|....+|+....++ .+.+|+..... ..++...|+.++..+.. -.+++++... ...+..++++||
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 4566777778999876555 46677665421 23445566666666632 2345554421 123567899999
Q ss_pred cCCCChhh----H----------hcC------CCCC---CCCCHHHHH------------HHHHHHHHHHHHHHh----C
Q 005718 592 MPNKSLNF----F----------LFD------PSRT---HLLGWQTRV------------KIIEGIAQGLLYLHQ----Y 632 (681)
Q Consensus 592 ~~~gsL~~----~----------l~~------~~~~---~~l~~~~~~------------~i~~~ia~~L~yLH~----~ 632 (681)
+++..+.. . ++. .... ..-.|.... .....+.+.++++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 98855421 0 010 0000 011121110 011223345555542 2
Q ss_pred CCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 633 ~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
....++|+|+.+.||+++.++...|.||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 23569999999999999988777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.017 Score=59.83 Aligned_cols=75 Identities=16% Similarity=0.215 Sum_probs=48.2
Q ss_pred CceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhC---CCCCeeEEEEEEEeCCeEEEEEEecC
Q 005718 517 SMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL---QHRNLVRLMGCCVEQGEKILIYEYMP 593 (681)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~~~lV~Ey~~ 593 (681)
+-.+.++.|....+|+.. .+++.+-||.-.. .....|..|.+-|+.| .-..+++++++....+..+||+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 344678989999999987 4677888887752 3345677888877777 34568899999888778899999998
Q ss_pred CC
Q 005718 594 NK 595 (681)
Q Consensus 594 ~g 595 (681)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 77
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.012 Score=61.57 Aligned_cols=140 Identities=17% Similarity=0.161 Sum_probs=95.6
Q ss_pred eeeecccCcEeEEEEEecCCcEEEEEEecCCC-----c-----------------cc----HHHHHHHHHHHhhCCCCCe
Q 005718 519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS-----G-----------------QG----LKEFKNEMMLIAKLQHRNL 572 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~-----~-----------------~~----~~~f~~Ei~~l~~l~H~nI 572 (681)
...|..|.-..||.+.-.+|..+|||+.+... . .. ..-...|++-|.+++...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 35688899999999999999999999776310 0 00 1124568888888876655
Q ss_pred eEEEEEEEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC
Q 005718 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD 652 (681)
Q Consensus 573 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~ 652 (681)
.-.--... ....|||+|+.....-.-. .+...++...+..+-.++++-|.-|-..+ ++||.||.--|+|+ .+
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~aPk---LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-hd 300 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWAAPK---LKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-HD 300 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCcCcc---cccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-EC
Confidence 42221111 2347999999643321111 12234566677777788888888887666 59999999999999 57
Q ss_pred CCeEEeecCCceee
Q 005718 653 MNPKISDFGMARMF 666 (681)
Q Consensus 653 ~~~kl~DFGla~~~ 666 (681)
|.+.|+|.+=+...
T Consensus 301 G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEH 314 (520)
T ss_pred CEEEEEEccccccC
Confidence 78999999887655
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.014 Score=60.29 Aligned_cols=32 Identities=28% Similarity=0.475 Sum_probs=26.6
Q ss_pred CCeeecccCCCcEEEcCCCC-eEEeecCCceee
Q 005718 635 LRIIHRDLKASNILLDSDMN-PKISDFGMARMF 666 (681)
Q Consensus 635 ~~ivHrDlkp~NiLl~~~~~-~kl~DFGla~~~ 666 (681)
..++|+|+.|.|||+++++. .-|.||+.|.+-
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 35899999999999997555 569999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.024 Score=59.39 Aligned_cols=141 Identities=26% Similarity=0.317 Sum_probs=82.5
Q ss_pred eeecccCcEeEEEEEecC-------CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCC-eeEEEEEEEeCCeEEEEEEe
Q 005718 520 CKLGEGGFGPVYKGKLLN-------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN-LVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~-------~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~Ey 591 (681)
+.+..|-.-.+|+....+ ++.+++|+..... .......+|.+++..+.... ..++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456666666889887654 4678888865532 22344567877777774322 3456655532 368999
Q ss_pred cCCCChhhHh-----------------cCCCCC------CCCC--HHHHHH--------------------------HHH
Q 005718 592 MPNKSLNFFL-----------------FDPSRT------HLLG--WQTRVK--------------------------IIE 620 (681)
Q Consensus 592 ~~~gsL~~~l-----------------~~~~~~------~~l~--~~~~~~--------------------------i~~ 620 (681)
+++..+.... +..... ...+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9887664311 110000 0111 111100 112
Q ss_pred HHHHHHHHHHh------CCCCCeeecccCCCcEEEcCC----CCeEEeecCCcee
Q 005718 621 GIAQGLLYLHQ------YSRLRIIHRDLKASNILLDSD----MNPKISDFGMARM 665 (681)
Q Consensus 621 ~ia~~L~yLH~------~~~~~ivHrDlkp~NiLl~~~----~~~kl~DFGla~~ 665 (681)
.+.+-+..|.. .....++|+|+.|.|||++++ +.++|+||..|..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22233344432 234568999999999999975 8899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.027 Score=58.88 Aligned_cols=136 Identities=17% Similarity=0.255 Sum_probs=78.7
Q ss_pred EEEEEecCCcEEEEEEec-CCCcccHHHHHHHHHHHhhCCC--CCeeEEEEEEEeCC--eEEEEEEecCCCChhhHhcCC
Q 005718 530 VYKGKLLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQH--RNLVRLMGCCVEQG--EKILIYEYMPNKSLNFFLFDP 604 (681)
Q Consensus 530 Vy~~~~~~~~~VAVK~l~-~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~--~~~lV~Ey~~~gsL~~~l~~~ 604 (681)
+|..... ++.+.+.+-. ...........+|..+|+.+.- .-+.+.++.|.++. ..+.||||.++....+.+...
T Consensus 41 t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~ 119 (321)
T COG3173 41 TFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPE 119 (321)
T ss_pred eEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcc
Confidence 4444333 5666666221 1123344566778888887743 45667777787766 679999999873322111000
Q ss_pred -----------------------------------CCCCCCCHHHHHHH--------HHHHHHHHHHHHhC-----CCCC
Q 005718 605 -----------------------------------SRTHLLGWQTRVKI--------IEGIAQGLLYLHQY-----SRLR 636 (681)
Q Consensus 605 -----------------------------------~~~~~l~~~~~~~i--------~~~ia~~L~yLH~~-----~~~~ 636 (681)
...+...|....+. .-...+-..+|+++ ++..
T Consensus 120 ~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~ 199 (321)
T COG3173 120 SLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPV 199 (321)
T ss_pred cchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCce
Confidence 00011112222210 01223334455432 3356
Q ss_pred eeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 637 IIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 637 ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
++|+|+.+.||+++.+..+=|.||+++.+-
T Consensus 200 lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 200 LVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred eeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 999999999999999888999999999763
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.0037 Score=64.09 Aligned_cols=131 Identities=17% Similarity=0.163 Sum_probs=89.4
Q ss_pred CCCceeeecccCcEeEEEEEecCCcEEEEEEecCCC-----------------c-----ccHHHHHHHHHHHhhCC-C-C
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS-----------------G-----QGLKEFKNEMMLIAKLQ-H-R 570 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~-----------------~-----~~~~~f~~Ei~~l~~l~-H-~ 570 (681)
-+.+.++||-|.-+.||.+...+|++.++|.=+... . .+.-...+|...|+.+. | -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 456789999999999999999889988887322110 0 01123466888888884 2 3
Q ss_pred CeeEEEEEEEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc
Q 005718 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 650 (681)
Q Consensus 571 nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~ 650 (681)
-|++.+++ ...++|||++.+-.|...- +..+..+...-+++ -+--|..++ +||+|..-=||+++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~~lm~---~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPTLYDDLMG---LIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeee------ecCChHHHHHHHHH---HHHHHHHcC---ceecccchheeEEe
Confidence 46666654 4568999999888875332 12233344333333 333444445 99999999999999
Q ss_pred CCCCeEEeecC
Q 005718 651 SDMNPKISDFG 661 (681)
Q Consensus 651 ~~~~~kl~DFG 661 (681)
++..++++||=
T Consensus 237 dd~~i~vIDFP 247 (465)
T KOG2268|consen 237 DDDKIVVIDFP 247 (465)
T ss_pred cCCCEEEeech
Confidence 99999999994
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.032 Score=59.59 Aligned_cols=142 Identities=17% Similarity=0.225 Sum_probs=80.1
Q ss_pred eeecccCcEeEEEEEecC-----CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCee-EEEEEEEeCCeEEEEEEecC
Q 005718 520 CKLGEGGFGPVYKGKLLN-----GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV-RLMGCCVEQGEKILIYEYMP 593 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~-----~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~ 593 (681)
+.|..|-.-.+|+....+ ++.+.+|........... -.+|..++..+...++. ++++.+..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 455556677889887532 357888877654332222 26788888887544433 555655332 5899998
Q ss_pred CCChhhH-----------------hcCCC-C--CCCCCHHHHHHHHHH-----------------HHHHHHHH----Hh-
Q 005718 594 NKSLNFF-----------------LFDPS-R--THLLGWQTRVKIIEG-----------------IAQGLLYL----HQ- 631 (681)
Q Consensus 594 ~gsL~~~-----------------l~~~~-~--~~~l~~~~~~~i~~~-----------------ia~~L~yL----H~- 631 (681)
+.++... +++.. . .....+.+...+..+ +...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7666421 11111 0 111112222222211 11112222 21
Q ss_pred CCCCCeeecccCCCcEEEcC-CCCeEEeecCCceee
Q 005718 632 YSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMF 666 (681)
Q Consensus 632 ~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~~~ 666 (681)
.....++|+|+++.|||+++ +..++|+||..|..-
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 22345899999999999986 468999999988743
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.00082 Score=77.95 Aligned_cols=148 Identities=18% Similarity=0.197 Sum_probs=99.9
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
..+.+.+.+-+.++.++.++.+.-.. +...++|..... .....+..+.+-.++-..+||-+++..--+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 34566777788889999988775432 333333333221 11122333334333334456777766655667788999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
+++|..+++|...|+... ..+..-....+..+.++++|||... ++|+|++|.|+|+..+++.+++|||+.+.
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccc
Confidence 999999999988884432 2233333345566788999999875 89999999999999999999999995543
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.12 Score=55.85 Aligned_cols=80 Identities=11% Similarity=0.011 Sum_probs=52.9
Q ss_pred eeeecccCcEeEEEEEecCCcEEEEEEecCCCc-------ccHHHHHHHHHHHhhCC---CCCeeEEEEEEEeCCeEEEE
Q 005718 519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG-------QGLKEFKNEMMLIAKLQ---HRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~-------~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV 588 (681)
.+.||.|..-.||+.... ++.+.||.-..... ....+-..|...|..+. ..++++++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 468899999999998874 45688886652111 13344455566666553 357888998876 446788
Q ss_pred EEecCC--CChhhHh
Q 005718 589 YEYMPN--KSLNFFL 601 (681)
Q Consensus 589 ~Ey~~~--gsL~~~l 601 (681)
|||+++ ..+.+.+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999976 3444333
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.08 Score=56.19 Aligned_cols=79 Identities=15% Similarity=0.138 Sum_probs=50.9
Q ss_pred eecccCcEeEEEEEecCC-cEEEEEEecCC-------CcccHHHHHHHHHHHhhCC--CC-CeeEEEEEEEeCCeEEEEE
Q 005718 521 KLGEGGFGPVYKGKLLNG-QEVAVKRLSSQ-------SGQGLKEFKNEMMLIAKLQ--HR-NLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~~-~~VAVK~l~~~-------~~~~~~~f~~Ei~~l~~l~--H~-nIv~l~g~~~~~~~~~lV~ 589 (681)
.||.|..-.||++...++ +.|.||.-.+. -+...++..-|.+.|.... -| .+++++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 578899999999998654 57888844321 1334556667777776652 23 46666543 556667999
Q ss_pred EecCC-CChhhHh
Q 005718 590 EYMPN-KSLNFFL 601 (681)
Q Consensus 590 Ey~~~-gsL~~~l 601 (681)
|+++. ..|...|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 99954 3344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.29 Score=51.28 Aligned_cols=29 Identities=28% Similarity=0.357 Sum_probs=25.4
Q ss_pred CCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 635 LRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 635 ~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 46899999999999987 678999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.13 Score=54.20 Aligned_cols=136 Identities=24% Similarity=0.303 Sum_probs=79.9
Q ss_pred CcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCC------eeEEEEEE----EeCCeEEEEEEecCCC
Q 005718 526 GFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN------LVRLMGCC----VEQGEKILIYEYMPNK 595 (681)
Q Consensus 526 ~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~l~g~~----~~~~~~~lV~Ey~~~g 595 (681)
.--.+|+....+++. ++|..... ....+...|+..+..+.-.. |..+-|-. ..+...+-++||++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 345688888877776 77877664 45566667777777663211 22222211 1113778999999998
Q ss_pred Chhh-H----h--------------cC-----CCCCCCCCHHH-------------HHHHHHHHHHHHHHHHhCC----C
Q 005718 596 SLNF-F----L--------------FD-----PSRTHLLGWQT-------------RVKIIEGIAQGLLYLHQYS----R 634 (681)
Q Consensus 596 sL~~-~----l--------------~~-----~~~~~~l~~~~-------------~~~i~~~ia~~L~yLH~~~----~ 634 (681)
.+.. . + .+ +.......|.. ......++...++.+++.- .
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 8772 1 0 00 01111223320 0112334444555554321 1
Q ss_pred ---CCeeecccCCCcEEEcCCCC-eEEeecCCce
Q 005718 635 ---LRIIHRDLKASNILLDSDMN-PKISDFGMAR 664 (681)
Q Consensus 635 ---~~ivHrDlkp~NiLl~~~~~-~kl~DFGla~ 664 (681)
..+||+|+.|.||+++.+.. +.+.||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 12999999999999998885 8999999875
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.15 Score=50.27 Aligned_cols=75 Identities=16% Similarity=0.258 Sum_probs=51.8
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhC---CCCCeeEEEEEEEeCCeEEEEEEecCCCC
Q 005718 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL---QHRNLVRLMGCCVEQGEKILIYEYMPNKS 596 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 596 (681)
+.+.-|.--.-|+... +..++-||+-.. .....|.+|+.-|..+ +--.|.+++..-.++++.++|+||++-+.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3444444333444333 456788886543 3456788887766655 44668899999999999999999999877
Q ss_pred hh
Q 005718 597 LN 598 (681)
Q Consensus 597 L~ 598 (681)
++
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 76
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.0026 Score=70.36 Aligned_cols=137 Identities=16% Similarity=0.096 Sum_probs=92.1
Q ss_pred ceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCC-eeEEEEEEEeCCeEEEEEEecCCC-
Q 005718 518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN-LVRLMGCCVEQGEKILIYEYMPNK- 595 (681)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~Ey~~~g- 595 (681)
....++++++++++|.+....+....+.+... ....-++++|.+.+||| .++.++-+...+..+++++++..+
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 33567889999999987654444446655432 44566889999999999 677676666677889999999877
Q ss_pred ChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 596 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 596 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
+-..... .....+..-+...+.+.-+++++|||+.- -+|+| ||+..+ ...|..||+.+.-+...
T Consensus 321 s~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 321 SSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred cccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 2211110 00111222233345566678999999764 58998 777654 77899999998877543
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.22 Score=52.28 Aligned_cols=32 Identities=25% Similarity=0.356 Sum_probs=28.5
Q ss_pred CCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 634 ~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
+..++|+|+.+.|+|++.++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34699999999999999999999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.87 E-value=0.12 Score=50.40 Aligned_cols=101 Identities=18% Similarity=0.145 Sum_probs=66.5
Q ss_pred EEEEEEecCCCcc-cHHHHHHHHHHHhhCCCCCeeEEEEEEEeC-CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHH
Q 005718 540 EVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVK 617 (681)
Q Consensus 540 ~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~ 617 (681)
+..+|++....-. ...-|..+.+++++++ .|+++. .++ -..-+++|+|-... .+. ..
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~---NDn~~~yGvIlE~Cy~~~------------i~~----~N 145 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLK---NDNNYKYGVILERCYKIK------------INF----SN 145 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEee---cCCCceeEEEEeeccCcc------------cch----hH
Confidence 3445655543333 5677889999999987 466665 233 34568899883211 111 11
Q ss_pred HHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCC
Q 005718 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662 (681)
Q Consensus 618 i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl 662 (681)
++..=++.|.-.|+.+ .+.+|+|-.|+||+-|..|.+||.|=+-
T Consensus 146 ~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 146 FITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 1221246777788543 4699999999999999999999999873
|
The function of this family is unknown. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.75 E-value=0.048 Score=53.82 Aligned_cols=30 Identities=37% Similarity=0.531 Sum_probs=21.4
Q ss_pred CeeecccCCCcEEE-cCCCCeEEeecCCcee
Q 005718 636 RIIHRDLKASNILL-DSDMNPKISDFGMARM 665 (681)
Q Consensus 636 ~ivHrDlkp~NiLl-~~~~~~kl~DFGla~~ 665 (681)
.+.|+|+.|.|||+ +.++.++++||-.|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 47899999999999 8899999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 681 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-33 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-32 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-27 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-27 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-25 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-16 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 2e-93
Identities = 77/195 (39%), Positives = 105/195 (53%), Gaps = 14/195 (7%)
Query: 497 RDSVLPCFSLASVSAATENFSMQC------KLGEGGFGPVYKGKLLNGQEVAVKRLSS-- 548
D+ FS + T NF + K+GEGGFG VYKG +N VAVK+L++
Sbjct: 8 SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMV 66
Query: 549 --QSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSR 606
+ + ++F E+ ++AK QH NLV L+G + + L+Y YMPN SL L
Sbjct: 67 DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126
Query: 607 THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
T L W R KI +G A G+ +LH+ IHRD+K++NILLD KISDFG+AR
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARAS 183
Query: 667 CGDELQGNTKRVVGT 681
T R+VGT
Sbjct: 184 EKFAQTVMTSRIVGT 198
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 6e-88
Identities = 77/180 (42%), Positives = 110/180 (61%), Gaps = 3/180 (1%)
Query: 504 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLK-EFKNEMM 562
FSL + A++NFS + LG GGFG VYKG+L +G VAVKRL + QG + +F+ E+
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-LGWQTRVKIIEG 621
+I+ HRNL+RL G C+ E++L+Y YM N S+ L + + L W R +I G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
A+GL YLH + +IIHRD+KA+NILLD + + DFG+A++ + T V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 5e-83
Identities = 72/179 (40%), Positives = 109/179 (60%), Gaps = 4/179 (2%)
Query: 504 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMML 563
L + AT NF + +G G FG VYKG L +G +VA+KR + +S QG++EF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-LGWQTRVKIIEGI 622
++ +H +LV L+G C E+ E ILIY+YM N +L L+ + + W+ R++I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
A+GL YLH + IIHRD+K+ NILLD + PKI+DFG+++ + + V GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 3e-64
Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 17/189 (8%)
Query: 504 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMML 563
++ + + G FG V+K +L + VAVK Q Q + + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 564 IAKLQHRNLVRLMGCCVE----QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 619
+ ++H N+++ +G + LI + SL+ FL + +++ W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 620 EGIAQGLLYLHQ-------YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 672
E +A+GL YLH+ + I HRD+K+ N+LL +++ I+DFG+A F +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 673 GNTKRVVGT 681
G+T VGT
Sbjct: 188 GDTHGQVGT 196
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 5e-57
Identities = 54/195 (27%), Positives = 86/195 (44%), Gaps = 23/195 (11%)
Query: 504 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMML 563
+ + S +N + +G G +G VYKG L + + VAVK S + Q K +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYR 60
Query: 564 IAKLQHRNLVRLMGCCVE-----QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI 618
+ ++H N+ R + + E +L+ EY PN SL +L H W + ++
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRL 116
Query: 619 IEGIAQGLLYLHQ------YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG---- 668
+ +GL YLH + + I HRDL + N+L+ +D ISDFG++ G
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 669 --DELQGNTKRVVGT 681
E VGT
Sbjct: 177 RPGEEDNAAISEVGT 191
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 4e-49
Identities = 51/170 (30%), Positives = 89/170 (52%), Gaps = 6/170 (3%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRN 571
+ +++ K+G G FG V++ + +G +VAVK L Q + + EF E+ ++ +L+H N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
+V MG + ++ EY+ SL L L + R+ + +A+G+ YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
I+HR+LK+ N+L+D K+ DFG++R+ L +K GT
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGT 202
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 11/169 (6%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
+ ++ +G G FG V K K ++VA+K++ S+S K F E+ ++++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
+L G C+ L+ EY SL L + +QG+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 634 RLRIIHRDLKASNILLDSDMN-PKISDFGMARMFCGDELQGNTKRVVGT 681
+IHRDLK N+LL + KI DFG A ++Q + G+
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGS 166
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-44
Identities = 38/157 (24%), Positives = 69/157 (43%), Gaps = 7/157 (4%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRN 571
+ + KL E G ++KG+ G ++ VK L + S + ++F E + H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 572 LVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
++ ++G C I +MP SL L + ++ VK +A+G+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFL 127
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
H L I L + ++++D DM +IS + F
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF 163
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-44
Identities = 47/181 (25%), Positives = 91/181 (50%), Gaps = 23/181 (12%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQG-------LKEFKNEMMLIA 565
+ ++G+GGFG V+KG+L+ + VA+K L +G +EF+ E+ +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
L H N+V+L G ++ E++P L L D + + W +++++ IA G
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALG 134
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDS-----DMNPKISDFGMARMFCGDELQGNTKRVVG 680
+ Y+ I+HRDL++ NI L S + K++DFG+++ + + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 681 T 681
Sbjct: 189 N 189
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 2e-44
Identities = 53/167 (31%), Positives = 77/167 (46%), Gaps = 17/167 (10%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRL----SSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
+G GGFG VY+ G EVAVK Q ++ + E L A L+H N++ L
Sbjct: 14 IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
G C+++ L+ E+ LN L + V IA+G+ YLH + +
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 637 IIHRDLKASNILLDSDMNP--------KISDFGMARMFCGDELQGNT 675
IIHRDLK+SNIL+ + KI+DFG+AR +
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-44
Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 6/158 (3%)
Query: 521 KLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
LG+G FG K G+ + +K L + + F E+ ++ L+H N+++ +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
+ I EY+ +L + W RV + IA G+ YLH + IIH
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 640 RDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
RDL + N L+ + N ++DFG+AR+ ++ Q R
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-43
Identities = 54/170 (31%), Positives = 83/170 (48%), Gaps = 10/170 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRN 571
++ ++G G FG VYKGK +G +VAVK L+ + Q L+ FKNE+ ++ K +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
++ MG I + ++ SL L + + I A+G+ YLH
Sbjct: 82 ILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA 138
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
IIHRDLK++NI L D KI DFG+A +++ G+
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 49/182 (26%), Positives = 81/182 (44%), Gaps = 21/182 (11%)
Query: 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNE--MMLIAKLQHR 570
+ ++ +G+G +G V++G G+ VAVK SS+ K + E + L+H
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHE 62
Query: 571 NLVRLMGCCVEQGEKI----LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
N++ + + LI Y SL +L + L + ++I+ IA GL
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGL 118
Query: 627 LYLH-----QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVV 679
+LH + I HRDLK+ NIL+ + I+D G+A M ++L V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 680 GT 681
GT
Sbjct: 179 GT 180
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 13/166 (7%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGC 578
+G+G FG VY G+ +G EVA++ + + + LK FK E+M + +H N+V MG
Sbjct: 40 LIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 579 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRII 638
C+ +I ++L + D L +I + I +G+ YLH I+
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLHA---KGIL 152
Query: 639 HRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR---VVGT 681
H+DLK+ N+ D + I+DFG+ + + + G
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGW 197
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 46/181 (25%), Positives = 81/181 (44%), Gaps = 21/181 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNE--MMLIAKLQHRN 571
+ M ++G+G +G V+ GK G++VAVK + + E + ++H N
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHEN 92
Query: 572 LVRLMGCCVEQGEKI----LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
++ + ++ LI +Y N SL +L ++ L ++ +K+ GL
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLC 148
Query: 628 YLH-----QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVVG 680
+LH + I HRDLK+ NIL+ + I+D G+A F +E+ VG
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 681 T 681
T
Sbjct: 209 T 209
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 21/177 (11%)
Query: 518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNE--MMLIAKLQHRNLVRL 575
+Q +G+G FG V++GK G+EVAVK SS+ + + E + L+H N++
Sbjct: 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGF 101
Query: 576 MGCCVEQGEKI----LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
+ + L+ +Y + SL +L + + + +K+ A GL +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 632 -----YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVVGT 681
+ I HRDLK+ NIL+ + I+D G+A D + VGT
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 54/165 (32%), Positives = 78/165 (47%), Gaps = 15/165 (9%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN-----GQEVAVKRLSSQSG-QGLKEFKNEMMLIAKL 567
LGEG FG V G+ VAVK L + +G Q +K E+ ++ L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 568 QHRNLVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
H ++++ GCC + G L+ EY+P SL +L H +G + + I +G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
+ YLH IHRDL A N+LLD+D KI DFG+A+
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 12/164 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ 568
+ +LG+G FG V + G+ VAVK+L + + L++F+ E+ ++ LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 569 HRNLVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
H N+V+ G C G + LI EY+P SL +L + ++ I +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
YL R IHRDL NIL++++ KI DFG+ ++ D+
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 12/164 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ 568
+ +LG+G FG V + G+ VAVK+L + + L++F+ E+ ++ LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 569 HRNLVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
H N+V+ G C G + LI EY+P SL +L + ++ I +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
YL R IHRDL NIL++++ KI DFG+ ++ D+
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-36
Identities = 48/152 (31%), Positives = 77/152 (50%), Gaps = 8/152 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
+ + +G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 77
Query: 574 RLMGCCVEQGEKILI-YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
+L+G VE+ + I EYM SL +L R+ L G +K + + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYL--- 133
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+HRDL A N+L+ D K+SDFG+ +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 52/165 (31%), Positives = 83/165 (50%), Gaps = 13/165 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKL 567
LGEG FG V + G++VAVK L +SG + + K E+ ++ L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 568 QHRNLVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
H N+V+ G C E G LI E++P+ SL +L P + + + ++K I +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
+ YL + +HRDL A N+L++S+ KI DFG+ + D+
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 7/159 (4%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRN 571
E+ + ++G G FG V+ G+L + VAVK + +F E ++ + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
+VRL+G C ++ ++ E + FL + L +T ++++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
IHRDL A N L+ KISDFGM+R
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 12/164 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ 568
+ +LG+G FG V + G VAVK+L ++F+ E+ ++ L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 569 HRNLVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
+V+ G G + L+ EY+P+ L FL L + I +G+
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
YL R +HRDL A NIL++S+ + KI+DFG+A++ D+
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 52/170 (30%), Positives = 80/170 (47%), Gaps = 22/170 (12%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG------QEVAVKRLSSQSGQGLKEFKNEMMLIAKL 567
+ ++ +LGEG FG V+ + N VAVK L + K+F+ E L+ L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------------FDPSRTHLLGWQT 614
QH ++V+ G C + I+++EYM + LN FL LG
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 615 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ I IA G++YL + +HRDL N L+ +++ KI DFGM+R
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-35
Identities = 47/152 (30%), Positives = 78/152 (51%), Gaps = 8/152 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
+ + +G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249
Query: 574 RLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
+L+G VE+ + ++ EYM SL +L R +LG +K + + + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL--- 305
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+HRDL A N+L+ D K+SDFG+ +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 52/169 (30%), Positives = 81/169 (47%), Gaps = 21/169 (12%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE------VAVKRLSSQSGQGLKEFKNEMMLIAKL 567
+ ++ +LGEG FG V+ + N VAVK L S ++F+ E L+ L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL------------FDPSRTHLLGWQTR 615
QH+++VR G C E ++++EYM + LN FL + LG
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ + +A G++YL + L +HRDL N L+ + KI DFGM+R
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 49/157 (31%), Positives = 81/157 (51%), Gaps = 6/157 (3%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
+ ++G G FG V+ G LN +VA+K + + ++F E ++ KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 66
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
+L G C+EQ L+ E+M + L+ +L ++ L +T + + + +G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
+IHRDL A N L+ + K+SDFGM R D+
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 50/163 (30%), Positives = 84/163 (51%), Gaps = 12/163 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKL 567
F LG G FG VYKG + E VA+K L + S + KE +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
+ ++ RL+G C+ ++ I + MP L ++ + +G Q + IA+G+
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 131
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
YL R++HRDL A N+L+ + + KI+DFG+A++ +E
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 55/171 (32%), Positives = 79/171 (46%), Gaps = 23/171 (13%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAK 566
+LGE FG VYKG L Q VA+K L G +EF++E ML A+
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------------FDPSRTHLLGWQ 613
LQH N+V L+G + +I+ Y + L+ FL D + L
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 614 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
V ++ IA G+ YL S ++H+DL N+L+ +N KISD G+ R
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 48/158 (30%), Positives = 84/158 (53%), Gaps = 6/158 (3%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG-QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
+ +M+ KLG G +G VY+G VAVK L + + ++EF E ++ +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 71
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
V+L+G C + +I E+M +L +L + +R + + + I+ + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYL--- 127
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
+ IHRDL A N L+ + K++DFG++R+ GD
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 49/157 (31%), Positives = 76/157 (48%), Gaps = 6/157 (3%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
++ + +LG G FG V GK +VA+K + S EF E ++ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLV 82
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
+L G C +Q +I EYM N L +L H Q +++ + + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
+ +HRDL A N L++ K+SDFG++R DE
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 46/165 (27%), Positives = 75/165 (45%), Gaps = 17/165 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE------VAVKRL-SSQSGQGLKEFKNEMMLIAK 566
E +M +LG+G FG VY+G + VA+K + + S + EF NE ++ +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------FDPSRTHLLGWQTRVKII 619
++VRL+G + ++I E M L +L + +++
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
IA G+ YL + + +HRDL A N ++ D KI DFGM R
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 51/157 (32%), Positives = 76/157 (48%), Gaps = 6/157 (3%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
E ++ +LG G FG V GK +VAVK + S EF E + KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLV 66
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
+ G C ++ ++ EY+ N L +L S L +++ + +G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
+ IHRDL A N L+D D+ K+SDFGM R D+
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-34
Identities = 52/169 (30%), Positives = 80/169 (47%), Gaps = 21/169 (12%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE---VAVKRL-SSQSGQGLKEFKNEMMLIAKL-Q 568
+ Q +GEG FG V K ++ A+KR+ S ++F E+ ++ KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------------FDPSRTHLLGWQTR 615
H N++ L+G C +G L EY P+ +L FL S L Q
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ +A+G+ YL S+ + IHRDL A NIL+ + KI+DFG++R
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-34
Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 12/163 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRLSSQSG-QGLKEFKNEMMLIAKL 567
LG G FG V+KG + E V +K + +SG Q + + M+ I L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
H ++VRL+G C ++ + +Y+P SL + LG Q + IA+G+
Sbjct: 73 DHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQIAKGMY 129
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
YL ++HR+L A N+LL S +++DFG+A + D+
Sbjct: 130 YL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 57/157 (36%), Positives = 81/157 (51%), Gaps = 6/157 (3%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
E + +LG G FG V+ G +VAVK L S F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
RL ++ I I EYM N SL FL PS L + + IA+G+ ++
Sbjct: 72 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFI---E 126
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
IHRDL+A+NIL+ ++ KI+DFG+AR+ +E
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-33
Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 6/157 (3%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
E+ ++ KLG G FG V+ +VAVK + S ++ F E ++ LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLV 246
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
+L ++ I I E+M SL FL + + IA+G+ ++
Sbjct: 247 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFI---E 301
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
+ IHRDL+A+NIL+ + + KI+DFG+AR+ +E
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-33
Identities = 47/158 (29%), Positives = 84/158 (53%), Gaps = 6/158 (3%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
+ +M+ KLG G +G VY+G VAVK L + + ++EF E ++ +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 278
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
V+L+G C + +I E+M +L +L + +R + + + I+ + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYL--- 334
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
+ IHR+L A N L+ + K++DFG++R+ GD
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRL--SSQSGQGLKEFKNEMMLIAKL 567
+ LGEG FG V +G L VAVK + + S + ++EF +E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 568 QHRNLVRLMGCCVEQG-----EKILIYEYMPNKSLNFFL---FDPSRTHLLGWQTRVKII 619
H N++RL+G C+E + ++I +M L+ +L + + QT +K +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
IA G+ YL S +HRDL A N +L DM ++DFG+++
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 50/179 (27%), Positives = 75/179 (41%), Gaps = 31/179 (17%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAK 566
N +GEG FG V++ + VAVK L S +F+ E L+A+
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL---------------------FDPS 605
+ N+V+L+G C L++EYM LN FL
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 606 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
L ++ I +A G+ YL S + +HRDL N L+ +M KI+DFG++R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 18/166 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG----QEVAVKRL--SSQSGQGLKEFKNEMMLIAKL 567
+ F++ LG+G FG V + +L +VAVK L + ++EF E + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 568 QHRNLVRLMGCCVEQGEKI------LIYEYMPNKSLNFFLFD---PSRTHLLGWQTRVKI 618
H ++ +L+G + K +I +M + L+ FL L QT V+
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ IA G+ YL S IHRDL A N +L DM ++DFG++R
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQ 568
++ +G G G V G+L VA+K L + + + ++F +E ++ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
H N++RL G +++ EYM N SL+ FL V ++ G+ G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRY 166
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
L S L +HRDL A N+L+DS++ K+SDFG++R+ D
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 50/164 (30%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRL---SSQSGQGLKEFKNEMMLIAK 566
++ + KLG+G FG V +G+ VAVK L + + +F E+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
L HRNL+RL G + K+ + E P SL L T + +A+G+
Sbjct: 78 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGM 134
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
YL R IHRDL A N+LL + KI DFG+ R ++
Sbjct: 135 GYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 50/163 (30%), Positives = 84/163 (51%), Gaps = 12/163 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKL 567
F LG G FG VYKG + E VA+K L + S + KE +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
+ ++ RL+G C+ ++ I + MP L ++ + +G Q + IA+G+
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 131
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
YL R++HRDL A N+L+ + + KI+DFG+A++ +E
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 12/158 (7%)
Query: 518 MQCKLGEGGFGPVYKGKLLNGQE---VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLV 573
+LG G FG V +G ++ VA+K L +E E ++ +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 574 RLMGCCVEQGEKILI-YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
RL+G C Q E +++ E L+ FL + +++ ++ G+ YL
Sbjct: 74 RLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL--- 126
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
+HRDL A N+LL + KISDFG+++ D+
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-33
Identities = 42/173 (24%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKL--------LNGQEVAVKRLSSQSGQGLKEFKNEMMLIA 565
E+ LG+G F ++KG L+ EV +K L + F +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
KL H++LV G CV E IL+ E++ SL+ +L + W+ +++ + +A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAA 125
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNP--------KISDFGMARMFCGDE 670
+ +L +IH ++ A NILL + + K+SD G++ +
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 43/150 (28%), Positives = 73/150 (48%), Gaps = 11/150 (7%)
Query: 521 KLGEGGFGPVYKGKLLNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
+G+G FG VY G+ ++ + A+K L Q ++ F E +L+ L H N++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 576 MGCCVEQGEKILI-YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
+G + + YM + L F+ P R + + +A+G+ YL +
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGMEYL---AE 142
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ +HRDL A N +LD K++DFG+AR
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLAR 172
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 43/150 (28%), Positives = 71/150 (47%), Gaps = 11/150 (7%)
Query: 521 KLGEGGFGPVYKGKLLNG----QEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
+G G FG VY G LL+ AVK L + +F E +++ H N++ L
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 576 MGCCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
+G C+ L + YM + L F+ + + + + +A+G+ YL +
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---AS 146
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ +HRDL A N +LD K++DFG+AR
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 54/165 (32%), Positives = 77/165 (46%), Gaps = 17/165 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAK 566
+N ++ LG G FG VY+G++ +VAVK L S Q +F E ++I+K
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGI 622
H+N+VR +G ++ + ++ E M L FL PS+ L + + I
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMAR 664
A G YL IHRD+ A N LL KI DFGMAR
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 44/173 (25%), Positives = 74/173 (42%), Gaps = 25/173 (14%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRL-SSQSGQGLKEFKNEMMLIAK 566
+ + LG G FG V + + VAVK L + + +E+ ++
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 567 L-QHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-------------FDPSRTHLLG 611
+ H N+V L+G C + G + +I E+ +L+ +L + L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ + +A+G+ +L + + IHRDL A NILL KI DFG+AR
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 54/165 (32%), Positives = 77/165 (46%), Gaps = 17/165 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAK 566
+N ++ LG G FG VY+G++ +VAVK L S Q +F E ++I+K
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGI 622
H+N+VR +G ++ + ++ E M L FL PS+ L + + I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMAR 664
A G YL IHRD+ A N LL KI DFGMAR
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 14/156 (8%)
Query: 521 KLGEGGFGPVYKGKLLNG---QEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
+LG G FG V KG + VAVK L + E E ++ +L + +VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 576 MGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
+G C + E L+ E LN +L + + ++++ ++ G+ YL
Sbjct: 84 IGIC--EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYL---EE 135
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
+HRDL A N+LL + KISDFG+++ DE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 52/179 (29%), Positives = 80/179 (44%), Gaps = 31/179 (17%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAK 566
+N + LGEG FG V K + VAVK L + S L++ +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL---------------------FDPS 605
+ H ++++L G C + G +LI EY SL FL D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 606 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
L + I+QG+ YL + ++++HRDL A NIL+ KISDFG++R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 52/163 (31%), Positives = 84/163 (51%), Gaps = 11/163 (6%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAKL 567
+ Q +G G FG VYKG L VA+K L + + + +F E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
H N++RL G + ++I EYM N +L+ FL + V ++ GIA G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMK 161
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
YL + + +HRDL A NIL++S++ K+SDFG++R+ D
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 11/150 (7%)
Query: 521 KLGEGGFGPVYKGKLLNG----QEVAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLVRL 575
+G G FG VY G LL+ AVK L + +F E +++ H N++ L
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 576 MGCCVEQGEKIL-IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
+G C+ L + YM + L F+ + + + + +A+G+ +L +
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL---AS 210
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ +HRDL A N +LD K++DFG+AR
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 59/251 (23%), Positives = 96/251 (38%), Gaps = 42/251 (16%)
Query: 453 RRKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAK-----GTRRDSVLPCFSLA 507
H + L K T + E S TR S LA
Sbjct: 4 SHHHHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLA 63
Query: 508 SVSAAT-----------ENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRL-S 547
VS + ++ LGEG FG V + + VAVK L
Sbjct: 64 GVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 123
Query: 548 SQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL----- 601
+ + L + +EM ++ + +H+N++ L+G C + G +I EY +L +L
Sbjct: 124 DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 183
Query: 602 --------FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 653
+ + ++ V +A+G+ YL + + IHRDL A N+L+ +
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENN 240
Query: 654 NPKISDFGMAR 664
KI+DFG+AR
Sbjct: 241 VMKIADFGLAR 251
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 46/174 (26%), Positives = 81/174 (46%), Gaps = 26/174 (14%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRL-SSQSGQGLKEFKNEMMLI 564
+ ++ LGEG FG V + + VAVK L + + L + +EM ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 565 AKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------------FDPSRTHLL 610
+ +H+N++ L+G C + G +I EY +L +L + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 611 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
++ V +A+G+ YL + + IHRDL A N+L+ + KI+DFG+AR
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 54/164 (32%), Positives = 85/164 (51%), Gaps = 14/164 (8%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQ 568
N S+ +G G FG V G+L + VA+K L + + ++F E ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTH--LLGWQTRVKIIEGIAQGL 626
H N++RL G + +++ EYM N SL+ FL R H V ++ GIA G+
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
YL S + +HRDL A NIL++S++ K+SDFG+ R+ D
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-32
Identities = 52/157 (33%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 242
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
+L E+ I + EYM SL FL + L V + IA G+ Y+
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYV---E 297
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
R+ +HRDL+A+NIL+ ++ K++DFG+AR+ +E
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-31
Identities = 52/157 (33%), Positives = 81/157 (51%), Gaps = 6/157 (3%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 325
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
+L E+ I + EYM SL FL L V + IA G+ Y+
Sbjct: 326 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV---E 380
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
R+ +HRDL+A+NIL+ ++ K++DFG+AR+ +E
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 11/162 (6%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQ 568
E + +GEG FG V++G ++ + VA+K + S ++F E + + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
H ++V+L+G E I I E L FL R + L + + ++ L Y
Sbjct: 75 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
L R +HRD+ A N+L+ S+ K+ DFG++R
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 11/162 (6%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQ 568
E+ + LGEG FG VY+G N + VAVK + ++F +E +++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
H ++V+L+G E+ I I E P L +L + L T V I + + Y
Sbjct: 72 HPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAY 128
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
L + +HRD+ NIL+ S K+ DFG++R ++
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 48/170 (28%), Positives = 71/170 (41%), Gaps = 22/170 (12%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE------VAVKRL-SSQSGQGLKEFKNEMMLIAK 566
N LG G FG V + + VAVK L S+ + +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 567 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----------FDPSRTHLLGWQT 614
L QH N+V L+G C G ++I EY L FL +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 615 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ +AQG+ +L + IHRD+ A N+LL + KI DFG+AR
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 48/174 (27%), Positives = 71/174 (40%), Gaps = 26/174 (14%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE------VAVKRL-SSQSGQGLKEFKNEMMLIAK 566
S LG G FG V + + VAVK L S + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 567 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG---- 621
L H N+V L+G C G ++I EY L FL + + + + +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 622 -----------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+A+G+ +L + IHRDL A NILL KI DFG+AR
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-31
Identities = 40/157 (25%), Positives = 71/157 (45%), Gaps = 10/157 (6%)
Query: 518 MQCKLGEGGFGPVYKGKLLNGQE---VAVKRL-SSQSGQGLKEFKNEMMLIAKLQHRNLV 573
+LG G FG V +G ++ VA+K L +E E ++ +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
RL+G C + + + E L+ FL + +++ ++ G+ YL
Sbjct: 400 RLIGVCQAEALML-VMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL---E 453
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
+HR+L A N+LL + KISDFG+++ D+
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-31
Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 39/209 (18%)
Query: 491 DAKGTRRDSVLPCFSLASVSAAT-----------ENFSMQCKLGEGGFGPVYKGKLLN-- 537
D +++ LA VS + + LGEG FG V + +
Sbjct: 35 DYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLD 94
Query: 538 ------GQEVAVKRL-SSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIY 589
+VAVK L S + + L + +EM ++ + +H+N++ L+G C + G +I
Sbjct: 95 KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 154
Query: 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG--------------IAQGLLYLHQYSRL 635
EY +L +L R L + +A+G+ YL +
Sbjct: 155 EYASKGNLREYLQA-RRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASK 210
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ IHRDL A N+L+ D KI+DFG+AR
Sbjct: 211 KCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 42/162 (25%), Positives = 69/162 (42%), Gaps = 9/162 (5%)
Query: 509 VSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL 567
V +++ KLGEGGF V + L +G A+KR+ Q +E + E +
Sbjct: 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF 83
Query: 568 QHRNLVRLMGCCVEQGEK----ILIYEYMPNKSLNFFLFDPSRTH-LLGWQTRVKIIEGI 622
H N++RL+ C+ + L+ + +L + L + ++ GI
Sbjct: 84 NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+GL +H HRDLK +NILL + P + D G
Sbjct: 144 CRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 46/179 (25%), Positives = 68/179 (37%), Gaps = 31/179 (17%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE------VAVKRL-SSQSGQGLKEFKNEMMLIAK 566
EN LG G FG V + VAVK L + +E+ ++ +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 567 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKII 619
L H N+V L+G C G LI+EY L +L F + +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 620 EG--------------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ +A+G+ +L +HRDL A N+L+ KI DFG+AR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-30
Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 11/162 (6%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAKLQ 568
E + +GEG FG V++G ++ + VA+K + S ++F E + + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
H ++V+L+G E I I E L FL R L + + ++ L Y
Sbjct: 450 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
L R +HRD+ A N+L+ S+ K+ DFG++R
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 50/163 (30%), Positives = 81/163 (49%), Gaps = 9/163 (5%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
LG+G +G VY G+ L N +A+K + + + + E+ L L+H+N+V+ +G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 581 EQGEKILIY-EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
E I I+ E +P SL+ L QT + I +GL YLH +I+H
Sbjct: 90 E-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 640 RDLKASNILLDSDM-NPKISDFGMARMFCGDELQGNTKRVVGT 681
RD+K N+L+++ KISDFG ++ + T+ GT
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTETFTGT 186
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 48/166 (28%), Positives = 74/166 (44%), Gaps = 16/166 (9%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
+F LG+G FG V K + L+ + A+K++ + L +E+ML+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFF---------LFD--PSRTHLLGWQTRVKIIE 620
+VR +E+ + + KS F L+D S ++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
I + L Y+H IIHRDLK NI +D N KI DFG+A+
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 49/185 (26%), Positives = 80/185 (43%), Gaps = 28/185 (15%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
+F +G GGFG V+K K ++G+ +KR+ + ++ + E+ +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 573 VRLMGCCVEQGEKI----------------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRV 616
V GC + E+ +L ++ + R L +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 617 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK 676
++ E I +G+ Y+H ++I+RDLK SNI L KI DFG+ D G
Sbjct: 126 ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRT 179
Query: 677 RVVGT 681
R GT
Sbjct: 180 RSKGT 184
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-29
Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 9/171 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
E + K+GEG FG K +G++ +K +S S + +E + E+ ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
N+V+ E G ++ +Y L F + + L + I L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDL-FKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+I+HRD+K+ NI L D ++ DFG+AR+ +GT
Sbjct: 143 D---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 43/176 (24%), Positives = 73/176 (41%), Gaps = 17/176 (9%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 571
+F LG GGFG V++ K ++ A+KR+ ++ E+ +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 572 LVRLMGCCVE---------QGEKILIY---EYMPNKSLNFFLFDPSRTHLLGWQTRVKII 619
+VR +E K+ +Y + ++L ++ + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
IA+ + +LH ++HRDLK SNI D K+ DFG+ DE +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 48/169 (28%), Positives = 72/169 (42%), Gaps = 16/169 (9%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
++G G F VYKG EVA + + + FK E ++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 578 CCVEQGEK----ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
+ +L+ E M + +L +L R ++ + I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-R 148
Query: 634 RLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCGDELQGNTKRVVGT 681
IIHRDLK NI + + KI D G+A + K V+GT
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGT 193
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 42/173 (24%), Positives = 80/173 (46%), Gaps = 10/173 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAKLQH 569
NF ++ K+G G F VY+ LL+G VA+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV-KIIEGIAQGLLY 628
N+++ +E E ++ E L+ + + L + V K + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+H R++HRD+K +N+ + + K+ D G+ R F ++ +VGT
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 33/181 (18%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 564
ENF K+GEG +G VYK + L G+ VA+K++ L E+ L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPN------KSLNFFLFDPSRTHLLGWQTRVKI 618
+L H N+V+L+ + + L++E++ + +Q
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----- 111
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
+ QGL + H + R++HRDLK N+L++++ K++DFG+AR F G ++ T V
Sbjct: 112 ---LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEV 164
Query: 679 V 679
V
Sbjct: 165 V 165
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 41/165 (24%), Positives = 70/165 (42%), Gaps = 12/165 (7%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAKLQHRNL--VRLM 576
++G GG V++ Q A+K L Q L ++NE+ + KLQ + +RL
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
+ ++ E N LN +L + + W+ + + + + +HQ+
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKN-MLEAVHTIHQH---G 175
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
I+H DLK +N L+ D K+ DFG+A D VG
Sbjct: 176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 12/172 (6%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAKLQHRN 571
+S+ ++G GG V++ Q A+K L Q L ++NE+ + KLQ +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 572 L--VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
+RL + ++ E N LN +L + + W+ + + + + + +
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL--KKKKSIDPWERK-SYWKNMLEAVHTI 143
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
HQ+ I+H DLK +N L+ D K+ DFG+A D VGT
Sbjct: 144 HQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 191
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 43/172 (25%), Positives = 73/172 (42%), Gaps = 12/172 (6%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAKLQHRN 571
+S+ ++G GG V++ Q A+K L Q L ++NE+ + KLQ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 572 L--VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
+RL + ++ E N LN +L + + R + + + + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
HQ+ I+H DLK +N L+ D K+ DFG+A D VGT
Sbjct: 125 HQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 55/179 (30%), Positives = 88/179 (49%), Gaps = 31/179 (17%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLIA 565
E + K+GEG +G VYK K G+ VA+KR+ L E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPN--KSL---NFFLFDPSRTHLLGWQTRVKIIE 620
+L H N+V L+ + L++E+M K + N S+ + +Q
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ------- 127
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
+ +G+ + HQ+ RI+HRDLK N+L++SD K++DFG+AR F G ++ T VV
Sbjct: 128 -LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV 181
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 52/216 (24%), Positives = 82/216 (37%), Gaps = 29/216 (13%)
Query: 477 SVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGK-L 535
S + + D +G L + Q ++G G FG V++ K
Sbjct: 22 SGSAKLQRLGPETEDNEGVLLTEKLKPVD-YEYREEVHWMTHQPRVGRGSFGEVHRMKDK 80
Query: 536 LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY-EYMPN 594
G + AVK++ + + E++ A L +V L G E G + I+ E +
Sbjct: 81 QTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVRE-GPWVNIFMELLEG 134
Query: 595 KSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 649
SL + R + + +GL YLH RI+H D+KA N+LL
Sbjct: 135 GSLGQLIKQMGCLPEDRA--------LYYLGQALEGLEYLHT---RRILHGDVKADNVLL 183
Query: 650 DSDMNP-KISDFGMARMFCGDELQGNTKR---VVGT 681
SD + + DFG A D L + + GT
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 49/172 (28%), Positives = 88/172 (51%), Gaps = 12/172 (6%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
E + + +LG+G FG VYK K G A K + ++S + L+++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
+V+L+G G+ ++ E+ P +++ + L Q +V + + + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLHS 135
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 681
RIIHRDLKA N+L+ + + +++DFG L+ KR +GT
Sbjct: 136 ---KRIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGT 180
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 14/172 (8%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
+ ++ K+G+G G VY + GQEVA+++++ Q + NE++++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
+V + + E ++ EY+ SL D + + Q L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 681
++IHRD+K+ NILL D + K++DFG FC +KR +VGT
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGT 179
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 46/180 (25%), Positives = 82/180 (45%), Gaps = 32/180 (17%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 564
+ + K+GEG +G V+K K + VA+KR+ L + E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPN--KSL---NFFLFDPSRTHLLGWQTRVKII 619
+L+H+N+VRL + L++E+ K DP +Q
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ------ 109
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
+ +GL + H ++HRDLK N+L++ + K+++FG+AR F G ++ + VV
Sbjct: 110 --LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV 163
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 52/180 (28%), Positives = 85/180 (47%), Gaps = 30/180 (16%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
K+GEG G V + +G++VAVK + + Q + NE++++ QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG-IA------- 623
+V + + E ++ E++ +L T ++ ++V++ E IA
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGAL---------TDIV---SQVRLNEEQIATVCEAVL 151
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 681
Q L YLH +IHRD+K+ +ILL D K+SDFG FC + KR +VGT
Sbjct: 152 QALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGT 204
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 32/185 (17%)
Query: 511 AATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG-----LKEFKNEMMLI 564
+++ F KLG G + VYKG G VA+K + S +G ++E L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57
Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYM----------PNKSLNFFLFDPSRTHLLGWQT 614
+L+H N+VRL + + L++E+M + + WQ
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ- 116
Query: 615 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGN 674
+ QGL + H+ +I+HRDLK N+L++ K+ DFG+AR F G +
Sbjct: 117 -------LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTF 165
Query: 675 TKRVV 679
+ VV
Sbjct: 166 SSEVV 170
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 42/176 (23%), Positives = 79/176 (44%), Gaps = 10/176 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
E++ + +G G +G K + +G+ + K S + + +E+ L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 571 NLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTHLLGWQTRV-KIIEGIAQGLL 627
N+VR +++ L + EY L + ++ + V +++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 628 YLHQ--YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
H+ ++HRDLK +N+ LD N K+ DFG+AR+ D T VGT
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 42/155 (27%), Positives = 67/155 (43%), Gaps = 12/155 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKE-FKNEMMLIAKLQH 569
+ LG+GGF ++ + A K + S +E E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 570 RNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
+++V G E + + ++ E +SL R L + R + I G Y
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEAR-YYLRQIVLGCQY 156
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
LH+ R+IHRDLK N+ L+ D+ KI DFG+A
Sbjct: 157 LHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 43/147 (29%), Positives = 66/147 (44%), Gaps = 12/147 (8%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKE-FKNEMMLIAKLQHRNLVRLMG 577
LG+GGF ++ + A K + S +E E+ + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 578 CCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
E + + ++ E +SL R L + R + I G YLH R R
Sbjct: 83 F-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEAR-YYLRQIVLGCQYLH---RNR 135
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMA 663
+IHRDLK N+ L+ D+ KI DFG+A
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 31/179 (17%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLIA 565
E + K+GEG +G VYK + G+ A+K++ L++ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPN--KSL---NFFLFDPSRTHLLGWQTRVKIIE 620
+L+H N+V+L + +L++E++ K L + Q
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ------- 108
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
+ G+ Y H R++HRDLK N+L++ + KI+DFG+AR F G ++ T +V
Sbjct: 109 -LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV 162
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 42/171 (24%), Positives = 75/171 (43%), Gaps = 13/171 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKL 567
S + + + LG+G V++G+ G A+K + + + E ++ KL
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 568 QHRNLVRLMGCCVEQGEKILIY---EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
H+N+V+L E+ E+ P SL L +PS + L + ++ +
Sbjct: 65 NHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 625 GLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMARMFCGDEL 671
G+ +L + I+HR++K NI+ D K++DFG AR DE
Sbjct: 124 GMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 52/182 (28%), Positives = 85/182 (46%), Gaps = 23/182 (12%)
Query: 509 VSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKN----EMM 562
V + + + LGEG F VYK + Q VA+K++ K+ E+
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN--KSL---NFFLFDPSRTHLLGWQTRVK 617
L+ +L H N++ L+ + L++++M + + N + PS
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM---- 120
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
QGL YLHQ+ I+HRDLK +N+LLD + K++DFG+A+ F G + T +
Sbjct: 121 ----TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQ 172
Query: 678 VV 679
VV
Sbjct: 173 VV 174
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 42/171 (24%), Positives = 75/171 (43%), Gaps = 13/171 (7%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKL 567
S + + + LG+G V++G+ G A+K + + + E ++ KL
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 568 QHRNLVRLMGCCVEQGEKILIY---EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
H+N+V+L E+ E+ P SL L +PS + L + ++ +
Sbjct: 65 NHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 625 GLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMARMFCGDEL 671
G+ +L + I+HR++K NI+ D K++DFG AR DE
Sbjct: 124 GMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 27/177 (15%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG-----LKEFKNEMMLIAKL 567
E + KLGEG + VYKGK L VA+K + + +G ++E L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPN--KSL---NFFLFDPSRTHLLGWQTRVKIIEGI 622
+H N+V L + L++EY+ K + + L +Q +
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ--------L 109
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
+GL Y H+ +++HRDLK N+L++ K++DFG+AR + VV
Sbjct: 110 LRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV 162
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 45/155 (29%), Positives = 69/155 (44%), Gaps = 10/155 (6%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGC 578
L EGGF VY+ + + +G+E A+KRL S + + E+ + KL H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 579 CVEQGEK-------ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
E+ L+ + L FL L T +KI + + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
+ IIHRDLK N+LL + K+ DFG A
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 49/155 (31%), Positives = 83/155 (53%), Gaps = 11/155 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKE-FKNEMMLIAKLQH 569
E+F + LG+G F VY+ + + G EVA+K + + G+ + +NE+ + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 570 RNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
+++ L E + L+ E N +N +L + + + R + I G+LY
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEAR-HFMHQIITGMLY 127
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
LH + I+HRDL SN+LL +MN KI+DFG+A
Sbjct: 128 LHSH---GILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 48/168 (28%), Positives = 73/168 (43%), Gaps = 14/168 (8%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNL 572
+ M+ +LG GGFG V + G++VA+K+ + +E + E+ ++ KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 573 VRL------MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
V + +L EY L +L L ++ I+ L
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 627 LYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDEL 671
YLH+ RIIHRDLK NI+L + KI D G A+ EL
Sbjct: 135 RYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 49/185 (26%), Positives = 77/185 (41%), Gaps = 38/185 (20%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 564
+ + KLGEG +G VYK + + VA+KR+ L+ + E+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKII 619
+LQHRN++ L LI+EY L ++ +Q
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQ------ 140
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARMFCGDELQGN 674
+ G+ + H R +HRDLK N+LL KI DFG+AR F G ++
Sbjct: 141 --LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQF 194
Query: 675 TKRVV 679
T ++
Sbjct: 195 THEII 199
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 48/181 (26%), Positives = 82/181 (45%), Gaps = 19/181 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 571
+++ +Q +G G V ++VA+KR++ + + E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG-IA------- 623
+V V + E L+ + + S+ + G + E IA
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDII---KHIVAKGEHKSGVLDESTIATILREVL 131
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM-ARMFCGDELQGNTKR--VVG 680
+GL YLH + IHRD+KA NILL D + +I+DFG+ A + G ++ N R VG
Sbjct: 132 EGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 681 T 681
T
Sbjct: 189 T 189
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 52/172 (30%), Positives = 86/172 (50%), Gaps = 14/172 (8%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
E F + KLGEG +G VYK GQ VA+K++ + L+E E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
+V+ G + + ++ EY S++ + L + I++ +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIAT-ILQSTLKGLEYLHF 143
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 681
+R IHRD+KA NILL+++ + K++DFG G KR V+GT
Sbjct: 144 ---MRKIHRDIKAGNILLNTEGHAKLADFG----VAGQLTDTMAKRNTVIGT 188
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 52/173 (30%), Positives = 82/173 (47%), Gaps = 16/173 (9%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQ 568
+ FS ++G G FG VY + + N + VA+K++S QS + ++ E+ + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
H N ++ GC + + L+ EY + + L + + L + + G QGL Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAY 169
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
LH +IHRD+KA NILL K+ DFG N+ VGT
Sbjct: 170 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANS--FVGT 213
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 44/180 (24%), Positives = 71/180 (39%), Gaps = 32/180 (17%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 564
E + K+GEG +G V+K + GQ VA+K+ E E+ ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56
Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFF-----LFDPSRTHLLGWQTRVKII 619
+L+H NLV L+ + L++EY + L+ + WQ
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ------ 110
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
Q + + H++ IHRD+K NIL+ K+ DFG AR+ V
Sbjct: 111 --TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA 164
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 46/201 (22%), Positives = 73/201 (36%), Gaps = 33/201 (16%)
Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKR--LSSQSGQGLKEFKNEM 561
++ S T F K+G G FG V+K K L+G A+KR + E+
Sbjct: 2 AMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV 61
Query: 562 MLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIE 620
A L QH ++VR E ++ EY SL + + R + +K +
Sbjct: 62 YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121
Query: 621 G-IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-------------------KISDF 660
+ +GL Y+H + ++H D+K SNI + P KI D
Sbjct: 122 LQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178
Query: 661 GMARMFCGDELQGNTKRVVGT 681
G + + G
Sbjct: 179 GHVTRI------SSPQVEEGD 193
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 21/204 (10%)
Query: 476 MSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKL 535
MS A D + + ++ +G G FG V++ KL
Sbjct: 5 MSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQR---EIAYTNCKVIGNGSFGVVFQAKL 61
Query: 536 LNGQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHRNLVRLMGCCVEQGEKI------LI 588
+ EVA+K++ K FKN E+ ++ ++H N+V L G+K L+
Sbjct: 62 VESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116
Query: 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVK-IIEGIAQGLLYLHQYSRLRIIHRDLKASNI 647
EY+P +++ ++ +K + + + L Y+H + I HRD+K N+
Sbjct: 117 LEYVP-ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNL 172
Query: 648 LLDSDMNP-KISDFGMARMFCGDE 670
LLD K+ DFG A++ E
Sbjct: 173 LLDPPSGVLKLIDFGSAKILIAGE 196
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 15/173 (8%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHR 570
E F+ K+G+G FG V+KG + VA+K + + + +++ + E+ ++++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
+ + G ++ + +I EY+ S D L I+ I +GL YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH 136
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 681
+ IHRD+KA+N+LL K++DFG G KR VGT
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFG----VAGQLTDTQIKRNTFVGT 182
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 45/182 (24%), Positives = 77/182 (42%), Gaps = 36/182 (19%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMM---------L 563
E + +GEG +G V K + G+ VA+K+ L+ ++M+ L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-------LESDDDKMVKKIAMREIKL 77
Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVK 617
+ +L+H NLV L+ C ++ L++E++ + ++ L D +Q
Sbjct: 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQ---- 132
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
I G+ + H + IIHRD+K NIL+ K+ DFG AR +
Sbjct: 133 ----IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDE 184
Query: 678 VV 679
V
Sbjct: 185 VA 186
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 40/179 (22%), Positives = 60/179 (33%), Gaps = 31/179 (17%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAK 566
S ++F +LG G +G V+K +G+ AVK + + E+ K
Sbjct: 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 567 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL------FDPSRTHLLGWQTRVKII 619
+ QH VRL E G L E SL ++
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRD------ 165
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM---------FCGD 669
L +LH ++H D+K +NI L K+ DFG+ GD
Sbjct: 166 --TLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGD 219
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 43/181 (23%), Positives = 77/181 (42%), Gaps = 25/181 (13%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLS-----------------SQSGQGLKE 556
++ + L +G F + + + + A+K+ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 557 FKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL-----NFFLFDPSRTHLLG 611
FKNE+ +I +++ + G E +IYEYM N S+ FF+ D + T +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
Q II+ + Y+H + I HRD+K SNIL+D + K+SDFG + ++
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 672 Q 672
+
Sbjct: 208 K 208
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 46/189 (24%), Positives = 77/189 (40%), Gaps = 47/189 (24%)
Query: 520 CKLGEGGFGPVYKGK---LLNGQEVAVKRLS----SQSGQGLKEFKNEMMLIAKLQHRNL 572
CK+G G +G VYK K + ++ A+K++ S S E+ L+ +L+H N+
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNV 80
Query: 573 VRLMGCCVEQGEKI--LIYEYM-------------PNKSLNFFLFDPSRTHLLGWQTRVK 617
+ L + ++ L+++Y + L +Q
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ---- 136
Query: 618 IIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQG 673
I G+ YLH ++HRDLK +NIL+ + KI+D G AR+F L+
Sbjct: 137 ----ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-NSPLKP 188
Query: 674 NT---KRVV 679
VV
Sbjct: 189 LADLDPVVV 197
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 35/195 (17%), Positives = 66/195 (33%), Gaps = 30/195 (15%)
Query: 505 SLASVSAATENFSMQCKLGEG--GFGPVYKGK-LLNGQEVAVKR--LSSQSGQGLKEFKN 559
++S + + +G+G V + G+ V V+R L + S + + +
Sbjct: 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75
Query: 560 EMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 619
E+ + H N+V + E ++ +M S L+ +
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA---------KDLICTHFMDGMN 126
Query: 620 EG-IA-------QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
E IA + L Y+H + +HR +KAS+IL+ D +S
Sbjct: 127 ELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183
Query: 672 QGNT-----KRVVGT 681
+ K V
Sbjct: 184 RQRVVHDFPKYSVKV 198
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 43/177 (24%), Positives = 80/177 (45%), Gaps = 8/177 (4%)
Query: 508 SVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QGLKEFKNEM-MLI 564
S+ ++ +LG G +G V K + + +GQ +AVKR+ + Q K ++ + +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
+ V G +G+ + E M F+ + + KI I +
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
L +LH S+L +IHRD+K SN+L+++ K+ DFG++ D++ + G
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDI--DAGC 172
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 50/178 (28%), Positives = 77/178 (43%), Gaps = 33/178 (18%)
Query: 510 SAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKN----EMM 562
S AT + ++G G +G VYK + +G VA+K R+ + G G E+
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-GGGGLPISTVREVA 63
Query: 563 LIAKLQ---HRNLVRLMGCCVEQGEKI-----LIYEYMPN------KSLNFFLFDPSRTH 608
L+ +L+ H N+VRLM C L++E++
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK 123
Query: 609 LLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
L Q +GL +LH I+HRDLK NIL+ S K++DFG+AR++
Sbjct: 124 DLMRQ--------FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY 170
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 49/194 (25%), Positives = 80/194 (41%), Gaps = 19/194 (9%)
Query: 487 EGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKR 545
E + D + +R ++F +LG G G V+K +G +A K
Sbjct: 6 ELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL 65
Query: 546 LSSQSGQG-LKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDP 604
+ + + E+ ++ + +V G GE + E+M SL+ L
Sbjct: 66 IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 125
Query: 605 SRT--HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG- 661
R +LG K+ + +GL YL + +I+HRD+K SNIL++S K+ DFG
Sbjct: 126 GRIPEQILG-----KVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV 178
Query: 662 -------MARMFCG 668
MA F G
Sbjct: 179 SGQLIDSMANSFVG 192
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 6e-23
Identities = 52/173 (30%), Positives = 78/173 (45%), Gaps = 30/173 (17%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS----SQSGQGLKEFKNEMMLIAKLQ 568
E+F + LG+G FG VY + + +A+K L ++G + + E+ + + L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLR 67
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIA 623
H N++RL G + LI EY P ++ L FD RT I +A
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELA 119
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM--------FCG 668
L Y H R+IHRD+K N+LL S KI+DFG + CG
Sbjct: 120 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG 169
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 48/191 (25%), Positives = 85/191 (44%), Gaps = 42/191 (21%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 564
+ K+G+G FG V+K + GQ+VA+K++ ++ K E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70
Query: 565 AKLQHRNLVRLMGCCVEQGEKI--------LIYEYMPN--KSL---NFFLFDPSRTHLLG 611
L+H N+V L+ C + L++++ + L F S +
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 130
Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF---CG 668
+ GL Y+H+ +I+HRD+KA+N+L+ D K++DFG+AR F
Sbjct: 131 QM--------LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 669 DELQGNTKRVV 679
+ T RVV
Sbjct: 180 SQPNRYTNRVV 190
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 7e-23
Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 15/177 (8%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHR 570
F + +G G +G VYKG+ + GQ A+K + +G +E K E+ ++ K HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHR 81
Query: 571 NLVRLMGCCVEQGEKI------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
N+ G +++ L+ E+ S+ L ++ + L + I I +
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILR 140
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
GL +LHQ ++IHRD+K N+LL + K+ DFG++ + NT +GT
Sbjct: 141 GLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGT 192
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 55/197 (27%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 491 DAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ 549
D G++ +V+ +++ +G G FG VY+ KL +G+ VA+K++
Sbjct: 31 DKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD 90
Query: 550 SGQGLKEFKN-EMMLIAKLQHRNLVRLMGCCVEQGEKI------LIYEYMP--------N 594
K FKN E+ ++ KL H N+VRL GEK L+ +Y+P +
Sbjct: 91 -----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 145
Query: 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 654
S L +Q + + L Y+H I HRD+K N+LLD D
Sbjct: 146 YSRAKQTLPVIYVKLYMYQ--------LFRSLAYIHS---FGICHRDIKPQNLLLDPDTA 194
Query: 655 P-KISDFGMARMFCGDE 670
K+ DFG A+ E
Sbjct: 195 VLKLCDFGSAKQLVRGE 211
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 8/153 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QGLKEFKNEM-MLIAKLQHR 570
E+ ++G G +G V K +GQ +AVKR+ S + K+ ++ +++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV--KIIEGIAQGLLY 628
+V+ G +G+ + E M + S + F + KI + L +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661
L L+IIHRD+K SNILLD N K+ DFG
Sbjct: 141 LK--ENLKIIHRDIKPSNILLDRSGNIKLCDFG 171
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 41/178 (23%), Positives = 70/178 (39%), Gaps = 24/178 (13%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEM-MLIAKLQHRNLV 573
+F + LG G G + + + ++VAVKR+ + E+ +L +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 574 RLMGCCVEQGEKI--LIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYL 629
R C E+ + + E L + + + +++ GL +L
Sbjct: 82 RYF--CTEKDRQFQYIAIELCAAT-----LQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 630 HQYSRLRIIHRDLKASNILL-----DSDMNPKISDFGMARMFCGDEL-QGNTKRVVGT 681
H L I+HRDLK NIL+ + ISDFG+ + V GT
Sbjct: 135 HS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 43/172 (25%), Positives = 83/172 (48%), Gaps = 31/172 (18%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK--LLNGQEVAVKRLSSQSGQ------GLKEFKNEMMLIA 565
+ + ++GEG +G V+K + G+ VA+KR+ Q+G+ ++E + +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-VLRHLE 69
Query: 566 KLQHRNLVRL----MGCCVEQGEKI-LIYEYMPN------KSLNFFLFDPSRTHLLGWQT 614
+H N+VRL ++ K+ L++E++ + + +Q
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ- 128
Query: 615 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
+ +GL +LH + R++HRDLK NIL+ S K++DFG+AR++
Sbjct: 129 -------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 97.8 bits (243), Expect = 4e-22
Identities = 18/189 (9%), Positives = 41/189 (21%), Gaps = 36/189 (19%)
Query: 509 VSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL---SSQSGQGLKEFKNEMMLI 564
+S + L G V+ + + ++ A+K + S L+
Sbjct: 57 LSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAA 116
Query: 565 AKLQHRNLVRLMGCC--------------------------VEQGEKILIYEYMP---NK 595
A+L + +L+
Sbjct: 117 ARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLEL 176
Query: 596 SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP 655
+ F G + + + L ++H N+ + D
Sbjct: 177 LFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRL 233
Query: 656 KISDFGMAR 664
+ D
Sbjct: 234 MLGDVSALW 242
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 97.8 bits (243), Expect = 7e-22
Identities = 28/194 (14%), Positives = 55/194 (28%), Gaps = 38/194 (19%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQH-------- 569
LG+ + G+ V +K+ K E++ + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 570 --------RNLVRLMGCC-----VEQGEKILIYEY---MP-----NKSLNFFLFDPSRTH 608
+LV+ + + P ++ L S TH
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 609 -LLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667
L R+++ + + L LH ++H L+ +I+LD ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 668 GDELQGNTKRVVGT 681
G R
Sbjct: 262 GASAVSPIGRGFAP 275
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 49/165 (29%), Positives = 81/165 (49%), Gaps = 11/165 (6%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG---LKEFKNEMMLIAKLQHRNLVRLM 576
KLG GG VY + + +VA+K + + LK F+ E+ ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
E L+ EY+ +L+ ++ L T + I G+ + H +R
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
I+HRD+K NIL+DS+ KI DFG+A+ + T V+GT
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGT 175
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 9e-22
Identities = 41/174 (23%), Positives = 76/174 (43%), Gaps = 15/174 (8%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
+ + + +LG G FG V++ G+ K +++ KNE+ ++ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYL 629
L+ L ++ E +LI E++ LFD + + + + + +GL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGT 681
H+ I+H D+K NI+ ++ KI DFG+A DE K T
Sbjct: 166 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTAT 213
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 1e-21
Identities = 46/183 (25%), Positives = 71/183 (38%), Gaps = 31/183 (16%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEM-MLIAKLQHRNLVRLMGCC 579
LG G G V G+ VAVKR+ E+ +L H N++R C
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYY--C 76
Query: 580 VEQGEK--ILIYEYMPNKSLNFFL----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
E ++ + E N +L + L + ++ IA G+ +LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-- 133
Query: 634 RLRIIHRDLKASNILLDS-------------DMNPKISDFGMARMFCGDE--LQGNTKRV 678
L+IIHRDLK NIL+ + ++ ISDFG+ + + + N
Sbjct: 134 -LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 679 VGT 681
GT
Sbjct: 193 SGT 195
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 44/179 (24%), Positives = 75/179 (41%), Gaps = 35/179 (19%)
Query: 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKN----EMMLIAKL 567
+ F ++ G+G FG V GK G VA+K++ F+N M +A L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-----PRFRNRELQIMQDLAVL 76
Query: 568 QHRNLVRLMGCCVEQGEK-------ILIYEYMP------NKSLNFFLFDPSRTH--LLGW 612
H N+V+L GE+ ++ EY+P ++ P + +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 613 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARMFCGDE 670
Q + + + LH S + + HRD+K N+L++ +D K+ DFG A+ E
Sbjct: 137 Q--------LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 50/172 (29%), Positives = 84/172 (48%), Gaps = 15/172 (8%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
S LG G FG V+K + G ++A K + ++ + +E KNE+ ++ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
+L + + +L+ EY+ LFD ++ L + ++ I +G+ ++HQ
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 632 YSRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGT 681
+ I+H DLK NIL + KI DFG+AR + E K GT
Sbjct: 206 ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGT 251
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 44/173 (25%), Positives = 75/173 (43%), Gaps = 30/173 (17%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS----SQSGQGLKEFKNEMMLIAKLQ 568
++F + LG+G FG VY + N +A+K L + G + + E+ + + L+
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLR 72
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIA 623
H N++R+ ++ L+ E+ P L L FD R+ + +A
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE--------LA 124
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM--------FCG 668
L Y H ++IHRD+K N+L+ KI+DFG + CG
Sbjct: 125 DALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCG 174
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 41/158 (25%), Positives = 68/158 (43%), Gaps = 24/158 (15%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLS----SQSGQGLKEFKNEMMLIAKLQHRNLVRL- 575
LGEG +G V + AVK L + G K E+ L+ +L+H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 576 --MGCCVEQGEKI-LIYEYMPNKSLNFFLFD-PSRTHLLGWQTRVK---IIEGIAQGLLY 628
+ E+ +K+ ++ EY + D Q +I+G+ Y
Sbjct: 73 DVLYN--EEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----Y 124
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
LH I+H+D+K N+LL + KIS G+A
Sbjct: 125 LH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 3e-21
Identities = 35/169 (20%), Positives = 64/169 (37%), Gaps = 23/169 (13%)
Query: 521 KLGEGGFGPVYKGK--LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRL-- 575
+ GG G +Y +NG+ V +K L + E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 576 MGCCVEQGEKILIY---EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
++ + Y EY+ +SL L + + I L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH-- 199
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+ +++ DLK NI+L + K+ D G + + GT
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI------NSFGYLYGT 240
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 37/161 (22%), Positives = 66/161 (40%), Gaps = 12/161 (7%)
Query: 508 SVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QGLKEFKNEM-MLI 564
A + ++G G G V+K + G +AVK++ + K ++ +++
Sbjct: 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVL 78
Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRT--HLLGWQTRVKIIEGI 622
+V+ G + + + E M + +LG K+ I
Sbjct: 79 KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAI 133
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
+ L YL + +IHRD+K SNILLD K+ DFG++
Sbjct: 134 VKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 93.9 bits (233), Expect = 7e-21
Identities = 26/171 (15%), Positives = 53/171 (30%), Gaps = 22/171 (12%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK------LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK 566
++ + LGEG F VY+ N Q+ +K + M +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL--FDPSRTHLLGWQTRVKIIEGIAQ 624
++ + Q +L+ E +L + + + ++ + +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 625 GLLYLHQYSRLRIIHRDLKASNILL-----------DSDMNPKISDFGMAR 664
+ +H IIH D+K N +L D + D G +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 44/183 (24%), Positives = 71/183 (38%), Gaps = 23/183 (12%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQSGQGLKEFKNEMMLIAK 566
+ + + +G+G F V + GQ+ AVK + +S G ++ K E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQT-RV--KIIEG 621
L+H ++V L+ G +++E+M L R + V +
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRV 678
I + L Y H IIHRD+K +LL S K+ FG+A E
Sbjct: 139 ILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGR 193
Query: 679 VGT 681
VGT
Sbjct: 194 VGT 196
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 42/170 (24%), Positives = 72/170 (42%), Gaps = 15/170 (8%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG---LKEFKNEMMLIAKLQHRNLVRLM 576
LG GG V+ + L + ++VAVK L + + F+ E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 577 GCCVEQGEKILIY----EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
+ + EY+ +L + + + +++I Q L + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQG-NTKRVVGT 681
+ IIHRD+K +NI++ + K+ DFG+AR T V+GT
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 54/177 (30%), Positives = 83/177 (46%), Gaps = 19/177 (10%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQH 569
E +++ C LG+G FG V K K + QE AVK + +S + E+ L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLL 627
N+++L + ++ E L FD R +II+ + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGIT 135
Query: 628 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGT 681
Y+H+ I+HRDLK NILL+S D + KI DFG++ F + K +GT
Sbjct: 136 YMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGT 186
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 59/198 (29%), Positives = 89/198 (44%), Gaps = 26/198 (13%)
Query: 497 RDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--------RLS 547
RD+ LP S EN+ + LG G V + +E AVK S
Sbjct: 2 RDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS 59
Query: 548 SQSGQGLKE-FKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD-- 603
++ Q L+E E+ ++ K+ H N+++L L+++ M L FD
Sbjct: 60 AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYL 115
Query: 604 PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
+ L +TR KI+ + + + LH+ L I+HRDLK NILLD DMN K++DFG +
Sbjct: 116 TEKVTLSEKETR-KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 664 RMFCGDELQGNTKRVVGT 681
E + V GT
Sbjct: 172 CQLDPGEK---LREVCGT 186
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 24/182 (13%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQSGQGLKE-FKNEMMLIA 565
+++ M +LG G F V K + G+E A K RLSS +E + E+ ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIA 623
+++H N++ L + + +LI E + LFD + L + + ++ I
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEAT-QFLKQIL 118
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQGNTKRVV 679
G+ YLH RI H DLK NI+L P K+ DFG+A K +
Sbjct: 119 DGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIF 172
Query: 680 GT 681
GT
Sbjct: 173 GT 174
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 45/182 (24%), Positives = 74/182 (40%), Gaps = 24/182 (13%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQSGQGLKE-FKNEMMLIA 565
+ + + +LG G F V K + G E A K + + +E + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIA 623
++ H N++ L + + +LI E + LFD + L + I+ I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEAT-SFIKQIL 125
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQGNTKRVV 679
G+ YLH +I H DLK NI+L P K+ DFG+A K +
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIF 179
Query: 680 GT 681
GT
Sbjct: 180 GT 181
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 40/179 (22%), Positives = 75/179 (41%), Gaps = 20/179 (11%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHR 570
+ F + KLG G FG V+ + +G E +K ++ +S +++ + E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTR---VKIIEGIAQG 625
N++++ + ++ E L + S + ++++ +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGT 681
L Y H ++H+DLK NIL KI DFG+A +F DE GT
Sbjct: 137 LAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGT 189
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 91.6 bits (227), Expect = 5e-20
Identities = 28/187 (14%), Positives = 57/187 (30%), Gaps = 43/187 (22%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSS---QSGQGLKEFKNEMMLIAKLQ--------- 568
LG+ + G+ V +K+ K E++ + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 569 ----------------HRNLVRLMGCCVEQGEK--ILIYEYMPNKSLNFF--LFDPSRTH 608
+ ++R+ + +Y M + F L S TH
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 609 -LLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--- 664
L R+++ + + L LH Y ++H L+ +I+LD ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 665 ---MFCG 668
+
Sbjct: 258 ARVVSSV 264
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 45/182 (24%), Positives = 74/182 (40%), Gaps = 24/182 (13%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQSGQGLKE-FKNEMMLIA 565
+ + + +LG G F V K + G E A K + + +E + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIA 623
++ H N++ L + + +LI E + LFD + L + I+ I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEAT-SFIKQIL 125
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQGNTKRVV 679
G+ YLH +I H DLK NI+L P K+ DFG+A K +
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIF 179
Query: 680 GT 681
GT
Sbjct: 180 GT 181
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 6e-20
Identities = 49/177 (27%), Positives = 79/177 (44%), Gaps = 19/177 (10%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQH 569
+E + KLG G +G V + + E A+K + +S S + E+ ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLL 627
N+++L ++ L+ E L FD R II+ + G+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAA-VIIKQVLSGVT 150
Query: 628 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGT 681
YLH+ I+HRDLK N+LL+S D KI DFG++ +F + K +GT
Sbjct: 151 YLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGT 201
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 6e-20
Identities = 49/167 (29%), Positives = 73/167 (43%), Gaps = 18/167 (10%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLMGCC 579
LGEG +G V + + VAVK + + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 580 VEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVK---IIEGIAQGLLYLHQYSR 634
E + L EY L FD + + ++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+ I HRD+K N+LLD N KISDFG+A +F + + ++ GT
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 6e-20
Identities = 42/214 (19%), Positives = 80/214 (37%), Gaps = 23/214 (10%)
Query: 477 SVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGK-L 535
+ S + P +++ + +LG G FG V++
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTER 179
Query: 536 LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNK 595
G A K + + + + E+ ++ L+H LV L + E ++IYE+M
Sbjct: 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239
Query: 596 SLNFFLFD---PSRTHLLGWQTRVKIIEGIAQ---GLLYLHQYSRLRIIHRDLKASNILL 649
LF+ + + + +E + Q GL ++H+ +H DLK NI+
Sbjct: 240 E----LFEKVADEHNKM----SEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMF 288
Query: 650 DSDMNP--KISDFGMARMFCGDELQGNTKRVVGT 681
+ + K+ DFG+ + + K GT
Sbjct: 289 TTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGT 319
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 8e-20
Identities = 54/177 (30%), Positives = 83/177 (46%), Gaps = 19/177 (10%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQH 569
E +++ C LG+G FG V K K + QE AVK + +S + E+ L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLL 627
N+++L + ++ E L FD R +II+ + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGIT 135
Query: 628 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGT 681
Y+H+ I+HRDLK NILL+S D + KI DFG++ F + K +GT
Sbjct: 136 YMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGT 186
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 9e-20
Identities = 49/167 (29%), Positives = 73/167 (43%), Gaps = 18/167 (10%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLMGCC 579
LGEG +G V + + VAVK + + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 580 VEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVK---IIEGIAQGLLYLHQYSR 634
E + L EY L FD + + ++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+ I HRD+K N+LLD N KISDFG+A +F + + ++ GT
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 9e-20
Identities = 44/167 (26%), Positives = 71/167 (42%), Gaps = 37/167 (22%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQ--SGQGLKE-FKNEMMLIAKLQHRNLVRLMG 577
LGEG FG V Q+VA+K +S Q + + E+ + L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 578 CCVEQGEKILIYEYMPNKSLNFF--------LFD--PSRTHLLGWQTRVK---IIEGIAQ 624
Y+ + + LFD + + + R II I
Sbjct: 75 -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE- 122
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
Y H R +I+HRDLK N+LLD ++N KI+DFG++ +
Sbjct: 123 ---YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 9e-20
Identities = 50/159 (31%), Positives = 81/159 (50%), Gaps = 21/159 (13%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGC 578
+G+G F V + +L G+EVA+K + + + L++ E+ ++ L H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 579 CVEQGEKI-LIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVK---IIEGIAQGLLYLHQY 632
+E + + LI EY + FD + + + R K I+ + Y H
Sbjct: 83 -IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH-- 131
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
+ RI+HRDLKA N+LLD+DMN KI+DFG + F
Sbjct: 132 -QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-19
Identities = 54/178 (30%), Positives = 85/178 (47%), Gaps = 20/178 (11%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQ 568
++ + Q LG+G FG V K + GQE AVK +S + + E+ L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGL 626
H N+++L ++G L+ E L FD SR +II + G+
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAA-RIIRQVLSGI 139
Query: 627 LYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGT 681
Y+H+ +I+HRDLK N+LL+S D N +I DFG++ F + K +GT
Sbjct: 140 TYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGT 191
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 39/175 (22%), Positives = 73/175 (41%), Gaps = 17/175 (9%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
+ ++++ +G G +G V A K++ + + FK E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYL 629
++RL + + L+ E LF+ + +I++ + + Y
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAA-RIMKDVLSAVAYC 122
Query: 630 HQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGT 681
H+ L + HRDLK N L + D K+ DFG+A F ++ + VGT
Sbjct: 123 HK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGT 171
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 37/178 (20%), Positives = 63/178 (35%), Gaps = 38/178 (21%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQS---GQGLKEFKNEMMLIA 565
+S LG G FG V+ +EV VK ++ L + E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFF----------LFD--PSRTHLLGWQ 613
+++H N++++ + N+ LF L
Sbjct: 85 RVEHANIIKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL 131
Query: 614 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
I + + YL IIHRD+K NI++ D K+ DFG A +L
Sbjct: 132 AS-YIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL 185
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 41/165 (24%), Positives = 62/165 (37%), Gaps = 11/165 (6%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG---LKEFKNEMMLIAKLQHRNLVRLM 576
+G GG G VY+ + + + VA+K +S + E +LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
G+ + + L L R L V I+ I L H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154
Query: 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
HRD+K NIL+ +D + DFG+A DE VGT
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTVGT 198
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 38/168 (22%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVK---RLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
LG G FG V G+ L G +VAVK R +S + + K E+ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 578 CCVEQGEKILIYEYMPNKSLNFF---------LFD--PSRTHLLGWQTRVK---IIEGIA 623
Y+ + + F LFD + + R I+ +
Sbjct: 77 -----------YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
Y H R ++HRDLK N+LLD+ MN KI+DFG++ M E
Sbjct: 126 ----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 45/181 (24%), Positives = 80/181 (44%), Gaps = 23/181 (12%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-------RLSSQSGQGLKE-FKNEMML 563
+ + + +G G V + G E AVK RLS + + ++E + E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 564 IAKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIE 620
+ ++ H +++ L+ L+++ M L FD + L +TR I+
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETR-SIMR 207
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
+ + + +LH I+HRDLK NILLD +M ++SDFG + E + + G
Sbjct: 208 SLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCG 261
Query: 681 T 681
T
Sbjct: 262 T 262
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 35/174 (20%), Positives = 70/174 (40%), Gaps = 16/174 (9%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
E + + LG G FG V++ + + K + G K E+ ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRN 62
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYL 629
++ L E ++I+E++ + F+ + L + V + + + L +L
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDELQGNTKRVVGT 681
H I H D++ NI+ + + KI +FG AR + + +
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTA 166
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 51/168 (30%), Positives = 76/168 (45%), Gaps = 38/168 (22%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
LG G FG V GK L G +VAVK L+ Q S + + + E+ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 578 CCVEQGEKILIYEYMPNKSLNFF---------LFD--PSRTHLLGWQTRVK---IIEGIA 623
Y+ + S F LFD L ++R I+ G+
Sbjct: 82 -----------YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD 130
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
Y H R ++HRDLK N+LLD+ MN KI+DFG++ M E
Sbjct: 131 ----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 50/185 (27%), Positives = 76/185 (41%), Gaps = 30/185 (16%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQSGQGLKE-FKNEMMLIA 565
+ + +LG G F V K + G + A K R S +E + E+ ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 566 KLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTR---VKIIE 620
++QH N++ L + + ILI E + LFD + L T + ++
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGE----LFDFLAEKESL----TEEEATEFLK 121
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQGNTK 676
I G+ YLH L+I H DLK NI+L P KI DFG+A K
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FK 175
Query: 677 RVVGT 681
+ GT
Sbjct: 176 NIFGT 180
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 6e-19
Identities = 42/183 (22%), Positives = 74/183 (40%), Gaps = 26/183 (14%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS--------SQSGQGLKEFKNEMML 563
+ + M LG G G V ++VA++ +S ++ + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEG 621
+ KL H ++++ + + ++ E M L FD L +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 247
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRV 678
+ + YLH+ IIHRDLK N+LL S D KI+DFG +++ L + +
Sbjct: 248 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 301
Query: 679 VGT 681
GT
Sbjct: 302 CGT 304
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 43/183 (23%), Positives = 73/183 (39%), Gaps = 26/183 (14%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQSGQGLKE---FKNEMML 563
+ + M LG G G V ++VA+K + + S + + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEG 621
+ KL H ++++ + + ++ E M L FD L +
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 122
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRV 678
+ + YLH IIHRDLK N+LL S D KI+DFG +++ L + +
Sbjct: 123 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 176
Query: 679 VGT 681
GT
Sbjct: 177 CGT 179
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 19/177 (10%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQH 569
++N+ ++ +LG+G F V + G E A K + S + ++ + E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLL 627
N+VRL E+ L+++ + L F+ +R I+ I + +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCIQQILESIA 119
Query: 628 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGT 681
Y H I+HR+LK N+LL S K++DFG+A GT
Sbjct: 120 YCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGT 170
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 7e-19
Identities = 38/216 (17%), Positives = 69/216 (31%), Gaps = 50/216 (23%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK-----RLSSQSGQGLKEFKNEMMLIAK 566
+ + ++ +G+G +G V A+K ++ + + ++ K E+ L+ K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYM-------------------------PNKSLNFFL 601
L H N+ RL ++ L+ E +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 602 FDPSRTHLLGWQTRV------------KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 649
+ + R I+ I L YLH I HRD+K N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201
Query: 650 DSD--MNPKISDFGMARMFCGDELQGNT--KRVVGT 681
++ K+ DFG+++ F GT
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 43/180 (23%), Positives = 74/180 (41%), Gaps = 40/180 (22%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLS-----------------SQSGQGLKEFKNEMML 563
+G+G +G V + A+K LS + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 564 ------IA---KLQHRNLVRLMGCCVEQGEKILIY---EYMPNKSLNFFLFD-PSRTHLL 610
IA KL H N+V+L+ ++ + +Y E + + + P+ L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 611 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
Q R + + +G+ YLH +IIHRD+K SN+L+ D + KI+DFG++ F G +
Sbjct: 136 EDQAR-FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 55/179 (30%), Positives = 78/179 (43%), Gaps = 24/179 (13%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEF---KNEMMLIAKLQH 569
E+F LGEG F V + L +E A+K L + + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 570 RNLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
V+L Q ++ L Y N L ++ FD + T R E I
Sbjct: 90 PFFVKLYFTF--QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-------RFYTAE-I 139
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
L YLH IIHRDLK NILL+ DM+ +I+DFG A++ + Q VGT
Sbjct: 140 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 19/177 (10%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQH 569
++N+ ++ +LG+G F V + G E A K + S + ++ + E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLL 627
N+VRL E+ L+++ + L F+ +R I+ I + +
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCIQQILESIA 142
Query: 628 YLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGT 681
Y H I+HR+LK N+LL S K++DFG+A E GT
Sbjct: 143 YCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 193
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 4e-18
Identities = 42/175 (24%), Positives = 71/175 (40%), Gaps = 18/175 (10%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
+ F LG G F V+ K L G+ A+K + +NE+ ++ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYL 629
+V L L+ + + L FD R +I+ + + YL
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDAS-LVIQQVLSAVKYL 122
Query: 630 HQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVGT 681
H+ I+HRDLK N+L + + I+DFG+++M + GT
Sbjct: 123 HE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STACGT 170
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 5e-18
Identities = 49/188 (26%), Positives = 80/188 (42%), Gaps = 30/188 (15%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS-------------SQSGQGLKEFK 558
E++ KLG G +G V K E A+K + + +E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 559 NEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRV 616
NE+ L+ L H N+++L ++ L+ E+ L F+ +R
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAA- 149
Query: 617 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQG 673
I++ I G+ YLH+ I+HRD+K NILL++ +N KI DFG++ F D
Sbjct: 150 NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL- 205
Query: 674 NTKRVVGT 681
+ +GT
Sbjct: 206 --RDRLGT 211
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 45/172 (26%), Positives = 67/172 (38%), Gaps = 20/172 (11%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCC 579
LGEG V L+ QE AVK + Q G E+ ++ + Q HRN++ L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 580 VEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637
E+ L++E M S+ R H + +++ +A L +LH I
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEAS-VVVQDVASALDFLHN---KGI 132
Query: 638 IHRDLKASNILL---DSDMNPKISDFGMARMF-----CGDELQGNTKRVVGT 681
HRDLK NIL + KI DF + C G+
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 8e-18
Identities = 50/186 (26%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 506 LASVSAA--TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNE 560
+A+++ TE + + +LG+G F V + +L GQE A + S + ++ + E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 561 MMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKI 618
+ L+H N+VRL E+G LI++ + L F+ +R +
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADAS-HC 115
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNT 675
I+ I + +L+ HQ + ++HR+LK N+LL S K++DFG+A G+ Q
Sbjct: 116 IQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAW 170
Query: 676 KRVVGT 681
GT
Sbjct: 171 FGFAGT 176
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 1e-17
Identities = 37/187 (19%), Positives = 78/187 (41%), Gaps = 57/187 (30%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 562
+ + ++ +G G +G V + L + VA+K++ + F++ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104
Query: 563 LIAKLQHRNLVRLMGCCV----EQGEKI-LIYEYMP---------NKSLN-----FFLFD 603
++ +L H ++V+++ + E+ +++ ++ E L L+
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY- 163
Query: 604 PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
+ G+ Y+H S I+HRDLK +N L++ D + K+ DFG+A
Sbjct: 164 ---------N--------LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLA 203
Query: 664 RMFCGDE 670
R E
Sbjct: 204 RTVDYPE 210
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 46/171 (26%), Positives = 72/171 (42%), Gaps = 20/171 (11%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR-NLVRLM 576
+LG G F V + GQE A K + + E +E+ ++ + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFD---PSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
E ILI EY +F P ++ +++I+ I +G+ YLHQ
Sbjct: 96 EVYENTSEIILILEYAAGGE----IFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ-- 149
Query: 634 RLRIIHRDLKASNILL---DSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
I+H DLK NILL + KI DFGM+R + ++GT
Sbjct: 150 -NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGT 196
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 7e-17
Identities = 37/199 (18%), Positives = 75/199 (37%), Gaps = 49/199 (24%)
Query: 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKN-EMMLIAKLQHR 570
++ +S+ LG G FG V + + +G+ A+K++ +KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV-------------- 616
N+++L+ G++ P+ + +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 617 -----KIIEG-------------------IAQGLLYLHQYSRLRIIHRDLKASNILLDSD 652
K+++ + + + ++H L I HRD+K N+L++S
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK 177
Query: 653 MNP-KISDFGMARMFCGDE 670
N K+ DFG A+ E
Sbjct: 178 DNTLKLCDFGSAKKLIPSE 196
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 17/149 (11%), Positives = 50/149 (33%), Gaps = 14/149 (9%)
Query: 521 KLGEGGFGPVYKGK--LLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHRNLVRL 575
G ++ L ++VA+ + Q L+E + + ++++ + R+
Sbjct: 38 FHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
+ + +++ E++ SL T ++ ++ +A H R
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGA-IRAMQSLAAAADAAH---RA 148
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ S + + D + ++
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 41/174 (23%), Positives = 66/174 (37%), Gaps = 27/174 (15%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL------SSQSGQGLKEFKNEMMLIAKL 567
+ + LG GGFG VY G + + VA+K + E++L+ K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 568 QHR--NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIA 623
++RL+ +LI E LFD R L R +
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELAR-SFFWQVL 159
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARM--------FCG 668
+ + + H ++HRD+K NIL+D + K+ DFG + F G
Sbjct: 160 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDG 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 46/234 (19%), Positives = 71/234 (30%), Gaps = 66/234 (28%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 571
+F +G GGFG V++ K ++ A+KR+ ++ E+ +AKL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI------------- 618
+VR +E + E + P + VKI
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 619 --IEGIAQGLLY----------LHQYSRLR-----------------------------I 637
+ LY L + R +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK----------RVVGT 681
+HRDLK SNI D K+ DFG+ DE + VGT
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 37/176 (21%), Positives = 65/176 (36%), Gaps = 20/176 (11%)
Query: 513 TENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
T+ + ++ +G G + + E AVK + +E +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYL 629
++ L + ++ E M L D + + ++ I + + YL
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREAS-AVLFTITKTVEYL 132
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQGNTKRVVGT 681
H ++HRDLK SNIL + +I DFG A+ + G T
Sbjct: 133 HA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLMTPCYT 183
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 39/179 (21%), Positives = 62/179 (34%), Gaps = 49/179 (27%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLS----------SQSGQGLKEFKNEMMLIAKLQHR 570
LG+GGFG V+ G L + +VA+K + S S E + A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFF----------LFD--PSRTHLLGWQTRVKI 618
++RL ++ + LFD + L +R
Sbjct: 99 GVIRL-------------LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CF 144
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARM--------FCG 668
+ + + H ++HRD+K NIL+D K+ DFG + F G
Sbjct: 145 FGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDG 200
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 39/180 (21%), Positives = 64/180 (35%), Gaps = 34/180 (18%)
Query: 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKE--FKN---------EM 561
+++Q + G +G V G G VA+KR+ + G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 562 MLIAKLQHRNLVRLMGC----CVEQGEKI-LIYEYMPN------KSLNFFLFDPSRTHLL 610
L+ H N++ L K+ L+ E M + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 611 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
+ I GL LH+ ++HRDL NILL + + I DF +AR D
Sbjct: 141 -YH--------ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 38/168 (22%), Positives = 62/168 (36%), Gaps = 40/168 (23%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQHRNLVRLMGCC 579
+G G FG + L + VAVK + G + E + E++ L+H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRF---- 81
Query: 580 VEQGEKILIYEYMPNKSLNFF---------LFD--PSRTHLLGWQTRVK---IIEGIAQG 625
E + + L++ + + R ++ G++
Sbjct: 82 ---------KEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS-- 130
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSD--MNPKISDFGMARMFCGDEL 671
Y H ++I HRDLK N LLD KI DFG ++
Sbjct: 131 --YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 76.8 bits (188), Expect = 3e-15
Identities = 36/199 (18%), Positives = 58/199 (29%), Gaps = 46/199 (23%)
Query: 512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRL--------SSQSGQGLKEFKNEMML 563
TE K+GEG FG V++ + VA+K + + + +E E+++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 564 IAKLQ---------HRNLVRLMGCCVEQGE--KILIYEYMPNKSLNFFLFDPSR------ 606
+L + L QG +L+ + S D
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 607 ------------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 648
T L T I+ + L LR HRDL N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 649 LDSDMNPKISDFGMARMFC 667
L K+ +
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 41/168 (24%), Positives = 69/168 (41%), Gaps = 20/168 (11%)
Query: 521 KLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGC 578
LGEG F K + Q AVK +S + + E+ + + H N+V+L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74
Query: 579 CVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636
+Q L+ E + L F+ + H + I+ + + ++H +
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEAS-YIMRKLVSAVSHMHD---VG 126
Query: 637 IIHRDLKASNILL---DSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
++HRDLK N+L + ++ KI DFG AR+ D K T
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFT 172
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 25/178 (14%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
++ F ++ +LG G VY+ K + A+K L + K + E+ ++ +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--PSRTHLLGWQTR---VKIIEGIAQGL 626
+++L E L+ E + L FD + + + ++ I + +
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYY----SERDAADAVKQILEAV 161
Query: 627 LYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
YLH+ I+HRDLK N+L D KI+DFG++++ L K V GT
Sbjct: 162 AYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGT 213
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 40/181 (22%), Positives = 64/181 (35%), Gaps = 44/181 (24%)
Query: 521 KLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGC 578
LG G G V + GQ+ A+K L + + E+ + ++V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILD- 89
Query: 579 CVEQGEKILIYEYMPNKSLNFF----------LFDPSRTHLLGWQT-----RVKIIEGIA 623
+YE M + LF R G Q +I+ I
Sbjct: 90 ---------VYENMHHGKRCLLIIMECMEGGELFS--RIQERGDQAFTEREAAEIMRDIG 138
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
+ +LH I HRD+K N+L + D K++DFG A+ + LQ
Sbjct: 139 TAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT----PCY 191
Query: 681 T 681
T
Sbjct: 192 T 192
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 38/184 (20%), Positives = 76/184 (41%), Gaps = 43/184 (23%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HR 570
+++ + KLG G + V++ + N ++V VK L K+ K E+ ++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGP 91
Query: 571 NLVRLMGCCVEQGEK--ILIYEYMPNKSLN------------FFLFDPSRTHLLGWQTRV 616
N++ L + + L++E++ N F+++ +L
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY-----EIL------ 140
Query: 617 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCGDELQGNT 675
+ L Y H S I+HRD+K N+++D + ++ D+G+A Q
Sbjct: 141 -------KALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYN 188
Query: 676 KRVV 679
RV
Sbjct: 189 VRVA 192
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 36/187 (19%), Positives = 71/187 (37%), Gaps = 57/187 (30%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 562
+N+ ++ +G G +G VY + VA+K+++ + F++ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREIT 77
Query: 563 LIAKLQHRNLVRLMGCCVEQGEKI-----LIYEYMP---------NKSLN-----FFLFD 603
++ +L+ ++RL + ++ E L L
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTIL-- 135
Query: 604 PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663
+ + G ++H IIHRDLK +N LL+ D + K+ DFG+A
Sbjct: 136 --------YN--------LLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLA 176
Query: 664 RMFCGDE 670
R ++
Sbjct: 177 RTINSEK 183
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 47/169 (27%), Positives = 72/169 (42%), Gaps = 19/169 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQ---SGQGLKEFKNEMMLIAKLQH 569
F LG+GGFG V ++ ++ A K+L + +G NE ++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 570 RNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
R +V L E + + L+ M L F ++ + + E I GL
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLED 301
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA---------RMFCG 668
LH R RI++RDLK NILLD + +ISD G+A + G
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVG 347
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 12/174 (6%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQ---SGQGLKEFKNEMMLIAKLQH 569
+ F LG GGFG V+ ++ ++ A K+L+ + +G + E ++AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 570 RNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI-IEGIAQGLL 627
R +V L E + L+ M + + +++ + + R I GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+LHQ II+RDLK N+LLD D N +ISD G+A + TK GT
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGT 352
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 40/171 (23%), Positives = 76/171 (44%), Gaps = 38/171 (22%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 562
+ + +G G +G V +G++VA+K+LS + F++ E++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75
Query: 563 LIAKLQHRNLVRLM-----GCCVEQGEKI-LIYEYMP---NKSLNFFLFDPSRTHLLGWQ 613
L+ +QH N++ L+ + L+ +M K + + +L+ +Q
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV-YQ 134
Query: 614 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ +GL Y+H ++HRDLK N+ ++ D KI DFG+AR
Sbjct: 135 --------MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 44/176 (25%), Positives = 78/176 (44%), Gaps = 37/176 (21%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 562
++ +GEG +G V LN VA+K++S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 563 LIAKLQHRNLVRLMGC----CVEQGEKI-LIYEYMP---NKSLNFFLFDPSRTHLLGWQT 614
++ + +H N++ + +EQ + + ++ + M K L +Q
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ- 136
Query: 615 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
I +GL Y+H S ++HRDLK SN+LL++ + KI DFG+AR+ D
Sbjct: 137 -------ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 43/177 (24%), Positives = 73/177 (41%), Gaps = 30/177 (16%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
+ LG GG G V+ + VA+K++ Q +K E+ +I +L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 572 LVRLM--------------GCCVEQGEKILIYEYMP---NKSLNFFLFDPSRTHLLGWQT 614
+V++ G E ++ EYM L L +Q
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQ- 128
Query: 615 RVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCGDE 670
+ +GL Y+H + ++HRDLK +N+ +++ D+ KI DFG+AR+
Sbjct: 129 -------LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 8e-14
Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 32/168 (19%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 562
+ + +G G G V + + VA+K+LS + F+N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113
Query: 563 LIAKLQHRNLVRLM------GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV 616
L+ + H+N++ L+ E + L+ E M L + L +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSY 168
Query: 617 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ + + G+ +LH IIHRDLK SNI++ SD KI DFG+AR
Sbjct: 169 LLYQ-MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 1e-13
Identities = 44/181 (24%), Positives = 77/181 (42%), Gaps = 29/181 (16%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEF------KNEMMLIAK 566
+FS+ +G GGFG VY + + ++ A+K L + + + + + L++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 567 LQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIE 620
+V + +K+ I + M L++ L F + R E
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-------RFYAAE 300
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
I GL ++H +++RDLK +NILLD + +ISD G+A F + VG
Sbjct: 301 -IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVG 352
Query: 681 T 681
T
Sbjct: 353 T 353
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 46/171 (26%), Positives = 78/171 (45%), Gaps = 38/171 (22%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 562
+ + +G G G V + + VA+K+LS + F+N E++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76
Query: 563 LIAKLQHRNLVRLM-----GCCVEQGEKI-LIYEYMPNKSLNFFL---FDPSRTHLLGWQ 613
L+ + H+N++ L+ +E+ + + ++ E M +L + D R L +Q
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQ 135
Query: 614 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ G+ +LH IIHRDLK SNI++ SD KI DFG+AR
Sbjct: 136 --------MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 39/181 (21%), Positives = 66/181 (36%), Gaps = 43/181 (23%)
Query: 521 KLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGC 578
LG G G V + ++ A+K L + + E+ L + ++VR++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD- 122
Query: 579 CVEQGEKILIYEYMPNKSLNFF----------LFDPSRTHLLGWQT---R--VKIIEGIA 623
+YE + LF R G Q R +I++ I
Sbjct: 123 ---------VYENLYAGRKCLLIVMECLDGGELFS--RIQDRGDQAFTEREASEIMKSIG 171
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCGDELQGNTKRVVG 680
+ + YLH + I HRD+K N+L S + K++DFG A+ +
Sbjct: 172 EAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCY 225
Query: 681 T 681
T
Sbjct: 226 T 226
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 40/191 (20%), Positives = 77/191 (40%), Gaps = 57/191 (29%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 562
+ +F ++ LGEG +G V G+ VA+K++ F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 563 LIAKLQHRNLVRLMGC----CVEQGEKI-LIYEYMP--------NKSLN-----FFLFDP 604
++ +H N++ + E ++ +I E M + L+ +F+
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI--- 118
Query: 605 SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+Q + + LH + +IHRDLK SN+L++S+ + K+ DFG+AR
Sbjct: 119 -------YQ--------TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160
Query: 665 MFCGDELQGNT 675
+ +
Sbjct: 161 IIDESAADNSE 171
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 40/168 (23%), Positives = 71/168 (42%), Gaps = 31/168 (18%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 562
+ +G G +G V G +VA+K+L + F++ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELR 76
Query: 563 LIAKLQHRNLVRLM-----GCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRV 616
L+ ++H N++ L+ ++ L+ +M L + + LG
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM----KHEKLGEDRIQ 131
Query: 617 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
++ + +GL Y+H IIHRDLK N+ ++ D KI DFG+AR
Sbjct: 132 FLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 48/207 (23%), Positives = 76/207 (36%), Gaps = 28/207 (13%)
Query: 479 ATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAAT-ENFSMQCKLGEGGFGPVYKGKL-L 536
A + E + ++ L + S + A + F LG G FG V K
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 537 NGQEVAVKRLSSQSGQGLKEF---KNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 593
+G A+K L Q LK+ NE ++ + LV+L + ++ EY+
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 594 NKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 648
+ L F R + I YLH +I+RDLK N+L
Sbjct: 125 GGEMFSHLRRIGRFSEPHA-------RFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLL 173
Query: 649 LDSDMNPKISDFGMARM-------FCG 668
+D +++DFG A+ CG
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWTLCG 200
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 5e-13
Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 27/171 (15%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEF---KNEMMLIAKLQH 569
++F + LG G FG V+ + + A+K L + LK+ +E ++++ + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQ 624
++R+ G + + +I +Y+ L L F + E +
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-------KFYAAE-VCL 117
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM-------FCG 668
L YLH II+RDLK NILLD + + KI+DFG A+ CG
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG 165
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 46/191 (24%), Positives = 83/191 (43%), Gaps = 54/191 (28%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 562
+ + KLG+G +G V+K G+ VAVK++ F+N E+M
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60
Query: 563 LIAKLQ-HRNLVRLMGCCV-EQGEKI-LIYEYMP--------NKSLN-----FFLFDPSR 606
++ +L H N+V L+ + + L+++YM L + +
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVV----- 115
Query: 607 THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
+Q + + + YLH S ++HRD+K SNILL+++ + K++DFG++R F
Sbjct: 116 -----YQ--------LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSF 159
Query: 667 CGDELQGNTKR 677
N
Sbjct: 160 VNIRRVTNNIP 170
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 36/166 (21%), Positives = 61/166 (36%), Gaps = 46/166 (27%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGC 578
LG G G V + ++ A+K L + + E+ L + Q ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD- 78
Query: 579 CVEQGEKILIYEYMPNKSLNFF----------LFD--PSRTHLLGWQTR------VKIIE 620
+YE + LF R +I++
Sbjct: 79 ---------VYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-----QAFTEREASEIMK 124
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMA 663
I + + YLH + I HRD+K N+L S + K++DFG A
Sbjct: 125 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 46/171 (26%), Positives = 72/171 (42%), Gaps = 37/171 (21%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKN---------EMM 562
E + +G G +G V G VAVK+LS + F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELR 80
Query: 563 LIAKLQHRNLVRLM-----GCCVEQGEKI-LIYEYMP---NKSLNFFLFDPSRTHLLGWQ 613
L+ ++H N++ L+ +E+ + L+ M N + L +Q
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 614 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
I +GL Y+H IIHRDLK SN+ ++ D KI DFG+AR
Sbjct: 141 --------ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 35/166 (21%), Positives = 61/166 (36%), Gaps = 19/166 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQG-LKEFKNEM-MLIA 565
+ + LG G FG V + + VAVK L + + +E+ +LI
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 566 KLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
H N+V L+G C + G + +I E+ +L+ +L R + + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
G + + I DLK + S + S F + E
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 20/43 (46%), Positives = 27/43 (62%), Gaps = 3/43 (6%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+A+G+ +L + + IHRDL A NILL KI DFG+AR
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 43/173 (24%), Positives = 71/173 (41%), Gaps = 12/173 (6%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAKLQH 569
E+F + +G G FG V KL N +V A+K L+ E F+ E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 570 RNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
+ + L + + L+ +Y L L L R + E + +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAE-MVIAIDS 190
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+HQ L +HRD+K NIL+D + + +++DFG D + VGT
Sbjct: 191 VHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGT 239
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 49/182 (26%), Positives = 75/182 (41%), Gaps = 33/182 (18%)
Query: 514 ENFSMQCKLGEGGFGPVYKG-KLLNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAKLQH 569
++F + +G+G FG V K + A+K ++ Q E +N E+ ++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 570 RNLVRLMGCCVEQ-GEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEG------ 621
LV L Q E + ++ + + L R HL Q V E
Sbjct: 75 PFLVNLWYSF--QDEEDMFMVVDLLLGGDL--------RYHL---QQNVHFKEETVKLFI 121
Query: 622 --IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
+ L YL RIIHRD+K NILLD + I+DF +A M + +
Sbjct: 122 CELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMA 175
Query: 680 GT 681
GT
Sbjct: 176 GT 177
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-11
Identities = 23/126 (18%), Positives = 43/126 (34%), Gaps = 20/126 (15%)
Query: 26 DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVD 85
+ +T + G+ L + + Y T VW +N
Sbjct: 2 NLLTNGEGLYAGQSLDVEP--YHFIMQEDCNL------VLYD--HSTSVWASNTGIL-GK 50
Query: 86 SNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSY 145
+ ++GN V+ + +W+S+ R N V L + GN+V+ GS
Sbjct: 51 KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY---------GSD 101
Query: 146 LWQSFD 151
+W +
Sbjct: 102 IWSTGT 107
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 2e-11
Identities = 21/117 (17%), Positives = 44/117 (37%), Gaps = 13/117 (11%)
Query: 26 DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVD 85
++++ + G L + L + Y VW +N
Sbjct: 2 NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNF------VLYDS--GKPVWASNTGGLGSG 52
Query: 86 SNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREK--FSSNT 140
L NNGNLV+ +Q++ +IW + + + + V L N+V+ +++ +
Sbjct: 53 CRLTLH--NNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPVVWATGS 107
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 40/173 (23%), Positives = 69/173 (39%), Gaps = 12/173 (6%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAKLQH 569
++F + +G G F V K+ +V A+K ++ E F+ E ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 570 RNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
R + +L + + L+ EY L L + R + E I +
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMARFYLAE-IVMAIDS 177
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+H+ L +HRD+K NILLD + +++DFG D + VGT
Sbjct: 178 VHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGT 226
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 3e-11
Identities = 25/125 (20%), Positives = 47/125 (37%), Gaps = 19/125 (15%)
Query: 25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIV 84
+D + + G L + + L ++ + VW + N
Sbjct: 1 SDRLNSGHQLDTGGSLAEGG--YLFIIQNDCN-----LVLYDN---NRAVWASGTNGK-- 48
Query: 85 DSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGS 144
S VL + N+GNLV+ + IW+SN +R+ N L N+V+ + +
Sbjct: 49 ASGCVLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIY------DNSNN 101
Query: 145 YLWQS 149
+W +
Sbjct: 102 AIWAT 106
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 43/180 (23%), Positives = 71/180 (39%), Gaps = 28/180 (15%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAKLQH 569
E++ + +G G FG V + + ++V A+K LS + F E ++A
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ----- 624
+V+L + ++ EYMP L+ + + E A+
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGG------------DLVNLMSNYDVPEKWARFYTAE 176
Query: 625 ---GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
L +H + IHRD+K N+LLD + K++DFG M E VGT
Sbjct: 177 VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGT 232
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 35/167 (20%), Positives = 63/167 (37%), Gaps = 23/167 (13%)
Query: 521 KLGEGGFGPVYKGKLLNGQ------EVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR 574
+G+GGFG +Y + + + VK S +G E K Q + +R
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 575 LMGCCVEQGEKILIY--EYMPNKSLNFFLFD---PSRTHLLGWQTR---VKIIEGIAQGL 626
K KS F + D + + K + ++ +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRI 161
Query: 627 L----YLHQYSRLRIIHRDLKASNILLDSDMNPKI--SDFGMARMFC 667
L Y+H++ +H D+KASN+LL+ ++ D+G+A +C
Sbjct: 162 LDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYC 205
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 55/232 (23%), Positives = 85/232 (36%), Gaps = 37/232 (15%)
Query: 457 KEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENF 516
+E T +++ D LK + R+ PS+ G + + F
Sbjct: 97 EEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVS------LAKPKHRVTMNEF 150
Query: 517 SMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEF---KNEMMLIAKLQHRNL 572
LG+G FG V K A+K L + E E ++ +H L
Sbjct: 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210
Query: 573 VRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIAQGL 626
L + +++ + EY L F L F R G + I L
Sbjct: 211 TALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE--------IVSAL 261
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM----------FCG 668
YLH S +++RDLK N++LD D + KI+DFG+ + FCG
Sbjct: 262 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG 311
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 56/208 (26%), Positives = 84/208 (40%), Gaps = 36/208 (17%)
Query: 484 EPSEGDGDAKGTRRDSVLPCFSLASVSAAT-ENFSMQCKLGEGGFGPVYKGKLLNGQEV- 541
EP + + S +S A +F +G+G FG V + +
Sbjct: 7 EPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFY 66
Query: 542 AVKRLSSQSGQGLKEFKNEMM----LIAKLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKS 596
AVK L ++ KE K+ M L+ ++H LV L + +K+ + +Y+
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGE 125
Query: 597 LNFF------LFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 650
L F+ F R R E IA L YLH L I++RDLK NILLD
Sbjct: 126 L-FYHLQRERCFLEPRA-------RFYAAE-IASALGYLHS---LNIVYRDLKPENILLD 173
Query: 651 SDMNPKISDFGMARM----------FCG 668
S + ++DFG+ + FCG
Sbjct: 174 SQGHIVLTDFGLCKENIEHNSTTSTFCG 201
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 27/171 (15%), Positives = 55/171 (32%), Gaps = 31/171 (18%)
Query: 521 KLGEGGFGPVYKGK---------LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
G +Y+ Q+ ++K L ++ G+ E LQ
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 572 LVRLMGCCVEQGEKI--LIYEYMPNKSLNFFLFD---PSRTHLLGWQTR----VKIIEGI 622
+L I + + F + S L + + + +
Sbjct: 108 WKKLYST---PLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQV 164
Query: 623 AQGLL----YLHQYSRLRIIHRDLKASNILLDSDMNPKI--SDFGMARMFC 667
A LL +LH+ +H ++ A NI +D + ++ + +G A +C
Sbjct: 165 ACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 37/166 (22%), Positives = 61/166 (36%), Gaps = 27/166 (16%)
Query: 515 NFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
NF + K+G G FG + GK L + VA+K +S + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIP 68
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR---VKIIEGIAQGLL--- 627
++ ++ E L PS L R +K + IA L+
Sbjct: 69 QVYYFGPCGKYNAMVLE----------LLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRM 118
Query: 628 -YLHQYSRLRIIHRDLKASNILLDSDMNPK-----ISDFGMARMFC 667
Y+H + +I+RD+K N L+ N I DF +A+ +
Sbjct: 119 EYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 40/161 (24%), Positives = 69/161 (42%), Gaps = 31/161 (19%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRNLV-RLM 576
K+G G FG +Y G + +EVA+K + ++ Q L E K + LQ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK----IYRILQGGTGIPNVR 69
Query: 577 GCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR---VKIIEGIAQGLL----YL 629
VE +L+ + L PS L + +R +K + +A ++ ++
Sbjct: 70 WFGVEGDYNVLVMD----------LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPK---ISDFGMARMFC 667
H S +HRD+K N L+ I DFG+A+ +
Sbjct: 120 HSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 43/175 (24%), Positives = 67/175 (38%), Gaps = 32/175 (18%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEF---KNEMMLIAKLQH 569
+F LG+G FG V + A+K L + E E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 570 RNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGIA 623
L L + +++ + EY L F L F R G + I
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE--------IV 115
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM----------FCG 668
L YLH +++RD+K N++LD D + KI+DFG+ + FCG
Sbjct: 116 SALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 167
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 40/168 (23%), Positives = 73/168 (43%), Gaps = 31/168 (18%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
++ + ++GEG FG +++G LLN Q+VA+K S + Q E++ +L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---T 66
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR---VKIIEGIAQGLL 627
+ + E +L+ + L PS LL R VK + A+ +L
Sbjct: 67 GIPNVYYFGQEGLHNVLVID----------LLGPSLEDLLDLCGRKFSVKTVAMAAKQML 116
Query: 628 ----YLHQYSRLRIIHRDLKASNILLDSDMNPK-----ISDFGMARMF 666
+H+ S +++RD+K N L+ + + DFGM + +
Sbjct: 117 ARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 40/168 (23%), Positives = 71/168 (42%), Gaps = 31/168 (18%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQH- 569
+ + K+G G FG +Y G + G+EVA+K + ++ Q E K + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESK----IYKMMQGG 64
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR---VKIIEGIAQGL 626
+ + C E +++ E L PS L + +R +K + +A +
Sbjct: 65 VGIPTIRWCGAEGDYNVMVME----------LLGPSLEDLFNFCSRKFSLKTVLLLADQM 114
Query: 627 L----YLHQYSRLRIIHRDLKASNILLDSDMNPK---ISDFGMARMFC 667
+ Y+H + IHRD+K N L+ I DFG+A+ +
Sbjct: 115 ISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 32/165 (19%), Positives = 60/165 (36%), Gaps = 22/165 (13%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVA---VKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLM 576
K+G GGFG +Y ++ A VK ++G E K + AK
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRV-AKKDCIKKWIER 102
Query: 577 GCCVEQGEKILIY---EYMPNKSLNFFLFD---PSRTHLLGWQTR--VKIIEGIAQGLL- 627
G + +S F + + + G + + +L
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLD 162
Query: 628 ---YLHQYSRLRIIHRDLKASNILLDSDMNPKI--SDFGMARMFC 667
Y+H+ +H D+KA+N+LL ++ +D+G++ +C
Sbjct: 163 VLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYC 204
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 48/236 (20%), Positives = 80/236 (33%), Gaps = 46/236 (19%)
Query: 454 RKHKEKETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAAT 513
H + + ++++L S E K + L F L V
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLG-LQDFDLLRV---- 59
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAKLQ 568
+G G + V +L + A++ + + ++
Sbjct: 60 --------IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 569 HRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
H LV L C + ++ + EY+ L F + R E I
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAE-I 162
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM----------ARMFCG 668
+ L YLH+ II+RDLK N+LLDS+ + K++D+GM FCG
Sbjct: 163 SLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 215
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 7e-10
Identities = 49/187 (26%), Positives = 72/187 (38%), Gaps = 54/187 (28%)
Query: 514 ENFSMQCKLGEGGFGPVY----KGKLLNGQEVAVKRLSSQSGQGLKEF---------KNE 560
F + LG+G FG V+ Q A+K L K K E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKME 76
Query: 561 MMLIAKLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 619
++ ++ H +V+L + K+ LI +++ L F L V
Sbjct: 77 RDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDL-FT-------RL---SKEVMFT 124
Query: 620 EG--------IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM--------- 662
E +A L +LH L II+RDLK NILLD + + K++DFG+
Sbjct: 125 EEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181
Query: 663 -ARMFCG 668
A FCG
Sbjct: 182 KAYSFCG 188
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 9e-10
Identities = 18/118 (15%), Positives = 41/118 (34%), Gaps = 14/118 (11%)
Query: 26 DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVD 85
+ + + L + + + L + + Y+ +W +N +
Sbjct: 3 NVLLSGQTLHADHSLQAGA--YTLTIQNKCNL------VKYQN--GRQIWASNTDRR--G 50
Query: 86 SNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREK--FSSNTS 141
S LT+ ++GNLV+ + + +W S + L G V+ +S +
Sbjct: 51 SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPVLWSLGPN 108
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 1e-09
Identities = 50/182 (27%), Positives = 79/182 (43%), Gaps = 42/182 (23%)
Query: 514 ENFSMQCKLGEGGFGPVY---KGKLLNGQEV-AVKRLSSQS-GQGLKEF---KNEMMLIA 565
E F + LG+GG+G V+ K N ++ A+K L + K+ K E ++
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 566 KLQHRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
+++H +V L+ + G K+ LI EY+ L F L + +E A
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL-FM-------QL---EREGIFMEDTAC 124
Query: 625 --------GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM----------ARMF 666
L +LHQ II+RDLK NI+L+ + K++DFG+ F
Sbjct: 125 FYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF 181
Query: 667 CG 668
CG
Sbjct: 182 CG 183
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 48/179 (26%), Positives = 73/179 (40%), Gaps = 39/179 (21%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEM----MLIAKLQ 568
E+F + LG+G FG V+ + + A+K L + + M +L +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 569 HRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ--- 624
H L + C + E + + EY+ L + H+ Q+ K A
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDL-MY-------HI---QSCHKFDLSRATFYA 124
Query: 625 -----GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM----------FCG 668
GL +LH I++RDLK NILLD D + KI+DFGM + FCG
Sbjct: 125 AEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCG 180
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 46/176 (26%), Positives = 72/176 (40%), Gaps = 33/176 (18%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAKLQ 568
+F+ LG+G FG V + E+ AVK L + + M+ L +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 569 HRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
L +L C + +++ + EY+ L + + F E I
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAE-I 130
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM----------ARMFCG 668
A GL +L II+RDLK N++LDS+ + KI+DFGM + FCG
Sbjct: 131 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCG 183
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 2e-09
Identities = 17/124 (13%), Positives = 45/124 (36%), Gaps = 13/124 (10%)
Query: 20 LLSLATDTITPATL-IGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVAN 78
+ S D P L + +++ + ++ + + Y + +W N
Sbjct: 4 IFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNL------VLYDN--NNPIWATN 55
Query: 79 RNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREK--F 136
+ + +G LV++ + +W S ++ + + V L N+V+ +
Sbjct: 56 TGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGDALW 113
Query: 137 SSNT 140
++ T
Sbjct: 114 ATQT 117
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 41/176 (23%), Positives = 68/176 (38%), Gaps = 33/176 (18%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAKLQ 568
++F + +G G + V +L + A+K + + ++
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 569 HRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
H LV L C + ++ + EY+ L F + R E I
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAE-I 119
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM----------ARMFCG 668
+ L YLH+ II+RDLK N+LLDS+ + K++D+GM FCG
Sbjct: 120 SLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 172
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 46/176 (26%), Positives = 72/176 (40%), Gaps = 33/176 (18%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAKLQ 568
+F+ LG+G FG V + E+ AVK L + + M+ L +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 569 HRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFL-----FDPSRTHLLGWQTRVKIIEGI 622
L +L C + +++ + EY+ L + + F E I
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAE-I 451
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM----------ARMFCG 668
A GL +L II+RDLK N++LDS+ + KI+DFGM + FCG
Sbjct: 452 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCG 504
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 4e-09
Identities = 19/120 (15%), Positives = 41/120 (34%), Gaps = 15/120 (12%)
Query: 23 LATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSP 82
+ + ++ +L + + +L + Y W +N +
Sbjct: 4 FTNNLLFSGQVLYGDGRLTAKN--HQLVMQGDCNL------VLYGG---KYGWQSNTHG- 51
Query: 83 IVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVL--REKFSSNT 140
+ L + + G L++ + IWSS S + V L D G V+ F +++
Sbjct: 52 -NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYGPAIFETSS 110
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 5e-09
Identities = 24/118 (20%), Positives = 46/118 (38%), Gaps = 14/118 (11%)
Query: 26 DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVD 85
+ + + GE L ++ + + Y D +W N D
Sbjct: 2 NILYSGETLSPGEFL--NNGRYVFIMQEDCNL------VLYDV--DKPIWATNTGGL--D 49
Query: 86 SNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREK--FSSNTS 141
L++ ++GNLV+ + + IW+SN E N V L N+V+ +++ T+
Sbjct: 50 RRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTARWATGTN 107
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 6e-09
Identities = 47/179 (26%), Positives = 74/179 (41%), Gaps = 39/179 (21%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAKLQ 568
+NF LG+G FG V ++ ++ AVK L + + M L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 569 HRNLVRLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ--- 624
H L +L CC + +++ + E++ L F H+ Q + E A+
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDL-MF-------HI---QKSRRFDEARARFYA 130
Query: 625 -----GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM----------ARMFCG 668
L++LH II+RDLK N+LLD + + K++DFGM FCG
Sbjct: 131 AEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCG 186
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 40/166 (24%), Positives = 66/166 (39%), Gaps = 31/166 (18%)
Query: 516 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHR- 570
+ + +G+G FG V K + + VA+K + ++ Q E + L+ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR----LLELMNKHD 111
Query: 571 -----NLVRLMGCCVEQGEKILIYEYM-PN-----KSLNFFLFDPSRTHLLGWQTRVKII 619
+V L + + L++E + N ++ NF + T Q
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQ------ 165
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMA 663
+ LL+L L IIH DLK NILL + KI DFG +
Sbjct: 166 --MCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 23/58 (39%), Positives = 32/58 (55%), Gaps = 14/58 (24%)
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM-----------ARMFCG 668
I L +LH+ L II+RD+K NILLDS+ + ++DFG+ A FCG
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 2e-08
Identities = 23/120 (19%), Positives = 37/120 (30%), Gaps = 17/120 (14%)
Query: 23 LATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSP 82
L T+ + + L + F+L Y G W N+
Sbjct: 1 LGTNYLLSGQTLDTEGHLKNGD--FDLVMQDDCNLVL-YNGNWQS------------NTA 45
Query: 83 IVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVL--REKFSSNT 140
+ LT+ + G LV+ N +W S N A + G LV+ F +
Sbjct: 46 NNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGPSVFKIDP 105
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 37/170 (21%), Positives = 63/170 (37%), Gaps = 37/170 (21%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSG---QGLKEFK-------NEMMLIAKLQH 569
KLG G F V+ K ++N VA+K + E K + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 570 RNLVRLMGCCVEQGEKI----LIYEYM-PN-----KSLNFFLFDPSRTHLLGWQTRVKII 619
++++L+ +G +++E + N K + Q
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ------ 139
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP------KISDFGMA 663
+ GL Y+H R IIH D+K N+L++ +P KI+D G A
Sbjct: 140 --LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 39/160 (24%), Positives = 62/160 (38%), Gaps = 33/160 (20%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHR------N 571
+G+G FG V K Q VA+K + ++ Q +E + ++ L+ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHLRKQDKDNTMN 160
Query: 572 LVRLMGCCVEQGEKILIYEYM-PN-----KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625
++ ++ + + +E + N K F F I Q
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHS--------ILQC 212
Query: 626 LLYLHQYSRLRIIHRDLKASNILLDSDMNP--KISDFGMA 663
L LH + RIIH DLK NILL K+ DFG +
Sbjct: 213 LDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 2e-07
Identities = 15/109 (13%), Positives = 41/109 (37%), Gaps = 10/109 (9%)
Query: 24 ATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPI 83
+ + + ++ D +L +++ + L + K +VW + +
Sbjct: 5 VRNVLFSSQVMYDNAQL--ATRDYSLVMRDDCNL------VLTKGSKTNIVWESGTSGR- 55
Query: 84 VDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVL 132
+ + +G++G L + + ++ SN + + V L G V+
Sbjct: 56 -GQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVV 103
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 9e-05
Identities = 14/73 (19%), Positives = 30/73 (41%), Gaps = 7/73 (9%)
Query: 78 NRNSPIVDSNAVLTIGNNGNLVL-LNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKF 136
N+ + + L + ++ NLVL I+W S S ++ +L +G L + +
Sbjct: 16 YDNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITD-- 73
Query: 137 SSNTSEGSYLWQS 149
+ ++ S
Sbjct: 74 ----DRLNTVFVS 82
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 2e-06
Identities = 81/538 (15%), Positives = 144/538 (26%), Gaps = 165/538 (30%)
Query: 224 DPTNTSYLFRPIVEQKEDEIIYR---------YESYSSRILMMLKINPSGDVQRLIWH-- 272
D + + + K++E++ + Y+ S I + PS + I
Sbjct: 59 DAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR-QPSMMTRMYIEQRD 117
Query: 273 EMSTGWQVF----------FTA---------PNNFCQLYGY--CG----ANSVCSVDDT- 306
+ QVF + P + G G A VC
Sbjct: 118 RLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQ 177
Query: 307 ------------ANCECLKGFKLKLQN--NQTWPRECVRSHSSDCITRE---------RF 343
NC + LQ Q P RS S I R
Sbjct: 178 CKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237
Query: 344 IKFDDIKLPYLV--DVSLNESMNLKECEAECLK----NC----TCRAYANSKVTGGGSGC 393
+K + LV +V A+ +C T R +VT S
Sbjct: 238 LKSKPYENCLLVLLNV----------QNAKAWNAFNLSCKILLTTR---FKQVTDFLSAA 284
Query: 394 LMWFGDLIDIRKITGYNNGQPIYVRVPDSEPGD--KKLLWI--FVILVLPAALLPGFFIF 449
L + + + ++ D P D +++L + ++ ++ G +
Sbjct: 285 TTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW 344
Query: 450 CRWRRKHKEK-ETTMESSQDLLKFDIYMSVATRTNEPSEGDGDAKGTRRDSVLPCFSLAS 508
W+ + +K T +ESS ++L EP+E R+ F S
Sbjct: 345 DNWKHVNCDKLTTIIESSLNVL-------------EPAE-------YRK-----MFDRLS 379
Query: 509 VSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ 568
V F + ++ + + V V +L S L+ K
Sbjct: 380 V------FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS------------LVEKQP 421
Query: 569 HRNLVRLMGC-------CVEQGE--KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKII 619
+ + + + + ++ Y N F D +L
Sbjct: 422 KESTISIPSIYLELKVKLENEYALHRSIVDHY--NIPKTFDSDDLIPPYLDQ-------- 471
Query: 620 EGIAQGLLYLHQY-----SRLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCGDEL 671
Y + + + R + LD + KI A G L
Sbjct: 472 --------YFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSIL 521
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 5e-05
Identities = 41/272 (15%), Positives = 85/272 (31%), Gaps = 63/272 (23%)
Query: 435 ILVLPAALLPGFFIFCRWRRKHKEKETTMESSQDLLKFD---IYMSVATRTNEPSEGDGD 491
I++ A+ +F W K++E + +++L+ + + + T +PS
Sbjct: 54 IIMSKDAVSGTLRLF--WTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPS-MMTR 110
Query: 492 AKGTRRD---SVLPCFSLASVSAATENFSMQCKL------------GEGGFGPVYKGKLL 536
+RD + F+ +VS ++ L G G G K +
Sbjct: 111 MYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTWV- 166
Query: 537 NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI-----LIYEY 591
A+ S Q +FK I L + C + L+Y+
Sbjct: 167 -----ALDVCLSYKVQCKMDFK-----IFWLN-------LKNCNSPETVLEMLQKLLYQI 209
Query: 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 651
PN + + + Q ++ LL Y ++ +++ +
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRR-------LLKSKPYENCLLVLLNVQNAKAWNAF 262
Query: 652 DMNPKI----SDFGMARMFCGDELQGNTKRVV 679
+++ KI + D L T +
Sbjct: 263 NLSCKILLTTRFKQVT-----DFLSAATTTHI 289
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 1e-04
Identities = 60/373 (16%), Positives = 98/373 (26%), Gaps = 142/373 (38%)
Query: 49 LGFFSPGKS--------KYKYLGIWYKQVPDTVVW--VANRNSPIVDSNAVLTIGNNGNL 98
LG GK+ YK ++ + W + N NSP VL +
Sbjct: 159 LGS---GKTWVALDVCLSYKVQ----CKMDFKIFWLNLKNCNSP----ETVLEMLQK--- 204
Query: 99 VLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYL----------WQ 148
LL Q D W+S + + LR S E L W
Sbjct: 205 -LLYQIDPN-WTSRSDHSSNIK--LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWN 260
Query: 149 SFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSV 208
+F+ LL T R + +T D S T H+ +
Sbjct: 261 AFNLSCKILL----------TTRFKQVT-----DFLSAATTT---------HISL----- 291
Query: 209 KLSCTGPWNGLAFGADPTNTSYLFRPIVEQKEDEIIYRYESYSSRILMMLKINPSGDVQR 268
+ + P L ++ + ++ E +L NP
Sbjct: 292 --------DHHSMTLTPDEVKSLLLKYLDCRPQDL--PRE--------VLTTNPR--RLS 331
Query: 269 LIW---HEMSTGWQVFFTAPNNFCQLYGYCGANSVCSVDDTANCECL-KGFKLKLQNNQT 324
+I + W N+ + NC+ L + L N
Sbjct: 332 IIAESIRDGLATWD-------NWKHV----------------NCDKLTTIIESSL-NVLE 367
Query: 325 WPRECVRSHSSDCITRERFIKF----DDIKLPYLV------DVSLNESMN-LKECEAECL 373
P E R+ F + +P ++ DV ++ M + + L
Sbjct: 368 -PAE----------YRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL 416
Query: 374 -----KNCTCRAY 381
K T
Sbjct: 417 VEKQPKESTISIP 429
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 39/179 (21%), Positives = 62/179 (34%), Gaps = 34/179 (18%)
Query: 516 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHR- 570
F + K+G+G FG V + + N + AVK + + E ++ K+Q+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD----ILKKIQNDD 92
Query: 571 ----NLVRLMGCCVEQG------EK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKI 618
N+V+ G + E +YE + N+ F L +
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEII--TRNNYNGFHIEDIKLYCIE----- 145
Query: 619 IEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR 677
I + L YL ++ + H DLK NILLD K TK
Sbjct: 146 ---ILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 8e-06
Identities = 21/80 (26%), Positives = 28/80 (35%), Gaps = 11/80 (13%)
Query: 70 PDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGN 129
D VW N AVL NG + +L + +W+S SR V L N
Sbjct: 167 RDDRVWSTNTAGKGTGCRAVLQ--PNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRN 224
Query: 130 LVLREKFSSNTSEGSYLWQS 149
L + G LW +
Sbjct: 225 LAIY---------GGALWTT 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 45.7 bits (107), Expect = 2e-05
Identities = 25/147 (17%), Positives = 49/147 (33%), Gaps = 12/147 (8%)
Query: 71 DTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNL 130
D VW +N + + ++G LV+L + I WSS + N V L +
Sbjct: 44 DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTV 100
Query: 131 VLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFT 190
+ LW S ++++ N L + + S
Sbjct: 101 TIYG---------PGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSP 151
Query: 191 FRLEIRVLPHLCIYNGSVKLSCTGPWN 217
+RL + +L +++ ++ T
Sbjct: 152 YRLSMETDCNLVLFDRDDRVWSTNTAG 178
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 40.7 bits (94), Expect = 8e-04
Identities = 19/91 (20%), Positives = 36/91 (39%), Gaps = 7/91 (7%)
Query: 65 WYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQL 124
+ Q D + + S L++ + NLVL + D +WS+N + + A L
Sbjct: 129 YSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFD-RDDRVWSTNTAGKGTGCRAVL 187
Query: 125 LDTGNLVLREKFSSNTSEGSYLWQSFDCPSD 155
G + + T++ +W S + S
Sbjct: 188 QPNGRMDVL------TNQNIAVWTSGNSRSA 212
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 34/172 (19%), Positives = 59/172 (34%), Gaps = 44/172 (25%)
Query: 516 FSMQCKLGEGGFGPVYKGK--LLNGQEVAVKRLSSQSG---QGLKEFK----------NE 560
+ + LGEG FG V + G+ VAVK + + E + N
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 561 MMLIAKL----QHRN---LV-RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGW 612
++ +H +V L+G Y+++ K F F + +
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELLGLST--------YDFI--KENGFLPFRLDHIRKMAY 125
Query: 613 QTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
Q I + + +LH ++ H DLK NIL + + + R
Sbjct: 126 Q--------ICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.5 bits (101), Expect = 1e-04
Identities = 35/211 (16%), Positives = 61/211 (28%), Gaps = 33/211 (15%)
Query: 22 SLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNS 81
+ T + + G+ L+S +Q F+L G L I VWVAN
Sbjct: 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGN-----LVIQD---NGATVWVANEQQ 62
Query: 82 PIV------DSNAVLTIGNNGNLVLLNQTDGIIWSS-----NLSREVKNPVAQLLDTGNL 130
P + A L L + + +W + + + L D GN+
Sbjct: 63 PFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNI 122
Query: 131 VLREKFSSNTSEGSYLWQSFDCPSDTLLI--GMNMGWDLKTGRERY-------LTSWRTA 181
VL + + + S L + G G + L ++
Sbjct: 123 VLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGDGNLVAYGPN 182
Query: 182 DDPS-----PGNFTFRLEIRVLPHLCIYNGS 207
+ G R + +L +Y
Sbjct: 183 GAATWNAGTQGKGAVRAVFQGDGNLVVYGAG 213
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.5 bits (101), Expect = 1e-04
Identities = 13/88 (14%), Positives = 30/88 (34%), Gaps = 7/88 (7%)
Query: 71 DTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNL 130
W A +GNLV+ + ++W S+ + + V +L G++
Sbjct: 183 GAATWNAGTQGK---GAVRAVFQGDGNLVVYGAGNAVLWHSH-TGGHASAVLRLQANGSI 238
Query: 131 VL---REKFSSNTSEGSYLWQSFDCPSD 155
+ + ++ + +Y P
Sbjct: 239 AILDEKPVWARFGFQPTYRHIRKINPDQ 266
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 30/168 (17%), Positives = 57/168 (33%), Gaps = 36/168 (21%)
Query: 516 FSMQCKLGEGGFGPVYKG--KLLNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHR 570
+ + LGEG FG V + +VA+K + + E ++ K++ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN----VLKKIKEK 76
Query: 571 ------NLVRLMGCCVEQG------EK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRV 616
V + G E +E++ K NF + + +Q
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFL--KENNFQPYPLPHVRHMAYQ--- 131
Query: 617 KIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
+ L +LH ++ H DLK NIL + + + +
Sbjct: 132 -----LCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSC 171
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 42/178 (23%), Positives = 71/178 (39%), Gaps = 38/178 (21%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ--------HRN 571
KLG G F V+ + + VA+K + S + +E+ L+ ++
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREM 102
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR----------VK-IIE 620
+V+L+ G N + +F+ HLL W + VK II+
Sbjct: 103 VVQLLDDFKISG---------VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 621 GIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
+ QGL YLH ++ RIIH D+K NILL +++ + R+ +
Sbjct: 154 QVLQGLDYLH--TKCRIIHTDIKPENILL------SVNEQYIRRLAAEATEWQRSGAP 203
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 681 | |||
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.98 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.98 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.97 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.97 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.97 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.97 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.96 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.95 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.95 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.95 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.94 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.93 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.93 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.93 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.93 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.93 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.93 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.93 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.93 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.93 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.93 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.93 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.93 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.93 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.93 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.93 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.92 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.92 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.92 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.92 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.92 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.92 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.92 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.92 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.92 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.92 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.92 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.92 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.92 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.92 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.92 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.92 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.92 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.92 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.92 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.92 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.92 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.92 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.92 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.92 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.92 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.92 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.92 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.91 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.91 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.91 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.91 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.91 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.91 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.91 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.91 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.91 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.91 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.91 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.91 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.91 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.91 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.91 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.91 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.91 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.91 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.91 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.91 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.91 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.91 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.91 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.91 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.91 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.91 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.91 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.91 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.91 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.91 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.91 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.91 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.91 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.91 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.91 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.91 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.91 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.91 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.91 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.91 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.91 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.91 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.91 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.91 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.9 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.9 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.9 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.9 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.9 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.9 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.9 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.9 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.9 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.9 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.9 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.9 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.9 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.9 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.9 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.9 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.9 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.9 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.9 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.9 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.9 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.9 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.9 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.9 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.9 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.9 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.9 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.9 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.9 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.9 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.9 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.9 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.9 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.9 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.9 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.9 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.9 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.9 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.9 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.9 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.9 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.9 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.9 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.9 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.89 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.89 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.89 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.89 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.89 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.89 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.89 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.89 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.89 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.89 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.89 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.89 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.89 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.89 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.89 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.89 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.89 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.89 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.89 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.89 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.89 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.89 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.89 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.89 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.89 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.89 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.89 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.89 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.89 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.89 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.89 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.89 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.89 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.89 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.89 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.89 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.89 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.89 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.89 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.89 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.89 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.89 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.89 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.89 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.89 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.89 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.89 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.89 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.89 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.89 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.89 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.89 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.89 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.89 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.88 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.88 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.88 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.88 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.88 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.88 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.88 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.88 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.88 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.88 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.88 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.88 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.88 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.88 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.88 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.88 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.88 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.88 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.88 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.88 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.87 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.87 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.87 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.87 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.87 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.87 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.87 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.87 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.87 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.87 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.87 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.87 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.87 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.87 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.87 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.86 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.86 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.86 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.86 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.86 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.86 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.85 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.85 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.85 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.85 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.85 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.85 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.85 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.84 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.82 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.82 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.79 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.79 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.75 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.74 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.71 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.7 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.68 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.62 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.61 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.37 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.34 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.31 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.19 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.16 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.16 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.99 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.92 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.54 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.52 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.43 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.38 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.32 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.2 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.17 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.85 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.83 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.77 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.7 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.51 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.24 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.02 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.97 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.84 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.82 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.78 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.76 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.13 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.1 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.36 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.94 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.62 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 86.18 |
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=354.75 Aligned_cols=232 Identities=19% Similarity=0.195 Sum_probs=177.5
Q ss_pred cccccccCCCCccCCCCEEEeCCCeEEEEeeCCCCCCcEEEEEEEeCCCCceEEEccCCCCCcCC----cceEEEeeCCc
Q 005718 22 SLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDS----NAVLTIGNNGN 97 (681)
Q Consensus 22 ~~~~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~l~i~~~~~~~~~vW~an~~~p~~~~----~~~l~~~~~g~ 97 (681)
+++.|+|.+|++|++|++|+|++|.|+||||.++ ++|| |+ +.+ +||+|||+.|+.++ +++|+|+.||+
T Consensus 11 ~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~-~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G~ 82 (276)
T 3m7h_A 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD-NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYVQ 82 (276)
T ss_dssp CTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE-TTE-EEEECSTTSTTEEEEECCCTTCCSEEEES
T ss_pred cccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC-CCC-eEEECCCCCCcCCcccccceEEEEeCCCc
Confidence 5567999999999999999999999999999543 5666 77 566 99999999999874 78999999999
Q ss_pred EEE--EeCCCcEEEeecCccc-----cCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCCccccCCccccceeccC
Q 005718 98 LVL--LNQTDGIIWSSNLSRE-----VKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLKTG 170 (681)
Q Consensus 98 l~l--~~~~~~~~w~~~~~~~-----~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~PtDtlLpgq~l~~~~~~g 170 (681)
|+| .|+++.+||++++... ..++.|+|+|+|||||++ +.+|||| ||||||||||+++.+.++|
T Consensus 83 Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--------~~~lWqS--~ptdtlLpg~~~~~~l~~g 152 (276)
T 3m7h_A 83 YGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--------SLALWNG--TPAIPLVPGAIDSLLLAPG 152 (276)
T ss_dssp SSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--------EEEEEES--CTTSCCCCSCTTCEEECSS
T ss_pred EEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--------CceeeCc--ccccccccccccccccccC
Confidence 999 7888899999997642 245789999999999996 3589999 9999999999999888887
Q ss_pred ceeEEEEeccCCCCCCcceEEEeecCCccEEEEEcC-CeEEEeeCCCCCccccccCCCCccceecEEEeeCc-eEEEEEE
Q 005718 171 RERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNG-SVKLSCTGPWNGLAFGADPTNTSYLFRPIVEQKED-EIIYRYE 248 (681)
Q Consensus 171 ~~~~l~S~~s~~dps~G~y~~~~~~~g~~~~~~~~~-~~~~w~sg~w~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 248 (681)
.. | ++.+||++|.|+++||++|.. ++|++ ...||++|+|++............ +.+.+..+ .+.+++.
T Consensus 153 ~~--L---~S~~dps~G~fsl~l~~dGnl--vLy~~~~~~yW~Sgt~~~~~~~l~l~~dGn---Lvl~d~~~~~vWsS~t 222 (276)
T 3m7h_A 153 SE--L---VQGVVYGAGASKLVFQGDGNL--VAYGPNGAATWNAGTQGKGAVRAVFQGDGN---LVVYGAGNAVLWHSHT 222 (276)
T ss_dssp EE--E---CTTCEEEETTEEEEECTTSCE--EEECTTSSEEEECCCTTTTCCEEEECTTSC---EEEECTTSCEEEECSC
T ss_pred cc--c---ccCCCCCCceEEEeecCCceE--EEEeCCCeEEEECCCCCCccEEEEEcCCCe---EEEEeCCCcEEEEecC
Confidence 55 6 578899999999999999964 45654 589999999976432111111111 11223322 2222222
Q ss_pred ecCCceEEEEEEcccCcEEEEEEEecCCceEEEEeecC
Q 005718 249 SYSSRILMMLKINPSGDVQRLIWHEMSTGWQVFFTAPN 286 (681)
Q Consensus 249 ~~~~~~~~rl~Ld~dG~l~~y~~~~~~~~W~~~~~~p~ 286 (681)
.....+|++||.||+|++|.| ...|..++..|.
T Consensus 223 --~~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 223 --GGHASAVLRLQANGSIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp --TTCTTCEEEECTTSCEEEEEE---EEEEESSSCCTT
T ss_pred --CCCCCEEEEEcCCccEEEEcC---CCeEEccCccCC
Confidence 222347999999999999998 234655555443
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=306.92 Aligned_cols=215 Identities=14% Similarity=0.210 Sum_probs=161.9
Q ss_pred ccccccCCCCccCCCCEEEeCCCeEEEEeeCCCCCCcEEEEEEEeCCCCceEEEccCCCCCcCCcceEEEeeCCcEEEEe
Q 005718 23 LATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLN 102 (681)
Q Consensus 23 ~~~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~l~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~ 102 (681)
++.|+|.+|++|.+|++| ++|.|+|||+.+++ + ++|.. .++||+|||+.| ..+.|+|+.||||||+|
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l-~ly~~--~~~vW~an~~~~---~~~~l~l~~dGnLvl~d 72 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----L-VLFDS--DVRVWASNTAGA---TGCRAVLQSDGLLVILT 72 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----E-EEEES--SSEEECCCCCSC---SCCBCCBCSSSCBCCBC
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----E-EEEEC--CEEEEECCCCCC---CCeEEEEcCCCcEEEEc
Confidence 457999999999999999 59999999998765 2 34552 699999999988 46899999999999999
Q ss_pred CCCcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCCccc-cCCcccccee-ccCc-----eeEE
Q 005718 103 QTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTL-LIGMNMGWDL-KTGR-----ERYL 175 (681)
Q Consensus 103 ~~~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~PtDtl-Lpgq~l~~~~-~~g~-----~~~l 175 (681)
.++.+||+|++........|+|+|+|||||++ . ++||||||||||+ ||+| +.+. .+|+ ++.|
T Consensus 73 ~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~--------~-~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L 141 (236)
T 1dlp_A 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG--------P-GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTL 141 (236)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC--------S-EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEE
T ss_pred CCCcEEEeCCccccCCcEEEEEeCCCCEEEec--------C-CEEECCCCCCcccccCCc--cceEEecCCcCCCccceE
Confidence 99999999998654445689999999999994 1 7999999998776 5554 3343 4443 4678
Q ss_pred EEeccCCCCCCcceEEEeecCCccEEEEEcCCeEEEeeCCCCCccccccCC--CCccceecEEEeeCceEEEEEEecCCc
Q 005718 176 TSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGLAFGADPT--NTSYLFRPIVEQKEDEIIYRYESYSSR 253 (681)
Q Consensus 176 ~S~~s~~dps~G~y~~~~~~~g~~~~~~~~~~~~~w~sg~w~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (681)
++ ..||++|.|+|+|+++| +++++++...||++++|++. +...+. ....++ .+..++++.++.+.... .
T Consensus 142 ~s---~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl~--ly~~~~~~vw~s~~~~~-~ 212 (236)
T 1dlp_A 142 HA---TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRMD--VLTNQNIAVWTSGNSRS-A 212 (236)
T ss_dssp CS---SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEEE--EEETTTEEEEECCCCCS-S
T ss_pred Ec---CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcEE--EEeCCCcEEEEeCCCCC-C
Confidence 74 78999999999999999 56778888899999999653 333333 121111 12122333433333222 2
Q ss_pred eEEEEEEcccCcEEEEE
Q 005718 254 ILMMLKINPSGDVQRLI 270 (681)
Q Consensus 254 ~~~rl~Ld~dG~l~~y~ 270 (681)
..+|++||+||++++|.
T Consensus 213 ~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 213 GRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp SCCEEEECSSSCEEEEC
T ss_pred CCEEEEEcCCCcEEEeC
Confidence 45799999999999984
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=297.18 Aligned_cols=166 Identities=33% Similarity=0.525 Sum_probs=142.0
Q ss_pred hCCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 586 (681)
.++|.+.++||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 357888899999999999999864 36789999998766667789999999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeE
Q 005718 587 LIYEYMPNKSLNFFLFDP----------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK 656 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~k 656 (681)
||||||++|+|.++|... .....++|.+++.|+.||++||+|||+++ ||||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 999999999999999542 23456899999999999999999999987 99999999999999999999
Q ss_pred EeecCCceeecCCCccCCCcceecC
Q 005718 657 ISDFGMARMFCGDELQGNTKRVVGT 681 (681)
Q Consensus 657 l~DFGla~~~~~~~~~~~~~~~~GT 681 (681)
|+|||+|+.....+....+....||
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt 193 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLP 193 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEEC
T ss_pred ECCcccceecCCCCceeecCceecC
Confidence 9999999987655443333344554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.90 Aligned_cols=166 Identities=31% Similarity=0.526 Sum_probs=134.4
Q ss_pred hCCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 586 (681)
.++|.+.++||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 356788899999999999999864 36789999998776667789999999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCC
Q 005718 587 LIYEYMPNKSLNFFLFDPS------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 654 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~ 654 (681)
||||||++|+|.++|.... ....++|.+++.|+.|||+||+|||+.+ ||||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 9999999999999996532 1246899999999999999999999987 999999999999999999
Q ss_pred eEEeecCCceeecCCCccCCCcceecC
Q 005718 655 PKISDFGMARMFCGDELQGNTKRVVGT 681 (681)
Q Consensus 655 ~kl~DFGla~~~~~~~~~~~~~~~~GT 681 (681)
+||+|||+||.+...+....+.+..||
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt 223 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLP 223 (329)
T ss_dssp EEECCCC----------------CCCC
T ss_pred EEEcccccceeccCCCcceecCccccc
Confidence 999999999987655444334444554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=292.67 Aligned_cols=165 Identities=33% Similarity=0.491 Sum_probs=140.0
Q ss_pred CCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 586 (681)
.++++.++||+|+||+||+|.+. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34667799999999999999863 36789999997643 344678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC
Q 005718 587 LIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 653 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~ 653 (681)
||||||++|+|.++|..... ...++|.+++.|+.|||+||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999964321 245899999999999999999999987 99999999999999999
Q ss_pred CeEEeecCCceeecCCCccCCCcceecC
Q 005718 654 NPKISDFGMARMFCGDELQGNTKRVVGT 681 (681)
Q Consensus 654 ~~kl~DFGla~~~~~~~~~~~~~~~~GT 681 (681)
.+||+|||+||.+...+....++...||
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt 210 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLP 210 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBC
T ss_pred CEEECCcccceeccCCCceeEecccccC
Confidence 9999999999987655544434445555
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=288.95 Aligned_cols=162 Identities=30% Similarity=0.416 Sum_probs=145.1
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|++.+.||+|+||+||++... +++.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999985 5889999999753 2344678999999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+++|+|.++|. +...+++.++..++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+..+
T Consensus 112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999994 3346899999999999999999999988 999999999999999999999999999998766
Q ss_pred CccCCCcceecC
Q 005718 670 ELQGNTKRVVGT 681 (681)
Q Consensus 670 ~~~~~~~~~~GT 681 (681)
.....+.+++||
T Consensus 186 ~~~~~~~~~~GT 197 (311)
T 4aw0_A 186 SKQARANSFVGT 197 (311)
T ss_dssp TTCCCBCCCCSC
T ss_pred CCcccccCcccC
Confidence 655556667887
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=288.53 Aligned_cols=163 Identities=29% Similarity=0.478 Sum_probs=133.2
Q ss_pred HhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
...+++.+.++||+|+||+||+|.+.+ .||||+++.. .....++|.+|+.++++++|||||+++|++.+ +..+||
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 345678889999999999999998753 6999998753 33456789999999999999999999998865 568999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||||++|+|.++|... ...+++.+++.|+.|||+||+|||+++ ||||||||+||||++++.+||+|||+|+....
T Consensus 110 mEy~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999999543 345899999999999999999999987 99999999999999999999999999998765
Q ss_pred CCccCCCcceecC
Q 005718 669 DELQGNTKRVVGT 681 (681)
Q Consensus 669 ~~~~~~~~~~~GT 681 (681)
......+.+.+||
T Consensus 185 ~~~~~~~~~~~GT 197 (307)
T 3omv_A 185 WSGSQQVEQPTGS 197 (307)
T ss_dssp ---------CCCC
T ss_pred CCcceeecccccC
Confidence 4444344556676
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-33 Score=290.89 Aligned_cols=160 Identities=27% Similarity=0.395 Sum_probs=142.4
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
.+.|++.++||+|+||.||+|... +++.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 357999999999999999999985 5899999999765555567789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCCc
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 671 (681)
|++|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+..+..
T Consensus 153 ~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 153 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999999842 34899999999999999999999988 99999999999999999999999999998865443
Q ss_pred cCCCcceecC
Q 005718 672 QGNTKRVVGT 681 (681)
Q Consensus 672 ~~~~~~~~GT 681 (681)
. +.+++||
T Consensus 226 ~--~~~~~GT 233 (346)
T 4fih_A 226 R--RKSLVGT 233 (346)
T ss_dssp C--BCCCCSC
T ss_pred c--ccccccC
Confidence 3 3446776
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=290.29 Aligned_cols=151 Identities=26% Similarity=0.418 Sum_probs=130.5
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
++|++.++||+|+||.||+|... +++.||||++.+. .....+.|.+|+.+|++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999975 5899999999754 23446789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|+++|+|.++|... ....+++.++..|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+..
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999542 3345789999999999999999999988 99999999999999999999999999998754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.4e-32 Score=292.65 Aligned_cols=160 Identities=27% Similarity=0.395 Sum_probs=143.2
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
.+.|++.++||+|+||.||+|... +++.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 467999999999999999999985 5899999999876555667899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCCc
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 671 (681)
|++|+|.+++.. ..+++.++..|+.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+.+..+..
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999999832 34899999999999999999999988 99999999999999999999999999998865443
Q ss_pred cCCCcceecC
Q 005718 672 QGNTKRVVGT 681 (681)
Q Consensus 672 ~~~~~~~~GT 681 (681)
. ..+++||
T Consensus 303 ~--~~~~~GT 310 (423)
T 4fie_A 303 R--RKSLVGT 310 (423)
T ss_dssp C--BCCCEEC
T ss_pred c--ccccccC
Confidence 3 3456787
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=276.53 Aligned_cols=154 Identities=27% Similarity=0.401 Sum_probs=127.8
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC--------
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-------- 583 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-------- 583 (681)
++|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35889999999999999999975 58899999997543 334567999999999999999999999987654
Q ss_pred ----eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEee
Q 005718 584 ----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD 659 (681)
Q Consensus 584 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D 659 (681)
..++||||+++|+|.+++..........+..+..|+.||++||+|||+++ ||||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976554445677788899999999999999988 99999999999999999999999
Q ss_pred cCCceeecCCC
Q 005718 660 FGMARMFCGDE 670 (681)
Q Consensus 660 FGla~~~~~~~ 670 (681)
||+|+.+..+.
T Consensus 162 FGla~~~~~~~ 172 (299)
T 4g31_A 162 FGLVTAMDQDE 172 (299)
T ss_dssp CCCC-------
T ss_pred CccceecCCCc
Confidence 99999886543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=277.97 Aligned_cols=162 Identities=29% Similarity=0.374 Sum_probs=130.7
Q ss_pred CCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC----eEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG----EKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV~ 589 (681)
++|.+.++||+|+||.||+|++ .|+.||||++.... .....+..|+..+.+++|||||+++|+|.+.+ +.+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577889999999999999998 58899999997532 22223445666677889999999999998764 689999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-----SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
|||++|+|.++|.. ..++|..+.+++.|+++||+|||++ +.++||||||||+||||++++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999943 3589999999999999999999986 23469999999999999999999999999999
Q ss_pred eecCCCccC--CCcceecC
Q 005718 665 MFCGDELQG--NTKRVVGT 681 (681)
Q Consensus 665 ~~~~~~~~~--~~~~~~GT 681 (681)
......... .+...+||
T Consensus 157 ~~~~~~~~~~~~~~~~~GT 175 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGT 175 (303)
T ss_dssp EEETTTTEESCC-----CC
T ss_pred cccCCCCceeeeccccccc
Confidence 886544322 23345666
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=274.08 Aligned_cols=158 Identities=31% Similarity=0.455 Sum_probs=132.9
Q ss_pred CCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe----CCeEEEE
Q 005718 516 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEKILI 588 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV 588 (681)
|++.++||+|+||.||+|... .++.||||++... .....+.|.+|+.++++++|||||++++++.+ .+..+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 356678999999999999985 4889999999653 33445789999999999999999999999875 3467999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC-CCCeEEeecCCceeec
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFC 667 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~~~~ 667 (681)
||||++|+|.++|. +...+++..+..++.||++||+|||+++ ++||||||||+||||+. ++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999994 3446899999999999999999999874 35999999999999984 7899999999998754
Q ss_pred CCCccCCCcceecC
Q 005718 668 GDELQGNTKRVVGT 681 (681)
Q Consensus 668 ~~~~~~~~~~~~GT 681 (681)
... +.+++||
T Consensus 184 ~~~----~~~~~GT 193 (290)
T 3fpq_A 184 ASF----AKAVIGT 193 (290)
T ss_dssp TTS----BEESCSS
T ss_pred CCc----cCCcccC
Confidence 322 3345676
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=283.49 Aligned_cols=175 Identities=26% Similarity=0.386 Sum_probs=146.1
Q ss_pred ccHHHHHHhhCCCCceeeecccCcEeEEEEEecC------CcEEEEEEecCCC-cccHHHHHHHHHHHhhCC-CCCeeEE
Q 005718 504 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQ-HRNLVRL 575 (681)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~------~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l 575 (681)
+...+.+.+.++|++.++||+|+||.||+|.+.. ++.||||++.... ....++|.+|+.+|.++. |||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3445566777899999999999999999998643 3579999998653 334578999999999995 5999999
Q ss_pred EEEEEeC-CeEEEEEEecCCCChhhHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecc
Q 005718 576 MGCCVEQ-GEKILIYEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRD 641 (681)
Q Consensus 576 ~g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD 641 (681)
+|+|.+. +..+||||||++|+|.++|.... ....+++.+++.|+.|||+||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999765 57899999999999999995421 1345899999999999999999999987 99999
Q ss_pred cCCCcEEEcCCCCeEEeecCCceeecCCCccCCCcceecC
Q 005718 642 LKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681 (681)
Q Consensus 642 lkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~GT 681 (681)
|||+||||++++.+||+|||+||.+..+.....++..+||
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt 250 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEEC
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeecccccc
Confidence 9999999999999999999999988665544444455665
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=278.59 Aligned_cols=158 Identities=28% Similarity=0.341 Sum_probs=132.7
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
.+.|.+.++||+|+||.||+|... .++.||||+++.... ..+|+.++++++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356788899999999999999985 489999999976422 24699999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC-CeEEeecCCceeecCCC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMFCGDE 670 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~~~~~~ 670 (681)
|++|+|.++|.+ ...+++.++..|+.||++||+|||+++ ||||||||+||||+.++ .+||+|||+|+.+..+.
T Consensus 132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999943 345899999999999999999999987 99999999999999987 69999999999886544
Q ss_pred ccC---CCcceecC
Q 005718 671 LQG---NTKRVVGT 681 (681)
Q Consensus 671 ~~~---~~~~~~GT 681 (681)
... ....++||
T Consensus 206 ~~~~~~~~~~~~GT 219 (336)
T 4g3f_A 206 LGKSLLTGDYIPGT 219 (336)
T ss_dssp --------CCCCCC
T ss_pred cccceecCCccccC
Confidence 321 22345676
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-32 Score=279.18 Aligned_cols=160 Identities=28% Similarity=0.351 Sum_probs=130.9
Q ss_pred CCCCceeeecccCcEeEEEEEec----CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
++|++.+.||+|+||+||+|+.. .++.||||++++.. ......+.+|+.+|++++|||||++++++.+.+..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999862 36789999997542 2334578899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||||+++|+|.++|.. ...+++.++..++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999943 346899999999999999999999988 9999999999999999999999999999765
Q ss_pred CCCccCCCcceecC
Q 005718 668 GDELQGNTKRVVGT 681 (681)
Q Consensus 668 ~~~~~~~~~~~~GT 681 (681)
..... ..+++||
T Consensus 178 ~~~~~--~~~~~GT 189 (304)
T 3ubd_A 178 DHEKK--AYSFCGT 189 (304)
T ss_dssp ---CC--CCSCCCC
T ss_pred CCCcc--ccccccC
Confidence 44332 3345676
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-31 Score=268.07 Aligned_cols=158 Identities=28% Similarity=0.489 Sum_probs=125.4
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|++.+.||+|+||.||+|... +++.||||++.+.. ....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999975 58999999997542 234567999999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+ +|+|.+++.+ ...+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6789888843 345899999999999999999999988 999999999999999999999999999987543
Q ss_pred CccCCCcceecC
Q 005718 670 ELQGNTKRVVGT 681 (681)
Q Consensus 670 ~~~~~~~~~~GT 681 (681)
.. ..+.+||
T Consensus 166 ~~---~~~~~GT 174 (275)
T 3hyh_A 166 NF---LKTSCGS 174 (275)
T ss_dssp ------------
T ss_pred Cc---cCCeeEC
Confidence 32 2234665
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-29 Score=268.08 Aligned_cols=162 Identities=25% Similarity=0.435 Sum_probs=135.4
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEe------CC
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE------QG 583 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------~~ 583 (681)
.++|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.+|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 367999999999999999999985 58999999997542 2345678999999999999999999998764 35
Q ss_pred eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCc
Q 005718 584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla 663 (681)
..|||||||+ |+|.+++. ....+++.++..++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 67988884 3456899999999999999999999988 999999999999999999999999999
Q ss_pred eeecCCCc--cCCCcceecC
Q 005718 664 RMFCGDEL--QGNTKRVVGT 681 (681)
Q Consensus 664 ~~~~~~~~--~~~~~~~~GT 681 (681)
+.+..... .....+++||
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT 225 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVAT 225 (398)
T ss_dssp BCC-------CCCCCSSCCC
T ss_pred eecccCccccccccccceeC
Confidence 98754322 2234456776
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-28 Score=258.59 Aligned_cols=150 Identities=23% Similarity=0.381 Sum_probs=133.0
Q ss_pred HHHHhhCCCCceeeecccCcEeEEEEEec----CCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeC
Q 005718 508 SVSAATENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ 582 (681)
Q Consensus 508 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 582 (681)
.+....+.|++.++||+|+||.||+|+.+ .++.||||++.+. ....++.+|+++|..+ +||||+++++++.+.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 33445688999999999999999999863 3678999998764 3456788999999998 799999999999999
Q ss_pred CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC-CCeEEeecC
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFG 661 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFG 661 (681)
++.+|||||+++|+|.+++. .+++.++..++.||++||+|||+++ ||||||||+||||+.+ +.+||+|||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 99999999999999999982 3789999999999999999999988 9999999999999877 799999999
Q ss_pred CceeecC
Q 005718 662 MARMFCG 668 (681)
Q Consensus 662 la~~~~~ 668 (681)
+|+.+..
T Consensus 164 la~~~~~ 170 (361)
T 4f9c_A 164 LAQGTHD 170 (361)
T ss_dssp TCEECTT
T ss_pred CCcccCC
Confidence 9997644
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=272.68 Aligned_cols=159 Identities=27% Similarity=0.355 Sum_probs=135.0
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHH---HHHHHHHhhCCCCCeeEEEEEEEeCCeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEF---KNEMMLIAKLQHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f---~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 585 (681)
.++|++.++||+|+||.||++... .++.||||++.+.. ......+ +.++.++..++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999985 48999999996531 1222333 3446677788999999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
||||||+++|+|.++|.. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999943 345899999999999999999999987 99999999999999999999999999998
Q ss_pred ecCCCccCCCcceecC
Q 005718 666 FCGDELQGNTKRVVGT 681 (681)
Q Consensus 666 ~~~~~~~~~~~~~~GT 681 (681)
+..... .+++||
T Consensus 342 ~~~~~~----~t~~GT 353 (689)
T 3v5w_A 342 FSKKKP----HASVGT 353 (689)
T ss_dssp CSSCCC----CSCCSC
T ss_pred cCCCCC----CCccCC
Confidence 855432 335676
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=269.99 Aligned_cols=153 Identities=24% Similarity=0.413 Sum_probs=137.7
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
.++|++.+.||+|+||.||++..+ .++.||||++........+.+.+|+.+|+.++|||||++++++.+.+..+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999985 5899999999876556677899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC--CCeEEeecCCceeecCC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD--MNPKISDFGMARMFCGD 669 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~--~~~kl~DFGla~~~~~~ 669 (681)
|++|+|.++|.+ ....+++.++..++.||++||+|||+++ |+||||||+||||+.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999843 2345899999999999999999999988 9999999999999854 79999999999988654
Q ss_pred C
Q 005718 670 E 670 (681)
Q Consensus 670 ~ 670 (681)
.
T Consensus 311 ~ 311 (573)
T 3uto_A 311 Q 311 (573)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.5e-27 Score=245.68 Aligned_cols=163 Identities=43% Similarity=0.727 Sum_probs=145.5
Q ss_pred ccHHHHHHhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC
Q 005718 504 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG 583 (681)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 583 (681)
+.+.++...+++|++.+.||+|+||.||+|...+++.||||++........+.+.+|+.++++++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34445566788999999999999999999998889999999998766667788999999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCC
Q 005718 584 EKILIYEYMPNKSLNFFLFDPSR-THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl 662 (681)
..++||||+++|+|.+++..... ...+++.++..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999865432 335899999999999999999999987 99999999999999999999999999
Q ss_pred ceeecCC
Q 005718 663 ARMFCGD 669 (681)
Q Consensus 663 a~~~~~~ 669 (681)
++.....
T Consensus 186 ~~~~~~~ 192 (321)
T 2qkw_B 186 SKKGTEL 192 (321)
T ss_dssp CEECSSS
T ss_pred ccccccc
Confidence 9976543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.5e-26 Score=235.95 Aligned_cols=152 Identities=28% Similarity=0.483 Sum_probs=137.8
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
.++|.+.+.||+|+||.||++... +++.||+|++........+.|.+|+.++.+++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 357889999999999999999985 4889999999776666778899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
+++++|.+++... ...+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999999542 345899999999999999999999988 999999999999999999999999999987543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=233.76 Aligned_cols=153 Identities=25% Similarity=0.416 Sum_probs=138.4
Q ss_pred hhCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
..++|++.+.||+|+||.||++.. .+++.||||++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 456899999999999999999987 4588999999976655567889999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 670 (681)
|+++++|.+++.. ..+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999843 34889999999999999999999987 9999999999999999999999999999876544
Q ss_pred c
Q 005718 671 L 671 (681)
Q Consensus 671 ~ 671 (681)
.
T Consensus 171 ~ 171 (297)
T 3fxz_A 171 S 171 (297)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=251.13 Aligned_cols=160 Identities=22% Similarity=0.287 Sum_probs=139.9
Q ss_pred HHHHHHhhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEe
Q 005718 506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 581 (681)
Q Consensus 506 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 581 (681)
+.++....++|++.++||+|+||.||++.... ++.||||++.+.. ....+.+.+|..++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 44555667899999999999999999999865 7889999997521 1223348899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecC
Q 005718 582 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661 (681)
Q Consensus 582 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG 661 (681)
.+..++||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999999542 345899999999999999999999987 9999999999999999999999999
Q ss_pred CceeecCCC
Q 005718 662 MARMFCGDE 670 (681)
Q Consensus 662 la~~~~~~~ 670 (681)
+|+.+..+.
T Consensus 221 la~~~~~~~ 229 (437)
T 4aw2_A 221 SCLKLMEDG 229 (437)
T ss_dssp TCEECCTTS
T ss_pred hhhhcccCC
Confidence 998875544
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-25 Score=234.61 Aligned_cols=160 Identities=28% Similarity=0.396 Sum_probs=142.1
Q ss_pred cccHHHHHHhhCC----------CCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCC
Q 005718 503 CFSLASVSAATEN----------FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571 (681)
Q Consensus 503 ~~~~~~~~~~~~~----------f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n 571 (681)
.++..++..+++. |...+.||+|+||.||+|... +++.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 3566666655543 677789999999999999986 68999999998766666788999999999999999
Q ss_pred eeEEEEEEEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC
Q 005718 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS 651 (681)
Q Consensus 572 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~ 651 (681)
|+++++++...+..++||||+++++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 99999999999999999999999999999832 35899999999999999999999987 999999999999999
Q ss_pred CCCeEEeecCCceeecCC
Q 005718 652 DMNPKISDFGMARMFCGD 669 (681)
Q Consensus 652 ~~~~kl~DFGla~~~~~~ 669 (681)
++.+||+|||+++.+..+
T Consensus 177 ~~~~kl~Dfg~~~~~~~~ 194 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKD 194 (321)
T ss_dssp TCCEEECCCTTCEECCSS
T ss_pred CCcEEEeeeeeeeecccC
Confidence 999999999999987554
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=240.00 Aligned_cols=170 Identities=43% Similarity=0.725 Sum_probs=148.8
Q ss_pred CCcccHHHHHHhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCc-ccHHHHHHHHHHHhhCCCCCeeEEEEEE
Q 005718 501 LPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGCC 579 (681)
Q Consensus 501 ~~~~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~ 579 (681)
...+++.++....++|++.+.||+|+||.||+|...+++.||||++..... .....+.+|+.++.+++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456888999999999999999999999999999988899999999976432 2334789999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChhhHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEe
Q 005718 580 VEQGEKILIYEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 658 (681)
Q Consensus 580 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~ 658 (681)
.+.+..++||||+++|+|.+++.... ....+++..+..++.|+++||+|||+.+..+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999996543 33458999999999999999999999833349999999999999999999999
Q ss_pred ecCCceeecCCC
Q 005718 659 DFGMARMFCGDE 670 (681)
Q Consensus 659 DFGla~~~~~~~ 670 (681)
|||+|+.+....
T Consensus 177 Dfg~~~~~~~~~ 188 (326)
T 3uim_A 177 DFGLAKLMDYKD 188 (326)
T ss_dssp CCSSCEECCSSS
T ss_pred cCccccccCccc
Confidence 999999875443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-25 Score=232.38 Aligned_cols=165 Identities=43% Similarity=0.654 Sum_probs=147.2
Q ss_pred CCcccHHHHHHhhCCCCce------eeecccCcEeEEEEEecCCcEEEEEEecCCC----cccHHHHHHHHHHHhhCCCC
Q 005718 501 LPCFSLASVSAATENFSMQ------CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHR 570 (681)
Q Consensus 501 ~~~~~~~~~~~~~~~f~~~------~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l~H~ 570 (681)
...|++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4568899999999998877 8999999999999987 67899999987532 23457899999999999999
Q ss_pred CeeEEEEEEEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc
Q 005718 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 650 (681)
Q Consensus 571 nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~ 650 (681)
||+++++++.+.+..++||||+++++|.+++........+++..+..++.||++||+|||+.+ |+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 999999999999999999999999999999865444556899999999999999999999987 99999999999999
Q ss_pred CCCCeEEeecCCceeecCC
Q 005718 651 SDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 651 ~~~~~kl~DFGla~~~~~~ 669 (681)
.++.+||+|||+++.....
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKF 186 (307)
T ss_dssp TTCCEEECCCTTCEECCSC
T ss_pred CCCcEEEeecccccccccc
Confidence 9999999999999987543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=236.47 Aligned_cols=152 Identities=30% Similarity=0.412 Sum_probs=133.1
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
.++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999986 58899999986542 2334678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 670 (681)
|+++++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999999843 345899999999999999999999987 9999999999999999999999999999875433
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=235.51 Aligned_cols=154 Identities=25% Similarity=0.375 Sum_probs=135.4
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC-------
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------- 583 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------- 583 (681)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356889999999999999999986 68999999997543 345678999999999999999999999987654
Q ss_pred --------------------------------------------------eEEEEEEecCCCChhhHhcCCCCCCCCCHH
Q 005718 584 --------------------------------------------------EKILIYEYMPNKSLNFFLFDPSRTHLLGWQ 613 (681)
Q Consensus 584 --------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~ 613 (681)
..++||||+++++|.+++..........+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 379999999999999999766555566778
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 614 TRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 614 ~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
.+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 89999999999999999987 999999999999999999999999999988654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=238.36 Aligned_cols=150 Identities=25% Similarity=0.334 Sum_probs=134.5
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.++|++.+.||+|+||.||++... +++.||||++++. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357899999999999999999985 5889999999753 234567789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||+++|+|..++. +...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+....
T Consensus 84 ~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999884 2345889999999999999999999987 99999999999999999999999999987543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.1e-26 Score=247.13 Aligned_cols=157 Identities=22% Similarity=0.264 Sum_probs=137.7
Q ss_pred HHHHHhhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC
Q 005718 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ 582 (681)
Q Consensus 507 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~ 582 (681)
..+....++|.+.+.||+|+||.||++.... ++.||+|++.+.. ....+.+.+|+.++..++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3445566889999999999999999999864 7899999987521 22334588999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCC
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl 662 (681)
+..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999999843 24789999999999999999999987 99999999999999999999999999
Q ss_pred ceeecCCC
Q 005718 663 ARMFCGDE 670 (681)
Q Consensus 663 a~~~~~~~ 670 (681)
|+.+....
T Consensus 215 a~~~~~~~ 222 (410)
T 3v8s_A 215 CMKMNKEG 222 (410)
T ss_dssp CEECCTTS
T ss_pred eEeeccCC
Confidence 99875543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=236.33 Aligned_cols=151 Identities=31% Similarity=0.481 Sum_probs=135.8
Q ss_pred hCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
..+|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46799999999999999999998 46899999999753 3344667899999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+++++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999843 245889999999999999999999987 999999999999999999999999999877543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.2e-26 Score=246.64 Aligned_cols=161 Identities=22% Similarity=0.285 Sum_probs=140.4
Q ss_pred cHHHHHHhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEE
Q 005718 505 SLASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580 (681)
Q Consensus 505 ~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~ 580 (681)
.+.+.....++|++.+.||+|+||.||++... +++.||||++.+.. ....+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34455556789999999999999999999985 58999999997531 223445889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeec
Q 005718 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 660 (681)
Q Consensus 581 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF 660 (681)
+.+..++||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 999999999999999999999432 235889999999999999999999987 999999999999999999999999
Q ss_pred CCceeecCCC
Q 005718 661 GMARMFCGDE 670 (681)
Q Consensus 661 Gla~~~~~~~ 670 (681)
|+|+.+..+.
T Consensus 207 Gla~~~~~~~ 216 (412)
T 2vd5_A 207 GSCLKLRADG 216 (412)
T ss_dssp TTCEECCTTS
T ss_pred hhheeccCCC
Confidence 9999876543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=240.53 Aligned_cols=155 Identities=30% Similarity=0.510 Sum_probs=135.5
Q ss_pred hhCCCCceeeecccCcEeEEEEEec--------CCcEEEEEEecCCC-cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEe
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE 581 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~--------~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 581 (681)
..++|.+.+.||+|+||.||+|... .+..||||+++... ....+++.+|+.+++++ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3467899999999999999999863 24579999997643 33457899999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCChhhHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEE
Q 005718 582 QGEKILIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 648 (681)
Q Consensus 582 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiL 648 (681)
.+..++||||+++|+|.+++..... ...+++.+++.++.||++||+|||+.+ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 9999999999999999999854321 235789999999999999999999987 999999999999
Q ss_pred EcCCCCeEEeecCCceeecCC
Q 005718 649 LDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 649 l~~~~~~kl~DFGla~~~~~~ 669 (681)
|+.++.+||+|||+|+.+...
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~ 256 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNI 256 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCC
T ss_pred ECCCCCEEEccccCCcccCcc
Confidence 999999999999999977543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=239.26 Aligned_cols=151 Identities=26% Similarity=0.403 Sum_probs=133.6
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 586 (681)
..++|++.+.||+|+||.||++... +++.||||++++. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3578999999999999999999985 4889999999753 233456788999999988 7999999999999999999
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+||||+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+..
T Consensus 101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999843 345899999999999999999999987 999999999999999999999999999865
Q ss_pred cC
Q 005718 667 CG 668 (681)
Q Consensus 667 ~~ 668 (681)
..
T Consensus 175 ~~ 176 (353)
T 3txo_A 175 IC 176 (353)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=235.44 Aligned_cols=163 Identities=31% Similarity=0.488 Sum_probs=135.8
Q ss_pred hCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC----eEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG----EKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV 588 (681)
.++|++.++||+|+||.||+|... ++.||||++... ......+..|+.++.+++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 467999999999999999999885 789999999753 334456677999999999999999999998754 47999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCCeeecccCCCcEEEcCCCCeEEeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-------SRLRIIHRDLKASNILLDSDMNPKISDFG 661 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------~~~~ivHrDlkp~NiLl~~~~~~kl~DFG 661 (681)
|||+++|+|.+++.. ..+++.++..++.|+++||+|||+. ++.+|+||||||+|||++.++.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 999999999999943 3489999999999999999999987 11139999999999999999999999999
Q ss_pred CceeecCCCccCCCcceecC
Q 005718 662 MARMFCGDELQGNTKRVVGT 681 (681)
Q Consensus 662 la~~~~~~~~~~~~~~~~GT 681 (681)
+|+.+............+||
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt 196 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGT 196 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCC
T ss_pred cccccccccCccccccCccC
Confidence 99988655443333333443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-25 Score=240.87 Aligned_cols=149 Identities=25% Similarity=0.375 Sum_probs=131.4
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC---cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 587 (681)
.++|++.++||+|+||.||+++... ++.||||++++.. ....+.+..|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4679999999999999999999864 7889999997642 22345678899999887 89999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+...
T Consensus 131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999998843 345899999999999999999999987 9999999999999999999999999998743
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-25 Score=229.88 Aligned_cols=151 Identities=30% Similarity=0.470 Sum_probs=133.7
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.++|++.+.||+|+||.||++... .++.||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999975 58899999986432 23456899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||+++++|.+++.. ...+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999843 345899999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 005718 669 D 669 (681)
Q Consensus 669 ~ 669 (681)
.
T Consensus 164 ~ 164 (294)
T 4eqm_A 164 T 164 (294)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-25 Score=235.64 Aligned_cols=151 Identities=27% Similarity=0.408 Sum_probs=133.5
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 585 (681)
...++|.+.+.||+|+||.||++... +++.||||++++.. ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999985 48899999997532 23456788899999877 999999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 94 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999843 345889999999999999999999987 99999999999999999999999999987
Q ss_pred ec
Q 005718 666 FC 667 (681)
Q Consensus 666 ~~ 667 (681)
..
T Consensus 168 ~~ 169 (345)
T 1xjd_A 168 NM 169 (345)
T ss_dssp CC
T ss_pred cc
Confidence 54
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=231.88 Aligned_cols=151 Identities=27% Similarity=0.386 Sum_probs=135.2
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc------ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 585 (681)
.+.|.+.+.||+|+||.||++... +++.||||.+.+... ...+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999985 488999999976432 2357899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC----CeEEeecC
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFG 661 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~DFG 661 (681)
++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999943 346899999999999999999999987 99999999999998877 79999999
Q ss_pred CceeecCC
Q 005718 662 MARMFCGD 669 (681)
Q Consensus 662 la~~~~~~ 669 (681)
+|+.+...
T Consensus 165 ~a~~~~~~ 172 (361)
T 2yab_A 165 LAHEIEDG 172 (361)
T ss_dssp SCEECCTT
T ss_pred CceEcCCC
Confidence 99987543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5e-25 Score=232.34 Aligned_cols=152 Identities=30% Similarity=0.536 Sum_probs=134.7
Q ss_pred hCCCCceeeecccCcEeEEEEEec----CCcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
.++|++.+.||+|+||.||+|... .+..||||+++.. .....+.|.+|+.++.+++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467899999999999999999984 3446999999864 33446789999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||||+++++|.+++... ...+++.++..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999999543 345899999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 005718 668 GD 669 (681)
Q Consensus 668 ~~ 669 (681)
.+
T Consensus 203 ~~ 204 (325)
T 3kul_A 203 DD 204 (325)
T ss_dssp --
T ss_pred cC
Confidence 54
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=233.69 Aligned_cols=160 Identities=29% Similarity=0.538 Sum_probs=133.1
Q ss_pred HHHHhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeE
Q 005718 508 SVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 508 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 585 (681)
.+.....+|++.+.||+|+||.||++.. .++.||||++.... ....+++.+|+.++++++||||+++++++.+.+..
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3344567899999999999999999987 57899999997643 33456899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++||||+++++|.+++........+++..++.++.||++||+|||+.+ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999999965433345899999999999999999999864 3499999999999999999999999999987
Q ss_pred ecCC
Q 005718 666 FCGD 669 (681)
Q Consensus 666 ~~~~ 669 (681)
....
T Consensus 189 ~~~~ 192 (309)
T 3p86_A 189 KAST 192 (309)
T ss_dssp ----
T ss_pred cccc
Confidence 6443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.9e-25 Score=234.39 Aligned_cols=148 Identities=26% Similarity=0.381 Sum_probs=132.4
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 588 (681)
++|++.+.||+|+||.||++... +++.||||++.+.. ....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57899999999999999999985 47899999997542 23456788999999988 899999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+...
T Consensus 89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999843 345899999999999999999999987 9999999999999999999999999998653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=238.26 Aligned_cols=164 Identities=27% Similarity=0.447 Sum_probs=139.9
Q ss_pred ccHHHHHHhhCCCCceeeecccCcEeEEEEEe------cCCcEEEEEEecCCC-cccHHHHHHHHHHHhhC-CCCCeeEE
Q 005718 504 FSLASVSAATENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRL 575 (681)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~------~~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l 575 (681)
+.........++|.+.+.||+|+||.||+|.+ .+++.||||+++... ....+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 44566667788999999999999999999974 235789999998643 33456799999999999 89999999
Q ss_pred EEEEEeCC-eEEEEEEecCCCChhhHhcCCCC------------------------------------------------
Q 005718 576 MGCCVEQG-EKILIYEYMPNKSLNFFLFDPSR------------------------------------------------ 606 (681)
Q Consensus 576 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------ 606 (681)
++++.+.+ ..++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998765 48999999999999999965432
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCC
Q 005718 607 ---------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 607 ---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 670 (681)
...+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+..+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 122889999999999999999999987 9999999999999999999999999999775443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.4e-25 Score=227.81 Aligned_cols=150 Identities=25% Similarity=0.416 Sum_probs=128.6
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc--------------------------ccHHHHHHHHHHHh
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--------------------------QGLKEFKNEMMLIA 565 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--------------------------~~~~~f~~Ei~~l~ 565 (681)
.++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467999999999999999999875 578999999865321 12356899999999
Q ss_pred hCCCCCeeEEEEEEEe--CCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccC
Q 005718 566 KLQHRNLVRLMGCCVE--QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLK 643 (681)
Q Consensus 566 ~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk 643 (681)
+++||||+++++++.+ .+..++||||+++++|.+++ ....+++.++..++.||++||+|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56899999999999998765 2346899999999999999999999987 9999999
Q ss_pred CCcEEEcCCCCeEEeecCCceeecCC
Q 005718 644 ASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 644 p~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
|+|||++.++.+||+|||+|+.+...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~ 190 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGS 190 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSS
T ss_pred HHHEEECCCCCEEEecCCCccccccc
Confidence 99999999999999999999987543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=5.7e-25 Score=231.15 Aligned_cols=150 Identities=27% Similarity=0.405 Sum_probs=134.5
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.++|++.+.||+|+||.||++... +++.||+|++++.. ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357899999999999999999985 58899999997531 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999943 345889999999999999999999887 99999999999999999999999999997643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.9e-25 Score=224.97 Aligned_cols=150 Identities=32% Similarity=0.545 Sum_probs=136.5
Q ss_pred hCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
.++|++.+.||+|+||.||++...+++.||+|++... ....+++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 4678899999999999999999988889999999864 345678999999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
++++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+|+....
T Consensus 88 ~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 88 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp TTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccc
Confidence 999999999542 345899999999999999999999988 99999999999999999999999999987644
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.6e-25 Score=236.33 Aligned_cols=151 Identities=25% Similarity=0.385 Sum_probs=135.5
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.++|.+.+.||+|+||.||++.... ++.||+|++.+. .....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 3678999999999999999999854 789999998653 234467889999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||+.+|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999943 345899999999999999999999988 99999999999999999999999999998754
Q ss_pred C
Q 005718 669 D 669 (681)
Q Consensus 669 ~ 669 (681)
.
T Consensus 168 ~ 168 (384)
T 4fr4_A 168 E 168 (384)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-25 Score=238.37 Aligned_cols=152 Identities=34% Similarity=0.572 Sum_probs=128.3
Q ss_pred hCCCCceeeecccCcEeEEEEEec----CCcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
..+|++.+.||+|+||.||+|... .+..||||+++.. .....++|.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 457899999999999999999875 4678999999764 33445789999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||||+++++|.+++... ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999542 345899999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 005718 668 GD 669 (681)
Q Consensus 668 ~~ 669 (681)
.+
T Consensus 199 ~~ 200 (373)
T 2qol_A 199 DD 200 (373)
T ss_dssp --
T ss_pred cC
Confidence 54
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-24 Score=227.06 Aligned_cols=151 Identities=23% Similarity=0.339 Sum_probs=135.3
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
.++|.+.+.||+|+||.||++... +++.+|+|.+... ....+.+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999985 4789999998753 34556789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC--CCCeEEeecCCceeecCC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS--DMNPKISDFGMARMFCGD 669 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~--~~~~kl~DFGla~~~~~~ 669 (681)
+++++|.+++.. ....+++.++..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999943 2345899999999999999999999987 999999999999987 789999999999987543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.2e-25 Score=232.41 Aligned_cols=150 Identities=29% Similarity=0.393 Sum_probs=125.1
Q ss_pred hCCCCceeeecccCcEeEEEEEe----cCCcEEEEEEecCCC----cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL----LNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE 584 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~----~~~~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 584 (681)
.++|++.+.||+|+||.||++.. ..++.||+|++++.. ......+.+|+.++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999987 368899999997642 2334568899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
.++||||+++++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999843 345788999999999999999999987 9999999999999999999999999998
Q ss_pred eecC
Q 005718 665 MFCG 668 (681)
Q Consensus 665 ~~~~ 668 (681)
....
T Consensus 170 ~~~~ 173 (327)
T 3a62_A 170 ESIH 173 (327)
T ss_dssp ----
T ss_pred cccc
Confidence 6543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=238.32 Aligned_cols=152 Identities=18% Similarity=0.229 Sum_probs=132.5
Q ss_pred HHhhCCCCceeeecccCcEeEEEEE------ecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCC---CCCeeEEEEEEE
Q 005718 510 SAATENFSMQCKLGEGGFGPVYKGK------LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ---HRNLVRLMGCCV 580 (681)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fG~Vy~~~------~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~ 580 (681)
....++|.+.+.||+|+||.||+|. ...++.||||++... ...++..|+.++.+++ |+||+++++++.
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3446789999999999999999994 345789999999754 3567888888888886 999999999999
Q ss_pred eCCeEEEEEEecCCCChhhHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC-------
Q 005718 581 EQGEKILIYEYMPNKSLNFFLFDP--SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS------- 651 (681)
Q Consensus 581 ~~~~~~lV~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~------- 651 (681)
..+..++||||+++|+|.+++... .....+++.++..|+.||++||+|||+.+ ||||||||+||||+.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence 999999999999999999999532 13456899999999999999999999987 999999999999998
Q ss_pred ----CCCeEEeecCCceeec
Q 005718 652 ----DMNPKISDFGMARMFC 667 (681)
Q Consensus 652 ----~~~~kl~DFGla~~~~ 667 (681)
++.+||+|||+|+.+.
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~ 234 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMK 234 (365)
T ss_dssp ----CTTEEECCCTTCEEGG
T ss_pred cccccCCEEEeeCchhhhhh
Confidence 8999999999998764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.4e-25 Score=234.05 Aligned_cols=151 Identities=27% Similarity=0.354 Sum_probs=134.0
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCC---CcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 586 (681)
..++|.+.+.||+|+||.||++.... ++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34689999999999999999999865 788999999753 223457788999999988 8999999999999999999
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+..
T Consensus 98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999843 245889999999999999999999987 999999999999999999999999999875
Q ss_pred cC
Q 005718 667 CG 668 (681)
Q Consensus 667 ~~ 668 (681)
..
T Consensus 172 ~~ 173 (353)
T 2i0e_A 172 IW 173 (353)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=239.66 Aligned_cols=152 Identities=30% Similarity=0.471 Sum_probs=135.3
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
..++|.+.+.||+|+||.||+|... +++.||||.++... ....++|.+|+.++++++||||+++++++.+.+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 4567889999999999999999986 68899999987543 233457899999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||+++|+|.+++.. ....+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 192 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 192 ELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp ECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999843 2335889999999999999999999988 99999999999999999999999999987643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-24 Score=227.98 Aligned_cols=155 Identities=29% Similarity=0.431 Sum_probs=136.7
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC--eEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG--EKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV 588 (681)
.++|.+.+.||+|+||.||+|.... ++.||||++.... ....+.+.+|+.++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 3578999999999999999999864 8899999997543 344678899999999999999999999998765 78999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEE----cCCCCeEEeecCCce
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMAR 664 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl----~~~~~~kl~DFGla~ 664 (681)
|||+++++|.+++........+++.++..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999966544455899999999999999999999987 9999999999999 778889999999999
Q ss_pred eecCCC
Q 005718 665 MFCGDE 670 (681)
Q Consensus 665 ~~~~~~ 670 (681)
.+....
T Consensus 165 ~~~~~~ 170 (319)
T 4euu_A 165 ELEDDE 170 (319)
T ss_dssp ECCTTC
T ss_pred ecCCCC
Confidence 875543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-24 Score=224.62 Aligned_cols=149 Identities=27% Similarity=0.437 Sum_probs=130.2
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999985 48899999997542 2335778999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|++++.+..+. . ....+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 82 ~~~~~l~~~~~-~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQDLKKYFD-S--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHH-H--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCCCHHHHHH-h--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 99864444433 2 2345899999999999999999999987 99999999999999999999999999998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.6e-25 Score=223.14 Aligned_cols=153 Identities=32% Similarity=0.489 Sum_probs=137.7
Q ss_pred hhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
..++|++.+.||+|+||.||++...++..||||++... ....+++.+|+.++.+++||||+++++++.+....++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 34678999999999999999999988889999999764 34567899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 670 (681)
+++++|.+++.. ....+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+|+....+.
T Consensus 85 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999843 2345899999999999999999999987 9999999999999999999999999999775543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=9.4e-25 Score=232.62 Aligned_cols=149 Identities=26% Similarity=0.333 Sum_probs=134.4
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|++.+.||+|+||.||++... +++.||||++.+.. ....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57899999999999999999985 58899999996532 234578899999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999843 235889999999999999999999988 99999999999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=4e-25 Score=234.35 Aligned_cols=159 Identities=31% Similarity=0.513 Sum_probs=139.0
Q ss_pred HHHHHhhCCCCceeeecccCcEeEEEEEecC------CcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEE
Q 005718 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579 (681)
Q Consensus 507 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~------~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~ 579 (681)
..+....++|.+.+.||+|+||.||++.... ++.||||+++... ....+.+.+|+.++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 4445567899999999999999999999753 4789999998643 33457899999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChhhHhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 005718 580 VEQGEKILIYEYMPNKSLNFFLFDPSR---------------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRII 638 (681)
Q Consensus 580 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv 638 (681)
.+.+..++||||+++++|.+++..... ...+++.+++.++.||++||+|||+.+ |+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 999999999999999999999854321 246899999999999999999999987 99
Q ss_pred ecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 639 HRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 639 HrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||||||+|||++.++.+||+|||+++.+..
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 226 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYS 226 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTG
T ss_pred cCCCCcceEEECCCCeEEEeecCCCccccc
Confidence 999999999999999999999999987643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-24 Score=226.68 Aligned_cols=150 Identities=27% Similarity=0.391 Sum_probs=134.5
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc------ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 585 (681)
.+.|.+.+.||+|+||.||++... +++.||||.+..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356899999999999999999985 488999999875322 2467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC----CeEEeecC
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFG 661 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~DFG 661 (681)
++||||+++++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999943 345899999999999999999999987 99999999999999887 79999999
Q ss_pred CceeecC
Q 005718 662 MARMFCG 668 (681)
Q Consensus 662 la~~~~~ 668 (681)
+|+.+..
T Consensus 164 ~a~~~~~ 170 (326)
T 2y0a_A 164 LAHKIDF 170 (326)
T ss_dssp TCEECCT
T ss_pred CCeECCC
Confidence 9998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=227.23 Aligned_cols=150 Identities=32% Similarity=0.449 Sum_probs=131.8
Q ss_pred hhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
..++|++.++||+|+||.||++...+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 347899999999999999999999889999999997542 223467899999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||+++ +|.+++.. ....+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 99985 77777744 2345889999999999999999999987 9999999999999999999999999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.92 E-value=7.8e-25 Score=225.67 Aligned_cols=152 Identities=30% Similarity=0.489 Sum_probs=134.7
Q ss_pred HhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
...++|++.+.||+|+||.||++...++..||||++... ....+++.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 345789999999999999999999988889999999864 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|+++++|.+++... ...+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 100 YMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred ccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999542 345899999999999999999999987 99999999999999999999999999987644
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=231.92 Aligned_cols=153 Identities=25% Similarity=0.373 Sum_probs=136.5
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
.+.|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.++.+++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 367999999999999999999985 5889999999876555667899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC--CCCeEEeecCCceeecCC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS--DMNPKISDFGMARMFCGD 669 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~--~~~~kl~DFGla~~~~~~ 669 (681)
+++|+|.+++.. ....+++.++..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.+..+
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999843 2335899999999999999999999987 999999999999974 467999999999987554
Q ss_pred C
Q 005718 670 E 670 (681)
Q Consensus 670 ~ 670 (681)
.
T Consensus 205 ~ 205 (387)
T 1kob_A 205 E 205 (387)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=234.64 Aligned_cols=155 Identities=32% Similarity=0.503 Sum_probs=135.8
Q ss_pred hhCCCCceeeecccCcEeEEEEEec--------CCcEEEEEEecCCC-cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEe
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE 581 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~--------~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 581 (681)
..++|.+.+.||+|+||.||+|... .+..||||+++... ....+++.+|+++++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4578999999999999999999862 23579999997643 34457899999999999 99999999999999
Q ss_pred CCeEEEEEEecCCCChhhHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEE
Q 005718 582 QGEKILIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 648 (681)
Q Consensus 582 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiL 648 (681)
.+..++||||+++|+|.+++..... ...+++.++..++.||++||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999854321 245899999999999999999999987 999999999999
Q ss_pred EcCCCCeEEeecCCceeecCC
Q 005718 649 LDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 649 l~~~~~~kl~DFGla~~~~~~ 669 (681)
|+.++.+||+|||+|+.+...
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~ 244 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHI 244 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCC
T ss_pred EcCCCcEEEcccCcccccccc
Confidence 999999999999999977543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.2e-25 Score=229.24 Aligned_cols=156 Identities=32% Similarity=0.536 Sum_probs=136.3
Q ss_pred hhCCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCe
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE 584 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 584 (681)
..++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 4578999999999999999999862 34789999997643 3445789999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccC
Q 005718 585 KILIYEYMPNKSLNFFLFDPSR---------------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLK 643 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk 643 (681)
.++||||+++++|.+++..... ...+++.++..++.||++||+|||+.+ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999864322 234789999999999999999999987 9999999
Q ss_pred CCcEEEcCCCCeEEeecCCceeecCCC
Q 005718 644 ASNILLDSDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 644 p~NiLl~~~~~~kl~DFGla~~~~~~~ 670 (681)
|+|||+++++.+||+|||+|+.+....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~ 204 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEED 204 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTS
T ss_pred hheEEEcCCCCEEEccccccccccccc
Confidence 999999999999999999999875443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=4.7e-25 Score=228.84 Aligned_cols=152 Identities=32% Similarity=0.553 Sum_probs=132.0
Q ss_pred hCCCCceeeecccCcEeEEEEEe-----cCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC--CeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-----LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEK 585 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 585 (681)
.++|++.+.||+|+||.||++.+ .+++.||||++........+.+.+|+.++.+++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46789999999999999999984 25789999999876666678899999999999999999999998654 568
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++||||+++++|.+++... ...+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999999543 334889999999999999999999987 99999999999999999999999999998
Q ss_pred ecCC
Q 005718 666 FCGD 669 (681)
Q Consensus 666 ~~~~ 669 (681)
+..+
T Consensus 164 ~~~~ 167 (295)
T 3ugc_A 164 LPQD 167 (295)
T ss_dssp ----
T ss_pred ccCC
Confidence 7543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-24 Score=229.62 Aligned_cols=152 Identities=27% Similarity=0.432 Sum_probs=134.4
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
..++|.+.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3567999999999999999999985 4889999999754 233456789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC---CeEEeecCCcee
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARM 665 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~---~~kl~DFGla~~ 665 (681)
|||+++|+|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++ .+||+|||+|+.
T Consensus 107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999998843 345899999999999999999999987 99999999999998654 599999999998
Q ss_pred ecCC
Q 005718 666 FCGD 669 (681)
Q Consensus 666 ~~~~ 669 (681)
+...
T Consensus 181 ~~~~ 184 (362)
T 2bdw_A 181 VNDS 184 (362)
T ss_dssp CTTC
T ss_pred ecCC
Confidence 7543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-24 Score=228.41 Aligned_cols=155 Identities=25% Similarity=0.398 Sum_probs=134.3
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC-----CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 586 (681)
.+.|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357899999999999999999875 5889999998642 1234678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCC---eEEeecCC
Q 005718 587 LIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGM 662 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~---~kl~DFGl 662 (681)
+||||+++++|.+.+... .....+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998877432 22345889999999999999999999987 999999999999987654 99999999
Q ss_pred ceeecCCC
Q 005718 663 ARMFCGDE 670 (681)
Q Consensus 663 a~~~~~~~ 670 (681)
|+.+....
T Consensus 180 a~~~~~~~ 187 (351)
T 3c0i_A 180 AIQLGESG 187 (351)
T ss_dssp CEECCTTS
T ss_pred eeEecCCC
Confidence 99875543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=231.10 Aligned_cols=158 Identities=30% Similarity=0.483 Sum_probs=134.7
Q ss_pred HHhhCCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCC-CcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEe
Q 005718 510 SAATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE 581 (681)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 581 (681)
....++|.+.+.||+|+||.||+|... .++.||||++... .....+.+.+|+.++.++ +||||+++++++.+
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 345678999999999999999999862 3567999999754 233457899999999999 99999999999999
Q ss_pred CCeEEEEEEecCCCChhhHhcCCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecc
Q 005718 582 QGEKILIYEYMPNKSLNFFLFDPSRT--------------------HLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRD 641 (681)
Q Consensus 582 ~~~~~lV~Ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD 641 (681)
.+..++||||+++|+|.+++...... ..+++.++..++.||++||+|||+.+ |+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 99999999999999999999654321 34789999999999999999999987 99999
Q ss_pred cCCCcEEEcCCCCeEEeecCCceeecCCC
Q 005718 642 LKASNILLDSDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 642 lkp~NiLl~~~~~~kl~DFGla~~~~~~~ 670 (681)
|||+||||+.++.+||+|||+|+.+..+.
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~ 226 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDS 226 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCc
Confidence 99999999999999999999998775443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=243.10 Aligned_cols=155 Identities=30% Similarity=0.513 Sum_probs=138.6
Q ss_pred HhhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
....+|.+.+.||+|+||.||+|.+.. +..||||.++.. ....++|.+|+.++++++||||+++++++.+.+..+|||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 345678899999999999999999865 789999999864 345788999999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+++|+|.+++.... ...+++..++.|+.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+..+
T Consensus 296 E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 296 EFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp ECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 9999999999995432 345889999999999999999999987 999999999999999999999999999987554
Q ss_pred C
Q 005718 670 E 670 (681)
Q Consensus 670 ~ 670 (681)
.
T Consensus 372 ~ 372 (495)
T 1opk_A 372 T 372 (495)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.8e-25 Score=242.90 Aligned_cols=150 Identities=26% Similarity=0.314 Sum_probs=124.8
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.++|++.+.||+|+||.||++... +++.||||++... .......+.+|+.++..++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999975 5889999999753 233456788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
|||+++|+|.+++.. ...+++..+..++.||++||+|||+ .+ |+||||||+||||+.++.+||+|||+|+...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999998843 3468999999999999999999998 66 9999999999999999999999999998754
Q ss_pred C
Q 005718 668 G 668 (681)
Q Consensus 668 ~ 668 (681)
.
T Consensus 301 ~ 301 (446)
T 4ejn_A 301 K 301 (446)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.91 E-value=6.4e-25 Score=242.41 Aligned_cols=153 Identities=31% Similarity=0.473 Sum_probs=136.5
Q ss_pred HHhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 510 SAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
....++|.+.+.||+|+||.||+|...++..||||+++.. ....++|.+|+.++++++||||+++++++. .+..++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 4456789999999999999999999988889999999864 356789999999999999999999999986 66789999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||+++|+|.+++... ....+++..++.++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 262 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred eecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 999999999999542 1235788999999999999999999987 99999999999999999999999999998754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-24 Score=220.48 Aligned_cols=152 Identities=22% Similarity=0.393 Sum_probs=137.0
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
..++|++.+.||+|+||.||+|.... +..+|+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 34679999999999999999999865 67899999987655667899999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEE---cCCCCeEEeecCCceeec
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFC 667 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~DFGla~~~~ 667 (681)
|+++++|.+++.. ...+++.++..++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+.+.
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999988843 345889999999999999999999987 9999999999999 788999999999998875
Q ss_pred CC
Q 005718 668 GD 669 (681)
Q Consensus 668 ~~ 669 (681)
..
T Consensus 161 ~~ 162 (277)
T 3f3z_A 161 PG 162 (277)
T ss_dssp TT
T ss_pred Cc
Confidence 44
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.91 E-value=7.1e-25 Score=230.60 Aligned_cols=157 Identities=31% Similarity=0.524 Sum_probs=122.9
Q ss_pred HHhhCCCCceeeecccCcEeEEEEEecCC----cEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC
Q 005718 510 SAATENFSMQCKLGEGGFGPVYKGKLLNG----QEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG 583 (681)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~----~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 583 (681)
....++|++.+.||+|+||.||+|..... ..||||++... .....+++.+|+.++++++||||+++++++.+..
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 34567899999999999999999987543 27999999764 3445678999999999999999999999998876
Q ss_pred eE------EEEEEecCCCChhhHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCC
Q 005718 584 EK------ILIYEYMPNKSLNFFLFDP---SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 654 (681)
Q Consensus 584 ~~------~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~ 654 (681)
.. ++||||+++++|.+++... .....+++.++..++.||++||+|||+.+ |+||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence 55 9999999999999998432 12235899999999999999999999987 999999999999999999
Q ss_pred eEEeecCCceeecCC
Q 005718 655 PKISDFGMARMFCGD 669 (681)
Q Consensus 655 ~kl~DFGla~~~~~~ 669 (681)
+||+|||+|+.+...
T Consensus 176 ~kl~Dfg~a~~~~~~ 190 (323)
T 3qup_A 176 VCVADFGLSRKIYSG 190 (323)
T ss_dssp EEECCCCC-------
T ss_pred EEEeecccccccccc
Confidence 999999999877543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=224.06 Aligned_cols=148 Identities=28% Similarity=0.449 Sum_probs=132.1
Q ss_pred CCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
++|++.+.||+|+||.||++....++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4788999999999999999999779999999997542 22347788999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+++ +|.+++... ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFG 151 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence 985 888887442 345889999999999999999999987 9999999999999999999999999998764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-24 Score=234.15 Aligned_cols=149 Identities=26% Similarity=0.331 Sum_probs=123.4
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC---cccHHHHHHHHHH-HhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMML-IAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~---~~~~~~f~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
.++|++.+.||+|+||.||+++... ++.||||++.+.. ....+.+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 4679999999999999999999864 7889999997642 2234456677766 467899999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999999843 345788999999999999999999987 9999999999999999999999999998753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=6e-25 Score=235.78 Aligned_cols=153 Identities=35% Similarity=0.531 Sum_probs=132.5
Q ss_pred hCCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 585 (681)
.++|.+.+.||+|+||.||+|... .++.||||++... ......++.+|+.++.+++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467899999999999999999853 3568999999754 344556799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhcCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC---CeEEe
Q 005718 586 ILIYEYMPNKSLNFFLFDP----SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKIS 658 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~---~~kl~ 658 (681)
++||||+++|+|.+++... .....+++.+++.++.||++||+|||+.+ |+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 9999999999999998532 12245899999999999999999999988 99999999999999554 59999
Q ss_pred ecCCceeecC
Q 005718 659 DFGMARMFCG 668 (681)
Q Consensus 659 DFGla~~~~~ 668 (681)
|||+|+.+..
T Consensus 227 DFG~a~~~~~ 236 (367)
T 3l9p_A 227 DFGMARDIYR 236 (367)
T ss_dssp CCHHHHHHHH
T ss_pred CCcccccccc
Confidence 9999986643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.9e-24 Score=220.91 Aligned_cols=147 Identities=31% Similarity=0.456 Sum_probs=127.0
Q ss_pred hCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhh--CCCCCeeEEEEEEEeC----CeEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK--LQHRNLVRLMGCCVEQ----GEKI 586 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~~----~~~~ 586 (681)
.++|++.+.||+|+||.||+|.. +++.||||++... ..+.+..|.+++.. ++||||+++++++.+. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46799999999999999999988 6889999998653 34556667776666 7999999999997653 4689
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeecccCCCcEEEcCCCCeEEe
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH--------QYSRLRIIHRDLKASNILLDSDMNPKIS 658 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivHrDlkp~NiLl~~~~~~kl~ 658 (681)
+||||+++|+|.+++. ...+++..+..++.||++||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999993 235899999999999999999999 555 9999999999999999999999
Q ss_pred ecCCceeecCCC
Q 005718 659 DFGMARMFCGDE 670 (681)
Q Consensus 659 DFGla~~~~~~~ 670 (681)
|||+|+.+....
T Consensus 156 Dfg~a~~~~~~~ 167 (301)
T 3q4u_A 156 DLGLAVMHSQST 167 (301)
T ss_dssp CCTTCEEEETTT
T ss_pred eCCCeeeccccc
Confidence 999998875543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.8e-24 Score=240.29 Aligned_cols=154 Identities=29% Similarity=0.365 Sum_probs=136.9
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
..++|.+.+.||+|+||.||++... +++.||||++.+. .......+.+|+.++.+++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3567999999999999999999985 5899999999653 22345678999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999986532 234899999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 005718 668 GD 669 (681)
Q Consensus 668 ~~ 669 (681)
..
T Consensus 338 ~~ 339 (576)
T 2acx_A 338 EG 339 (576)
T ss_dssp TT
T ss_pred cC
Confidence 44
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.91 E-value=4.1e-24 Score=239.34 Aligned_cols=155 Identities=28% Similarity=0.404 Sum_probs=137.5
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.++|.+.+.||+|+||.||++... +++.||||++.+.. ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467889999999999999999985 58999999997532 23456789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 589 YEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
|||+++|+|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999986543 2346899999999999999999999987 9999999999999999999999999999875
Q ss_pred CCC
Q 005718 668 GDE 670 (681)
Q Consensus 668 ~~~ 670 (681)
...
T Consensus 341 ~~~ 343 (543)
T 3c4z_A 341 AGQ 343 (543)
T ss_dssp TTC
T ss_pred CCC
Confidence 543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-24 Score=226.24 Aligned_cols=155 Identities=30% Similarity=0.516 Sum_probs=135.0
Q ss_pred hhCCCCceeeecccCcEeEEEEEec--------CCcEEEEEEecCCC-cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEe
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE 581 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~--------~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 581 (681)
..++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4578999999999999999999863 35689999997643 34457899999999999 99999999999999
Q ss_pred CCeEEEEEEecCCCChhhHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEE
Q 005718 582 QGEKILIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 648 (681)
Q Consensus 582 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiL 648 (681)
.+..++||||+++++|.+++..... ...+++.+++.++.||++||+|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999965432 234889999999999999999999987 999999999999
Q ss_pred EcCCCCeEEeecCCceeecCC
Q 005718 649 LDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 649 l~~~~~~kl~DFGla~~~~~~ 669 (681)
++.++.+||+|||+|+.+...
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~ 210 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNI 210 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTT
T ss_pred EcCCCCEEEcccccccccccc
Confidence 999999999999999987553
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-24 Score=235.92 Aligned_cols=153 Identities=27% Similarity=0.425 Sum_probs=133.3
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
..++|++.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4567999999999999999999874 58899999987542 23456789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc---CCCCeEEeecCCcee
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARM 665 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~---~~~~~kl~DFGla~~ 665 (681)
|||+++|+|.+.+.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+|+.
T Consensus 89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999988843 345899999999999999999999987 99999999999998 467899999999988
Q ss_pred ecCCC
Q 005718 666 FCGDE 670 (681)
Q Consensus 666 ~~~~~ 670 (681)
+....
T Consensus 163 ~~~~~ 167 (444)
T 3soa_A 163 VEGEQ 167 (444)
T ss_dssp CCTTC
T ss_pred ecCCC
Confidence 76543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.4e-24 Score=236.12 Aligned_cols=151 Identities=28% Similarity=0.491 Sum_probs=135.7
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367999999999999999999985 58999999997532 22356789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||+++|+|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 95 ~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999943 345899999999999999999999987 99999999999999999999999999998754
Q ss_pred C
Q 005718 669 D 669 (681)
Q Consensus 669 ~ 669 (681)
.
T Consensus 169 ~ 169 (476)
T 2y94_A 169 G 169 (476)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-24 Score=230.27 Aligned_cols=147 Identities=31% Similarity=0.442 Sum_probs=126.5
Q ss_pred eeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCCCCh
Q 005718 519 QCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSL 597 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 597 (681)
.+.||+|+||.||+|... +++.||+|+++.......+++.+|+.++.+++||||+++++++.+.+..+|||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 568999999999999874 5889999999876556678899999999999999999999999999999999999999999
Q ss_pred hhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEE--cCCCCeEEeecCCceeecCCC
Q 005718 598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL--DSDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 598 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl--~~~~~~kl~DFGla~~~~~~~ 670 (681)
.+++.. ....+++.++..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+.+....
T Consensus 174 ~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 174 FDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp HHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 888843 2335889999999999999999999987 9999999999999 567899999999999875543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=230.04 Aligned_cols=147 Identities=24% Similarity=0.338 Sum_probs=130.3
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
.++|.+.+.||+|+||.||++... .++.||||++... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS-TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC-ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999986 5889999999764 33446788999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCC--eEEeecCCceee
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--PKISDFGMARMF 666 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~--~kl~DFGla~~~ 666 (681)
+++|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||||+.++. +||+|||+|+..
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 999999999843 335899999999999999999999987 999999999999987765 999999999854
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.7e-25 Score=229.28 Aligned_cols=151 Identities=25% Similarity=0.374 Sum_probs=128.7
Q ss_pred hCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC----e
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG----E 584 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~ 584 (681)
.++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++.+++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999997 468899999997642 233467899999999999999999999987654 3
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
.++||||+++++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 4999999999999999843 345899999999999999999999987 9999999999999999999999999998
Q ss_pred eecCC
Q 005718 665 MFCGD 669 (681)
Q Consensus 665 ~~~~~ 669 (681)
.+...
T Consensus 165 ~~~~~ 169 (311)
T 3ork_A 165 AIADS 169 (311)
T ss_dssp -----
T ss_pred ccccc
Confidence 77543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=228.78 Aligned_cols=148 Identities=21% Similarity=0.297 Sum_probs=126.7
Q ss_pred hCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCC--------cccHHHHHHHHHHHhhCC---------CCCeeEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--------GQGLKEFKNEMMLIAKLQ---------HRNLVRL 575 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~--------~~~~~~f~~Ei~~l~~l~---------H~nIv~l 575 (681)
.++|++.+.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788999999999999999998 67999999997542 223478899999998885 8999988
Q ss_pred EEEEE------------------------------eCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 005718 576 MGCCV------------------------------EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQG 625 (681)
Q Consensus 576 ~g~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~ 625 (681)
.+.+. +.+..+|||||+++|++.+.+.+ ..+++.++..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 88754 26789999999999976666622 457899999999999999
Q ss_pred HHHHH-hCCCCCeeecccCCCcEEEcCCC--------------------CeEEeecCCceeecC
Q 005718 626 LLYLH-QYSRLRIIHRDLKASNILLDSDM--------------------NPKISDFGMARMFCG 668 (681)
Q Consensus 626 L~yLH-~~~~~~ivHrDlkp~NiLl~~~~--------------------~~kl~DFGla~~~~~ 668 (681)
|+||| +.+ |+||||||+||||+.++ .+||+|||+|+.+..
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~ 234 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD 234 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence 99999 887 99999999999999887 899999999998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=5.2e-24 Score=218.41 Aligned_cols=150 Identities=30% Similarity=0.411 Sum_probs=134.6
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
.++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 357899999999999999999985 58899999987532 3345789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|+++++|.+++.. ...+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 9999999998843 345889999999999999999999987 99999999999999999999999999987643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=228.04 Aligned_cols=150 Identities=26% Similarity=0.449 Sum_probs=132.6
Q ss_pred hCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.++|.+.+.||+|+||.||+|.. ..++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36799999999999999999997 458899999986531 22346789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||+ +|+|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 6788888743 345899999999999999999999988 99999999999999999999999999997754
Q ss_pred C
Q 005718 669 D 669 (681)
Q Consensus 669 ~ 669 (681)
.
T Consensus 161 ~ 161 (336)
T 3h4j_B 161 G 161 (336)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-24 Score=234.79 Aligned_cols=150 Identities=25% Similarity=0.433 Sum_probs=131.5
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC-----Ce
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----GE 584 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~ 584 (681)
.++|.+.+.||+|+||.||+|... .++.||||++... .....+.+.+|+.++++++|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 478999999999999999999975 4788999999753 234457899999999999999999999999876 57
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
.++||||++ ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999997 599998843 345899999999999999999999988 9999999999999999999999999999
Q ss_pred eecCC
Q 005718 665 MFCGD 669 (681)
Q Consensus 665 ~~~~~ 669 (681)
.+...
T Consensus 178 ~~~~~ 182 (432)
T 3n9x_A 178 TINSE 182 (432)
T ss_dssp EC---
T ss_pred ccccc
Confidence 87543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.8e-24 Score=235.06 Aligned_cols=151 Identities=30% Similarity=0.507 Sum_probs=133.8
Q ss_pred HhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC-eEEEEE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG-EKILIY 589 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~ 589 (681)
...++|++.+.||+|+||.||+|... ++.||||+++... ..+.|.+|+.++++++||||+++++++.+.+ ..++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 34567889999999999999999985 6799999998643 5678999999999999999999999988775 799999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||+++|+|.+++... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 267 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp ECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 999999999999543 2234789999999999999999999987 99999999999999999999999999996543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=225.96 Aligned_cols=157 Identities=31% Similarity=0.442 Sum_probs=136.9
Q ss_pred HhhCCCCceeeecccCcEeEEEEEe------cCCcEEEEEEecCCCc-ccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeC
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ 582 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~------~~~~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 582 (681)
...++|.+.+.||+|+||.||+|.. ..++.||||++..... ...+.+.+|+.++.++ +||||+++++++.+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3457899999999999999999985 2367899999986432 3457899999999999 999999999999999
Q ss_pred CeEEEEEEecCCCChhhHhcCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcE
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPSR---------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNI 647 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~Ni 647 (681)
+..++||||+++|+|.+++..... ...+++.++..++.||++||+|||+.+ |+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence 999999999999999999854322 224899999999999999999999987 99999999999
Q ss_pred EEcCCCCeEEeecCCceeecCCC
Q 005718 648 LLDSDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 648 Ll~~~~~~kl~DFGla~~~~~~~ 670 (681)
+++.++.+||+|||+|+.+....
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~ 199 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDS 199 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCT
T ss_pred EEcCCCCEEEccccccccccccc
Confidence 99999999999999999876543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-24 Score=224.22 Aligned_cols=151 Identities=26% Similarity=0.252 Sum_probs=128.3
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 588 (681)
.++|++.++||+|+||+||+|... +++.||||++.... .....++..|+..+.++ +|+||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 357999999999999999999986 68999999987532 23344556666666555 999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+....
T Consensus 136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 67888887432 345899999999999999999999987 99999999999999999999999999988754
Q ss_pred C
Q 005718 669 D 669 (681)
Q Consensus 669 ~ 669 (681)
.
T Consensus 210 ~ 210 (311)
T 3p1a_A 210 A 210 (311)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=228.29 Aligned_cols=152 Identities=26% Similarity=0.355 Sum_probs=130.8
Q ss_pred hhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCC--CCeeEEEEEEEeCCeEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQH--RNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~l 587 (681)
..++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| +||+++++++.+.+..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 34679999999999999999999988999999998753 23445789999999999976 999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||| +.+++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+||||+ ++.+||+|||+|+.+.
T Consensus 87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 567899999843 345889999999999999999999987 99999999999997 6789999999999876
Q ss_pred CCCc
Q 005718 668 GDEL 671 (681)
Q Consensus 668 ~~~~ 671 (681)
.+..
T Consensus 159 ~~~~ 162 (343)
T 3dbq_A 159 PDTT 162 (343)
T ss_dssp ----
T ss_pred cccc
Confidence 5443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.2e-24 Score=225.60 Aligned_cols=150 Identities=23% Similarity=0.281 Sum_probs=132.5
Q ss_pred hCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.+++++ +||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46799999999999999999997 468899999987542 234688999999999 99999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCC-----eEEeecCCcee
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-----PKISDFGMARM 665 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~-----~kl~DFGla~~ 665 (681)
|+ +++|.+++... ...+++.++..++.||++||+|||+.+ |+||||||+||||+.++. +||+|||+|+.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998542 346899999999999999999999987 999999999999998887 99999999998
Q ss_pred ecCCC
Q 005718 666 FCGDE 670 (681)
Q Consensus 666 ~~~~~ 670 (681)
+....
T Consensus 160 ~~~~~ 164 (330)
T 2izr_A 160 YIDPE 164 (330)
T ss_dssp SBCTT
T ss_pred eecCC
Confidence 75543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=8.6e-24 Score=220.96 Aligned_cols=149 Identities=29% Similarity=0.403 Sum_probs=133.3
Q ss_pred CCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCc--ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
++|++.+.||+|+||.||++.... ++.||||++..... ...+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 578999999999999999999854 88999999865432 235678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|+++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+|+.+..
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 9999999988743 345889999999999999999999987 99999999999999999999999999998754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.9e-24 Score=231.13 Aligned_cols=155 Identities=29% Similarity=0.431 Sum_probs=136.1
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC--eEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG--EKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV 588 (681)
.++|.+.+.||+|+||.||+|.... ++.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 3578999999999999999999864 8899999997542 344677889999999999999999999998765 78999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEE----cCCCCeEEeecCCce
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKISDFGMAR 664 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl----~~~~~~kl~DFGla~ 664 (681)
|||+++|+|.+++........+++.++..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999965444445899999999999999999999987 9999999999999 777889999999999
Q ss_pred eecCCC
Q 005718 665 MFCGDE 670 (681)
Q Consensus 665 ~~~~~~ 670 (681)
.+..+.
T Consensus 165 ~~~~~~ 170 (396)
T 4eut_A 165 ELEDDE 170 (396)
T ss_dssp ECCCGG
T ss_pred EccCCC
Confidence 875543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=227.70 Aligned_cols=152 Identities=33% Similarity=0.550 Sum_probs=128.1
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-Cc----EEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~----~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 586 (681)
.++|++.+.||+|+||.||+|.... ++ .||+|.+... .....++|.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 3568999999999999999998743 33 4688888643 3345678999999999999999999999998765 77
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+|+||+.+|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 899999999999998543 345899999999999999999999987 999999999999999999999999999987
Q ss_pred cCCC
Q 005718 667 CGDE 670 (681)
Q Consensus 667 ~~~~ 670 (681)
....
T Consensus 168 ~~~~ 171 (327)
T 3poz_A 168 GAEE 171 (327)
T ss_dssp TTTC
T ss_pred cCCc
Confidence 5544
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=238.15 Aligned_cols=149 Identities=22% Similarity=0.395 Sum_probs=122.5
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC-----Ce
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----GE 584 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~ 584 (681)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+++.+|+.+|.+++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999875 5889999999753 234457899999999999999999999998543 57
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
.++||||++ ++|.+++.. ...+++..+..++.||++||+|||+.+ ||||||||+||||+.++.+||+|||+|+
T Consensus 132 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999985 688888843 345899999999999999999999987 9999999999999999999999999999
Q ss_pred eecC
Q 005718 665 MFCG 668 (681)
Q Consensus 665 ~~~~ 668 (681)
.+..
T Consensus 205 ~~~~ 208 (458)
T 3rp9_A 205 TVDY 208 (458)
T ss_dssp CTTS
T ss_pred hccC
Confidence 8753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=227.85 Aligned_cols=153 Identities=31% Similarity=0.503 Sum_probs=130.7
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-CcE----EEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQE----VAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~----VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 586 (681)
.++|++.+.||+|+||.||+|.... ++. ||+|.+.... ....+.+.+|+.++.+++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 3578899999999999999998743 443 8888876432 334467788999999999999999999886 56788
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+||||+++|+|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999998543 345788999999999999999999987 999999999999999999999999999987
Q ss_pred cCCCc
Q 005718 667 CGDEL 671 (681)
Q Consensus 667 ~~~~~ 671 (681)
..+..
T Consensus 166 ~~~~~ 170 (325)
T 3kex_A 166 PPDDK 170 (325)
T ss_dssp CCCTT
T ss_pred Ccccc
Confidence 65443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9e-24 Score=221.87 Aligned_cols=152 Identities=30% Similarity=0.454 Sum_probs=119.7
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
.++|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 357899999999999999999875 48899999997543 3345778999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 591 YMPNKSLNFFLFDP---SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 591 y~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
|++ ++|.+++... .....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5888887432 12245889999999999999999999987 9999999999999999999999999999874
Q ss_pred C
Q 005718 668 G 668 (681)
Q Consensus 668 ~ 668 (681)
.
T Consensus 160 ~ 160 (317)
T 2pmi_A 160 I 160 (317)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.2e-24 Score=228.71 Aligned_cols=152 Identities=18% Similarity=0.291 Sum_probs=135.4
Q ss_pred hhCCCCceeeeccc--CcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEE
Q 005718 512 ATENFSMQCKLGEG--GFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 512 ~~~~f~~~~~LG~G--~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 586 (681)
..++|++.++||+| +||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34679999999999 99999999986 58999999997542 334567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+||||+++++|.+++.... ...+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||++..+
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999985432 234899999999999999999999987 999999999999999999999999998765
Q ss_pred c
Q 005718 667 C 667 (681)
Q Consensus 667 ~ 667 (681)
.
T Consensus 179 ~ 179 (389)
T 3gni_B 179 I 179 (389)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=9.7e-25 Score=229.36 Aligned_cols=159 Identities=29% Similarity=0.460 Sum_probs=137.1
Q ss_pred HHHHhhCCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEE
Q 005718 508 SVSAATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580 (681)
Q Consensus 508 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~ 580 (681)
+.....++|.+.+.||+|+||.||+|... .++.||||.+.... .....++.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34455678999999999999999999864 26789999997543 234567999999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChhhHhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC
Q 005718 581 EQGEKILIYEYMPNKSLNFFLFDPS-------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 653 (681)
Q Consensus 581 ~~~~~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~ 653 (681)
+.+..++||||+++++|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence 9999999999999999999984321 1245689999999999999999999987 99999999999999999
Q ss_pred CeEEeecCCceeecCC
Q 005718 654 NPKISDFGMARMFCGD 669 (681)
Q Consensus 654 ~~kl~DFGla~~~~~~ 669 (681)
.+||+|||+++.+...
T Consensus 176 ~~kl~Dfg~~~~~~~~ 191 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYET 191 (322)
T ss_dssp CEEECCTTCCCGGGGG
T ss_pred eEEECcCccccccccc
Confidence 9999999999876443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=239.32 Aligned_cols=153 Identities=32% Similarity=0.531 Sum_probs=132.8
Q ss_pred HhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
...++|++.++||+|+||.||+|...++..||||+++... ...++|.+|+.++++++||||+++++++.+ +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 4457789999999999999999999888889999998643 456789999999999999999999999876 67899999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
|+++|+|.+++... ....+++.++..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+..+
T Consensus 259 ~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 259 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 99999999999431 2245889999999999999999999987 999999999999999999999999999987543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.9e-24 Score=226.46 Aligned_cols=149 Identities=26% Similarity=0.405 Sum_probs=122.0
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
..+.|.+.+.||+|+||.||+|.... ++.||||++... ...+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 45779999999999999999999864 788999999764 245678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC---CCCeEEeecCCceeec
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFC 667 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~DFGla~~~~ 667 (681)
|+++++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+|+...
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999843 345899999999999999999999987 999999999999975 8899999999999775
Q ss_pred C
Q 005718 668 G 668 (681)
Q Consensus 668 ~ 668 (681)
.
T Consensus 203 ~ 203 (349)
T 2w4o_A 203 H 203 (349)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=231.49 Aligned_cols=151 Identities=28% Similarity=0.375 Sum_probs=133.7
Q ss_pred hCCCCceeeecccCcEeEEEEEe----cCCcEEEEEEecCCC----cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCC
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL----LNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQG 583 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~----~~~~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 583 (681)
.++|.+.+.||+|+||.||++.. ..++.||||+++... ....+.+.+|+.++.++ +||||+++++++.+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999987 368899999987532 23346678899999999 7999999999999999
Q ss_pred eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCc
Q 005718 584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla 663 (681)
..++||||+++++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999843 335889999999999999999999987 999999999999999999999999999
Q ss_pred eeecCC
Q 005718 664 RMFCGD 669 (681)
Q Consensus 664 ~~~~~~ 669 (681)
+.+..+
T Consensus 207 ~~~~~~ 212 (355)
T 1vzo_A 207 KEFVAD 212 (355)
T ss_dssp EECCGG
T ss_pred eecccC
Confidence 987543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.8e-24 Score=222.16 Aligned_cols=150 Identities=27% Similarity=0.440 Sum_probs=134.1
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-C-------cEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-G-------QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE 584 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~-------~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 584 (681)
.++|.+.+.||+|+||.||+|.... + ..||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4678899999999999999998753 3 4699999987666677889999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCC--------eE
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--------PK 656 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~--------~k 656 (681)
.++||||+++++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999542 334889999999999999999999988 999999999999998887 99
Q ss_pred EeecCCceeec
Q 005718 657 ISDFGMARMFC 667 (681)
Q Consensus 657 l~DFGla~~~~ 667 (681)
|+|||+++...
T Consensus 162 l~Dfg~~~~~~ 172 (289)
T 4fvq_A 162 LSDPGISITVL 172 (289)
T ss_dssp ECCCCSCTTTS
T ss_pred eccCccccccc
Confidence 99999997653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=3.4e-24 Score=224.29 Aligned_cols=164 Identities=27% Similarity=0.447 Sum_probs=138.9
Q ss_pred ccHHHHHHhhCCCCceeeecccCcEeEEEEEe------cCCcEEEEEEecCCC-cccHHHHHHHHHHHhhC-CCCCeeEE
Q 005718 504 FSLASVSAATENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRL 575 (681)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~------~~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l 575 (681)
+.........++|.+.+.||+|+||.||++.. ..++.||||++.... ....+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34455556678999999999999999999985 235789999997643 23456799999999999 79999999
Q ss_pred EEEEEeCC-eEEEEEEecCCCChhhHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecc
Q 005718 576 MGCCVEQG-EKILIYEYMPNKSLNFFLFDPSR-------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRD 641 (681)
Q Consensus 576 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD 641 (681)
++++.+.+ ..++||||+++++|.+++..... ...+++..+..++.||++||.|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99988754 58999999999999999965432 223789999999999999999999987 99999
Q ss_pred cCCCcEEEcCCCCeEEeecCCceeecCCC
Q 005718 642 LKASNILLDSDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 642 lkp~NiLl~~~~~~kl~DFGla~~~~~~~ 670 (681)
|||+||+++.++.+||+|||+|+.+..+.
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 202 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDP 202 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCT
T ss_pred CccceEEECCCCCEEECCCccccccccCc
Confidence 99999999999999999999999775443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.90 E-value=9.7e-24 Score=225.46 Aligned_cols=162 Identities=27% Similarity=0.318 Sum_probs=139.7
Q ss_pred CCcccHHHHHHhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCC-----CCCeeE
Q 005718 501 LPCFSLASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-----HRNLVR 574 (681)
Q Consensus 501 ~~~~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----H~nIv~ 574 (681)
...+++.+.....++|.+.++||+|+||.||++... +++.||||++.. .....+.+..|+.++..++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 344555666667789999999999999999999984 588999999975 3445567888999999996 999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC---
Q 005718 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS--- 651 (681)
Q Consensus 575 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~--- 651 (681)
+++++...+..++||||+ +++|.+++.... ...+++.++..++.||++||+|||+.+ |+||||||+||||+.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 999999999999999999 899999985432 234889999999999999999999987 999999999999975
Q ss_pred ----------------------CCCeEEeecCCceeecC
Q 005718 652 ----------------------DMNPKISDFGMARMFCG 668 (681)
Q Consensus 652 ----------------------~~~~kl~DFGla~~~~~ 668 (681)
++.+||+|||+|+....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~ 214 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence 78999999999987643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.6e-24 Score=227.25 Aligned_cols=157 Identities=24% Similarity=0.332 Sum_probs=133.3
Q ss_pred HHHhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC-----CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC
Q 005718 509 VSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ 582 (681)
Q Consensus 509 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~ 582 (681)
+....++|.+.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3456688999999999999999999984 5788999998643 234567899999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhHhcCCC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPS-------------------------------------RTHLLGWQTRVKIIEGIAQG 625 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~~ 625 (681)
+..++||||+++|+|.+++.... ....+++..+..++.||++|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999884110 01123567788899999999
Q ss_pred HHHHHhCCCCCeeecccCCCcEEEcCCC--CeEEeecCCceeecC
Q 005718 626 LLYLHQYSRLRIIHRDLKASNILLDSDM--NPKISDFGMARMFCG 668 (681)
Q Consensus 626 L~yLH~~~~~~ivHrDlkp~NiLl~~~~--~~kl~DFGla~~~~~ 668 (681)
|+|||+.+ |+||||||+|||++.++ .+||+|||+|+.+..
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~ 222 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK 222 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence 99999987 99999999999998776 899999999997643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=7.6e-24 Score=217.78 Aligned_cols=153 Identities=35% Similarity=0.533 Sum_probs=134.8
Q ss_pred HhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
...++|++.+.||+|+||.||+|...+++.||||.+... ....+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 345679999999999999999999988889999999764 345678999999999999999999999876 456899999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
|+++++|.+++... ....+++.++..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.+...
T Consensus 88 ~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 88 YMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp CCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred cCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 99999999998432 1225889999999999999999999987 999999999999999999999999999987544
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.1e-24 Score=220.11 Aligned_cols=153 Identities=32% Similarity=0.552 Sum_probs=131.9
Q ss_pred hCCCCceeeecccCcEeEEEEEe-----cCCcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC--Ce
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-----LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GE 584 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~ 584 (681)
.+.|++.+.||+|+||.||++.+ ..++.||||++... .....+.+.+|+.++.+++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35588899999999999999984 35789999999754 334567899999999999999999999999876 67
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
.++||||+++++|.+++.. ....+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 8999999999999999843 2335899999999999999999999987 9999999999999999999999999999
Q ss_pred eecCCC
Q 005718 665 MFCGDE 670 (681)
Q Consensus 665 ~~~~~~ 670 (681)
.+....
T Consensus 175 ~~~~~~ 180 (302)
T 4e5w_A 175 AIETDK 180 (302)
T ss_dssp ECCTTC
T ss_pred cccCCC
Confidence 875543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.2e-24 Score=223.44 Aligned_cols=152 Identities=30% Similarity=0.468 Sum_probs=135.1
Q ss_pred hCCCCceeeecccCcEeEEEEEe-----cCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEE--eCCeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-----LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV--EQGEK 585 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~ 585 (681)
.++|++.+.||+|+||.||++.+ ..++.||||++........+.+.+|+.++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36789999999999999999984 357899999998766666778999999999999999999999987 45678
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++||||+++++|.+++... ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999998432 235899999999999999999999987 99999999999999999999999999998
Q ss_pred ecCC
Q 005718 666 FCGD 669 (681)
Q Consensus 666 ~~~~ 669 (681)
+...
T Consensus 177 ~~~~ 180 (327)
T 3lxl_A 177 LPLD 180 (327)
T ss_dssp CCTT
T ss_pred cccC
Confidence 7543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.5e-24 Score=227.44 Aligned_cols=158 Identities=32% Similarity=0.498 Sum_probs=136.2
Q ss_pred HHHhhCCCCceeeecccCcEeEEEEEecC-C-----cEEEEEEecCCC-cccHHHHHHHHHHHhhC-CCCCeeEEEEEEE
Q 005718 509 VSAATENFSMQCKLGEGGFGPVYKGKLLN-G-----QEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCV 580 (681)
Q Consensus 509 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-~-----~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~ 580 (681)
.....++|.+.+.||+|+||.||+|.... + ..||+|.+.... ....+.+.+|+.++.++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34456889999999999999999998743 2 479999997643 33457799999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCChhhHhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEE
Q 005718 581 EQGEKILIYEYMPNKSLNFFLFDPS-----------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL 649 (681)
Q Consensus 581 ~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl 649 (681)
+.+..++||||+++|+|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 9999999999999999999985321 1335789999999999999999999987 9999999999999
Q ss_pred cCCCCeEEeecCCceeecCC
Q 005718 650 DSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 650 ~~~~~~kl~DFGla~~~~~~ 669 (681)
+.++.+||+|||+|+.+..+
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~ 217 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMND 217 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGC
T ss_pred CCCCeEEECccccccccccc
Confidence 99999999999999976544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.2e-24 Score=217.34 Aligned_cols=150 Identities=32% Similarity=0.530 Sum_probs=136.0
Q ss_pred hCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
.++|++.+.||+|+||.||++...+++.||+|++... ....+++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-TBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEcccc-CCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 4678899999999999999999988889999999864 334578999999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
++++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999998542 345789999999999999999999987 99999999999999999999999999987643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.90 E-value=9e-24 Score=216.16 Aligned_cols=152 Identities=35% Similarity=0.539 Sum_probs=125.3
Q ss_pred hCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCC----cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.++|++.+.||+|+||.||++... ++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 467899999999999999999984 7899999987542 23357899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC--------CCCeEEeec
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS--------DMNPKISDF 660 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~--------~~~~kl~DF 660 (681)
|||+++++|.+++. ...+++..+..++.|+++||+|||+.+..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999983 345899999999999999999999987566999999999999986 678999999
Q ss_pred CCceeecCC
Q 005718 661 GMARMFCGD 669 (681)
Q Consensus 661 Gla~~~~~~ 669 (681)
|+|+.+...
T Consensus 161 g~~~~~~~~ 169 (271)
T 3dtc_A 161 GLAREWHRT 169 (271)
T ss_dssp CC-------
T ss_pred Ccccccccc
Confidence 999876543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=2.8e-24 Score=221.99 Aligned_cols=155 Identities=30% Similarity=0.517 Sum_probs=138.7
Q ss_pred HhhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
...++|++.+.||+|+||.||++.... ++.||+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 456789999999999999999999865 788999999763 445678999999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+++++|.+++... ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+|+.+..+
T Consensus 89 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp ECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999999999543 2345899999999999999999999988 999999999999999999999999999987654
Q ss_pred C
Q 005718 670 E 670 (681)
Q Consensus 670 ~ 670 (681)
.
T Consensus 165 ~ 165 (288)
T 3kfa_A 165 T 165 (288)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=223.01 Aligned_cols=151 Identities=24% Similarity=0.330 Sum_probs=135.0
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
...+|.+.+.||+|+||.||++...+ ++.+|+|++... .....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 34679999999999999999999864 788999998653 22345678999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||||+++++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 119 v~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999998843 345889999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 005718 668 G 668 (681)
Q Consensus 668 ~ 668 (681)
.
T Consensus 193 ~ 193 (335)
T 2owb_A 193 Y 193 (335)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=9.8e-24 Score=217.32 Aligned_cols=155 Identities=26% Similarity=0.373 Sum_probs=134.2
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 588 (681)
.++|++.+.||+|+||.||++... +++.||||++... ......++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999986 6899999998753 234467789999999999 999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC---------------
Q 005718 589 YEYMPNKSLNFFLFDPSR-THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD--------------- 652 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~--------------- 652 (681)
|||+++++|.+++..... ...+++.++..++.||++||+|||+.+ |+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999853211 245899999999999999999999987 9999999999999844
Q ss_pred ----CCeEEeecCCceeecCCC
Q 005718 653 ----MNPKISDFGMARMFCGDE 670 (681)
Q Consensus 653 ----~~~kl~DFGla~~~~~~~ 670 (681)
..+||+|||+++......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~ 188 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ 188 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC
T ss_pred cCCceEEEEcccccccccCCcc
Confidence 479999999999876543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.90 E-value=8.2e-24 Score=228.66 Aligned_cols=150 Identities=28% Similarity=0.527 Sum_probs=123.8
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCC-CCCeeEEEEEEEeCC--e
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQG--E 584 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~--~ 584 (681)
...++|++.+.||+|+||.||+|... .++.||||++... .....+.+.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999874 5889999998653 3344567889999999997 999999999998654 7
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
.++||||++ ++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999998 688888832 35889999999999999999999988 9999999999999999999999999999
Q ss_pred eecC
Q 005718 665 MFCG 668 (681)
Q Consensus 665 ~~~~ 668 (681)
.+..
T Consensus 158 ~~~~ 161 (388)
T 3oz6_A 158 SFVN 161 (388)
T ss_dssp ESSS
T ss_pred cccc
Confidence 7643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=217.76 Aligned_cols=150 Identities=24% Similarity=0.329 Sum_probs=134.2
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.++|.+.+.||+|+||.||++.... ++.+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 4678899999999999999999864 788999998653 223456789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||+++++|.+++.. ...+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999998832 345889999999999999999999987 99999999999999999999999999998753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=220.33 Aligned_cols=151 Identities=27% Similarity=0.392 Sum_probs=135.0
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc------ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 585 (681)
.++|.+.+.||+|+||.||++... +++.||||.+..... ...+++.+|+.++.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467899999999999999999985 588999999875422 2367899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC----CeEEeecC
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFG 661 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~DFG 661 (681)
++||||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999943 345889999999999999999999987 99999999999999888 79999999
Q ss_pred CceeecCC
Q 005718 662 MARMFCGD 669 (681)
Q Consensus 662 la~~~~~~ 669 (681)
+++.+...
T Consensus 165 ~~~~~~~~ 172 (321)
T 2a2a_A 165 LAHEIEDG 172 (321)
T ss_dssp TCEECCTT
T ss_pred cceecCcc
Confidence 99987543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.90 E-value=5.7e-24 Score=245.45 Aligned_cols=162 Identities=28% Similarity=0.372 Sum_probs=138.1
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCC---CcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 586 (681)
..++|.+.+.||+|+||.||++.... ++.||||++++. .....+.+..|..++..+ +|++|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 45689999999999999999999854 788999999753 233456788899999988 7999999999999999999
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|||||+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|+..
T Consensus 419 lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999943 245899999999999999999999987 999999999999999999999999999975
Q ss_pred cCCCccCCCcceecC
Q 005718 667 CGDELQGNTKRVVGT 681 (681)
Q Consensus 667 ~~~~~~~~~~~~~GT 681 (681)
..+... +..+.||
T Consensus 493 ~~~~~~--~~~~~GT 505 (674)
T 3pfq_A 493 IWDGVT--TKTFCGT 505 (674)
T ss_dssp CCTTCC--BCCCCSC
T ss_pred ccCCcc--cccccCC
Confidence 443322 2334554
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-23 Score=216.10 Aligned_cols=152 Identities=31% Similarity=0.475 Sum_probs=132.7
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
+.|.....||+|+||.||+|... +++.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555569999999999999974 57899999998765566788999999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC-CCCeEEeecCCceeecC
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCG 668 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~-~~~~kl~DFGla~~~~~ 668 (681)
++++|.+++........+++..+..++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||+++.+..
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 99999999965444445678899999999999999999987 999999999999987 89999999999988754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.5e-24 Score=229.60 Aligned_cols=151 Identities=26% Similarity=0.355 Sum_probs=129.6
Q ss_pred hCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCC--CcccHHHHHHHHHHHhhCC--CCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQ--HRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV 588 (681)
...|.+.+.||+|+||.||++....++.||||++... .....+.+.+|+.++.+++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3569999999999999999999888999999998653 2345678999999999995 59999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|| +.+++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+||||+ ++.+||+|||+|+.+..
T Consensus 135 ~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 568899999853 235788999999999999999999987 99999999999995 58899999999998765
Q ss_pred CCc
Q 005718 669 DEL 671 (681)
Q Consensus 669 ~~~ 671 (681)
+..
T Consensus 207 ~~~ 209 (390)
T 2zmd_A 207 DTT 209 (390)
T ss_dssp ---
T ss_pred CCc
Confidence 443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=5.6e-24 Score=220.22 Aligned_cols=149 Identities=35% Similarity=0.542 Sum_probs=123.8
Q ss_pred hhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
..++|++.++||+|+||.||++.... .||||+++... ....+.|.+|+.++++++||||+++++++ .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 45789999999999999999998743 59999987542 34457899999999999999999999965 556789999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||+++++|.+++.. ....+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 99 QWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp ECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999999843 3345899999999999999999999987 99999999999999999999999999987654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=216.04 Aligned_cols=151 Identities=30% Similarity=0.500 Sum_probs=134.5
Q ss_pred hCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.++|.+.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 45799999999999999999997 468899999996431 22347889999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||+++++|.+++... ...+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999998542 345899999999999999999999987 99999999999999999999999999988753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.3e-24 Score=218.98 Aligned_cols=154 Identities=24% Similarity=0.416 Sum_probs=133.0
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
.++|.+.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 367899999999999999999985 58899999987643 3456889999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEE---cCCCCeEEeecCCceee
Q 005718 591 YMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMF 666 (681)
Q Consensus 591 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~DFGla~~~ 666 (681)
|+++++|.+++... .....+++..+..++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+.+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999888432 12356899999999999999999999987 9999999999999 45678999999999887
Q ss_pred cCC
Q 005718 667 CGD 669 (681)
Q Consensus 667 ~~~ 669 (681)
...
T Consensus 178 ~~~ 180 (285)
T 3is5_A 178 KSD 180 (285)
T ss_dssp ---
T ss_pred CCc
Confidence 543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-23 Score=219.58 Aligned_cols=148 Identities=28% Similarity=0.367 Sum_probs=130.3
Q ss_pred CCCCce-eeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEEE
Q 005718 514 ENFSMQ-CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 514 ~~f~~~-~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
+.|.+. +.||+|+||.||++... +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567774 68999999999999874 5889999999876556678899999999985 79999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCC---eEEeecCCceeec
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMFC 667 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~---~kl~DFGla~~~~ 667 (681)
|+++++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++. +||+|||+++.+.
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999843 345889999999999999999999987 999999999999998776 9999999998764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=2.5e-24 Score=242.37 Aligned_cols=153 Identities=32% Similarity=0.526 Sum_probs=135.6
Q ss_pred HHhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 510 SAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
+...++|++.++||+|+||.||+|.+.++..||||+++... ...++|.+|+.+|++++|+||+++++++.+ +..+|||
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 34457788999999999999999999888889999998643 456789999999999999999999999866 6789999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||+++|+|.++|... ....+++.+++.|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+..
T Consensus 341 e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 999999999999431 2245889999999999999999999987 99999999999999999999999999997754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.4e-24 Score=225.14 Aligned_cols=150 Identities=32% Similarity=0.476 Sum_probs=131.5
Q ss_pred hCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCc---ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.+.|...+.||+|+||.||+|.. .+++.||||++..... ...+++.+|+.++++++||||+++++++.+.+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45688899999999999999997 4688999999975322 2346789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||+. |+|.+++.. ....+++.++..++.|+++||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 677777632 2345899999999999999999999987 99999999999999999999999999987754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.8e-23 Score=215.31 Aligned_cols=152 Identities=28% Similarity=0.434 Sum_probs=136.3
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
..+.|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 3467899999999999999999874 58899999997543 345688999999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+++++|.+++. ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 100 e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 100 EYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp ECCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EeCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999999983 245899999999999999999999987 999999999999999999999999999887554
Q ss_pred C
Q 005718 670 E 670 (681)
Q Consensus 670 ~ 670 (681)
.
T Consensus 173 ~ 173 (303)
T 3a7i_A 173 Q 173 (303)
T ss_dssp B
T ss_pred c
Confidence 3
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.3e-24 Score=225.52 Aligned_cols=153 Identities=25% Similarity=0.373 Sum_probs=134.3
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc--------ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ 582 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~ 582 (681)
..++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4568999999999999999999874 588999999976421 1334678899999999999999999999999
Q ss_pred CeEEEEEEecCCC-ChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecC
Q 005718 583 GEKILIYEYMPNK-SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661 (681)
Q Consensus 583 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG 661 (681)
+..++||||+..| +|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 99998843 335899999999999999999999987 9999999999999999999999999
Q ss_pred CceeecCCC
Q 005718 662 MARMFCGDE 670 (681)
Q Consensus 662 la~~~~~~~ 670 (681)
+|+.+....
T Consensus 176 ~a~~~~~~~ 184 (335)
T 3dls_A 176 SAAYLERGK 184 (335)
T ss_dssp TCEECCTTC
T ss_pred cceECCCCC
Confidence 999875543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.6e-23 Score=214.23 Aligned_cols=151 Identities=27% Similarity=0.442 Sum_probs=133.6
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
.++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999985 4889999998653 2334577899999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCC---eEEeecCCceee
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGMARMF 666 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~---~kl~DFGla~~~ 666 (681)
||+++++|.+.+.. ...+++.++..++.|+++||+|||+.+ |+||||||+||+++.++. +||+|||+++..
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999888843 345899999999999999999999987 999999999999987655 999999999877
Q ss_pred cCC
Q 005718 667 CGD 669 (681)
Q Consensus 667 ~~~ 669 (681)
...
T Consensus 159 ~~~ 161 (284)
T 3kk8_A 159 NDS 161 (284)
T ss_dssp CSS
T ss_pred ccC
Confidence 543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=222.00 Aligned_cols=141 Identities=26% Similarity=0.332 Sum_probs=124.8
Q ss_pred eeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCC-CCCeeEEEEEEEeCCeEEEEEEecCCCCh
Q 005718 520 CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYEYMPNKSL 597 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 597 (681)
+.||+|+||.||++... +++.||||++... ....+.+|+.++.++. ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 78999999999999985 4889999999653 4567889999999996 99999999999999999999999999999
Q ss_pred hhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC---CeEEeecCCceeecCC
Q 005718 598 NFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARMFCGD 669 (681)
Q Consensus 598 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~---~~kl~DFGla~~~~~~ 669 (681)
.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++ .+||+|||+|+....+
T Consensus 94 ~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 94 FERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp HHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 999843 345899999999999999999999987 99999999999998765 8999999999976543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.7e-24 Score=219.79 Aligned_cols=152 Identities=25% Similarity=0.401 Sum_probs=124.2
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC----CcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 586 (681)
..++|++.+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence 34679999999999999999998743 4569999987643 33456799999999999999999999997 456789
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+||||+++++|.+++... ...+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999998532 335889999999999999999999987 999999999999999999999999999987
Q ss_pred cCC
Q 005718 667 CGD 669 (681)
Q Consensus 667 ~~~ 669 (681)
...
T Consensus 167 ~~~ 169 (281)
T 1mp8_A 167 EDS 169 (281)
T ss_dssp ---
T ss_pred Ccc
Confidence 543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=229.72 Aligned_cols=151 Identities=25% Similarity=0.346 Sum_probs=128.1
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--------cccHHHHHHHHHHHhhCCCCCeeEEEEEEEe
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 581 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 581 (681)
...++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34678999999999999999999875 47899999987531 112235889999999999999999999874
Q ss_pred CCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC---CeEEe
Q 005718 582 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---NPKIS 658 (681)
Q Consensus 582 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~---~~kl~ 658 (681)
.+..++||||+++|+|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+||||+.++ .+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 5668999999999999988843 345899999999999999999999987 99999999999997544 59999
Q ss_pred ecCCceeecC
Q 005718 659 DFGMARMFCG 668 (681)
Q Consensus 659 DFGla~~~~~ 668 (681)
|||+|+.+..
T Consensus 285 DFG~a~~~~~ 294 (419)
T 3i6u_A 285 DFGHSKILGE 294 (419)
T ss_dssp CSSTTTSCC-
T ss_pred ecccceecCC
Confidence 9999998754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-23 Score=221.59 Aligned_cols=154 Identities=28% Similarity=0.412 Sum_probs=128.4
Q ss_pred HHHhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhC--CCCCeeEEEEEEEeC----
Q 005718 509 VSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL--QHRNLVRLMGCCVEQ---- 582 (681)
Q Consensus 509 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l--~H~nIv~l~g~~~~~---- 582 (681)
.....++|++.+.||+|+||.||+|... ++.||||++... ....+..|.+++..+ +||||+++++++.+.
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3445678999999999999999999985 889999998643 234455566655554 999999999999988
Q ss_pred CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeecccCCCcEEEcCCCCeEE
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS-----RLRIIHRDLKASNILLDSDMNPKI 657 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivHrDlkp~NiLl~~~~~~kl 657 (681)
...++||||+++|+|.+++.. ..+++.++..++.|+++||+|||+.. +.+|+||||||+|||++.++.+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 789999999999999999933 35899999999999999999999871 123999999999999999999999
Q ss_pred eecCCceeecCCC
Q 005718 658 SDFGMARMFCGDE 670 (681)
Q Consensus 658 ~DFGla~~~~~~~ 670 (681)
+|||+|+.+....
T Consensus 184 ~Dfg~a~~~~~~~ 196 (337)
T 3mdy_A 184 ADLGLAVKFISDT 196 (337)
T ss_dssp CCCTTCEECC---
T ss_pred EeCCCceeecccc
Confidence 9999998775443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4e-23 Score=216.94 Aligned_cols=147 Identities=35% Similarity=0.555 Sum_probs=130.7
Q ss_pred CCceeeecccCcEeEEEEEec-----CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC--CeEEE
Q 005718 516 FSMQCKLGEGGFGPVYKGKLL-----NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKIL 587 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~-----~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l 587 (681)
|++.+.||+|+||.||++.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999998652 57889999998643 34467799999999999999999999999984 67899
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||||+++++|.+++.. ..+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999943 24899999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 005718 668 GD 669 (681)
Q Consensus 668 ~~ 669 (681)
..
T Consensus 186 ~~ 187 (318)
T 3lxp_A 186 EG 187 (318)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.9e-24 Score=221.53 Aligned_cols=159 Identities=31% Similarity=0.539 Sum_probs=127.7
Q ss_pred HHHHhhCCCCceeeecccCcEeEEEEEecC----CcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe
Q 005718 508 SVSAATENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE 581 (681)
Q Consensus 508 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 581 (681)
.+....++|.+.+.||+|+||.||+|.... ++.||||++... .....+.+.+|+.++++++||||+++++++.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 334456789999999999999999998642 457999998754 23345779999999999999999999999987
Q ss_pred CC-----eEEEEEEecCCCChhhHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC
Q 005718 582 QG-----EKILIYEYMPNKSLNFFLFDP---SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 653 (681)
Q Consensus 582 ~~-----~~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~ 653 (681)
.+ ..++||||+++++|.+++... .....+++.+++.++.||++||.|||+.+ |+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCC
Confidence 65 349999999999999998432 23456899999999999999999999987 99999999999999999
Q ss_pred CeEEeecCCceeecCC
Q 005718 654 NPKISDFGMARMFCGD 669 (681)
Q Consensus 654 ~~kl~DFGla~~~~~~ 669 (681)
.+||+|||+++.+...
T Consensus 185 ~~kl~Dfg~~~~~~~~ 200 (313)
T 3brb_A 185 TVCVADFGLSKKIYSG 200 (313)
T ss_dssp CEEECSCSCC------
T ss_pred cEEEeecCcceecccc
Confidence 9999999999877543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=3.9e-23 Score=213.55 Aligned_cols=151 Identities=28% Similarity=0.507 Sum_probs=132.0
Q ss_pred hCCCCcee-eecccCcEeEEEEEec---CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 513 TENFSMQC-KLGEGGFGPVYKGKLL---NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 513 ~~~f~~~~-~LG~G~fG~Vy~~~~~---~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
.++|.+.+ .||+|+||.||+|... .++.||||+++... ....+++.+|+.++.+++||||+++++++ +.+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35566666 9999999999999863 47789999998643 34567899999999999999999999999 5677999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||||+++++|.+++.. ....+++.++..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999853 3345899999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 005718 668 GD 669 (681)
Q Consensus 668 ~~ 669 (681)
.+
T Consensus 162 ~~ 163 (287)
T 1u59_A 162 AD 163 (287)
T ss_dssp TC
T ss_pred cC
Confidence 43
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=216.28 Aligned_cols=150 Identities=30% Similarity=0.408 Sum_probs=132.0
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.++|++.+.||+|+||.||++.... ++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4679999999999999999998754 6789999986531 22356789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999998843 245889999999999999999999887 99999999999999999999999999976543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-23 Score=220.54 Aligned_cols=152 Identities=32% Similarity=0.569 Sum_probs=134.1
Q ss_pred hCCCCceeeecccCcEeEEEEEe-----cCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC--eE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-----LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG--EK 585 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~ 585 (681)
.++|++.+.||+|+||.||++.. .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45688999999999999999984 357899999998766666788999999999999999999999987654 67
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++||||+++++|.+++... ...+++.++..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+|+.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999999542 335889999999999999999999987 99999999999999999999999999998
Q ss_pred ecCC
Q 005718 666 FCGD 669 (681)
Q Consensus 666 ~~~~ 669 (681)
+..+
T Consensus 195 ~~~~ 198 (326)
T 2w1i_A 195 LPQD 198 (326)
T ss_dssp CCSS
T ss_pred cccc
Confidence 7544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=224.89 Aligned_cols=152 Identities=22% Similarity=0.371 Sum_probs=126.8
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC------CcEEEEEEecCCCccc-----------HHHHHHHHHHHhhCCCCCeeE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQG-----------LKEFKNEMMLIAKLQHRNLVR 574 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~------~~~VAVK~l~~~~~~~-----------~~~f~~Ei~~l~~l~H~nIv~ 574 (681)
..++|++.+.||+|+||.||+|.+.. ++.||||++....... ...+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998854 3689999987643211 123445666777889999999
Q ss_pred EEEEEEeC----CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc
Q 005718 575 LMGCCVEQ----GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD 650 (681)
Q Consensus 575 l~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~ 650 (681)
+++++.+. ...+|||||+ +++|.+++.. ....+++.+++.|+.||++||+|||+.+ |+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999875 4589999999 9999999854 2346899999999999999999999987 99999999999999
Q ss_pred --CCCCeEEeecCCceeecCC
Q 005718 651 --SDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 651 --~~~~~kl~DFGla~~~~~~ 669 (681)
.++.+||+|||+|+.+...
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~ 207 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPE 207 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGG
T ss_pred cCCCCeEEEEECCcceecccC
Confidence 8899999999999987544
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-23 Score=220.24 Aligned_cols=150 Identities=30% Similarity=0.464 Sum_probs=130.1
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
.++|++.+.||+|+||.||++.... ++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 3579999999999999999999854 8899999986542 223456889999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999888633 335899999999999999999999987 99999999999999999999999999987644
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-23 Score=217.84 Aligned_cols=151 Identities=23% Similarity=0.283 Sum_probs=130.2
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc---ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.++|.+.+.||+|+||.||++... +++.||||++..... ...+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999985 588999999975422 2347789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||+++++|.+++.. ...+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999843 345889999999999999999999987 99999999999999999999999999987754
Q ss_pred C
Q 005718 669 D 669 (681)
Q Consensus 669 ~ 669 (681)
.
T Consensus 187 ~ 187 (309)
T 2h34_A 187 E 187 (309)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.90 E-value=3.4e-23 Score=213.26 Aligned_cols=150 Identities=28% Similarity=0.434 Sum_probs=133.4
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC------cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 585 (681)
.++|.+.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356889999999999999999986 58899999987532 12467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC----CeEEeecC
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFG 661 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~DFG 661 (681)
++||||+++++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999843 345899999999999999999999987 99999999999998877 89999999
Q ss_pred CceeecC
Q 005718 662 MARMFCG 668 (681)
Q Consensus 662 la~~~~~ 668 (681)
+++.+..
T Consensus 158 ~~~~~~~ 164 (283)
T 3bhy_A 158 IAHKIEA 164 (283)
T ss_dssp TCEECC-
T ss_pred cceeccC
Confidence 9987744
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=219.19 Aligned_cols=153 Identities=27% Similarity=0.411 Sum_probs=133.3
Q ss_pred hhCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe----CCeEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEKI 586 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~ 586 (681)
..++|++.+.||+|+||.||++.. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 457899999999999999999997 4689999999876666667889999999999999999999999873 34789
Q ss_pred EEEEecCCCChhhHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 587 LIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
+||||+++++|.+++... .....+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999988532 12456899999999999999999999987 99999999999999999999999999886
Q ss_pred ec
Q 005718 666 FC 667 (681)
Q Consensus 666 ~~ 667 (681)
..
T Consensus 184 ~~ 185 (317)
T 2buj_A 184 AC 185 (317)
T ss_dssp SC
T ss_pred cc
Confidence 53
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=223.32 Aligned_cols=158 Identities=27% Similarity=0.366 Sum_probs=132.8
Q ss_pred cHHHHHHhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCc-----------ccHHHHHHHHHHHhhCCCCCee
Q 005718 505 SLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG-----------QGLKEFKNEMMLIAKLQHRNLV 573 (681)
Q Consensus 505 ~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~-----------~~~~~f~~Ei~~l~~l~H~nIv 573 (681)
...++....++|.+.+.||+|+||.||+|...+++.||||++..... ...+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 45677788899999999999999999999988899999999865321 1137899999999999999999
Q ss_pred EEEEEEEeC-----CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEE
Q 005718 574 RLMGCCVEQ-----GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 648 (681)
Q Consensus 574 ~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiL 648 (681)
++++++... ...++||||++ |+|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999998653 36899999998 577777753 3345899999999999999999999987 999999999999
Q ss_pred EcCCCCeEEeecCCceeecC
Q 005718 649 LDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 649 l~~~~~~kl~DFGla~~~~~ 668 (681)
++.++.+||+|||+|+....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~ 186 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTA 186 (362)
T ss_dssp ECTTCCEEECCTTC------
T ss_pred EcCCCCEEEEecCccccccc
Confidence 99999999999999986544
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=222.81 Aligned_cols=152 Identities=30% Similarity=0.454 Sum_probs=126.1
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcc-----cHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCe
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE 584 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 584 (681)
...++|.+.+.||+|+||.||++... +++.||||++...... ..+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999985 4889999999753221 12468899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
.++||||+++ +|..++.. ....+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 78888743 2345788899999999999999999988 9999999999999999999999999999
Q ss_pred eecC
Q 005718 665 MFCG 668 (681)
Q Consensus 665 ~~~~ 668 (681)
.+..
T Consensus 161 ~~~~ 164 (346)
T 1ua2_A 161 SFGS 164 (346)
T ss_dssp TTTS
T ss_pred eccC
Confidence 7743
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.5e-23 Score=230.70 Aligned_cols=152 Identities=30% Similarity=0.455 Sum_probs=132.1
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc-------------ccHHHHHHHHHHHhhCCCCCeeEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-------------QGLKEFKNEMMLIAKLQHRNLVRLMG 577 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~-------------~~~~~f~~Ei~~l~~l~H~nIv~l~g 577 (681)
..++|.+.++||+|+||.||++... .++.||||++..... ...+++.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999985 478999999875321 33567999999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC---C
Q 005718 578 CCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM---N 654 (681)
Q Consensus 578 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~---~ 654 (681)
++.+....++||||+++|+|.+.+.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999988843 345899999999999999999999987 99999999999998775 6
Q ss_pred eEEeecCCceeecCC
Q 005718 655 PKISDFGMARMFCGD 669 (681)
Q Consensus 655 ~kl~DFGla~~~~~~ 669 (681)
+||+|||+|+.+..+
T Consensus 188 ~kl~Dfg~a~~~~~~ 202 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD 202 (504)
T ss_dssp EEECCCTTCEECCTT
T ss_pred EEEEECCCCEEcCCC
Confidence 999999999987554
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-23 Score=238.54 Aligned_cols=150 Identities=28% Similarity=0.499 Sum_probs=129.8
Q ss_pred CCCCcee-eecccCcEeEEEEEec---CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 514 ENFSMQC-KLGEGGFGPVYKGKLL---NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 514 ~~f~~~~-~LG~G~fG~Vy~~~~~---~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
+++.+.+ .||+|+||.||+|.+. ++..||||+++... ....++|.+|+.++++++||||+++++++.+ +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 4444445 7999999999999874 35679999998643 3457889999999999999999999999876 668999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||+++|+|.+++.. ....+++.++..|+.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 414 ~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999954 3445899999999999999999999987 99999999999999999999999999998754
Q ss_pred C
Q 005718 669 D 669 (681)
Q Consensus 669 ~ 669 (681)
+
T Consensus 489 ~ 489 (613)
T 2ozo_A 489 D 489 (613)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=219.52 Aligned_cols=151 Identities=30% Similarity=0.452 Sum_probs=126.6
Q ss_pred hCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
.++|++.+.||+|+||.||++... ++.||||++... ...+.|.+|+.++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 356888999999999999999984 688999999753 45678999999999999999999999876 4478999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCC-eEEeecCCceeecC
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-PKISDFGMARMFCG 668 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~-~kl~DFGla~~~~~ 668 (681)
++++|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+|+.+..
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999966544445788999999999999999999954345999999999999998886 79999999987643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=217.80 Aligned_cols=150 Identities=27% Similarity=0.494 Sum_probs=132.3
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
..++|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4578999999999999999999986 488999999987666677899999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|+++++|.+++... ...+++..+..++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 99999999988432 345889999999999999999999987 999999999999999999999999998643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-23 Score=221.14 Aligned_cols=153 Identities=34% Similarity=0.548 Sum_probs=129.4
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC-----CcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN-----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 585 (681)
...+|.+.+.||+|+||.||+|.... +..||||.+.... ......+.+|+.++.+++||||+++++++.+.+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 34678888999999999999998743 2359999997643 33456799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++||||+++++|.+++.. ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999853 2345899999999999999999999987 99999999999999999999999999998
Q ss_pred ecCC
Q 005718 666 FCGD 669 (681)
Q Consensus 666 ~~~~ 669 (681)
+...
T Consensus 197 ~~~~ 200 (333)
T 1mqb_A 197 LEDD 200 (333)
T ss_dssp ----
T ss_pred hccc
Confidence 7543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-23 Score=220.28 Aligned_cols=151 Identities=32% Similarity=0.545 Sum_probs=126.2
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-Cc----EEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~----~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 586 (681)
.++|++.+.||+|+||.||+|.... ++ .||+|.+... .....+++.+|+.++.+++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 4679999999999999999998743 44 3678877643 3456788999999999999999999999998765 78
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+|+||+.+|+|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 899999999999998543 345889999999999999999999987 999999999999999999999999999987
Q ss_pred cCC
Q 005718 667 CGD 669 (681)
Q Consensus 667 ~~~ 669 (681)
...
T Consensus 168 ~~~ 170 (327)
T 3lzb_A 168 GAE 170 (327)
T ss_dssp ---
T ss_pred cCc
Confidence 543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.4e-23 Score=221.04 Aligned_cols=155 Identities=23% Similarity=0.364 Sum_probs=136.5
Q ss_pred HHHhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc--------ccHHHHHHHHHHHhhC-CCCCeeEEEEE
Q 005718 509 VSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--------QGLKEFKNEMMLIAKL-QHRNLVRLMGC 578 (681)
Q Consensus 509 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--------~~~~~f~~Ei~~l~~l-~H~nIv~l~g~ 578 (681)
.....++|.+.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445578999999999999999999985 689999999875431 1145688999999999 89999999999
Q ss_pred EEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEe
Q 005718 579 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 658 (681)
Q Consensus 579 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~ 658 (681)
+......++||||+++++|.+++.+ ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999843 345899999999999999999999987 9999999999999999999999
Q ss_pred ecCCceeecCC
Q 005718 659 DFGMARMFCGD 669 (681)
Q Consensus 659 DFGla~~~~~~ 669 (681)
|||+++.+...
T Consensus 243 DfG~~~~~~~~ 253 (365)
T 2y7j_A 243 DFGFSCHLEPG 253 (365)
T ss_dssp CCTTCEECCTT
T ss_pred ecCcccccCCC
Confidence 99999987543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3e-23 Score=231.49 Aligned_cols=151 Identities=27% Similarity=0.396 Sum_probs=129.5
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
.+.|++.+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999985 57899999997542 334678999999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC---CCeEEeecCCceee
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFGMARMF 666 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~---~~~kl~DFGla~~~ 666 (681)
||+++|+|.+.+.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.. +.+||+|||+|+.+
T Consensus 116 e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999888843 345889999999999999999999987 9999999999999764 45999999999987
Q ss_pred cCC
Q 005718 667 CGD 669 (681)
Q Consensus 667 ~~~ 669 (681)
...
T Consensus 190 ~~~ 192 (494)
T 3lij_A 190 ENQ 192 (494)
T ss_dssp BTT
T ss_pred CCC
Confidence 544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.1e-23 Score=213.48 Aligned_cols=150 Identities=21% Similarity=0.320 Sum_probs=132.3
Q ss_pred hCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999997 468899999986532 335678899999999 89999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCC-----eEEeecCCcee
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-----PKISDFGMARM 665 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~-----~kl~DFGla~~ 665 (681)
|+ +++|.+++... ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++. +||+|||+|+.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999999532 335899999999999999999999887 999999999999987776 99999999998
Q ss_pred ecCCC
Q 005718 666 FCGDE 670 (681)
Q Consensus 666 ~~~~~ 670 (681)
+....
T Consensus 161 ~~~~~ 165 (298)
T 1csn_A 161 YRDPV 165 (298)
T ss_dssp SBCTT
T ss_pred ccccc
Confidence 76543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.8e-23 Score=213.19 Aligned_cols=152 Identities=28% Similarity=0.354 Sum_probs=134.5
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---------cccHHHHHHHHHHHhhCC-CCCeeEEEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---------GQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCV 580 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---------~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~ 580 (681)
..++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++.++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3478999999999999999999985 57899999997532 122456889999999995 999999999999
Q ss_pred eCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeec
Q 005718 581 EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 660 (681)
Q Consensus 581 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF 660 (681)
+.+..++||||+++++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999843 345889999999999999999999987 999999999999999999999999
Q ss_pred CCceeecCC
Q 005718 661 GMARMFCGD 669 (681)
Q Consensus 661 Gla~~~~~~ 669 (681)
|+++.+...
T Consensus 169 g~~~~~~~~ 177 (298)
T 1phk_A 169 GFSCQLDPG 177 (298)
T ss_dssp TTCEECCTT
T ss_pred cchhhcCCC
Confidence 999987543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.7e-23 Score=218.80 Aligned_cols=149 Identities=29% Similarity=0.536 Sum_probs=128.7
Q ss_pred hCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEe--------
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE-------- 581 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-------- 581 (681)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36799999999999999999998 468899999986542 2335678899999999999999999999987
Q ss_pred CCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecC
Q 005718 582 QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661 (681)
Q Consensus 582 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG 661 (681)
.+..++||||+++ +|...+... ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 4568999999985 666666432 234899999999999999999999987 9999999999999999999999999
Q ss_pred Cceeec
Q 005718 662 MARMFC 667 (681)
Q Consensus 662 la~~~~ 667 (681)
+|+.+.
T Consensus 170 ~a~~~~ 175 (351)
T 3mi9_A 170 LARAFS 175 (351)
T ss_dssp TCEECC
T ss_pred hccccc
Confidence 999875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.3e-23 Score=214.27 Aligned_cols=152 Identities=32% Similarity=0.522 Sum_probs=126.7
Q ss_pred hhCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCC-----cccHHHHHHHHHHHhhC---CCCCeeEEEEEEEeC
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAKL---QHRNLVRLMGCCVEQ 582 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-----~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~ 582 (681)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999997 458899999986422 12234667777777766 499999999999876
Q ss_pred C-----eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEE
Q 005718 583 G-----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKI 657 (681)
Q Consensus 583 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl 657 (681)
. ..++||||++ ++|.+++.... ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 5899999997 59999885533 234899999999999999999999988 999999999999999999999
Q ss_pred eecCCceeecC
Q 005718 658 SDFGMARMFCG 668 (681)
Q Consensus 658 ~DFGla~~~~~ 668 (681)
+|||+|+.+..
T Consensus 162 ~Dfg~a~~~~~ 172 (308)
T 3g33_A 162 ADFGLARIYSY 172 (308)
T ss_dssp CSCSCTTTSTT
T ss_pred eeCccccccCC
Confidence 99999987754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-23 Score=230.81 Aligned_cols=147 Identities=29% Similarity=0.383 Sum_probs=124.5
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC------C
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------G 583 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~ 583 (681)
.++|++.+.||+|+||.||++... .++.||||++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999875 4889999999754 334467889999999999999999999999754 4
Q ss_pred eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCc
Q 005718 584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla 663 (681)
..++||||++++ |.+.+.. .+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 679999999865 5555521 3789999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 005718 664 RMFCG 668 (681)
Q Consensus 664 ~~~~~ 668 (681)
+....
T Consensus 212 ~~~~~ 216 (464)
T 3ttj_A 212 RTAGT 216 (464)
T ss_dssp -----
T ss_pred eecCC
Confidence 98754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-23 Score=219.59 Aligned_cols=160 Identities=28% Similarity=0.479 Sum_probs=136.0
Q ss_pred ccHHHHHHhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEe
Q 005718 504 FSLASVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE 581 (681)
Q Consensus 504 ~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 581 (681)
+.+.++....++|++.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++.++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 344445566789999999999999999999984 5889999998753 34567889999999999 89999999999987
Q ss_pred ------CCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCe
Q 005718 582 ------QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP 655 (681)
Q Consensus 582 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~ 655 (681)
.+..++||||+++++|.+++... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 46889999999999999998543 2346889999999999999999999987 9999999999999999999
Q ss_pred EEeecCCceeecC
Q 005718 656 KISDFGMARMFCG 668 (681)
Q Consensus 656 kl~DFGla~~~~~ 668 (681)
||+|||+++.+..
T Consensus 169 kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 169 KLVDFGVSAQLDR 181 (326)
T ss_dssp EECCCTTTC----
T ss_pred EEeeCcCceecCc
Confidence 9999999987643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3e-23 Score=212.90 Aligned_cols=151 Identities=27% Similarity=0.457 Sum_probs=134.7
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467999999999999999999986 68899999986532 23456889999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999843 235789999999999999999999988 99999999999999999999999999987754
Q ss_pred C
Q 005718 669 D 669 (681)
Q Consensus 669 ~ 669 (681)
.
T Consensus 164 ~ 164 (276)
T 2h6d_A 164 G 164 (276)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.2e-23 Score=219.17 Aligned_cols=148 Identities=22% Similarity=0.358 Sum_probs=128.0
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
..++|++.+.||+|+||.||++... +++.||||++.+... .+.+|++++.++ +||||+++++++.+++..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3467999999999999999999985 488999999976432 234678888887 7999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC----CCeEEeecCCcee
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD----MNPKISDFGMARM 665 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~----~~~kl~DFGla~~ 665 (681)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||+|+.
T Consensus 96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999999854 345899999999999999999999987 9999999999998543 3599999999998
Q ss_pred ecCC
Q 005718 666 FCGD 669 (681)
Q Consensus 666 ~~~~ 669 (681)
+...
T Consensus 170 ~~~~ 173 (342)
T 2qr7_A 170 LRAE 173 (342)
T ss_dssp CBCT
T ss_pred CcCC
Confidence 7544
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=221.55 Aligned_cols=150 Identities=29% Similarity=0.452 Sum_probs=127.0
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc--ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
...++|++.++||+|+||.||++... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34568999999999999999999874 588999999975432 234568899999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc-----CCCCeEEeecCC
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-----SDMNPKISDFGM 662 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~-----~~~~~kl~DFGl 662 (681)
||||++ ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||||+ .++.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999998 589888843 334889999999999999999999987 99999999999994 455699999999
Q ss_pred ceeec
Q 005718 663 ARMFC 667 (681)
Q Consensus 663 a~~~~ 667 (681)
|+.+.
T Consensus 184 a~~~~ 188 (329)
T 3gbz_A 184 ARAFG 188 (329)
T ss_dssp HHHHC
T ss_pred ccccC
Confidence 98764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-23 Score=221.51 Aligned_cols=152 Identities=28% Similarity=0.439 Sum_probs=134.8
Q ss_pred hCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcc---c--------------HHHHHHHHHHHhhCCCCCeeEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQ---G--------------LKEFKNEMMLIAKLQHRNLVRL 575 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~---~--------------~~~f~~Ei~~l~~l~H~nIv~l 575 (681)
.++|.+.+.||+|+||.||++.. +++.||||++...... . .+.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 8999999998753211 1 1889999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCChhhH------hcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecccCCCcEE
Q 005718 576 MGCCVEQGEKILIYEYMPNKSLNFF------LFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNIL 648 (681)
Q Consensus 576 ~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NiL 648 (681)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.||++||.|||+ .+ |+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 422 224568999999999999999999998 76 999999999999
Q ss_pred EcCCCCeEEeecCCceeecCC
Q 005718 649 LDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 649 l~~~~~~kl~DFGla~~~~~~ 669 (681)
++.++.+||+|||+++.+...
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~ 205 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK 205 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT
T ss_pred EcCCCcEEEeccccccccccc
Confidence 999999999999999986443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.9e-23 Score=216.57 Aligned_cols=162 Identities=28% Similarity=0.381 Sum_probs=137.6
Q ss_pred ccHHHHHHhhCCCCce-eeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhC-CCCCeeEEEEE
Q 005718 504 FSLASVSAATENFSMQ-CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLMGC 578 (681)
Q Consensus 504 ~~~~~~~~~~~~f~~~-~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~ 578 (681)
..+.......+.|.+. +.||+|+||.||++... +++.||||++... ......++.+|+.++.++ +||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3444455666778877 88999999999999985 4889999998753 234467899999999999 57999999999
Q ss_pred EEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC---CCCe
Q 005718 579 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNP 655 (681)
Q Consensus 579 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~---~~~~ 655 (681)
+.+.+..++||||+++|+|.+++... ....+++.++..++.||++||+|||+.+ |+||||||+|||++. ++.+
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence 99999999999999999999998543 2346899999999999999999999987 999999999999988 7899
Q ss_pred EEeecCCceeecCC
Q 005718 656 KISDFGMARMFCGD 669 (681)
Q Consensus 656 kl~DFGla~~~~~~ 669 (681)
||+|||+|+.+...
T Consensus 174 kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 174 KIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCGGGCEEC---
T ss_pred EEeeCccccccCCc
Confidence 99999999987543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.6e-23 Score=215.88 Aligned_cols=148 Identities=28% Similarity=0.431 Sum_probs=125.2
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEE-----------
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV----------- 580 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~----------- 580 (681)
.++|.+.+.||+|+||.||+|.... ++.||||++........+++.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999999865 8899999998766666788999999999999999999999873
Q ss_pred ---eCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc-CCCCeE
Q 005718 581 ---EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPK 656 (681)
Q Consensus 581 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~-~~~~~k 656 (681)
+....++||||++ |+|.+++. ...+++..+..++.||++||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 4468899999998 69999883 235789999999999999999999987 99999999999997 567999
Q ss_pred EeecCCceeecC
Q 005718 657 ISDFGMARMFCG 668 (681)
Q Consensus 657 l~DFGla~~~~~ 668 (681)
|+|||+++.+..
T Consensus 162 l~Dfg~~~~~~~ 173 (320)
T 2i6l_A 162 IGDFGLARIMDP 173 (320)
T ss_dssp ECCCTTCBCC--
T ss_pred EccCccccccCC
Confidence 999999998753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=4.3e-23 Score=212.85 Aligned_cols=149 Identities=27% Similarity=0.408 Sum_probs=132.9
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57899999999999999999985 47789999986431 223567899999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999843 235889999999999999999999887 99999999999999999999999999987644
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-23 Score=221.69 Aligned_cols=148 Identities=30% Similarity=0.485 Sum_probs=127.5
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcc-cHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
++|.+.+.||+|+||.||+|... +++.||||++...... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999985 5889999999754221 122456799999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
++ ++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKS 151 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence 98 5888887432 345889999999999999999999987 9999999999999999999999999998764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=2.6e-23 Score=215.73 Aligned_cols=149 Identities=28% Similarity=0.442 Sum_probs=129.2
Q ss_pred CCCceeeecccCcEeEEEEEecC-C---cEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeE-EEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLLN-G---QEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK-ILI 588 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~~-~---~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~-~lV 588 (681)
.|...+.||+|+||.||+|...+ + ..+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667899999999999998643 2 369999997643 34467899999999999999999999999876655 999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||+.+++|.+++.. ....+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999954 2345789999999999999999999987 99999999999999999999999999987644
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-23 Score=216.17 Aligned_cols=152 Identities=30% Similarity=0.524 Sum_probs=130.8
Q ss_pred hCCCCceeeecccCcEeEEEEEecC----CcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEe-CCeEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE-QGEKI 586 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~ 586 (681)
...|++.+.||+|+||.||+|...+ ...+|+|.+.... ....+.+.+|+.++++++||||+++++++.+ .+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4568888999999999999998643 2358999987643 3445789999999999999999999998754 45789
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+||||+++++|.+++.. ....+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+|+.+
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999954 3345789999999999999999999987 999999999999999999999999999877
Q ss_pred cCC
Q 005718 667 CGD 669 (681)
Q Consensus 667 ~~~ 669 (681)
...
T Consensus 179 ~~~ 181 (298)
T 3f66_A 179 YDK 181 (298)
T ss_dssp SCG
T ss_pred ccc
Confidence 543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.7e-23 Score=215.65 Aligned_cols=149 Identities=30% Similarity=0.491 Sum_probs=131.7
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe----------
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE---------- 581 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~---------- 581 (681)
.++|++.+.||+|+||.||+|... +++.||||++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457899999999999999999974 688999999965 33456789999999999999999999999876
Q ss_pred ---CCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEe
Q 005718 582 ---QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 658 (681)
Q Consensus 582 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~ 658 (681)
....++||||+++++|.+++... ...+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 35679999999999999999542 335778899999999999999999987 9999999999999999999999
Q ss_pred ecCCceeec
Q 005718 659 DFGMARMFC 667 (681)
Q Consensus 659 DFGla~~~~ 667 (681)
|||+++.+.
T Consensus 159 dfg~~~~~~ 167 (303)
T 1zy4_A 159 DFGLAKNVH 167 (303)
T ss_dssp CCCCCSCTT
T ss_pred eCcchhhcc
Confidence 999998764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=9.1e-23 Score=216.06 Aligned_cols=151 Identities=29% Similarity=0.422 Sum_probs=132.8
Q ss_pred HHHhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhh--CCCCCeeEEEEEEEeCC---
Q 005718 509 VSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAK--LQHRNLVRLMGCCVEQG--- 583 (681)
Q Consensus 509 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~~~--- 583 (681)
.....++|.+.+.||+|+||.||++.. .++.||||++... ..+.+..|.+++.. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 345567899999999999999999998 5889999999643 34677888888887 79999999999998876
Q ss_pred -eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeecccCCCcEEEcCCCC
Q 005718 584 -EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH--------QYSRLRIIHRDLKASNILLDSDMN 654 (681)
Q Consensus 584 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivHrDlkp~NiLl~~~~~ 654 (681)
..++||||+++|+|.+++.. ..+++.++..++.|+++||+||| +.+ |+||||||+||||+.++.
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSC
T ss_pred ceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCC
Confidence 88999999999999999943 35889999999999999999999 555 999999999999999999
Q ss_pred eEEeecCCceeecCCC
Q 005718 655 PKISDFGMARMFCGDE 670 (681)
Q Consensus 655 ~kl~DFGla~~~~~~~ 670 (681)
+||+|||+|+.+....
T Consensus 186 ~kL~Dfg~~~~~~~~~ 201 (342)
T 1b6c_B 186 CCIADLGLAVRHDSAT 201 (342)
T ss_dssp EEECCCTTCEEEETTT
T ss_pred EEEEECCCceeccccc
Confidence 9999999999876543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.7e-23 Score=214.65 Aligned_cols=151 Identities=26% Similarity=0.360 Sum_probs=128.5
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC----cccHHHHHHHHHHHhhCCCCCeeEEEEEEE--eCCeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQHRNLVRLMGCCV--EQGEK 585 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~ 585 (681)
.++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999985 57899999997532 234578999999999999999999999985 44578
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++||||++++ |.+++... ....+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999887 66665432 2345899999999999999999999987 99999999999999999999999999998
Q ss_pred ecC
Q 005718 666 FCG 668 (681)
Q Consensus 666 ~~~ 668 (681)
+..
T Consensus 159 ~~~ 161 (305)
T 2wtk_C 159 LHP 161 (305)
T ss_dssp CCT
T ss_pred cCc
Confidence 753
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=225.75 Aligned_cols=151 Identities=30% Similarity=0.535 Sum_probs=123.1
Q ss_pred CCCCceeeecccCcEeEEEEEecC--C--cEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEe-CCeEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN--G--QEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE-QGEKIL 587 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~--~--~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~l 587 (681)
..|.+.+.||+|+||.||+|...+ + ..||||.++... ....++|.+|+.++++++||||+++++++.+ .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 346777999999999999998642 2 368999987542 3456789999999999999999999999765 457899
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||||+++|+|.+++.. ....+++.++..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999954 2345788999999999999999999987 9999999999999999999999999998764
Q ss_pred CC
Q 005718 668 GD 669 (681)
Q Consensus 668 ~~ 669 (681)
..
T Consensus 244 ~~ 245 (373)
T 3c1x_A 244 DK 245 (373)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=223.11 Aligned_cols=148 Identities=28% Similarity=0.416 Sum_probs=124.5
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC------
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------ 583 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 583 (681)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+++.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999984 5899999999653 2334567899999999999999999999998653
Q ss_pred eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCc
Q 005718 584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla 663 (681)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 7899998843 35889999999999999999999988 999999999999999999999999999
Q ss_pred eeecC
Q 005718 664 RMFCG 668 (681)
Q Consensus 664 ~~~~~ 668 (681)
+....
T Consensus 176 ~~~~~ 180 (367)
T 1cm8_A 176 RQADS 180 (367)
T ss_dssp EECCS
T ss_pred ccccc
Confidence 98754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.6e-23 Score=212.96 Aligned_cols=150 Identities=30% Similarity=0.483 Sum_probs=131.5
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe---------
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--------- 581 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--------- 581 (681)
...+|++.+.||+|+||.||++... +++.||+|++.... +.+.+|+.++.+++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467899999999999999999986 68999999997543 356789999999999999999998865
Q ss_pred -------CCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCC
Q 005718 582 -------QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN 654 (681)
Q Consensus 582 -------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~ 654 (681)
....++||||+++++|.+++... ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 34579999999999999998542 2345889999999999999999999987 999999999999999999
Q ss_pred eEEeecCCceeecCC
Q 005718 655 PKISDFGMARMFCGD 669 (681)
Q Consensus 655 ~kl~DFGla~~~~~~ 669 (681)
+||+|||+++.+...
T Consensus 161 ~kl~Dfg~~~~~~~~ 175 (284)
T 2a19_B 161 VKIGDFGLVTSLKND 175 (284)
T ss_dssp EEECCCTTCEESSCC
T ss_pred EEECcchhheecccc
Confidence 999999999987554
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.89 E-value=5.7e-23 Score=222.90 Aligned_cols=147 Identities=23% Similarity=0.317 Sum_probs=124.4
Q ss_pred hCCCCce-eeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHh-hCCCCCeeEEEEEEEe----CCeE
Q 005718 513 TENFSMQ-CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIA-KLQHRNLVRLMGCCVE----QGEK 585 (681)
Q Consensus 513 ~~~f~~~-~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~-~l~H~nIv~l~g~~~~----~~~~ 585 (681)
.++|.+. +.||+|+||.||++... +++.||||++... ..+.+|+.++. ..+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3466665 68999999999999985 4889999998642 45678888874 4589999999999876 5678
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC---CCCeEEeecCC
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGM 662 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~DFGl 662 (681)
+|||||+++|+|.+++.... ...+++.++..|+.||++||+|||+.+ |+||||||+||||+. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999999999996532 345899999999999999999999987 999999999999997 78999999999
Q ss_pred ceeecC
Q 005718 663 ARMFCG 668 (681)
Q Consensus 663 a~~~~~ 668 (681)
|+....
T Consensus 211 a~~~~~ 216 (400)
T 1nxk_A 211 AKETTS 216 (400)
T ss_dssp CEECC-
T ss_pred ccccCC
Confidence 997754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=8e-23 Score=213.90 Aligned_cols=152 Identities=31% Similarity=0.498 Sum_probs=130.2
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
...++|.+.+.||+|+||.||+|... +++.||||.+... ...+++.+|+.++.+++||||+++++++.+.+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34578999999999999999999985 4889999999753 34578899999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+++++|.+++.. ....+++.++..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+...
T Consensus 104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999842 2345889999999999999999999987 999999999999999999999999999887543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.2e-23 Score=215.02 Aligned_cols=154 Identities=24% Similarity=0.436 Sum_probs=127.3
Q ss_pred hCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
..+|++.+.||+|+||.||++.. .+++.||||++... .....+++.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999997 46889999999753 233456789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 589 YEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
|||+++++|.+++... .....+++.++..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999988432 12345889999999999999999999987 9999999999999999999999999998775
Q ss_pred CC
Q 005718 668 GD 669 (681)
Q Consensus 668 ~~ 669 (681)
..
T Consensus 188 ~~ 189 (310)
T 2wqm_A 188 SK 189 (310)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.2e-23 Score=214.68 Aligned_cols=151 Identities=29% Similarity=0.481 Sum_probs=130.5
Q ss_pred hhCCCCcee-eecccCcEeEEEEEec---CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeE
Q 005718 512 ATENFSMQC-KLGEGGFGPVYKGKLL---NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 512 ~~~~f~~~~-~LG~G~fG~Vy~~~~~---~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 585 (681)
..++|.+.+ .||+|+||.||+|... .++.||||++.... ....+++.+|+.+++.++||||+++++++ +.+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 346788877 9999999999999652 36789999997642 23357899999999999999999999998 66788
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++||||+++++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 999999999999999943 335889999999999999999999987 99999999999999999999999999998
Q ss_pred ecCC
Q 005718 666 FCGD 669 (681)
Q Consensus 666 ~~~~ 669 (681)
+..+
T Consensus 167 ~~~~ 170 (291)
T 1xbb_A 167 LRAD 170 (291)
T ss_dssp CCTT
T ss_pred eccC
Confidence 7544
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.3e-23 Score=215.93 Aligned_cols=150 Identities=24% Similarity=0.391 Sum_probs=131.4
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
.++|.+.+.||+|+||.||++... +++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467899999999999999999985 5889999999865444557789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEE---cCCCCeEEeecCCceeecC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~DFGla~~~~~ 668 (681)
+++++|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999988843 335889999999999999999999987 9999999999999 7889999999999987543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.7e-23 Score=216.57 Aligned_cols=150 Identities=35% Similarity=0.592 Sum_probs=130.1
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcE--EEEEEecCC-CcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQE--VAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~--VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 588 (681)
++|++.+.||+|+||.||++... ++.. +|||.+... .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57889999999999999999875 4554 599988753 234456789999999999 999999999999999999999
Q ss_pred EEecCCCChhhHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCe
Q 005718 589 YEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP 655 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~ 655 (681)
|||+++++|.+++.... ....+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996542 2346899999999999999999999987 9999999999999999999
Q ss_pred EEeecCCceee
Q 005718 656 KISDFGMARMF 666 (681)
Q Consensus 656 kl~DFGla~~~ 666 (681)
||+|||+++..
T Consensus 182 kL~Dfg~~~~~ 192 (327)
T 1fvr_A 182 KIADFGLSRGQ 192 (327)
T ss_dssp EECCTTCEESS
T ss_pred EEcccCcCccc
Confidence 99999999854
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-22 Score=214.15 Aligned_cols=145 Identities=23% Similarity=0.413 Sum_probs=129.9
Q ss_pred hCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCcccHHHHHHHHHHHhhCC-CCCeeEEEEEEEe--CCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVE--QGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~--~~~~~lV 588 (681)
.++|++.+.||+|+||.||++.. .+++.||||++... ..+.+.+|+.++.+++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36799999999999999999987 45889999999753 3578899999999996 9999999999998 6788999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC-CeEEeecCCceeec
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMFC 667 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~~~ 667 (681)
|||+++++|.+++. .+++.++..++.||++||+|||+.+ |+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999998882 3788999999999999999999987 99999999999999777 89999999999875
Q ss_pred CC
Q 005718 668 GD 669 (681)
Q Consensus 668 ~~ 669 (681)
..
T Consensus 183 ~~ 184 (330)
T 3nsz_A 183 PG 184 (330)
T ss_dssp TT
T ss_pred CC
Confidence 43
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.7e-23 Score=215.55 Aligned_cols=150 Identities=25% Similarity=0.353 Sum_probs=127.4
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--------cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ 582 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~ 582 (681)
..++|.+.+.||+|+||.||++... +++.||||.+.... ......+.+|+.++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999985 47899999987532 12234588999999999999999999998765
Q ss_pred CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCC---eEEee
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISD 659 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~---~kl~D 659 (681)
+ .++||||+++++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 8999999999999998843 345889999999999999999999987 999999999999987664 99999
Q ss_pred cCCceeecC
Q 005718 660 FGMARMFCG 668 (681)
Q Consensus 660 FGla~~~~~ 668 (681)
||+++.+..
T Consensus 161 fg~~~~~~~ 169 (322)
T 2ycf_A 161 FGHSKILGE 169 (322)
T ss_dssp CTTCEECCC
T ss_pred Cccceeccc
Confidence 999998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=3.2e-23 Score=221.52 Aligned_cols=149 Identities=27% Similarity=0.359 Sum_probs=133.7
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
.++|.+.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999985 5889999999764 23445789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
|+++++|.+++.. ...+++..+..++.|+++||+|||+. + |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 9999999999843 33588999999999999999999985 6 9999999999999999999999999997653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.4e-23 Score=217.34 Aligned_cols=149 Identities=34% Similarity=0.569 Sum_probs=122.3
Q ss_pred hCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHH--HhhCCCCCeeEEEEEEEe-----CCeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMML--IAKLQHRNLVRLMGCCVE-----QGEK 585 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~--l~~l~H~nIv~l~g~~~~-----~~~~ 585 (681)
.++|++.+.||+|+||.||+|.. +++.||||++... ....+..|.++ +..++|+||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46899999999999999999987 6789999999753 23444444444 445899999999986653 2267
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeeecccCCCcEEEcCCCCeEEee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS------RLRIIHRDLKASNILLDSDMNPKISD 659 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~ivHrDlkp~NiLl~~~~~~kl~D 659 (681)
++||||+++|+|.+++.. ...++..+..++.||++||+|||+.. +.+|+||||||+||||+.++.+||+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 899999999999999933 23488999999999999999999881 11399999999999999999999999
Q ss_pred cCCceeecCC
Q 005718 660 FGMARMFCGD 669 (681)
Q Consensus 660 FGla~~~~~~ 669 (681)
||+|+.+...
T Consensus 164 FG~a~~~~~~ 173 (336)
T 3g2f_A 164 FGLSMRLTGN 173 (336)
T ss_dssp CTTCEECSSS
T ss_pred ccceeecccc
Confidence 9999987543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.5e-23 Score=229.52 Aligned_cols=152 Identities=30% Similarity=0.455 Sum_probs=135.2
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
..++|++.+.||+|+||.||++... .++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999985 58899999986532 3456789999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEE---cCCCCeEEeecCCce
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMAR 664 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~DFGla~ 664 (681)
||||+.+++|.+.+.. ...+++.++..++.||++||.|||+.+ |+||||||+|||+ +.++.+||+|||+|+
T Consensus 104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999998854 345889999999999999999999987 9999999999999 567899999999998
Q ss_pred eecCC
Q 005718 665 MFCGD 669 (681)
Q Consensus 665 ~~~~~ 669 (681)
.+...
T Consensus 178 ~~~~~ 182 (484)
T 3nyv_A 178 HFEAS 182 (484)
T ss_dssp HBCCC
T ss_pred Ecccc
Confidence 77543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.5e-23 Score=230.55 Aligned_cols=152 Identities=30% Similarity=0.487 Sum_probs=134.0
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
..++|.+.++||+|+||.||++... +++.||||++... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467999999999999999999985 5889999998643 234567899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc---CCCCeEEeecCCcee
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARM 665 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~---~~~~~kl~DFGla~~ 665 (681)
|||+++++|.+.+.. ...+++.++..++.||++||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.
T Consensus 100 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999888843 345899999999999999999999987 99999999999995 456799999999987
Q ss_pred ecCC
Q 005718 666 FCGD 669 (681)
Q Consensus 666 ~~~~ 669 (681)
+...
T Consensus 174 ~~~~ 177 (486)
T 3mwu_A 174 FQQN 177 (486)
T ss_dssp BCCC
T ss_pred CCCC
Confidence 7543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-23 Score=219.38 Aligned_cols=154 Identities=34% Similarity=0.528 Sum_probs=130.4
Q ss_pred hhCCCCceeeecccCcEeEEEEEe------cCCcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCe
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKL------LNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE 584 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~------~~~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 584 (681)
..++|.+.+.||+|+||.||+|.. ..++.||||++... ......++.+|+.++++++||||+++++++.+.+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 346899999999999999999984 24678999999754 33456689999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC---CCCeEE
Q 005718 585 KILIYEYMPNKSLNFFLFDPS----RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKI 657 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~---~~~~kl 657 (681)
.++||||+++++|.+++.... ....+++.+++.++.||++||.|||+.+ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999996432 1245889999999999999999999987 999999999999984 446999
Q ss_pred eecCCceeecC
Q 005718 658 SDFGMARMFCG 668 (681)
Q Consensus 658 ~DFGla~~~~~ 668 (681)
+|||+++.+..
T Consensus 185 ~Dfg~~~~~~~ 195 (327)
T 2yfx_A 185 GDFGMARDIYR 195 (327)
T ss_dssp CCCHHHHHHHC
T ss_pred Ccccccccccc
Confidence 99999986543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=8.3e-23 Score=210.90 Aligned_cols=151 Identities=31% Similarity=0.620 Sum_probs=129.1
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCccc-------HHHHHHHHHHHhhCCCCCeeEEEEEEEeCCe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQG-------LKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE 584 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~-------~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 584 (681)
.++|++.+.||+|+||.||++... +++.||||++....... .+.+.+|+.++.+++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467999999999999999999984 58899999986542211 267899999999999999999999986655
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCC-----eEEee
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN-----PKISD 659 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~-----~kl~D 659 (681)
++||||+++++|.+.+.+. ...+++..+..++.|+++||+|||+.+ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 6999999999998888543 346899999999999999999999874 34999999999999988776 99999
Q ss_pred cCCceeecC
Q 005718 660 FGMARMFCG 668 (681)
Q Consensus 660 FGla~~~~~ 668 (681)
||+|+....
T Consensus 173 fg~~~~~~~ 181 (287)
T 4f0f_A 173 FGLSQQSVH 181 (287)
T ss_dssp CTTCBCCSS
T ss_pred CCccccccc
Confidence 999986543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=217.66 Aligned_cols=155 Identities=26% Similarity=0.419 Sum_probs=120.8
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
...++|.+.+.||+|+||.||++... +++.||||++.... ....+++.+|+.++.+++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 44678999999999999999999874 57899999987542 33456789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCc
Q 005718 589 YEYMPNKSLNFFLFD-----PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla 663 (681)
|||+++++|.+++.. ......+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999998842 123445899999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 005718 664 RMFCG 668 (681)
Q Consensus 664 ~~~~~ 668 (681)
+.+..
T Consensus 169 ~~~~~ 173 (303)
T 2vwi_A 169 AFLAT 173 (303)
T ss_dssp HHCC-
T ss_pred heecc
Confidence 87643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.4e-23 Score=219.30 Aligned_cols=150 Identities=19% Similarity=0.324 Sum_probs=124.1
Q ss_pred hCCCCceeeecccCcEeEEEEEec----CCcEEEEEEecCCCcc-----------cHHHHHHHHHHHhhCCCCCeeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQSGQ-----------GLKEFKNEMMLIAKLQHRNLVRLMG 577 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~~~~-----------~~~~f~~Ei~~l~~l~H~nIv~l~g 577 (681)
.++|.+.+.||+|+||.||+|... .+..+|||++...... ..+.+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999985 4678999998764321 1234677888999999999999999
Q ss_pred EEEe----CCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC
Q 005718 578 CCVE----QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM 653 (681)
Q Consensus 578 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~ 653 (681)
++.+ ....++||||+ +++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+||||+.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9998 77899999999 9999999843 236899999999999999999999987 99999999999999887
Q ss_pred --CeEEeecCCceeecCC
Q 005718 654 --NPKISDFGMARMFCGD 669 (681)
Q Consensus 654 --~~kl~DFGla~~~~~~ 669 (681)
.+||+|||+|+.+..+
T Consensus 189 ~~~~kL~Dfg~a~~~~~~ 206 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPN 206 (345)
T ss_dssp TTSEEECCCTTCEESSGG
T ss_pred CCcEEEEeCCCceecccc
Confidence 9999999999987543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=221.01 Aligned_cols=157 Identities=30% Similarity=0.403 Sum_probs=134.3
Q ss_pred HHhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCC-CCCeeEEEEEEEe------
Q 005718 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVE------ 581 (681)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~------ 581 (681)
.....+|++.++||+|+||.||++... +++.||||++........+.+.+|+.++.++. ||||+++++++..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 344568999999999999999999975 58899999997666666778999999999995 9999999999953
Q ss_pred --CCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEee
Q 005718 582 --QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD 659 (681)
Q Consensus 582 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D 659 (681)
....++||||++ |+|.+++........+++.++..++.||++||+|||+.+ .+|+||||||+|||++.++.+||+|
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEec
Confidence 335799999996 788888754333446899999999999999999999864 3499999999999999999999999
Q ss_pred cCCceeecC
Q 005718 660 FGMARMFCG 668 (681)
Q Consensus 660 FGla~~~~~ 668 (681)
||+++.+..
T Consensus 182 fg~~~~~~~ 190 (337)
T 3ll6_A 182 FGSATTISH 190 (337)
T ss_dssp CTTCBCCSS
T ss_pred Cccceeccc
Confidence 999998754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=8.3e-23 Score=218.78 Aligned_cols=149 Identities=26% Similarity=0.406 Sum_probs=130.7
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC-----CeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----GEK 585 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~ 585 (681)
.++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999875 57889999997543 33347889999999999999999999998765 368
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++||||++ ++|.+++.. ..+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 588888832 34889999999999999999999987 99999999999999999999999999998
Q ss_pred ecCC
Q 005718 666 FCGD 669 (681)
Q Consensus 666 ~~~~ 669 (681)
....
T Consensus 178 ~~~~ 181 (364)
T 3qyz_A 178 ADPD 181 (364)
T ss_dssp CCGG
T ss_pred cCCC
Confidence 7544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1e-22 Score=210.73 Aligned_cols=152 Identities=29% Similarity=0.423 Sum_probs=130.6
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe----CCeEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEKI 586 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~ 586 (681)
..|.+.+.||+|+||.||+|... .+..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45788889999999999999885 4778999998753 33446789999999999999999999999876 35689
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc-CCCCeEEeecCCcee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARM 665 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~-~~~~~kl~DFGla~~ 665 (681)
+||||+++++|.+++.. ...+++..+..++.||++||+|||+.+ .+|+||||||+|||++ +++.+||+|||+|+.
T Consensus 106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999943 345889999999999999999999864 3499999999999998 788999999999986
Q ss_pred ecCC
Q 005718 666 FCGD 669 (681)
Q Consensus 666 ~~~~ 669 (681)
....
T Consensus 182 ~~~~ 185 (290)
T 1t4h_A 182 KRAS 185 (290)
T ss_dssp CCTT
T ss_pred cccc
Confidence 6443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-22 Score=209.86 Aligned_cols=143 Identities=10% Similarity=0.076 Sum_probs=126.9
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCc---ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.++|++.+.||+|+||.||+|.... ++.||||++..... ...+.+.+|+..+.+++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 4679999999999999999999854 88999999986432 2347899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCc
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla 663 (681)
|||+++++|.+++.. . ....+...|+.||++||+|||+.+ |+||||||+||||+.++.+||+++|..
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecccc
Confidence 999999999999832 1 345678899999999999999988 999999999999999999999987754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.3e-23 Score=237.50 Aligned_cols=144 Identities=31% Similarity=0.487 Sum_probs=125.6
Q ss_pred eeecccCcEeEEEEEec---CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 520 CKLGEGGFGPVYKGKLL---NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~---~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
++||+|+||.||+|.+. .++.||||+++... ....++|.+|+.++.+++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 48999999999999763 35789999998642 334678999999999999999999999986 4568899999999
Q ss_pred CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCC
Q 005718 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 670 (681)
|+|.+++.. ...+++.++..|+.||++||+|||+.+ ||||||||+||||+.++.+||+|||+|+.+..+.
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 999999943 345889999999999999999999987 9999999999999999999999999999875443
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=211.31 Aligned_cols=150 Identities=29% Similarity=0.495 Sum_probs=129.8
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 57899999999999999999985 58899999987542 2234678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|++ ++|.+++.... ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 83 ~~~-~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 155 (299)
T 2r3i_A 83 FLH-QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155 (299)
T ss_dssp CCS-EEHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ccc-CCHHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccC
Confidence 998 68988885432 234788999999999999999999987 99999999999999999999999999987643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.88 E-value=6.2e-23 Score=222.26 Aligned_cols=151 Identities=26% Similarity=0.414 Sum_probs=125.2
Q ss_pred hCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCe------EE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE------KI 586 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~------~~ 586 (681)
..+|.+.+.||+|+||.||+|....+..+|+|++..... ...+|+.+++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 356899999999999999999998777799998865322 12369999999999999999999975443 78
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc-CCCCeEEeecCCcee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARM 665 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~-~~~~~kl~DFGla~~ 665 (681)
+||||++++.+............+++..+..++.||++||+|||+.+ |+||||||+||||+ .++.+||+|||+|+.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999987655444322223456889999999999999999999987 99999999999999 799999999999998
Q ss_pred ecCCC
Q 005718 666 FCGDE 670 (681)
Q Consensus 666 ~~~~~ 670 (681)
+....
T Consensus 192 ~~~~~ 196 (394)
T 4e7w_A 192 LIAGE 196 (394)
T ss_dssp CCTTC
T ss_pred ccCCC
Confidence 75443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=219.25 Aligned_cols=153 Identities=24% Similarity=0.374 Sum_probs=125.1
Q ss_pred HHhhCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC------
Q 005718 510 SAATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------ 582 (681)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------ 582 (681)
....++|++.+.||+|+||.||+|.. .+++.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999987 4589999999875422 224699999999999999999998543
Q ss_pred --------------------------------CeEEEEEEecCCCChhhHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 005718 583 --------------------------------GEKILIYEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYL 629 (681)
Q Consensus 583 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yL 629 (681)
...++||||++ ++|.+.+... .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34889999998 5777666421 2345689999999999999999999
Q ss_pred HhCCCCCeeecccCCCcEEEc-CCCCeEEeecCCceeecCCC
Q 005718 630 HQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 630 H~~~~~~ivHrDlkp~NiLl~-~~~~~kl~DFGla~~~~~~~ 670 (681)
|+.+ |+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 196 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE 196 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence 9887 99999999999998 68899999999999875443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.88 E-value=9.1e-24 Score=227.41 Aligned_cols=151 Identities=16% Similarity=0.208 Sum_probs=124.4
Q ss_pred hhCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCC---CcccHHHHHHHH---HHHhhCCCCCeeEEE-------E
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQ---SGQGLKEFKNEM---MLIAKLQHRNLVRLM-------G 577 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~---~~~~~~~f~~Ei---~~l~~l~H~nIv~l~-------g 577 (681)
..++|.+.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+ .++++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 346788999999999999999997 45899999999742 334567899999 555666899999988 6
Q ss_pred EEEeCC-----------------eEEEEEEecCCCChhhHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 005718 578 CCVEQG-----------------EKILIYEYMPNKSLNFFLFDPS----RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLR 636 (681)
Q Consensus 578 ~~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 636 (681)
++.+.+ ..++||||+ +|+|.+++.... ....+++..+..|+.||++||+|||+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 666543 278999999 689999985321 1123446888899999999999999987
Q ss_pred eeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 637 IIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 637 ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|+||||||+||||+.++.+||+|||+|+..
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~ 256 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEET
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheec
Confidence 999999999999999999999999999964
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9e-23 Score=208.33 Aligned_cols=151 Identities=25% Similarity=0.429 Sum_probs=132.2
Q ss_pred hCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC--CeEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ--GEKILI 588 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV 588 (681)
.++|.+.+.||+|+||.||+|... ++.||||++.... ....+.|.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357889999999999999999984 7899999997642 34456899999999999999999999999887 788999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|||+++|+|.+++... ....+++.++..++.||++||+|||+.+ .+|+||||||+||+++.++.+||.|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999999653 2235899999999999999999999863 34999999999999999999999999987654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-23 Score=234.92 Aligned_cols=151 Identities=16% Similarity=0.195 Sum_probs=114.4
Q ss_pred eeecccCcEeEEEEEe-cCCcEEEEEEecCCC----------cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEE
Q 005718 520 CKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS----------GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~----------~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 587 (681)
...+.|..|.+..++. --|+.++||.+.+.. ....++|.+|+++|+++ +|+||+++++++.+++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 3456677776665442 247889999997531 22346799999999999 79999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||||++|++|.+.|.+ ...++.. +|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+.
T Consensus 320 VMEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EEecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999999954 3345543 58999999999999998 9999999999999999999999999999875
Q ss_pred CCCccCCCcceecC
Q 005718 668 GDELQGNTKRVVGT 681 (681)
Q Consensus 668 ~~~~~~~~~~~~GT 681 (681)
.+... +.+++||
T Consensus 391 ~~~~~--~~t~vGT 402 (569)
T 4azs_A 391 QDCSW--PTNLVQS 402 (569)
T ss_dssp ---CC--SHHHHHH
T ss_pred CCCcc--ccCceec
Confidence 54332 3334554
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=6e-23 Score=211.40 Aligned_cols=152 Identities=31% Similarity=0.464 Sum_probs=129.9
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC----CcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 586 (681)
..++|.+.+.||+|+||.||+|.... +..||||.+... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34678999999999999999998643 236999999865 33456789999999999999999999998764 4568
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+||||+++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.+
T Consensus 89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999843 2345889999999999999999999987 999999999999999999999999999877
Q ss_pred cCC
Q 005718 667 CGD 669 (681)
Q Consensus 667 ~~~ 669 (681)
...
T Consensus 164 ~~~ 166 (281)
T 3cc6_A 164 EDE 166 (281)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-22 Score=215.99 Aligned_cols=148 Identities=26% Similarity=0.427 Sum_probs=130.3
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC-----CeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----GEK 585 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~ 585 (681)
.++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999985 58899999997542 33456788999999999999999999998764 678
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++||||++ ++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 688888843 35889999999999999999999987 99999999999999999999999999998
Q ss_pred ecC
Q 005718 666 FCG 668 (681)
Q Consensus 666 ~~~ 668 (681)
+..
T Consensus 162 ~~~ 164 (353)
T 2b9h_A 162 IDE 164 (353)
T ss_dssp CC-
T ss_pred ccc
Confidence 754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.2e-23 Score=216.14 Aligned_cols=160 Identities=25% Similarity=0.341 Sum_probs=134.2
Q ss_pred cccHHHHHHhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCC--CcccHHHHHHHHHHHhhCC--CCCeeEEEEE
Q 005718 503 CFSLASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQ--HRNLVRLMGC 578 (681)
Q Consensus 503 ~~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~ 578 (681)
.+.+..+....++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++ |+||++++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 34455556667889999999999999999999988999999998653 2345678999999999996 5999999999
Q ss_pred EEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEe
Q 005718 579 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 658 (681)
Q Consensus 579 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~ 658 (681)
+.+.+..++||| +.+++|.+++.. ...+++.++..++.||++||.|||+.+ |+||||||+|||+++ +.+||+
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~ 168 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLI 168 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEEC
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEe
Confidence 999999999999 568899999843 345789999999999999999999987 999999999999964 899999
Q ss_pred ecCCceeecCCC
Q 005718 659 DFGMARMFCGDE 670 (681)
Q Consensus 659 DFGla~~~~~~~ 670 (681)
|||+++.+....
T Consensus 169 Dfg~~~~~~~~~ 180 (313)
T 3cek_A 169 DFGIANQMQPDT 180 (313)
T ss_dssp CCSSSCC-----
T ss_pred eccccccccCcc
Confidence 999999875443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3.4e-23 Score=213.96 Aligned_cols=154 Identities=27% Similarity=0.383 Sum_probs=120.9
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc-cc-HHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QG-LKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~-~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
..++|++.+.||+|+||.||++... +++.||||++..... .. .+.+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3578999999999999999999984 688999999976422 22 23345555567888999999999999999999999
Q ss_pred EEecCCCChhhHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 589 YEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
|||++ |+|.+++... .....+++..+..++.|+++||+|||+. + |+||||||+||+++.++.+||+|||+|+.+
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99997 4877766321 2345689999999999999999999997 7 999999999999999999999999999877
Q ss_pred cCC
Q 005718 667 CGD 669 (681)
Q Consensus 667 ~~~ 669 (681)
...
T Consensus 161 ~~~ 163 (290)
T 3fme_A 161 VDD 163 (290)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.6e-23 Score=211.20 Aligned_cols=156 Identities=24% Similarity=0.416 Sum_probs=131.7
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe--CCeEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEKIL 587 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~l 587 (681)
.++|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467999999999999999999985 5889999999753 23345679999999999999999999998865 568999
Q ss_pred EEEecCCCChhhHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 588 IYEYMPNKSLNFFLFDPS-RTHLLGWQTRVKIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
||||+++++|.+++.... ....+++..+..++.|+++||+|||+.+ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999985421 2345899999999999999999999875 2349999999999999999999999999998
Q ss_pred eecC
Q 005718 665 MFCG 668 (681)
Q Consensus 665 ~~~~ 668 (681)
.+..
T Consensus 165 ~~~~ 168 (279)
T 2w5a_A 165 ILNH 168 (279)
T ss_dssp HC--
T ss_pred eecc
Confidence 7644
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=5.6e-23 Score=220.38 Aligned_cols=148 Identities=32% Similarity=0.432 Sum_probs=115.9
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC------C
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------G 583 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~ 583 (681)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999999874 5889999999753 233457889999999999999999999998754 5
Q ss_pred eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCc
Q 005718 584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla 663 (681)
..++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 6888888732 45899999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 005718 664 RMFCG 668 (681)
Q Consensus 664 ~~~~~ 668 (681)
+....
T Consensus 180 ~~~~~ 184 (367)
T 2fst_X 180 RHTAD 184 (367)
T ss_dssp -----
T ss_pred ccccc
Confidence 87643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.8e-22 Score=208.59 Aligned_cols=147 Identities=24% Similarity=0.342 Sum_probs=127.4
Q ss_pred CCCCce-eeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHH-hhCCCCCeeEEEEEEEe----CCeEE
Q 005718 514 ENFSMQ-CKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLI-AKLQHRNLVRLMGCCVE----QGEKI 586 (681)
Q Consensus 514 ~~f~~~-~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l-~~l~H~nIv~l~g~~~~----~~~~~ 586 (681)
++|.+. +.||+|+||.||++... +++.||||++... ..+.+|+.++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 567776 77999999999999984 5889999998642 4567888887 55699999999999987 67889
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC---CCCeEEeecCCc
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMA 663 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~DFGla 663 (681)
+||||+++++|.+++... ....+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999999543 2335899999999999999999999987 999999999999998 788999999999
Q ss_pred eeecCC
Q 005718 664 RMFCGD 669 (681)
Q Consensus 664 ~~~~~~ 669 (681)
+...+.
T Consensus 168 ~~~~~~ 173 (299)
T 3m2w_A 168 KETTGE 173 (299)
T ss_dssp EECTTC
T ss_pred cccccc
Confidence 987553
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-22 Score=216.94 Aligned_cols=147 Identities=29% Similarity=0.380 Sum_probs=124.6
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC------
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------ 583 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 583 (681)
.++|.+.+.||+|+||.||+|... .++.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999875 5889999999753 2334567899999999999999999999998665
Q ss_pred eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCc
Q 005718 584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla 663 (681)
..++||||+++ +|.+.+. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999975 6777773 23788999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 005718 664 RMFCG 668 (681)
Q Consensus 664 ~~~~~ 668 (681)
+....
T Consensus 175 ~~~~~ 179 (371)
T 2xrw_A 175 RTAGT 179 (371)
T ss_dssp -----
T ss_pred ccccc
Confidence 87644
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=235.50 Aligned_cols=148 Identities=22% Similarity=0.326 Sum_probs=128.3
Q ss_pred hCCCCceeeecccCcEeEEEEEec--CCcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCe-----
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL--NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE----- 584 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~--~~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----- 584 (681)
.++|++.+.||+|+||.||++.+. +++.||||++... .....+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999985 5889999998753 23445678999999999999999999999987665
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
.+|||||+++++|.+++.. .+++.+++.|+.||++||.|||+.+ ||||||||+||||+.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999887632 5899999999999999999999987 9999999999999885 89999999999
Q ss_pred eecCC
Q 005718 665 MFCGD 669 (681)
Q Consensus 665 ~~~~~ 669 (681)
.+...
T Consensus 230 ~~~~~ 234 (681)
T 2pzi_A 230 RINSF 234 (681)
T ss_dssp ETTCC
T ss_pred hcccC
Confidence 87543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=222.06 Aligned_cols=148 Identities=28% Similarity=0.452 Sum_probs=121.4
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC----C--eEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ----G--EKI 586 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~----~--~~~ 586 (681)
.+|.+.+.||+|+||.||+|... .++.||||++.... +.+.+|+.++++++||||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999985 48999999986532 2234699999999999999999998642 2 367
Q ss_pred EEEEecCCCChhhHhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC-CCeEEeecCCce
Q 005718 587 LIYEYMPNKSLNFFLFD-PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMAR 664 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFGla~ 664 (681)
+||||+++ +|.+.+.. ......+++..+..++.||++||+|||+.+ |+||||||+||||+.+ +.+||+|||+|+
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 55544421 123456899999999999999999999887 9999999999999965 568999999999
Q ss_pred eecCC
Q 005718 665 MFCGD 669 (681)
Q Consensus 665 ~~~~~ 669 (681)
.+...
T Consensus 206 ~~~~~ 210 (420)
T 1j1b_A 206 QLVRG 210 (420)
T ss_dssp ECCTT
T ss_pred hcccC
Confidence 87543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-22 Score=216.16 Aligned_cols=159 Identities=25% Similarity=0.316 Sum_probs=119.5
Q ss_pred HHHHhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCe--
Q 005718 508 SVSAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE-- 584 (681)
Q Consensus 508 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-- 584 (681)
......++|++.+.||+|+||.||+|... +++.||||++... ......+.+|+..+..++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34566789999999999999999999985 5889999998653 2334566788888999999999999999976443
Q ss_pred -----EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeeecccCCCcEEEcC-CCCeE
Q 005718 585 -----KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH--QYSRLRIIHRDLKASNILLDS-DMNPK 656 (681)
Q Consensus 585 -----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~ivHrDlkp~NiLl~~-~~~~k 656 (681)
.++||||++++.+..+.........+++..+..++.|++.||.||| +.+ |+||||||+||||+. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence 7899999987533322211134456788999999999999999999 666 999999999999997 89999
Q ss_pred EeecCCceeecCCC
Q 005718 657 ISDFGMARMFCGDE 670 (681)
Q Consensus 657 l~DFGla~~~~~~~ 670 (681)
|+|||+|+.+....
T Consensus 173 l~Dfg~a~~~~~~~ 186 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE 186 (360)
T ss_dssp ECCCTTCBCCCTTS
T ss_pred EeeCCCceecCCCC
Confidence 99999999875443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=7.5e-23 Score=210.30 Aligned_cols=149 Identities=32% Similarity=0.537 Sum_probs=125.3
Q ss_pred hCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC-CeEEEEEEe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-GEKILIYEY 591 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV~Ey 591 (681)
.++|++.+.||+|+||.||++.. .++.||||++... ...+.+.+|+.++.+++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46799999999999999999987 4789999999753 3567899999999999999999999997655 478999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
+++++|.+++... ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999998432 1223788999999999999999999987 99999999999999999999999999987643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3e-22 Score=206.86 Aligned_cols=153 Identities=30% Similarity=0.480 Sum_probs=134.5
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
...++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999985 5889999998653 23456789999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC---CCeEEeecCCce
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD---MNPKISDFGMAR 664 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~---~~~kl~DFGla~ 664 (681)
|+||+++++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+||+++.+ ..+||+|||+++
T Consensus 99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999888843 235889999999999999999999987 9999999999999764 469999999998
Q ss_pred eecCC
Q 005718 665 MFCGD 669 (681)
Q Consensus 665 ~~~~~ 669 (681)
.+...
T Consensus 173 ~~~~~ 177 (287)
T 2wei_A 173 CFQQN 177 (287)
T ss_dssp TBCCC
T ss_pred eecCC
Confidence 77543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=5.3e-22 Score=217.31 Aligned_cols=151 Identities=23% Similarity=0.287 Sum_probs=129.6
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhC------CCCCeeEEEEEEEeCCe
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKL------QHRNLVRLMGCCVEQGE 584 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l------~H~nIv~l~g~~~~~~~ 584 (681)
...+|++.+.||+|+||.||+|.... ++.||||++... ....+.+.+|+.++..+ +|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 34679999999999999999998754 789999999763 34456778888888776 57799999999999999
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCC--eEEeecCC
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN--PKISDFGM 662 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~--~kl~DFGl 662 (681)
.++||||+. ++|.+++.... ...+++..+..++.||++||+|||+.+ |+||||||+||||+.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999996 68888875432 234899999999999999999999987 999999999999999887 99999999
Q ss_pred ceeecC
Q 005718 663 ARMFCG 668 (681)
Q Consensus 663 a~~~~~ 668 (681)
|+....
T Consensus 249 a~~~~~ 254 (429)
T 3kvw_A 249 SCYEHQ 254 (429)
T ss_dssp CEETTC
T ss_pred ceecCC
Confidence 987543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-22 Score=210.17 Aligned_cols=151 Identities=32% Similarity=0.462 Sum_probs=123.8
Q ss_pred hCCCCceeeecccCcEeEEEEEec--CCc--EEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL--NGQ--EVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~--~~~--~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 585 (681)
.++|++.+.||+|+||.||+|.+. +++ .||||+++.. .....+.+.+|+.++.+++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467999999999999999999863 233 6899998754 2344678999999999999999999999988765 7
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++|+||+++++|.+++... ...+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999998532 345889999999999999999999987 99999999999999999999999999998
Q ss_pred ecCC
Q 005718 666 FCGD 669 (681)
Q Consensus 666 ~~~~ 669 (681)
+...
T Consensus 171 ~~~~ 174 (291)
T 1u46_A 171 LPQN 174 (291)
T ss_dssp CCC-
T ss_pred cccc
Confidence 7544
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=6.2e-23 Score=218.72 Aligned_cols=147 Identities=18% Similarity=0.302 Sum_probs=128.1
Q ss_pred hCCCCceeeecccCcEeEEEEEecC---------CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeE---------
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN---------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVR--------- 574 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~---------~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~--------- 574 (681)
.++|.+.+.||+|+||.||+|.... ++.||||++... +.+.+|+.++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999864 789999998753 46789999999999999887
Q ss_pred ------EEEEEEe-CCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcE
Q 005718 575 ------LMGCCVE-QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNI 647 (681)
Q Consensus 575 ------l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~Ni 647 (681)
+++++.. +...++||||+ +++|.+++... ....+++.++..++.||++||+|||+.+ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6788877 67899999999 99999999542 2356899999999999999999999987 99999999999
Q ss_pred EEcCCC--CeEEeecCCceeecCC
Q 005718 648 LLDSDM--NPKISDFGMARMFCGD 669 (681)
Q Consensus 648 Ll~~~~--~~kl~DFGla~~~~~~ 669 (681)
|++.++ .+||+|||+|+.+...
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~ 214 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPS 214 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGG
T ss_pred EEcCCCCceEEEecCcceeeccCC
Confidence 999998 8999999999887543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.9e-22 Score=232.08 Aligned_cols=154 Identities=25% Similarity=0.413 Sum_probs=132.7
Q ss_pred HHhhCCCCceeeecccCcEeEEEEEecC----CcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCe
Q 005718 510 SAATENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE 584 (681)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 584 (681)
....++|.+.+.||+|+||.||+|.+.. +..||||++.... ....+.|.+|+.++++++||||+++++++. .+.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3445789999999999999999998743 4579999987543 334578999999999999999999999985 456
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
.++||||+++|+|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 465 ~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp CEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence 8999999999999999953 2335889999999999999999999987 9999999999999999999999999999
Q ss_pred eecCC
Q 005718 665 MFCGD 669 (681)
Q Consensus 665 ~~~~~ 669 (681)
.+...
T Consensus 540 ~~~~~ 544 (656)
T 2j0j_A 540 YMEDS 544 (656)
T ss_dssp SCCC-
T ss_pred ecCCC
Confidence 87543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.87 E-value=4.2e-22 Score=206.24 Aligned_cols=151 Identities=22% Similarity=0.351 Sum_probs=124.3
Q ss_pred hhCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEE-EEeCCeEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGC-CVEQGEKILIY 589 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~-~~~~~~~~lV~ 589 (681)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ..+++.+|+.++.+++|++++..+.. ..+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999997 468899999876532 22457889999999987776655554 46778899999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEE---cCCCCeEEeecCCceee
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMF 666 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~DFGla~~~ 666 (681)
||+ +++|.+++... ...+++.++..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+.+
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999998532 335899999999999999999999987 9999999999999 78899999999999987
Q ss_pred cCCC
Q 005718 667 CGDE 670 (681)
Q Consensus 667 ~~~~ 670 (681)
....
T Consensus 159 ~~~~ 162 (296)
T 4hgt_A 159 RDAR 162 (296)
T ss_dssp BCTT
T ss_pred cCcc
Confidence 6543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.5e-22 Score=217.10 Aligned_cols=149 Identities=28% Similarity=0.476 Sum_probs=115.5
Q ss_pred CCCCc-eeeecccCcEeEEEEEec---CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe--CCeEEE
Q 005718 514 ENFSM-QCKLGEGGFGPVYKGKLL---NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEKIL 587 (681)
Q Consensus 514 ~~f~~-~~~LG~G~fG~Vy~~~~~---~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~l 587 (681)
+.|.+ .++||+|+||.||+|... +++.||||++.... ..+.+.+|+.++++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34554 458999999999999975 47889999997542 33578899999999999999999999965 678999
Q ss_pred EEEecCCCChhhHhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEE----cCCCCeEE
Q 005718 588 IYEYMPNKSLNFFLFDP------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL----DSDMNPKI 657 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl----~~~~~~kl 657 (681)
||||+++ +|.+++... .....+++..+..|+.||+.||+|||+.+ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 676666311 12234899999999999999999999988 9999999999999 77889999
Q ss_pred eecCCceeecC
Q 005718 658 SDFGMARMFCG 668 (681)
Q Consensus 658 ~DFGla~~~~~ 668 (681)
+|||+|+.+..
T Consensus 174 ~Dfg~a~~~~~ 184 (405)
T 3rgf_A 174 ADMGFARLFNS 184 (405)
T ss_dssp CCTTCCC----
T ss_pred EECCCceecCC
Confidence 99999998754
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.6e-22 Score=171.16 Aligned_cols=105 Identities=19% Similarity=0.366 Sum_probs=90.7
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEEeeCCCCCCcEEEEEEEeCCCCceEEEccCCCCCcCCcceEEEeeCCcEEEEeCC
Q 005718 25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT 104 (681)
Q Consensus 25 ~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~l~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (681)
.++|.+||.|.+|++|.| |.|.|.|+.+++ |.+ |. ..++||+|||+.|.. ..+.|.|+.||||||+|++
T Consensus 1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvl-y~--~~~~vW~ant~~~~~-~~~~L~l~~dGnLvL~d~~ 69 (105)
T 4h3o_A 1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVL-YD--HSTSTWASNTEIGGK-SGCSAVLQSDGNFVVYDSS 69 (105)
T ss_dssp CCEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEE-EE--TTEEEEECCCCCTTC-CSCEEEECTTSCEEEECTT
T ss_pred CCCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEE-EE--CCEEEEEecCCCCCC-ccEEEEEeCCccEEEECCC
Confidence 378999999999999988 789999998887 434 44 358999999999965 4589999999999999999
Q ss_pred CcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeee
Q 005718 105 DGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS 149 (681)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqS 149 (681)
+.+||+|++.+....+.|+|+||||||||+. +||||
T Consensus 70 ~~~vWss~t~~~~~~~~l~L~ddGNlVly~~---------~~W~S 105 (105)
T 4h3o_A 70 GRSLWASHSTRGSGNYILILQDDGNVIIYGS---------DIWST 105 (105)
T ss_dssp CCEEEECCCCCCSSCEEEEECTTSCEEEEES---------EEEEC
T ss_pred cEEEEEecCCCCCCCEEEEEeCCCeEEEECC---------cEecC
Confidence 9999999987655667899999999999963 59998
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.87 E-value=7.7e-22 Score=204.36 Aligned_cols=150 Identities=23% Similarity=0.381 Sum_probs=127.6
Q ss_pred hCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEE-EEEeCCeEEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMG-CCVEQGEKILIYE 590 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g-~~~~~~~~~lV~E 590 (681)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ..+++.+|+.++.+++|++++..+. +..+++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 57899999999999999999997 568899999987543 2356889999999998877554444 4467788999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEE---cCCCCeEEeecCCceeec
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFC 667 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~DFGla~~~~ 667 (681)
|+ +++|.+++... ...+++.++..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+.+.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 99999998532 335899999999999999999999987 9999999999999 488899999999999876
Q ss_pred CCC
Q 005718 668 GDE 670 (681)
Q Consensus 668 ~~~ 670 (681)
...
T Consensus 160 ~~~ 162 (296)
T 3uzp_A 160 DAR 162 (296)
T ss_dssp CTT
T ss_pred ccc
Confidence 543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.3e-22 Score=212.17 Aligned_cols=155 Identities=25% Similarity=0.407 Sum_probs=124.9
Q ss_pred HHhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc------ccHHHHHHHHHHHhhC----CCCCeeEEEEE
Q 005718 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAKL----QHRNLVRLMGC 578 (681)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~------~~~~~f~~Ei~~l~~l----~H~nIv~l~g~ 578 (681)
....++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 345678999999999999999999874 588999999975422 1233466788888888 89999999999
Q ss_pred EEeCCeEEEEEEe-cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc-CCCCeE
Q 005718 579 CVEQGEKILIYEY-MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPK 656 (681)
Q Consensus 579 ~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~-~~~~~k 656 (681)
+.+.+..++|+|| +.+++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 789999999843 335899999999999999999999987 99999999999999 889999
Q ss_pred EeecCCceeecCCC
Q 005718 657 ISDFGMARMFCGDE 670 (681)
Q Consensus 657 l~DFGla~~~~~~~ 670 (681)
|+|||+++.+....
T Consensus 181 l~dfg~~~~~~~~~ 194 (312)
T 2iwi_A 181 LIDFGSGALLHDEP 194 (312)
T ss_dssp ECCCSSCEECCSSC
T ss_pred EEEcchhhhcccCc
Confidence 99999999876543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.87 E-value=3.8e-22 Score=209.77 Aligned_cols=152 Identities=30% Similarity=0.510 Sum_probs=127.0
Q ss_pred hhCCCCceeeecccCcEeEEEEEec--CCcEEEEEEecCCC--cccHHHHHHHHHHHhhC---CCCCeeEEEEEEE----
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL--NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKL---QHRNLVRLMGCCV---- 580 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~--~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~---- 580 (681)
..++|++.+.||+|+||.||++... +++.||||++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999983 57899999986432 12233556677766655 8999999999987
Q ss_pred -eCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEee
Q 005718 581 -EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISD 659 (681)
Q Consensus 581 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~D 659 (681)
.....++||||++ |+|.+++.... ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 69998885432 234889999999999999999999987 99999999999999999999999
Q ss_pred cCCceeecC
Q 005718 660 FGMARMFCG 668 (681)
Q Consensus 660 FGla~~~~~ 668 (681)
||+++.+..
T Consensus 164 fg~~~~~~~ 172 (326)
T 1blx_A 164 FGLARIYSF 172 (326)
T ss_dssp CCSCCCCCG
T ss_pred CcccccccC
Confidence 999987753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.87 E-value=6.2e-22 Score=219.34 Aligned_cols=150 Identities=23% Similarity=0.366 Sum_probs=129.8
Q ss_pred hCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCC-CCeeEEEEEEEeCCeEEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH-RNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E 590 (681)
.++|++.++||+|+||.||+|.. .+++.||||++..... ..++..|++++..++| +++..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999997 4588999998875432 3457889999999966 677778888888999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEE---cCCCCeEEeecCCceeec
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFC 667 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl---~~~~~~kl~DFGla~~~~ 667 (681)
|+ +++|.+++... ...+++.+++.|+.||+.||+|||+.+ ||||||||+|||| +.++.+||+|||+|+.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999998532 345899999999999999999999987 9999999999999 688999999999999886
Q ss_pred CCC
Q 005718 668 GDE 670 (681)
Q Consensus 668 ~~~ 670 (681)
...
T Consensus 158 ~~~ 160 (483)
T 3sv0_A 158 DTS 160 (483)
T ss_dssp CTT
T ss_pred CCc
Confidence 543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.87 E-value=3.6e-22 Score=214.42 Aligned_cols=148 Identities=26% Similarity=0.422 Sum_probs=126.8
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeE---
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK--- 585 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~--- 585 (681)
..++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3478999999999999999999875 58899999997642 23357889999999999999999999999877654
Q ss_pred ---EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCC
Q 005718 586 ---ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662 (681)
Q Consensus 586 ---~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl 662 (681)
++||||++ ++|.+++. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 68887772 23889999999999999999999987 99999999999999999999999999
Q ss_pred ceeecC
Q 005718 663 ARMFCG 668 (681)
Q Consensus 663 a~~~~~ 668 (681)
|+....
T Consensus 191 a~~~~~ 196 (371)
T 4exu_A 191 ARHADA 196 (371)
T ss_dssp C-----
T ss_pred cccccc
Confidence 987644
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=8.7e-22 Score=207.73 Aligned_cols=150 Identities=23% Similarity=0.340 Sum_probs=129.9
Q ss_pred hCCCCceeeecccCcEeEEEEEe-c-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCC------CeeEEEEEEEeCCe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-L-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHR------NLVRLMGCCVEQGE 584 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~------nIv~l~g~~~~~~~ 584 (681)
.++|++.+.||+|+||.||++.. . +++.||||+++.. ....+.+.+|+.++..++|+ +++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999987 3 5789999999753 34567788999999888665 49999999999999
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC-------------
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS------------- 651 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~------------- 651 (681)
.++||||+ +++|.+++.... ...+++.++..++.||++||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 889998885432 235789999999999999999999987 999999999999987
Q ss_pred ------CCCeEEeecCCceeecC
Q 005718 652 ------DMNPKISDFGMARMFCG 668 (681)
Q Consensus 652 ------~~~~kl~DFGla~~~~~ 668 (681)
++.+||+|||+|+....
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~ 189 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDE 189 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTS
T ss_pred ccccccCCCceEeeCcccccCcc
Confidence 66899999999987643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.8e-22 Score=215.53 Aligned_cols=135 Identities=26% Similarity=0.344 Sum_probs=113.4
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCC--------CCCeeEEEEEEE---
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ--------HRNLVRLMGCCV--- 580 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~--------H~nIv~l~g~~~--- 580 (681)
.++|++.++||+|+||.||++... +++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999874 5789999999753 445678899999999885 788999999988
Q ss_pred -eCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecccCCCcEEEcCCC
Q 005718 581 -EQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDM 653 (681)
Q Consensus 581 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NiLl~~~~ 653 (681)
++...++||||+. ++|.+.+... ....+++..+..++.||++||+|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 115 VNGTHICMVFEVLG-HHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp TTEEEEEEEECCCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred CCCceEEEEEeccC-ccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 4568899999995 5555555332 224589999999999999999999997 6 99999999999999775
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-22 Score=216.72 Aligned_cols=150 Identities=11% Similarity=0.137 Sum_probs=112.0
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc---ccHHHHHHHHHHHhhC--CCCCeeEEE-------EEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKL--QHRNLVRLM-------GCC 579 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l--~H~nIv~l~-------g~~ 579 (681)
..+|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888999999999999999975 688999999987432 3355677885444444 799988755 444
Q ss_pred EeC-----------------CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 005718 580 VEQ-----------------GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTR------VKIIEGIAQGLLYLHQYSRLR 636 (681)
Q Consensus 580 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~~ 636 (681)
... ...++||||++ |+|.+++... ...+.+..+ ..++.||++||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 433 33799999999 8999999542 222344555 788899999999999987
Q ss_pred eeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 637 IIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 637 ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|+||||||+||||+.++.+||+|||+|+....
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~ 246 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC
Confidence 99999999999999999999999999997743
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=5.4e-22 Score=211.46 Aligned_cols=147 Identities=26% Similarity=0.425 Sum_probs=126.8
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCe-----
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGE----- 584 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----- 584 (681)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999985 58899999997532 2335678999999999999999999999987653
Q ss_pred -EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCc
Q 005718 585 -KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663 (681)
Q Consensus 585 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla 663 (681)
.++||||++ ++|.+++. ..+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 68877762 23889999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 005718 664 RMFCG 668 (681)
Q Consensus 664 ~~~~~ 668 (681)
+....
T Consensus 174 ~~~~~ 178 (353)
T 3coi_A 174 RHADA 178 (353)
T ss_dssp TC---
T ss_pred cCCCC
Confidence 87643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=8.9e-23 Score=213.95 Aligned_cols=154 Identities=29% Similarity=0.500 Sum_probs=130.2
Q ss_pred HHHHHHhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC
Q 005718 506 LASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG 583 (681)
Q Consensus 506 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 583 (681)
..+.....++|++.+.||+|+||.||+|.... .+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34444556889999999999999999998854 59999987532 233466888999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCc
Q 005718 584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla 663 (681)
..++||||+++++|.+++.. ....+++.++..++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||+|
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred ceEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCc
Confidence 99999999999999999944 2345888999999999999999999987 99999999999998 679999999998
Q ss_pred eeec
Q 005718 664 RMFC 667 (681)
Q Consensus 664 ~~~~ 667 (681)
+...
T Consensus 177 ~~~~ 180 (319)
T 2y4i_B 177 SISG 180 (319)
T ss_dssp C---
T ss_pred cccc
Confidence 8653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.8e-22 Score=207.76 Aligned_cols=152 Identities=28% Similarity=0.382 Sum_probs=126.2
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHH-HHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMM-LIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
.++|.+.+.||+|+||.||++... +++.||||++.... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467888999999999999999985 58899999997642 233455666666 677789999999999999999999999
Q ss_pred EecCCCChhhHhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 590 EYMPNKSLNFFLFD--PSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 590 Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
||+++ +|.+++.. ......+++..+..++.|+++||.|||+. + |+||||||+|||++.++.+||+|||+++.+
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 77766632 11244688999999999999999999997 7 999999999999999999999999999877
Q ss_pred cC
Q 005718 667 CG 668 (681)
Q Consensus 667 ~~ 668 (681)
..
T Consensus 177 ~~ 178 (327)
T 3aln_A 177 VD 178 (327)
T ss_dssp --
T ss_pred cc
Confidence 44
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=4.6e-22 Score=209.11 Aligned_cols=154 Identities=23% Similarity=0.366 Sum_probs=132.6
Q ss_pred HHhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcc------cHHHHHHHHHHHhhCC--CCCeeEEEEEEE
Q 005718 510 SAATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQ------GLKEFKNEMMLIAKLQ--HRNLVRLMGCCV 580 (681)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~------~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~ 580 (681)
....++|++.+.||+|+||.||+|... +++.||||++...... ..+.+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 345678999999999999999999874 5889999999754211 2345778999999995 599999999999
Q ss_pred eCCeEEEEEEecCC-CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc-CCCCeEEe
Q 005718 581 EQGEKILIYEYMPN-KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKIS 658 (681)
Q Consensus 581 ~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~-~~~~~kl~ 658 (681)
+.+..++|+||+.. ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999986 899998843 345889999999999999999999987 99999999999999 78899999
Q ss_pred ecCCceeecCC
Q 005718 659 DFGMARMFCGD 669 (681)
Q Consensus 659 DFGla~~~~~~ 669 (681)
|||+++.+...
T Consensus 193 Dfg~~~~~~~~ 203 (320)
T 3a99_A 193 DFGSGALLKDT 203 (320)
T ss_dssp CCTTCEECCSS
T ss_pred eCccccccccc
Confidence 99999987543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1e-21 Score=215.47 Aligned_cols=150 Identities=26% Similarity=0.313 Sum_probs=120.7
Q ss_pred CCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
+.|...+.||+|+||+||.+...+++.||||++... ..+.+.+|+.++.++ +||||+++++++.+.+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345556889999999998776677999999998653 345678999999876 8999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC-------------CCe
Q 005718 593 PNKSLNFFLFDPSRTH----LLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-------------MNP 655 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~-------------~~~ 655 (681)
+ |+|.+++....... ...+..+..++.||+.||+|||+.+ |+||||||+||||+.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999996532211 1123345789999999999999987 9999999999999754 489
Q ss_pred EEeecCCceeecCCC
Q 005718 656 KISDFGMARMFCGDE 670 (681)
Q Consensus 656 kl~DFGla~~~~~~~ 670 (681)
||+|||+|+.+..+.
T Consensus 168 kL~DFG~a~~~~~~~ 182 (434)
T 2rio_A 168 LISDFGLCKKLDSGQ 182 (434)
T ss_dssp EECCCTTCEECCC--
T ss_pred EEcccccceecCCCC
Confidence 999999999886543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.7e-21 Score=203.63 Aligned_cols=149 Identities=23% Similarity=0.300 Sum_probs=121.0
Q ss_pred hCCCCcee-eecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe----CCeEE
Q 005718 513 TENFSMQC-KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEKI 586 (681)
Q Consensus 513 ~~~f~~~~-~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~ 586 (681)
.++|.+.+ .||+|+||.||++... +++.||||++... . .........+..++||||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 46788854 6999999999999986 5899999999653 1 222223334567799999999999876 45689
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC---CCCeEEeecCCc
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMA 663 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~DFGla 663 (681)
+||||+++|+|.+++.... ...+++.++..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+|
T Consensus 103 lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999996532 246899999999999999999999987 999999999999976 455999999999
Q ss_pred eeecCC
Q 005718 664 RMFCGD 669 (681)
Q Consensus 664 ~~~~~~ 669 (681)
+.....
T Consensus 179 ~~~~~~ 184 (336)
T 3fhr_A 179 KETTQN 184 (336)
T ss_dssp EEC---
T ss_pred eecccc
Confidence 877543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-21 Score=214.89 Aligned_cols=149 Identities=23% Similarity=0.358 Sum_probs=121.3
Q ss_pred hhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
...+|.+.+.||+|+||+||.....+++.||||++..... ..+.+|+.+++++ +||||+++++++.+.+..++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 3456888899999999997665566789999999976432 2356799999999 89999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC-----CCCeEEeecCCcee
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-----DMNPKISDFGMARM 665 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~-----~~~~kl~DFGla~~ 665 (681)
|++ |+|.+++..... .....++..++.||++||+|||+.+ |+||||||+||||+. ...+||+|||+|+.
T Consensus 99 ~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 996 599988854322 2344456789999999999999987 999999999999953 33688999999998
Q ss_pred ecCC
Q 005718 666 FCGD 669 (681)
Q Consensus 666 ~~~~ 669 (681)
+...
T Consensus 173 ~~~~ 176 (432)
T 3p23_A 173 LAVG 176 (432)
T ss_dssp C---
T ss_pred ccCC
Confidence 7543
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=5.9e-21 Score=167.00 Aligned_cols=110 Identities=23% Similarity=0.404 Sum_probs=95.6
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEEeeCCCCCCcEEEEEEEeCCCCceEEEccCCCCCcCCcceEEEeeCCcEEEEeCC
Q 005718 25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT 104 (681)
Q Consensus 25 ~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~l~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (681)
.|+|.+|+.|.+|++|+ ++|.|+|+|+.+++ .++|+ ..++||.||++.| +.++.+.|+.||||||+|.+
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn------lvl~~--~~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~~~~ 69 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN------FVLYD--SGKPVWASNTGGL--GSGCRLTLHNNGNLVIYDQS 69 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC------EEEEE--TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc------EEEEE--CCEEEEECCCCCC--CCcEEEEEeCCCCEEEECCC
Confidence 37899999999999999 99999999998886 37777 4699999999876 34589999999999999998
Q ss_pred CcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCC
Q 005718 105 DGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPS 154 (681)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~Pt 154 (681)
+.++|+|.+........++|+|+|||||++ + ++||||+||.
T Consensus 70 ~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~--------~-~~W~S~~~~~ 110 (110)
T 3a0c_A 70 NRVIWQTKTNGKEDHYVLVLQQDRNVVIYG--------P-VVWATGSGPA 110 (110)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEEC--------S-EEEECSCCC-
T ss_pred CcEEEecCCCCCCCCEEEEEeCCccEEEEC--------C-CEecCCCcCC
Confidence 999999998754456789999999999984 2 6999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.8e-21 Score=204.26 Aligned_cols=150 Identities=23% Similarity=0.350 Sum_probs=127.2
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-C-cEEEEEEecCCCcccHHHHHHHHHHHhhCCCCC------eeEEEEEEEeCCe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-G-QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN------LVRLMGCCVEQGE 584 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~-~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~l~g~~~~~~~ 584 (681)
.++|++.+.||+|+||.||++.... + +.||||+++.. ....+.+.+|+.++++++|++ ++.+.+++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 4789999999999999999999743 3 68999999753 345677889999999987665 9999999999999
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEE---------------
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILL--------------- 649 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl--------------- 649 (681)
.++||||+ +++|.+++... ....+++.++..++.||++||+|||+.+ |+||||||+||||
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 55665665432 2235899999999999999999999887 9999999999999
Q ss_pred ----cCCCCeEEeecCCceeecC
Q 005718 650 ----DSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 650 ----~~~~~~kl~DFGla~~~~~ 668 (681)
+.++.+||+|||+|+....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~ 194 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHE 194 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTS
T ss_pred cccccCCCcEEEeecCccccccc
Confidence 6678999999999987543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.8e-21 Score=203.72 Aligned_cols=151 Identities=22% Similarity=0.348 Sum_probs=116.1
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc-cc-HHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-QG-LKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~-~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
..++|++.+.||+|+||.||++... +++.||||++..... .. .+.+..+..+++.++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3467899999999999999999985 588999999976432 22 23344555677888999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
|||+ ++.+..+... ....+++..+..++.||++||.|||+. + |+||||||+||+++.++.+||+|||+++.+.
T Consensus 103 ~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 4555544421 234588999999999999999999985 6 9999999999999999999999999998764
Q ss_pred C
Q 005718 668 G 668 (681)
Q Consensus 668 ~ 668 (681)
.
T Consensus 177 ~ 177 (318)
T 2dyl_A 177 D 177 (318)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=6.6e-21 Score=168.82 Aligned_cols=108 Identities=15% Similarity=0.308 Sum_probs=94.6
Q ss_pred ccccccCCCCccCCCCEEE--eCCCeEEEEeeCCCCCCcEEEEEEEeCCCCceEEEccCCCCCcCCcceEEEeeCCcEEE
Q 005718 23 LATDTITPATLIGDGEKLV--SSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVL 100 (681)
Q Consensus 23 ~~~~~l~~g~~l~~~~~l~--S~~g~f~~gf~~~~~~~~~~l~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l 100 (681)
++.++|.+|++|.+|++|+ |++|.|+|+|+.+++ .+||++ .++||+||++.| +.++.|.|+.||||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn------lvly~~--~~~vW~sn~~~~--~~~~~l~l~~dGNLVl 75 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN------LVLYDN--NNPIWATNTGGL--GNGCRAVLQPDGVLVV 75 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC------EEEEET--TEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC------EEEEEC--CEEEEeCCCccC--CCceEEEEccCCEEEE
Confidence 4578999999999999999 999999999999876 367874 799999999877 3458999999999999
Q ss_pred EeCCCcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeee
Q 005718 101 LNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS 149 (681)
Q Consensus 101 ~~~~~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqS 149 (681)
+|.++.++|+|.+........++|+|+|||||++. ++|||
T Consensus 76 ~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~~---------~~W~S 115 (119)
T 1b2p_A 76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD---------ALWAT 115 (119)
T ss_dssp ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEES---------EEEEC
T ss_pred EeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEECc---------cEeCC
Confidence 99999999999876544567899999999999952 69998
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.7e-22 Score=225.71 Aligned_cols=153 Identities=29% Similarity=0.399 Sum_probs=132.1
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe------CCeE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE------QGEK 585 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------~~~~ 585 (681)
++|.+.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++.+++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67999999999999999999874 5889999998764 33446779999999999999999999998765 6678
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCC---eEEeecCC
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMN---PKISDFGM 662 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~---~kl~DFGl 662 (681)
++||||+++|+|.+++........+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 999999999999999976555456888999999999999999999987 999999999999997765 99999999
Q ss_pred ceeecCC
Q 005718 663 ARMFCGD 669 (681)
Q Consensus 663 a~~~~~~ 669 (681)
|+.+...
T Consensus 171 a~~~~~~ 177 (676)
T 3qa8_A 171 AKELDQG 177 (676)
T ss_dssp CCBTTSC
T ss_pred ccccccc
Confidence 9987543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=6.4e-21 Score=205.53 Aligned_cols=154 Identities=25% Similarity=0.333 Sum_probs=129.0
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCC-CC-----CeeEEEEEEEeCC
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HR-----NLVRLMGCCVEQG 583 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~-----nIv~l~g~~~~~~ 583 (681)
...++|.+.+.||+|+||.||+|... +++.||||+++.. ....+++..|+.++..++ |+ +|+++.+++...+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 34578999999999999999999875 5788999999753 344567788998888884 55 4999999999999
Q ss_pred eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc--CCCCeEEeecC
Q 005718 584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--SDMNPKISDFG 661 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~--~~~~~kl~DFG 661 (681)
..++||||++ ++|.+++.... ...+++..+..++.||+.||.|||.+ ..+|+||||||+||||+ .++.+||+|||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred ceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 9999999996 59988885432 23488999999999999999999953 23499999999999994 57789999999
Q ss_pred CceeecC
Q 005718 662 MARMFCG 668 (681)
Q Consensus 662 la~~~~~ 668 (681)
+|+.+..
T Consensus 207 ~a~~~~~ 213 (382)
T 2vx3_A 207 SSCQLGQ 213 (382)
T ss_dssp TCEETTC
T ss_pred Cceeccc
Confidence 9998743
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.85 E-value=2.7e-21 Score=207.29 Aligned_cols=150 Identities=23% Similarity=0.379 Sum_probs=128.4
Q ss_pred hCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCCcccHHHHHHHHHHHhhCC-----------CCCeeEEEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-----------HRNLVRLMGCCV 580 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----------H~nIv~l~g~~~ 580 (681)
..+|.+.+.||+|+||.||+|.. .+++.||||++.. .....+.+.+|+.++.+++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46799999999999999999997 4588999999975 3345677889999998886 899999999998
Q ss_pred eCC----eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecccCCCcEEEc-----
Q 005718 581 EQG----EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLD----- 650 (681)
Q Consensus 581 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NiLl~----- 650 (681)
..+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 789999999 889999885432 23488999999999999999999997 7 99999999999994
Q ss_pred -CCCCeEEeecCCceeecC
Q 005718 651 -SDMNPKISDFGMARMFCG 668 (681)
Q Consensus 651 -~~~~~kl~DFGla~~~~~ 668 (681)
..+.+||+|||+|+.+..
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~ 190 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDE 190 (373)
T ss_dssp TTEEEEEECCCTTCEETTB
T ss_pred cCcceEEEcccccccccCC
Confidence 444799999999998754
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=5.8e-21 Score=196.87 Aligned_cols=144 Identities=17% Similarity=0.155 Sum_probs=115.3
Q ss_pred HHHHHhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCc------------------ccHHHHHHHHHHHhhCC
Q 005718 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG------------------QGLKEFKNEMMLIAKLQ 568 (681)
Q Consensus 507 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~------------------~~~~~f~~Ei~~l~~l~ 568 (681)
..+......|.+.+.||+|+||.||+|...+++.||||.++.... .....+.+|+.++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344455667778899999999999999997789999999974321 13457899999999998
Q ss_pred CCCeeEEEEEEEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEE
Q 005718 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 648 (681)
Q Consensus 569 H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiL 648 (681)
| +++.+++.. +..++||||+++++|.+ +.. .....++.||++||.|||+.+ |+||||||+|||
T Consensus 163 ~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 163 G---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp T---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred C---CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 5 444444433 45699999999999987 411 123469999999999999987 999999999999
Q ss_pred EcCCCCeEEeecCCceeecC
Q 005718 649 LDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 649 l~~~~~~kl~DFGla~~~~~ 668 (681)
++ ++.+||+|||+|+....
T Consensus 226 l~-~~~vkl~DFG~a~~~~~ 244 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVEVGE 244 (282)
T ss_dssp EE-TTEEEECCCTTCEETTS
T ss_pred EE-CCcEEEEECCCCeECCC
Confidence 99 99999999999997643
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.9e-21 Score=218.46 Aligned_cols=135 Identities=20% Similarity=0.237 Sum_probs=108.7
Q ss_pred ceeeecccCcEeEEEEEecCCcEEEEEEecCCCc--------ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG--------QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~--------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
..++||+|+||.||++.. .++.+++|+...... ...+++.+|++++++++||||+++..++...++.+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 347899999999999954 567888887654221 11345899999999999999997777777888889999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+++++|.+++.. +..++.|+++||+|||+++ |+||||||+|||++. .+||+|||+|+.+...
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999843 4589999999999999987 999999999999998 9999999999988654
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=5.4e-20 Score=162.42 Aligned_cols=110 Identities=18% Similarity=0.323 Sum_probs=94.0
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEEeeCCCCCCcEEEEEEEeCCCCceEEEccCCCCCcCCcceEEEeeCCcEEEEeCC
Q 005718 25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT 104 (681)
Q Consensus 25 ~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~l~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (681)
.|+|.+||+|.+|++|+ +|.|+|+|+.+++ + ++|. ..++||+||++.| +.++.|.|+.||||||+|.+
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----l-vly~--~~~~vW~sn~~~~--~~~~~l~l~~~GnLvl~d~~ 69 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----L-VKYQ--NGRQIWASNTDRR--GSGCRLTLLSDGNLVIYDHN 69 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----E-EEEE--TTEEEEECSCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----E-EEEe--CCEEEEeCCCCCC--CCceEEEECCCCcEEEECCC
Confidence 48999999999999998 8999999988775 2 4466 4789999999988 34689999999999999988
Q ss_pred CcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCCc
Q 005718 105 DGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSD 155 (681)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~PtD 155 (681)
+.++|+|.+........|+|+|+|||||++ . ++||||.++..
T Consensus 70 ~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~--------~-~~W~S~~~~~~ 111 (115)
T 2dpf_A 70 NNDVWGSACWGDNGKYALVLQKDGRFVIYG--------P-VLWSLGPNGCR 111 (115)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEEC--------S-EEECSSTTCBC
T ss_pred ceEEEEcCCCCCCCCEEEEEeCCCeEEEEC--------C-CEEECCCCCCc
Confidence 899999988644456789999999999994 2 79999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.82 E-value=5.2e-20 Score=161.74 Aligned_cols=110 Identities=23% Similarity=0.403 Sum_probs=93.7
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEEeeCCCCCCcEEEEEEEeCCCCceEEEccCCCCCcCCcceEEEeeCCcEEEEeCC
Q 005718 25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT 104 (681)
Q Consensus 25 ~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~l~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (681)
+|+|.+||.|.+|++| ++|.|+|+|+.+++ .++|+. .++||+||++.+ +.++.|.|+.||||||+| +
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn------lvl~~~--~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~ 67 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN------LVLYDN--NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-G 67 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC------EEEEET--TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-T
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc------EEEEEC--CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-C
Confidence 4899999999999999 58999999999886 356774 689999999864 345899999999999999 7
Q ss_pred CcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCC
Q 005718 105 DGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCP 153 (681)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~P 153 (681)
+.++|+|.+........++|+++|||||++.. +.++||||++.
T Consensus 68 ~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~------~~~~W~S~~~~ 110 (112)
T 1xd5_A 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS------NNAIWATHTNV 110 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTT------SCEEEECCCCC
T ss_pred CEEEEECCccCCCCCEEEEEeCCCcEEEECCC------CceEEECCCcc
Confidence 88999998765445678999999999999743 56899999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-19 Score=197.79 Aligned_cols=151 Identities=18% Similarity=0.231 Sum_probs=114.5
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc---ccHHHHHHHHHHHhhCCC-CCe---------------
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQH-RNL--------------- 572 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H-~nI--------------- 572 (681)
...|...+.||+|+||.||+|... +++.||||++..... ...+.|.+|+.+++.++| +|.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 445778899999999999999964 589999999884322 336789999999999987 221
Q ss_pred e------EEEEEEEe-----CCeEEEEEEecCCCChhhHhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 005718 573 V------RLMGCCVE-----QGEKILIYEYMPNKSLNFFLFD----PSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637 (681)
Q Consensus 573 v------~l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 637 (681)
+ .+..+... ....+++|+++ +++|.+++.. ......+++..++.|+.||++||+|||+.+ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 1 11111111 12456777765 6889888731 123445788899999999999999999987 9
Q ss_pred eecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 638 IHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 638 vHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
+||||||+||||+.++.+||+|||+|+...
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~ 262 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecC
Confidence 999999999999999999999999998764
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=5.4e-19 Score=154.32 Aligned_cols=103 Identities=24% Similarity=0.414 Sum_probs=88.1
Q ss_pred cccCCCCccCCCCEEEeCCCeEEEEeeCCCCCCcEEEEEEEeCCCCceEEEccCCCCCcCCcceEEEeeCCcEEEEeCCC
Q 005718 26 DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTD 105 (681)
Q Consensus 26 ~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~l~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~ 105 (681)
++|.+||.|.+|+.|+ +|.|+|.|+.+++ | +.|.. .++||.+|++.+ +.++.|.|+.||||||+|.++
T Consensus 2 ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----L-vly~~--~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~~ 69 (109)
T 3dzw_A 2 NILYSGETLSPGEFLN--NGRYVFIMQEDCN-----L-VLYDV--DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPRN 69 (109)
T ss_dssp CEEETTEEECTTCEEE--ETTEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--SSSCEEEECTTSCEEEECTTS
T ss_pred CCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----E-EEEeC--CEEEEECCcccC--CCCEEEEEeCCCCEEEECCCC
Confidence 6899999999999996 7999999998886 2 44663 689999999876 345899999999999999988
Q ss_pred cEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeee
Q 005718 106 GIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS 149 (681)
Q Consensus 106 ~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqS 149 (681)
.++|++++.+......|+|+||||||||+. ++|||
T Consensus 70 ~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---------~~W~s 104 (109)
T 3dzw_A 70 NPIWASNTGGENGNYVCVLQKDRNVVIYGT---------ARWAT 104 (109)
T ss_dssp CEEEECCCCCSSSCEEEEECTTSCEEEEES---------CCCCC
T ss_pred CEEEECCCCCCCCCEEEEEeCCCEEEEECC---------CEEeC
Confidence 999999987544457899999999999963 69998
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=6.4e-19 Score=179.24 Aligned_cols=139 Identities=16% Similarity=0.177 Sum_probs=107.6
Q ss_pred CCCceeeecccCcEeEEEEEe-cCCcE--EEEEEecCCCcc------------------------cHHHHHHHHHHHhhC
Q 005718 515 NFSMQCKLGEGGFGPVYKGKL-LNGQE--VAVKRLSSQSGQ------------------------GLKEFKNEMMLIAKL 567 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~-~~~~~--VAVK~l~~~~~~------------------------~~~~f~~Ei~~l~~l 567 (681)
-|.+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+..+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 466788999999999999998 67888 999987543111 113688999999999
Q ss_pred CCCCe--eEEEEEEEeCCeEEEEEEecCC-C----ChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeee
Q 005718 568 QHRNL--VRLMGCCVEQGEKILIYEYMPN-K----SLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH-QYSRLRIIH 639 (681)
Q Consensus 568 ~H~nI--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivH 639 (681)
+|+++ +.++.. ...+|||||+.+ | +|.+.... .++.+...++.|++++|.||| +.+ |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 88753 444442 356899999942 4 66655421 123456789999999999999 777 999
Q ss_pred cccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 640 RDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 640 rDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||||+|||++. .+||+|||+|+....
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETTS
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCCC
Confidence 999999999988 999999999987743
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.75 E-value=1.1e-17 Score=146.85 Aligned_cols=107 Identities=16% Similarity=0.309 Sum_probs=89.4
Q ss_pred cccccCCCCccCCCCEEEeCCCeEEEEeeCCCCCCcEEEEEEEeCCCCceEEEccCCCCCcCCcceEEEeeCCcEEEEeC
Q 005718 24 ATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQ 103 (681)
Q Consensus 24 ~~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~l~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~ 103 (681)
+.++|.+||.|.+|+.|. +|.|.|.|+.+++ | +.|.....++||.+|+..+ +.++.|.|+.||||||+|.
T Consensus 5 ~~~tL~~gq~L~~g~~L~--~g~~~L~~q~dGN-----L-vL~~~~~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~d~ 74 (113)
T 3mez_B 5 VRNVLFSSQVMYDNAQLA--TRDYSLVMRDDCN-----L-VLTKGSKTNIVWESGTSGR--GQHCFMRLGHSGELDITDD 74 (113)
T ss_dssp CSSEEETTCEEETTCEEE--ETTEEEEECTTSC-----E-EEEETTTTEEEEECCCTTS--CSSCEEEECTTSCEEEECT
T ss_pred cCCEeCCCCEECCCCEeE--cCCEEEEEcCCCE-----E-EEEECCCCEEEEECCcccC--CcCEEEEEeCCCcEEEECC
Confidence 569999999999999997 4889999988876 4 3355324689999999876 3458999999999999999
Q ss_pred CCcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeee
Q 005718 104 TDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS 149 (681)
Q Consensus 104 ~~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqS 149 (681)
++.++|++++.+....+.|+|+||||||||+ .++|+|
T Consensus 75 ~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---------~~~W~s 111 (113)
T 3mez_B 75 RLNTVFVSNTVGQEGDYVLILQINGQAVVYG---------PAVWST 111 (113)
T ss_dssp TSCEEEECSCCCSSSCCEEEECTTSCEEEEC---------SEEEES
T ss_pred CCCEEEECCCcCCCCCEEEEEcCCceEEEec---------CCEecC
Confidence 8999999998654445789999999999995 369997
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.74 E-value=7.2e-18 Score=147.17 Aligned_cols=105 Identities=18% Similarity=0.305 Sum_probs=86.8
Q ss_pred ccccccCCCCccCCCCEEEeCCCeEEEEeeCCCCCCcEEEEEEEeCCCCceEEEccCCCCCcCCcceEEEeeCCcEEEEe
Q 005718 23 LATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLN 102 (681)
Q Consensus 23 ~~~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~l~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~ 102 (681)
++.|+|.+||.|.+|+.|+|. .|.|-|+.+++ | +.|.. ++||.+|+... +.++.|.|+.||||||+|
T Consensus 4 ~~~dtL~~gq~L~~g~~L~sg--~~~L~~q~dGn-----L-vl~~~---~~vW~snt~~~--~~~~~l~l~~dGNLvl~d 70 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTAK--NHQLVMQGDCN-----L-VLYGG---KYGWQSNTHGN--GEHCFLRLNHKGELIIKD 70 (110)
T ss_dssp CBTTEEETTCEEETTEEEECS--SCEEEECTTSC-----E-EEECS---SSCEECCCTTS--SSSCEEEECTTSCEEEEC
T ss_pred cccCEECCCCEecCCCEEEeC--CEEEEEcCCCe-----E-EEECC---eEEEECCCcCC--CcCEEEEEeCCCcEEEEe
Confidence 467999999999999999985 48887877775 3 33653 58999999863 345799999999999999
Q ss_pred CCCcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeee
Q 005718 103 QTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS 149 (681)
Q Consensus 103 ~~~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqS 149 (681)
.++.++|++++.+....+.|+|+||||||||+. ++|+|
T Consensus 71 ~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~~---------~~W~t 108 (110)
T 3r0e_B 71 DDFKTIWSSRSSSKQGEYVLILQDDGFGVIYGP---------AIFET 108 (110)
T ss_dssp TTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---------EEEES
T ss_pred CCCCEEEEcCCcCCCCCEEEEEcCCccEEEecC---------CEecC
Confidence 999999999986544457899999999999952 69997
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.71 E-value=3.9e-17 Score=142.27 Aligned_cols=108 Identities=20% Similarity=0.323 Sum_probs=89.9
Q ss_pred cccccCCCCccCCCCEEEeCCCeEEEEeeCCCCCCcEEEEEEEeCCCCceEEEccCCCCCcCCcceEEEeeCCcEEEEeC
Q 005718 24 ATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQ 103 (681)
Q Consensus 24 ~~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~l~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~ 103 (681)
+.|+|.+||.|.+|+.| .+|.|.|.|+.+++ -+.|.. +|.+|+..+ +.++.|.|+.||||||+|.
T Consensus 2 ~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN------Lvl~~~-----~Wssnt~~~--~~~~~l~l~~dGnLvl~d~ 66 (109)
T 3r0e_A 2 GTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN------LVLYNG-----NWQSNTANN--GRDCKLTLTDYGELVIKNG 66 (109)
T ss_dssp CCSEEETTCEECTTCEE--EETTEEEEECTTSC------EEEETT-----TEECCCTTS--CSSCEEEECTTSCEEEECT
T ss_pred ccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe------EEEEeC-----eEEcCCCCC--CCcEEEEEcCCCeEEEEeC
Confidence 67999999999999999 57999999988886 244552 799998875 3468999999999999999
Q ss_pred CCcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCCccccCC
Q 005718 104 TDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIG 160 (681)
Q Consensus 104 ~~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~PtDtlLpg 160 (681)
++.++|++++.+......|+|+||||||||+ .++|+| .|.+||
T Consensus 67 ~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---------~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 67 DGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---------PSVFKI-----DPWVRG 109 (109)
T ss_dssp TSCEEEECCCCCSSSCCEEEEETTTEEEEEC---------SEEEEE-----CTTSCC
T ss_pred CCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---------cCEECC-----CCccCC
Confidence 8999999998654446789999999999995 369996 555554
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.70 E-value=8.9e-17 Score=141.04 Aligned_cols=97 Identities=23% Similarity=0.397 Sum_probs=79.5
Q ss_pred CCCcCCcceEEEeeCCcEEEEeCCCcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCCccccCC
Q 005718 81 SPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIG 160 (681)
Q Consensus 81 ~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~PtDtlLpg 160 (681)
.|+.+....|.|+.||+|+|++. +.+||++++.+......|+|+++|||||++ . +.++||||+
T Consensus 14 ~~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~------~~~~W~S~~--------- 76 (112)
T 1xd5_A 14 GSLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-G------SRAIWASNT--------- 76 (112)
T ss_dssp CEEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-T------TEEEEECCC---------
T ss_pred CEEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-C------CEEEEECCc---------
Confidence 34445557899999999999988 789999998653345789999999999998 4 579999993
Q ss_pred ccccceeccCceeEEEEeccCCCCCCcceEEEeecCCccEEEEEc-CCeEEEeeCCCCC
Q 005718 161 MNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYN-GSVKLSCTGPWNG 218 (681)
Q Consensus 161 q~l~~~~~~g~~~~l~S~~s~~dps~G~y~~~~~~~g~~~~~~~~-~~~~~w~sg~w~g 218 (681)
+|++|.|+++|+++|. +++|+ +...||++++|+|
T Consensus 77 ----------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 ----------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp ----------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred ----------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4456889999999998 45565 4679999999986
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.7e-16 Score=138.64 Aligned_cols=90 Identities=21% Similarity=0.331 Sum_probs=74.7
Q ss_pred CCcceEEEeeCCcEEEEeCCCcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCCccccCCcccc
Q 005718 85 DSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMG 164 (681)
Q Consensus 85 ~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~PtDtlLpgq~l~ 164 (681)
+...+|.|+.||||||++ .+.+||++++.+......|+|+|+|||||++.+ +.++||||
T Consensus 19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~------~~~~W~S~-------------- 77 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQS------NRVIWQTK-------------- 77 (110)
T ss_dssp TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT------CCEEEECC--------------
T ss_pred CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCC------CcEEEecC--------------
Confidence 345789999999999999 478999999875444678999999999999863 67999999
Q ss_pred ceeccCceeEEEEeccCCCCCCcceEEEeecCCccEEEEEcCCeEEEeeCCC
Q 005718 165 WDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPW 216 (681)
Q Consensus 165 ~~~~~g~~~~l~S~~s~~dps~G~y~~~~~~~g~~~~~~~~~~~~~w~sg~w 216 (681)
.++++|.|+++|+++|. ++++++ .||+++++
T Consensus 78 -----------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 -----------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp -----------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred -----------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 24567899999999998 455765 89999876
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.62 E-value=2.3e-15 Score=133.17 Aligned_cols=86 Identities=24% Similarity=0.293 Sum_probs=72.3
Q ss_pred ceEEEeeCCcEEEEeCCCcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCCccccCCcccccee
Q 005718 88 AVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDL 167 (681)
Q Consensus 88 ~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~PtDtlLpgq~l~~~~ 167 (681)
..|.|+.||+|+|++. +.+||++++.+......|+|+|+|||||++.+ +.++||||
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~------~~~lW~S~----------------- 87 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE------NVTVWQSP----------------- 87 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT------CCEEEECS-----------------
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCC------CcEEEcCC-----------------
Confidence 6799999999999998 78999999875444578999999999999863 67999999
Q ss_pred ccCceeEEEEeccCCCCCCcceEEEeecCCccEEEEEcCCeEEEeeCC
Q 005718 168 KTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP 215 (681)
Q Consensus 168 ~~g~~~~l~S~~s~~dps~G~y~~~~~~~g~~~~~~~~~~~~~w~sg~ 215 (681)
.+|++|.|+++|+++|. +++++ ..||++|+
T Consensus 88 --------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 --------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp --------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred --------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 34567999999999998 44555 38999886
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.61 E-value=2e-15 Score=131.89 Aligned_cols=103 Identities=16% Similarity=0.262 Sum_probs=84.1
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEEeeCCCCCCcEEEEEEEeCCCCceEEEccCCCCCcCCcceEEEeeCCcEEEEeCC
Q 005718 25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT 104 (681)
Q Consensus 25 ~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~l~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (681)
.++|.+||.|.+|+.| .+|.|.|.|+.+++ | +.|.. . . ||.+|+..+ +.++.|.|+.||||||+|.+
T Consensus 2 ~~~l~~gq~L~~g~~L--~~g~~~L~~q~dGn-----L-vl~~~-~-~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~~ 68 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQL--SYESAAFVMQGDCN-----L-VLYNE-A-G-GFQSNTHGR--GVDCTLRLNNRGQLEIHSAN 68 (111)
T ss_dssp TTEEETTCEECTTCEE--EETTEEEEECTTSC-----E-EEECS-S-C-CEECCCTTS--CSSCEEEECTTSCEEEECSS
T ss_pred cCEeCCCCEeCCCCEE--ecCCEEEEEccCCe-----E-EEECC-C-C-EEECCcccC--CcCEEEEEcCCCcEEEEeCC
Confidence 4789999999999999 47899999988876 3 44653 2 3 999999876 34589999999999999987
Q ss_pred Cc-EEEeecCcc--ccCCceEEEecCCCEEEeecCCCCCCCCceeeee
Q 005718 105 DG-IIWSSNLSR--EVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS 149 (681)
Q Consensus 105 ~~-~~w~~~~~~--~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqS 149 (681)
+. ++|+|++.. ......|+|++|||||||+ .++|+|
T Consensus 69 ~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---------~~~W~s 107 (111)
T 3mez_A 69 SNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---------PAIWST 107 (111)
T ss_dssp CSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---------SEEEEC
T ss_pred CCEEEEEeccccCCCCcCEEEEECCCCeEEEec---------cCEEcc
Confidence 76 599998642 2345789999999999995 369997
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=3e-15 Score=131.88 Aligned_cols=91 Identities=30% Similarity=0.369 Sum_probs=75.6
Q ss_pred cceEEEeeCCcEEEEeCCCcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCCccccCCccccce
Q 005718 87 NAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWD 166 (681)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~PtDtlLpgq~l~~~ 166 (681)
...|.|+.||+|+|++ .+.+||++++.+......++|+++|||||++.+ +.++||||++
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~------~~~vW~S~~~-------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHN------NNDVWGSACW-------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTT------CCEEEECCCC--------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCC------ceEEEEcCCC--------------
Confidence 4679999999999998 478999999865444578999999999999853 6799999997
Q ss_pred eccCceeEEEEeccCCCCCCcceEEEeecCCccEEEEEcCCeEEEeeCCCCCc
Q 005718 167 LKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNGL 219 (681)
Q Consensus 167 ~~~g~~~~l~S~~s~~dps~G~y~~~~~~~g~~~~~~~~~~~~~w~sg~w~g~ 219 (681)
+++|.|++.|+++|+ ++++++ .||++++|...
T Consensus 80 -----------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 -----------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp -----------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred -----------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 345789999999998 455665 89999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.1e-15 Score=162.20 Aligned_cols=143 Identities=13% Similarity=0.162 Sum_probs=104.5
Q ss_pred HHHHhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCc--------------ccHH--------HHHHHHHHHh
Q 005718 508 SVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG--------------QGLK--------EFKNEMMLIA 565 (681)
Q Consensus 508 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~--------------~~~~--------~f~~Ei~~l~ 565 (681)
.+.....-|.+.+.||+|+||.||+|...+|+.||||+++.... .... ....|...|.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 33444445899999999999999999998999999998764210 0001 1245677777
Q ss_pred hCCCCCe--eEEEEEEEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccC
Q 005718 566 KLQHRNL--VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLK 643 (681)
Q Consensus 566 ~l~H~nI--v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlk 643 (681)
++++.++ ...++. . ..+|||||+++++|..+... .....++.||+.+|.|||..+ |||||||
T Consensus 169 rL~~~gv~vp~p~~~--~--~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLK 232 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQ--S--RHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFN 232 (397)
T ss_dssp HHHHTTCSCCCEEEE--E--TTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred HHHhcCCCCCeeeec--c--CceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCC
Confidence 7755544 333332 2 23799999999888655411 123467899999999999987 9999999
Q ss_pred CCcEEEcCCC----------CeEEeecCCceee
Q 005718 644 ASNILLDSDM----------NPKISDFGMARMF 666 (681)
Q Consensus 644 p~NiLl~~~~----------~~kl~DFGla~~~ 666 (681)
|.||||++++ .+.|+||+=+...
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9999998876 3899999977654
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.37 E-value=2.5e-12 Score=112.58 Aligned_cols=96 Identities=19% Similarity=0.267 Sum_probs=74.5
Q ss_pred CCCCCcCCcceEEEeeCCcEEEEeC-CCcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCCccc
Q 005718 79 RNSPIVDSNAVLTIGNNGNLVLLNQ-TDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTL 157 (681)
Q Consensus 79 ~~~p~~~~~~~l~~~~~g~l~l~~~-~~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~PtDtl 157 (681)
.++|+.+....|.++.||||||++. .+.++|++++.+......|+|+++|||||++.+ +.++|||=.+
T Consensus 17 ~g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~------~~~iW~S~t~----- 85 (113)
T 3mez_B 17 DNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDR------LNTVFVSNTV----- 85 (113)
T ss_dssp TTCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTT------SCEEEECSCC-----
T ss_pred CCCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCC------CCEEEECCCc-----
Confidence 4556665667899999999999998 488999999875444678999999999999864 6789997211
Q ss_pred cCCccccceeccCceeEEEEeccCCCCCCcceEEEeecCCccEEEEEcCCeEEEeeCC
Q 005718 158 LIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP 215 (681)
Q Consensus 158 Lpgq~l~~~~~~g~~~~l~S~~s~~dps~G~y~~~~~~~g~~~~~~~~~~~~~w~sg~ 215 (681)
...|.|.+.|+.+|.+.++ + ...|.+|+
T Consensus 86 --------------------------~~~~~~~~~L~~dGnlvly--~--~~~W~s~~ 113 (113)
T 3mez_B 86 --------------------------GQEGDYVLILQINGQAVVY--G--PAVWSTAA 113 (113)
T ss_dssp --------------------------CSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred --------------------------CCCCCEEEEEcCCceEEEe--c--CCEecCCC
Confidence 0125689999999998764 4 57898875
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.34 E-value=3.8e-12 Score=110.99 Aligned_cols=96 Identities=17% Similarity=0.196 Sum_probs=72.4
Q ss_pred CCCCcCCcceEEEeeCCcEEEEeCCCcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCCccccC
Q 005718 80 NSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLI 159 (681)
Q Consensus 80 ~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~PtDtlLp 159 (681)
+.++......|.++.||||||++..+ +|++++.+......|+|+++|||||++.+ ...++|||..+
T Consensus 14 g~~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~-----~~~~vW~S~t~------- 79 (111)
T 3mez_A 14 DNQLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSAN-----SNTPVWVYPRS------- 79 (111)
T ss_dssp TCEEEETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSS-----CSSCSEEESSS-------
T ss_pred CCEEecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCC-----CCEEEEEeccc-------
Confidence 34444455789999999999999876 99999875444579999999999999864 23369998621
Q ss_pred CccccceeccCceeEEEEeccCCCCCCcceEEEeecCCccEEEEEcCCeEEEeeCC
Q 005718 160 GMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP 215 (681)
Q Consensus 160 gq~l~~~~~~g~~~~l~S~~s~~dps~G~y~~~~~~~g~~~~~~~~~~~~~w~sg~ 215 (681)
.....|.|.+.|+++|.+.++ + ..+|.++.
T Consensus 80 ----------------------~~~~~~~~~l~Lq~dGNlvly--~--~~~W~s~t 109 (111)
T 3mez_A 80 ----------------------VNTVRGNYAATLGPDQHVTIY--G--PAIWSTPA 109 (111)
T ss_dssp ----------------------CCCCSSCCEEEECTTSCEEEE--C--SEEEECCC
T ss_pred ----------------------cCCCCcCEEEEECCCCeEEEe--c--cCEEccCC
Confidence 011347899999999998765 4 57898775
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=9.1e-12 Score=126.62 Aligned_cols=111 Identities=19% Similarity=0.418 Sum_probs=85.9
Q ss_pred ccccccCCCCc----cCCCCEEEeC----CCeEEEEeeCCCCCCcEEEEEEEeCCCCceEEEccCCCCCcCCcceEEEee
Q 005718 23 LATDTITPATL----IGDGEKLVSS----SQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGN 94 (681)
Q Consensus 23 ~~~~~l~~g~~----l~~~~~l~S~----~g~f~~gf~~~~~~~~~~l~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~ 94 (681)
...|++.||++ |..|+.|.|+ .|.|.|.+...+ ..+ + |.+ ..+++|.+++..+ +. +.|.++.
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S~~dps~G~fsl~l~~dG---nlv--L-y~~-~~~~yW~Sgt~~~--~~-~~l~l~~ 203 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGDG---NLV--A-YGP-NGAATWNAGTQGK--GA-VRAVFQG 203 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECTTCEEEETTEEEEECTTS---CEE--E-ECT-TSSEEEECCCTTT--TC-CEEEECT
T ss_pred ccccccccccccccccccCcccccCCCCCCceEEEeecCCc---eEE--E-EeC-CCeEEEECCCCCC--cc-EEEEEcC
Confidence 34689999999 8888888654 355555554444 232 2 443 3589999999876 23 7899999
Q ss_pred CCcEEEEeCCCcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccC
Q 005718 95 NGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDC 152 (681)
Q Consensus 95 ~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~ 152 (681)
||+|+++|.++.++|++++.+. ....|+|++|||||||+. .++|||||+
T Consensus 204 dGnLvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~~--------~~~Wqsf~~ 252 (276)
T 3m7h_A 204 DGNLVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILDE--------KPVWARFGF 252 (276)
T ss_dssp TSCEEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEEE--------EEEEESSSC
T ss_pred CCeEEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEcC--------CCeEEccCc
Confidence 9999999998889999997653 458999999999999962 479999998
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=1.1e-11 Score=125.79 Aligned_cols=147 Identities=18% Similarity=0.093 Sum_probs=115.2
Q ss_pred HhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEE
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
.....|.+...++.|+.+.||+.... ++.+++|+...........+.+|+.+++.+ +|..+.++++++.+.+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 34456888888888889999999864 678999998753222334688899999988 4678899999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS------------------------------------ 633 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------ 633 (681)
||+++.+|.+.+.. ......++.+++++|..||...
T Consensus 90 e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 99999999876411 1223477889999999999811
Q ss_pred --------------------CCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 634 --------------------RLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 634 --------------------~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
...++|+|++|.|||++++..+.|+||+.|..-
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 134899999999999987666779999988643
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.19 E-value=7.4e-11 Score=102.58 Aligned_cols=87 Identities=20% Similarity=0.275 Sum_probs=67.2
Q ss_pred CcceEEEeeCCcEEEEeCCCcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCCccccCCccccc
Q 005718 86 SNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGW 165 (681)
Q Consensus 86 ~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~PtDtlLpgq~l~~ 165 (681)
....|.++.||||||++. .++|++++.+......++|+++|||||++.+ +.++|||-.+-
T Consensus 24 g~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~------~~~iW~S~t~~------------ 83 (110)
T 3r0e_B 24 KNHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDD------FKTIWSSRSSS------------ 83 (110)
T ss_dssp SSCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTT------CCEEEECCCCC------------
T ss_pred CCEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCC------CCEEEEcCCcC------------
Confidence 347899999999999987 5899999875434578999999999999864 67899983210
Q ss_pred eeccCceeEEEEeccCCCCCCcceEEEeecCCccEEEEEcCCeEEEeeCC
Q 005718 166 DLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP 215 (681)
Q Consensus 166 ~~~~g~~~~l~S~~s~~dps~G~y~~~~~~~g~~~~~~~~~~~~~w~sg~ 215 (681)
..|.|.+.++++|++.++ + ...|.+|.
T Consensus 84 -------------------~~~~~~~~L~~dGNlvly--~--~~~W~t~~ 110 (110)
T 3r0e_B 84 -------------------KQGEYVLILQDDGFGVIY--G--PAIFETSS 110 (110)
T ss_dssp -------------------SSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred -------------------CCCCEEEEEcCCccEEEe--c--CCEecCCC
Confidence 124589999999998664 4 37888763
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=1.2e-10 Score=101.12 Aligned_cols=87 Identities=23% Similarity=0.287 Sum_probs=67.1
Q ss_pred cceEEEeeCCcEEEEeCCCcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCCccccCCccccce
Q 005718 87 NAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWD 166 (681)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~PtDtlLpgq~l~~~ 166 (681)
...|.|+.||||||++. +.++|++++.+......++|+++|||||++.+ +.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~------~~~~W~S~t~~------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPR------NNPIWASNTGG------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTT------SCEEEECCCCC-------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCC------CCEEEECCCCC-------------
Confidence 47899999999999988 68999999875434578999999999999864 67899974211
Q ss_pred eccCceeEEEEeccCCCCCCcceEEEeecCCccEEEEEcCCeEEEeeCC
Q 005718 167 LKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP 215 (681)
Q Consensus 167 ~~~g~~~~l~S~~s~~dps~G~y~~~~~~~g~~~~~~~~~~~~~w~sg~ 215 (681)
..+.|.+.++++|++.++ +. ..|.++.
T Consensus 80 ------------------~~~~~~~~L~ddGNlvly--~~--~~W~s~t 106 (109)
T 3dzw_A 80 ------------------ENGNYVCVLQKDRNVVIY--GT--ARWATGT 106 (109)
T ss_dssp ------------------SSSCEEEEECTTSCEEEE--ES--CCCCCCC
T ss_pred ------------------CCCCEEEEEeCCCEEEEE--CC--CEEeCCC
Confidence 124688999999998664 32 5676654
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.16 E-value=1e-10 Score=101.43 Aligned_cols=94 Identities=23% Similarity=0.356 Sum_probs=71.6
Q ss_pred CCCCCcCCcceEEEeeCCcEEEEeCCCcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCCcccc
Q 005718 79 RNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLL 158 (681)
Q Consensus 79 ~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~PtDtlL 158 (681)
.++|+.+....|.++.||||||+++ +|++++.+......++|+++|||||++.+ +.++|+|- |
T Consensus 14 ~g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~------~~~vWss~-----t-- 76 (109)
T 3r0e_A 14 TEGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGD------GSTVWKSG-----A-- 76 (109)
T ss_dssp TTCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTT------SCEEEECC-----C--
T ss_pred CCCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCC------CCEEEcCC-----C--
Confidence 3444444557899999999999985 79999875444678999999999999864 67899751 1
Q ss_pred CCccccceeccCceeEEEEeccCCCCCCcceEEEeecCCccEEEEEcCCeEEEeeCCCC
Q 005718 159 IGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWN 217 (681)
Q Consensus 159 pgq~l~~~~~~g~~~~l~S~~s~~dps~G~y~~~~~~~g~~~~~~~~~~~~~w~sg~w~ 217 (681)
....+.|.+.++++|+..++ + ...|.+++|-
T Consensus 77 ------------------------~~~~~~~~~~L~~dGNlvly--~--~~~W~s~t~~ 107 (109)
T 3r0e_A 77 ------------------------QSVKGNYAAVVHPDGRLVVF--G--PSVFKIDPWV 107 (109)
T ss_dssp ------------------------CCSSSCCEEEEETTTEEEEE--C--SEEEEECTTS
T ss_pred ------------------------cCCCcCEEEEEcCCCeEEEE--e--cCEECCCCcc
Confidence 00235789999999987664 4 5889999884
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=1e-10 Score=117.96 Aligned_cols=139 Identities=17% Similarity=0.180 Sum_probs=103.1
Q ss_pred CCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCC--eeEEEEEEEeCCeEEEEEEe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN--LVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~Ey 591 (681)
..+.+....+.|..+.||+....+++.+++|..... ....+..|+.+++.+++.+ +.+++++...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 345543333455669999998777788999987653 2345778999988885434 66789988888889999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS-------------------------------------- 633 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------------- 633 (681)
+++.+|. ... .. ...++.++++.|..||...
T Consensus 97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9998884 211 11 2356788888888888743
Q ss_pred -----------------CCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 634 -----------------RLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 634 -----------------~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
...++|+|++|.|||++++..++|+||+.|...
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 123999999999999987766779999998764
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.99 E-value=2.5e-09 Score=91.97 Aligned_cols=83 Identities=23% Similarity=0.335 Sum_probs=63.5
Q ss_pred ceEEEeeCCcEEEEeCCCcEEEeecCccc-cCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCCccccCCccccce
Q 005718 88 AVLTIGNNGNLVLLNQTDGIIWSSNLSRE-VKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWD 166 (681)
Q Consensus 88 ~~l~~~~~g~l~l~~~~~~~~w~~~~~~~-~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~PtDtlLpgq~l~~~ 166 (681)
-+|.++.||||||++. +.+||++++... .....+.|+++|||||+|.+ +.++|+|= |
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~------~~~vWss~-----t---------- 78 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSS------GRSLWASH-----S---------- 78 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTT------CCEEEECC-----C----------
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCC------cEEEEEec-----C----------
Confidence 5799999999999985 579999998643 34578999999999999874 77899861 0
Q ss_pred eccCceeEEEEeccCCCCCCcceEEEeecCCccEEEEEcCCeEEEe
Q 005718 167 LKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSC 212 (681)
Q Consensus 167 ~~~g~~~~l~S~~s~~dps~G~y~~~~~~~g~~~~~~~~~~~~~w~ 212 (681)
....+.|.+.|+++|++.++ +. ..|.
T Consensus 79 ----------------~~~~~~~~l~L~ddGNlVly--~~--~~W~ 104 (105)
T 4h3o_A 79 ----------------TRGSGNYILILQDDGNVIIY--GS--DIWS 104 (105)
T ss_dssp ----------------CCCSSCEEEEECTTSCEEEE--ES--EEEE
T ss_pred ----------------CCCCCCEEEEEeCCCeEEEE--CC--cEec
Confidence 11346789999999998664 32 4665
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.3e-09 Score=115.79 Aligned_cols=142 Identities=13% Similarity=0.224 Sum_probs=106.8
Q ss_pred ceeeecccCcEeEEEEEecCCcEEEEEEec--CCC-cccHHHHHHHHHHHhhCC--CCCeeEEEEEEEeC---CeEEEEE
Q 005718 518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLS--SQS-GQGLKEFKNEMMLIAKLQ--HRNLVRLMGCCVEQ---GEKILIY 589 (681)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~--~~~-~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~---~~~~lV~ 589 (681)
..+.|+.|.+..||+....+ ..+++|+.. ... ......+.+|..+++.++ +..++++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 45789999999999998754 577788765 321 123457788999999886 45688999988776 3589999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS------------------------------------ 633 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------ 633 (681)
||+++..+.+.. ...++..++..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998774322 123677888899999999999999731
Q ss_pred -------------------CCCeeecccCCCcEEEcCCCC--eEEeecCCcee
Q 005718 634 -------------------RLRIIHRDLKASNILLDSDMN--PKISDFGMARM 665 (681)
Q Consensus 634 -------------------~~~ivHrDlkp~NiLl~~~~~--~kl~DFGla~~ 665 (681)
...++|+|++|.|||++.++. +.|.||++|..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999999875
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.92 E-value=3e-09 Score=105.94 Aligned_cols=89 Identities=26% Similarity=0.289 Sum_probs=70.4
Q ss_pred cceEEEeeCCcEEEEeCCCcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCCccccCCccccce
Q 005718 87 NAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWD 166 (681)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~PtDtlLpgq~l~~~ 166 (681)
.-.|.|+.||+|+|++. +.+||.+++.+. ....++|+++|||||++.+ +.++|+|+++
T Consensus 27 ~f~l~f~~~gnl~ly~~-~~~vW~an~~~~-~~~~l~l~~dGnLvl~d~~------~~~vW~s~~~-------------- 84 (236)
T 1dlp_A 27 SFRFTMQSDCNLVLFDS-DVRVWASNTAGA-TGCRAVLQSDGLLVILTAQ------NTIRWSSGTK-------------- 84 (236)
T ss_dssp TEEEEECTTSCEEEEES-SSEEECCCCCSC-SCCBCCBCSSSCBCCBCTT------TCCSCCCCCC--------------
T ss_pred CEEEEECCCCcEEEEEC-CEEEEECCCCCC-CCeEEEEcCCCcEEEEcCC------CcEEEeCCcc--------------
Confidence 35788888999999987 689999998654 5678999999999999864 7789999865
Q ss_pred eccCceeEEEEeccCCCCCCcceEEEeecCCccEEEEEcCCeEEEeeCCCCC
Q 005718 167 LKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPWNG 218 (681)
Q Consensus 167 ~~~g~~~~l~S~~s~~dps~G~y~~~~~~~g~~~~~~~~~~~~~w~sg~w~g 218 (681)
..+|.|.+.|+.+|++.++ +. .+|.+..+..
T Consensus 85 -----------------~~~~~~~~~l~d~Gnlvl~--~~--~~W~S~~~p~ 115 (236)
T 1dlp_A 85 -----------------GSIGNYVLVLQPDRTVTIY--GP--GLWDSGTSNK 115 (236)
T ss_dssp -----------------CCSSCCEEEECSSSCEEEE--CS--EEEECSCCCS
T ss_pred -----------------ccCCcEEEEEeCCCCEEEe--cC--CEEECCCCCC
Confidence 0235688999999987664 32 8999877653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.43 E-value=3.4e-07 Score=94.61 Aligned_cols=136 Identities=20% Similarity=0.227 Sum_probs=99.9
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCC--eeEEEEEEEeCC---eEEEEEEecC
Q 005718 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRN--LVRLMGCCVEQG---EKILIYEYMP 593 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~n--Iv~l~g~~~~~~---~~~lV~Ey~~ 593 (681)
+.++.|....||+.. ..+++|+... ......+.+|.+++..+ .+.. +.+++......+ ..++|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 568999999999853 4688887653 23456789999999887 4433 456665543333 3488999999
Q ss_pred CCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 005718 594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS---------------------------------------- 633 (681)
Q Consensus 594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------- 633 (681)
+..|..... ..++..++..++.++++.|+.||...
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 988865331 23566777888888888888888621
Q ss_pred ---------------CCCeeecccCCCcEEEcC--CCCeEEeecCCceee
Q 005718 634 ---------------RLRIIHRDLKASNILLDS--DMNPKISDFGMARMF 666 (681)
Q Consensus 634 ---------------~~~ivHrDlkp~NiLl~~--~~~~kl~DFGla~~~ 666 (681)
...++|+|++|.||++++ ...+.|+||+.+..-
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 135899999999999998 456889999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=2.8e-06 Score=87.85 Aligned_cols=137 Identities=21% Similarity=0.199 Sum_probs=97.5
Q ss_pred eeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCC---CeeEEEEEEE-eCCeEEEEEEecCC
Q 005718 519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHR---NLVRLMGCCV-EQGEKILIYEYMPN 594 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~l~g~~~-~~~~~~lV~Ey~~~ 594 (681)
.+.++.|....||+. ++.+++|+... ......+..|.++|..+.+. .+.+++.++. ..+..++||||+++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 367888888899987 46778887532 33456789999999999642 4677777775 34567899999999
Q ss_pred CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 005718 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY------------------------------------------ 632 (681)
Q Consensus 595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------------ 632 (681)
..+...... .++..++..++.++++.|+.||..
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888663211 134455556666666666666643
Q ss_pred ---------------CCCCeeecccCCCcEEEcC---CCC-eEEeecCCceee
Q 005718 633 ---------------SRLRIIHRDLKASNILLDS---DMN-PKISDFGMARMF 666 (681)
Q Consensus 633 ---------------~~~~ivHrDlkp~NiLl~~---~~~-~kl~DFGla~~~ 666 (681)
....++|+|++|.|||++. ++. +.|+||+.+..-
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2234699999999999987 455 489999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=2.7e-06 Score=86.01 Aligned_cols=137 Identities=18% Similarity=0.176 Sum_probs=97.4
Q ss_pred eeecccCcE-eEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEEEEecCCCC
Q 005718 520 CKLGEGGFG-PVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKS 596 (681)
Q Consensus 520 ~~LG~G~fG-~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 596 (681)
+.+..|..+ .||+.... ++..+.+|+-.. ....++.+|...|+.+ .+--|.++++++.+.+..++|||++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345555554 68988764 456788887653 2356788899988887 34558899999999999999999999988
Q ss_pred hhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 005718 597 LNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS------------------------------------------- 633 (681)
Q Consensus 597 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------------- 633 (681)
+.+.... .......+..++++.|..||...
T Consensus 107 ~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 7665411 01122345556666666666421
Q ss_pred ------------CCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 634 ------------RLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 634 ------------~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
...++|+|+.+.|||++.+..+-|+||+.|..-
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 123799999999999998777789999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=3.3e-06 Score=89.19 Aligned_cols=80 Identities=8% Similarity=0.013 Sum_probs=55.6
Q ss_pred eeee-cccCcEeEEEEEec-------CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCC-C--CCeeEEEEEEEeC--
Q 005718 519 QCKL-GEGGFGPVYKGKLL-------NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQ-H--RNLVRLMGCCVEQ-- 582 (681)
Q Consensus 519 ~~~L-G~G~fG~Vy~~~~~-------~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~-H--~nIv~l~g~~~~~-- 582 (681)
.+.| +.|....+|+.... +++.+++|+..... ......+..|+.+++.+. + ..+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88888999998764 25678888765422 111245678888888773 2 4678888887655
Q ss_pred -CeEEEEEEecCCCChh
Q 005718 583 -GEKILIYEYMPNKSLN 598 (681)
Q Consensus 583 -~~~~lV~Ey~~~gsL~ 598 (681)
+..++||||+++..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987664
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=4.1e-05 Score=82.06 Aligned_cols=75 Identities=9% Similarity=0.134 Sum_probs=50.4
Q ss_pred eeeecccCcEeEEEEEec-CCcEEEEEEecCCCc-------ccHHHHHHHHHHHhhCCC---CCeeEEEEEEEeCCeEEE
Q 005718 519 QCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG-------QGLKEFKNEMMLIAKLQH---RNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~-------~~~~~f~~Ei~~l~~l~H---~nIv~l~g~~~~~~~~~l 587 (681)
.+.||.|..+.||++... +++.++||....... ...+++..|.+++..+.+ ..+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999764 467899997653211 233566778888887732 345566654 4555689
Q ss_pred EEEecCCC
Q 005718 588 IYEYMPNK 595 (681)
Q Consensus 588 V~Ey~~~g 595 (681)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.83 E-value=9.8e-05 Score=76.93 Aligned_cols=141 Identities=16% Similarity=0.161 Sum_probs=80.8
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCC--CCCeeEEEE------EEEeCCeEEEEEEe
Q 005718 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ--HRNLVRLMG------CCVEQGEKILIYEY 591 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~--H~nIv~l~g------~~~~~~~~~lV~Ey 591 (681)
+.|+.|....||+....++ .+++|+.... ..++..|..++..+. .-.+++++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999987554 5888888752 233344555554442 123344443 12346778999999
Q ss_pred cCCCChh-----h------H---hc----CCC-C------CCCCCHHHHH------------------------------
Q 005718 592 MPNKSLN-----F------F---LF----DPS-R------THLLGWQTRV------------------------------ 616 (681)
Q Consensus 592 ~~~gsL~-----~------~---l~----~~~-~------~~~l~~~~~~------------------------------ 616 (681)
+++..+. . . ++ ... . .....|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 0 0 10 100 0 0112332211
Q ss_pred -HHHHHHHHHHHHHHh----------CCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 617 -KIIEGIAQGLLYLHQ----------YSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 617 -~i~~~ia~~L~yLH~----------~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
.+..++.+++++|+. .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111224456667763 1245699999999999998888999999998864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00017 Score=73.60 Aligned_cols=80 Identities=16% Similarity=0.234 Sum_probs=59.3
Q ss_pred CCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCC-C--CCeeEEEEEEEeCCeEEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-H--RNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H--~nIv~l~g~~~~~~~~~lV~E 590 (681)
....-.+.+|.|..+.||+.++.+|+.+.+|+...........|..|.+.|+.+. . .-+++++++ +. .++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEE
Confidence 3455567899999999999999999999999876544444567888999888774 2 245666654 22 378999
Q ss_pred ecCCCCh
Q 005718 591 YMPNKSL 597 (681)
Q Consensus 591 y~~~gsL 597 (681)
|++.+..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00021 Score=73.71 Aligned_cols=139 Identities=20% Similarity=0.133 Sum_probs=92.6
Q ss_pred ceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCC---CCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 518 MQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ---HRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
-.+.|+.|....+|+... +++.+.+|+.... ....+..|.+.|+.+. ...++++++++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346799999999999886 4667888876542 3567888988888873 36788999998888899999999998
Q ss_pred CChhh--------H---hcCCCC-C------------------CCCCHHHHH---HHH----------------HHHHHH
Q 005718 595 KSLNF--------F---LFDPSR-T------------------HLLGWQTRV---KII----------------EGIAQG 625 (681)
Q Consensus 595 gsL~~--------~---l~~~~~-~------------------~~l~~~~~~---~i~----------------~~ia~~ 625 (681)
..+.. . |+.... . -.-+|.+.. ++. ..+..-
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 76521 1 111100 0 012454322 111 111111
Q ss_pred -HHHHHh-CCCCCeeecccCCCcEEEcCCCCeEEeecC
Q 005718 626 -LLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFG 661 (681)
Q Consensus 626 -L~yLH~-~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG 661 (681)
...|.. ..++.++|+|+.+.|++++.++ +.|.||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223421 2346799999999999999887 8999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00033 Score=75.53 Aligned_cols=73 Identities=12% Similarity=0.160 Sum_probs=46.3
Q ss_pred eeeecccCcEeEEEEEecCCcEEEEEEecCC------C-c--ccHHHHHHHHHHHh-hCCCCCeeEEEEEEEeCCeEEEE
Q 005718 519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ------S-G--QGLKEFKNEMMLIA-KLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~------~-~--~~~~~f~~Ei~~l~-~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
.+.||.|....||+... +++.++||..... . . .....+..|+..+. ...+..+++++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 47899999999999965 4678899933211 0 1 12334444544332 22335677777765 5667899
Q ss_pred EEec-CC
Q 005718 589 YEYM-PN 594 (681)
Q Consensus 589 ~Ey~-~~ 594 (681)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0016 Score=67.24 Aligned_cols=158 Identities=13% Similarity=0.116 Sum_probs=86.1
Q ss_pred cHHHHHHhhCCCCc-----eeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCC--CCeeEEEE
Q 005718 505 SLASVSAATENFSM-----QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH--RNLVRLMG 577 (681)
Q Consensus 505 ~~~~~~~~~~~f~~-----~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g 577 (681)
+..++......|.+ .+.|+.|....+|+....++ .+++|..... ...+++..|+.++..+.. -.+.+++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 33444444444543 24567788889999987655 5778887652 122345567776666532 12334432
Q ss_pred E------EEeCCeEEEEEEecCCCChhh----H----------hc----CCCCC--C---CCCHHHHHH-----------
Q 005718 578 C------CVEQGEKILIYEYMPNKSLNF----F----------LF----DPSRT--H---LLGWQTRVK----------- 617 (681)
Q Consensus 578 ~------~~~~~~~~lV~Ey~~~gsL~~----~----------l~----~~~~~--~---~l~~~~~~~----------- 617 (681)
. ....+..++++||+++..+.. . ++ ..... . ...|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 123466789999998865421 0 10 10000 0 112322111
Q ss_pred -HHHHHHHHHHHHHhC----CCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 618 -IIEGIAQGLLYLHQY----SRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 618 -i~~~ia~~L~yLH~~----~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
+...+.+.++.++.. ....++|+|+.+.|||++.+..+.|+||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244555666532 234689999999999998876668999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0031 Score=65.44 Aligned_cols=33 Identities=27% Similarity=0.431 Sum_probs=28.1
Q ss_pred CCCeeecccCCCcEEEcCC----CCeEEeecCCceee
Q 005718 634 RLRIIHRDLKASNILLDSD----MNPKISDFGMARMF 666 (681)
Q Consensus 634 ~~~ivHrDlkp~NiLl~~~----~~~kl~DFGla~~~ 666 (681)
...++|+|+.+.|||++.+ ..+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 4469999999999999874 67999999998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0059 Score=62.99 Aligned_cols=143 Identities=15% Similarity=0.144 Sum_probs=82.7
Q ss_pred eeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCC--CCeeEEEEE-----EEeCCeEEEEEEec
Q 005718 520 CKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH--RNLVRLMGC-----CVEQGEKILIYEYM 592 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~-----~~~~~~~~lV~Ey~ 592 (681)
..++ |....||+....+|+.+++|..... ....+.+..|..++..+.. -.+++++.. ....+..+++||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 7778899987767778999988643 1234566778877777632 234444442 22355678999999
Q ss_pred CCCChhh-----H---------hc----CCC--CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhC-
Q 005718 593 PNKSLNF-----F---------LF----DPS--RTHLLGWQTR----VKI---------------IEGIAQGLLYLHQY- 632 (681)
Q Consensus 593 ~~gsL~~-----~---------l~----~~~--~~~~l~~~~~----~~i---------------~~~ia~~L~yLH~~- 632 (681)
++..+.. . ++ ... ......+... ..+ ...+.+.++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8754320 0 00 000 0111222111 000 11111223333221
Q ss_pred ---CCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 633 ---SRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 633 ---~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
....++|+|+++.|||++ + .+.|+||+.+..-
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 234589999999999998 4 8999999887643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0028 Score=64.76 Aligned_cols=139 Identities=12% Similarity=0.115 Sum_probs=74.5
Q ss_pred eeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCe-eEEEEEEEeCCeEEEEEEec-CCCC
Q 005718 519 QCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-VRLMGCCVEQGEKILIYEYM-PNKS 596 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~-~~gs 596 (681)
.+.|+.|-...+|+. +.+.+|+....... .....+|..++..+...++ .+++++ +.+.-++|+||+ ++..
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 578989999999998 56778877643211 1122457766666632222 456554 344457899999 6544
Q ss_pred hhhH------------------hcCCCC--CCCCCHHHH-HHHHH--------------HHHHHHH----HHHh-CCCCC
Q 005718 597 LNFF------------------LFDPSR--THLLGWQTR-VKIIE--------------GIAQGLL----YLHQ-YSRLR 636 (681)
Q Consensus 597 L~~~------------------l~~~~~--~~~l~~~~~-~~i~~--------------~ia~~L~----yLH~-~~~~~ 636 (681)
+... |+.... ......... ..+.. .+.+.+. .|.. .....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 4210 011100 000111111 01100 0111111 1111 22345
Q ss_pred eeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 637 IIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 637 ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
++|+|+.|.||+ ..++.+.|+||..|..-
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 899999999999 56678899999988743
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0025 Score=68.78 Aligned_cols=73 Identities=18% Similarity=0.274 Sum_probs=49.1
Q ss_pred eeeecccCcEeEEEEEecC--------CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCC-eeEEEEEEEeCCeEEEEE
Q 005718 519 QCKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN-LVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~--------~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~ 589 (681)
.+.|+.|-...+|+....+ ++.+.+|+.... ...+.+..|..++..+...+ .+++++.+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 3678888889999998753 467888887431 12255667888888874333 366776543 2 2899
Q ss_pred EecCCCCh
Q 005718 590 EYMPNKSL 597 (681)
Q Consensus 590 Ey~~~gsL 597 (681)
||+++..|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.012 Score=63.77 Aligned_cols=74 Identities=14% Similarity=0.136 Sum_probs=46.9
Q ss_pred eeeecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCe-eEEEEEEEeCCeEEEEEEecCCCC
Q 005718 519 QCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL-VRLMGCCVEQGEKILIYEYMPNKS 596 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gs 596 (681)
.+.|+.|-...+|+....+ ++.+.+|+....... ...-..|..++..+...++ .++++.+ .+. +||||+++..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~G--~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TNG--RIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TTE--EEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CCe--EEEEeeCCcc
Confidence 3678888889999998865 467888876442211 1112578888888854444 5677766 232 5999998754
Q ss_pred h
Q 005718 597 L 597 (681)
Q Consensus 597 L 597 (681)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0039 Score=66.02 Aligned_cols=141 Identities=21% Similarity=0.233 Sum_probs=81.4
Q ss_pred eeecccCcEeEEEEEecC--------CcEEEEEEecCCCcccHHHHHHHHHHHhhCC-CCCeeEEEEEEEeCCeEEEEEE
Q 005718 520 CKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~--------~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E 590 (681)
+.|..|-...+|+....+ ++.+.+|+.-. .......+.+|.++++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 567777778899988742 46788887533 2234566678988888773 3223667766543 28999
Q ss_pred ecCCCChhhH-----------------hcCC--CCCCCCC--HHHHHHHHHHHH-------------------HHHHHHH
Q 005718 591 YMPNKSLNFF-----------------LFDP--SRTHLLG--WQTRVKIIEGIA-------------------QGLLYLH 630 (681)
Q Consensus 591 y~~~gsL~~~-----------------l~~~--~~~~~l~--~~~~~~i~~~ia-------------------~~L~yLH 630 (681)
|+++..|..- |+.. .-.+... +.+..++..++. +.+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998655311 0111 1111122 334444443321 1233332
Q ss_pred ----h-CCCCCeeecccCCCcEEEcCC----CCeEEeecCCcee
Q 005718 631 ----Q-YSRLRIIHRDLKASNILLDSD----MNPKISDFGMARM 665 (681)
Q Consensus 631 ----~-~~~~~ivHrDlkp~NiLl~~~----~~~kl~DFGla~~ 665 (681)
. .....++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 123458999999999999876 6899999998874
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.13 E-value=0.026 Score=58.73 Aligned_cols=32 Identities=22% Similarity=0.363 Sum_probs=28.3
Q ss_pred CCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 635 ~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
..++|+|+.+.||+++.++.+.|+||+.+..-
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46999999999999998888999999887754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.10 E-value=0.011 Score=62.34 Aligned_cols=73 Identities=14% Similarity=0.144 Sum_probs=42.6
Q ss_pred eeecccCcEeEEEEEecC---------CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCC-eeEEEEEEEeCCeEEEEE
Q 005718 520 CKLGEGGFGPVYKGKLLN---------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN-LVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~---------~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~ 589 (681)
+.|+.|-.-.+|+....+ ++.+.+|+...... .......|..++..+...+ +.++++.. .+ ++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence 567778788899988754 25788887654321 1122356777777763223 45666543 22 6899
Q ss_pred EecCCCCh
Q 005718 590 EYMPNKSL 597 (681)
Q Consensus 590 Ey~~~gsL 597 (681)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.94 E-value=0.43 Score=50.96 Aligned_cols=74 Identities=12% Similarity=0.119 Sum_probs=46.1
Q ss_pred eeeecccCcEeEEEEEecC--------CcEEEEEEecCCCcccHHHHHHHHHHHhhCC-CCCeeEEEEEEEeCCeEEEEE
Q 005718 519 QCKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~--------~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~ 589 (681)
.+.+..|-.-.+|+....+ ++.+.+++...... ....-.+|..+++.+. +.-..++++.+ .+ ++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 3567777788899988753 56788887644321 1122356777777763 22245666533 22 6899
Q ss_pred EecCCCCh
Q 005718 590 EYMPNKSL 597 (681)
Q Consensus 590 Ey~~~gsL 597 (681)
||+++..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.62 E-value=1.1 Score=47.39 Aligned_cols=29 Identities=28% Similarity=0.424 Sum_probs=24.8
Q ss_pred eeecccCCCcEEE------cCCCCeEEeecCCcee
Q 005718 637 IIHRDLKASNILL------DSDMNPKISDFGMARM 665 (681)
Q Consensus 637 ivHrDlkp~NiLl------~~~~~~kl~DFGla~~ 665 (681)
++|+|+.+.|||+ +++..++++||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4566799999998864
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=86.18 E-value=0.69 Score=36.74 Aligned_cols=34 Identities=26% Similarity=0.506 Sum_probs=27.6
Q ss_pred ccCHHHHHHHhhcCCceeeeeeccccCCCccceeecc
Q 005718 362 SMNLKECEAECLKNCTCRAYANSKVTGGGSGCLMWFG 398 (681)
Q Consensus 362 ~~s~~~C~~~Cl~nCsC~a~~y~~~~~~~~gC~~w~~ 398 (681)
..++++|+..|+.+=.|.||.|.. ....|+++.+
T Consensus 29 ~~sl~~Cq~aC~a~~~C~aFTyN~---~s~~CflKs~ 62 (82)
T 2ll3_A 29 ASSLSECRARCQAEKECSHYTYNV---KSGLCYPKRG 62 (82)
T ss_dssp CSSHHHHHHHHHHCTTEEEEEEET---TTTEEEEEES
T ss_pred CCCHHHHHHHhhccCCCCeEEecc---CCCceEcccC
Confidence 468999999999999999999963 1234998754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 681 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-45 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-44 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-42 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-42 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-40 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-40 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-40 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-38 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-38 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-38 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-37 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-37 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-35 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-31 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-27 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-27 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-23 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 3e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-19 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 2e-14 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 2e-14 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 3e-14 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 1e-07 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 9e-13 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 2e-08 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-47
Identities = 49/168 (29%), Positives = 81/168 (48%), Gaps = 6/168 (3%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
++ ++G G FG VYKGK V + +++ + Q L+ FKNE+ ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
MG + ++ ++ SL L + I AQG+ YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHA-- 122
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
IIHRDLK++NI L D+ KI DFG+A + +++ G+
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 4e-46
Identities = 44/172 (25%), Positives = 76/172 (44%), Gaps = 11/172 (6%)
Query: 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGL-KEFKNEMMLIAKLQH 569
++F +LG G G V+K +G +A K + + + + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
+V G GE + E+M SL+ L R + Q K+ + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+ +I+HRD+K SNIL++S K+ DFG++ + VGT
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGT 166
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-45
Identities = 41/164 (25%), Positives = 80/164 (48%), Gaps = 6/164 (3%)
Query: 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN 571
+ + + +LG+G FG VYK + A K + ++S + L+++ E+ ++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
+V+L+ + ++ E+ +++ + + R L + + L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHD 128
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
+IIHRDLKA NIL D + K++DFG++ + ++
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 6e-45
Identities = 57/168 (33%), Positives = 81/168 (48%), Gaps = 7/168 (4%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
E + +LG G FG V+ G +VAVK L Q F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
RL Q +I EYM N SL FL PS L + + IA+G+ ++ +
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEE-- 127
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
IHRDL+A+NIL+ ++ KI+DFG+AR+ +E
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFP 173
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 2e-44
Identities = 48/168 (28%), Positives = 83/168 (49%), Gaps = 7/168 (4%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
+ ++G G FG V+ G LN +VA+K + + ++F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
+L G C+EQ L++E+M + L + ++ L +T + + + +G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCL--SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+IHRDL A N L+ + K+SDFGM R D+ ++
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFP 165
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 4e-44
Identities = 51/173 (29%), Positives = 78/173 (45%), Gaps = 16/173 (9%)
Query: 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQ 568
+ FS ++G G FG VY + + N + VA+K++S QS + ++ E+ + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
H N ++ GC + + L+ EY + + L + G QGL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
LH +IHRD+KA NILL K+ DFG A + VGT
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGT 174
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (395), Expect = 1e-43
Identities = 48/166 (28%), Positives = 85/166 (51%), Gaps = 6/166 (3%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
+ +M+ KLG G +G VY+G VAVK L + + ++EF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
V+L+G C + +I E+M +L +L + +R + + + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE-- 132
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRV 678
+ IHRDL A N L+ + K++DFG++R+ GD +
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 155 bits (392), Expect = 5e-43
Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 19/191 (9%)
Query: 504 FSLASVSAATENFS---------MQCKLGEGGFGPVYKGKLL----NGQEVAVKRL-SSQ 549
F+ + A F+ ++ +G G FG V G L VA+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 550 SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL 609
+ + ++F +E ++ + H N++ L G + ++I E+M N SL+ FL
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 610 LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669
V ++ GIA G+ YL +HRDL A NIL++S++ K+SDFG++R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 670 ELQGNTKRVVG 680
+G
Sbjct: 182 TSDPTYTSALG 192
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 8e-43
Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 7/168 (4%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
++ + +LG G FG V GK +VA+K + S EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
+L G C +Q +I EYM N L +L + H Q +++ + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLES-- 118
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+ +HRDL A N L++ K+SDFG++R DE +
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 164
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 1e-42
Identities = 40/170 (23%), Positives = 78/170 (45%), Gaps = 8/170 (4%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHR 570
E++ + +G G +G K + +G+ + K L S + + +E+ L+ +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 571 NLVRLMGCCVEQGEKIL--IYEYMPNKSLNFFLFDPSRTH-LLGWQTRVKIIEGIAQGLL 627
N+VR +++ L + EY L + ++ L + ++++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 628 YLHQYSR--LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
H+ S ++HRDLK +N+ LD N K+ DFG+AR+ D
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-42
Identities = 47/170 (27%), Positives = 76/170 (44%), Gaps = 8/170 (4%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLS-SQSGQGLKEFKNEMMLIAKLQHRN 571
E++ + LGEG +G V + VAVK + ++ + K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
+V+ G E + L EY L + + + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+ I HRD+K N+LLD N KISDFG+A +F + + ++ GT
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 3e-42
Identities = 47/154 (30%), Positives = 79/154 (51%), Gaps = 8/154 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
+ + +G+G FG V G G +VAVK + + + + F E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 574 RLMGCCVEQGEKI-LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
+L+G VE+ + ++ EYM SL +L R+ +LG +K + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 633 SRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
+HRDL A N+L+ D K+SDFG+ +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 4e-42
Identities = 47/172 (27%), Positives = 78/172 (45%), Gaps = 17/172 (9%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCV 580
+G+G FG V++GK G+EVAVK SS+ + + E+ L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67
Query: 581 EQGEKI----LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ----- 631
+ L+ +Y + SL +L + + + +K+ A GL +LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC--GDELQGNTKRVVGT 681
+ I HRDLK+ NIL+ + I+D G+A D + VGT
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-41
Identities = 49/166 (29%), Positives = 81/166 (48%), Gaps = 6/166 (3%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 574 RLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
+L + ++ EYM SL FL + +L V + IA G+ Y+ +
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM- 132
Query: 634 RLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
+HRDL+A+NIL+ ++ K++DFG+AR+ +E
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 176
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (375), Expect = 1e-40
Identities = 49/196 (25%), Positives = 80/196 (40%), Gaps = 31/196 (15%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQGL-KEFKNEMMLIAK 566
N +GEG FG V++ + VAVK L ++ + +F+ E L+A+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL----------------- 609
+ N+V+L+G C L++EYM LN FL S +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 610 ----LGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665
L ++ I +A G+ YL + + +HRDL N L+ +M KI+DFG++R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 666 FCGDELQGNTKRVVGT 681
+
Sbjct: 190 IYSADYYKADGNDAIP 205
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 1e-40
Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 12/176 (6%)
Query: 512 ATENFSMQ-CKLGEGGFGPVYKGKLL---NGQEVAVKRLSSQSGQG-LKEFKNEMMLIAK 566
+N + +LG G FG V +G +VA+K L + + +E E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
L + +VRL+G C + +L+ E L+ FL + +++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 122
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR-VVGT 681
YL + +HRDL A N+LL + KISDFG+++ D+ +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 3e-40
Identities = 46/178 (25%), Positives = 85/178 (47%), Gaps = 10/178 (5%)
Query: 505 SLASVSAATENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMML 563
S+ SV + ++ K+G+G G VY + GQEVA+++++ Q + NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 564 IAKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIA 623
+ + ++ N+V + + E ++ EY+ SL + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECL 126
Query: 624 QGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
Q L +LH ++IHRD+K+ NILL D + K++DFG + Q +VGT
Sbjct: 127 QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 179
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 5e-40
Identities = 49/172 (28%), Positives = 76/172 (44%), Gaps = 14/172 (8%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQH 569
E+F + LG+G FG VY + + +A+K L + + + E+ + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
N++RL G + LI EY P ++ L S+ Q I +A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
H R+IHRD+K N+LL S KI+DFG + + GT
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGT 167
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 6e-40
Identities = 47/196 (23%), Positives = 73/196 (37%), Gaps = 31/196 (15%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQSGQG-LKEFKNEMMLIAK 566
EN LG G FG V +VAVK L ++ + +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 567 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFD--------------------PS 605
L H N+V L+G C G LI+EY L +L
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 606 RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665
++L ++ + +A+G+ +L +HRDL A N+L+ KI DFG+AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 666 FCGDELQGNTKRVVGT 681
D
Sbjct: 214 IMSDSNYVVRGNARLP 229
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 6e-40
Identities = 49/191 (25%), Positives = 70/191 (36%), Gaps = 26/191 (13%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQG-LKEFKNEMMLIAK 566
S LG G FG V + VAVK L + + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 567 L-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL---------------L 610
L H N+V L+G C G ++I EY L FL + + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 611 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
+ + +A+G+ +L IHRDL A NILL KI DFG+AR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 671 LQGNTKRVVGT 681
Sbjct: 200 NYVVKGNARLP 210
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 51/174 (29%), Positives = 85/174 (48%), Gaps = 12/174 (6%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRLS-SQSGQGLKEFKNEMMLIAKL 567
F LG G FG VYKG + E VA+K L + S + KE +E ++A +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
+ ++ RL+G C+ LI + MP L ++ + G Q + IA+G+
Sbjct: 69 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMN 125
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
YL R++HRDL A N+L+ + + KI+DFG+A++ +E + + +
Sbjct: 126 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 4e-38
Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 13/167 (7%)
Query: 521 KLGEGGFGPVYKGKLLN---GQEVAVKRLSSQSGQG--LKEFKNEMMLIAKLQHRNLVRL 575
+LG G FG V KG + VAVK L +++ E E ++ +L + +VR+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 576 MGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
+G C E +L+ E LN +L + + ++++ ++ G+ YL +
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE---S 126
Query: 636 RIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTK-RVVGT 681
+HRDL A N+LL + KISDFG+++ DE +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-38
Identities = 47/171 (27%), Positives = 68/171 (39%), Gaps = 10/171 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQH 569
E+F LGEG F V + L +E A+K L + E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
V+L + + Y N L ++ I L YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYL 124
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 680
H IIHRDLK NILL+ DM+ +I+DFG A++ + Q VG
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 4e-38
Identities = 49/169 (28%), Positives = 74/169 (43%), Gaps = 16/169 (9%)
Query: 521 KLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMG 577
++G G F VYKG EVA L + + + FK E ++ LQH N+VR
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 578 CCVEQGEK----ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS 633
+ +L+ E M + +L +L R ++ + I +GL +LH +
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 634 RLRIIHRDLKASNILLDS-DMNPKISDFGMARMFCGDELQGNTKRVVGT 681
IIHRDLK NI + + KI D G+A + K V+GT
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGT 176
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 142 bits (359), Expect = 6e-38
Identities = 36/156 (23%), Positives = 69/156 (44%), Gaps = 8/156 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
+++ + +LG G FG V++ G A K + + + + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
V L + E ++IYE+M L + D + V+ + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141
Query: 633 SRLRIIHRDLKASNILLDSDMNP--KISDFGMARMF 666
+H DLK NI+ + + K+ DFG+
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-37
Identities = 52/186 (27%), Positives = 80/186 (43%), Gaps = 24/186 (12%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNG---QEVAVKRLS-SQSGQGLKEFKNEMMLIAKL-Q 568
+ Q +GEG FG V K ++ + A+KR+ S ++F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFL-------------FDPSRTHLLGWQTR 615
H N++ L+G C +G L EY P+ +L FL S L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 616 VKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
+ +A+G+ YL Q + IHRDL A NIL+ + KI+DFG++R
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183
Query: 676 KRVVGT 681
Sbjct: 184 TMGRLP 189
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 4e-37
Identities = 48/175 (27%), Positives = 72/175 (41%), Gaps = 13/175 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAK 566
++ + KLG+G FG V +G+ VAVK L + + +F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
L HRNL+RL G ++ E P SL T + +A+G+
Sbjct: 68 LDHRNLIRLYGVV-LTPPMKMVTELAPLGSL--LDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
YL R IHRDL A N+LL + KI DFG+ R ++ +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 139 bits (351), Expect = 7e-37
Identities = 37/161 (22%), Positives = 73/161 (45%), Gaps = 8/161 (4%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
+ + + +LG G FG V++ G+ K +++ KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
+ L ++ E +LI E++ L + + + + + + +GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 633 SRLRIIHRDLKASNILLDSDMNP--KISDFGMARMFCGDEL 671
I+H D+K NI+ ++ KI DFG+A DE+
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 8e-37
Identities = 45/169 (26%), Positives = 77/169 (45%), Gaps = 13/169 (7%)
Query: 521 KLGEGGFGPVYKGKLLN----GQEVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHRNLVRL 575
+G G FG VY G LL+ AVK L+ + G + +F E +++ H N++ L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 576 MGCCVE-QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
+G C+ +G +++ YM + L F + TH + + +A+G+ +
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDL--RNFIRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKR--VVGT 681
+ +HRDL A N +LD K++DFG+AR E +
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 137 bits (345), Expect = 5e-36
Identities = 42/166 (25%), Positives = 68/166 (40%), Gaps = 13/166 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNE---MMLIAK 566
+FS+ +G GGFG VY + G+ A+K L + QG NE + L++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
+V + + I + M L++ L I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EADMRFYAAEIILGL 120
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 672
++H +++RDLK +NILLD + +ISD G+A F +
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 163
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 6e-36
Identities = 40/165 (24%), Positives = 74/165 (44%), Gaps = 5/165 (3%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHR 570
++ +GEG +G V +N VA+K++S Q + E+ ++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
N++ + + + Y+ + L+ +T L + I +GL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
++HRDLK SN+LL++ + KI DFG+AR+ D
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 7e-36
Identities = 41/173 (23%), Positives = 74/173 (42%), Gaps = 12/173 (6%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQSGQGLKE-FKNEMMLIAKLQ 568
E + +GEG FG V++G ++ VA+K + + ++E F E + + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
H ++V+L+G E +I E L F R + L + + ++ L Y
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGEL--RSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
L R +HRD+ A N+L+ S+ K+ DFG++R +
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLP 172
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-35
Identities = 46/190 (24%), Positives = 74/190 (38%), Gaps = 25/190 (13%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSGQG-LKEFKNEM-MLIA 565
+ + LG G FG V + + VAVK L + + +E+ +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 566 KLQHRNLVRLMGCCVEQGEKILI-YEYMPNKSLNFFLFDPSRTHL-------------LG 611
H N+V L+G C + G +++ E+ +L+ +L + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 612 WQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671
+ + +A+G+ +L + IHRDL A NILL KI DFG+AR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 672 QGNTKRVVGT 681
Sbjct: 190 YVRKGDARLP 199
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-35
Identities = 46/182 (25%), Positives = 78/182 (42%), Gaps = 17/182 (9%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLS-SQSGQGLKEFKNEMMLIAK 566
E +M +LG+G FG VY+G VA+K ++ + S + EF NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLF-------DPSRTHLLGWQTRVKII 619
++VRL+G + ++I E M L +L + +++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 620 EGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVV 679
IA G+ YL+ + +HRDL A N ++ D KI DFGM R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 680 GT 681
Sbjct: 197 LP 198
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 5e-35
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 11/168 (6%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQE-----VAVKRLSSQSGQG-LKEFKNEMMLIAKL 567
+ Q +G G FG VYKG L VA+K L + + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 568 QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
H N++RL G + ++I EYM N + F + V ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 628 YLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
YL + +HRDL A NIL++S++ K+SDFG++R+ D T
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 130 bits (329), Expect = 2e-34
Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 10/157 (6%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQH 569
++F + LG G FG V+ + NG+ A+K L + ++ +E ++++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
++R+ G + + +I +Y+ LF R K A+ L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFY--AAEVCLAL 117
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
II+RDLK NILLD + + KI+DFG A+
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 154
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 127 bits (320), Expect = 2e-33
Identities = 51/179 (28%), Positives = 82/179 (45%), Gaps = 20/179 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--------SSQSGQGLKE-FKNEMML 563
EN+ + LG G V + +E AVK + S++ Q L+E E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 564 IAKLQ-HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
+ K+ H N+++L L+++ M L +L + L + KI+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+ + LH +L I+HRDLK NILLD DMN K++DFG + E + V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGT 172
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 3e-33
Identities = 51/191 (26%), Positives = 82/191 (42%), Gaps = 26/191 (13%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL--------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLI 564
+ + LGEG FG V + + +VAVK L S + + L + +EM ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 565 AKL-QHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHL-------------L 610
+ +H+N++ L+G C + G +I EY +L +L L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 611 GWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
+ V +A+G+ YL + IHRDL A N+L+ D KI+DFG+AR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 671 LQGNTKRVVGT 681
T
Sbjct: 190 YYKKTTNGRLP 200
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 126 bits (318), Expect = 4e-33
Identities = 43/164 (26%), Positives = 75/164 (45%), Gaps = 8/164 (4%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHRN 571
E + K+GEG +G VYK + G+ A+K RL + E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 572 LVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ 631
+V+L + +L++E++ L T + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118
Query: 632 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNT 675
R++HRDLK N+L++ + KI+DFG+AR F +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 6e-33
Identities = 34/156 (21%), Positives = 67/156 (42%), Gaps = 9/156 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
E + + LG G FG V++ + + K + + G K E+ ++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
+ L E ++I+E++ + + + L + V + + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 633 SRLRIIHRDLKASNILLDSDMNP--KISDFGMARMF 666
I H D++ NI+ + + KI +FG AR
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-32
Identities = 46/169 (27%), Positives = 73/169 (43%), Gaps = 15/169 (8%)
Query: 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLV 573
+++ +G G FG VY+ KL +G+ VA+K++ + E+ ++ KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 574 RLMGCCVEQGEK------ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLL 627
RL GEK L+ +Y+P L + + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 628 YLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCGDELQGNT 675
Y+H I HRD+K N+LLD D K+ DFG A+ E +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 3e-32
Identities = 49/160 (30%), Positives = 84/160 (52%), Gaps = 8/160 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
ENF K+GEG +G VYK + L G+ VA+K RL +++ E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
N+V+L+ + + L++E++ F D S + + + QGL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
+ R++HRDLK N+L++++ K++DFG+AR F
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 122 bits (306), Expect = 1e-31
Identities = 42/178 (23%), Positives = 76/178 (42%), Gaps = 15/178 (8%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAKLQ 568
++ + + LG GG V+ + L ++VAVK L ++ F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 569 HRNLVRLMGCCVEQGEKI----LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
H +V + + ++ EY+ +L + + + +++I Q
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC-GDELQGNTKRVVGT 681
L + H + IIHRD+K +NI++ + K+ DFG+AR T V+GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 2e-31
Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 13/173 (7%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKN----EMMLIAKLQ 568
E+F + LG+G FG V+ + Q A+K L + + + +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 569 HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
H L + + + EY+ L + + + I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
LH I++RDLK NILLD D + KI+DFGM + + + NT GT
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 166
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 4e-31
Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 521 KLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKE-----FKNEMMLIAKLQHRNLVR 574
LGEG F VYK + N Q VA+K++ K+ E+ L+ +L H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 575 LMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSR 634
L+ + L++++M + +L + QGL YLHQ+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 635 LRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669
I+HRDLK +N+LLD + K++DFG+A+ F
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 121 bits (305), Expect = 4e-31
Identities = 42/174 (24%), Positives = 75/174 (43%), Gaps = 14/174 (8%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAKLQHR 570
+ + + LG G F V + + VA+K ++ ++ +G +NE+ ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
N+V L G LI + + L + + + ++I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH 124
Query: 631 QYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
I+HRDLK N+L D D ISDFG+++M + GT
Sbjct: 125 DL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGT 172
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 8e-30
Identities = 40/172 (23%), Positives = 66/172 (38%), Gaps = 12/172 (6%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQH 569
+F LG+G FG V + G+ A+K L + + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 570 RNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
L L + EY L F L SR + + A+ + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYG---AEIVSAL 118
Query: 630 HQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+++RD+K N++LD D + KI+DFG+ + D K GT
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGT 168
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 1e-29
Identities = 42/181 (23%), Positives = 83/181 (45%), Gaps = 19/181 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHR 570
+ K+G+G FG V+K + GQ+VA+K++ ++ E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 571 NLVRLMGCCVEQGEKI--------LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGI 622
N+V L+ C + L++++ + + ++++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 623 AQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF--CGDELQGNTKRVVG 680
GL Y+H+ +I+HRD+KA+N+L+ D K++DFG+AR F + V
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 681 T 681
T
Sbjct: 184 T 184
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 1e-29
Identities = 48/180 (26%), Positives = 83/180 (46%), Gaps = 16/180 (8%)
Query: 512 ATENFSMQCKLGEGGFGPVYKGKLL--NGQEVAVKRLSSQSGQG--LKEFKNE---MMLI 564
A + + ++GEG +G V+K + L G+ VA+KR+ Q+G+ E + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 565 AKLQHRNLVRLMGCCVEQGEKILIYEYMPNKSLN---FFLFDPSRTHLLGWQTRVKIIEG 621
+H N+VRL C + + ++ D + +T ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 622 IAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
+ +GL +LH R++HRDLK NIL+ S K++DFG+AR++ Q VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-29
Identities = 41/160 (25%), Positives = 71/160 (44%), Gaps = 9/160 (5%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVK--RLSSQSGQGLKEFKNEMMLIAKLQHR 570
+ + K+GEG +G V+K K + VA+K RL E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
N+VRL + L++E+ +F G + + Q L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670
++HRDLK N+L++ + K+++FG+AR F
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 114 bits (285), Expect = 4e-28
Identities = 44/197 (22%), Positives = 75/197 (38%), Gaps = 10/197 (5%)
Query: 477 SVATRTNEPSEGDGDAKGTRRDSVLPCFSLASVSAATENFSMQCKLGEGGFGPVYKGK-L 535
+ A + +E + D + + + +A + F LG G FG V K
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK 63
Query: 536 LNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592
+G A+K L Q + ++ NE ++ + LV+L + ++ EY+
Sbjct: 64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD 652
+ L R I YLH L +I+RDLK N+L+D
Sbjct: 124 AGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQ 177
Query: 653 MNPKISDFGMARMFCGD 669
+++DFG A+ G
Sbjct: 178 GYIQVTDFGFAKRVKGR 194
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 111 bits (278), Expect = 1e-27
Identities = 35/179 (19%), Positives = 74/179 (41%), Gaps = 18/179 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL 572
++ + ++GEG FG +++G LLN Q+VA+K +S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 573 VRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY 632
+ + ++G ++ + SL L R +T + + + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE- 119
Query: 633 SRLRIIHRDLKASNILLDSDMNP-----KISDFGMARMFCGDELQGN-----TKRVVGT 681
+++RD+K N L+ + + DFGM + + + + K + GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 2e-27
Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 15/168 (8%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLS----SQSGQGLKEFKNEMMLIA 565
ENF + LG G +G V+ + + G+ A+K L Q + + + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 566 KLQHR-NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
++ LV L + + LI +Y+ L L R T ++ + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER------FTEHEVQIYVGE 137
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQ 672
+L L +L II+RD+K NILLDS+ + ++DFG+++ F DE +
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 4e-27
Identities = 46/179 (25%), Positives = 77/179 (43%), Gaps = 20/179 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRL------SSQSGQGLKEFKNEMMLIAK 566
+ + +LG G F V K + G + A K + SS+ G ++ + E+ ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 567 LQHRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
+QH N++ L + + ILI E + L FL + L + + ++ I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG- 125
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARMFCGDELQGNTKRVVGT 681
++ L+I H DLK NI+L P KI DFG+A K + GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGT 179
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 4e-27
Identities = 38/176 (21%), Positives = 65/176 (36%), Gaps = 19/176 (10%)
Query: 516 FSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKE------FKNEMMLIAKLQ 568
+ + LG GGFG VY G + + VA+K + E E++L+ K+
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 569 --HRNLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
++RL+ +LI E F + L + + + +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAV 123
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCGDELQGNTKRVVGT 681
+ H ++HRD+K NIL+D + K+ DFG + GT
Sbjct: 124 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGT 172
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 5e-27
Identities = 34/158 (21%), Positives = 64/158 (40%), Gaps = 18/158 (11%)
Query: 522 LGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCC 579
LG G G V + ++ A+K L + + E+ L + Q ++VR++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74
Query: 580 ----VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRL 635
+ +++ E + L + D + +I++ I + + YLH +
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS---I 130
Query: 636 RIIHRDLKASNILLDSDMNP---KISDFGMARMFCGDE 670
I HRD+K N+L S K++DFG A+
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 108 bits (271), Expect = 9e-27
Identities = 38/170 (22%), Positives = 68/170 (40%), Gaps = 16/170 (9%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
K+G G FG +Y G + G+EVA+K ++ + E + +Q + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 580 VEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIH 639
+G+ ++ + SL SR +T + + + + + Y+H IH
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH---SKNFIH 126
Query: 640 RDLKASNIL---LDSDMNPKISDFGMARMFCGDELQGN-----TKRVVGT 681
RD+K N L I DFG+A+ + + K + GT
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 1e-26
Identities = 41/162 (25%), Positives = 67/162 (41%), Gaps = 17/162 (10%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAKLQHR 570
+ +G G +G V G +VA+K+L QS K E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 571 NLVRLMGCCVEQG------EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
N++ L+ + L+ +M + LG ++ + +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
GL Y+H IIHRDLK N+ ++ D KI DFG+AR
Sbjct: 133 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 102 bits (256), Expect = 9e-26
Identities = 30/154 (19%), Positives = 60/154 (38%), Gaps = 20/154 (12%)
Query: 521 KLGEGGFGPVYKGKLLNGQEVAVK--RLSSQSGQGLK--------EFKNEMMLIAKLQHR 570
+GEG V+ E VK ++ S + +K F + A+ + R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 571 NLVRLMGCCVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH 630
L +L G V + +Y + N ++ L D + + + ++++ I + + +
Sbjct: 67 ALQKLQGLAVPK-----VYAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 631 QYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664
I+H DL N+L+ + I DF +
Sbjct: 121 HR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 105 bits (262), Expect = 2e-25
Identities = 35/173 (20%), Positives = 74/173 (42%), Gaps = 20/173 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRN 571
+++ + KLG G + V++ + N ++V VK L K+ K E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 572 LVRLMGCCVEQGEK--ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYL 629
++ L + + L++E++ N L + I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145
Query: 630 HQYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARMFCGDELQGNTKRVVGT 681
H + I+HRD+K N+++D + ++ D+G+A + + V +
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVAS 192
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 1e-23
Identities = 44/177 (24%), Positives = 73/177 (41%), Gaps = 21/177 (11%)
Query: 514 ENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS--SQSGQGLKEFKNEMMLIAKLQHR 570
+ + +G G G V + + VA+K+LS Q+ K E++L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 571 NLVRLMGCCVEQG------EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQ 624
N++ L+ Q + L+ E M + + ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLC 130
Query: 625 GLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681
G+ +LH IIHRDLK SNI++ SD KI DFG+AR + V T
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVT 181
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 2e-23
Identities = 46/158 (29%), Positives = 68/158 (43%), Gaps = 7/158 (4%)
Query: 513 TENFSMQCKLGEGGFGPVYKGK-LLNGQEVAVKRLS--SQSGQGLKEFKNEMMLIAKLQH 569
E + +G G +G V G VAVK+LS QS K E+ L+ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 570 RNLVRLMGCCVEQGEKILI-YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLY 628
N++ L+ Y+ + L + + L +I I +GL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 629 LHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666
+H IIHRDLK SN+ ++ D KI DFG+AR
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT 171
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 87.3 bits (216), Expect = 3e-21
Identities = 24/117 (20%), Positives = 47/117 (40%), Gaps = 14/117 (11%)
Query: 34 IGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIG 93
+ +GE L + Q ++ + + L ++ T VW +N +
Sbjct: 4 LTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYD---HSTSVWASNTGIL-GKKGCKAVLQ 58
Query: 94 NNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSF 150
++GN V+ + +W+S+ R N V L + GN+V+ GS +W +
Sbjct: 59 SDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY---------GSDIWSTG 106
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 88.2 bits (217), Expect = 2e-19
Identities = 36/177 (20%), Positives = 66/177 (37%), Gaps = 23/177 (12%)
Query: 521 KLGEGGFGPVYKGK-LLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCC 579
KLG G F V+ K ++N VA+K + + ++E+ L+ ++ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 580 VEQGEKILIY-------------EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGL 626
K+L + + L + +I + + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 627 LYLHQYSRLRIIHRDLKASNILLDSDMNP------KISDFGMARMFCGDELQGNTKR 677
Y+H+ R IIH D+K N+L++ +P KI+D G A + R
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 67.7 bits (165), Expect = 2e-14
Identities = 26/126 (20%), Positives = 45/126 (35%), Gaps = 21/126 (16%)
Query: 26 DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVD 85
+ + + GE L S F L ++ D +W N
Sbjct: 2 NILYSGETLSTGEFLNYGS--FVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--S 49
Query: 86 SNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSY 145
+ L++ +GNLV+ N ++ IW+SN + N V L N+V+ G+
Sbjct: 50 RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIY---------GTD 100
Query: 146 LWQSFD 151
W +
Sbjct: 101 RWATGT 106
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 67.7 bits (165), Expect = 2e-14
Identities = 22/131 (16%), Positives = 46/131 (35%), Gaps = 20/131 (15%)
Query: 20 LLSLATDTITPATLI-GDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVAN 78
+ S D P L + +++ + ++ + + Y + +W N
Sbjct: 4 IFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNL------VLYD--NNNPIWATN 55
Query: 79 RNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSS 138
AVL +G LV++ + +W S ++ + + V L N+V+
Sbjct: 56 TGGLGNGCRAVLQ--PDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIY----- 108
Query: 139 NTSEGSYLWQS 149
G LW +
Sbjct: 109 ----GDALWAT 115
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 67.6 bits (165), Expect = 3e-14
Identities = 20/99 (20%), Positives = 39/99 (39%), Gaps = 10/99 (10%)
Query: 64 IWY-KQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVA 122
I Y Q D + + S L++ + NLVL ++ D +WS+N + + A
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRA 70
Query: 123 QLLDTGNLVLREKFSSNTSEGSYLWQSFD--CPSDTLLI 159
L G + + T++ +W S + + +
Sbjct: 71 VLQPNGRMDVL------TNQNIAVWTSGNSRSAGRYVFV 103
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 48.4 bits (115), Expect = 1e-07
Identities = 15/63 (23%), Positives = 24/63 (38%), Gaps = 2/63 (3%)
Query: 70 PDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGN 129
D VW N+ + + NG + +L + +W+S SR V L N
Sbjct: 52 RDDRVWS--TNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRN 109
Query: 130 LVL 132
L +
Sbjct: 110 LAI 112
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 62.9 bits (152), Expect = 9e-13
Identities = 25/131 (19%), Positives = 48/131 (36%), Gaps = 19/131 (14%)
Query: 25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIV 84
+D + + G L + + + Y + VW + N
Sbjct: 1 SDRLNSGHQLDTGGSLAEGG--YLFIIQNDCNL------VLYD--NNRAVWASGTNGKA- 49
Query: 85 DSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGS 144
S VL + N+GNLV+ + IW+SN +R+ N L N+V+ + + +
Sbjct: 50 -SGCVLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYD------NSNN 101
Query: 145 YLWQSFDCPSD 155
+W + +
Sbjct: 102 AIWATHTNVGN 112
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 50.7 bits (121), Expect = 2e-08
Identities = 29/124 (23%), Positives = 45/124 (36%), Gaps = 16/124 (12%)
Query: 20 LLSLATDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANR 79
L L+ + P TL + L SS F S L ++ D VW +N
Sbjct: 4 LFGLSHEGSHPQTLHAA-QSLELSS--FRFTMQSDCN-----LVLFD---SDVRVWASNT 52
Query: 80 NSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREK--FS 137
+ + ++G LV+L + I WSS + N V L + + +
Sbjct: 53 AG---ATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWD 109
Query: 138 SNTS 141
S TS
Sbjct: 110 SGTS 113
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 681 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.97 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.97 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.97 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.97 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.97 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.97 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.97 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.96 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.96 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.96 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.96 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.96 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.96 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.96 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.96 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.96 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.96 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.96 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.96 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.96 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.96 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.96 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.95 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.95 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.95 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.95 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.95 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.95 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.95 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.95 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.95 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.95 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.95 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.95 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.95 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.95 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.95 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.95 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.94 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.94 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.94 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.94 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.94 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.93 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.93 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.93 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.93 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.93 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.92 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.92 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.92 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.92 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.91 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.91 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.9 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.87 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.86 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.85 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.82 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.69 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.67 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.59 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.52 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.36 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.12 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.08 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.01 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.81 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.51 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.9 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.25 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.67 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.57 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.88 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 91.65 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 87.1 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 85.11 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 81.41 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.5e-32 Score=276.41 Aligned_cols=162 Identities=29% Similarity=0.404 Sum_probs=139.7
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
++|++.++||+|+||.||+|... +++.||||++.... ....+++.+|+.++++++||||+++++++.+.+..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999985 58899999997542 23456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCCc
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 671 (681)
+++|+|.++|.. ...+++.++..++.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+..+..
T Consensus 85 ~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999843 346899999999999999999999987 99999999999999999999999999998865544
Q ss_pred cCCCcceecC
Q 005718 672 QGNTKRVVGT 681 (681)
Q Consensus 672 ~~~~~~~~GT 681 (681)
......++||
T Consensus 159 ~~~~~~~~GT 168 (271)
T d1nvra_ 159 ERLLNKMCGT 168 (271)
T ss_dssp ECCBCCCCSC
T ss_pred cccccceeeC
Confidence 4334456776
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=4.3e-32 Score=278.53 Aligned_cols=158 Identities=30% Similarity=0.508 Sum_probs=140.7
Q ss_pred HHhhCCCCceeeecccCcEeEEEEEecC-CcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEE
Q 005718 510 SAATENFSMQCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 510 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
+...++|++.++||+|+||.||+|.+.. ++.||||+++.. ....++|.+|+.+|++++|||||+++++|.+++..++|
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 3455789999999999999999999864 889999999764 45678899999999999999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||+++|+|.+++... ....+++..++.|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+..
T Consensus 92 ~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 92 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp EECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCC
Confidence 9999999999998543 2346899999999999999999999987 99999999999999999999999999998865
Q ss_pred CCcc
Q 005718 669 DELQ 672 (681)
Q Consensus 669 ~~~~ 672 (681)
+...
T Consensus 168 ~~~~ 171 (287)
T d1opja_ 168 DTYT 171 (287)
T ss_dssp SSSE
T ss_pred CCce
Confidence 5433
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.7e-31 Score=271.79 Aligned_cols=151 Identities=26% Similarity=0.432 Sum_probs=137.5
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
.++|++.++||+|+||+||+|... +++.||||++........+.+.+|+.++++++||||+++++++.+.+..+|||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 357999999999999999999974 5899999999865555678899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 670 (681)
+++|+|.+++.+ ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+..+.
T Consensus 99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999988732 35899999999999999999999987 9999999999999999999999999999886544
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-31 Score=271.55 Aligned_cols=151 Identities=32% Similarity=0.559 Sum_probs=131.5
Q ss_pred CCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecC
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMP 593 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 593 (681)
++|++.++||+|+||.||+|.+.+++.||||+++.. ....++|.+|+.++++++||||++++|+|.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 578899999999999999999988889999999863 4556889999999999999999999999999999999999999
Q ss_pred CCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCC
Q 005718 594 NKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 594 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 670 (681)
+|+|.+++.. ....+++..++.|+.||++||+|||+.+ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9999999854 3345889999999999999999999987 9999999999999999999999999999875544
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.7e-31 Score=271.91 Aligned_cols=154 Identities=35% Similarity=0.535 Sum_probs=136.0
Q ss_pred hhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
..++|++.++||+|+||.||+|.+++++.||||+++.. ....++|.+|+.++++++|||||+++|++.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 35678899999999999999999988889999999764 4456789999999999999999999998754 567899999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCCc
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 671 (681)
+++|+|.+++... ....+++.+++.|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+.....
T Consensus 89 ~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc
Confidence 9999999887432 2235899999999999999999999987 99999999999999999999999999998865443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-31 Score=273.20 Aligned_cols=162 Identities=33% Similarity=0.498 Sum_probs=132.2
Q ss_pred hhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
..++|++.++||+|+||.||+|+.+ ..||||+++.. .....++|.+|+.++.+++|||||++++++.+ +..+|||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 3567899999999999999999874 36999998753 34556889999999999999999999998754 5689999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+++|+|.+++... ...+++.+++.|+.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 83 Ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 83 QWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp ECCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred ecCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999999543 345899999999999999999999987 999999999999999999999999999988654
Q ss_pred CccCCCcceecC
Q 005718 670 ELQGNTKRVVGT 681 (681)
Q Consensus 670 ~~~~~~~~~~GT 681 (681)
.......++.||
T Consensus 158 ~~~~~~~~~~gt 169 (276)
T d1uwha_ 158 SGSHQFEQLSGS 169 (276)
T ss_dssp --------CCCC
T ss_pred CCcccccccccC
Confidence 443334445555
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.5e-31 Score=272.68 Aligned_cols=150 Identities=27% Similarity=0.437 Sum_probs=137.1
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
+.|++.+.||+|+||.||+|... +++.||||++........+.|.+|+.+|++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56899999999999999999985 58899999998766667788999999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
++|+|.+++.+ ....+++.++..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 99999998743 2345899999999999999999999988 99999999999999999999999999987643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.1e-31 Score=268.71 Aligned_cols=162 Identities=30% Similarity=0.416 Sum_probs=137.2
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|++.+.||+|+||+||+|... +++.||||++.+. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999985 5889999998753 2334578999999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ ||||||||+||||++++.+||+|||+|+.+..+
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999883 3346899999999999999999999988 999999999999999999999999999998655
Q ss_pred CccCCCcceecC
Q 005718 670 ELQGNTKRVVGT 681 (681)
Q Consensus 670 ~~~~~~~~~~GT 681 (681)
.........+||
T Consensus 162 ~~~~~~~~~~GT 173 (288)
T d1uu3a_ 162 SKQARANSFVGT 173 (288)
T ss_dssp --------CCCC
T ss_pred CcccccccccCC
Confidence 444334445666
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.4e-30 Score=261.07 Aligned_cols=153 Identities=31% Similarity=0.507 Sum_probs=138.5
Q ss_pred hCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
.++|++.++||+|+||.||+|++++++.||||+++.. ....++|++|+.++++++||||++++|+|.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 3678999999999999999999988889999999864 445688999999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCCc
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDEL 671 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~ 671 (681)
++|+|..++.. ....+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 82 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999998744 3345789999999999999999999987 99999999999999999999999999998755443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=9.2e-31 Score=270.10 Aligned_cols=153 Identities=33% Similarity=0.538 Sum_probs=126.7
Q ss_pred hCCCCceeeecccCcEeEEEEEecC-C---cEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN-G---QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~-~---~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
.++|++.++||+|+||+||+|.+.. + ..||||++... .....++|.+|+.+|++++|||||+++|++.+.+..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3567888999999999999998753 2 25899988754 34456789999999999999999999999999999999
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||||+++|+|.+++... ...+++.+++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 105 v~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 99999999999988542 345899999999999999999999987 9999999999999999999999999999886
Q ss_pred CCC
Q 005718 668 GDE 670 (681)
Q Consensus 668 ~~~ 670 (681)
.+.
T Consensus 180 ~~~ 182 (299)
T d1jpaa_ 180 DDT 182 (299)
T ss_dssp ---
T ss_pred CCC
Confidence 544
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.7e-31 Score=275.47 Aligned_cols=150 Identities=27% Similarity=0.357 Sum_probs=135.2
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
.++|++.++||+|+||.||+|... +++.||||+++.. .....+++.+|+.+|++++|||||++++++.+.++.++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 568999999999999999999975 5889999999764 23345689999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-SRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|+++|+|.+++.+ ...+++.++..++.||++||.|||+. + |+||||||+||||++++.+||+|||+|+.+..
T Consensus 85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999943 34589999999999999999999974 6 99999999999999999999999999997744
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.9e-30 Score=261.07 Aligned_cols=150 Identities=30% Similarity=0.417 Sum_probs=134.9
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|++.+.||+|+||.||+|... +++.||||++.+. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46899999999999999999985 5889999998643 2334678899999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+++|+|.+++. ....+++.++..++.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999984 3345899999999999999999999987 999999999999999999999999999877543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.3e-30 Score=264.69 Aligned_cols=157 Identities=25% Similarity=0.421 Sum_probs=126.5
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEe--CCeEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE--QGEKILI 588 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV 588 (681)
++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999975 58899999997642 3345679999999999999999999999975 4568999
Q ss_pred EEecCCCChhhHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 589 YEYMPNKSLNFFLFDP-SRTHLLGWQTRVKIIEGIAQGLLYLHQYS--RLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
|||+++|+|.+++.+. .....+++.++..++.||++||+|||+.+ ..+||||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998532 12446899999999999999999999864 23599999999999999999999999999998
Q ss_pred ecCCC
Q 005718 666 FCGDE 670 (681)
Q Consensus 666 ~~~~~ 670 (681)
+..+.
T Consensus 164 ~~~~~ 168 (269)
T d2java1 164 LNHDT 168 (269)
T ss_dssp C----
T ss_pred cccCC
Confidence 85543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.8e-30 Score=265.71 Aligned_cols=152 Identities=33% Similarity=0.537 Sum_probs=132.0
Q ss_pred hCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
.++|++.+.||+|+||+||+|.+++++.||||+++.. ....++|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 4679999999999999999999988889999999753 4566889999999999999999999999854 5678999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCC
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 670 (681)
++|+|..++... ....+++.+++.|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 999999888442 2345899999999999999999999987 9999999999999999999999999999875444
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9.8e-30 Score=260.30 Aligned_cols=152 Identities=28% Similarity=0.503 Sum_probs=131.4
Q ss_pred hCCCCcee-eecccCcEeEEEEEec---CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 513 TENFSMQC-KLGEGGFGPVYKGKLL---NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 513 ~~~f~~~~-~LG~G~fG~Vy~~~~~---~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
.++|.+.+ +||+|+||.||+|.++ ++..||||+++... ....++|.+|+++|++++|||||+++|++.+ +..+|
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 35566667 4999999999999864 34579999997643 3456789999999999999999999999864 56899
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
||||+++|+|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999998843 3345899999999999999999999987 9999999999999999999999999999886
Q ss_pred CCC
Q 005718 668 GDE 670 (681)
Q Consensus 668 ~~~ 670 (681)
...
T Consensus 161 ~~~ 163 (285)
T d1u59a_ 161 ADD 163 (285)
T ss_dssp TCS
T ss_pred ccc
Confidence 544
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.5e-30 Score=268.30 Aligned_cols=168 Identities=29% Similarity=0.422 Sum_probs=137.9
Q ss_pred HhhCCCCceeeecccCcEeEEEEEecC-C-----cEEEEEEecCC-CcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeC
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLLN-G-----QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ 582 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~-~-----~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 582 (681)
...++|++.++||+|+||+||+|.... + ..||||.+... .......|.+|+.++.++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 345789999999999999999998743 2 36999998654 334456899999999998 899999999999999
Q ss_pred CeEEEEEEecCCCChhhHhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccc
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPSR--------------------THLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDL 642 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDl 642 (681)
+..++||||+++|+|.++|..... ...+++.+++.|+.||++||+|||+++ ||||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 999999999999999999965321 235899999999999999999999987 999999
Q ss_pred CCCcEEEcCCCCeEEeecCCceeecCCCccCCCcceecC
Q 005718 643 KASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681 (681)
Q Consensus 643 kp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~GT 681 (681)
||+|||++.++.+||+|||+|+............+..||
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 229 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 229 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEEC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCC
Confidence 999999999999999999999987665543333334444
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.96 E-value=1.6e-29 Score=266.20 Aligned_cols=152 Identities=24% Similarity=0.418 Sum_probs=137.3
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
++|++.++||+|+||.||+|... +++.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999975 58899999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC--CCCeEEeecCCceeecCCC
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS--DMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~--~~~~kl~DFGla~~~~~~~ 670 (681)
++|+|.+++.+ ....+++.++..|+.||+.||+|||+++ ||||||||+||||+. ++.+||+|||+|+.+....
T Consensus 106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999843 2345899999999999999999999988 999999999999964 5789999999999885543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.96 E-value=2.1e-29 Score=265.50 Aligned_cols=152 Identities=25% Similarity=0.376 Sum_probs=137.1
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
++|++.++||+|+||.||+|... +++.||||++........+.+.+|+.+|++++||||+++++++.+.+..+|||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999974 58999999998765556678899999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc--CCCCeEEeecCCceeecCCC
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD--SDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~--~~~~~kl~DFGla~~~~~~~ 670 (681)
++|+|.+.+.. ....+++.++..|+.||++||+|||+.+ ||||||||+||||+ .++.+||+|||+|+.+..+.
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999887743 3445899999999999999999999988 99999999999998 57899999999999886544
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.1e-29 Score=265.84 Aligned_cols=160 Identities=26% Similarity=0.344 Sum_probs=140.2
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|++.+.||+|+||.||+++.. +++.||||++++. .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999999984 5899999999753 2335678899999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
||+++|+|.+++. +...+++..+..++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999984 3446889999999999999999999998 999999999999999999999999999977544
Q ss_pred CccCCCcceecC
Q 005718 670 ELQGNTKRVVGT 681 (681)
Q Consensus 670 ~~~~~~~~~~GT 681 (681)
... ...++||
T Consensus 159 ~~~--~~~~~GT 168 (337)
T d1o6la_ 159 GAT--MKTFCGT 168 (337)
T ss_dssp TCC--BCCCEEC
T ss_pred Ccc--cccceeC
Confidence 332 3345666
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.1e-30 Score=262.03 Aligned_cols=153 Identities=34% Similarity=0.558 Sum_probs=128.7
Q ss_pred hCCCCceeeecccCcEeEEEEEecCC-----cEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNG-----QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~-----~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 586 (681)
...|++.++||+|+||.||+|.++.. ..||||++... .....++|.+|+.++.+++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688889999999999999987542 36999999754 3334567999999999999999999999999999999
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+||||+.++++.+++.. ....+++.+++.++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 86 ~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999988743 2345899999999999999999999987 999999999999999999999999999987
Q ss_pred cCCC
Q 005718 667 CGDE 670 (681)
Q Consensus 667 ~~~~ 670 (681)
..+.
T Consensus 161 ~~~~ 164 (283)
T d1mqba_ 161 EDDP 164 (283)
T ss_dssp ----
T ss_pred cCCC
Confidence 5543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.2e-29 Score=258.82 Aligned_cols=144 Identities=31% Similarity=0.486 Sum_probs=125.1
Q ss_pred eeecccCcEeEEEEEecC---CcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 005718 520 CKLGEGGFGPVYKGKLLN---GQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYMPN 594 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~---~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 594 (681)
++||+|+||.||+|.+.+ ++.||||+++.. .....++|.+|+.+|++++|||||+++|+|. .+..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCCEEEEEEcCCC
Confidence 579999999999998743 467999999753 2334568999999999999999999999985 4567899999999
Q ss_pred CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCC
Q 005718 595 KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 595 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 670 (681)
|+|.+++.. ...+++.+++.++.||++||+|||+.+ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccc
Confidence 999999843 345899999999999999999999987 9999999999999999999999999999876544
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.7e-29 Score=256.46 Aligned_cols=150 Identities=29% Similarity=0.435 Sum_probs=128.7
Q ss_pred CCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe----CCeEEEE
Q 005718 516 FSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE----QGEKILI 588 (681)
Q Consensus 516 f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV 588 (681)
|++.++||+|+||+||+|... +++.||+|++... .....+.|.+|+++|++++|||||++++++.+ +...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 356678999999999999985 4789999998753 33445679999999999999999999999875 3467999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc-CCCCeEEeecCCceeec
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARMFC 667 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~-~~~~~kl~DFGla~~~~ 667 (681)
|||+++|+|.+++.. ...+++.++..++.||++||+|||+++ ++|+||||||+||||+ +++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999843 346899999999999999999999874 4599999999999996 57899999999998764
Q ss_pred CC
Q 005718 668 GD 669 (681)
Q Consensus 668 ~~ 669 (681)
..
T Consensus 167 ~~ 168 (270)
T d1t4ha_ 167 AS 168 (270)
T ss_dssp TT
T ss_pred CC
Confidence 43
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=6.2e-30 Score=264.39 Aligned_cols=172 Identities=30% Similarity=0.462 Sum_probs=142.6
Q ss_pred HHHHHHhhCCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCCCc-ccHHHHHHHHHHHhhCCCCCeeEEEEE
Q 005718 506 LASVSAATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAKLQHRNLVRLMGC 578 (681)
Q Consensus 506 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~ 578 (681)
+.+++.+.++|++.+.||+|+||.||+|+.+ +++.||||++..... ...++|.+|+.++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3445567789999999999999999999864 346899999976433 345689999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCChhhHhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 005718 579 CVEQGEKILIYEYMPNKSLNFFLFDPS---------------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRI 637 (681)
Q Consensus 579 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 637 (681)
|.+.+..++||||+++|+|.++|.... ....+++.+++.|+.|+++||+|||+.+ |
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence 999999999999999999999985321 1234889999999999999999999987 9
Q ss_pred eecccCCCcEEEcCCCCeEEeecCCceeecCCCccCCCcceec
Q 005718 638 IHRDLKASNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVG 680 (681)
Q Consensus 638 vHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~G 680 (681)
|||||||+||||+.++.+||+|||+|+.+.+.......++..|
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~ 204 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAI 204 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCB
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCc
Confidence 9999999999999999999999999998765544333333333
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=1e-29 Score=263.13 Aligned_cols=149 Identities=31% Similarity=0.505 Sum_probs=132.8
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc---ccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG---QGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
..|+..+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45899999999999999999874 588999999975432 23467899999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||+++|+|..++. ....+++.++..++.||++||.|||+++ ||||||||+||||++++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999987663 2346899999999999999999999988 99999999999999999999999999997644
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.96 E-value=5.6e-29 Score=253.58 Aligned_cols=150 Identities=29% Similarity=0.385 Sum_probs=134.2
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc---------ccHHHHHHHHHHHhhCC-CCCeeEEEEEEEeC
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG---------QGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQ 582 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~---------~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~ 582 (681)
++|++.+.||+|+||+||+|+.. +++.+|||++.+... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 67999999999999999999974 588999999875421 11246889999999996 99999999999999
Q ss_pred CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCC
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGM 662 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGl 662 (681)
+..+|||||+++|+|.++|.. ...+++.++..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999943 345899999999999999999999988 99999999999999999999999999
Q ss_pred ceeecCC
Q 005718 663 ARMFCGD 669 (681)
Q Consensus 663 a~~~~~~ 669 (681)
|+.+...
T Consensus 157 a~~~~~~ 163 (277)
T d1phka_ 157 SCQLDPG 163 (277)
T ss_dssp CEECCTT
T ss_pred eeEccCC
Confidence 9988553
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=1.3e-29 Score=262.27 Aligned_cols=152 Identities=25% Similarity=0.368 Sum_probs=123.6
Q ss_pred hhCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
..+.|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|+.+|++++||||+++++++.+++..+|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3467999999999999999999985 58899999997543 233467889999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEc---CCCCeEEeecCCceee
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLD---SDMNPKISDFGMARMF 666 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~---~~~~~kl~DFGla~~~ 666 (681)
||+++|+|.++|.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+|+..
T Consensus 87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999943 346899999999999999999999987 99999999999994 5789999999999987
Q ss_pred cCC
Q 005718 667 CGD 669 (681)
Q Consensus 667 ~~~ 669 (681)
...
T Consensus 161 ~~~ 163 (307)
T d1a06a_ 161 DPG 163 (307)
T ss_dssp ---
T ss_pred cCC
Confidence 543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=3.9e-29 Score=259.71 Aligned_cols=149 Identities=28% Similarity=0.419 Sum_probs=134.1
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|++.+.||+|+||+||+|+.+ +++.||||++++. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56899999999999999999985 5899999999753 2344678999999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||+++|+|..++. ....+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+..
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999998883 3445788888999999999999999987 99999999999999999999999999998754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.4e-28 Score=253.04 Aligned_cols=151 Identities=28% Similarity=0.406 Sum_probs=134.7
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC------cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS------GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 585 (681)
.+.|++.+.||+|+||.||+|... +++.||||++.+.. ....+.|.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999984 58999999986431 22467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC----CeEEeecC
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM----NPKISDFG 661 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~----~~kl~DFG 661 (681)
+|||||+++|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999843 346899999999999999999999988 99999999999998776 49999999
Q ss_pred CceeecCC
Q 005718 662 MARMFCGD 669 (681)
Q Consensus 662 la~~~~~~ 669 (681)
+|+.+...
T Consensus 163 ~a~~~~~~ 170 (293)
T d1jksa_ 163 LAHKIDFG 170 (293)
T ss_dssp TCEECTTS
T ss_pred hhhhcCCC
Confidence 99987543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.7e-28 Score=252.90 Aligned_cols=151 Identities=23% Similarity=0.337 Sum_probs=134.3
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
.++|.+.+.||+|+||+||+|... +++.||||.++.. ......+.+|+.+|++++||||+++++++.+.++.+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 367999999999999999999985 5889999999864 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC--CCeEEeecCCceeecCC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD--MNPKISDFGMARMFCGD 669 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~--~~~kl~DFGla~~~~~~ 669 (681)
+++|+|.+++.. ....+++.++..|+.||++||+|||+.+ |+||||||+|||++.+ ..+||+|||+|+.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999943 2335899999999999999999999987 9999999999999854 48999999999987543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=9.4e-29 Score=257.32 Aligned_cols=162 Identities=31% Similarity=0.500 Sum_probs=131.5
Q ss_pred CCCCceeeecccCcEeEEEEEecC-Cc----EEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~----~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 587 (681)
.+|++.++||+|+||+||+|.+.. ++ +||||+++.. .....++|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999998743 43 5899988753 345578899999999999999999999999875 5678
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeec
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFC 667 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~ 667 (681)
++||+.+|+|.+++.. ....+++..++.++.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999888754 3446899999999999999999999987 9999999999999999999999999999886
Q ss_pred CCCccCCCcceecC
Q 005718 668 GDELQGNTKRVVGT 681 (681)
Q Consensus 668 ~~~~~~~~~~~~GT 681 (681)
..+....+...+||
T Consensus 163 ~~~~~~~~~~~~gt 176 (317)
T d1xkka_ 163 AEEKEYHAEGGKVP 176 (317)
T ss_dssp TTCC--------CC
T ss_pred cccccccccccccC
Confidence 65544434444454
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=7e-29 Score=256.27 Aligned_cols=172 Identities=26% Similarity=0.390 Sum_probs=132.5
Q ss_pred HHHHHhhCCCCceeeecccCcEeEEEEEecC------CcEEEEEEecCC-CcccHHHHHHHHHHHhhC-CCCCeeEEEEE
Q 005718 507 ASVSAATENFSMQCKLGEGGFGPVYKGKLLN------GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGC 578 (681)
Q Consensus 507 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~------~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~ 578 (681)
.+.+...++|++.++||+|+||.||+|.... ++.||||+++.. .....+++..|...+.++ +|+||++++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 3444556789999999999999999998632 468999999754 334456788888888777 78999999999
Q ss_pred EEeC-CeEEEEEEecCCCChhhHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCC
Q 005718 579 CVEQ-GEKILIYEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKA 644 (681)
Q Consensus 579 ~~~~-~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp 644 (681)
+.+. ...++||||+++|+|.++|.... ....+++.++..++.||++||+|||+++ ||||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 8765 46899999999999999985322 1345889999999999999999999987 99999999
Q ss_pred CcEEEcCCCCeEEeecCCceeecCCCccCCCcceecC
Q 005718 645 SNILLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681 (681)
Q Consensus 645 ~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~GT 681 (681)
+||||++++.+||+|||+|+..............+||
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 199 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 199 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCG
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeC
Confidence 9999999999999999999987665554444455665
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.95 E-value=2.5e-28 Score=257.14 Aligned_cols=149 Identities=26% Similarity=0.333 Sum_probs=134.8
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 589 (681)
++|++.+.||+|+||.||+|... +++.||||++.+. .....+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999985 5899999998643 2234578899999999999999999999999999999999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
||+.+|+|..++.. ...+++..+..++.||++||.|||+++ ||||||||+||||+.++.+||+|||+|+.+..
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999843 345899999999999999999999988 99999999999999999999999999998754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=9.7e-29 Score=256.10 Aligned_cols=159 Identities=30% Similarity=0.470 Sum_probs=136.8
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG 583 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 583 (681)
...++|.+.++||+|+||.||+|.+. .++.||||+++.. .......|.+|+.++++++||||++++++|...+
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 34478889999999999999999873 2568999999754 3334457999999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhHhcCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeE
Q 005718 584 EKILIYEYMPNKSLNFFLFDP-------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPK 656 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~k 656 (681)
..++||||+++|+|.+++... .....+++..+..++.|+++||.|||+.+ |+||||||+||||++++++|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEE
Confidence 999999999999999987421 12234789999999999999999999987 99999999999999999999
Q ss_pred EeecCCceeecCCCcc
Q 005718 657 ISDFGMARMFCGDELQ 672 (681)
Q Consensus 657 l~DFGla~~~~~~~~~ 672 (681)
|+|||+|+.+......
T Consensus 174 l~DFGla~~~~~~~~~ 189 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYY 189 (308)
T ss_dssp ECCTTCCCGGGGGGCE
T ss_pred EeecccceeccCCcce
Confidence 9999999987654433
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=2.4e-28 Score=258.58 Aligned_cols=151 Identities=27% Similarity=0.359 Sum_probs=130.6
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHH---HHHHHhhCCCCCeeEEEEEEEeCCeEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKN---EMMLIAKLQHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~---Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 586 (681)
++|++.++||+|+||.||+|... +++.||||++.+.. ......+.+ |+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999985 58999999986421 122333444 467777889999999999999999999
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+||||+++|+|.++|.. ...+++.++..++.||+.||+|||+.+ ||||||||+||||++++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999843 345788999999999999999999988 999999999999999999999999999988
Q ss_pred cCCC
Q 005718 667 CGDE 670 (681)
Q Consensus 667 ~~~~ 670 (681)
....
T Consensus 158 ~~~~ 161 (364)
T d1omwa3 158 SKKK 161 (364)
T ss_dssp SSSC
T ss_pred CCCc
Confidence 6543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=9.9e-29 Score=251.66 Aligned_cols=152 Identities=26% Similarity=0.414 Sum_probs=124.1
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC----CcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEE
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~----~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 586 (681)
..++|++.+.||+|+||.||+|.+.. +..||||.++... ....+.|.+|+.++++++||||+++++++. .+..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 34679999999999999999998743 3468999987543 334567999999999999999999999985 46789
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+||||+++|+|.+++.. ....+++..++.++.||++||.|||+.+ ||||||||+||++++++.+||+|||+|+.+
T Consensus 84 iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 99999999999988743 3345899999999999999999999987 999999999999999999999999999987
Q ss_pred cCC
Q 005718 667 CGD 669 (681)
Q Consensus 667 ~~~ 669 (681)
...
T Consensus 159 ~~~ 161 (273)
T d1mp8a_ 159 EDS 161 (273)
T ss_dssp ---
T ss_pred cCC
Confidence 543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.6e-28 Score=252.11 Aligned_cols=151 Identities=29% Similarity=0.394 Sum_probs=126.2
Q ss_pred CCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC----eEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG----EKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV~ 589 (681)
.+|.+.+.||+|+||.||+|++ +++.||||++.... .....+..|+..+.+++||||++++++|.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4677889999999999999997 67899999996532 22222344555566789999999999998754 689999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQY-----SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
||+++|+|.++|.+ ..++|.+++.++.|+++||+|||+. +..+||||||||+||||+.++.+||+|||+|+
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999943 3589999999999999999999974 23469999999999999999999999999999
Q ss_pred eecCCC
Q 005718 665 MFCGDE 670 (681)
Q Consensus 665 ~~~~~~ 670 (681)
.+....
T Consensus 157 ~~~~~~ 162 (303)
T d1vjya_ 157 RHDSAT 162 (303)
T ss_dssp EEETTT
T ss_pred cccCCC
Confidence 885543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.3e-28 Score=251.00 Aligned_cols=151 Identities=30% Similarity=0.485 Sum_probs=130.0
Q ss_pred CCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
++|++.++||+|+||+||+|.. .+++.||||+++... ....+.+.+|+.++++++||||+++++++.+.++.++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999997 458999999996542 2345789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
|+.++.+..... .....+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|+....+
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 998655544332 23445899999999999999999999988 999999999999999999999999999987543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.5e-28 Score=252.07 Aligned_cols=151 Identities=27% Similarity=0.412 Sum_probs=132.2
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC---CcccHHHHHHHHHHHh-hCCCCCeeEEEEEEEeCCeEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIA-KLQHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~---~~~~~~~f~~Ei~~l~-~l~H~nIv~l~g~~~~~~~~~lV 588 (681)
++|.+.+.||+|+||+||+|+.. +++.||||++++. .....+.+..|..++. .++||||+++++++.+++..+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999985 5889999999753 1234556777777665 68999999999999999999999
Q ss_pred EEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecC
Q 005718 589 YEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCG 668 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~ 668 (681)
|||+++|+|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999984 3345789999999999999999999987 99999999999999999999999999997654
Q ss_pred CC
Q 005718 669 DE 670 (681)
Q Consensus 669 ~~ 670 (681)
..
T Consensus 156 ~~ 157 (320)
T d1xjda_ 156 GD 157 (320)
T ss_dssp TT
T ss_pred cc
Confidence 33
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=8.9e-28 Score=248.87 Aligned_cols=147 Identities=31% Similarity=0.548 Sum_probs=128.3
Q ss_pred eeeecccCcEeEEEEEecCC----cEEEEEEecCC-CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC-CeEEEEEEec
Q 005718 519 QCKLGEGGFGPVYKGKLLNG----QEVAVKRLSSQ-SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-GEKILIYEYM 592 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~~----~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV~Ey~ 592 (681)
.++||+|+||+||+|.+.+. ..||||+++.. .....++|.+|++++++++||||++++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999997542 25899999753 444567899999999999999999999998875 5889999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCC
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 670 (681)
++|+|.+++.. ....+++..++.++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999998854 3345678899999999999999999987 9999999999999999999999999999876544
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2e-28 Score=249.12 Aligned_cols=153 Identities=32% Similarity=0.447 Sum_probs=124.6
Q ss_pred hCCCCceeeecccCcEeEEEEEecC--C--cEEEEEEecCC---CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLN--G--QEVAVKRLSSQ---SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEK 585 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~--~--~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 585 (681)
.++|++.+.||+|+||.||+|++.. + ..||||++.+. .....++|.+|+.+|++++||||++++|++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3579999999999999999998632 2 36899998754 23345789999999999999999999999965 567
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
++||||+++|++.+.+.. ....+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 86 ~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 899999999999988743 2345899999999999999999999987 99999999999999999999999999998
Q ss_pred ecCCCc
Q 005718 666 FCGDEL 671 (681)
Q Consensus 666 ~~~~~~ 671 (681)
+.....
T Consensus 161 ~~~~~~ 166 (273)
T d1u46a_ 161 LPQNDD 166 (273)
T ss_dssp CCC-CC
T ss_pred cccCCC
Confidence 855443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.95 E-value=5.2e-28 Score=248.04 Aligned_cols=150 Identities=27% Similarity=0.424 Sum_probs=134.7
Q ss_pred CCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 591 (681)
++|++.++||+|+||+||+|..++++.||||++.... ....+.+.+|+.+|++++||||+++++++.+.+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5789999999999999999999889999999997542 23357899999999999999999999999999999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
+.++.+..+. .....+++.++..++.||++||+|||+.+ ||||||||+||||+.++.+||+|||+|..+...
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9988777776 33456899999999999999999999987 999999999999999999999999999887543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=6.3e-28 Score=250.09 Aligned_cols=152 Identities=35% Similarity=0.578 Sum_probs=131.8
Q ss_pred CCCCceeeecccCcEeEEEEEecC-Cc--EEEEEEecCC-CcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLLN-GQ--EVAVKRLSSQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKILI 588 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~--~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 588 (681)
++|++.++||+|+||.||+|.+++ +. .||||++... .....++|.+|+++|.++ +||||++++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678889999999999999998854 43 5788888643 334566899999999999 799999999999999999999
Q ss_pred EEecCCCChhhHhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCe
Q 005718 589 YEYMPNKSLNFFLFDP-------------SRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNP 655 (681)
Q Consensus 589 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~ 655 (681)
|||+++|+|.++|... .....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999643 23456899999999999999999999987 9999999999999999999
Q ss_pred EEeecCCceeecC
Q 005718 656 KISDFGMARMFCG 668 (681)
Q Consensus 656 kl~DFGla~~~~~ 668 (681)
||+|||+|+....
T Consensus 167 kl~DfG~a~~~~~ 179 (309)
T d1fvra_ 167 KIADFGLSRGQEV 179 (309)
T ss_dssp EECCTTCEESSCE
T ss_pred EEccccccccccc
Confidence 9999999987643
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.1e-28 Score=252.66 Aligned_cols=168 Identities=29% Similarity=0.382 Sum_probs=140.9
Q ss_pred HhhCCCCceeeecccCcEeEEEEEec------CCcEEEEEEecCCC-cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeC
Q 005718 511 AATENFSMQCKLGEGGFGPVYKGKLL------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQ 582 (681)
Q Consensus 511 ~~~~~f~~~~~LG~G~fG~Vy~~~~~------~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 582 (681)
...++|++.++||+|+||.||+|++. .++.||||+++... .....+|.+|+.+++++ +|||||+++++|.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 44578999999999999999999862 35689999998643 33456799999999999 799999999999999
Q ss_pred CeEEEEEEecCCCChhhHhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcE
Q 005718 583 GEKILIYEYMPNKSLNFFLFDPS---------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNI 647 (681)
Q Consensus 583 ~~~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~Ni 647 (681)
+..++||||+++|+|.+++.... ....+++.++..++.||++||+|||+++ ||||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence 99999999999999999985322 2235889999999999999999999988 99999999999
Q ss_pred EEcCCCCeEEeecCCceeecCCCccCCCcceecC
Q 005718 648 LLDSDMNPKISDFGMARMFCGDELQGNTKRVVGT 681 (681)
Q Consensus 648 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~GT 681 (681)
|++.++.+||+|||+|+...............||
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt 210 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEEC
T ss_pred cccccCcccccccchheeccCCCcceEeeecccC
Confidence 9999999999999999987654443333334444
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.6e-28 Score=250.05 Aligned_cols=146 Identities=30% Similarity=0.420 Sum_probs=125.2
Q ss_pred eeeecccCcEeEEEEEec-CCcEEEEEEecCCCcc-----cHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEEec
Q 005718 519 QCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYEYM 592 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 592 (681)
+++||+|+||+||+|... +++.||||+++..... ..+.+.+|+.++++++|||||++++++.++++.+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 579999999999999985 5889999999754221 1346889999999999999999999999999999999999
Q ss_pred CCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCCC
Q 005718 593 PNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGDE 670 (681)
Q Consensus 593 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~~ 670 (681)
+++++..++ .....+++.++..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..+.
T Consensus 83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 988877665 23445788899999999999999999988 9999999999999999999999999998875543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.94 E-value=1.2e-27 Score=244.24 Aligned_cols=150 Identities=26% Similarity=0.378 Sum_probs=132.0
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC---cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC----e
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG----E 584 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~ 584 (681)
.++|++.+.||+|+||.||+|... +++.||||+++... ....+.|.+|+.++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999974 68899999997642 233467999999999999999999999998654 4
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
.+|||||+++++|.+++.. ...+++.++..++.||++||+|||+++ |+||||||+||||+.++..+|+|||+++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 7999999999999988833 345899999999999999999999987 9999999999999999999999999998
Q ss_pred eecC
Q 005718 665 MFCG 668 (681)
Q Consensus 665 ~~~~ 668 (681)
....
T Consensus 160 ~~~~ 163 (277)
T d1o6ya_ 160 AIAD 163 (277)
T ss_dssp ECC-
T ss_pred hhcc
Confidence 7644
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=8.3e-28 Score=248.00 Aligned_cols=166 Identities=30% Similarity=0.458 Sum_probs=135.5
Q ss_pred hhCCCCceeeecccCcEeEEEEEecC--------CcEEEEEEecCCC-cccHHHHHHHHHHHhhC-CCCCeeEEEEEEEe
Q 005718 512 ATENFSMQCKLGEGGFGPVYKGKLLN--------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE 581 (681)
Q Consensus 512 ~~~~f~~~~~LG~G~fG~Vy~~~~~~--------~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 581 (681)
..++|.+.++||+|+||.||+|+... +..||||+++... .....++.+|...+.++ +|||||+++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 34688999999999999999998632 2479999997653 34457889999999888 89999999999999
Q ss_pred CCeEEEEEEecCCCChhhHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEE
Q 005718 582 QGEKILIYEYMPNKSLNFFLFDPS-------------RTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNIL 648 (681)
Q Consensus 582 ~~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiL 648 (681)
++..++||||+++|+|.++|.... ....+++.+++.++.||++||+|||+.+ ||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence 999999999999999999996542 1245899999999999999999999988 999999999999
Q ss_pred EcCCCCeEEeecCCceeecCCCccCCCcceec
Q 005718 649 LDSDMNPKISDFGMARMFCGDELQGNTKRVVG 680 (681)
Q Consensus 649 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~G 680 (681)
++.++.+||+|||+++..........+....|
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 199 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 199 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCC
T ss_pred ecCCCCeEeccchhhccccccccccccccCCC
Confidence 99999999999999998866554433333343
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.6e-28 Score=245.43 Aligned_cols=150 Identities=31% Similarity=0.533 Sum_probs=126.2
Q ss_pred hCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC-CeEEEEEEe
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-GEKILIYEY 591 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV~Ey 591 (681)
.++|++.+.||+|+||.||+|.+ .+..||||+++.. ...++|.+|++++++++||||++++|+|.+. +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 35688899999999999999998 4678999999753 3457899999999999999999999999764 567999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
+++|+|.++|... ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC
Confidence 9999999998542 2235899999999999999999999987 999999999999999999999999999987543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=7.4e-27 Score=244.36 Aligned_cols=149 Identities=23% Similarity=0.327 Sum_probs=127.0
Q ss_pred hCCCCcee-eecccCcEeEEEEEe-cCCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEe----CCeE
Q 005718 513 TENFSMQC-KLGEGGFGPVYKGKL-LNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVE----QGEK 585 (681)
Q Consensus 513 ~~~f~~~~-~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~~ 585 (681)
.++|.+.+ .||+|+||.||+|.. .+++.||||+++.. +.+.+|+.++.++ +||||+++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35788765 599999999999997 45889999998642 5677899887655 89999999999875 3578
Q ss_pred EEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC---CCCeEEeecCC
Q 005718 586 ILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGM 662 (681)
Q Consensus 586 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~DFGl 662 (681)
++|||||++|+|.++|.+. ....+++.++..|+.||+.||+|||+.+ |+||||||+|||+++ .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999999643 2346899999999999999999999988 999999999999985 45799999999
Q ss_pred ceeecCCC
Q 005718 663 ARMFCGDE 670 (681)
Q Consensus 663 a~~~~~~~ 670 (681)
|+......
T Consensus 161 a~~~~~~~ 168 (335)
T d2ozaa1 161 AKETTSHN 168 (335)
T ss_dssp CEECCCCC
T ss_pred eeeccCCC
Confidence 99876544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.8e-27 Score=239.70 Aligned_cols=150 Identities=24% Similarity=0.370 Sum_probs=128.5
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCc------ccHHHHHHHHHHHhhCC--CCCeeEEEEEEEeCCe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAKLQ--HRNLVRLMGCCVEQGE 584 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~------~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~ 584 (681)
++|++.++||+|+||.||+|... +++.||||++.+... ....++.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999974 589999999875321 12244678999999986 8999999999999999
Q ss_pred EEEEEEecCC-CChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCC-CCeEEeecCC
Q 005718 585 KILIYEYMPN-KSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSD-MNPKISDFGM 662 (681)
Q Consensus 585 ~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~-~~~kl~DFGl 662 (681)
.++||||+.+ +++.+++. ....+++.++..++.||++||+|||+++ |+||||||+||||+.+ +.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 57777773 3346899999999999999999999988 9999999999999854 7999999999
Q ss_pred ceeecCC
Q 005718 663 ARMFCGD 669 (681)
Q Consensus 663 a~~~~~~ 669 (681)
|+.....
T Consensus 158 a~~~~~~ 164 (273)
T d1xwsa_ 158 GALLKDT 164 (273)
T ss_dssp CEECCSS
T ss_pred ceecccc
Confidence 9986443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.3e-26 Score=236.17 Aligned_cols=150 Identities=27% Similarity=0.425 Sum_probs=134.6
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCCeEEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 590 (681)
++|++.++||+|+||+||+|+.. +++.||||+++... ....+++.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999974 58899999986542 3346789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceeecCC
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMFCGD 669 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~~~~ 669 (681)
++.+++|..++. ....+++..+..++.|+++||+|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999988774 3345789999999999999999999987 999999999999999999999999999987543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.4e-26 Score=244.23 Aligned_cols=149 Identities=29% Similarity=0.439 Sum_probs=124.2
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC------CeEEE
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------GEKIL 587 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~l 587 (681)
+|+..++||+|+||+||+|+.. .++.||||++..... .+.+|+.+|++++||||+++++++... .+.+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888899999999999999985 589999999976432 234699999999999999999998653 35789
Q ss_pred EEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC-CeEEeecCCceee
Q 005718 588 IYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMF 666 (681)
Q Consensus 588 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~~ 666 (681)
||||++++.+..+.........+++.++..++.||++||+|||+++ |+||||||+||||+.++ .+||+|||+|+.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755444322234456899999999999999999999887 99999999999999775 8999999999987
Q ss_pred cCCC
Q 005718 667 CGDE 670 (681)
Q Consensus 667 ~~~~ 670 (681)
...+
T Consensus 174 ~~~~ 177 (350)
T d1q5ka_ 174 VRGE 177 (350)
T ss_dssp CTTS
T ss_pred cCCc
Confidence 5543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.6e-26 Score=243.25 Aligned_cols=151 Identities=25% Similarity=0.398 Sum_probs=127.0
Q ss_pred hCCCCceeeecccCcEeEEEEEe-cCCcEEEEEEecCCC-cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC----eEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKL-LNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG----EKI 586 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~-~~~~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~ 586 (681)
+.+|++.++||+|+||+||+|.. .+++.||||++.+.. ....+.+++|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999987 468999999997543 334568899999999999999999999987643 234
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCceee
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMARMF 666 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~~ 666 (681)
+++||+.+|+|.+++.. ..+++..+..++.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 55667779999999842 35899999999999999999999987 999999999999999999999999999987
Q ss_pred cCCC
Q 005718 667 CGDE 670 (681)
Q Consensus 667 ~~~~ 670 (681)
....
T Consensus 160 ~~~~ 163 (345)
T d1pmea_ 160 DPDH 163 (345)
T ss_dssp CGGG
T ss_pred cCCC
Confidence 5543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.93 E-value=4.9e-26 Score=237.91 Aligned_cols=145 Identities=23% Similarity=0.434 Sum_probs=127.5
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCC-CCCeeEEEEEEEeC--CeEEEEE
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQ--GEKILIY 589 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~ 589 (681)
++|++.++||+|+||+||+|+.. +++.||||+++.. ..+++.+|+.+|+.++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999984 5889999999753 3567899999999995 99999999999854 5689999
Q ss_pred EecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCC-CeEEeecCCceeecC
Q 005718 590 EYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARMFCG 668 (681)
Q Consensus 590 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~-~~kl~DFGla~~~~~ 668 (681)
||+++++|..+. +.+++.++..++.||++||+|||+++ |+||||||+||||+.++ .+||+|||+|+.+..
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997654 24889999999999999999999988 99999999999998655 699999999998765
Q ss_pred CC
Q 005718 669 DE 670 (681)
Q Consensus 669 ~~ 670 (681)
..
T Consensus 183 ~~ 184 (328)
T d3bqca1 183 GQ 184 (328)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=9.2e-26 Score=234.77 Aligned_cols=150 Identities=27% Similarity=0.511 Sum_probs=127.9
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC-------
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ------- 582 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------- 582 (681)
.++|++.++||+|+||+||+|... +++.||||++... .....+++.+|+.+|++++||||+++++.+...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 468999999999999999999974 6899999998643 233457789999999999999999999998653
Q ss_pred -CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecC
Q 005718 583 -GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFG 661 (681)
Q Consensus 583 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFG 661 (681)
.+.++||||++++.+.... .....++......++.||++||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 4679999999988776555 33445788999999999999999999987 9999999999999999999999999
Q ss_pred CceeecC
Q 005718 662 MARMFCG 668 (681)
Q Consensus 662 la~~~~~ 668 (681)
+|+.+..
T Consensus 163 ~~~~~~~ 169 (318)
T d3blha1 163 LARAFSL 169 (318)
T ss_dssp TCEECCC
T ss_pred eeeeccc
Confidence 9987754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=7.3e-26 Score=238.36 Aligned_cols=149 Identities=28% Similarity=0.418 Sum_probs=124.0
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEeCC------
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQG------ 583 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 583 (681)
.++|++.++||+|+||+||+|... +++.||||+++.. .....+.+.+|+.+|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999975 5899999999753 2234567899999999999999999999998654
Q ss_pred eEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCc
Q 005718 584 EKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 663 (681)
Q Consensus 584 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla 663 (681)
+.++||||+ +.+|..++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 579999999 556776662 235899999999999999999999988 999999999999999999999999999
Q ss_pred eeecCC
Q 005718 664 RMFCGD 669 (681)
Q Consensus 664 ~~~~~~ 669 (681)
+.....
T Consensus 169 ~~~~~~ 174 (346)
T d1cm8a_ 169 RQADSE 174 (346)
T ss_dssp EECCSS
T ss_pred eccCCc
Confidence 987543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=3e-26 Score=238.48 Aligned_cols=152 Identities=28% Similarity=0.396 Sum_probs=132.6
Q ss_pred CCCCceeeecccCcEeEEEEEec----CCcEEEEEEecCCC----cccHHHHHHHHHHHhhCCC-CCeeEEEEEEEeCCe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL----NGQEVAVKRLSSQS----GQGLKEFKNEMMLIAKLQH-RNLVRLMGCCVEQGE 584 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~----~~~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~ 584 (681)
++|++.+.||+|+||+||+|... +++.||||.+++.. ....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999862 37899999987532 2335678899999999955 899999999999999
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
.+++|||+.+|+|.+++. ....++......++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999984 3345678888999999999999999987 9999999999999999999999999999
Q ss_pred eecCCCc
Q 005718 665 MFCGDEL 671 (681)
Q Consensus 665 ~~~~~~~ 671 (681)
.+.....
T Consensus 178 ~~~~~~~ 184 (322)
T d1vzoa_ 178 EFVADET 184 (322)
T ss_dssp ECCGGGG
T ss_pred hhccccc
Confidence 8755443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.92 E-value=2.3e-25 Score=228.85 Aligned_cols=149 Identities=21% Similarity=0.324 Sum_probs=128.7
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCC-CCeeEEEEEEEeCCeEEEEEE
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQH-RNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E 590 (681)
.++|++.++||+|+||.||+|... +++.||||++.... ..+.+.+|++.+..++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999975 58899999886532 23457788999999955 899999999999999999999
Q ss_pred ecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC-----CCCeEEeecCCcee
Q 005718 591 YMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS-----DMNPKISDFGMARM 665 (681)
Q Consensus 591 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~-----~~~~kl~DFGla~~ 665 (681)
|+ +++|.+++.. ....+++.++..++.|++.||+|||+.+ ||||||||+||||+. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 6898888743 3345899999999999999999999987 999999999999974 56799999999998
Q ss_pred ecCC
Q 005718 666 FCGD 669 (681)
Q Consensus 666 ~~~~ 669 (681)
+...
T Consensus 156 ~~~~ 159 (293)
T d1csna_ 156 YRDP 159 (293)
T ss_dssp SBCT
T ss_pred cccC
Confidence 7543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.7e-25 Score=231.25 Aligned_cols=152 Identities=29% Similarity=0.479 Sum_probs=124.0
Q ss_pred hCCCCceeeecccCcEeEEEEEec-C-CcEEEEEEecCCC--cccHHHHHHHHHHHhhC---CCCCeeEEEEEEEe----
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-N-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAKL---QHRNLVRLMGCCVE---- 581 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~-~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~---- 581 (681)
.++|++.++||+|+||+||+|... . ++.||||+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 3 5679999986432 22233456677666555 89999999999864
Q ss_pred -CCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeec
Q 005718 582 -QGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDF 660 (681)
Q Consensus 582 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DF 660 (681)
....+++|||++++++...... ....+++.....++.||+.||+|||+++ ||||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 2468999999998877655432 3445889999999999999999999988 999999999999999999999999
Q ss_pred CCceeecCC
Q 005718 661 GMARMFCGD 669 (681)
Q Consensus 661 Gla~~~~~~ 669 (681)
|+++.....
T Consensus 161 g~~~~~~~~ 169 (305)
T d1blxa_ 161 GLARIYSFQ 169 (305)
T ss_dssp CSCCCCCGG
T ss_pred hhhhhhccc
Confidence 999976443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.91 E-value=8.2e-25 Score=225.46 Aligned_cols=149 Identities=23% Similarity=0.386 Sum_probs=123.0
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCC-eeEEEEEEEeCCeEEEEEEe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN-LVRLMGCCVEQGEKILIYEY 591 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~Ey 591 (681)
++|++.++||+|+||.||+|... +++.||||++.... ..+++..|++++++++|+| |+.+.++..+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999874 58899999887543 2346788999999997665 56666777888999999999
Q ss_pred cCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcC---CCCeEEeecCCceeecC
Q 005718 592 MPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARMFCG 668 (681)
Q Consensus 592 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~---~~~~kl~DFGla~~~~~ 668 (681)
+. ++|...+.. ....+++.++..++.|+++||+|||+++ ||||||||+|||++. +..+||+|||+|+.+..
T Consensus 85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 95 455555432 2345899999999999999999999988 999999999999864 45799999999998865
Q ss_pred CC
Q 005718 669 DE 670 (681)
Q Consensus 669 ~~ 670 (681)
..
T Consensus 159 ~~ 160 (299)
T d1ckia_ 159 AR 160 (299)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=3.6e-25 Score=233.18 Aligned_cols=149 Identities=30% Similarity=0.384 Sum_probs=126.1
Q ss_pred hCCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCC--cccHHHHHHHHHHHhhCCCCCeeEEEEEEEeC-----Ce
Q 005718 513 TENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAKLQHRNLVRLMGCCVEQ-----GE 584 (681)
Q Consensus 513 ~~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~ 584 (681)
.++|++.++||+|+||+||+|... +++.||||++++.. ....+++.+|+.+|++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999974 68999999997542 33456789999999999999999999998643 34
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
.++++||+.+|+|.+++.. +.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+|.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 5677888899999999832 35899999999999999999999988 9999999999999999999999999998
Q ss_pred eecC
Q 005718 665 MFCG 668 (681)
Q Consensus 665 ~~~~ 668 (681)
....
T Consensus 170 ~~~~ 173 (348)
T d2gfsa1 170 HTDD 173 (348)
T ss_dssp CCTG
T ss_pred ccCc
Confidence 7643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=2.5e-24 Score=227.31 Aligned_cols=146 Identities=28% Similarity=0.373 Sum_probs=121.0
Q ss_pred CCCCceeeecccCcEeEEEEEec-CCcEEEEEEecCC--CcccHHHHHHHHHHHhhCCCCCeeEEEEEEEe------CCe
Q 005718 514 ENFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAKLQHRNLVRLMGCCVE------QGE 584 (681)
Q Consensus 514 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------~~~ 584 (681)
++|++.++||+|+||+||+|.+. +++.||||++... .....+++.+|+.++++++||||+++++++.. ..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999985 5899999999754 23345678999999999999999999999964 368
Q ss_pred EEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 585 KILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 585 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
.++||||+.++.+.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999776554332 24789999999999999999999998 9999999999999999999999999998
Q ss_pred eecC
Q 005718 665 MFCG 668 (681)
Q Consensus 665 ~~~~ 668 (681)
....
T Consensus 168 ~~~~ 171 (355)
T d2b1pa1 168 TAGT 171 (355)
T ss_dssp ----
T ss_pred cccc
Confidence 7654
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.87 E-value=4.3e-22 Score=172.85 Aligned_cols=112 Identities=23% Similarity=0.411 Sum_probs=95.1
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEEeeCCCCCCcEEEEEEEeCCCCceEEEccCCCCCcCCcceEEEeeCCcEEEEeCC
Q 005718 25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT 104 (681)
Q Consensus 25 ~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~l~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (681)
+|+|.+||.|.+|+.|+ +|.|.|.|+.+|+ |.+ |. ..++||.||++.|. .++.|.|+.||+|+|++.
T Consensus 1 tDtL~~gq~L~~g~~l~--~g~~~l~~q~DGN-----Lvl-y~--~~~~vW~s~~~~~~--~~~~l~l~~dGnLvl~~~- 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLA--EGGYLFIIQNDCN-----LVL-YD--NNRAVWASGTNGKA--SGCVLKMQNDGNLVIYSG- 67 (112)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EE--TTEEEEECCCTTSC--SSEEEEECTTSCEEEEET-
T ss_pred CCEecCCCEecCCCEEE--ECCEEEEEcCCCC-----EEE-Ec--CCcEEEEccCccCC--CCcEEEEeccccEEEEec-
Confidence 48999999999999997 5899999999887 444 44 35899999999873 457899999999999997
Q ss_pred CcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCCc
Q 005718 105 DGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSD 155 (681)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~PtD 155 (681)
+.++|++++.+......|+|+|+||||||+.+ +.++|||+.+|++
T Consensus 68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~------~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS------NNAIWATHTNVGN 112 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTT------SCEEEECCCCCCC
T ss_pred CCeEEEEeeccCCCceEEEEcCCCCEEEECCC------CcEEecCCCccCC
Confidence 56788888776556789999999999999864 6789999999986
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.86 E-value=5.6e-22 Score=170.46 Aligned_cols=107 Identities=22% Similarity=0.353 Sum_probs=92.3
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEEeeCCCCCCcEEEEEEEeCCCCceEEEccCCCCCcCCcceEEEeeCCcEEEEeCC
Q 005718 25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT 104 (681)
Q Consensus 25 ~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~l~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (681)
+|+|.+|+.|.+|++|. +|.|.|.|+.+|+ |.|+ . ..++||.||++.| +..+.|.|+.||+|+|++++
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly-~--~~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl~~~~ 68 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLY-D--VDKPIWATNTGGL--SRSCFLSMQTDGNLVVYNPS 68 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEE-E--TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEE-e--CCceeeEeCCCCC--CCccEEEEeccceEEEECCC
Confidence 47899999999999994 6999999999987 4454 3 3588999999988 44578999999999999999
Q ss_pred CcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccC
Q 005718 105 DGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDC 152 (681)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~ 152 (681)
+.+||++++.+......|+|+||||||||+. ++||||+|
T Consensus 69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---------~~W~S~t~ 107 (108)
T d1jpca_ 69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGT---------DRWATGTH 107 (108)
T ss_dssp CCEEEECCCCCSCSCEEEEECTTSCEEEEEC---------CCCCCCCC
T ss_pred ccceEEccccCCCCcEEEEEcCCCCEEEeCC---------CcccCCCC
Confidence 9999999987655567899999999999964 49999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.85 E-value=3.1e-21 Score=165.83 Aligned_cols=108 Identities=20% Similarity=0.332 Sum_probs=92.0
Q ss_pred ccccCCCCccCCCCEEEeCCCeEEEEeeCCCCCCcEEEEEEEeCCCCceEEEccCCCCCcCCcceEEEeeCCcEEEEeCC
Q 005718 25 TDTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQT 104 (681)
Q Consensus 25 ~~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~l~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (681)
.|+|.+|+.|.+|+.|. +|.|.|+|+.+++ | +.|. ..++||+||++.|+. ..+.|.|+.||+|||+|.+
T Consensus 1 ~~~L~~g~~L~~g~~l~--~g~~~l~~q~dgn-----L-vl~~--~~~~vW~ant~~~~~-~~~~l~l~~dGnLvl~~~~ 69 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSLD--VEPYHFIMQEDCN-----L-VLYD--HSTSVWASNTGILGK-KGCKAVLQSDGNFVVYDAE 69 (109)
T ss_dssp CCEEETTCEEETTCEEE--ETTEEEEECTTSC-----E-EEEE--TTEEEEECCCCCTTC-CCCEEEECTTSCEEEECSS
T ss_pred CCCccCCCEEeCCCEEE--eCCEEEEecCCCe-----E-EEEe--CCEEEEEeCCCCCCc-eeEEEEEcCCceEEEEeCC
Confidence 37899999999999996 5889999998887 3 3444 358899999999865 4588999999999999999
Q ss_pred CcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccC
Q 005718 105 DGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDC 152 (681)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~ 152 (681)
+.+||+|++......+.|+|+||||||||+. ++|||+-|
T Consensus 70 g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---------~~W~S~t~ 108 (109)
T d1kj1a_ 70 GRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---------DIWSTGTY 108 (109)
T ss_dssp SCEEEECCCCCCSSCCEEEECTTSCEEEECC---------EEEECCCC
T ss_pred CcEEEEEeeECCCCCEEEEEeCCCcEEEECC---------CEecCCCc
Confidence 9999999987555677899999999999953 59999865
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=4.1e-21 Score=183.91 Aligned_cols=133 Identities=19% Similarity=0.203 Sum_probs=105.8
Q ss_pred CceeeecccCcEeEEEEEecCCcEEEEEEecCCCc------------------ccHHHHHHHHHHHhhCCCCCeeEEEEE
Q 005718 517 SMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSG------------------QGLKEFKNEMMLIAKLQHRNLVRLMGC 578 (681)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~------------------~~~~~f~~Ei~~l~~l~H~nIv~l~g~ 578 (681)
.+.++||+|+||.||+|...+|+.||||+++.... .....+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 46789999999999999998899999998753210 012345678889999999999988765
Q ss_pred EEeCCeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecccCCCcEEEcCCCCeEEe
Q 005718 579 CVEQGEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYSRLRIIHRDLKASNILLDSDMNPKIS 658 (681)
Q Consensus 579 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDlkp~NiLl~~~~~~kl~ 658 (681)
. . .+++|||+++..+..+ +......++.|++++|+|||+.+ |+||||||+|||++++ .++|+
T Consensus 83 ~--~--~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E--G--NAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E--T--TEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c--C--CEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 2 2 3799999988665432 22334578999999999999987 9999999999999865 58999
Q ss_pred ecCCceeec
Q 005718 659 DFGMARMFC 667 (681)
Q Consensus 659 DFGla~~~~ 667 (681)
|||+|+...
T Consensus 145 DFG~a~~~~ 153 (191)
T d1zara2 145 DFPQSVEVG 153 (191)
T ss_dssp CCTTCEETT
T ss_pred ECCCcccCC
Confidence 999998774
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.82 E-value=1.7e-20 Score=197.99 Aligned_cols=151 Identities=21% Similarity=0.298 Sum_probs=120.2
Q ss_pred CCCceeeecccCcEeEEEEEec-CCcEEEEEEecCCCcccHHHHHHHHHHHhhCC-----------CCCeeEEEEEEEeC
Q 005718 515 NFSMQCKLGEGGFGPVYKGKLL-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-----------HRNLVRLMGCCVEQ 582 (681)
Q Consensus 515 ~f~~~~~LG~G~fG~Vy~~~~~-~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----------H~nIv~l~g~~~~~ 582 (681)
+|+++++||+|+||+||+|+.. +++.||||++++. ....+.+.+|+.++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 5999999999999999999974 6899999999864 334567788999888875 57899999887643
Q ss_pred --CeEEEEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecccCCCcEEEcCCCC-----
Q 005718 583 --GEKILIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMN----- 654 (681)
Q Consensus 583 --~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NiLl~~~~~----- 654 (681)
...+++++++..+..............+++..+..++.||++||+|||+ .+ |+||||||+||||+.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence 5667777777665443333223344567889999999999999999998 54 999999999999986653
Q ss_pred -eEEeecCCceeecCC
Q 005718 655 -PKISDFGMARMFCGD 669 (681)
Q Consensus 655 -~kl~DFGla~~~~~~ 669 (681)
+||+|||.|+.....
T Consensus 170 ~~kl~dfg~s~~~~~~ 185 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH 185 (362)
T ss_dssp EEEECCCTTCEETTBC
T ss_pred eeeEeecccccccccc
Confidence 999999999876543
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.69 E-value=7.2e-17 Score=140.05 Aligned_cols=103 Identities=15% Similarity=0.365 Sum_probs=83.2
Q ss_pred cccCCCCccCCCCEEEeCCCeEEEEeeCCCCCCcEEEEEEEeCCCCceEEEccCCCCCcCCcceEEEeeCCcEEEEeCCC
Q 005718 26 DTITPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTD 105 (681)
Q Consensus 26 ~~l~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~l~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~ 105 (681)
++|.+||+| .+.+.+|.|.|.|+.+|| | +.|. ..++||.+|+..+ +..+.|.|+.||+|+|+|.++
T Consensus 15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----L-VLy~--~~~~vWssnt~~~--~~~~~l~l~~dGnLvL~d~~g 80 (119)
T d1b2pa_ 15 QILHATESL----EILFGTHVYRFIMQTDCN-----L-VLYD--NNNPIWATNTGGL--GNGCRAVLQPDGVLVVITNEN 80 (119)
T ss_dssp CEEETTCEE----EEEETTEEEEEEECTTSC-----E-EEEE--TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTTC
T ss_pred CEEeCCCeE----EEecCCceEEEEECCCCc-----E-EEEE--CCeEEEEecCCCC--CcceEEEEEeCCCEEEECCCC
Confidence 445555554 246679999999999998 3 4455 4688999999877 345789999999999999999
Q ss_pred cEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeecc
Q 005718 106 GIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFD 151 (681)
Q Consensus 106 ~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd 151 (681)
.+||++++.+......|+|+||||||||+. ++|||-.
T Consensus 81 ~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg~---------~~W~S~T 117 (119)
T d1b2pa_ 81 VTVWQSPVAGKAGHYVLVLQPDRNVVIYGD---------ALWATQT 117 (119)
T ss_dssp CEEEECSCCCCSSCEEEEECTTSCEEEEES---------EEEECCC
T ss_pred cEEEECCCcCCCCceEEEEcCCCCEEEECC---------CEeccCC
Confidence 999999987655667899999999999953 6999854
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.67 E-value=3.7e-17 Score=142.33 Aligned_cols=102 Identities=22% Similarity=0.277 Sum_probs=86.4
Q ss_pred EEEEeC-CCCceEEEccCCCCCcCCcceEEEeeCCcEEEEeCCCcEEEeecCccccCCceEEEecCCCEEEeecCCCCCC
Q 005718 63 GIWYKQ-VPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTS 141 (681)
Q Consensus 63 ~i~~~~-~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~ 141 (681)
.|||.. +.++.+|++|+++|+....-+|.++.||||+|++. +.++|++++.+......|.|+++|||||++.+
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~----- 84 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQ----- 84 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETT-----
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCC-----
Confidence 488987 77899999999999987777899999999999986 67899999876556678999999999999874
Q ss_pred CCceeeeeccCCCccccCCccccceeccCceeEEEEeccCCCCCCcceEEEeecCCccEEE
Q 005718 142 EGSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLC 202 (681)
Q Consensus 142 ~~~~~wqSFd~PtDtlLpgq~l~~~~~~g~~~~l~S~~s~~dps~G~y~~~~~~~g~~~~~ 202 (681)
+.++||||. +.++|.|.|.||++|.+.++
T Consensus 85 -~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 85 -NIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp -TEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred -CCEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEEe
Confidence 789999973 23568899999999998664
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.59 E-value=3.7e-16 Score=134.49 Aligned_cols=109 Identities=23% Similarity=0.265 Sum_probs=88.9
Q ss_pred EEEeC-CCCceEEEccCCCCCcCCcceEEEeeCCcEEEEeCCCcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCC
Q 005718 64 IWYKQ-VPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSE 142 (681)
Q Consensus 64 i~~~~-~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~ 142 (681)
|||.- ...+..|+.+.++++....-+|.|+.||||||++. +.++|++++.+ ..+..|.|+++|||||++..
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~~~vW~s~t~~-~~~~~l~l~~dGNLvl~d~~------ 74 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAG-ATGCRAVLQSDGLLVILTAQ------ 74 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEES-SSEEECCCCCS-CSCCBCCBCSSSCBCCBCTT------
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEcC-CeeEEEcccCC-CCceEEEEeccCCEEEEccC------
Confidence 56654 45567789999999987777899999999999985 67999999875 46788999999999999864
Q ss_pred CceeeeeccCCCccccCCccccceeccCceeEEEEeccCCCCCCcceEEEeecCCccEEEEEcCCeEEEeeCC
Q 005718 143 GSYLWQSFDCPSDTLLIGMNMGWDLKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP 215 (681)
Q Consensus 143 ~~~~wqSFd~PtDtlLpgq~l~~~~~~g~~~~l~S~~s~~dps~G~y~~~~~~~g~~~~~~~~~~~~~w~sg~ 215 (681)
+.+||||+. +.++|.|.|.|+++|.+.+ |. ..+|.+|.
T Consensus 75 ~~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlvl--Y~--~~~Wssgt 112 (115)
T d1dlpa1 75 NTIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVTI--YG--PGLWDSGT 112 (115)
T ss_dssp TCCSCCCCC-------------------------------CCCSSCCEEEECSSSCEEE--EC--SEEEECSC
T ss_pred CCEEEEcCC-------------------------------CCCCCCEEEEECCCCcEEE--eC--CCeecCCC
Confidence 678999863 3457999999999999755 43 37899875
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.52 E-value=6.3e-15 Score=126.68 Aligned_cols=100 Identities=22% Similarity=0.354 Sum_probs=80.4
Q ss_pred CCCCccCCCCEEEeCCCeEEEEeeCCCCCCcEEEEEEEeCCCCceEEEccCCCCCcCCcceEEEeeCCcEEEEeCCCcEE
Q 005718 29 TPATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGII 108 (681)
Q Consensus 29 ~~g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~l~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~ 108 (681)
+..|+|.+++.| .+|.|.|.|+.+|+ |.+ |. ...+||.+|+..+ ..+.+.|+.||+|||+|.++.+|
T Consensus 12 ~~~~tl~~~~~l--~~g~~~l~~q~DGN-----LvL-~~--~~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~v 78 (115)
T d1dlpa1 12 SHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVL-FD--SDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIR 78 (115)
T ss_dssp CSCSCCCTTCEE--CSTTEEEEECTTSC-----EEE-EE--SSSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCS
T ss_pred CCcceecCCCcE--EcCCEEEEECCCCe-----EEE-Ec--CCeeEEEcccCCC---CceEEEEeccCCEEEEccCCCEE
Confidence 334666666666 67889999999987 444 44 3578999997653 35789999999999999999999
Q ss_pred EeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeec
Q 005718 109 WSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSF 150 (681)
Q Consensus 109 w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSF 150 (681)
|++.+........++|++|||||||+. ++|+|-
T Consensus 79 WsS~t~~~~g~y~l~Lq~DGNlvlY~~---------~~Wssg 111 (115)
T d1dlpa1 79 WSSGTKGSIGNYVLVLQPDRTVTIYGP---------GLWDSG 111 (115)
T ss_dssp CCCCCCCCSSCCEEEECSSSCEEEECS---------EEEECS
T ss_pred EEcCCCCCCCCEEEEECCCCcEEEeCC---------CeecCC
Confidence 999987656677899999999999942 699984
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.36 E-value=9.5e-13 Score=114.04 Aligned_cols=98 Identities=20% Similarity=0.342 Sum_probs=76.0
Q ss_pred CCccCCCCEEEeCCCeEEEEeeCCCCCCcEEEEEEEeCCCCceEEEccCCCCCcCCcceEEEeeCCcEEEEeCCCcEEEe
Q 005718 31 ATLIGDGEKLVSSSQIFELGFFSPGKSKYKYLGIWYKQVPDTVVWVANRNSPIVDSNAVLTIGNNGNLVLLNQTDGIIWS 110 (681)
Q Consensus 31 g~~l~~~~~l~S~~g~f~~gf~~~~~~~~~~l~i~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~ 110 (681)
.+.|.+++.| ..|.|.|.|+.+|+ |.+ |. ...+||.++.... +..+.+.|+.+|||||+|.++.++|+
T Consensus 23 ~~~l~~~q~l--~~g~y~L~~q~DGN-----LvL-~~--~~~~vW~s~t~~~--~~~~~~~l~~~GnLvl~d~~~~~lW~ 90 (120)
T d1dlpa2 23 PQTLHATQSL--QLSPYRLSMETDCN-----LVL-FD--RDDRVWSTNTAGK--GTGCRAVLQPNGRMDVLTNQNIAVWT 90 (120)
T ss_dssp CCEECSSCCC--BCSSCEEEEETTTE-----EEE-EB--TTBCCSCCCCCSS--CSSCEEEEETTTEEEEEETTTEEEEE
T ss_pred ccEEcCCCee--EcCCEEEEEcCCCc-----EEE-ec--CCcEEEEEccccC--CCcEEEEEeCCeeEEEEcCCCCEEEE
Confidence 3445555555 46779999998886 433 44 3578999986543 45578999999999999999999999
Q ss_pred ecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeee
Q 005718 111 SNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQS 149 (681)
Q Consensus 111 ~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqS 149 (681)
+++.+......++|++|||||||+. ++|.|
T Consensus 91 S~t~~~~~~~~l~Lq~DGnlvlY~~---------~~W~t 120 (120)
T d1dlpa2 91 SGNSRSAGRYVFVLQPDRNLAIYGG---------ALWTT 120 (120)
T ss_dssp CCCCCSSSCCEEEECSSSCEEEECC---------CCCBC
T ss_pred eCCCCCCCcEEEEECCCCcEEEeCC---------CcccC
Confidence 9987656677899999999999943 58976
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.12 E-value=1.6e-10 Score=99.44 Aligned_cols=85 Identities=22% Similarity=0.246 Sum_probs=67.6
Q ss_pred eEEEeeCCcEEEEeCCCcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCCccccCCccccceec
Q 005718 89 VLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDLK 168 (681)
Q Consensus 89 ~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~PtDtlLpgq~l~~~~~ 168 (681)
.|.++.||||||++. +.++|++++.+......+.|+++|||||++.+ +.++|+|.
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~------g~~vWsS~------------------ 87 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE------NVTVWQSP------------------ 87 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT------CCEEEECS------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCC------CcEEEECC------------------
Confidence 689999999999876 56899999876555789999999999999864 77899852
Q ss_pred cCceeEEEEeccCCCCCCcceEEEeecCCccEEEEEcCCeEEEeeCC
Q 005718 169 TGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGP 215 (681)
Q Consensus 169 ~g~~~~l~S~~s~~dps~G~y~~~~~~~g~~~~~~~~~~~~~w~sg~ 215 (681)
..-+.|.|.+.|+++|.+.++ . ...|.++.
T Consensus 88 -------------t~~~~~~~~l~Lq~DGNlvlY--g--~~~W~S~T 117 (119)
T d1b2pa_ 88 -------------VAGKAGHYVLVLQPDRNVVIY--G--DALWATQT 117 (119)
T ss_dssp -------------CCCCSSCEEEEECTTSCEEEE--E--SEEEECCC
T ss_pred -------------CcCCCCceEEEEcCCCCEEEE--C--CCEeccCC
Confidence 111346799999999998764 3 36888775
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.08 E-value=2e-10 Score=97.39 Aligned_cols=85 Identities=24% Similarity=0.330 Sum_probs=66.0
Q ss_pred ceEEEeeCCcEEEEeCCCcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCCccccCCcccccee
Q 005718 88 AVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDL 167 (681)
Q Consensus 88 ~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~PtDtlLpgq~l~~~~ 167 (681)
-+|.++.||||||++. +.+||++++.+......+.|+++|||||++.+ +.++|+|
T Consensus 21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~------g~~vWsS------------------ 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNPS------NKPIWAS------------------ 75 (108)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT------CCEEEEC------------------
T ss_pred EEEEECCCCeEEEEeC-CceeeEeCCCCCCCccEEEEeccceEEEECCC------ccceEEc------------------
Confidence 5799999999999885 57999999876555678999999999999874 7899986
Q ss_pred ccCceeEEEEeccCCCCCCcceEEEeecCCccEEEEEcCCeEEEeeC
Q 005718 168 KTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTG 214 (681)
Q Consensus 168 ~~g~~~~l~S~~s~~dps~G~y~~~~~~~g~~~~~~~~~~~~~w~sg 214 (681)
......+.|.+.|+++|++.++ .. ..|.++
T Consensus 76 -------------~t~~~~~~~~l~L~ddGNlVly--~~--~~W~S~ 105 (108)
T d1jpca_ 76 -------------NTGGQNGNYVCILQKDRNVVIY--GT--DRWATG 105 (108)
T ss_dssp -------------CCCCSCSCEEEEECTTSCEEEE--EC--CCCCCC
T ss_pred -------------cccCCCCcEEEEEcCCCCEEEe--CC--CcccCC
Confidence 1112346789999999998664 32 356554
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.01 E-value=1.1e-09 Score=92.62 Aligned_cols=87 Identities=26% Similarity=0.388 Sum_probs=66.9
Q ss_pred ceEEEeeCCcEEEEeCCCcEEEeecCccc-cCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCCccccCCccccce
Q 005718 88 AVLTIGNNGNLVLLNQTDGIIWSSNLSRE-VKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWD 166 (681)
Q Consensus 88 ~~l~~~~~g~l~l~~~~~~~~w~~~~~~~-~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~PtDtlLpgq~l~~~ 166 (681)
-.|.|+.||||||+.. +.+||++++... .....+.|+++|||||++.+ +.++|+|
T Consensus 21 ~~l~~q~dgnLvl~~~-~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~------g~~vW~s----------------- 76 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYDH-STSVWASNTGILGKKGCKAVLQSDGNFVVYDAE------GRSLWAS----------------- 76 (109)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCCCEEEECTTSCEEEECSS------SCEEEEC-----------------
T ss_pred EEEEecCCCeEEEEeC-CEEEEEeCCCCCCceeEEEEEcCCceEEEEeCC------CcEEEEE-----------------
Confidence 5789999999999874 679999988642 34578999999999999864 7889986
Q ss_pred eccCceeEEEEeccCCCCCCcceEEEeecCCccEEEEEcCCeEEEeeCCC
Q 005718 167 LKTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNGSVKLSCTGPW 216 (681)
Q Consensus 167 ~~~g~~~~l~S~~s~~dps~G~y~~~~~~~g~~~~~~~~~~~~~w~sg~w 216 (681)
......|.|.+.|+++|++.+ ++ ...|.++.+
T Consensus 77 --------------~t~~~~~~~~l~L~ddGNlvl--y~--~~~W~S~t~ 108 (109)
T d1kj1a_ 77 --------------HSVRGNGNYVLVLQEDGNVVI--YG--SDIWSTGTY 108 (109)
T ss_dssp --------------CCCCCSSCCEEEECTTSCEEE--EC--CEEEECCCC
T ss_pred --------------eeECCCCCEEEEEeCCCcEEE--EC--CCEecCCCc
Confidence 011134678999999999865 44 368887754
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.81 E-value=1.7e-08 Score=85.82 Aligned_cols=87 Identities=23% Similarity=0.412 Sum_probs=66.4
Q ss_pred ceEEEeeCCcEEEEeCCCcEEEeecCccccCCceEEEecCCCEEEeecCCCCCCCCceeeeeccCCCccccCCcccccee
Q 005718 88 AVLTIGNNGNLVLLNQTDGIIWSSNLSREVKNPVAQLLDTGNLVLREKFSSNTSEGSYLWQSFDCPSDTLLIGMNMGWDL 167 (681)
Q Consensus 88 ~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~~~gnlvl~~~~~~~~~~~~~~wqSFd~PtDtlLpgq~l~~~~ 167 (681)
-.|.|+.||||||++. +.+||++++.+....+.+.|+.+|||||++. +.++|.|
T Consensus 21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~-------~~~~w~s------------------ 74 (112)
T d1xd5a_ 21 YLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYSG-------SRAIWAS------------------ 74 (112)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEET-------TEEEEEC------------------
T ss_pred EEEEEcCCCCEEEEcC-CcEEEEccCccCCCCcEEEEeccccEEEEec-------CCeEEEE------------------
Confidence 5799999999999874 6799999877555567899999999999984 3456654
Q ss_pred ccCceeEEEEeccCCCCCCcceEEEeecCCccEEEEEcC-CeEEEeeCC
Q 005718 168 KTGRERYLTSWRTADDPSPGNFTFRLEIRVLPHLCIYNG-SVKLSCTGP 215 (681)
Q Consensus 168 ~~g~~~~l~S~~s~~dps~G~y~~~~~~~g~~~~~~~~~-~~~~w~sg~ 215 (681)
...-..|.|.+.|+.+|.+.+ ++. ....|.++.
T Consensus 75 -------------~t~~~~~~~~l~L~ddGNlvl--y~~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 -------------NTNRQNGNYYLILQRDRNVVI--YDNSNNAIWATHT 108 (112)
T ss_dssp -------------CCCCSCCCCEEEECTTSCEEE--ECTTSCEEEECCC
T ss_pred -------------eeccCCCceEEEEcCCCCEEE--ECCCCcEEecCCC
Confidence 111234678999999999866 443 457898765
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.51 E-value=2.6e-07 Score=90.72 Aligned_cols=149 Identities=18% Similarity=0.118 Sum_probs=102.0
Q ss_pred HHHHhhCCCCceeeecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhC-CCCCeeEEEEEEEeCCeEE
Q 005718 508 SVSAATENFSMQCKLGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL-QHRNLVRLMGCCVEQGEKI 586 (681)
Q Consensus 508 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 586 (681)
++......|+..+..+.++...||+... +++.+.+|+...........+.+|...+..+ .+--+.+++.+..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3444456677655544445578998875 4556778887654444445677888887766 3555788888888899999
Q ss_pred EEEEecCCCChhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 005718 587 LIYEYMPNKSLNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLHQYS--------------------------------- 633 (681)
Q Consensus 587 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--------------------------------- 633 (681)
+|||++++..+....... .....++.++++.|+.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999998886554211 112234555555666666321
Q ss_pred -----------------------CCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 634 -----------------------RLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 634 -----------------------~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
...++|+|+.|.|||++++..+.|.||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999877678999998875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.90 E-value=2.5e-05 Score=75.59 Aligned_cols=132 Identities=19% Similarity=0.187 Sum_probs=86.8
Q ss_pred eeecccC-cEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhC--CCCCeeEEEEEEEeCCeEEEEEEecCCCC
Q 005718 520 CKLGEGG-FGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKL--QHRNLVRLMGCCVEQGEKILIYEYMPNKS 596 (681)
Q Consensus 520 ~~LG~G~-fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l--~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 596 (681)
+.+..|. -..||+....++..+.+|...... ...+..|...++.+ ....+.+++++..+++..++|||++++..
T Consensus 16 ~~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp EECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EEcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 3455554 367999998788888889776543 23456677777666 33457788888888889999999998866
Q ss_pred hhhHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH----------------------------------------------
Q 005718 597 LNFFLFDPSRTHLLGWQTRVKIIEGIAQGLLYLH---------------------------------------------- 630 (681)
Q Consensus 597 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH---------------------------------------------- 630 (681)
+.+.. ... ...+.++++.|+-||
T Consensus 93 ~~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 93 LLSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred ccccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 53211 000 011122222223332
Q ss_pred -----hC----CCCCeeecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 631 -----QY----SRLRIIHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 631 -----~~----~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
.. ....++|+|+.|.|||++++..+.|+||+.+..
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 21 112379999999999999877778999998875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.25 E-value=0.00036 Score=72.00 Aligned_cols=76 Identities=11% Similarity=0.146 Sum_probs=49.3
Q ss_pred eeeecccCcEeEEEEEecC-CcEEEEEEecCC-------CcccHHHHHHHHHHHhhC-CC--CCeeEEEEEEEeCCeEEE
Q 005718 519 QCKLGEGGFGPVYKGKLLN-GQEVAVKRLSSQ-------SGQGLKEFKNEMMLIAKL-QH--RNLVRLMGCCVEQGEKIL 587 (681)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~-~~~VAVK~l~~~-------~~~~~~~f~~Ei~~l~~l-~H--~nIv~l~g~~~~~~~~~l 587 (681)
.+.||.|..-.||+....+ ++.+.||.-.+. -.....+...|.+.|..+ .+ ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3679999999999998754 678888854321 112334556677777665 33 346666654 5556689
Q ss_pred EEEecCCCC
Q 005718 588 IYEYMPNKS 596 (681)
Q Consensus 588 V~Ey~~~gs 596 (681)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.67 E-value=0.0054 Score=61.01 Aligned_cols=135 Identities=14% Similarity=0.140 Sum_probs=78.9
Q ss_pred EeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCCe--eEEE-----EEEEeCCeEEEEEEecCCCChhh-
Q 005718 528 GPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRNL--VRLM-----GCCVEQGEKILIYEYMPNKSLNF- 599 (681)
Q Consensus 528 G~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI--v~l~-----g~~~~~~~~~lV~Ey~~~gsL~~- 599 (681)
=.||+....+|+.+++|+.++. ....+++..|+..+..|....+ +..+ ......+..+.+++++++..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 3699999999999999988764 3456778888888877743222 2111 11234667889999998644321
Q ss_pred ---Hh--------------cC--CCCCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----CCCCCe
Q 005718 600 ---FL--------------FD--PSRTHLLGWQ-------------------TRVKIIEGIAQGLLYLHQ----YSRLRI 637 (681)
Q Consensus 600 ---~l--------------~~--~~~~~~l~~~-------------------~~~~i~~~ia~~L~yLH~----~~~~~i 637 (681)
.+ .. .......++. .+-.+...+.+.++.+.. ..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 00 00 0111111111 111122222333333332 223468
Q ss_pred eecccCCCcEEEcCCCCeEEeecCCcee
Q 005718 638 IHRDLKASNILLDSDMNPKISDFGMARM 665 (681)
Q Consensus 638 vHrDlkp~NiLl~~~~~~kl~DFGla~~ 665 (681)
||+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999743 56899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.57 E-value=0.011 Score=60.45 Aligned_cols=72 Identities=15% Similarity=0.200 Sum_probs=47.0
Q ss_pred eeecccCcEeEEEEEecCC--------cEEEEEEecCCCcccHHHHHHHHHHHhhCC-CCCeeEEEEEEEeCCeEEEEEE
Q 005718 520 CKLGEGGFGPVYKGKLLNG--------QEVAVKRLSSQSGQGLKEFKNEMMLIAKLQ-HRNLVRLMGCCVEQGEKILIYE 590 (681)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~--------~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E 590 (681)
+.|+.|-.=.+|+....++ +.|.+++.- . ........+|..+++.+. +.=..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 6788787888999987542 345555543 2 223345567888888874 3334577777643 58899
Q ss_pred ecCCCCh
Q 005718 591 YMPNKSL 597 (681)
Q Consensus 591 y~~~gsL 597 (681)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.88 E-value=0.12 Score=50.24 Aligned_cols=157 Identities=13% Similarity=0.068 Sum_probs=79.8
Q ss_pred cHHHHHHhhCCCCceee-----ecccCcEeEEEEEecCCcEEEEEEecCCCcccHHHHHHHHHHHhhCCCCC--eeEEEE
Q 005718 505 SLASVSAATENFSMQCK-----LGEGGFGPVYKGKLLNGQEVAVKRLSSQSGQGLKEFKNEMMLIAKLQHRN--LVRLMG 577 (681)
Q Consensus 505 ~~~~~~~~~~~f~~~~~-----LG~G~fG~Vy~~~~~~~~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g 577 (681)
+..+++....+|.+.+. |..|--=+.|+....+++ +++|+..... ..+++..|+.++..+.+.+ +...+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 45666666777876433 445555678998886654 7788776532 2234445566666553222 221111
Q ss_pred ------EEEeCCeEEEEEEecCCCChhhHh--------------------cCCCCCCCCCH------------------H
Q 005718 578 ------CCVEQGEKILIYEYMPNKSLNFFL--------------------FDPSRTHLLGW------------------Q 613 (681)
Q Consensus 578 ------~~~~~~~~~lV~Ey~~~gsL~~~l--------------------~~~~~~~~l~~------------------~ 613 (681)
+.........++++..+......- +.......... .
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 112245566777777654332100 00000000000 0
Q ss_pred HHHHHHHHHHHHHHHHHh-CCCCCeeecccCCCcEEEcCCCCeEEeecCCce
Q 005718 614 TRVKIIEGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 664 (681)
Q Consensus 614 ~~~~i~~~ia~~L~yLH~-~~~~~ivHrDlkp~NiLl~~~~~~kl~DFGla~ 664 (681)
.....+..+...+.-.+. .-+.++||+|+.++||+++.+...-|.||+.|.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011112222222222221 223469999999999999988777899999875
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.65 E-value=0.026 Score=34.77 Aligned_cols=31 Identities=26% Similarity=0.647 Sum_probs=24.8
Q ss_pred CCCccccccCCCccccCC-CCCCCCccCCcccc
Q 005718 287 NFCQLYGYCGANSVCSVD-DTANCECLKGFKLK 318 (681)
Q Consensus 287 ~~C~~~g~CG~~g~C~~~-~~~~C~C~~Gf~~~ 318 (681)
|+|.+-+.||. |.|+.- ..-.|.|..||+|-
T Consensus 2 dECsignpCGn-GTCtNviGgFec~C~~GFepg 33 (39)
T d1emoa2 2 DECSVGNPCGN-GTCKNVIGGFECTCEEGFEPG 33 (39)
T ss_dssp CGGGTTCSSSS-SCEEECSSSEEECCSSSSCCC
T ss_pred CccccCCccCC-ceeeecccceEEeecCCcCCC
Confidence 68999999984 889643 34479999999874
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.10 E-value=0.098 Score=34.33 Aligned_cols=30 Identities=27% Similarity=0.745 Sum_probs=23.7
Q ss_pred CCCcc-ccccCCCccccCC-CCCCCCccCCcc
Q 005718 287 NFCQL-YGYCGANSVCSVD-DTANCECLKGFK 316 (681)
Q Consensus 287 ~~C~~-~g~CG~~g~C~~~-~~~~C~C~~Gf~ 316 (681)
|+|.. ...|..+|.|... ..-.|.|++||+
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence 57875 5789999999754 345899999995
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.11 E-value=0.19 Score=32.28 Aligned_cols=29 Identities=28% Similarity=0.779 Sum_probs=22.3
Q ss_pred CCCccccccCCCccccCC-CCCCCCccCCcc
Q 005718 287 NFCQLYGYCGANSVCSVD-DTANCECLKGFK 316 (681)
Q Consensus 287 ~~C~~~g~CG~~g~C~~~-~~~~C~C~~Gf~ 316 (681)
|+|. ...|...|.|... ..-.|.|++||+
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~ 30 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFE 30 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEE
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCC
Confidence 4565 5789999999754 355899999996
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.41 E-value=0.23 Score=31.90 Aligned_cols=29 Identities=24% Similarity=0.690 Sum_probs=22.0
Q ss_pred CCCccccccCCCccccCC-CCCCCCccCCcc
Q 005718 287 NFCQLYGYCGANSVCSVD-DTANCECLKGFK 316 (681)
Q Consensus 287 ~~C~~~g~CG~~g~C~~~-~~~~C~C~~Gf~ 316 (681)
|+|. +..|...|.|... +.-.|.|++||.
T Consensus 2 d~C~-~~PC~n~g~C~~~~~~y~C~C~~G~~ 31 (39)
T d2vj3a2 2 NECV-SNPCQNDATCLDQIGEFQCICMPGYE 31 (39)
T ss_dssp CTTT-TCCCCSSCEEEECSSCEEEECCTTEE
T ss_pred cCCc-CCCCCCCCEEECCCCCEEEeCCCCCc
Confidence 4563 4679999999754 345899999996
|